19076	HMR136_AA393717_1_tr0_r1_1_gPRT		Comparison report between AA393717_P1 and TDR4_HUMANunique   	Sequence name: TDR4_HUMAN                                    
						head followed by partial WT sequence a mismatch.1.An isolated	                                                            
						chimeric polypeptide encoding for AA393717_P1, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 19076 x TDR4_HUMAN   ..                        
						90% and most preferably at least 95% homologous to a         	                                                            
						RTRTRRLFQKKETAMAAEASKTGPSRSSYQRMGRKSQPWGAAEIQCTRCGRRVSRSSGHH 	Alignment segment 1/1:                                       
						CELQCGHAFCELCLLMTEECTTIICPDCEVATAVNTRQRYYPMAGYIKEDSIMEKLQPKT 	                                                            
						IKNCSQDFKKTADQLTTGLERSASTDKTLLNSSAVMLDTNTAEEIDEALNTAHHSFEQLS 	                     Quality: 6254.00                      Escore:       0                                               
						IAGKALEHMQKQTIEERERVIEVVEKQFDQLLAFFDSRKKNLCEEFARTTDDYLSNLIKA 	             Matching length:     633                Total length:     633                                               
						KSYIEEKKNNLNAAMNIARALQLSPSLRTYCDLNQIIRTLQLTSDSELAQVSSPQLRNPP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.84                                               
						RLSVNCSEIICMFNNMGKIEFRDSTKCYPQENEIRQNVQKKYNNKKELSCYDTYPPLEKK 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.84                                               
						KVDMSVLTSEAPPPPLQPETNDVHLEAKNFQPQKDVATASPKTIAVLPQMGSSPDVIIEE 	                        Gaps:       0                        
						IIEDNVETCGTDDLGETPRYPKKPLQKNSSVPFGSKAGSAELVFVSHVIDPCHFYIRKYS 	                                                            
						QIKDAKVLEKKVNEFCNRSSHLDPSDILELGARIFVSSIKNGMWCRGTITELIPIEGRNT 	Alignment:                                                   
						RKPCSPTRLFVHEVALIQIFMVDFGNSEVLIVTGVVDTHVRPEHSAKQHIALNDLCLVLR 	                  .         .         .         .         .  
						KSEPYTEGLLKDIQPLAQPCSLKDIVPQNSNEGWEEEAKVEFLKMVNNKAVSMKVFREED 	     993 MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLY 1042                                                         
						GVLIVDLQKPPPNKISSDMPVSLRDALVFMELAKFKSQSLRSHFEKNTTLHYHPPILPKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MTDVSVTVCHINSPGDFYLQLIEGLDILFLLKTIEEFYKSEDGENLEILCPVQDQACVAK 	       1 MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLY 50                                                           
						FEDGIWYRAKVIGLPGHQEVEVKYVDFGNTAKITIKDVRKIKDEFLNAPEKAIKCKLAYI 	                  .         .         .         .         .  
						EPYKRTMQWSKEAKEKFEEKAQDKFMTCSVIKILEDNVLLVELFDSLGAPEMTTTSINDQ 	    1043 DVGVELVVNVDCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACD 1092                                                         
						LVKEGLASYEIGYILKDNSQKHIEVWDPSPEEIISNEVHNLNPVSAKSLPNENFQSLYNK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ELPVHICNVISPEKIYVQWLLTENLLNSLEEK                             	      51 DVGVELVVNVDCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACD 100                                                          
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						1 - 992 of AA393717_P1, a second amino acid sequence being at	    1093 CLSLYLTGAVATIILQVDSEENNTTWPLPVKIFCRDEKGERVDVSKYLIK 1142                                                         
						MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLYDVGVELVVNV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACDCLSLYLTGAVATIILQVDSE 	     101 CLSLYLTGAVATIILQVDSEENNTTWPLPVKIFCRDEKGERVDVSKYLIK 150                                                          
						ENNTTWPLPVKIFCRDEKGERVDVSKYLIKKGLALRERRINNLDNSHSLSEKSLEVPLEQ 	                  .         .         .         .         .  
						EDSVVTNCIKTNFDPDKKTADIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVS 	    1143 KGLALRERRINNLDNSHSLSEKSLEVPLEQEDSVVTNCIKTNFDPDKKTA 1192                                                         
						CVGDDGTIFVVPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTPVGNVWQPDAI 	     151 KGLALRERRINNLDNSHSLSEKSLEVPLEQEDSVVTNCIKTNFDPDKKTA 200                                                          
						EVLQQLLSKRQVDIHIMKPRSDHDKKYEE                                	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 1 - 389	    1193 DIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVSCVGDDGTIFV 1242                                                         
						of TDR4_HUMAN, which also corresponds to amino acids 993 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1381 of AA393717_P1, a bridging amino acid E corresponding to	     201 DIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVSCVGDDGTIFV 250                                                          
						amino acid 1382 of AA393717_P1, and a third amino acid       	                  .         .         .         .         .  
						QWEIRFEELLSAETDTPLLPPYLSSSLPSPGELYAVQVKHVVSPNEVYICLDSIETSNQS 	    1243 VPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 1292                                                         
						NQHSDTDDSGVSGESESESLDEALQRVNKKVEALPPLTDFRTEMPCLAEYDDGLWYRAKI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VAIKEFNPLSILVQFVDYGSTAKLTLNRLCQIPSHLMRYPARAIKVLLAGFKPPLRDLGE 	     251 VPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 300                                                          
						TRIPYCPKWSMEALWAMIDCLQGKQLYAVSMAPAPEQIVTLYDDEQHPVHMPLVEMGLAD 	                  .         .         .         .         .  
						KDE                                                          	    1293 VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTP 1342                                                         
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 391 - 633 of TDR4_HUMAN, which also corresponds  	     301 VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTP 350                                                          
						to amino acids 1383 - 1625 of AA393717_P1, wherein said first	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence, bridging    	    1343 VGNVWQPDAIEVLQQLLSKRQVDIHIMKPRSDHDKKYEEEQWEIRFEELL 1392                                                         
						amino acid and third amino acid sequence are contiguous and  	         |||||||||||||||||||||||||||||||||||||||:||||||||||  
						in a sequential order.2.An isolated polypeptide encoding for 	     351 VGNVWQPDAIEVLQQLLSKRQVDIHIMKPRSDHDKKYEEKQWEIRFEELL 400                                                          
						a head of AA393717_P1, comprising a polypeptide being at     	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	    1393 SAETDTPLLPPYLSSSLPSPGELYAVQVKHVVSPNEVYICLDSIETSNQS 1442                                                         
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RTRTRRLFQKKETAMAAEASKTGPSRSSYQRMGRKSQPWGAAEIQCTRCGRRVSRSSGHH 	     401 SAETDTPLLPPYLSSSLPSPGELYAVQVKHVVSPNEVYICLDSIETSNQS 450                                                          
						CELQCGHAFCELCLLMTEECTTIICPDCEVATAVNTRQRYYPMAGYIKEDSIMEKLQPKT 	                  .         .         .         .         .  
						IKNCSQDFKKTADQLTTGLERSASTDKTLLNSSAVMLDTNTAEEIDEALNTAHHSFEQLS 	    1443 NQHSDTDDSGVSGESESESLDEALQRVNKKVEALPPLTDFRTEMPCLAEY 1492                                                         
						IAGKALEHMQKQTIEERERVIEVVEKQFDQLLAFFDSRKKNLCEEFARTTDDYLSNLIKA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KSYIEEKKNNLNAAMNIARALQLSPSLRTYCDLNQIIRTLQLTSDSELAQVSSPQLRNPP 	     451 NQHSDTDDSGVSGESESESLDEALQRVNKKVEALPPLTDFRTEMPCLAEY 500                                                          
						RLSVNCSEIICMFNNMGKIEFRDSTKCYPQENEIRQNVQKKYNNKKELSCYDTYPPLEKK 	                  .         .         .         .         .  
						KVDMSVLTSEAPPPPLQPETNDVHLEAKNFQPQKDVATASPKTIAVLPQMGSSPDVIIEE 	    1493 DDGLWYRAKIVAIKEFNPLSILVQFVDYGSTAKLTLNRLCQIPSHLMRYP 1542                                                         
						IIEDNVETCGTDDLGETPRYPKKPLQKNSSVPFGSKAGSAELVFVSHVIDPCHFYIRKYS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QIKDAKVLEKKVNEFCNRSSHLDPSDILELGARIFVSSIKNGMWCRGTITELIPIEGRNT 	     501 DDGLWYRAKIVAIKEFNPLSILVQFVDYGSTAKLTLNRLCQIPSHLMRYP 550                                                          
						RKPCSPTRLFVHEVALIQIFMVDFGNSEVLIVTGVVDTHVRPEHSAKQHIALNDLCLVLR 	                  .         .         .         .         .  
						KSEPYTEGLLKDIQPLAQPCSLKDIVPQNSNEGWEEEAKVEFLKMVNNKAVSMKVFREED 	    1543 ARAIKVLLAGFKPPLRDLGETRIPYCPKWSMEALWAMIDCLQGKQLYAVS 1592                                                         
						GVLIVDLQKPPPNKISSDMPVSLRDALVFMELAKFKSQSLRSHFEKNTTLHYHPPILPKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MTDVSVTVCHINSPGDFYLQLIEGLDILFLLKTIEEFYKSEDGENLEILCPVQDQACVAK 	     551 ARAIKVLLAGFKPPLRDLGETRIPYCPKWSMEALWAMIDCLQGKQLYAVS 600                                                          
						FEDGIWYRAKVIGLPGHQEVEVKYVDFGNTAKITIKDVRKIKDEFLNAPEKAIKCKLAYI 	                  .         .         .                      
						EPYKRTMQWSKEAKEKFEEKAQDKFMTCSVIKILEDNVLLVELFDSLGAPEMTTTSINDQ 	    1593 MAPAPEQIVTLYDDEQHPVHMPLVEMGLADKDE                  1625                                                         
						LVKEGLASYEIGYILKDNSQKHIEVWDPSPEEIISNEVHNLNPVSAKSLPNENFQSLYNK 	         |||||||||||||||||||||||||||||||||                   
						ELPVHICNVISPEKIYVQWLLTENLLNSLEEK                             	     601 MAPAPEQIVTLYDDEQHPVHMPLVEMGLADKDE                  633                                                          
						preferably at least about 95% homologous to the sequence of  	                                                            
						AA393717_P1.                                                 	                                                            

19074	HMR136_AA393717_2_tr0_r1_1_gPRT		Comparison report between AA393717_P2 and TDR4_HUMANunique   	Sequence name: TDR4_HUMAN                                    
						head followed by partial WT sequence a mismatch.1.An isolated	                                                            
						chimeric polypeptide encoding for AA393717_P2, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 19074 x TDR4_HUMAN   ..                        
						90% and most preferably at least 95% homologous to a         	                                                            
						SGLALGGCSRRKRQRWRQRLRRLGLLGLPTSEWGGRVSPGVPLKSSAPGHHCELQCGHAF 	Alignment segment 1/1:                                       
						CELCLLMTEECTTIICPDCEVATAVNTRQRYYPMAGYIKEDSIMEKLQPKTIKNCSQDFK 	                                                            
						KTADQLTTGLERSASTDKTLLNSSAVMLDTNTAEEIDEALNTAHHSFEQLSIAGKALEHM 	                     Quality: 6254.00                      Escore:       0                                               
						QKQTIEERERVIEVVEKQFDQLLAFFDSRKKNLCEEFARTTDDYLSNLIKAKSYIEEKKN 	             Matching length:     633                Total length:     633                                               
						NLNAAMNIARALQLSPSLRTYCDLNQIIRTLQLTSDSELAQVSSPQLRNPPRLSVNCSEI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.84                                               
						ICMFNNMGKIEFRDSTKCYPQENEIRQNVQKKYNNKKELSCYDTYPPLEKKKVDMSVLTS 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.84                                               
						EAPPPPLQPETNDVHLEAKNFQPQKDVATASPKTIAVLPQMGSSPDVIIEEIIEDNVETC 	                        Gaps:       0                        
						GTDDLGETPRYPKKPLQKNSSVPFGSKAGSAELVFVSHVIDPCHFYIRKYSQIKDAKVLE 	                                                            
						KKVNEFCNRSSHLDPSDILELGARIFVSSIKNGMWCRGTITELIPIEGRNTRKPCSPTRL 	Alignment:                                                   
						FVHEVALIQIFMVDFGNSEVLIVTGVVDTHVRPEHSAKQHIALNDLCLVLRKSEPYTEGL 	                  .         .         .         .         .  
						LKDIQPLAQPCSLKDIVPQNSNEGWEEEAKVEFLKMVNNKAVSMKVFREEDGVLIVDLQK 	     984 MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLY 1033                                                         
						PPPNKISSDMPVSLRDALVFMELAKFKSQSLRSHFEKNTTLHYHPPILPKEMTDVSVTVC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HINSPGDFYLQLIEGLDILFLLKTIEEFYKSEDGENLEILCPVQDQACVAKFEDGIWYRA 	       1 MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLY 50                                                           
						KVIGLPGHQEVEVKYVDFGNTAKITIKDVRKIKDEFLNAPEKAIKCKLAYIEPYKRTMQW 	                  .         .         .         .         .  
						SKEAKEKFEEKAQDKFMTCSVIKILEDNVLLVELFDSLGAPEMTTTSINDQLVKEGLASY 	    1034 DVGVELVVNVDCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACD 1083                                                         
						EIGYILKDNSQKHIEVWDPSPEEIISNEVHNLNPVSAKSLPNENFQSLYNKELPVHICNV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ISPEKIYVQWLLTENLLNSLEEK                                      	      51 DVGVELVVNVDCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACD 100                                                          
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						1 - 983 of AA393717_P2, a second amino acid sequence being at	    1084 CLSLYLTGAVATIILQVDSEENNTTWPLPVKIFCRDEKGERVDVSKYLIK 1133                                                         
						MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLYDVGVELVVNV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACDCLSLYLTGAVATIILQVDSE 	     101 CLSLYLTGAVATIILQVDSEENNTTWPLPVKIFCRDEKGERVDVSKYLIK 150                                                          
						ENNTTWPLPVKIFCRDEKGERVDVSKYLIKKGLALRERRINNLDNSHSLSEKSLEVPLEQ 	                  .         .         .         .         .  
						EDSVVTNCIKTNFDPDKKTADIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVS 	    1134 KGLALRERRINNLDNSHSLSEKSLEVPLEQEDSVVTNCIKTNFDPDKKTA 1183                                                         
						CVGDDGTIFVVPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTPVGNVWQPDAI 	     151 KGLALRERRINNLDNSHSLSEKSLEVPLEQEDSVVTNCIKTNFDPDKKTA 200                                                          
						EVLQQLLSKRQVDIHIMKPRSDHDKKYEE                                	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 1 - 389	    1184 DIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVSCVGDDGTIFV 1233                                                         
						of TDR4_HUMAN, which also corresponds to amino acids 984 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						1372 of AA393717_P2, a bridging amino acid E corresponding to	     201 DIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVSCVGDDGTIFV 250                                                          
						amino acid 1373 of AA393717_P2, and a third amino acid       	                  .         .         .         .         .  
						QWEIRFEELLSAETDTPLLPPYLSSSLPSPGELYAVQVKHVVSPNEVYICLDSIETSNQS 	    1234 VPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 1283                                                         
						NQHSDTDDSGVSGESESESLDEALQRVNKKVEALPPLTDFRTEMPCLAEYDDGLWYRAKI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VAIKEFNPLSILVQFVDYGSTAKLTLNRLCQIPSHLMRYPARAIKVLLAGFKPPLRDLGE 	     251 VPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 300                                                          
						TRIPYCPKWSMEALWAMIDCLQGKQLYAVSMAPAPEQIVTLYDDEQHPVHMPLVEMGLAD 	                  .         .         .         .         .  
						KDE                                                          	    1284 VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTP 1333                                                         
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 391 - 633 of TDR4_HUMAN, which also corresponds  	     301 VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTP 350                                                          
						to amino acids 1374 - 1616 of AA393717_P2, wherein said first	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence, bridging    	    1334 VGNVWQPDAIEVLQQLLSKRQVDIHIMKPRSDHDKKYEEEQWEIRFEELL 1383                                                         
						amino acid and third amino acid sequence are contiguous and  	         |||||||||||||||||||||||||||||||||||||||:||||||||||  
						in a sequential order.2.An isolated polypeptide encoding for 	     351 VGNVWQPDAIEVLQQLLSKRQVDIHIMKPRSDHDKKYEEKQWEIRFEELL 400                                                          
						a head of AA393717_P2, comprising a polypeptide being at     	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	    1384 SAETDTPLLPPYLSSSLPSPGELYAVQVKHVVSPNEVYICLDSIETSNQS 1433                                                         
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SGLALGGCSRRKRQRWRQRLRRLGLLGLPTSEWGGRVSPGVPLKSSAPGHHCELQCGHAF 	     401 SAETDTPLLPPYLSSSLPSPGELYAVQVKHVVSPNEVYICLDSIETSNQS 450                                                          
						CELCLLMTEECTTIICPDCEVATAVNTRQRYYPMAGYIKEDSIMEKLQPKTIKNCSQDFK 	                  .         .         .         .         .  
						KTADQLTTGLERSASTDKTLLNSSAVMLDTNTAEEIDEALNTAHHSFEQLSIAGKALEHM 	    1434 NQHSDTDDSGVSGESESESLDEALQRVNKKVEALPPLTDFRTEMPCLAEY 1483                                                         
						QKQTIEERERVIEVVEKQFDQLLAFFDSRKKNLCEEFARTTDDYLSNLIKAKSYIEEKKN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NLNAAMNIARALQLSPSLRTYCDLNQIIRTLQLTSDSELAQVSSPQLRNPPRLSVNCSEI 	     451 NQHSDTDDSGVSGESESESLDEALQRVNKKVEALPPLTDFRTEMPCLAEY 500                                                          
						ICMFNNMGKIEFRDSTKCYPQENEIRQNVQKKYNNKKELSCYDTYPPLEKKKVDMSVLTS 	                  .         .         .         .         .  
						EAPPPPLQPETNDVHLEAKNFQPQKDVATASPKTIAVLPQMGSSPDVIIEEIIEDNVETC 	    1484 DDGLWYRAKIVAIKEFNPLSILVQFVDYGSTAKLTLNRLCQIPSHLMRYP 1533                                                         
						GTDDLGETPRYPKKPLQKNSSVPFGSKAGSAELVFVSHVIDPCHFYIRKYSQIKDAKVLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KKVNEFCNRSSHLDPSDILELGARIFVSSIKNGMWCRGTITELIPIEGRNTRKPCSPTRL 	     501 DDGLWYRAKIVAIKEFNPLSILVQFVDYGSTAKLTLNRLCQIPSHLMRYP 550                                                          
						FVHEVALIQIFMVDFGNSEVLIVTGVVDTHVRPEHSAKQHIALNDLCLVLRKSEPYTEGL 	                  .         .         .         .         .  
						LKDIQPLAQPCSLKDIVPQNSNEGWEEEAKVEFLKMVNNKAVSMKVFREEDGVLIVDLQK 	    1534 ARAIKVLLAGFKPPLRDLGETRIPYCPKWSMEALWAMIDCLQGKQLYAVS 1583                                                         
						PPPNKISSDMPVSLRDALVFMELAKFKSQSLRSHFEKNTTLHYHPPILPKEMTDVSVTVC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HINSPGDFYLQLIEGLDILFLLKTIEEFYKSEDGENLEILCPVQDQACVAKFEDGIWYRA 	     551 ARAIKVLLAGFKPPLRDLGETRIPYCPKWSMEALWAMIDCLQGKQLYAVS 600                                                          
						KVIGLPGHQEVEVKYVDFGNTAKITIKDVRKIKDEFLNAPEKAIKCKLAYIEPYKRTMQW 	                  .         .         .                      
						SKEAKEKFEEKAQDKFMTCSVIKILEDNVLLVELFDSLGAPEMTTTSINDQLVKEGLASY 	    1584 MAPAPEQIVTLYDDEQHPVHMPLVEMGLADKDE                  1616                                                         
						EIGYILKDNSQKHIEVWDPSPEEIISNEVHNLNPVSAKSLPNENFQSLYNKELPVHICNV 	         |||||||||||||||||||||||||||||||||                   
						ISPEKIYVQWLLTENLLNSLEEK                                      	     601 MAPAPEQIVTLYDDEQHPVHMPLVEMGLADKDE                  633                                                          
						preferably at least about 95% homologous to the sequence of  	                                                            
						AA393717_P2.                                                 	                                                            

19080	HMR136_AA393717_3_tr0_r1_1_gPRT		Comparison report between AA393717_P3 and TDR4_HUMANunique   	Sequence name: TDR4_HUMAN                                    
						head followed by partial WT sequence a mismatch.1.An isolated	                                                            
						chimeric polypeptide encoding for AA393717_P3, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 19080 x TDR4_HUMAN   ..                        
						90% and most preferably at least 95% homologous to a         	                                                            
						RTRTRRLFQKKETAMAAEASKTGPSRSSYQRMGRKSQPWGAAEIQCTRCGRRVSRSSGHH 	Alignment segment 1/1:                                       
						CELQCGHAFCELCLLMTEECTTIICPDCEVATAVNTRQRYYPMAGYIKEDSIMEKLQPKT 	                                                            
						IKNCSQDFKKTADQLTTGLERSASTDKTLLNSSAVMLDTNTAEEIDEALNTAHHSFEQLS 	                     Quality: 6254.00                      Escore:       0                                               
						IAGKALEHMQKQTIEERERVIEVVEKQFDQLLAFFDSRKKNLCEEFARTTDDYLSNLIKA 	             Matching length:     633                Total length:     633                                               
						KSYIEEKKNNLNAAMNIARALQLSPSLRTYCDLNQIIRTLQLTSDSELAQVSSPQLRNPP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.84                                               
						RLSVNCSEIICMFNNMGKIEFRDSTKCYPQENEIRQNVQKKYNNKKELSCYDTYPPLEKK 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.84                                               
						KVDMSVLTSEAPPPPLQPETNDVHLEAKNFQPQKDVATASPKTIAVLPQMGSSPDVIIEE 	                        Gaps:       0                        
						IIEDNVETCGTDDLGETPRYPKKPLQKNSSVPFGSKAGSAELVFVSHVIDPCHFYIRKYS 	                                                            
						QIKDAKVLEKKVNEFCNRSSHLDPSDILELGARIFVSSIKNGMWCRGTITELIPIEGRNT 	Alignment:                                                   
						RKPCSPTRLFVHEVALIQIFMVDFGNSEVLIVTGVVDTHVRPEHSAKQHIALNDLCLVLR 	                  .         .         .         .         .  
						KSEPYTEGLLKDIQPLAQPCSLKDIVPQNSNEGWEEEAKVEFLKMVNNKAVSMKVFREED 	    1042 MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLY 1091                                                         
						GVLIVDLQKPPPNKISSDMPVSLRDALVFMELAKFKSQSLRSHFEKNTTLHYHPPILPKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MTDVSVTVCHINSPGDFYLQLIEGLDILFLLKTIEEFYKSEDGENLEILCPVQDQACVAK 	       1 MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLY 50                                                           
						FEDGIWYRAKVIELNHWESCWKSCIDRTKQQKLIIQKPVNSSLMLTVCLSHAILIVKVQI 	                  .         .         .         .         .  
						KGLPGHQEVEVKYVDFGNTAKITIKDVRKIKDEFLNAPEKAIKCKLAYIEPYKRTMQWSK 	    1092 DVGVELVVNVDCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACD 1141                                                         
						EAKEKFEEKAQDKFMTCSVIKILEDNVLLVELFDSLGAPEMTTTSINDQLVKEGLASYEI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GYILKDNSQKHIEVWDPSPEEIISNEVHNLNPVSAKSLPNENFQSLYNKELPVHICNVIS 	      51 DVGVELVVNVDCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACD 100                                                          
						PEKIYVQWLLTENLLNSLEEK                                        	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	    1142 CLSLYLTGAVATIILQVDSEENNTTWPLPVKIFCRDEKGERVDVSKYLIK 1191                                                         
						1 - 1041 of AA393717_P3, a second amino acid sequence being  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLYDVGVELVVNV 	     101 CLSLYLTGAVATIILQVDSEENNTTWPLPVKIFCRDEKGERVDVSKYLIK 150                                                          
						DCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACDCLSLYLTGAVATIILQVDSE 	                  .         .         .         .         .  
						ENNTTWPLPVKIFCRDEKGERVDVSKYLIKKGLALRERRINNLDNSHSLSEKSLEVPLEQ 	    1192 KGLALRERRINNLDNSHSLSEKSLEVPLEQEDSVVTNCIKTNFDPDKKTA 1241                                                         
						EDSVVTNCIKTNFDPDKKTADIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CVGDDGTIFVVPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 	     151 KGLALRERRINNLDNSHSLSEKSLEVPLEQEDSVVTNCIKTNFDPDKKTA 200                                                          
						VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTPVGNVWQPDAI 	                  .         .         .         .         .  
						EVLQQLLSKRQVDIHIMKPRSDHDKKYEE                                	    1242 DIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVSCVGDDGTIFV 1291                                                         
						at least 90 % homologous to corresponding to amino acids 1 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						389 of TDR4_HUMAN, which also corresponds to amino acids 1042	     201 DIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVSCVGDDGTIFV 250                                                          
						- 1430 of AA393717_P3, a bridging amino acid E corresponding 	                  .         .         .         .         .  
						to amino acid 1431 of AA393717_P3, and a third amino acid    	    1292 VPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 1341                                                         
						QWEIRFEELLSAETDTPLLPPYLSSSLPSPGELYAVQVKHVVSPNEVYICLDSIETSNQS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NQHSDTDDSGVSGESESESLDEALQRVNKKVEALPPLTDFRTEMPCLAEYDDGLWYRAKI 	     251 VPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 300                                                          
						VAIKEFNPLSILVQFVDYGSTAKLTLNRLCQIPSHLMRYPARAIKVLLAGFKPPLRDLGE 	                  .         .         .         .         .  
						TRIPYCPKWSMEALWAMIDCLQGKQLYAVSMAPAPEQIVTLYDDEQHPVHMPLVEMGLAD 	    1342 VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTP 1391                                                         
						KDE                                                          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     301 VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTP 350                                                          
						amino acids 391 - 633 of TDR4_HUMAN, which also corresponds  	                  .         .         .         .         .  
						to amino acids 1432 - 1674 of AA393717_P3, wherein said first	    1392 VGNVWQPDAIEVLQQLLSKRQVDIHIMKPRSDHDKKYEEEQWEIRFEELL 1441                                                         
						amino acid sequence, second amino acid sequence, bridging    	         |||||||||||||||||||||||||||||||||||||||:||||||||||  
						amino acid and third amino acid sequence are contiguous and  	     351 VGNVWQPDAIEVLQQLLSKRQVDIHIMKPRSDHDKKYEEKQWEIRFEELL 400                                                          
						in a sequential order.2.An isolated polypeptide encoding for 	                  .         .         .         .         .  
						a head of AA393717_P3, comprising a polypeptide being at     	    1442 SAETDTPLLPPYLSSSLPSPGELYAVQVKHVVSPNEVYICLDSIETSNQS 1491                                                         
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     401 SAETDTPLLPPYLSSSLPSPGELYAVQVKHVVSPNEVYICLDSIETSNQS 450                                                          
						RTRTRRLFQKKETAMAAEASKTGPSRSSYQRMGRKSQPWGAAEIQCTRCGRRVSRSSGHH 	                  .         .         .         .         .  
						CELQCGHAFCELCLLMTEECTTIICPDCEVATAVNTRQRYYPMAGYIKEDSIMEKLQPKT 	    1492 NQHSDTDDSGVSGESESESLDEALQRVNKKVEALPPLTDFRTEMPCLAEY 1541                                                         
						IKNCSQDFKKTADQLTTGLERSASTDKTLLNSSAVMLDTNTAEEIDEALNTAHHSFEQLS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IAGKALEHMQKQTIEERERVIEVVEKQFDQLLAFFDSRKKNLCEEFARTTDDYLSNLIKA 	     451 NQHSDTDDSGVSGESESESLDEALQRVNKKVEALPPLTDFRTEMPCLAEY 500                                                          
						KSYIEEKKNNLNAAMNIARALQLSPSLRTYCDLNQIIRTLQLTSDSELAQVSSPQLRNPP 	                  .         .         .         .         .  
						RLSVNCSEIICMFNNMGKIEFRDSTKCYPQENEIRQNVQKKYNNKKELSCYDTYPPLEKK 	    1542 DDGLWYRAKIVAIKEFNPLSILVQFVDYGSTAKLTLNRLCQIPSHLMRYP 1591                                                         
						KVDMSVLTSEAPPPPLQPETNDVHLEAKNFQPQKDVATASPKTIAVLPQMGSSPDVIIEE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IIEDNVETCGTDDLGETPRYPKKPLQKNSSVPFGSKAGSAELVFVSHVIDPCHFYIRKYS 	     501 DDGLWYRAKIVAIKEFNPLSILVQFVDYGSTAKLTLNRLCQIPSHLMRYP 550                                                          
						QIKDAKVLEKKVNEFCNRSSHLDPSDILELGARIFVSSIKNGMWCRGTITELIPIEGRNT 	                  .         .         .         .         .  
						RKPCSPTRLFVHEVALIQIFMVDFGNSEVLIVTGVVDTHVRPEHSAKQHIALNDLCLVLR 	    1592 ARAIKVLLAGFKPPLRDLGETRIPYCPKWSMEALWAMIDCLQGKQLYAVS 1641                                                         
						KSEPYTEGLLKDIQPLAQPCSLKDIVPQNSNEGWEEEAKVEFLKMVNNKAVSMKVFREED 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVLIVDLQKPPPNKISSDMPVSLRDALVFMELAKFKSQSLRSHFEKNTTLHYHPPILPKE 	     551 ARAIKVLLAGFKPPLRDLGETRIPYCPKWSMEALWAMIDCLQGKQLYAVS 600                                                          
						MTDVSVTVCHINSPGDFYLQLIEGLDILFLLKTIEEFYKSEDGENLEILCPVQDQACVAK 	                  .         .         .                      
						FEDGIWYRAKVIELNHWESCWKSCIDRTKQQKLIIQKPVNSSLMLTVCLSHAILIVKVQI 	    1642 MAPAPEQIVTLYDDEQHPVHMPLVEMGLADKDE                  1674                                                         
						KGLPGHQEVEVKYVDFGNTAKITIKDVRKIKDEFLNAPEKAIKCKLAYIEPYKRTMQWSK 	         |||||||||||||||||||||||||||||||||                   
						EAKEKFEEKAQDKFMTCSVIKILEDNVLLVELFDSLGAPEMTTTSINDQLVKEGLASYEI 	     601 MAPAPEQIVTLYDDEQHPVHMPLVEMGLADKDE                  633                                                          
						GYILKDNSQKHIEVWDPSPEEIISNEVHNLNPVSAKSLPNENFQSLYNKELPVHICNVIS 	                                                            
						PEKIYVQWLLTENLLNSLEEK                                        	                                                            
						preferably at least about 95% homologous to the sequence of  	                                                            
						AA393717_P3.                                                 	                                                            

19082	HMR136_AA393717_4_tr0_r1_1_gPRT		Comparison report between AA393717_P4 and TDR4_HUMANunique   	Sequence name: TDR4_HUMAN                                    
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon, followed by a unique insertion, a mismatch and a       	Sequence documentation:                                      
						followed by a unique tail.1.An isolated chimeric polypeptide 	                                                            
						encoding for AA393717_P4, comprising a first amino acid      	Alignment of: 19082 x TDR4_HUMAN   ..                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment segment 1/1:                                       
						most preferably at least 95% homologous to a polypeptide     	                                                            
						RTRTRRLFQKKETAMAAEASKTGPSRSSYQRMGRKSQPWGAAEIQCTRCGRRVSRSSGHH 	                     Quality: 4068.00                      Escore:       0                                               
						CELQCGHAFCELCLLMTEECTTIICPDCEVATAVNTRQRYYPMAGYIKEDSIMEKLQPKT 	             Matching length:     432                Total length:     478                                               
						IKNCSQDFKKTADQLTTGLERSASTDKTLLNSSAVMLDTNTAEEIDEALNTAHHSFEQLS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.77                                               
						IAGKALEHMQKQTIEERERVIEVVEKQFDQLLAFFDSRKKNLCEEFARTTDDYLSNLIKA 	    Total Percent Similarity:   90.38      Total Percent Identity:   90.17                                               
						KSYIEEKKNNLNAAMNIARALQLSPSLRTYCDLNQIIRTLQLTSDSELAQVSSPQLRNPP 	                        Gaps:       2                        
						RLSVNCSEIICMFNNMGKIEFRDSTKCYPQENEIRQNVQKKYNNKKELSCYDTYPPLEKK 	                                                            
						KVDMSVLTSEAPPPPLQPETNDVHLEAKNFQPQKDVATASPKTIAVLPQMGSSPDVIIEE 	Alignment:                                                   
						IIEDNVETCGTDDLGETPRYPKKPLQKNSSVPFGSKAGSAELVFVSHVIDPCHFYIRKYS 	                  .         .         .         .         .  
						QIKDAKVLEKKVNEFCNRSSHLDPSDILELGARIFVSSIKNGMWCRGTITELIPIEGRNT 	     993 MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLY 1042                                                         
						RKPCSPTRLFVHEVALIQIFMVDFGNSEVLIVTGVVDTHVRPEHSAKQHIALNDLCLVLR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KSEPYTEGLLKDIQPLAQPCSLKDIVPQNSNEGWEEEAKVEFLKMVNNKAVSMKVFREED 	       1 MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLY 50                                                           
						GVLIVDLQKPPPNKISSDMPVSLRDALVFMELAKFKSQSLRSHFEKNTTLHYHPPILPKE 	                  .         .         .         .         .  
						MTDVSVTVCHINSPGDFYLQLIEGLDILFLLKTIEEFYKSEDGENLEILCPVQDQACVAK 	    1043 DVGVELVVNVDCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACD 1092                                                         
						FEDGIWYRAKVIGLPGHQEVEVKYVDFGNTAKITIKDVRKIKDEFLNAPEKAIKCKLAYI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EPYKRTMQWSKEAKEKFEEKAQDKFMTCSVIKILEDNVLLVELFDSLGAPEMTTTSINDQ 	      51 DVGVELVVNVDCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACD 100                                                          
						LVKEGLASYEIGYILKDNSQKHIEVWDPSPEEIISNEVHNLNPVSAKSLPNENFQSLYNK 	                  .         .         .         .         .  
						ELPVHICNVISPEKIYVQWLLTENLLNSLEEK                             	    1093 CLSLYLTGAVATIILQ....ENNTTWPLPVKIFCRDEKGERVDVSKYLIK 1138                                                         
						having the sequence corresponding to amino acids 1 - 992 of  	         ||||||||||||||||    ||||||||||||||||||||||||||||||  
						AA393717_P4, a second amino acid sequence being at least 90 %	     101 CLSLYLTGAVATIILQVDSEENNTTWPLPVKIFCRDEKGERVDVSKYLIK 150                                                          
						MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLYDVGVELVVNV 	                  .         .         .         .         .  
						DCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACDCLSLYLTGAVATIILQ     	    1139 KGLALRERRINNLDNSHSLSEKSLEVPLEQEDSVVTNCIKTNFDPDKKTA 1188                                                         
						homologous to corresponding to amino acids 1 - 116 of        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TDR4_HUMAN, which also corresponds to amino acids 993 - 1108 	     151 KGLALRERRINNLDNSHSLSEKSLEVPLEQEDSVVTNCIKTNFDPDKKTA 200                                                          
						of AA393717_P4, a third amino acid sequence being at least 90	                  .         .         .         .         .  
						ENNTTWPLPVKIFCRDEKGERVDVSKYLIKKGLALRERRINNLDNSHSLSEKSLEVPLEQ 	    1189 DIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVSCVGDDGTIFV 1238                                                         
						EDSVVTNCIKTNFDPDKKTADIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CVGDDGTIFVVPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 	     201 DIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVSCVGDDGTIFV 250                                                          
						VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTPVGNVWQPDAI 	                  .         .         .         .         .  
						EVLQQLLSKRQVDIHIM                                            	    1239 VPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 1288                                                         
						% homologous to corresponding to amino acids 121 - 377 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TDR4_HUMAN, which also corresponds to amino acids 1109 - 1365	     251 VPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 300                                                          
						of AA393717_P4, a fourth amino acid sequence being at least  	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	    1289 VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTP 1338                                                         
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	     301 VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTP 350                                                          
						ELPKNPWEKLSIHLYFDGMSLSYFMAYYKYCTSEHTEEMLKE corresponding to  	                  .         .         .         .         .  
						amino acids 1366 - 1407 of AA393717_P4, a fifth amino acid   	    1339 VGNVWQPDAIEVLQQLLSKRQVDIHIMELPKNPWEKLSIHLYFDGMSLSY 1388                                                         
						sequence being at least 90 % homologous to KPRSDHDKKYEE      	         |||||||||||||||||||||||||||                         
						corresponding to amino acids 378 - 389 of TDR4_HUMAN, which  	     351 VGNVWQPDAIEVLQQLLSKRQVDIHIM....................... 377                                                          
						also corresponds to amino acids 1408 - 1419 of AA393717_P4, a	                  .         .         .         .         .  
						bridging amino acid E corresponding to amino acid 1420 of    	    1389 FMAYYKYCTSEHTEEMLKEKPRSDHDKKYEEEQWEIRFEELLSAETDTPL 1438                                                         
						AA393717_P4, a sixth amino acid sequence being at least 90 % 	                            ||||||||||||:||||||||||||||||||  
						homologous to QWEIRFEELLSAETDTPLLPPYLSSSLPSPGELYAVQVKHVVSPNE 	     378 ...................KPRSDHDKKYEEKQWEIRFEELLSAETDTPL 408                                                          
						corresponding to amino acids 391 - 436 of TDR4_HUMAN, which  	                  .         .                                
						also corresponds to amino acids 1421 - 1466 of AA393717_P4,  	    1439 LPPYLSSSLPSPGELYAVQVKHVVSPNE                       1466                                                         
						and a seventh amino acid sequence being at least 70%,        	         ||||||||||||||||||||||||||||                        
						optionally at least 80%, preferably at least 85%, more       	     409 LPPYLSSSLPSPGELYAVQVKHVVSPNE                       436                                                          
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	                                                            
						KLLTSLTSIVTQMIVESAGNQNPRALMKHCRGLIRR corresponding to amino  	                                                            
						acids 1467 - 1502 of AA393717_P4, wherein said first amino   	                                                            
						acid sequence, second amino acid sequence, third amino acid  	                                                            
						sequence, fourth amino acid sequence, fifth amino acid       	                                                            
						sequence, bridging amino acid, sixth amino acid sequence and 	                                                            
						seventh amino acid sequence are contiguous and in a          	                                                            
						sequential order.2.An isolated polypeptide encoding for a    	                                                            
						head of AA393717_P4, comprising a polypeptide being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						RTRTRRLFQKKETAMAAEASKTGPSRSSYQRMGRKSQPWGAAEIQCTRCGRRVSRSSGHH 	                                                            
						CELQCGHAFCELCLLMTEECTTIICPDCEVATAVNTRQRYYPMAGYIKEDSIMEKLQPKT 	                                                            
						IKNCSQDFKKTADQLTTGLERSASTDKTLLNSSAVMLDTNTAEEIDEALNTAHHSFEQLS 	                                                            
						IAGKALEHMQKQTIEERERVIEVVEKQFDQLLAFFDSRKKNLCEEFARTTDDYLSNLIKA 	                                                            
						KSYIEEKKNNLNAAMNIARALQLSPSLRTYCDLNQIIRTLQLTSDSELAQVSSPQLRNPP 	                                                            
						RLSVNCSEIICMFNNMGKIEFRDSTKCYPQENEIRQNVQKKYNNKKELSCYDTYPPLEKK 	                                                            
						KVDMSVLTSEAPPPPLQPETNDVHLEAKNFQPQKDVATASPKTIAVLPQMGSSPDVIIEE 	                                                            
						IIEDNVETCGTDDLGETPRYPKKPLQKNSSVPFGSKAGSAELVFVSHVIDPCHFYIRKYS 	                                                            
						QIKDAKVLEKKVNEFCNRSSHLDPSDILELGARIFVSSIKNGMWCRGTITELIPIEGRNT 	                                                            
						RKPCSPTRLFVHEVALIQIFMVDFGNSEVLIVTGVVDTHVRPEHSAKQHIALNDLCLVLR 	                                                            
						KSEPYTEGLLKDIQPLAQPCSLKDIVPQNSNEGWEEEAKVEFLKMVNNKAVSMKVFREED 	                                                            
						GVLIVDLQKPPPNKISSDMPVSLRDALVFMELAKFKSQSLRSHFEKNTTLHYHPPILPKE 	                                                            
						MTDVSVTVCHINSPGDFYLQLIEGLDILFLLKTIEEFYKSEDGENLEILCPVQDQACVAK 	                                                            
						FEDGIWYRAKVIGLPGHQEVEVKYVDFGNTAKITIKDVRKIKDEFLNAPEKAIKCKLAYI 	                                                            
						EPYKRTMQWSKEAKEKFEEKAQDKFMTCSVIKILEDNVLLVELFDSLGAPEMTTTSINDQ 	                                                            
						LVKEGLASYEIGYILKDNSQKHIEVWDPSPEEIISNEVHNLNPVSAKSLPNENFQSLYNK 	                                                            
						ELPVHICNVISPEKIYVQWLLTENLLNSLEEK                             	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						AA393717_P4.3.An isolated chimeric polypeptide encoding for  	                                                            
						an edge portion of AA393717_P4, comprising a polypeptide     	                                                            
						having a length "n", wherein n is at least about 10 amino    	                                                            
						acids in length, optionally at least about 20 amino acids in 	                                                            
						length, preferably at least about 30 amino acids in length,  	                                                            
						more preferably at least about 40 amino acids in length and  	                                                            
						most preferably at least about 50 amino acids in length,     	                                                            
						wherein at least two amino acids comprise QE, having a       	                                                            
						structure as follows: a sequence starting from any of amino  	                                                            
						acid numbers 1108-x to 1109; and ending at any of amino acid 	                                                            
						numbers 1109+ ((n-2) - x), in which x varies from 0 to       	                                                            
						n-2.4.An isolated polypeptide encoding for an edge portion of	                                                            
						AA393717_P4, comprising an amino acid sequence being at least	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						ELPKNPWEKLSIHLYFDGMSLSYFMAYYKYCTSEHTEEMLKE, corresponding to 	                                                            
						AA393717_P4.5.An isolated polypeptide encoding for a tail of 	                                                            
						AA393717_P4, comprising a polypeptide being at least 70%,    	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						KLLTSLTSIVTQMIVESAGNQNPRALMKHCRGLIRR in AA393717_P4.         	                                                            

19078	HMR136_AA393717_5_tr0_r1_1_gPRT		Comparison report between AA393717_P5 and TDR4_HUMANunique   	Sequence name: TDR4_HUMAN                                    
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon, followed by a unique insertion, a mismatch and a       	Sequence documentation:                                      
						followed by a unique tail.1.An isolated chimeric polypeptide 	                                                            
						encoding for AA393717_P5, comprising a first amino acid      	Alignment of: 19078 x TDR4_HUMAN   ..                        
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	Alignment segment 1/1:                                       
						most preferably at least 95% homologous to a polypeptide     	                                                            
						RTRTRRLFQKKETAMAAEASKTGPSRSSYQRMGRKSQPWGAAEIQCTRCGRRVSRSSGHH 	                     Quality: 3922.00                      Escore:       0                                               
						CELQCGHAFCELCLLMTEECTTIICPDCEVATAVNTRQRYYPMAGYIKEDSIMEKLQPKT 	             Matching length:     417                Total length:     463                                               
						IKNCSQDFKKTADQLTTGLERSASTDKTLLNSSAVMLDTNTAEEIDEALNTAHHSFEQLS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.76                                               
						IAGKALEHMQKQTIEERERVIEVVEKQFDQLLAFFDSRKKNLCEEFARTTDDYLSNLIKA 	    Total Percent Similarity:   90.06      Total Percent Identity:   89.85                                               
						KSYIEEKKNNLNAAMNIARALQLSPSLRTYCDLNQIIRTLQLTSDSELAQVSSPQLRNPP 	                        Gaps:       2                        
						RLSVNCSEIICMFNNMGKIEFRDSTKCYPQENEIRQNVQKKYNNKKELSCYDTYPPLEKK 	                                                            
						KVDMSVLTSEAPPPPLQPETNDVHLEAKNFQPQKDVATASPKTIAVLPQMGSSPDVIIEE 	Alignment:                                                   
						IIEDNVETCGTDDLGETPRYPKKPLQKNSSVPFGSKAGSAELVFVSHVIDPCHFYIRKYS 	                  .         .         .         .         .  
						QIKDAKVLEKKVNEFCNRSSHLDPSDILELGARIFVSSIKNGMWCRGTITELIPIEGRNT 	     993 MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLY 1042                                                         
						RKPCSPTRLFVHEVALIQIFMVDFGNSEVLIVTGVVDTHVRPEHSAKQHIALNDLCLVLR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KSEPYTEGLLKDIQPLAQPCSLKDIVPQNSNEGWEEEAKVEFLKMVNNKAVSMKVFREED 	       1 MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLY 50                                                           
						GVLIVDLQKPPPNKISSDMPVSLRDALVFMELAKFKSQSLRSHFEKNTTLHYHPPILPKE 	                  .         .         .         .         .  
						MTDVSVTVCHINSPGDFYLQLIEGLDILFLLKTIEEFYKSEDGENLEILCPVQDQACVAK 	    1043 DVGVELVVNVDCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACD 1092                                                         
						FEDGIWYRAKVIGLPGHQEVEVKYVDFGNTAKITIKDVRKIKDEFLNAPEKAIKCKLAYI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EPYKRTMQWSKEAKEKFEEKAQDKFMTCSVIKILEDNVLLVELFDSLGAPEMTTTSINDQ 	      51 DVGVELVVNVDCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACD 100                                                          
						LVKEGLASYEIGYILKDNSQKHIEVWDPSPEEIISNEVHNLNPVSAKSLPNENFQSLYNK 	                  .         .         .         .         .  
						ELPVHICNVISPEKIYVQWLLTENLLNSLEEK                             	    1093 CLSLYLTGAVATIILQ....ENNTTWPLPVKIFCRDEKGERVDVSKYLIK 1138                                                         
						having the sequence corresponding to amino acids 1 - 992 of  	         ||||||||||||||||    ||||||||||||||||||||||||||||||  
						AA393717_P5, a second amino acid sequence being at least 90 %	     101 CLSLYLTGAVATIILQVDSEENNTTWPLPVKIFCRDEKGERVDVSKYLIK 150                                                          
						MIAAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLYDVGVELVVNV 	                  .         .         .         .         .  
						DCLRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACDCLSLYLTGAVATIILQ     	    1139 KGLALRERRINNLDNSHSLSEKSLEVPLEQEDSVVTNCIKTNFDPDKKTA 1188                                                         
						homologous to corresponding to amino acids 1 - 116 of        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TDR4_HUMAN, which also corresponds to amino acids 993 - 1108 	     151 KGLALRERRINNLDNSHSLSEKSLEVPLEQEDSVVTNCIKTNFDPDKKTA 200                                                          
						of AA393717_P5, a third amino acid sequence being at least 90	                  .         .         .         .         .  
						ENNTTWPLPVKIFCRDEKGERVDVSKYLIKKGLALRERRINNLDNSHSLSEKSLEVPLEQ 	    1189 DIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVSCVGDDGTIFV 1238                                                         
						EDSVVTNCIKTNFDPDKKTADIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CVGDDGTIFVVPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 	     201 DIISEQKVSEFQEKILEPRTTRGYKPPAIPNMNVFEATVSCVGDDGTIFV 250                                                          
						VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTPVGNVWQPDAI 	                  .         .         .         .         .  
						EVLQQLLSKRQVDIHIM                                            	    1239 VPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 1288                                                         
						% homologous to corresponding to amino acids 121 - 377 of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TDR4_HUMAN, which also corresponds to amino acids 1109 - 1365	     251 VPKLSEFELIKMTNEIQSNLKCLGLLEPYFWKKGEACAVRGSDTLWYRGK 300                                                          
						of AA393717_P5, a fourth amino acid sequence being at least  	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	    1289 VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTP 1338                                                         
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	     301 VMEVVGGAVRVQYLDHGFTEKIPQCHLYPILLYPDIPQFCIPCQLHNTTP 350                                                          
						ELPKNPWEKLSIHLYFDGMSLSYFMAYYKYCTSEHTEEMLKE corresponding to  	                  .         .         .         .         .  
						amino acids 1366 - 1407 of AA393717_P5, a fifth amino acid   	    1339 VGNVWQPDAIEVLQQLLSKRQVDIHIMELPKNPWEKLSIHLYFDGMSLSY 1388                                                         
						sequence being at least 90 % homologous to KPRSDHDKKYEE      	         |||||||||||||||||||||||||||                         
						corresponding to amino acids 378 - 389 of TDR4_HUMAN, which  	     351 VGNVWQPDAIEVLQQLLSKRQVDIHIM....................... 377                                                          
						also corresponds to amino acids 1408 - 1419 of AA393717_P5, a	                  .         .         .         .         .  
						bridging amino acid E corresponding to amino acid 1420 of    	    1389 FMAYYKYCTSEHTEEMLKEKPRSDHDKKYEEEQWEIRFEELLSAETDTPL 1438                                                         
						AA393717_P5, a sixth amino acid sequence being at least 90 % 	                            ||||||||||||:||||||||||||||||||  
						homologous to QWEIRFEELLSAETDTPLLPPYLSSSLPSPG corresponding  	     378 ...................KPRSDHDKKYEEKQWEIRFEELLSAETDTPL 408                                                          
						to amino acids 391 - 421 of TDR4_HUMAN, which also           	                  .                                          
						corresponds to amino acids 1421 - 1451 of AA393717_P5, and a 	    1439 LPPYLSSSLPSPG                                      1451                                                         
						seventh amino acid sequence being at least 70%, optionally at	         |||||||||||||                                       
						least 80%, preferably at least 85%, more preferably at least 	     409 LPPYLSSSLPSPG                                      421                                                          
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence TVGYDRLSSRKTTLCCVHGSSTRTDSDII	                                                            
						corresponding to amino acids 1452 - 1480 of AA393717_P5,     	                                                            
						wherein said first amino acid sequence, second amino acid    	                                                            
						sequence, third amino acid sequence, fourth amino acid       	                                                            
						sequence, fifth amino acid sequence, bridging amino acid,    	                                                            
						sixth amino acid sequence and seventh amino acid sequence are	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of AA393717_P5, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						RTRTRRLFQKKETAMAAEASKTGPSRSSYQRMGRKSQPWGAAEIQCTRCGRRVSRSSGHH 	                                                            
						CELQCGHAFCELCLLMTEECTTIICPDCEVATAVNTRQRYYPMAGYIKEDSIMEKLQPKT 	                                                            
						IKNCSQDFKKTADQLTTGLERSASTDKTLLNSSAVMLDTNTAEEIDEALNTAHHSFEQLS 	                                                            
						IAGKALEHMQKQTIEERERVIEVVEKQFDQLLAFFDSRKKNLCEEFARTTDDYLSNLIKA 	                                                            
						KSYIEEKKNNLNAAMNIARALQLSPSLRTYCDLNQIIRTLQLTSDSELAQVSSPQLRNPP 	                                                            
						RLSVNCSEIICMFNNMGKIEFRDSTKCYPQENEIRQNVQKKYNNKKELSCYDTYPPLEKK 	                                                            
						KVDMSVLTSEAPPPPLQPETNDVHLEAKNFQPQKDVATASPKTIAVLPQMGSSPDVIIEE 	                                                            
						IIEDNVETCGTDDLGETPRYPKKPLQKNSSVPFGSKAGSAELVFVSHVIDPCHFYIRKYS 	                                                            
						QIKDAKVLEKKVNEFCNRSSHLDPSDILELGARIFVSSIKNGMWCRGTITELIPIEGRNT 	                                                            
						RKPCSPTRLFVHEVALIQIFMVDFGNSEVLIVTGVVDTHVRPEHSAKQHIALNDLCLVLR 	                                                            
						KSEPYTEGLLKDIQPLAQPCSLKDIVPQNSNEGWEEEAKVEFLKMVNNKAVSMKVFREED 	                                                            
						GVLIVDLQKPPPNKISSDMPVSLRDALVFMELAKFKSQSLRSHFEKNTTLHYHPPILPKE 	                                                            
						MTDVSVTVCHINSPGDFYLQLIEGLDILFLLKTIEEFYKSEDGENLEILCPVQDQACVAK 	                                                            
						FEDGIWYRAKVIGLPGHQEVEVKYVDFGNTAKITIKDVRKIKDEFLNAPEKAIKCKLAYI 	                                                            
						EPYKRTMQWSKEAKEKFEEKAQDKFMTCSVIKILEDNVLLVELFDSLGAPEMTTTSINDQ 	                                                            
						LVKEGLASYEIGYILKDNSQKHIEVWDPSPEEIISNEVHNLNPVSAKSLPNENFQSLYNK 	                                                            
						ELPVHICNVISPEKIYVQWLLTENLLNSLEEK                             	                                                            
						to the sequence of AA393717_P5.3.An isolated chimeric        	                                                            
						polypeptide encoding for an edge portion of AA393717_P5,     	                                                            
						comprising a polypeptide having a length "n", wherein n is at	                                                            
						least about 10 amino acids in length, optionally at least    	                                                            
						about 20 amino acids in length, preferably at least about 30 	                                                            
						amino acids in length, more preferably at least about 40     	                                                            
						amino acids in length and most preferably at least about 50  	                                                            
						amino acids in length, wherein at least two amino acids      	                                                            
						comprise QE, having a structure as follows: a sequence       	                                                            
						starting from any of amino acid numbers 1108-x to 1109; and  	                                                            
						ending at any of amino acid numbers 1109+ ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for an edge portion of AA393717_P5, comprising an   	                                                            
						amino acid sequence being at least 70%, optionally at least  	                                                            
						about 80%, preferably at least about 85%, more preferably at 	                                                            
						least about 90% and most preferably at least about 95%       	                                                            
						homologous to the sequence encoding for                      	                                                            
						ELPKNPWEKLSIHLYFDGMSLSYFMAYYKYCTSEHTEEMLKE, corresponding to 	                                                            
						AA393717_P5.5.An isolated polypeptide encoding for a tail of 	                                                            
						AA393717_P5, comprising a polypeptide being at least 70%,    	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						TVGYDRLSSRKTTLCCVHGSSTRTDSDII in AA393717_P5.                	                                                            

840	HMR136_AA393779_4_tr0_r1_1_gPRT		Comparison report between AA393779_P4 and Q8NCV2partial WT   	Sequence name: Q8NCV2                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA393779_P4, comprising a first     	Sequence documentation:                                      
						MHTTESKNEHLEDENFQTSTTPQSLIDPNNTAHEETKTVLSDTEEIKPQTKKETYISCPL 	                                                            
						RGVLNVIITNGVILFVIWCMTWSILGSEALPGGNLFGLFIIFYSAIIGGKILQLIRIPLV 	Alignment of: 840 x Q8NCV2   ..                              
						PPLPPLLGMLLAGFTIRNVPFINEHVHVPNTWSSILRSIALTIILIRAGLGLDPQALRHL 	                                                            
						KVVCFRLAVGPCLMEASAAAVFSHFIMKFPWQWAFLLG                       	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 218 of Q8NCV2, which also   	                     Quality: 2125.00                      Escore:       0                                               
						corresponds to amino acids 1 - 218 of AA393779_P4, and a     	             Matching length:     218                Total length:     218                                               
						second amino acid sequence being at least 70%, optionally at 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 80%, preferably at least 85%, more preferably at least 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	                        Gaps:       0                        
						FVLGAVSPAVVVPYMMVLQENGYGVEEGIPTLLMAASSMDDILAITGFNTCLSIVFSSGG 	                                                            
						ILNNAIASIRNVCISLLAGIVLGFFVRYFPSEDQAANVLVYMDLEDYAH            	Alignment:                                                   
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						219 - 327 of AA393779_P4, wherein said first amino acid      	       1 MHTTESKNEHLEDENFQTSTTPQSLIDPNNTAHEETKTVLSDTEEIKPQT 50                                                           
						sequence and second amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	       1 MHTTESKNEHLEDENFQTSTTPQSLIDPNNTAHEETKTVLSDTEEIKPQT 50                                                           
						tail of AA393779_P4, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	      51 KKETYISCPLRGVLNVIITNGVILFVIWCMTWSILGSEALPGGNLFGLFI 100                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FVLGAVSPAVVVPYMMVLQENGYGVEEGIPTLLMAASSMDDILAITGFNTCLSIVFSSGG 	      51 KKETYISCPLRGVLNVIITNGVILFVIWCMTWSILGSEALPGGNLFGLFI 100                                                          
						ILNNAIASIRNVCISLLAGIVLGFFVRYFPSEDQAANVLVYMDLEDYAH            	                  .         .         .         .         .  
						at least about 95% homologous to the sequence in AA393779_P4.	     101 IFYSAIIGGKILQLIRIPLVPPLPPLLGMLLAGFTIRNVPFINEHVHVPN 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 IFYSAIIGGKILQLIRIPLVPPLPPLLGMLLAGFTIRNVPFINEHVHVPN 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 TWSSILRSIALTIILIRAGLGLDPQALRHLKVVCFRLAVGPCLMEASAAA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 TWSSILRSIALTIILIRAGLGLDPQALRHLKVVCFRLAVGPCLMEASAAA 200                                                          
						                                                            	                  .                                          
						                                                            	     201 VFSHFIMKFPWQWAFLLG                                 218                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     201 VFSHFIMKFPWQWAFLLG                                 218                                                          

20178	HMR136_AA397547_2_tr0_r1_1_gPRT		Comparison report between AA397547_P2 and Q96M95partial WT   	Sequence name: Q96M95                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA397547_P2, comprising a first amino acid      	                                                            
						MRHDLMQSAQEGQEKIERAKARLARYMEEKDDEILQQNNELARLQMRFDRARSNVIFWES 	Alignment of: 20178 x Q96M95   ..                            
						RWAHIQNTAAKKTLLLGTIKMATLNLFQIVSKHLKEVTEVALEDTHKQLDMIQQFIQDRS 	                                                            
						DIWAEVKKKEQQRVRI                                             	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 181 - 316 of Q96M95, which also corresponds to   	                     Quality: 1335.00                      Escore:       0                                               
						amino acids 1 - 136 of AA397547_P2.                          	             Matching length:     136                Total length:     136                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MRHDLMQSAQEGQEKIERAKARLARYMEEKDDEILQQNNELARLQMRFDR 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     181 MRHDLMQSAQEGQEKIERAKARLARYMEEKDDEILQQNNELARLQMRFDR 230                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ARSNVIFWESRWAHIQNTAAKKTLLLGTIKMATLNLFQIVSKHLKEVTEV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     231 ARSNVIFWESRWAHIQNTAAKKTLLLGTIKMATLNLFQIVSKHLKEVTEV 280                                                          
						                                                            	                  .         .         .                      
						                                                            	     101 ALEDTHKQLDMIQQFIQDRSDIWAEVKKKEQQRVRI               136                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     281 ALEDTHKQLDMIQQFIQDRSDIWAEVKKKEQQRVRI               316                                                          

						Comparison report between AA397547_P2 and Q8N6Q0unique head  	Sequence name: Q8N6Q0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA397547_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 20178 x Q8N6Q0   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						MRHDLMQSAQEGQEKIERAKARLARYMEEKDDEILQQNNELARLQMRFDRARSNVIFW   	                                                            
						corresponding to amino acids 1 - 58 of AA397547_P2, and a    	                     Quality:  757.00                      Escore:       0                                               
						ESRWAHIQNTAAKKTLLLGTIKMATLNLFQIVSKHLKEVTEVALEDTHKQLDMIQQFIQD 	             Matching length:      78                Total length:      78                                               
						RSDIWAEVKKKEQQRVRI                                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						second amino acid sequence being at least 90 % homologous to 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 165 - 242 of Q8N6Q0, which also 	                        Gaps:       0                        
						corresponds to amino acids 59 - 136 of AA397547_P2, wherein  	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a head of AA397547_P2, comprising a 	      59 ESRWAHIQNTAAKKTLLLGTIKMATLNLFQIVSKHLKEVTEVALEDTHKQ 108                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     165 ESRWAHIQNTAAKKTLLLGTIKMATLNLFQIVSKHLKEVTEVALEDTHKQ 214                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .                                
						to the sequence                                              	     109 LDMIQQFIQDRSDIWAEVKKKEQQRVRI                       136                                                          
						MRHDLMQSAQEGQEKIERAKARLARYMEEKDDEILQQNNELARLQMRFDRARSNVIFW of	         ||||||||||||||||||||||||||||                        
						AA397547_P2.                                                 	     215 LDMIQQFIQDRSDIWAEVKKKEQQRVRI                       242                                                          

21463	HMR136_AA397955_2_tr0_r1_1_gPRT		Comparison report between AA397955_P2 and Q9BYF1partial WT   	Sequence name: Q9BYF1                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA397955_P2, comprising a first     	Sequence documentation:                                      
						MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQ 	                                                            
						NMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTIL 	Alignment of: 21463 x Q9BYF1   ..                            
						NTMSTIYSTGKVCNPDNPQECLLLEPGLNEIMANSLDYNERLWAWESWRSEVGKQLRPLY 	                                                            
						EEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHL 	Alignment segment 1/1:                                       
						HAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQ 	                                                            
						AWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFR    	                     Quality: 3584.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     357                Total length:     357                                               
						corresponding to amino acids 1 - 357 of Q9BYF1, which also   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 357 of AA397955_P2, and a     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						polypeptide having the sequence CRPKHQSEDKPKISSWR            	                  .         .         .         .         .  
						corresponding to amino acids 358 - 374 of AA397955_P2,       	       1 MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNY 50                                                           
						wherein said first amino acid sequence and second amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	       1 MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNY 50                                                           
						isolated polypeptide encoding for a tail of AA397955_P2,     	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	      51 NTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQAL 100                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	      51 NTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQAL 100                                                          
						about 95% homologous to the sequence CRPKHQSEDKPKISSWR in    	                  .         .         .         .         .  
						AA397955_P2.                                                 	     101 QQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 QQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNE 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 IMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 IMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 DYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 AYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWD 350                                                          
						                                                            	                                                             
						                                                            	     351 LGKGDFR                                            357                                                          
						                                                            	         |||||||                                             
						                                                            	     351 LGKGDFR                                            357                                                          

						Comparison report between AA397955_P2 and Q9UFZ6short unique 	Sequence name: Q9UFZ6                                        
						head followed by partial WT sequence a mismatch and a        	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for AA397955_P2, comprising a first amino acid      	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 21463 x Q9UFZ6   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						having the sequence M corresponding to amino acids 1 - 1 of  	                                                            
						AA397955_P2, a second amino acid sequence being at least 90 %	                     Quality: 3562.00                      Escore:       0                                               
						homologous to SSSSWLLLSLVAVTAA corresponding to amino acids 1	             Matching length:     356                Total length:     356                                               
						- 16 of Q9UFZ6, which also corresponds to amino acids 2 - 17 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.72                                               
						of AA397955_P2, a bridging amino acid Q corresponding to     	    Total Percent Similarity:  100.00      Total Percent Identity:   99.72                                               
						amino acid 18 of AA397955_P2, a third amino acid sequence    	                        Gaps:       0                        
						STIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQST 	                                                            
						LAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNP 	Alignment:                                                   
						QECLLLEPGLNEIMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYED 	                  .         .         .         .         .  
						YGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPSYISP 	       2 SSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYN 51                                                           
						IGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQAWDAQRIFKEAEKFFVSV 	         ||||||||||||||||:|||||||||||||||||||||||||||||||||  
						GLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFR                      	       1 SSSSWLLLSLVAVTAAHSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYN 50                                                           
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 18 - 356 of Q9UFZ6, which also corresponds to amino    	      52 TNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQ 101                                                          
						acids 19 - 357 of AA397955_P2, and a fourth amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      51 TNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQ 100                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     102 QNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNEI 151                                                          
						having the sequence CRPKHQSEDKPKISSWR corresponding to amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 358 - 374 of AA397955_P2, wherein said first amino acid	     101 QNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNEI 150                                                          
						sequence, second amino acid sequence, bridging amino acid,   	                  .         .         .         .         .  
						third amino acid sequence and fourth amino acid sequence are 	     152 MANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGD 201                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of AA397955_P2, comprising a 	     151 MANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGD 200                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     202 YWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNA 251                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence CRPKHQSEDKPKISSWR in AA397955_P2.            	     201 YWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     252 YPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQA 301                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 YPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     302 WDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDL 351                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 WDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDL 350                                                          
						                                                            	                                                             
						                                                            	     352 GKGDFR                                             357                                                          
						                                                            	         ||||||                                              
						                                                            	     351 GKGDFR                                             356                                                          

						Comparison report between AA397955_P2 and AAH48094partial WT 	Sequence name: AAH48094                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA397955_P2, comprising a first     	Sequence documentation:                                      
						MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQ 	                                                            
						NMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTIL 	Alignment of: 21463 x AAH48094   ..                          
						NTMSTIYSTGKVCNPDNPQECLLLEPGLNEIMANSLDYNERLWAWESWRSEVGKQLRPLY 	                                                            
						EEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHL 	Alignment segment 1/1:                                       
						HAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQ 	                                                            
						AWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFR    	                     Quality: 3584.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     357                Total length:     357                                               
						corresponding to amino acids 12 - 368 of AAH48094, which also	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 357 of AA397955_P2, and a     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						polypeptide having the sequence CRPKHQSEDKPKISSWR            	                  .         .         .         .         .  
						corresponding to amino acids 358 - 374 of AA397955_P2,       	       1 MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNY 50                                                           
						wherein said first amino acid sequence and second amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	      12 MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNY 61                                                           
						isolated polypeptide encoding for a tail of AA397955_P2,     	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	      51 NTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQAL 100                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	      62 NTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQAL 111                                                          
						about 95% homologous to the sequence CRPKHQSEDKPKISSWR in    	                  .         .         .         .         .  
						AA397955_P2.                                                 	     101 QQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     112 QQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNE 161                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 IMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     162 IMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYG 211                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     212 DYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMN 261                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     262 AYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQ 311                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     312 AWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWD 361                                                          
						                                                            	                                                             
						                                                            	     351 LGKGDFR                                            357                                                          
						                                                            	         |||||||                                             
						                                                            	     362 LGKGDFR                                            368                                                          

						Comparison report between AA397955_P2 and Q9NRA7partial WT   	Sequence name: Q9NRA7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA397955_P2, comprising a first     	Sequence documentation:                                      
						MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQ 	                                                            
						NMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTIL 	Alignment of: 21463 x Q9NRA7   ..                            
						NTMSTIYSTGKVCNPDNPQECLLLEPGLNEIMANSLDYNERLWAWESWRSEVGKQLRPLY 	                                                            
						EEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHL 	Alignment segment 1/1:                                       
						HAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQ 	                                                            
						AWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFR    	                     Quality: 3584.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     357                Total length:     357                                               
						corresponding to amino acids 1 - 357 of Q9NRA7, which also   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 357 of AA397955_P2, and a     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						polypeptide having the sequence CRPKHQSEDKPKISSWR            	                  .         .         .         .         .  
						corresponding to amino acids 358 - 374 of AA397955_P2,       	       1 MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNY 50                                                           
						wherein said first amino acid sequence and second amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	       1 MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNY 50                                                           
						isolated polypeptide encoding for a tail of AA397955_P2,     	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	      51 NTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQAL 100                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	      51 NTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQAL 100                                                          
						about 95% homologous to the sequence CRPKHQSEDKPKISSWR in    	                  .         .         .         .         .  
						AA397955_P2.                                                 	     101 QQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 QQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNE 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 IMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 IMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYG 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 DYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 DYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 AYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 AYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWD 350                                                          
						                                                            	                                                             
						                                                            	     351 LGKGDFR                                            357                                                          
						                                                            	         |||||||                                             
						                                                            	     351 LGKGDFR                                            357                                                          

2719	HMR136_AA399058_2_tr0_r1_1_gPRT		Comparison report between AA399058_P2 and AAH50563partial WT 	Sequence name: AAH50563                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA399058_P2, comprising a first amino acid      	                                                            
						MVLQDENFVSKEEFQAVEKKLVEEKAAHAKTKVLLAKEEEKLQFALGEVEVLSKQLEKEK 	Alignment of: 2719 x AAH50563   ..                           
						LAFEKALSSVKSKVLQESSKKDQLITKCNGRREARALHHGYINGLFPNHPVPVSKAGFHS 	                                                            
						NTCPQLRIQAGPGGPHLRKGLKGPGRPRK                                	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 40 - 188 of AAH50563, which also corresponds to  	                     Quality: 1446.00                      Escore:       0                                               
						amino acids 1 - 149 of AA399058_P2.                          	             Matching length:     149                Total length:     149                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MVLQDENFVSKEEFQAVEKKLVEEKAAHAKTKVLLAKEEEKLQFALGEVE 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      40 MVLQDENFVSKEEFQAVEKKLVEEKAAHAKTKVLLAKEEEKLQFALGEVE 89                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 VLSKQLEKEKLAFEKALSSVKSKVLQESSKKDQLITKCNGRREARALHHG 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      90 VLSKQLEKEKLAFEKALSSVKSKVLQESSKKDQLITKCNGRREARALHHG 139                                                          
						                                                            	                  .         .         .         .            
						                                                            	     101 YINGLFPNHPVPVSKAGFHSNTCPQLRIQAGPGGPHLRKGLKGPGRPRK  149                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     140 YINGLFPNHPVPVSKAGFHSNTCPQLRIQAGPGGPHLRKGLKGPGRPRK  188                                                          

						Comparison report between AA399058_P2 and Q8N799partial WT   	Sequence name: Q8N799                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA399058_P2, comprising a first     	Sequence documentation:                                      
						MVLQDENFVSKEEFQAVEKKLVEEKAAHAKTKVLLAKEEEKLQFALGEVEVLSKQLEKEK 	                                                            
						LAFEKALSSVKSKVLQESSKKDQLITKCN                                	Alignment of: 2719 x Q8N799   ..                             
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 40 - 128 of Q8N799, which also  	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 89 of AA399058_P2, and a      	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality:  841.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:      89                Total length:      89                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence GRREARALHHGYINGLFPNHPVPVSKAGFHSNTCPQLRIQAGPGGPHLRKGLKGPGRPRK                             	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 90 - 149 of AA399058_P2, wherein	                        Gaps:       0                        
						said first amino acid sequence and second amino acid sequence	                                                            
						are contiguous and in a sequential order.2.An isolated       	Alignment:                                                   
						polypeptide encoding for a tail of AA399058_P2, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	       1 MVLQDENFVSKEEFQAVEKKLVEEKAAHAKTKVLLAKEEEKLQFALGEVE 50                                                           
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      40 MVLQDENFVSKEEFQAVEKKLVEEKAAHAKTKVLLAKEEEKLQFALGEVE 89                                                           
						to the sequence GRREARALHHGYINGLFPNHPVPVSKAGFHSNTCPQLRIQAGPGGPHLRKGLKGPGRPRK                                             	                  .         .         .                      
						in AA399058_P2.                                              	      51 VLSKQLEKEKLAFEKALSSVKSKVLQESSKKDQLITKCN            89                                                           
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	      90 VLSKQLEKEKLAFEKALSSVKSKVLQESSKKDQLITKCN            128                                                          

26733	HMR136_AA400393_0_tr0_r1_1_gPRT		Comparison report between AA400393_P0 and ATS6_HUMANpartial  	Sequence name: ATS6_HUMAN                                    
						WT sequence followed by mismatch and a followed by a unique  	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA400393_P0, comprising a first amino acid sequence being at 	                                                            
						MEILWKTLTWILSLIMASSEFHSDHRLSYSSQEEFLTYLEHYQLTIPIRVDQNGAFLSFT 	Alignment of: 26733 x ATS6_HUMAN   ..                        
						VKNDKHSRRRRSMDPIDPQQAVSKLFFKLSAYGKHFHLNLTLNTDFVSKHFTVEYWGKDG 	                                                            
						PQWKHDFLDNCHYTGYLQDQRSTTKVALSNCVGLHGVIATEDEEYFIEPLKNTTEDSKHF 	Alignment segment 1/1:                                       
						SYENGHPHVIYKKSALQQRHLYDHSHCGVSDFTRSGKPWWLNDTSTVSYSLPINNTHIHH 	                                                            
						RQKRSVSIERFVETLVVADKMMVGYHGRKDIEHYILSVMNIVAKLYRDSSLGNVVNIIVA 	                     Quality: 4200.00                      Escore:       0                                               
						RLIVLTEDQPNLEINHHADKSLDSFCKWQKSILSHQSDGNTIPENGIAHHDNAVLITRYD 	             Matching length:     423                Total length:     423                                               
						ICTYKNKPCGTLGLASVAGMCEPERSCSINEDIGLGSAFTIAHEI                	 Matching Percent Similarity:   99.53   Matching Percent Identity:   99.53                                               
						least 90 % homologous to corresponding to amino acids 1 - 405	    Total Percent Similarity:   99.53      Total Percent Identity:   99.53                                               
						of ATS6_HUMAN, which also corresponds to amino acids 1 - 405 	                        Gaps:       0                        
						of AA400393_P0, a bridging amino acid G corresponding to     	                                                            
						amino acid 406 of AA400393_P0, a second amino acid sequence  	Alignment:                                                   
						being at least 90 % homologous to HNFGMNHDGIGNSCG            	                  .         .         .         .         .  
						corresponding to amino acids 407 - 421 of ATS6_HUMAN, which  	       1 MEILWKTLTWILSLIMASSEFHSDHRLSYSSQEEFLTYLEHYQLTIPIRV 50                                                           
						also corresponds to amino acids 407 - 421 of AA400393_P0, and	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a third amino acid sequence being at least 70%, optionally at	       1 MEILWKTLTWILSLIMASSEFHSDHRLSYSSQEEFLTYLEHYQLTIPIRV 50                                                           
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	      51 DQNGAFLSFTVKNDKHSRRRRSMDPIDPQQAVSKLFFKLSAYGKHFHLNL 100                                                          
						TKGHEAAKLMAAHITANTNPFSWSACSRDYITSFLEKCVESSGVSAKATAVSPTVFQQLR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GHCVKLGILKKGGVIREIVFLLALGPRA                                 	      51 DQNGAFLSFTVKNDKHSRRRRSMDPIDPQQAVSKLFFKLSAYGKHFHLNL 100                                                          
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						422 - 509 of AA400393_P0, wherein said first amino acid      	     101 TLNTDFVSKHFTVEYWGKDGPQWKHDFLDNCHYTGYLQDQRSTTKVALSN 150                                                          
						sequence, bridging amino acid, second amino acid sequence and	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence are contiguous and in a sequential 	     101 TLNTDFVSKHFTVEYWGKDGPQWKHDFLDNCHYTGYLQDQRSTTKVALSN 150                                                          
						order.2.An isolated polypeptide encoding for a tail of       	                  .         .         .         .         .  
						AA400393_P0, comprising a polypeptide being at least 70%,    	     151 CVGLHGVIATEDEEYFIEPLKNTTEDSKHFSYENGHPHVIYKKSALQQRH 200                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     151 CVGLHGVIATEDEEYFIEPLKNTTEDSKHFSYENGHPHVIYKKSALQQRH 200                                                          
						TKGHEAAKLMAAHITANTNPFSWSACSRDYITSFLEKCVESSGVSAKATAVSPTVFQQLR 	                  .         .         .         .         .  
						GHCVKLGILKKGGVIREIVFLLALGPRA                                 	     201 LYDHSHCGVSDFTRSGKPWWLNDTSTVSYSLPINNTHIHHRQKRSVSIER 250                                                          
						least about 95% homologous to the sequence in AA400393_P0.   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LYDHSHCGVSDFTRSGKPWWLNDTSTVSYSLPINNTHIHHRQKRSVSIER 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 FVETLVVADKMMVGYHGRKDIEHYILSVMNIVAKLYRDSSLGNVVNIIVA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 FVETLVVADKMMVGYHGRKDIEHYILSVMNIVAKLYRDSSLGNVVNIIVA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RLIVLTEDQPNLEINHHADKSLDSFCKWQKSILSHQSDGNTIPENGIAHH 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RLIVLTEDQPNLEINHHADKSLDSFCKWQKSILSHQSDGNTIPENGIAHH 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DNAVLITRYDICTYKNKPCGTLGLASVAGMCEPERSCSINEDIGLGSAFT 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 DNAVLITRYDICTYKNKPCGTLGLASVAGMCEPERSCSINEDIGLGSAFT 400                                                          
						                                                            	                  .         .                                
						                                                            	     401 IAHEIGHNFGMNHDGIGNSCGTK                            423                                                          
						                                                            	         ||||| ||||||||||||||| |                             
						                                                            	     401 IAHEIVHNFGMNHDGIGNSCGRK                            423                                                          

26735	HMR136_AA400393_1_tr0_r1_1_gPRT		Comparison report between AA400393_P1 and ATS6_HUMANpartial  	Sequence name: ATS6_HUMAN                                    
						WT sequence followed by mismatch and a followed by a unique  	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA400393_P1, comprising a first amino acid sequence being at 	                                                            
						MEILWKTLTWILSLIMASSEFHSDHRLSYSSQEEFLTYLEHYQLTIPIRVDQNGAFLSFT 	Alignment of: 26735 x ATS6_HUMAN   ..                        
						VKNDKHSRRRRSMDPIDPQQAVSKLFFKLSAYGKHFHLNLTLNTDFVSKHFTVEYWGKDG 	                                                            
						PQWKHDFLDNCHYTGYLQDQRSTTKVALSNCVGLHGVIATEDEEYFIEPLKNTTEDSKHF 	Alignment segment 1/1:                                       
						SYENGHPHVIYKKSALQQRHLYDHSHCGVSDFTRSGKPWWLNDTSTVSYSLPINNTHIHH 	                                                            
						RQKRSVSIERFVETLVVADKMMVGYHGRKDIEHYILSVMNIVAKLYRDSSLGNVVNIIVA 	                     Quality: 4200.00                      Escore:       0                                               
						RLIVLTEDQPNLEINHHADKSLDSFCKWQKSILSHQSDGNTIPENGIAHHDNAVLITRYD 	             Matching length:     423                Total length:     423                                               
						ICTYKNKPCGTLGLASVAGMCEPERSCSINEDIGLGSAFTIAHEI                	 Matching Percent Similarity:   99.53   Matching Percent Identity:   99.53                                               
						least 90 % homologous to corresponding to amino acids 1 - 405	    Total Percent Similarity:   99.53      Total Percent Identity:   99.53                                               
						of ATS6_HUMAN, which also corresponds to amino acids 1 - 405 	                        Gaps:       0                        
						of AA400393_P1, a bridging amino acid G corresponding to     	                                                            
						amino acid 406 of AA400393_P1, a second amino acid sequence  	Alignment:                                                   
						being at least 90 % homologous to HNFGMNHDGIGNSCG            	                  .         .         .         .         .  
						corresponding to amino acids 407 - 421 of ATS6_HUMAN, which  	       1 MEILWKTLTWILSLIMASSEFHSDHRLSYSSQEEFLTYLEHYQLTIPIRV 50                                                           
						also corresponds to amino acids 407 - 421 of AA400393_P1, and	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a third amino acid sequence being at least 70%, optionally at	       1 MEILWKTLTWILSLIMASSEFHSDHRLSYSSQEEFLTYLEHYQLTIPIRV 50                                                           
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	      51 DQNGAFLSFTVKNDKHSRRRRSMDPIDPQQAVSKLFFKLSAYGKHFHLNL 100                                                          
						polypeptide having the sequence                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TKGHEAAKLMAAHITANTNPFSWSACSRDYITSFLEFLKLGDSISGS corresponding	      51 DQNGAFLSFTVKNDKHSRRRRSMDPIDPQQAVSKLFFKLSAYGKHFHLNL 100                                                          
						to amino acids 422 - 468 of AA400393_P1, wherein said first  	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid, second amino acid  	     101 TLNTDFVSKHFTVEYWGKDGPQWKHDFLDNCHYTGYLQDQRSTTKVALSN 150                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     101 TLNTDFVSKHFTVEYWGKDGPQWKHDFLDNCHYTGYLQDQRSTTKVALSN 150                                                          
						tail of AA400393_P1, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     151 CVGLHGVIATEDEEYFIEPLKNTTEDSKHFSYENGHPHVIYKKSALQQRH 200                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence                	     151 CVGLHGVIATEDEEYFIEPLKNTTEDSKHFSYENGHPHVIYKKSALQQRH 200                                                          
						TKGHEAAKLMAAHITANTNPFSWSACSRDYITSFLEFLKLGDSISGS in           	                  .         .         .         .         .  
						AA400393_P1.                                                 	     201 LYDHSHCGVSDFTRSGKPWWLNDTSTVSYSLPINNTHIHHRQKRSVSIER 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LYDHSHCGVSDFTRSGKPWWLNDTSTVSYSLPINNTHIHHRQKRSVSIER 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 FVETLVVADKMMVGYHGRKDIEHYILSVMNIVAKLYRDSSLGNVVNIIVA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 FVETLVVADKMMVGYHGRKDIEHYILSVMNIVAKLYRDSSLGNVVNIIVA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RLIVLTEDQPNLEINHHADKSLDSFCKWQKSILSHQSDGNTIPENGIAHH 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RLIVLTEDQPNLEINHHADKSLDSFCKWQKSILSHQSDGNTIPENGIAHH 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DNAVLITRYDICTYKNKPCGTLGLASVAGMCEPERSCSINEDIGLGSAFT 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 DNAVLITRYDICTYKNKPCGTLGLASVAGMCEPERSCSINEDIGLGSAFT 400                                                          
						                                                            	                  .         .                                
						                                                            	     401 IAHEIGHNFGMNHDGIGNSCGTK                            423                                                          
						                                                            	         ||||| ||||||||||||||| |                             
						                                                            	     401 IAHEIVHNFGMNHDGIGNSCGRK                            423                                                          

26737	HMR136_AA400393_2_tr0_r1_1_gPRT		Comparison report between AA400393_P2 and ATS6_HUMANpartial  	Sequence name: ATS6_HUMAN                                    
						WT sequence followed by mismatch and a followed by a unique  	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA400393_P2, comprising a first amino acid sequence being at 	                                                            
						MEILWKTLTWILSLIMASSEFHSDHRLSYSSQEEFLTYLEHYQLTIPIRVDQNGAFLSFT 	Alignment of: 26737 x ATS6_HUMAN   ..                        
						VKNDKHSRRRRSMDPIDPQQAVSKLFFKLSAYGKHFHLNLTLNTDFVSKHFTVEYWGKDG 	                                                            
						PQWKHDFLDNCHYTGYLQDQRSTTKVALSNCVGLHGVIATEDEEYFIEPLKNTTEDSKHF 	Alignment segment 1/1:                                       
						SYENGHPHVIYKKSALQQRHLYDHSHCGVSDFTRSGKPWWLNDTSTVSYSLPINNTHIHH 	                                                            
						RQKRSVSIERFVETLVVADKMMVGYHGRKDIEHYILSVMNIVAKLYRDSSLGNVVNIIVA 	                     Quality: 4200.00                      Escore:       0                                               
						RLIVLTEDQPNLEINHHADKSLDSFCKWQKSILSHQSDGNTIPENGIAHHDNAVLITRYD 	             Matching length:     423                Total length:     423                                               
						ICTYKNKPCGTLGLASVAGMCEPERSCSINEDIGLGSAFTIAHEI                	 Matching Percent Similarity:   99.53   Matching Percent Identity:   99.53                                               
						least 90 % homologous to corresponding to amino acids 1 - 405	    Total Percent Similarity:   99.53      Total Percent Identity:   99.53                                               
						of ATS6_HUMAN, which also corresponds to amino acids 1 - 405 	                        Gaps:       0                        
						of AA400393_P2, a bridging amino acid G corresponding to     	                                                            
						amino acid 406 of AA400393_P2, a second amino acid sequence  	Alignment:                                                   
						being at least 90 % homologous to HNFGMNHDGIGNSCG            	                  .         .         .         .         .  
						corresponding to amino acids 407 - 421 of ATS6_HUMAN, which  	       1 MEILWKTLTWILSLIMASSEFHSDHRLSYSSQEEFLTYLEHYQLTIPIRV 50                                                           
						also corresponds to amino acids 407 - 421 of AA400393_P2, and	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a third amino acid sequence being at least 70%, optionally at	       1 MEILWKTLTWILSLIMASSEFHSDHRLSYSSQEEFLTYLEHYQLTIPIRV 50                                                           
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	      51 DQNGAFLSFTVKNDKHSRRRRSMDPIDPQQAVSKLFFKLSAYGKHFHLNL 100                                                          
						polypeptide having the sequence                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TKGHEAAKLMAAHITANTNPFSWSACSRDYITSFLEFLKLGDSISGS corresponding	      51 DQNGAFLSFTVKNDKHSRRRRSMDPIDPQQAVSKLFFKLSAYGKHFHLNL 100                                                          
						to amino acids 422 - 468 of AA400393_P2, wherein said first  	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid, second amino acid  	     101 TLNTDFVSKHFTVEYWGKDGPQWKHDFLDNCHYTGYLQDQRSTTKVALSN 150                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     101 TLNTDFVSKHFTVEYWGKDGPQWKHDFLDNCHYTGYLQDQRSTTKVALSN 150                                                          
						tail of AA400393_P2, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     151 CVGLHGVIATEDEEYFIEPLKNTTEDSKHFSYENGHPHVIYKKSALQQRH 200                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence                	     151 CVGLHGVIATEDEEYFIEPLKNTTEDSKHFSYENGHPHVIYKKSALQQRH 200                                                          
						TKGHEAAKLMAAHITANTNPFSWSACSRDYITSFLEFLKLGDSISGS in           	                  .         .         .         .         .  
						AA400393_P2.                                                 	     201 LYDHSHCGVSDFTRSGKPWWLNDTSTVSYSLPINNTHIHHRQKRSVSIER 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LYDHSHCGVSDFTRSGKPWWLNDTSTVSYSLPINNTHIHHRQKRSVSIER 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 FVETLVVADKMMVGYHGRKDIEHYILSVMNIVAKLYRDSSLGNVVNIIVA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 FVETLVVADKMMVGYHGRKDIEHYILSVMNIVAKLYRDSSLGNVVNIIVA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 RLIVLTEDQPNLEINHHADKSLDSFCKWQKSILSHQSDGNTIPENGIAHH 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RLIVLTEDQPNLEINHHADKSLDSFCKWQKSILSHQSDGNTIPENGIAHH 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 DNAVLITRYDICTYKNKPCGTLGLASVAGMCEPERSCSINEDIGLGSAFT 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 DNAVLITRYDICTYKNKPCGTLGLASVAGMCEPERSCSINEDIGLGSAFT 400                                                          
						                                                            	                  .         .                                
						                                                            	     401 IAHEIGHNFGMNHDGIGNSCGTK                            423                                                          
						                                                            	         ||||| ||||||||||||||| |                             
						                                                            	     401 IAHEIVHNFGMNHDGIGNSCGRK                            423                                                          

27810	HMR136_AA400657_1_tr0_r1_1_gPRT		Comparison report between AA400657_P1 and Q96LJ0partial WT   	Sequence name: Q96LJ0                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for AA400657_P1, comprising a first     	Sequence documentation:                                      
						MSPSMLTGNSPRGCRLPSISSTTCGRQLEKVPEKRDSGMTEVERTYSANCSDFLESKGCF 	                                                            
						ANTTPSGKSVSSSSSVETGPSVSEPPGLPRVSAYVDTTADLDRKLSFSHSDHSSEMSLPE 	Alignment of: 27810 x Q96LJ0   ..                            
						VQKDKYPEEFSLLKLQTKDGHRPEWTFYPRFSSNIHTYHVGKQCFFNGVFLGNKRSLSER 	                                                            
						TVDKCFGRKKYDIDPRNGIPKLTPGDNPYMYPEQSKGFHKAGSMLPPVNFSI         	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 232 of Q96LJ0, which also   	                     Quality: 2701.00                      Escore:       0                                               
						corresponds to amino acids 1 - 232 of AA400657_P1, and a     	             Matching length:     279                Total length:     300                                               
						second amino acid sequence being at least 90 % homologous to 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LPFWVKEKANSLKNEIQEVEELDNWQPAVPLMHMLHLSGALDFPRQS corresponding	    Total Percent Similarity:   93.00      Total Percent Identity:   93.00                                               
						to amino acids 254 - 300 of Q96LJ0, which also corresponds to	                        Gaps:       1                        
						amino acids 233 - 279 of AA400657_P1, wherein said first     	                                                            
						amino acid sequence and second amino acid sequence are       	Alignment:                                                   
						contiguous and in a sequential order.2.An isolated chimeric  	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of AA400657_P1,     	       1 MSPSMLTGNSPRGCRLPSISSTTCGRQLEKVPEKRDSGMTEVERTYSANC 50                                                           
						comprising a polypeptide having a length "n", wherein n is at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 10 amino acids in length, optionally at least    	       1 MSPSMLTGNSPRGCRLPSISSTTCGRQLEKVPEKRDSGMTEVERTYSANC 50                                                           
						about 20 amino acids in length, preferably at least about 30 	                  .         .         .         .         .  
						amino acids in length, more preferably at least about 40     	      51 SDFLESKGCFANTTPSGKSVSSSSSVETGPSVSEPPGLPRVSAYVDTTAD 100                                                          
						amino acids in length and most preferably at least about 50  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, wherein at least two amino acids      	      51 SDFLESKGCFANTTPSGKSVSSSSSVETGPSVSEPPGLPRVSAYVDTTAD 100                                                          
						comprise IL, having a structure as follows: a sequence       	                  .         .         .         .         .  
						starting from any of amino acid numbers 232-x to 233; and    	     101 LDRKLSFSHSDHSSEMSLPEVQKDKYPEEFSLLKLQTKDGHRPEWTFYPR 150                                                          
						ending at any of amino acid numbers 233+ ((n-2) - x), in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which x varies from 0 to n-2.                                	     101 LDRKLSFSHSDHSSEMSLPEVQKDKYPEEFSLLKLQTKDGHRPEWTFYPR 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FSSNIHTYHVGKQCFFNGVFLGNKRSLSERTVDKCFGRKKYDIDPRNGIP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 FSSNIHTYHVGKQCFFNGVFLGNKRSLSERTVDKCFGRKKYDIDPRNGIP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KLTPGDNPYMYPEQSKGFHKAGSMLPPVNFSI.................. 232                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     201 KLTPGDNPYMYPEQSKGFHKAGSMLPPVNFSIVPYEKKFDTFIPLEPLPQ 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     233 ...LPFWVKEKANSLKNEIQEVEELDNWQPAVPLMHMLHLSGALDFPRQS 279                                                          
						                                                            	            |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 IPNLPFWVKEKANSLKNEIQEVEELDNWQPAVPLMHMLHLSGALDFPRQS 300                                                          

10154	HMR136_AA411929_4_tr0_r1_1_gPRT		Comparison report between AA411929_P4 and Q8TC48partial WT   	Sequence name: Q8TC48                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA411929_P4, comprising a first amino acid sequence being at 	                                                            
						MNENKDTDSKKSEEYEDDFEKDLEWLINENEKSDASIIEMACEKEENINQDLKENETVME 	Alignment of: 10154 x Q8TC48   ..                            
						HTKRHSDPDKSLQDEVSPRRNDIISVPGIQPLDPISDSDSENSFQESKLESQKDLEEEED 	                                                            
						EEVRRYIMEKIVQANKLLQNQEPVNDKRERKLKFKDQLVDLEVPPLEDTTT          	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 171	                                                            
						of Q8TC48, which also corresponds to amino acids 1 - 171 of  	                     Quality: 3620.00                      Escore:       0                                               
						AA411929_P4, a bridging amino acid F corresponding to amino  	             Matching length:     369                Total length:     369                                               
						acid 172 of AA411929_P4, a second amino acid sequence being  	 Matching Percent Similarity:   99.73   Matching Percent Identity:   99.73                                               
						KNYFENERNMFGKLSQLCISNDFGQEDVLLSLTNGSCEENKDRTILVERDGKFELLNLQD 	    Total Percent Similarity:   99.73      Total Percent Identity:   99.73                                               
						IASQGFLPPINNANSTENDPQQLLPRSSNSSVSGTKKEDSTAKIHAVTHSSTGEPLAYIA 	                        Gaps:       0                        
						QPPLNRKTCPSSAVNSDRSKGNGKSNHRTQSAHISPVTSTYCLSPRQKELQKQLEEKREK 	                                                            
						LKREEERRKIEEEKEKK                                            	Alignment:                                                   
						at least 90 % homologous to corresponding to amino acids 173 	                  .         .         .         .         .  
						- 369 of Q8TC48, which also corresponds to amino acids 173 - 	       1 MNENKDTDSKKSEEYEDDFEKDLEWLINENEKSDASIIEMACEKEENINQ 50                                                           
						369 of AA411929_P4, and a third amino acid sequence being at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least 80%, preferably at least 85%, 	       1 MNENKDTDSKKSEEYEDDFEKDLEWLINENEKSDASIIEMACEKEENINQ 50                                                           
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						RENDIVFKAWLQKKREQVLEMRRIQRAKEIEDMNSRQENRDPQQAFRLWLKKKHEEQMKE 	      51 DLKENETVMEHTKRHSDPDKSLQDEVSPRRNDIISVPGIQPLDPISDSDS 100                                                          
						RQTEELRKQEECLFFLKGTEGRERAFKQWLRRKRMEKMAEQQAVRERTRQLRLEAKRSKQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LQHHLYMSEAKPFRFTDHYN                                         	      51 DLKENETVMEHTKRHSDPDKSLQDEVSPRRNDIISVPGIQPLDPISDSDS 100                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 370 - 509 of AA411929_P4, wherein said first  	     101 ENSFQESKLESQKDLEEEEDEEVRRYIMEKIVQANKLLQNQEPVNDKRER 150                                                          
						amino acid sequence, bridging amino acid, second amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     101 ENSFQESKLESQKDLEEEEDEEVRRYIMEKIVQANKLLQNQEPVNDKRER 150                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of AA411929_P4, comprising a polypeptide being at least 	     151 KLKFKDQLVDLEVPPLEDTTTFKNYFENERNMFGKLSQLCISNDFGQEDV 200                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||| ||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     151 KLKFKDQLVDLEVPPLEDTTTSKNYFENERNMFGKLSQLCISNDFGQEDV 200                                                          
						RENDIVFKAWLQKKREQVLEMRRIQRAKEIEDMNSRQENRDPQQAFRLWLKKKHEEQMKE 	                  .         .         .         .         .  
						RQTEELRKQEECLFFLKGTEGRERAFKQWLRRKRMEKMAEQQAVRERTRQLRLEAKRSKQ 	     201 LLSLTNGSCEENKDRTILVERDGKFELLNLQDIASQGFLPPINNANSTEN 250                                                          
						LQHHLYMSEAKPFRFTDHYN                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence in AA411929_P4.	     201 LLSLTNGSCEENKDRTILVERDGKFELLNLQDIASQGFLPPINNANSTEN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 DPQQLLPRSSNSSVSGTKKEDSTAKIHAVTHSSTGEPLAYIAQPPLNRKT 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 DPQQLLPRSSNSSVSGTKKEDSTAKIHAVTHSSTGEPLAYIAQPPLNRKT 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 CPSSAVNSDRSKGNGKSNHRTQSAHISPVTSTYCLSPRQKELQKQLEEKR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 CPSSAVNSDRSKGNGKSNHRTQSAHISPVTSTYCLSPRQKELQKQLEEKR 350                                                          
						                                                            	                  .                                          
						                                                            	     351 EKLKREEERRKIEEEKEKK                                369                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     351 EKLKREEERRKIEEEKEKK                                369                                                          

						Comparison report between AA411929_P4 and O60780partial WT   	Sequence name: O60780                                        
						sequence with short unique insertion.1.An isolated chimeric  	                                                            
						polypeptide encoding for AA411929_P4, comprising a first     	Sequence documentation:                                      
						MNENKDTDSKKSEEYEDDFEKDLEWLINENEKSDASIIEMACEKEENINQDLKENETVME 	                                                            
						HTKRHSDPDKSLQDEVSPRRNDIISVPGIQPLDPISDSDSENSFQESKLESQKDLEEEED 	Alignment of: 10154 x O60780   ..                            
						EEVRRYIMEKIVQANKLLQNQEPVNDKRERKLKFKDQLVDLEVPPLEDTTTFKNYFENER 	                                                            
						NMFGKLSQLCISNDFGQEDVLLSLTNGSCEENKDRTILVERDGKFELLNLQDIASQGFLP 	Alignment segment 1/1:                                       
						PINNANSTENDPQQLLPRSSNSSVSGTKKEDSTAKIHAVTHSSTGEPLAYIAQPPLNRKT 	                                                            
						CPSSAVNSDRSKGNGKSNHRTQSAHISPVTSTYCLSPRQKELQKQLEEKREKLKREEERR 	                     Quality: 4947.00                      Escore:       0                                               
						KIEEEKEKKRENDIVFKAWLQKKREQVLEMRRIQRAKEIEDMNSR                	             Matching length:     508                Total length:     509                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 405 of O60780, which also   	    Total Percent Similarity:   99.80      Total Percent Identity:   99.80                                               
						corresponds to amino acids 1 - 405 of AA411929_P4, a second  	                        Gaps:       1                        
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment:                                                   
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						having the sequence Q corresponding to amino acids 406 - 406 	       1 MNENKDTDSKKSEEYEDDFEKDLEWLINENEKSDASIIEMACEKEENINQ 50                                                           
						of AA411929_P4, and a third amino acid sequence being at     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ENRDPQQAFRLWLKKKHEEQMKERQTEELRKQEECLFFLKGTEGRERAFKQWLRRKRMEK 	       1 MNENKDTDSKKSEEYEDDFEKDLEWLINENEKSDASIIEMACEKEENINQ 50                                                           
						MAEQQAVRERTRQLRLEAKRSKQLQHHLYMSEAKPFRFTDHYN                  	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 406 -  	      51 DLKENETVMEHTKRHSDPDKSLQDEVSPRRNDIISVPGIQPLDPISDSDS 100                                                          
						508 of O60780, which also corresponds to amino acids 407 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						509 of AA411929_P4, wherein said first amino acid sequence,  	      51 DLKENETVMEHTKRHSDPDKSLQDEVSPRRNDIISVPGIQPLDPISDSDS 100                                                          
						second amino acid sequence and third amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     101 ENSFQESKLESQKDLEEEEDEEVRRYIMEKIVQANKLLQNQEPVNDKRER 150                                                          
						polypeptide encoding for an edge portion of AA411929_P4,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising an amino acid sequence being at least 70%,        	     101 ENSFQESKLESQKDLEEEEDEEVRRYIMEKIVQANKLLQNQEPVNDKRER 150                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     151 KLKFKDQLVDLEVPPLEDTTTFKNYFENERNMFGKLSQLCISNDFGQEDV 200                                                          
						least about 95% homologous to the sequence encoding for Q,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to AA411929_P4.                                	     151 KLKFKDQLVDLEVPPLEDTTTFKNYFENERNMFGKLSQLCISNDFGQEDV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LLSLTNGSCEENKDRTILVERDGKFELLNLQDIASQGFLPPINNANSTEN 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LLSLTNGSCEENKDRTILVERDGKFELLNLQDIASQGFLPPINNANSTEN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 DPQQLLPRSSNSSVSGTKKEDSTAKIHAVTHSSTGEPLAYIAQPPLNRKT 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 DPQQLLPRSSNSSVSGTKKEDSTAKIHAVTHSSTGEPLAYIAQPPLNRKT 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 CPSSAVNSDRSKGNGKSNHRTQSAHISPVTSTYCLSPRQKELQKQLEEKR 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 CPSSAVNSDRSKGNGKSNHRTQSAHISPVTSTYCLSPRQKELQKQLEEKR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 EKLKREEERRKIEEEKEKKRENDIVFKAWLQKKREQVLEMRRIQRAKEIE 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 EKLKREEERRKIEEEKEKKRENDIVFKAWLQKKREQVLEMRRIQRAKEIE 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 DMNSRQENRDPQQAFRLWLKKKHEEQMKERQTEELRKQEECLFFLKGTEG 450                                                          
						                                                            	         ||||| ||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 DMNSR.ENRDPQQAFRLWLKKKHEEQMKERQTEELRKQEECLFFLKGTEG 449                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 RERAFKQWLRRKRMEKMAEQQAVRERTRQLRLEAKRSKQLQHHLYMSEAK 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     450 RERAFKQWLRRKRMEKMAEQQAVRERTRQLRLEAKRSKQLQHHLYMSEAK 499                                                          
						                                                            	                                                             
						                                                            	     501 PFRFTDHYN                                          509                                                          
						                                                            	         |||||||||                                           
						                                                            	     500 PFRFTDHYN                                          508                                                          

11179	HMR136_AA412289_6_tr0_r1_1_gPRT		Comparison report between AA412289_P6 and Q8N4G9partial WT   	Sequence name: Q8N4G9                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA412289_P6, comprising a first amino acid      	                                                            
						MDQEEGLKALDNIVTQFNAYEDFLDSQITTVDLYYLEDETLARQLVELGYRGTGERVKRE 	Alignment of: 11179 x Q8N4G9   ..                            
						DFEARKAAIEIARLAERAQQK                                        	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 1 - 81 of Q8N4G9, which also corresponds to amino	                                                            
						acids 1 - 81 of AA412289_P6.                                 	                     Quality:  769.00                      Escore:       0                                               
						                                                            	             Matching length:      81                Total length:      81                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MDQEEGLKALDNIVTQFNAYEDFLDSQITTVDLYYLEDETLARQLVELGY 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MDQEEGLKALDNIVTQFNAYEDFLDSQITTVDLYYLEDETLARQLVELGY 50                                                           
						                                                            	                  .         .         .                      
						                                                            	      51 RGTGERVKREDFEARKAAIEIARLAERAQQK                    81                                                           
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	      51 RGTGERVKREDFEARKAAIEIARLAERAQQK                    81                                                           

13467	HMR136_AA416662_1_tr0_r1_1_gPRT		Comparison report between AA416662_P1 and Q8IXQ8unique head  	Sequence name: Q8IXQ8                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA416662_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 13467 x Q8IXQ8   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MQKASHKNKKERGVSNKVKTSVHNLSKTQQTKLTVGSLGLGLIIIQHGPYLQITHLIRKG 	Alignment segment 1/1:                                       
						AAANDGKLQP                                                   	                                                            
						having the sequence corresponding to amino acids 1 - 70 of   	                     Quality: 1923.00                      Escore:       0                                               
						AA416662_P1, and a second amino acid sequence being at least 	             Matching length:     194                Total length:     194                                               
						GDVLISVGHANVLGYTLREFLQLLQHITIGTVLQIKVYRDFINIPEEWQEIYDLIPEAKF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PVTSTPKKIELAKDESFTSSDDNENVDLDKRLQYYRYPWSTVHHPARRPISISRDWHGYK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						KKNHTISVGKDINCDVMIHRDDKKEVRAPSPYWIMVKQDNESSSSSTSSTSDAFWLEDCA 	                        Gaps:       0                        
						QVEEGKAQLVSKVG                                               	                                                            
						90 % homologous to corresponding to amino acids 9 - 202 of   	Alignment:                                                   
						Q8IXQ8, which also corresponds to amino acids 71 - 264 of    	                  .         .         .         .         .  
						AA416662_P1, wherein said first amino acid sequence and      	      71 GDVLISVGHANVLGYTLREFLQLLQHITIGTVLQIKVYRDFINIPEEWQE 120                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	       9 GDVLISVGHANVLGYTLREFLQLLQHITIGTVLQIKVYRDFINIPEEWQE 58                                                           
						AA416662_P1, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     121 IYDLIPEAKFPVTSTPKKIELAKDESFTSSDDNENVDLDKRLQYYRYPWS 170                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MQKASHKNKKERGVSNKVKTSVHNLSKTQQTKLTVGSLGLGLIIIQHGPYLQITHLIRKG 	      59 IYDLIPEAKFPVTSTPKKIELAKDESFTSSDDNENVDLDKRLQYYRYPWS 108                                                          
						AAANDGKLQP                                                   	                  .         .         .         .         .  
						least about 95% homologous to the sequence of AA416662_P1.   	     171 TVHHPARRPISISRDWHGYKKKNHTISVGKDINCDVMIHRDDKKEVRAPS 220                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     109 TVHHPARRPISISRDWHGYKKKNHTISVGKDINCDVMIHRDDKKEVRAPS 158                                                          
						                                                            	                  .         .         .         .            
						                                                            	     221 PYWIMVKQDNESSSSSTSSTSDAFWLEDCAQVEEGKAQLVSKVG       264                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||        
						                                                            	     159 PYWIMVKQDNESSSSSTSSTSDAFWLEDCAQVEEGKAQLVSKVG       202                                                          

15612	HMR136_AA420996_4_tr0_r1_1_gPRT		Comparison report between AA420996_P4 and Q9BRQ4unique head  	Sequence name: Q9BRQ4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA420996_P4, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15612 x Q9BRQ4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MATGELGDLGGYYFRFLPQKTFQSLSSKEITSRLRQWS corresponding to amino	                                                            
						acids 1 - 38 of AA420996_P4, a second amino acid sequence    	                     Quality:  512.00                      Escore:       0                                               
						being at least 90 % homologous to                            	             Matching length:      52                Total length:      52                                               
						MLGRIKAQAFGFDQTFQSYRKDDFVMAFFKDPNVIPNLKLLSDSSGQWIILG         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 52 of Q9BRQ4, which also    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 39 - 90 of AA420996_P4, and a     	                        Gaps:       0                        
						third amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence FCWYVLSFSKES corresponding to	      39 MLGRIKAQAFGFDQTFQSYRKDDFVMAFFKDPNVIPNLKLLSDSSGQWII 88                                                           
						amino acids 91 - 102 of AA420996_P4, wherein said first amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence and third amino    	       1 MLGRIKAQAFGFDQTFQSYRKDDFVMAFFKDPNVIPNLKLLSDSSGQWII 50                                                           
						acid sequence are contiguous and in a sequential order.2.An  	                                                             
						isolated polypeptide encoding for a head of AA420996_P4,     	      89 LG                                                 90                                                           
						comprising a polypeptide being at least 70%, optionally at   	         ||                                                  
						least about 80%, preferably at least about 85%, more         	      51 LG                                                 52                                                           
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						MATGELGDLGGYYFRFLPQKTFQSLSSKEITSRLRQWS of AA420996_P4.3.An   	                                                            
						isolated polypeptide encoding for a tail of AA420996_P4,     	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence FCWYVLSFSKES in         	                                                            
						AA420996_P4.                                                 	                                                            

16206	HMR136_AA424272_1_tr0_r1_1_gPRT		Comparison report between AA424272_P1 and Q9H694unique head  	Sequence name: Q9H694                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA424272_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16206 x Q9H694   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						IMEETNTQIAWPSKLKIGAKSKKDPHIKVSGKKEDVKEAKEMIMSVLDTKSNRVTLKMDV 	Alignment segment 1/1:                                       
						SHTEHSHVIGKGGNNIKKVMEETGCHIHFPDSNRNNQAEKSNQVSIAGQPAGVESARVRI 	                                                            
						RELLPLVLMFELPIAGILQPVPDPNSPSIQHISQTYNISVSFKQRSRMYGATVIVRGSQN 	                     Quality: 4568.00                      Escore:       0                                               
						NTSAVKEGTAMLLEHLAGSLASAIPVSTQLDIAAQHHLFMMGRNGSNIKHIMQRTGAQIH 	             Matching length:     472                Total length:     472                                               
						FPDPSNPQKKSTVYLQGTIESVCLARQYLMGCLPLVLMFDMKEEIEVDPQFIAQL      	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.79                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:   99.79                                               
						to amino acids 1 - 295 of AA424272_P1, a second amino acid   	                        Gaps:       0                        
						MEQLDVFISIKPKPKQPSKSVIVKSVERNALNMYEARKCLLGLESSGVTIATSPSPASCP 	                                                            
						AGLACPSLDILASAGLGLTGLGLLGPTTLSLNTSTTPNSLLNALNSSVSPLQSPSSGTPS 	Alignment:                                                   
						PTLWAPPLANTSSATGFSAIPHLMIPSTAQATLTNILLSGVPTYGHTAPSPPPGLTPVDV 	                  .         .         .         .         .  
						HINSMQTEGKKISAALNGHAQSPDIKYGAISTSSLGEKVLSANHGDPSIQTSGSEQTSPK 	     296 MEQLDVFISIKPKPKQPSKSVIVKSVERNALNMYEARKCLLGLESSGVTI 345                                                          
						SSPTEGCNDAFVEVGMPRSPSHSGNAGDLKQMMCPSKVSCAKRQTVELLQGTKNSHLHST 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DRLLSDPELSATESPLADKKAPGSERAAERAAAAQQNSERAHLAPRSSYVNMQAFDYEQK 	       1 MEQLDVFISIKPKPKQPSKSVIVKSVERNALNMYEARKCLLGLESSGVTI 50                                                           
						KLLATKAMLKKPVVTEVRTPTNTWSGLGFSKSMPAETIKELRRANHVSYKPTMTTTYEGS 	                  .         .         .         .         .  
						SMSLSRSNSREHLGGGSESDNWRDRNGIGPGSHSEFAASIGSPKRKQNKS           	     346 ATSPSPASCPAGLACPSLDILASAGLGLTGLGLLGPTTLSLNTSTTPNSL 395                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 470 of Q9H694, which also corresponds to     	      51 ATSPSPASCPAGLACPSLDILASAGLGLTGLGLLGPTTLSLNTSTTPNSL 100                                                          
						amino acids 296 - 765 of AA424272_P1, and a third amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     396 LNALNSSVSPLQSPSSGTPSPTLWAPPLANTSSATGFSAIPHLMIPSTAQ 445                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     101 LNALNSSVSPLQSPSSGTPSPTLWAPPLANTSSATGFSAIPHLMIPSTAQ 150                                                          
						TEHYLSSSNYMDCISSLTGSNGCNLNSSFKGSDLPELFSKLGLGKYTDVFQQQEIDLQTF 	                  .         .         .         .         .  
						LTLTDQDLKELGITTFGARRKMLLAISVCDSVQIRNKILRAARIV                	     446 ATLTNILLSGVPTYGHTAPSPPPGLTPVDVHINSMQTEGKKISAALNGHA 495                                                          
						having the sequence corresponding to amino acids 766 - 870 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA424272_P1, wherein said first amino acid sequence, second  	     151 ATLTNILLSGVPTYGHTAPSPPPGLTPVDVHINSMQTEGKKISAALNGHA 200                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     496 QSPDIKYGAISTSSLGEKVLSANHGDPSIQTSGSEQTSPKSSPTEGCNDA 545                                                          
						polypeptide encoding for a head of AA424272_P1, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     201 QSPDIKYGAISTSSLGEKVLSANHGDPSIQTSGSEQTSPKSSPTEGCNDA 250                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     546 FVEVGMPRSPSHSGNAGDLKQMMCPSKVSCAKRQTVELLQGTKNSHLHST 595                                                          
						IMEETNTQIAWPSKLKIGAKSKKDPHIKVSGKKEDVKEAKEMIMSVLDTKSNRVTLKMDV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SHTEHSHVIGKGGNNIKKVMEETGCHIHFPDSNRNNQAEKSNQVSIAGQPAGVESARVRI 	     251 FVEVGMPRSPSHSGNAGDLKQMMCPSKVSCAKRQTVELLQGTKNSHLHST 300                                                          
						RELLPLVLMFELPIAGILQPVPDPNSPSIQHISQTYNISVSFKQRSRMYGATVIVRGSQN 	                  .         .         .         .         .  
						NTSAVKEGTAMLLEHLAGSLASAIPVSTQLDIAAQHHLFMMGRNGSNIKHIMQRTGAQIH 	     596 DRLLSDPELSATESPLADKKAPGSERAAERAAAAQQNSERAHLAPRSSYV 645                                                          
						FPDPSNPQKKSTVYLQGTIESVCLARQYLMGCLPLVLMFDMKEEIEVDPQFIAQL      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of AA424272_P1.3.An isolated polypeptide     	     301 DRLLSDPELSATESPLADKKAPGSERAAERAAAAQQNSERAHLAPRSSYV 350                                                          
						encoding for a tail of AA424272_P1, comprising a polypeptide 	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     646 NMQAFDYEQKKLLATKAMLKKPVVTEVRTPTNTWSGLGFSKSMPAETIKE 695                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TEHYLSSSNYMDCISSLTGSNGCNLNSSFKGSDLPELFSKLGLGKYTDVFQQQEIDLQTF 	     351 NMQAFDYEQKKLLATKAMLKKPVVTEVRTPTNTWSGLGFSKSMPAETIKE 400                                                          
						LTLTDQDLKELGITTFGARRKMLLAISVCDSVQIRNKILRAARIV                	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     696 LRRANHVSYKPTMTTTYEGSSMSLSRSNSREHLGGGSESDNWRDRNGIGP 745                                                          
						in AA424272_P1.                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 LRRANHVSYKPTMTTTYEGSSMSLSRSNSREHLGGGSESDNWRDRNGIGP 450                                                          
						                                                            	                  .         .                                
						                                                            	     746 GSHSEFAASIGSPKRKQNKSTE                             767                                                          
						                                                            	         ||||||||||||||||||||:|                              
						                                                            	     451 GSHSEFAASIGSPKRKQNKSSE                             472                                                          

16682	HMR136_AA424839_2_tr0_r1_1_gPRT		Comparison report between AA424839_P2 and AAH44240unique     	Sequence name: AAH44240                                      
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA424839_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 16682 x AAH44240   ..                          
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MKQAQALGPQMMGKPLYWGADRSSQVSSYPMHPLLQR    	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 37 of AA424839_P2, and a    	                                                            
						DLSLPSSLPQMPMTQTTNQPPIANGVLEYLEKELRNLNLAQPLPPDLKGRFGHPCSMLSS 	                     Quality: 2930.00                      Escore:       0                                               
						LGSEVVERRIIHLPPLIRDLSSSRRTSDSLHQQWLTPIPSRPWDLREGRSHHHYPDFHQE 	             Matching length:     287                Total length:     287                                               
						LQDRGPKSWALERRELDPSWSGRHRSSRLNGSPIHWSDRDSLSDVPSSSEARWRPSHPPF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RSRCQERPRRPSPRESTQRHGRRRRHRSYSPPLPSGLSSWSSEEDKERQPQSWRAHRRGS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						HSPHWPEEKPPSYRSLDITPGKNSRKKGSVERRSEKDSSHSGRSVVI              	                        Gaps:       0                        
						second amino acid sequence being at least 90 % homologous to 	                                                            
						corresponding to amino acids 216 - 502 of AAH44240, which    	Alignment:                                                   
						also corresponds to amino acids 38 - 324 of AA424839_P2,     	                  .         .         .         .         .  
						wherein said first amino acid sequence and second amino acid 	      38 DLSLPSSLPQMPMTQTTNQPPIANGVLEYLEKELRNLNLAQPLPPDLKGR 87                                                           
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of AA424839_P2,     	     216 DLSLPSSLPQMPMTQTTNQPPIANGVLEYLEKELRNLNLAQPLPPDLKGR 265                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	      88 FGHPCSMLSSLGSEVVERRIIHLPPLIRDLSSSRRTSDSLHQQWLTPIPS 137                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence                         	     266 FGHPCSMLSSLGSEVVERRIIHLPPLIRDLSSSRRTSDSLHQQWLTPIPS 315                                                          
						MKQAQALGPQMMGKPLYWGADRSSQVSSYPMHPLLQR of AA424839_P2.        	                  .         .         .         .         .  
						                                                            	     138 RPWDLREGRSHHHYPDFHQELQDRGPKSWALERRELDPSWSGRHRSSRLN 187                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     316 RPWDLREGRSHHHYPDFHQELQDRGPKSWALERRELDPSWSGRHRSSRLN 365                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     188 GSPIHWSDRDSLSDVPSSSEARWRPSHPPFRSRCQERPRRPSPRESTQRH 237                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     366 GSPIHWSDRDSLSDVPSSSEARWRPSHPPFRSRCQERPRRPSPRESTQRH 415                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     238 GRRRRHRSYSPPLPSGLSSWSSEEDKERQPQSWRAHRRGSHSPHWPEEKP 287                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     416 GRRRRHRSYSPPLPSGLSSWSSEEDKERQPQSWRAHRRGSHSPHWPEEKP 465                                                          
						                                                            	                  .         .         .                      
						                                                            	     288 PSYRSLDITPGKNSRKKGSVERRSEKDSSHSGRSVVI              324                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     466 PSYRSLDITPGKNSRKKGSVERRSEKDSSHSGRSVVI              502                                                          

16684	HMR136_AA424839_3_tr0_r1_1_gPRT		Comparison report between AA424839_P3 and AAH44240unique     	Sequence name: AAH44240                                      
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA424839_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 16684 x AAH44240   ..                          
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MKQAQALGPQMMGKPLYWGADRSSQVSSYPMHPLLQR    	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 37 of AA424839_P3, and a    	                                                            
						DLSLPSSLPQMPMTQTTNQPPIANGVLEYLEKELRNLNLAQPLPPDLKGRFGHPCSMLSS 	                     Quality: 2930.00                      Escore:       0                                               
						LGSEVVERRIIHLPPLIRDLSSSRRTSDSLHQQWLTPIPSRPWDLREGRSHHHYPDFHQE 	             Matching length:     287                Total length:     287                                               
						LQDRGPKSWALERRELDPSWSGRHRSSRLNGSPIHWSDRDSLSDVPSSSEARWRPSHPPF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RSRCQERPRRPSPRESTQRHGRRRRHRSYSPPLPSGLSSWSSEEDKERQPQSWRAHRRGS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						HSPHWPEEKPPSYRSLDITPGKNSRKKGSVERRSEKDSSHSGRSVVI              	                        Gaps:       0                        
						second amino acid sequence being at least 90 % homologous to 	                                                            
						corresponding to amino acids 216 - 502 of AAH44240, which    	Alignment:                                                   
						also corresponds to amino acids 38 - 324 of AA424839_P3,     	                  .         .         .         .         .  
						wherein said first amino acid sequence and second amino acid 	      38 DLSLPSSLPQMPMTQTTNQPPIANGVLEYLEKELRNLNLAQPLPPDLKGR 87                                                           
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of AA424839_P3,     	     216 DLSLPSSLPQMPMTQTTNQPPIANGVLEYLEKELRNLNLAQPLPPDLKGR 265                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	      88 FGHPCSMLSSLGSEVVERRIIHLPPLIRDLSSSRRTSDSLHQQWLTPIPS 137                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence                         	     266 FGHPCSMLSSLGSEVVERRIIHLPPLIRDLSSSRRTSDSLHQQWLTPIPS 315                                                          
						MKQAQALGPQMMGKPLYWGADRSSQVSSYPMHPLLQR of AA424839_P3.        	                  .         .         .         .         .  
						                                                            	     138 RPWDLREGRSHHHYPDFHQELQDRGPKSWALERRELDPSWSGRHRSSRLN 187                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     316 RPWDLREGRSHHHYPDFHQELQDRGPKSWALERRELDPSWSGRHRSSRLN 365                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     188 GSPIHWSDRDSLSDVPSSSEARWRPSHPPFRSRCQERPRRPSPRESTQRH 237                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     366 GSPIHWSDRDSLSDVPSSSEARWRPSHPPFRSRCQERPRRPSPRESTQRH 415                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     238 GRRRRHRSYSPPLPSGLSSWSSEEDKERQPQSWRAHRRGSHSPHWPEEKP 287                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     416 GRRRRHRSYSPPLPSGLSSWSSEEDKERQPQSWRAHRRGSHSPHWPEEKP 465                                                          
						                                                            	                  .         .         .                      
						                                                            	     288 PSYRSLDITPGKNSRKKGSVERRSEKDSSHSGRSVVI              324                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     466 PSYRSLDITPGKNSRKKGSVERRSEKDSSHSGRSVVI              502                                                          

16680	HMR136_AA424839_4_tr0_r1_1_gPRT		Comparison report between AA424839_P4 and AAH44240unique     	Sequence name: AAH44240                                      
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA424839_P4, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 16680 x AAH44240   ..                          
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MKQAQALGPQMMGKPLYWGADRSSQVSSYPMHPLLQR    	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 37 of AA424839_P4, and a    	                                                            
						DLSLPSSLPQMPMTQTTNQPPIANGVLEYLEKELRNLNLAQPLPPDLKGRFGHPCSMLSS 	                     Quality: 2930.00                      Escore:       0                                               
						LGSEVVERRIIHLPPLIRDLSSSRRTSDSLHQQWLTPIPSRPWDLREGRSHHHYPDFHQE 	             Matching length:     287                Total length:     287                                               
						LQDRGPKSWALERRELDPSWSGRHRSSRLNGSPIHWSDRDSLSDVPSSSEARWRPSHPPF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RSRCQERPRRPSPRESTQRHGRRRRHRSYSPPLPSGLSSWSSEEDKERQPQSWRAHRRGS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						HSPHWPEEKPPSYRSLDITPGKNSRKKGSVERRSEKDSSHSGRSVVI              	                        Gaps:       0                        
						second amino acid sequence being at least 90 % homologous to 	                                                            
						corresponding to amino acids 216 - 502 of AAH44240, which    	Alignment:                                                   
						also corresponds to amino acids 38 - 324 of AA424839_P4,     	                  .         .         .         .         .  
						wherein said first amino acid sequence and second amino acid 	      38 DLSLPSSLPQMPMTQTTNQPPIANGVLEYLEKELRNLNLAQPLPPDLKGR 87                                                           
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of AA424839_P4,     	     216 DLSLPSSLPQMPMTQTTNQPPIANGVLEYLEKELRNLNLAQPLPPDLKGR 265                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	      88 FGHPCSMLSSLGSEVVERRIIHLPPLIRDLSSSRRTSDSLHQQWLTPIPS 137                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence                         	     266 FGHPCSMLSSLGSEVVERRIIHLPPLIRDLSSSRRTSDSLHQQWLTPIPS 315                                                          
						MKQAQALGPQMMGKPLYWGADRSSQVSSYPMHPLLQR of AA424839_P4.        	                  .         .         .         .         .  
						                                                            	     138 RPWDLREGRSHHHYPDFHQELQDRGPKSWALERRELDPSWSGRHRSSRLN 187                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     316 RPWDLREGRSHHHYPDFHQELQDRGPKSWALERRELDPSWSGRHRSSRLN 365                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     188 GSPIHWSDRDSLSDVPSSSEARWRPSHPPFRSRCQERPRRPSPRESTQRH 237                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     366 GSPIHWSDRDSLSDVPSSSEARWRPSHPPFRSRCQERPRRPSPRESTQRH 415                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     238 GRRRRHRSYSPPLPSGLSSWSSEEDKERQPQSWRAHRRGSHSPHWPEEKP 287                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     416 GRRRRHRSYSPPLPSGLSSWSSEEDKERQPQSWRAHRRGSHSPHWPEEKP 465                                                          
						                                                            	                  .         .         .                      
						                                                            	     288 PSYRSLDITPGKNSRKKGSVERRSEKDSSHSGRSVVI              324                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     466 PSYRSLDITPGKNSRKKGSVERRSEKDSSHSGRSVVI              502                                                          

20420	HMR136_AA431567_0_tr0_r1_1_gPRT		Comparison report between AA431567_P0 and Q8NEC3unique head  	Sequence name: Q8NEC3                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for AA431567_P0, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 20420 x Q8NEC3   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence ECLSSGQTSQPLQSRRVISVPPQWSEYGELLTPQHLWTSNLFLRPECFSRHYVLSCHQPA                             	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 60 of AA431567_P0, a second 	                                                            
						SLGDTQHGEKLRRNCTIYRPWFSPYSYFVCADKESQLEAYDFPEVQQDEGKWDNCLSEDM 	                     Quality: 1897.00                      Escore:       0                                               
						AENICSSSSSPENTCPREATKKSRHGLDSITSQDILMASRWHPAQQNGYKCVACCRMYPT 	             Matching length:     187                Total length:     187                                               
						LDFLKSHIKRGFREGFSCKVYY                                       	 Matching Percent Similarity:   99.47   Matching Percent Identity:   99.47                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:   99.47      Total Percent Identity:   99.47                                               
						corresponding to amino acids 75 - 216 of Q8NEC3, which also  	                        Gaps:       0                        
						corresponds to amino acids 61 - 202 of AA431567_P0, a        	                                                            
						bridging amino acid R corresponding to amino acid 203 of     	Alignment:                                                   
						AA431567_P0, and a third amino acid sequence being at least  	                  .         .         .         .         .  
						90 % homologous to                                           	      61 SLGDTQHGEKLRRNCTIYRPWFSPYSYFVCADKESQLEAYDFPEVQQDEG 110                                                          
						KLKALWSKEQKARLGDRLSSGSCQAFNSPAEHLRQIGGEAYLCL corresponding to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 218 - 261 of Q8NEC3, which also corresponds to   	      75 SLGDTQHGEKLRRNCTIYRPWFSPYSYFVCADKESQLEAYDFPEVQQDEG 124                                                          
						amino acids 204 - 247 of AA431567_P0, wherein said first     	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence, bridging    	     111 KWDNCLSEDMAENICSSSSSPENTCPREATKKSRHGLDSITSQDILMASR 160                                                          
						amino acid and third amino acid sequence are contiguous and  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						in a sequential order.2.An isolated polypeptide encoding for 	     125 KWDNCLSEDMAENICSSSSSPENTCPREATKKSRHGLDSITSQDILMASR 174                                                          
						a head of AA431567_P0, comprising a polypeptide being at     	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	     161 WHPAQQNGYKCVACCRMYPTLDFLKSHIKRGFREGFSCKVYYRKLKALWS 210                                                          
						about 85%, more preferably at least about 90% and most       	         |||||||||||||||||||||||||||||||||||||||||| |||||||  
						preferably at least about 95% homologous to the sequence ECLSSGQTSQPLQSRRVISVPPQWSEYGELLTPQHLWTSNLFLRPECFSRHYVLSCHQPA    	     175 WHPAQQNGYKCVACCRMYPTLDFLKSHIKRGFREGFSCKVYYHKLKALWS 224                                                          
						of AA431567_P0.                                              	                  .         .         .                      
						                                                            	     211 KEQKARLGDRLSSGSCQAFNSPAEHLRQIGGEAYLCL              247                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     225 KEQKARLGDRLSSGSCQAFNSPAEHLRQIGGEAYLCL              261                                                          

21795	HMR136_AA434183_3_tr0_r1_1_gPRT		Comparison report between AA434183_P3 and HXD3_HUMANunique   	Sequence name: HXD3_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA434183_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 21795 x HXD3_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MLFEQGQQALELPECT corresponding to amino  	Alignment segment 1/1:                                       
						acids 1 - 16 of AA434183_P3, and a second amino acid sequence	                                                            
						MQKAAYYENPGLFGGYGYSKTTDTYGYSTPHQPYPPPAAASSLDTDYPGSACSIQSSAPL 	                     Quality: 4192.00                      Escore:       0                                               
						RAPAHKGAELNGSCMRPGTGNSQGGGGGSQPPGLNSEQQPPQPPPPPPTLPPSSPTNPGG 	             Matching length:     416                Total length:     416                                               
						GVPAKKPKGGPNASSSSATISKQIFPWMKESRQNSKQKNSCATAGESCEDKSPPGPASKR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VRTAYTSAQLVELEKEFHFNRYLCRPRRVEMANLLNLTERQIKIWFQNRRMKYKKDQKAK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GILHSPASQSPERSPPLGGAAGHVAYSGQLPPVPGLAYDAPSPPAFAKSQPNMYGLAAYT 	                        Gaps:       0                        
						APLSSCLPQQKRYAAPEFEPHPMASNGGGFASANLQGSPVYVGGNFVESMAPASGPVFNL 	                                                            
						GHLSHPSSASVDYSCAAQIPGNHHHGPCDPHPTYTDLSAHHSSQGRLPEAPKLTHL     	Alignment:                                                   
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 1 - 416 of HXD3_HUMAN, which also corresponds to amino 	      17 MQKAAYYENPGLFGGYGYSKTTDTYGYSTPHQPYPPPAAASSLDTDYPGS 66                                                           
						acids 17 - 432 of AA434183_P3, wherein said first amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	       1 MQKAAYYENPGLFGGYGYSKTTDTYGYSTPHQPYPPPAAASSLDTDYPGS 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of AA434183_P3, comprising a polypeptide being at least 	      67 ACSIQSSAPLRAPAHKGAELNGSCMRPGTGNSQGGGGGSQPPGLNSEQQP 116                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	      51 ACSIQSSAPLRAPAHKGAELNGSCMRPGTGNSQGGGGGSQPPGLNSEQQP 100                                                          
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						MLFEQGQQALELPECT of AA434183_P3.                             	     117 PQPPPPPPTLPPSSPTNPGGGVPAKKPKGGPNASSSSATISKQIFPWMKE 166                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 PQPPPPPPTLPPSSPTNPGGGVPAKKPKGGPNASSSSATISKQIFPWMKE 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     167 SRQNSKQKNSCATAGESCEDKSPPGPASKRVRTAYTSAQLVELEKEFHFN 216                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SRQNSKQKNSCATAGESCEDKSPPGPASKRVRTAYTSAQLVELEKEFHFN 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     217 RYLCRPRRVEMANLLNLTERQIKIWFQNRRMKYKKDQKAKGILHSPASQS 266                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 RYLCRPRRVEMANLLNLTERQIKIWFQNRRMKYKKDQKAKGILHSPASQS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     267 PERSPPLGGAAGHVAYSGQLPPVPGLAYDAPSPPAFAKSQPNMYGLAAYT 316                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 PERSPPLGGAAGHVAYSGQLPPVPGLAYDAPSPPAFAKSQPNMYGLAAYT 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     317 APLSSCLPQQKRYAAPEFEPHPMASNGGGFASANLQGSPVYVGGNFVESM 366                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 APLSSCLPQQKRYAAPEFEPHPMASNGGGFASANLQGSPVYVGGNFVESM 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     367 APASGPVFNLGHLSHPSSASVDYSCAAQIPGNHHHGPCDPHPTYTDLSAH 416                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 APASGPVFNLGHLSHPSSASVDYSCAAQIPGNHHHGPCDPHPTYTDLSAH 400                                                          
						                                                            	                  .                                          
						                                                            	     417 HSSQGRLPEAPKLTHL                                   432                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     401 HSSQGRLPEAPKLTHL                                   416                                                          

25505	HMR136_AA436996_4_tr0_r1_1_gPRT		Comparison report between AA436996_P4 and O95165partial WT   	Sequence name: O95165                                        
						sequence followed by short unique deletion and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AA436996_P4, comprising a first amino acid sequence being at 	                                                            
						LVEKYCEKSITVKVNSTYGNSSRNIVNQNVRENLKTLYRLTMDLCSKLKDYGLWQLFRTL 	Alignment of: 25505 x O95165   ..                            
						ELPLIPILAVMESHAIQVNKEEMEKTSALLGARLKELEQEAHFVAGERFLITSNNQLREI 	                                                            
						LFGKLKLHLLSQRNSLPRTGLQKYPST                                  	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 147	                                                            
						of O95165, which also corresponds to amino acids 1 - 147 of  	                     Quality: 1923.00                      Escore:       0                                               
						AA436996_P4, a second amino acid sequence being at least 90 %	             Matching length:     209                Total length:     210                                               
						SEALNALRDLHPLPKIILEYRQVHKIKSTFVDGLLACMKKGSISSTWNQTGTVTGRLSAK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						HP                                                           	    Total Percent Similarity:   99.52      Total Percent Identity:   99.52                                               
						homologous to corresponding to amino acids 149 - 210 of      	                        Gaps:       1                        
						O95165, which also corresponds to amino acids 148 - 209 of   	                                                            
						AA436996_P4, and a third amino acid sequence being at least  	Alignment:                                                   
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	       1 LVEKYCEKSITVKVNSTYGNSSRNIVNQNVRENLKTLYRLTMDLCSKLKD 50                                                           
						EGCARGTGDTRRQRANQEGGVRGGLWSREGAAGCLPWSSYSGSCPVFGEFFAEVQENQGL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RPSSYCPVSPDRLCGVHHGQKETPAKDSRS                               	       1 LVEKYCEKSITVKVNSTYGNSSRNIVNQNVRENLKTLYRLTMDLCSKLKD 50                                                           
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 210 - 299 of AA436996_P4, wherein said first  	      51 YGLWQLFRTLELPLIPILAVMESHAIQVNKEEMEKTSALLGARLKELEQE 100                                                          
						amino acid sequence, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	      51 YGLWQLFRTLELPLIPILAVMESHAIQVNKEEMEKTSALLGARLKELEQE 100                                                          
						order.2.An isolated chimeric polypeptide encoding for an edge	                  .         .         .         .         .  
						portion of AA436996_P4, comprising a polypeptide having a    	     101 AHFVAGERFLITSNNQLREILFGKLKLHLLSQRNSLPRTGLQKYPST.SE 149                                                          
						length "n", wherein n is at least about 10 amino acids in    	         ||||||||||||||||||||||||||||||||||||||||||||||| ||  
						length, optionally at least about 20 amino acids in length,  	     101 AHFVAGERFLITSNNQLREILFGKLKLHLLSQRNSLPRTGLQKYPSTVSE 150                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     150 ALNALRDLHPLPKIILEYRQVHKIKSTFVDGLLACMKKGSISSTWNQTGT 199                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise TS, having a structure as  	     151 ALNALRDLHPLPKIILEYRQVHKIKSTFVDGLLACMKKGSISSTWNQTGT 200                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .                                          
						148-x to 148; and ending at any of amino acid numbers 148+   	     200 VTGRLSAKHP                                         209                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	         ||||||||||                                          
						polypeptide encoding for a tail of AA436996_P4, comprising a 	     201 VTGRLSAKHP                                         210                                                          
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						EGCARGTGDTRRQRANQEGGVRGGLWSREGAAGCLPWSSYSGSCPVFGEFFAEVQENQGL 	                                                            
						RPSSYCPVSPDRLCGVHHGQKETPAKDSRS                               	                                                            
						to the sequence in AA436996_P4.                              	                                                            

28334	HMR136_AA442893_1_tr0_r1_1_gPRT		Comparison report between AA442893_P1 and SNG4_HUMANunique   	Sequence name: SNG4_HUMAN                                    
						head followed by partial WT sequence a mismatch.1.An isolated	                                                            
						chimeric polypeptide encoding for AA442893_P1, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 28334 x SNG4_HUMAN   ..                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence MSRALCQ corresponding to     	Alignment segment 1/1:                                       
						amino acids 1 - 7 of AA442893_P1, a second amino acid        	                                                            
						sequence being at least 90 % homologous to VFSLIV            	                     Quality: 1977.00                      Escore:       0                                               
						corresponding to amino acids 32 - 37 of SNG4_HUMAN, which    	             Matching length:     203                Total length:     203                                               
						also corresponds to amino acids 8 - 13 of AA442893_P1, a     	 Matching Percent Similarity:   99.51   Matching Percent Identity:   99.51                                               
						bridging amino acid F corresponding to amino acid 14 of      	    Total Percent Similarity:   99.51      Total Percent Identity:   99.51                                               
						AA442893_P1, and a third amino acid sequence being at least  	                        Gaps:       0                        
						SSLLTDGYQNKMESPQLHCILNSNSVACSFAVGAGFLAFLSCLAFLVLDTQETRIAGTRF 	                                                            
						KTAFQLLDFILAVLWAVVWFMGFCFLANQWQHSPPKEFLLGSSSAQAAIAFTFFSILVWI 	Alignment:                                                   
						FQAYLAFQDLRNDAPVPYKRFLDEGGMVLTTLPLPSANSPVNMPTTGPNSLSYASSALSP 	                  .         .         .         .         .  
						CLTAPKSPRLAMMPDN                                             	       8 VFSLIVFSSLLTDGYQNKMESPQLHCILNSNSVACSFAVGAGFLAFLSCL 57                                                           
						90 % homologous to corresponding to amino acids 39 - 234 of  	         |||||| |||||||||||||||||||||||||||||||||||||||||||  
						SNG4_HUMAN, which also corresponds to amino acids 15 - 210 of	      32 VFSLIVISSLLTDGYQNKMESPQLHCILNSNSVACSFAVGAGFLAFLSCL 81                                                           
						AA442893_P1, wherein said first amino acid sequence, second  	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid and third amino acid	      58 AFLVLDTQETRIAGTRFKTAFQLLDFILAVLWAVVWFMGFCFLANQWQHS 107                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of AA442893_P1,     	      82 AFLVLDTQETRIAGTRFKTAFQLLDFILAVLWAVVWFMGFCFLANQWQHS 131                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     108 PPKEFLLGSSSAQAAIAFTFFSILVWIFQAYLAFQDLRNDAPVPYKRFLD 157                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence MSRALCQ of AA442893_P1. 	     132 PPKEFLLGSSSAQAAIAFTFFSILVWIFQAYLAFQDLRNDAPVPYKRFLD 181                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     158 EGGMVLTTLPLPSANSPVNMPTTGPNSLSYASSALSPCLTAPKSPRLAMM 207                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     182 EGGMVLTTLPLPSANSPVNMPTTGPNSLSYASSALSPCLTAPKSPRLAMM 231                                                          
						                                                            	                                                             
						                                                            	     208 PDN                                                210                                                          
						                                                            	         |||                                                 
						                                                            	     232 PDN                                                234                                                          

28466	HMR136_AA442944_2_tr0_r1_1_gPRT		Comparison report between AA442944_P2 and Q96BL5unique head  	Sequence name: Q96BL5                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for AA442944_P2, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 28466 x Q96BL5   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						HLEPPPEEGTGDRGDLGGSPAASDAAGDMSSPDGPSFPSGPLSGGASPSGDEGFFPFVLE 	Alignment segment 1/1:                                       
						RRDSFLGGGPGPEEPEDLALQLQQKEKDLLLAAELGKMLLERNEELRRQLETLSAQHLER 	                                                            
						EERLQQENHELRRGLAARGAEWEARAVELEGDVEALRAQLGEQRSEQQDSGRERARALSE 	                     Quality:  931.00                      Escore:       0                                               
						LSEQNLRLSQQLAQASQTEQELQRELDALRGQCQAQALAGAELRTRLESLQGENQMLQSR 	             Matching length:     100                Total length:     100                                               
						RQDLEAQIRGLREEVEKGEGRLQTTHEELLLLRRERREHSLELERARSEAGEALSALRRL 	 Matching Percent Similarity:   99.00   Matching Percent Identity:   99.00                                               
						QRRVSELEEESRLQDADVSAASLQSELAHSLDDGDQGQGADAPGDTPTTRSPKTRKASSP 	    Total Percent Similarity:   99.00      Total Percent Identity:   99.00                                               
						QPSPPEEILEPPKKRTSLSPAEILEEKEVEVAKLQDEISLQQAELQSLREELQRQKELRA 	                        Gaps:       0                        
						QEDPGEALHSALSDRD                                             	                                                            
						polypeptide having the sequence corresponding to amino acids 	Alignment:                                                   
						1 - 436 of AA442944_P2, a second amino acid sequence being at	                  .         .         .         .         .  
						EAVNKALELSLQLNRVSLERDSLSRELLRAIRQKVALTQELEAWQDDMQVVIGQQLRSQR 	     437 EAVNKALELSLQLNRVSLERDSLSRELLRAIRQKVALTQELEAWQDDMQV 486                                                          
						QKELSASASSSTPRRAAPRFS                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 1 - 81 	       1 EAVNKALELSLQLNRVSLERDSLSRELLRAIRQKVALTQELEAWQDDMQV 50                                                           
						of Q96BL5, which also corresponds to amino acids 437 - 517 of	                  .         .         .         .         .  
						AA442944_P2, a bridging amino acid L corresponding to amino  	     487 VIGQQLRSQRQKELSASASSSTPRRAAPRFSLRLGPGPAGGFLSNLFRRT 536                                                          
						acid 518 of AA442944_P2, and a third amino acid sequence     	         ||||||||||||||||||||||||||||||| ||||||||||||||||||  
						being at least 90 % homologous to RLGPGPAGGFLSNLFRRT         	      51 VIGQQLRSQRQKELSASASSSTPRRAAPRFSPRLGPGPAGGFLSNLFRRT 100                                                          
						corresponding to amino acids 83 - 100 of Q96BL5, which also  	                                                            
						corresponds to amino acids 519 - 536 of AA442944_P2, wherein 	                                                            
						said first amino acid sequence, second amino acid sequence,  	                                                            
						bridging amino acid and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of AA442944_P2, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						HLEPPPEEGTGDRGDLGGSPAASDAAGDMSSPDGPSFPSGPLSGGASPSGDEGFFPFVLE 	                                                            
						RRDSFLGGGPGPEEPEDLALQLQQKEKDLLLAAELGKMLLERNEELRRQLETLSAQHLER 	                                                            
						EERLQQENHELRRGLAARGAEWEARAVELEGDVEALRAQLGEQRSEQQDSGRERARALSE 	                                                            
						LSEQNLRLSQQLAQASQTEQELQRELDALRGQCQAQALAGAELRTRLESLQGENQMLQSR 	                                                            
						RQDLEAQIRGLREEVEKGEGRLQTTHEELLLLRRERREHSLELERARSEAGEALSALRRL 	                                                            
						QRRVSELEEESRLQDADVSAASLQSELAHSLDDGDQGQGADAPGDTPTTRSPKTRKASSP 	                                                            
						QPSPPEEILEPPKKRTSLSPAEILEEKEVEVAKLQDEISLQQAELQSLREELQRQKELRA 	                                                            
						QEDPGEALHSALSDRD                                             	                                                            
						to the sequence of AA442944_P2.                              	                                                            

28464	HMR136_AA442944_4_tr0_r1_1_gPRT		Comparison report between AA442944_P4 and Q96BL5unique head  	Sequence name: Q96BL5                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for AA442944_P4, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 28464 x Q96BL5   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MSSPDGPSFPSGPLSGGASPSGDEGFFPFVLERRDSFLGGGPGPEEPEDLALQLQQKEKD 	Alignment segment 1/1:                                       
						LLLAAELGKMLLERNEELRRQLETLSAQHLEREEASQTEQELQRELDALRGQCQAQALAG 	                                                            
						AELRTRLESLQGENQMLQSRRQDLEAQIRGLREEVEKGEGRLQTTHEELLLLRRERREHS 	                     Quality:  931.00                      Escore:       0                                               
						LELERARSEAGEALSALRRLQRRVSELEEESRLQDADVSAASLQSELAHSLDDGDQGQGA 	             Matching length:     100                Total length:     100                                               
						DAPGDTPTTRSPKTRKASSPQPSPPEEILEPPKKRTSLSPAEILEEKEVEVAKLQDEISL 	 Matching Percent Similarity:   99.00   Matching Percent Identity:   99.00                                               
						QQAELQSLREELQRQKELRAQEDPGEALHSALSDRD                         	    Total Percent Similarity:   99.00      Total Percent Identity:   99.00                                               
						polypeptide having the sequence corresponding to amino acids 	                        Gaps:       0                        
						1 - 336 of AA442944_P4, a second amino acid sequence being at	                                                            
						EAVNKALELSLQLNRVSLERDSLSRELLRAIRQKVALTQELEAWQDDMQVVIGQQLRSQR 	Alignment:                                                   
						QKELSASASSSTPRRAAPRFS                                        	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 1 - 81 	     337 EAVNKALELSLQLNRVSLERDSLSRELLRAIRQKVALTQELEAWQDDMQV 386                                                          
						of Q96BL5, which also corresponds to amino acids 337 - 417 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA442944_P4, a bridging amino acid L corresponding to amino  	       1 EAVNKALELSLQLNRVSLERDSLSRELLRAIRQKVALTQELEAWQDDMQV 50                                                           
						acid 418 of AA442944_P4, and a third amino acid sequence     	                  .         .         .         .         .  
						being at least 90 % homologous to RLGPGPAGGFLSNLFRRT         	     387 VIGQQLRSQRQKELSASASSSTPRRAAPRFSLRLGPGPAGGFLSNLFRRT 436                                                          
						corresponding to amino acids 83 - 100 of Q96BL5, which also  	         ||||||||||||||||||||||||||||||| ||||||||||||||||||  
						corresponds to amino acids 419 - 436 of AA442944_P4, wherein 	      51 VIGQQLRSQRQKELSASASSSTPRRAAPRFSPRLGPGPAGGFLSNLFRRT 100                                                          
						said first amino acid sequence, second amino acid sequence,  	                                                            
						bridging amino acid and third amino acid sequence are        	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of AA442944_P4, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MSSPDGPSFPSGPLSGGASPSGDEGFFPFVLERRDSFLGGGPGPEEPEDLALQLQQKEKD 	                                                            
						LLLAAELGKMLLERNEELRRQLETLSAQHLEREEASQTEQELQRELDALRGQCQAQALAG 	                                                            
						AELRTRLESLQGENQMLQSRRQDLEAQIRGLREEVEKGEGRLQTTHEELLLLRRERREHS 	                                                            
						LELERARSEAGEALSALRRLQRRVSELEEESRLQDADVSAASLQSELAHSLDDGDQGQGA 	                                                            
						DAPGDTPTTRSPKTRKASSPQPSPPEEILEPPKKRTSLSPAEILEEKEVEVAKLQDEISL 	                                                            
						QQAELQSLREELQRQKELRAQEDPGEALHSALSDRD                         	                                                            
						to the sequence of AA442944_P4.                              	                                                            

4409	HMR136_AA446016_0_tr0_r1_1_gPRT		Comparison report between AA446016_P0 and AAH48311unique     	Sequence name: AAH48311                                      
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA446016_P0, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 4409 x AAH48311   ..                           
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MASWLYECLCEAELAQYYSHFTALGLQKIDELAKITMKDYSKLGVHDMNDRKRLFQLIKI 	Alignment segment 1/1:                                       
						IKIMQEEDKAVSIPERHLQTSSLRIKSQELRSGPRRQLNFDSPADNKDRNASNDGFEMCS 	                                                            
						LSDFSANEQKSTYLKVLEHMLPDDSQYHTKTGILNATAGDSYVQTEISTSLFSPNYLSAI 	                     Quality: 1981.00                      Escore:       0                                               
						LGDCDIPIIQRISHVSGYNYGIPHSCIRQNTSEKQNPWTEMEKIRVCVRKRPLGMREVRR 	             Matching length:     203                Total length:     203                                               
						GEINIITVEDKETLLVHEKKEAVDLTQYILQHVFYFDEVFGEACTNQDVYMKTTHPLIQH 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IFNGGNATCFAYGQTGAGKTYTMIGTHENPGLYALAAKDIFRQLEVSQPRKHLFVWISFY 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EIYCGQLYDLLNRRKRLFAREDSKHMVQIVGLQELQVDSVELLLEVILKGSKERSTGATG 	                        Gaps:       0                        
						VNADSSRSHAVIQIQIKDSAKRTFGRISFIDLAGSERAADARDSDRQTKMEGAEINQSLL 	                                                            
						ALKECIRALDQEHTHTPFRQSKLTQVLKDSFIGNAKTCMIANISPSHVATEHTLNTLRYA 	Alignment:                                                   
						DRVKELKKGIKCCTSVTSRNRTSGNSSPKRIQSSPGALSEDKCSPKKVKLGFQQSLTVAA 	                  .         .         .         .         .  
						PGSTRGKVHPLTSHPPNIPFTSAPKVSGKRGGSRGSPSQEWVIHASPVKGTVRSGHVAKK 	     956 SSFDLRKDASQSEVSGENEGNLPSPEEDGFTISLSHVAVPGSPDQRDTVT 1005                                                         
						KPEESAPLCSEKNRMGNKTVLGWESRASGPGEGLVRGKLSTKCKKVQTVQPVQKQLVSRV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ELSFGNAHHRAEYSQDSQRGTPARPASEAWTNIPPHQKEREEHLRFYHQQFQQPPLLQQK 	       1 SSFDLRKDASQSEVSGENEGNLPSPEEDGFTISLSHVAVPGSPDQRDTVT 50                                                           
						LKYQPLKRSLRQYRPPEGQLTNETPPLFHSYSENHDGAQVEELDDSDFSEDSFSHISSQR 	                  .         .         .         .         .  
						ATKQRNTLENSEDSFFLHQTWGQGPEKQVAERQQSLFSSPRTGDKKDLTKSWVDSRDPIN 	    1006 TPLREVSADGPIQVTSTVKNGHAVPGEDPRGQLGTHAEYASGLMSPLTMS 1055                                                         
						HRRAALDHSCSPSKGPVDWSRENSTSSGPSPRDSLAEKPYCSQVDFIYRQERGGG      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 1 - 955 of  	      51 TPLREVSADGPIQVTSTVKNGHAVPGEDPRGQLGTHAEYASGLMSPLTMS 100                                                          
						AA446016_P0, and a second amino acid sequence being at least 	                  .         .         .         .         .  
						SSFDLRKDASQSEVSGENEGNLPSPEEDGFTISLSHVAVPGSPDQRDTVTTPLREVSADG 	    1056 LLENPDNEGSPPSEQLVQDGATHSLVAESTGGPVVSHTVPSGDQEAALPV 1105                                                         
						PIQVTSTVKNGHAVPGEDPRGQLGTHAEYASGLMSPLTMSLLENPDNEGSPPSEQLVQDG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ATHSLVAESTGGPVVSHTVPSGDQEAALPVSSATRHLWLSSSPPDNKPGGDLPALGPGEK 	     101 LLENPDNEGSPPSEQLVQDGATHSLVAESTGGPVVSHTVPSGDQEAALPV 150                                                          
						TSYKAWLAGVWFVHRPHQVALQQ                                      	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 1 - 203 of   	    1106 SSATRHLWLSSSPPDNKPGGDLPALGPGEKTSYKAWLAGVWFVHRPHQVA 1155                                                         
						AAH48311, which also corresponds to amino acids 956 - 1158 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA446016_P0, wherein said first amino acid sequence and      	     151 SSATRHLWLSSSPPDNKPGGDLPALGPGEKTSYKAWLAGVWFVHRPHQVA 200                                                          
						second amino acid sequence are contiguous and in a sequential	                                                             
						order.2.An isolated polypeptide encoding for a head of       	    1156 LQQ                                                1158                                                         
						AA446016_P0, comprising a polypeptide being at least 70%,    	         |||                                                 
						optionally at least about 80%, preferably at least about 85%,	     201 LQQ                                                203                                                          
						more preferably at least about 90% and most preferably at    	                                                            
						MASWLYECLCEAELAQYYSHFTALGLQKIDELAKITMKDYSKLGVHDMNDRKRLFQLIKI 	                                                            
						IKIMQEEDKAVSIPERHLQTSSLRIKSQELRSGPRRQLNFDSPADNKDRNASNDGFEMCS 	                                                            
						LSDFSANEQKSTYLKVLEHMLPDDSQYHTKTGILNATAGDSYVQTEISTSLFSPNYLSAI 	                                                            
						LGDCDIPIIQRISHVSGYNYGIPHSCIRQNTSEKQNPWTEMEKIRVCVRKRPLGMREVRR 	                                                            
						GEINIITVEDKETLLVHEKKEAVDLTQYILQHVFYFDEVFGEACTNQDVYMKTTHPLIQH 	                                                            
						IFNGGNATCFAYGQTGAGKTYTMIGTHENPGLYALAAKDIFRQLEVSQPRKHLFVWISFY 	                                                            
						EIYCGQLYDLLNRRKRLFAREDSKHMVQIVGLQELQVDSVELLLEVILKGSKERSTGATG 	                                                            
						VNADSSRSHAVIQIQIKDSAKRTFGRISFIDLAGSERAADARDSDRQTKMEGAEINQSLL 	                                                            
						ALKECIRALDQEHTHTPFRQSKLTQVLKDSFIGNAKTCMIANISPSHVATEHTLNTLRYA 	                                                            
						DRVKELKKGIKCCTSVTSRNRTSGNSSPKRIQSSPGALSEDKCSPKKVKLGFQQSLTVAA 	                                                            
						PGSTRGKVHPLTSHPPNIPFTSAPKVSGKRGGSRGSPSQEWVIHASPVKGTVRSGHVAKK 	                                                            
						KPEESAPLCSEKNRMGNKTVLGWESRASGPGEGLVRGKLSTKCKKVQTVQPVQKQLVSRV 	                                                            
						ELSFGNAHHRAEYSQDSQRGTPARPASEAWTNIPPHQKEREEHLRFYHQQFQQPPLLQQK 	                                                            
						LKYQPLKRSLRQYRPPEGQLTNETPPLFHSYSENHDGAQVEELDDSDFSEDSFSHISSQR 	                                                            
						ATKQRNTLENSEDSFFLHQTWGQGPEKQVAERQQSLFSSPRTGDKKDLTKSWVDSRDPIN 	                                                            
						HRRAALDHSCSPSKGPVDWSRENSTSSGPSPRDSLAEKPYCSQVDFIYRQERGGG      	                                                            
						least about 95% homologous to the sequence of AA446016_P0.   	                                                            

4415	HMR136_AA446016_1_tr0_r1_1_gPRT		Comparison report between AA446016_P1 and AAH48311unique     	Sequence name: AAH48311                                      
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA446016_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 4415 x AAH48311   ..                           
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MASWLYECLCEAELAQYYSHFTALGLQKIDELAKITMKDYSKLGVHDMNDRKRLFQLIKI 	Alignment segment 1/1:                                       
						IKIMQEEDKAVSIPERHLQTSSLRIKSQELRSGPRRQLNFDSPADNKDRNASNDGFEMCS 	                                                            
						LSDFSANEQKSTYLKVLEHMLPDDSQYHTKTGILNATAGDSYVQTEISTSLFSPNYLSAI 	                     Quality: 1981.00                      Escore:       0                                               
						LGDCDIPIIQRISHVSGYNYGIPHSCIRQNTSEKQNPWTEMEKIRVCVRKRPLGMREVRR 	             Matching length:     203                Total length:     203                                               
						GEINIITVEDKETLLVHEKKEAVDLTQYILQVILKGSKERSTGATGVNADSSRSHAVIQI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QIKDSAKRTFGRISFIDLAGSERAADARDSDRQTKMEGAEINQSLLALKECIRALDQEHT 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						HTPFRQSKLTQVLKDSFIGNAKTCMIANISPSHVATEHTLNTLRYADRVKELKKGIKCCT 	                        Gaps:       0                        
						SVTSRNRTSGNSSPKRIQSSPGALSEDKCSPKKVKLGFQQSLTVAAPGSTRGKVHPLTSH 	                                                            
						PPNIPFTSAPKVSGKRGGSRGSPSQEWVIHASPVKGTVRSGHVAKKKPEESAPLCSEKNR 	Alignment:                                                   
						MGNKTVLGWESRASGPGEGLVRGKLSTKCKKVQTVQPVQKQLVSRVELSFGNAHHRAEYS 	                  .         .         .         .         .  
						QDSQRGTPARPASEAWTNIPPHQKEREEHLRFYHQQFQQPPLLQQKLKYQPLKRSLRQYR 	     822 SSFDLRKDASQSEVSGENEGNLPSPEEDGFTISLSHVAVPGSPDQRDTVT 871                                                          
						PPEGQLTNETPPLFHSYSENHDGAQVEELDDSDFSEDSFSHISSQRATKQRNTLENSEDS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FFLHQTWGQGPEKQVAERQQSLFSSPRTGDKKDLTKSWVDSRDPINHRRAALDHSCSPSK 	       1 SSFDLRKDASQSEVSGENEGNLPSPEEDGFTISLSHVAVPGSPDQRDTVT 50                                                           
						GPVDWSRENSTSSGPSPRDSLAEKPYCSQVDFIYRQERGGG                    	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 1 - 821 of  	     872 TPLREVSADGPIQVTSTVKNGHAVPGEDPRGQLGTHAEYASGLMSPLTMS 921                                                          
						AA446016_P1, and a second amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSFDLRKDASQSEVSGENEGNLPSPEEDGFTISLSHVAVPGSPDQRDTVTTPLREVSADG 	      51 TPLREVSADGPIQVTSTVKNGHAVPGEDPRGQLGTHAEYASGLMSPLTMS 100                                                          
						PIQVTSTVKNGHAVPGEDPRGQLGTHAEYASGLMSPLTMSLLENPDNEGSPPSEQLVQDG 	                  .         .         .         .         .  
						ATHSLVAESTGGPVVSHTVPSGDQEAALPVSSATRHLWLSSSPPDNKPGGDLPALGPGEK 	     922 LLENPDNEGSPPSEQLVQDGATHSLVAESTGGPVVSHTVPSGDQEAALPV 971                                                          
						TSYKAWLAGVWFVHRPHQVALQQ                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 1 - 203 of   	     101 LLENPDNEGSPPSEQLVQDGATHSLVAESTGGPVVSHTVPSGDQEAALPV 150                                                          
						AAH48311, which also corresponds to amino acids 822 - 1024 of	                  .         .         .         .         .  
						AA446016_P1, wherein said first amino acid sequence and      	     972 SSATRHLWLSSSPPDNKPGGDLPALGPGEKTSYKAWLAGVWFVHRPHQVA 1021                                                         
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     151 SSATRHLWLSSSPPDNKPGGDLPALGPGEKTSYKAWLAGVWFVHRPHQVA 200                                                          
						AA446016_P1, comprising a polypeptide being at least 70%,    	                                                             
						optionally at least about 80%, preferably at least about 85%,	    1022 LQQ                                                1024                                                         
						more preferably at least about 90% and most preferably at    	         |||                                                 
						MASWLYECLCEAELAQYYSHFTALGLQKIDELAKITMKDYSKLGVHDMNDRKRLFQLIKI 	     201 LQQ                                                203                                                          
						IKIMQEEDKAVSIPERHLQTSSLRIKSQELRSGPRRQLNFDSPADNKDRNASNDGFEMCS 	                                                            
						LSDFSANEQKSTYLKVLEHMLPDDSQYHTKTGILNATAGDSYVQTEISTSLFSPNYLSAI 	                                                            
						LGDCDIPIIQRISHVSGYNYGIPHSCIRQNTSEKQNPWTEMEKIRVCVRKRPLGMREVRR 	                                                            
						GEINIITVEDKETLLVHEKKEAVDLTQYILQVILKGSKERSTGATGVNADSSRSHAVIQI 	                                                            
						QIKDSAKRTFGRISFIDLAGSERAADARDSDRQTKMEGAEINQSLLALKECIRALDQEHT 	                                                            
						HTPFRQSKLTQVLKDSFIGNAKTCMIANISPSHVATEHTLNTLRYADRVKELKKGIKCCT 	                                                            
						SVTSRNRTSGNSSPKRIQSSPGALSEDKCSPKKVKLGFQQSLTVAAPGSTRGKVHPLTSH 	                                                            
						PPNIPFTSAPKVSGKRGGSRGSPSQEWVIHASPVKGTVRSGHVAKKKPEESAPLCSEKNR 	                                                            
						MGNKTVLGWESRASGPGEGLVRGKLSTKCKKVQTVQPVQKQLVSRVELSFGNAHHRAEYS 	                                                            
						QDSQRGTPARPASEAWTNIPPHQKEREEHLRFYHQQFQQPPLLQQKLKYQPLKRSLRQYR 	                                                            
						PPEGQLTNETPPLFHSYSENHDGAQVEELDDSDFSEDSFSHISSQRATKQRNTLENSEDS 	                                                            
						FFLHQTWGQGPEKQVAERQQSLFSSPRTGDKKDLTKSWVDSRDPINHRRAALDHSCSPSK 	                                                            
						GPVDWSRENSTSSGPSPRDSLAEKPYCSQVDFIYRQERGGG                    	                                                            
						least about 95% homologous to the sequence of AA446016_P1.   	                                                            

4411	HMR136_AA446016_2_tr0_r1_1_gPRT		Comparison report between AA446016_P2 and AAH48311unique     	Sequence name: AAH48311                                      
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA446016_P2, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 4411 x AAH48311   ..                           
						more preferably at least 90% and most preferably at least 95%	                                                            
						MASWLYECLCEAELAQYYSHFTALGLQKIDELAKITMKDYSKLGVHDMNDRKRLFQLIKI 	Alignment segment 1/1:                                       
						IKIMQEEDKAVSIPERHLQTSSLRIKSQELRSGPRRQLNFDSPADNKDRNASNDGFEMCS 	                                                            
						LSDFSANEQKSTYLKVLEHMLPDDSQYHTKTGILNATAGDSYVQTEISTSLFSPNYLSAI 	                     Quality: 1702.00                      Escore:       0                                               
						LGDCDIPIIQRISHVSGYNYGIPHSCIRQNTSEKQNPWTEMEKIRVCVRKRPLGMREVRR 	             Matching length:     177                Total length:     177                                               
						GEINIITVEDKETLLVHEKKEAVDLTQYILQHVFYFDEVFGEACTNQDVYMKTTHPLIQH 	 Matching Percent Similarity:   99.44   Matching Percent Identity:   99.44                                               
						IFNGGNATCFAYGQTGAGKTYTMIGTHENPGLYALAAKDIFRQLEVSQPRKHLFVWISFY 	    Total Percent Similarity:   99.44      Total Percent Identity:   99.44                                               
						EIYCGQLYDLLNRRKRLFAREDSKHMVQIVGLQELQVDSVELLLEVILKGSKERSTGATG 	                        Gaps:       0                        
						VNADSSRSHAVIQIQIKDSAKRTFGRISFIDLAGSERAADARDSDRQTKMEGAEINQSLL 	                                                            
						ALKECIRALDQEHTHTPFRQSKLTQVLKDSFIGNAKTCMIANISPSHVATEHTLNTLRYA 	Alignment:                                                   
						DRVKELKKGIKCCTSVTSRNRTSGNSSPKRIQSSPGALSEDKCSPKKVKLGFQQSLTVAA 	                  .         .         .         .         .  
						PGSTRGKVHPLTSHPPNIPFTSAPKVSGKRGGSRGSPSQEWVIHASPVKGTVRSGHVAKK 	     956 SSFDLRKDASQSEVSGENEGNLPSPEEDGFTISLSHVAVPGSPDQRDTVT 1005                                                         
						KPEESAPLCSEKNRMGNKTVLGWESRASGPGEGLVRGKLSTKCKKVQTVQPVQKQLVSRV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ELSFGNAHHRAEYSQDSQRGTPARPASEAWTNIPPHQKEREEHLRFYHQQFQQPPLLQQK 	       1 SSFDLRKDASQSEVSGENEGNLPSPEEDGFTISLSHVAVPGSPDQRDTVT 50                                                           
						LKYQPLKRSLRQYRPPEGQLTNETPPLFHSYSENHDGAQVEELDDSDFSEDSFSHISSQR 	                  .         .         .         .         .  
						ATKQRNTLENSEDSFFLHQTWGQGPEKQVAERQQSLFSSPRTGDKKDLTKSWVDSRDPIN 	    1006 TPLREVSADGPIQVTSTVKNGHAVPGEDPRGQLGTHAEYASGLMSPLTMS 1055                                                         
						HRRAALDHSCSPSKGPVDWSRENSTSSGPSPRDSLAEKPYCSQVDFIYRQERGGG      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	      51 TPLREVSADGPIQVTSTVKNGHAVPGEDPRGQLGTHAEYASGLMSPLTMS 100                                                          
						to amino acids 1 - 955 of AA446016_P2, a second amino acid   	                  .         .         .         .         .  
						SSFDLRKDASQSEVSGENEGNLPSPEEDGFTISLSHVAVPGSPDQRDTVTTPLREVSADG 	    1056 LLENPDNEGSPPSEQLVQDGATHSLVAESTGGPVVSHTVPSGDQEAALPV 1105                                                         
						PIQVTSTVKNGHAVPGEDPRGQLGTHAEYASGLMSPLTMSLLENPDNEGSPPSEQLVQDG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ATHSLVAESTGGPVVSHTVPSGDQEAALPVSSATRHLWLSSSPPDNKPGGDLPAL      	     101 LLENPDNEGSPPSEQLVQDGATHSLVAESTGGPVVSHTVPSGDQEAALPV 150                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .                                
						amino acids 1 - 175 of AAH48311, which also corresponds to   	    1106 SSATRHLWLSSSPPDNKPGGDLPALSP                        1132                                                         
						amino acids 956 - 1130 of AA446016_P2, and a third amino acid	         ||||||||||||||||||||||||| |                         
						sequence being at least 70%, optionally at least 80%,        	     151 SSATRHLWLSSSPPDNKPGGDLPALGP                        177                                                          
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						SPSPIRQHPADKLPSREADLGEACQSRETVLFSHEHMGSEQYDADAEETGLDGSWGFPGK 	                                                            
						PFTTIHMGVPHSGPTLTPRTGSSDVADQLWAQERKHPTRLGWQEFGLSTDPIKLPCNSEN 	                                                            
						VTWLKPRPISRCLARPSSPLVPSCSPKTAGTLRQPTLEQAQQVVIRAHQEQLDEMAELGF 	                                                            
						KEETLMSQLASNDFEDFVTQLDEIMVLKSKCIQSLRSQLQLYLTCHGPTAAPEGTVPS   	                                                            
						having the sequence corresponding to amino acids 1131 - 1368 	                                                            
						of AA446016_P2, wherein said first amino acid sequence,      	                                                            
						second amino acid sequence and third amino acid sequence are 	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of AA446016_P2, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MASWLYECLCEAELAQYYSHFTALGLQKIDELAKITMKDYSKLGVHDMNDRKRLFQLIKI 	                                                            
						IKIMQEEDKAVSIPERHLQTSSLRIKSQELRSGPRRQLNFDSPADNKDRNASNDGFEMCS 	                                                            
						LSDFSANEQKSTYLKVLEHMLPDDSQYHTKTGILNATAGDSYVQTEISTSLFSPNYLSAI 	                                                            
						LGDCDIPIIQRISHVSGYNYGIPHSCIRQNTSEKQNPWTEMEKIRVCVRKRPLGMREVRR 	                                                            
						GEINIITVEDKETLLVHEKKEAVDLTQYILQHVFYFDEVFGEACTNQDVYMKTTHPLIQH 	                                                            
						IFNGGNATCFAYGQTGAGKTYTMIGTHENPGLYALAAKDIFRQLEVSQPRKHLFVWISFY 	                                                            
						EIYCGQLYDLLNRRKRLFAREDSKHMVQIVGLQELQVDSVELLLEVILKGSKERSTGATG 	                                                            
						VNADSSRSHAVIQIQIKDSAKRTFGRISFIDLAGSERAADARDSDRQTKMEGAEINQSLL 	                                                            
						ALKECIRALDQEHTHTPFRQSKLTQVLKDSFIGNAKTCMIANISPSHVATEHTLNTLRYA 	                                                            
						DRVKELKKGIKCCTSVTSRNRTSGNSSPKRIQSSPGALSEDKCSPKKVKLGFQQSLTVAA 	                                                            
						PGSTRGKVHPLTSHPPNIPFTSAPKVSGKRGGSRGSPSQEWVIHASPVKGTVRSGHVAKK 	                                                            
						KPEESAPLCSEKNRMGNKTVLGWESRASGPGEGLVRGKLSTKCKKVQTVQPVQKQLVSRV 	                                                            
						ELSFGNAHHRAEYSQDSQRGTPARPASEAWTNIPPHQKEREEHLRFYHQQFQQPPLLQQK 	                                                            
						LKYQPLKRSLRQYRPPEGQLTNETPPLFHSYSENHDGAQVEELDDSDFSEDSFSHISSQR 	                                                            
						ATKQRNTLENSEDSFFLHQTWGQGPEKQVAERQQSLFSSPRTGDKKDLTKSWVDSRDPIN 	                                                            
						HRRAALDHSCSPSKGPVDWSRENSTSSGPSPRDSLAEKPYCSQVDFIYRQERGGG      	                                                            
						to the sequence of AA446016_P2.3.An isolated polypeptide     	                                                            
						encoding for a tail of AA446016_P2, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						SPSPIRQHPADKLPSREADLGEACQSRETVLFSHEHMGSEQYDADAEETGLDGSWGFPGK 	                                                            
						PFTTIHMGVPHSGPTLTPRTGSSDVADQLWAQERKHPTRLGWQEFGLSTDPIKLPCNSEN 	                                                            
						VTWLKPRPISRCLARPSSPLVPSCSPKTAGTLRQPTLEQAQQVVIRAHQEQLDEMAELGF 	                                                            
						KEETLMSQLASNDFEDFVTQLDEIMVLKSKCIQSLRSQLQLYLTCHGPTAAPEGTVPS   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA446016_P2.                                              	                                                            

4413	HMR136_AA446016_3_tr0_r1_1_gPRT		Comparison report between AA446016_P3 and AAH48311unique     	Sequence name: AAH48311                                      
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA446016_P3, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 4413 x AAH48311   ..                           
						more preferably at least 90% and most preferably at least 95%	                                                            
						MASWLYECLCEAELAQYYSHFTALGLQKIDELAKITMKDYSKLGVHDMNDRKRLFQLIKI 	Alignment segment 1/1:                                       
						IKIMQEEDKAVSIPERHLQTSSLRIKSQELRSGPRRQLNFDSPADNKDRNASNDGFEMCS 	                                                            
						LSDFSANEQKSTYLKVLEHMLPDDSQYHTKTGILNATAGDSYVQTEISTSLFSPNYLSAI 	                     Quality: 1702.00                      Escore:       0                                               
						LGDCDIPIIQRISHVSGYNYGIPHSCIRQNTSEKQNPWTEMEKIRVCVRKRPLGMREVRR 	             Matching length:     177                Total length:     177                                               
						GEINIITVEDKETLLVHEKKEAVDLTQYILQHVFYFDEVFGEACTNQDVYMKTTHPLIQH 	 Matching Percent Similarity:   99.44   Matching Percent Identity:   99.44                                               
						IFNGGNATCFAYGQTGAGKTYTMIGTHENPGLYALAAKDIFRQLEVSQPRKHLFVWISFY 	    Total Percent Similarity:   99.44      Total Percent Identity:   99.44                                               
						EIYCGQLYDLLNRRKRLFAREDSKHMVQIVGLQELQVDSVELLLEVILKGSKERSTGATG 	                        Gaps:       0                        
						VNADSSRSHAVIQIQIKDSAKRTFGRISFIDLAGSERAADARDSDRQTKMEGAEINQSLL 	                                                            
						ALKECIRALDQEHTHTPFRQSKLTQVLKDSFIGNAKTCMIANISPSHVATEHTLNTLRYA 	Alignment:                                                   
						DRVKELKKGIKCCTSVTSRNRTSGNSSPKRIQSSPGALSEDKCSPKKVKLGFQQSLTVAA 	                  .         .         .         .         .  
						PGSTRGKVHPLTSHPPNIPFTSAPKVSGKRGGSRGSPSQEWVIHASPVKGTVRSGHVAKK 	     956 SSFDLRKDASQSEVSGENEGNLPSPEEDGFTISLSHVAVPGSPDQRDTVT 1005                                                         
						KPEESAPLCSEKNRMGNKTVLGWESRASGPGEGLVRGKLSTKCKKVQTVQPVQKQLVSRV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ELSFGNAHHRAEYSQDSQRGTPARPASEAWTNIPPHQKEREEHLRFYHQQFQQPPLLQQK 	       1 SSFDLRKDASQSEVSGENEGNLPSPEEDGFTISLSHVAVPGSPDQRDTVT 50                                                           
						LKYQPLKRSLRQYRPPEGQLTNETPPLFHSYSENHDGAQVEELDDSDFSEDSFSHISSQR 	                  .         .         .         .         .  
						ATKQRNTLENSEDSFFLHQTWGQGPEKQVAERQQSLFSSPRTGDKKDLTKSWVDSRDPIN 	    1006 TPLREVSADGPIQVTSTVKNGHAVPGEDPRGQLGTHAEYASGLMSPLTMS 1055                                                         
						HRRAALDHSCSPSKGPVDWSRENSTSSGPSPRDSLAEKPYCSQVDFIYRQERGGG      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	      51 TPLREVSADGPIQVTSTVKNGHAVPGEDPRGQLGTHAEYASGLMSPLTMS 100                                                          
						to amino acids 1 - 955 of AA446016_P3, a second amino acid   	                  .         .         .         .         .  
						SSFDLRKDASQSEVSGENEGNLPSPEEDGFTISLSHVAVPGSPDQRDTVTTPLREVSADG 	    1056 LLENPDNEGSPPSEQLVQDGATHSLVAESTGGPVVSHTVPSGDQEAALPV 1105                                                         
						PIQVTSTVKNGHAVPGEDPRGQLGTHAEYASGLMSPLTMSLLENPDNEGSPPSEQLVQDG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ATHSLVAESTGGPVVSHTVPSGDQEAALPVSSATRHLWLSSSPPDNKPGGDLPAL      	     101 LLENPDNEGSPPSEQLVQDGATHSLVAESTGGPVVSHTVPSGDQEAALPV 150                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .                                
						amino acids 1 - 175 of AAH48311, which also corresponds to   	    1106 SSATRHLWLSSSPPDNKPGGDLPALSP                        1132                                                         
						amino acids 956 - 1130 of AA446016_P3, and a third amino acid	         ||||||||||||||||||||||||| |                         
						sequence being at least 70%, optionally at least 80%,        	     151 SSATRHLWLSSSPPDNKPGGDLPALGP                        177                                                          
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						SPSPIRQHPADKLPSREADLGEACQSRETVLFSHEHMGSEQYDADAEETGLDGSWGFPGK 	                                                            
						PFTTIHMGVPHSGPTLTPRTGSSDVADQLWAQERKHPTRLGWQEFGLSTDPIKLPCNSEN 	                                                            
						VTWLKPRPISRCLARPSSPLVPSCSPKTAGTLRQPTLEQAQQVVIRAHQEQLDEMAELGF 	                                                            
						KEETLMSQLASNDFEDFVTQLDEIMVLKSKCIQSLRSQLQLYLTCHGPTAAPEGTVPS   	                                                            
						having the sequence corresponding to amino acids 1131 - 1368 	                                                            
						of AA446016_P3, wherein said first amino acid sequence,      	                                                            
						second amino acid sequence and third amino acid sequence are 	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of AA446016_P3, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MASWLYECLCEAELAQYYSHFTALGLQKIDELAKITMKDYSKLGVHDMNDRKRLFQLIKI 	                                                            
						IKIMQEEDKAVSIPERHLQTSSLRIKSQELRSGPRRQLNFDSPADNKDRNASNDGFEMCS 	                                                            
						LSDFSANEQKSTYLKVLEHMLPDDSQYHTKTGILNATAGDSYVQTEISTSLFSPNYLSAI 	                                                            
						LGDCDIPIIQRISHVSGYNYGIPHSCIRQNTSEKQNPWTEMEKIRVCVRKRPLGMREVRR 	                                                            
						GEINIITVEDKETLLVHEKKEAVDLTQYILQHVFYFDEVFGEACTNQDVYMKTTHPLIQH 	                                                            
						IFNGGNATCFAYGQTGAGKTYTMIGTHENPGLYALAAKDIFRQLEVSQPRKHLFVWISFY 	                                                            
						EIYCGQLYDLLNRRKRLFAREDSKHMVQIVGLQELQVDSVELLLEVILKGSKERSTGATG 	                                                            
						VNADSSRSHAVIQIQIKDSAKRTFGRISFIDLAGSERAADARDSDRQTKMEGAEINQSLL 	                                                            
						ALKECIRALDQEHTHTPFRQSKLTQVLKDSFIGNAKTCMIANISPSHVATEHTLNTLRYA 	                                                            
						DRVKELKKGIKCCTSVTSRNRTSGNSSPKRIQSSPGALSEDKCSPKKVKLGFQQSLTVAA 	                                                            
						PGSTRGKVHPLTSHPPNIPFTSAPKVSGKRGGSRGSPSQEWVIHASPVKGTVRSGHVAKK 	                                                            
						KPEESAPLCSEKNRMGNKTVLGWESRASGPGEGLVRGKLSTKCKKVQTVQPVQKQLVSRV 	                                                            
						ELSFGNAHHRAEYSQDSQRGTPARPASEAWTNIPPHQKEREEHLRFYHQQFQQPPLLQQK 	                                                            
						LKYQPLKRSLRQYRPPEGQLTNETPPLFHSYSENHDGAQVEELDDSDFSEDSFSHISSQR 	                                                            
						ATKQRNTLENSEDSFFLHQTWGQGPEKQVAERQQSLFSSPRTGDKKDLTKSWVDSRDPIN 	                                                            
						HRRAALDHSCSPSKGPVDWSRENSTSSGPSPRDSLAEKPYCSQVDFIYRQERGGG      	                                                            
						to the sequence of AA446016_P3.3.An isolated polypeptide     	                                                            
						encoding for a tail of AA446016_P3, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						SPSPIRQHPADKLPSREADLGEACQSRETVLFSHEHMGSEQYDADAEETGLDGSWGFPGK 	                                                            
						PFTTIHMGVPHSGPTLTPRTGSSDVADQLWAQERKHPTRLGWQEFGLSTDPIKLPCNSEN 	                                                            
						VTWLKPRPISRCLARPSSPLVPSCSPKTAGTLRQPTLEQAQQVVIRAHQEQLDEMAELGF 	                                                            
						KEETLMSQLASNDFEDFVTQLDEIMVLKSKCIQSLRSQLQLYLTCHGPTAAPEGTVPS   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA446016_P3.                                              	                                                            

5246	HMR136_AA447108_2_tr0_r1_1_gPRT		Comparison report between AA447108_P2 and Q96B54partial WT   	Sequence name: Q96B54                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for AA447108_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MTETREPAETGGYASLEEDDEDLSP corresponding to amino acids 64 -  	Alignment of: 5246 x Q96B54   ..                             
						88 of Q96B54, which also corresponds to amino acids 1 - 25 of	                                                            
						AA447108_P2, and a second amino acid sequence being at least 	Alignment segment 1/1:                                       
						EPDSEEEEDEEEEEEETTDDPEYDPGYKVKQRLGGGRGGPSRRAPRAAQPPAQPCQLCGR 	                                                            
						SPLGEAPPGTPPCRLCCPATAPQEAPAPEGRALGEEEEEPPRAGEGRPAGREEEEEEEEE 	                     Quality: 1665.00                      Escore:       0                                               
						GTYHCTECEDSFDNLGELHGHFMLHARGEV                               	             Matching length:     175                Total length:     188                                               
						90 % homologous to corresponding to amino acids 102 - 251 of 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						Q96B54, which also corresponds to amino acids 26 - 175 of    	    Total Percent Similarity:   93.09      Total Percent Identity:   93.09                                               
						AA447108_P2, wherein said first amino acid sequence and      	                        Gaps:       1                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.2.An isolated chimeric polypeptide encoding for an edge	Alignment:                                                   
						portion of AA447108_P2, comprising a polypeptide having a    	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	       1 MTETREPAETGGYASLEEDDEDLSP.............EPDSEEEEDEEE 37                                                           
						length, optionally at least about 20 amino acids in length,  	         |||||||||||||||||||||||||             ||||||||||||  
						preferably at least about 30 amino acids in length, more     	      64 MTETREPAETGGYASLEEDDEDLSPGPEHSSDSEYTLSEPDSEEEEDEEE 113                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	      38 EEEETTDDPEYDPGYKVKQRLGGGRGGPSRRAPRAAQPPAQPCQLCGRSP 87                                                           
						at least two amino acids comprise PE, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     114 EEEETTDDPEYDPGYKVKQRLGGGRGGPSRRAPRAAQPPAQPCQLCGRSP 163                                                          
						25-x to 26; and ending at any of amino acid numbers 26+      	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	      88 LGEAPPGTPPCRLCCPATAPQEAPAPEGRALGEEEEEPPRAGEGRPAGRE 137                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     164 LGEAPPGTPPCRLCCPATAPQEAPAPEGRALGEEEEEPPRAGEGRPAGRE 213                                                          
						                                                            	                  .         .         .                      
						                                                            	     138 EEEEEEEEGTYHCTECEDSFDNLGELHGHFMLHARGEV             175                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     214 EEEEEEEEGTYHCTECEDSFDNLGELHGHFMLHARGEV             251                                                          

						Comparison report between AA447108_P2 and AAH45799partial WT 	Sequence name: AAH45799                                      
						sequence followed by mismatch and a featuring a skipped      	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA447108_P2, comprising a first amino acid sequence being at 	                                                            
						least 90 % homologous to MTETREPAETGGYASLEEDD corresponding  	Alignment of: 5246 x AAH45799   ..                           
						to amino acids 1 - 20 of AAH45799, which also corresponds to 	                                                            
						amino acids 1 - 20 of AA447108_P2, a bridging amino acid E   	Alignment segment 1/1:                                       
						corresponding to amino acid 21 of AA447108_P2, a second amino	                                                            
						acid sequence being at least 90 % homologous to DLSP         	                     Quality: 1657.00                      Escore:       0                                               
						corresponding to amino acids 22 - 25 of AAH45799, which also 	             Matching length:     175                Total length:     188                                               
						corresponds to amino acids 22 - 25 of AA447108_P2, and a     	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.43                                               
						EPDSEEEEDEEEEEEETTDDPEYDPGYKVKQRLGGGRGGPSRRAPRAAQPPAQPCQLCGR 	    Total Percent Similarity:   93.09      Total Percent Identity:   92.55                                               
						SPLGEAPPGTPPCRLCCPATAPQEAPAPEGRALGEEEEEPPRAGEGRPAGREEEEEEEEE 	                        Gaps:       1                        
						GTYHCTECEDSFDNLGELHGHFMLHARGEV                               	                                                            
						third amino acid sequence being at least 90 % homologous to  	Alignment:                                                   
						corresponding to amino acids 39 - 188 of AAH45799, which also	                  .         .         .         .         .  
						corresponds to amino acids 26 - 175 of AA447108_P2, wherein  	       1 MTETREPAETGGYASLEEDDEDLSP.............EPDSEEEEDEEE 37                                                           
						said first amino acid sequence, bridging amino acid, second  	         ||||||||||||||||||||:||||             ||||||||||||  
						amino acid sequence and third amino acid sequence are        	       1 MTETREPAETGGYASLEEDDDDLSPGPEHSSDSEYTLSEPDSEEEEDEEE 50                                                           
						contiguous and in a sequential order.2.An isolated chimeric  	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of AA447108_P2,     	      38 EEEETTDDPEYDPGYKVKQRLGGGRGGPSRRAPRAAQPPAQPCQLCGRSP 87                                                           
						comprising a polypeptide having a length "n", wherein n is at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 10 amino acids in length, optionally at least    	      51 EEEETTDDPEYDPGYKVKQRLGGGRGGPSRRAPRAAQPPAQPCQLCGRSP 100                                                          
						about 20 amino acids in length, preferably at least about 30 	                  .         .         .         .         .  
						amino acids in length, more preferably at least about 40     	      88 LGEAPPGTPPCRLCCPATAPQEAPAPEGRALGEEEEEPPRAGEGRPAGRE 137                                                          
						amino acids in length and most preferably at least about 50  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, wherein at least two amino acids      	     101 LGEAPPGTPPCRLCCPATAPQEAPAPEGRALGEEEEEPPRAGEGRPAGRE 150                                                          
						comprise PE, having a structure as follows: a sequence       	                  .         .         .                      
						starting from any of amino acid numbers 25-x to 26; and      	     138 EEEEEEEEGTYHCTECEDSFDNLGELHGHFMLHARGEV             175                                                          
						ending at any of amino acid numbers 26+ ((n-2) - x), in which	         ||||||||||||||||||||||||||||||||||||||              
						x varies from 0 to n-2.                                      	     151 EEEEEEEEGTYHCTECEDSFDNLGELHGHFMLHARGEV             188                                                          

5244	HMR136_AA447108_3_tr0_r1_1_gPRT		Comparison report between AA447108_P3 and Q96B54partial WT   	Sequence name: Q96B54                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA447108_P3, comprising a first amino acid      	                                                            
						MTETREPAETGGYASLEEDDEDLSPGPEHSSDSEYTLSEPDSEEEEDEEEEEEETTDDPE 	Alignment of: 5244 x Q96B54   ..                             
						YDPGYKVKQRLGGGRGGPSRRAPRAAQPPAQPCQLCGRSPLGEAPPGTPPCRLCCPATAP 	                                                            
						QEAPAPEGRALGEEEEEPPRAGEGRPAGREEEEEEEEEGTYHCTECEDSFDNLGELHGHF 	Alignment segment 1/1:                                       
						MLHARGEV                                                     	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 1894.00                      Escore:       0                                               
						amino acids 64 - 251 of Q96B54, which also corresponds to    	             Matching length:     188                Total length:     188                                               
						amino acids 1 - 188 of AA447108_P3.                          	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MTETREPAETGGYASLEEDDEDLSPGPEHSSDSEYTLSEPDSEEEEDEEE 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      64 MTETREPAETGGYASLEEDDEDLSPGPEHSSDSEYTLSEPDSEEEEDEEE 113                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 EEEETTDDPEYDPGYKVKQRLGGGRGGPSRRAPRAAQPPAQPCQLCGRSP 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     114 EEEETTDDPEYDPGYKVKQRLGGGRGGPSRRAPRAAQPPAQPCQLCGRSP 163                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LGEAPPGTPPCRLCCPATAPQEAPAPEGRALGEEEEEPPRAGEGRPAGRE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     164 LGEAPPGTPPCRLCCPATAPQEAPAPEGRALGEEEEEPPRAGEGRPAGRE 213                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 EEEEEEEEGTYHCTECEDSFDNLGELHGHFMLHARGEV             188                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     214 EEEEEEEEGTYHCTECEDSFDNLGELHGHFMLHARGEV             251                                                          

						Comparison report between AA447108_P3 and AAH45799partial WT 	Sequence name: AAH45799                                      
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for AA447108_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MTETREPAETGGYASLEEDD corresponding to amino acids 1 - 20 of  	Alignment of: 5244 x AAH45799   ..                           
						AAH45799, which also corresponds to amino acids 1 - 20 of    	                                                            
						AA447108_P3, a bridging amino acid E corresponding to amino  	Alignment segment 1/1:                                       
						acid 21 of AA447108_P3, and a second amino acid sequence     	                                                            
						DLSPGPEHSSDSEYTLSEPDSEEEEDEEEEEEETTDDPEYDPGYKVKQRLGGGRGGPSRR 	                     Quality: 1886.00                      Escore:       0                                               
						APRAAQPPAQPCQLCGRSPLGEAPPGTPPCRLCCPATAPQEAPAPEGRALGEEEEEPPRA 	             Matching length:     188                Total length:     188                                               
						GEGRPAGREEEEEEEEEGTYHCTECEDSFDNLGELHGHFMLHARGEV              	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.47                                               
						being at least 90 % homologous to corresponding to amino     	    Total Percent Similarity:  100.00      Total Percent Identity:   99.47                                               
						acids 22 - 188 of AAH45799, which also corresponds to amino  	                        Gaps:       0                        
						acids 22 - 188 of AA447108_P3, wherein said first amino acid 	                                                            
						sequence, bridging amino acid and second amino acid sequence 	Alignment:                                                   
						are contiguous and in a sequential order.                    	                  .         .         .         .         .  
						                                                            	       1 MTETREPAETGGYASLEEDDEDLSPGPEHSSDSEYTLSEPDSEEEEDEEE 50                                                           
						                                                            	         ||||||||||||||||||||:|||||||||||||||||||||||||||||  
						                                                            	       1 MTETREPAETGGYASLEEDDDDLSPGPEHSSDSEYTLSEPDSEEEEDEEE 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 EEEETTDDPEYDPGYKVKQRLGGGRGGPSRRAPRAAQPPAQPCQLCGRSP 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 EEEETTDDPEYDPGYKVKQRLGGGRGGPSRRAPRAAQPPAQPCQLCGRSP 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LGEAPPGTPPCRLCCPATAPQEAPAPEGRALGEEEEEPPRAGEGRPAGRE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 LGEAPPGTPPCRLCCPATAPQEAPAPEGRALGEEEEEPPRAGEGRPAGRE 150                                                          
						                                                            	                  .         .         .                      
						                                                            	     151 EEEEEEEEGTYHCTECEDSFDNLGELHGHFMLHARGEV             188                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     151 EEEEEEEEGTYHCTECEDSFDNLGELHGHFMLHARGEV             188                                                          

12387	HMR136_AA447928_4_tr0_r1_1_gPRT		Comparison report between AA447928_P4 and Q8N8T3partial WT   	Sequence name: Q8N8T3                                        
						sequence followed by mismatch, followed by a short unique    	                                                            
						deletion and a followed by a unique tail.1.An isolated       	Sequence documentation:                                      
						chimeric polypeptide encoding for AA447928_P4, comprising a  	                                                            
						MSSYFVNSLFSKYKTGESLRPNYYDCGFAQDLGGRPTVVYGPSSGGSFQHPSQIQEFYHG 	Alignment of: 12387 x Q8N8T3   ..                            
						PSSLSTAPYQQNPCAVACHGDP                                       	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 82 of Q8N8T3, which also    	                                                            
						corresponds to amino acids 1 - 82 of AA447928_P4, a bridging 	                     Quality: 2006.00                      Escore:       0                                               
						amino acid G corresponding to amino acid 83 of AA447928_P4, a	             Matching length:     211                Total length:     212                                               
						second amino acid sequence being at least 90 % homologous to 	 Matching Percent Similarity:   99.05   Matching Percent Identity:   99.05                                               
						NFYGYDPLQRQSLFGAQDPDLVQYADCKLAAASGLGEEAEGSEQSPSPTQLFPWMRPQ   	    Total Percent Similarity:   98.58      Total Percent Identity:   98.58                                               
						corresponding to amino acids 84 - 141 of Q8N8T3, which also  	                        Gaps:       1                        
						corresponds to amino acids 84 - 141 of AA447928_P4, a third  	                                                            
						AAGRRRGRQTYSRYQTLELEKEFLFNPYLTRKRRIEVSHALGLTERQVKIWFQNRRMKWK 	Alignment:                                                   
						KENNKDKF                                                     	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MSSYFVNSLFSKYKTGESLRPNYYDCGFAQDLGGRPTVVYGPSSGGSFQH 50                                                           
						corresponding to amino acids 143 - 210 of Q8N8T3, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 142 - 209 of AA447928_P4, and a   	       1 MSSYFVNSLFSKYKTGESLRPNYYDCGFAQDLGGRPTVVYGPSSGGSFQH 50                                                           
						fourth amino acid sequence being at least 70%, optionally at 	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	      51 PSQIQEFYHGPSSLSTAPYQQNPCAVACHGDPGNFYGYDPLQRQSLFGAQ 100                                                          
						90% and most preferably at least 95% homologous to a         	         |||||||||||||||||||||||||||||||| |||||||||||||||||  
						polypeptide having the sequence                              	      51 PSQIQEFYHGPSSLSTAPYQQNPCAVACHGDPDNFYGYDPLQRQSLFGAQ 100                                                          
						PSQSSLPSATPQLAGFLSGFSLFLLHPPPLV corresponding to amino acids 	                  .         .         .         .         .  
						210 - 240 of AA447928_P4, wherein said first amino acid      	     101 DPDLVQYADCKLAAASGLGEEAEGSEQSPSPTQLFPWMRPQ.AAGRRRGR 149                                                          
						sequence, bridging amino acid, second amino acid sequence,   	         ||||||||||||||||||||||||||||||||||||||||| ||||||||  
						third amino acid sequence and fourth amino acid sequence are 	     101 DPDLVQYADCKLAAASGLGEEAEGSEQSPSPTQLFPWMRPQAAAGRRRGR 150                                                          
						contiguous and in a sequential order.2.An isolated chimeric  	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of AA447928_P4,     	     150 QTYSRYQTLELEKEFLFNPYLTRKRRIEVSHALGLTERQVKIWFQNRRMK 199                                                          
						comprising a polypeptide having a length "n", wherein n is at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 10 amino acids in length, optionally at least    	     151 QTYSRYQTLELEKEFLFNPYLTRKRRIEVSHALGLTERQVKIWFQNRRMK 200                                                          
						about 20 amino acids in length, preferably at least about 30 	                  .                                          
						amino acids in length, more preferably at least about 40     	     200 WKKENNKDKFPS                                       211                                                          
						amino acids in length and most preferably at least about 50  	         |||||||||| |                                        
						amino acids in length, wherein at least two amino acids      	     201 WKKENNKDKFHS                                       212                                                          
						comprise QA, having a structure as follows: a sequence       	                                                            
						starting from any of amino acid numbers 142-x to 142; and    	                                                            
						ending at any of amino acid numbers 142+ ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.3.An isolated polypeptide       	                                                            
						encoding for a tail of AA447928_P4, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						PSQSSLPSATPQLAGFLSGFSLFLLHPPPLV in AA447928_P4.              	                                                            

12989	HMR136_AA448259_10_tr0_r1_1_gPRT		Comparison report between AA448259_P10 and Q9UHC4unique head 	Sequence name: Q9UHC4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA448259_P10, comprising a first amino acid sequence being at	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12989 x Q9UHC4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence GLTGPSPT     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 8 of AA448259_P10, a second 	                                                            
						EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPPWGDCSSASLN 	                     Quality: 1311.00                      Escore:       0                                               
						PNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKCGCRMVYMPGDVPVCSPQQYK 	             Matching length:     127                Total length:     127                                               
						NCAHPAI                                                      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 229 - 355 of Q9UHC4, which also 	                        Gaps:       0                        
						corresponds to amino acids 9 - 135 of AA448259_P10, and a    	                                                            
						third amino acid sequence being at least 70%, optionally at  	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       9 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 58                                                           
						polypeptide having the sequence                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GRTCWPWTSSLRPSTMRPWSRRRPMRCQSCLVTLGARWGCSSGPACSPSSRS         	     229 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 278                                                          
						corresponding to amino acids 136 - 187 of AA448259_P10,      	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	      59 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 108                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     279 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 328                                                          
						head of AA448259_P10, comprising a polypeptide being at least	                  .         .                                
						70%, optionally at least about 80%, preferably at least about	     109 GCRMVYMPGDVPVCSPQQYKNCAHPAI                        135                                                          
						85%, more preferably at least about 90% and most preferably  	         |||||||||||||||||||||||||||                         
						at least about 95% homologous to the sequence GLTGPSPT of    	     329 GCRMVYMPGDVPVCSPQQYKNCAHPAI                        355                                                          
						AA448259_P10.3.An isolated polypeptide encoding for a tail of	                                                            
						AA448259_P10, comprising a polypeptide being at least 70%,   	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						GRTCWPWTSSLRPSTMRPWSRRRPMRCQSCLVTLGARWGCSSGPACSPSSRS in      	                                                            
						AA448259_P10.                                                	                                                            

						Comparison report between AA448259_P10 and Q9UHC3unique head 	Sequence name: Q9UHC3                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA448259_P10, comprising a first amino acid sequence being at	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12989 x Q9UHC3   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence GLTGPSPT     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 8 of AA448259_P10, a second 	                                                            
						EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPPWGDCSSASLN 	                     Quality: 1311.00                      Escore:       0                                               
						PNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKCGCRMVYMPGDVPVCSPQQYK 	             Matching length:     127                Total length:     127                                               
						NCAHPAI                                                      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 229 - 355 of Q9UHC3, which also 	                        Gaps:       0                        
						corresponds to amino acids 9 - 135 of AA448259_P10, and a    	                                                            
						third amino acid sequence being at least 70%, optionally at  	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       9 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 58                                                           
						polypeptide having the sequence                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GRTCWPWTSSLRPSTMRPWSRRRPMRCQSCLVTLGARWGCSSGPACSPSSRS         	     229 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 278                                                          
						corresponding to amino acids 136 - 187 of AA448259_P10,      	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	      59 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 108                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     279 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 328                                                          
						head of AA448259_P10, comprising a polypeptide being at least	                  .         .                                
						70%, optionally at least about 80%, preferably at least about	     109 GCRMVYMPGDVPVCSPQQYKNCAHPAI                        135                                                          
						85%, more preferably at least about 90% and most preferably  	         |||||||||||||||||||||||||||                         
						at least about 95% homologous to the sequence GLTGPSPT of    	     329 GCRMVYMPGDVPVCSPQQYKNCAHPAI                        355                                                          
						AA448259_P10.3.An isolated polypeptide encoding for a tail of	                                                            
						AA448259_P10, comprising a polypeptide being at least 70%,   	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						GRTCWPWTSSLRPSTMRPWSRRRPMRCQSCLVTLGARWGCSSGPACSPSSRS in      	                                                            
						AA448259_P10.                                                	                                                            

						Comparison report between AA448259_P10 and O75906unique head 	Sequence name: O75906                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA448259_P10, comprising a first amino acid sequence being at	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12989 x O75906   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence GLTGPSPT     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 8 of AA448259_P10, a second 	                                                            
						EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPPWGDCSSASLN 	                     Quality: 1311.00                      Escore:       0                                               
						PNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKCGCRMVYMPGDVPVCSPQQYK 	             Matching length:     127                Total length:     127                                               
						NCAHPAI                                                      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 229 - 355 of O75906, which also 	                        Gaps:       0                        
						corresponds to amino acids 9 - 135 of AA448259_P10, and a    	                                                            
						third amino acid sequence being at least 70%, optionally at  	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       9 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 58                                                           
						polypeptide having the sequence                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GRTCWPWTSSLRPSTMRPWSRRRPMRCQSCLVTLGARWGCSSGPACSPSSRS         	     229 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 278                                                          
						corresponding to amino acids 136 - 187 of AA448259_P10,      	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	      59 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 108                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     279 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 328                                                          
						head of AA448259_P10, comprising a polypeptide being at least	                  .         .                                
						70%, optionally at least about 80%, preferably at least about	     109 GCRMVYMPGDVPVCSPQQYKNCAHPAI                        135                                                          
						85%, more preferably at least about 90% and most preferably  	         |||||||||||||||||||||||||||                         
						at least about 95% homologous to the sequence GLTGPSPT of    	     329 GCRMVYMPGDVPVCSPQQYKNCAHPAI                        355                                                          
						AA448259_P10.3.An isolated polypeptide encoding for a tail of	                                                            
						AA448259_P10, comprising a polypeptide being at least 70%,   	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						GRTCWPWTSSLRPSTMRPWSRRRPMRCQSCLVTLGARWGCSSGPACSPSSRS in      	                                                            
						AA448259_P10.                                                	                                                            

						Comparison report between AA448259_P10 and Q9UER8unique head 	Sequence name: Q9UER8                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA448259_P10, comprising a first amino acid sequence being at	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12989 x Q9UER8   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence GLTGPSPT     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 8 of AA448259_P10, a second 	                                                            
						EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPPWGDCSSASLN 	                     Quality: 1311.00                      Escore:       0                                               
						PNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKCGCRMVYMPGDVPVCSPQQYK 	             Matching length:     127                Total length:     127                                               
						NCAHPAI                                                      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 229 - 355 of Q9UER8, which also 	                        Gaps:       0                        
						corresponds to amino acids 9 - 135 of AA448259_P10, and a    	                                                            
						third amino acid sequence being at least 70%, optionally at  	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       9 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 58                                                           
						polypeptide having the sequence                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GRTCWPWTSSLRPSTMRPWSRRRPMRCQSCLVTLGARWGCSSGPACSPSSRS         	     229 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 278                                                          
						corresponding to amino acids 136 - 187 of AA448259_P10,      	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	      59 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 108                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     279 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 328                                                          
						head of AA448259_P10, comprising a polypeptide being at least	                  .         .                                
						70%, optionally at least about 80%, preferably at least about	     109 GCRMVYMPGDVPVCSPQQYKNCAHPAI                        135                                                          
						85%, more preferably at least about 90% and most preferably  	         |||||||||||||||||||||||||||                         
						at least about 95% homologous to the sequence GLTGPSPT of    	     329 GCRMVYMPGDVPVCSPQQYKNCAHPAI                        355                                                          
						AA448259_P10.3.An isolated polypeptide encoding for a tail of	                                                            
						AA448259_P10, comprising a polypeptide being at least 70%,   	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						GRTCWPWTSSLRPSTMRPWSRRRPMRCQSCLVTLGARWGCSSGPACSPSSRS in      	                                                            
						AA448259_P10.                                                	                                                            

12993	HMR136_AA448259_8_tr0_r1_1_gPRT		Comparison report between AA448259_P8 and Q9UHC4unique head  	Sequence name: Q9UHC4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA448259_P8, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12993 x Q9UHC4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence GLTGPSPT     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 8 of AA448259_P8, a second  	                                                            
						EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPPWGDCSSASLN 	                     Quality: 2586.00                      Escore:       0                                               
						PNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKCGCRMVYMPGDVPVCSPQQYK 	             Matching length:     258                Total length:     258                                               
						NCAHPAIDAMLRKDSCACPNPCASTRYAKELSMVRIPSRAAARFLARKLNRSEAYIAENV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LALDIFFEALNYETVEQKKAYEMSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKV 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LGYFWNRQHSQRHSSTNL                                           	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 229 - 486 of Q9UHC4, which also 	Alignment:                                                   
						corresponds to amino acids 9 - 266 of AA448259_P8, and a     	                  .         .         .         .         .  
						third amino acid sequence being at least 70%, optionally at  	       9 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 58                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	     229 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 278                                                          
						polypeptide having the sequence                              	                  .         .         .         .         .  
						LQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLVTQL corresponding  	      59 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 108                                                          
						to amino acids 267 - 311 of AA448259_P8, wherein said first  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	     279 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 328                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     109 GCRMVYMPGDVPVCSPQQYKNCAHPAIDAMLRKDSCACPNPCASTRYAKE 158                                                          
						AA448259_P8, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     329 GCRMVYMPGDVPVCSPQQYKNCAHPAIDAMLRKDSCACPNPCASTRYAKE 378                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence GLTGPSPT of       	     159 LSMVRIPSRAAARFLARKLNRSEAYIAENVLALDIFFEALNYETVEQKKA 208                                                          
						AA448259_P8.3.An isolated polypeptide encoding for a tail of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA448259_P8, comprising a polypeptide being at least 70%,    	     379 LSMVRIPSRAAARFLARKLNRSEAYIAENVLALDIFFEALNYETVEQKKA 428                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     209 YEMSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHS 258                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLVTQL in AA448259_P8.	     429 YEMSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHS 478                                                          
						                                                            	                                                             
						                                                            	     259 QRHSSTNL                                           266                                                          
						                                                            	         ||||||||                                            
						                                                            	     479 QRHSSTNL                                           486                                                          

						Comparison report between AA448259_P8 and Q9UHC3unique head  	Sequence name: Q9UHC3                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA448259_P8, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12993 x Q9UHC3   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence GLTGPSPT     	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 8 of AA448259_P8, a second  	                                                            
						EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPPWGDCSSASLN 	                     Quality: 2772.00                      Escore:       0                                               
						PNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKCGCRMVYMPGDVPVCSPQQYK 	             Matching length:     277                Total length:     277                                               
						NCAHPAIDAMLRKDSCACPNPCASTRYAKELSMVRIPSRAAARFLARKLNRSEAYIAENV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LALDIFFEALNYETVEQKKAYEMSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKV 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LGYFWNRQHSQRHSSTNLLQEGLGSHRTQVPHLSLGP                        	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 229 - 505 of Q9UHC3, which also 	Alignment:                                                   
						corresponds to amino acids 9 - 285 of AA448259_P8, and a     	                  .         .         .         .         .  
						third amino acid sequence being at least 70%, optionally at  	       9 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 58                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	     229 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 278                                                          
						polypeptide having the sequence RPPTPPCAVTKTLSASHRTCYLVTQL   	                  .         .         .         .         .  
						corresponding to amino acids 286 - 311 of AA448259_P8,       	      59 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 108                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     279 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 328                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of AA448259_P8, comprising a polypeptide being at least 	     109 GCRMVYMPGDVPVCSPQQYKNCAHPAIDAMLRKDSCACPNPCASTRYAKE 158                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     329 GCRMVYMPGDVPVCSPQQYKNCAHPAIDAMLRKDSCACPNPCASTRYAKE 378                                                          
						at least about 95% homologous to the sequence GLTGPSPT of    	                  .         .         .         .         .  
						AA448259_P8.3.An isolated polypeptide encoding for a tail of 	     159 LSMVRIPSRAAARFLARKLNRSEAYIAENVLALDIFFEALNYETVEQKKA 208                                                          
						AA448259_P8, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     379 LSMVRIPSRAAARFLARKLNRSEAYIAENVLALDIFFEALNYETVEQKKA 428                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence                   	     209 YEMSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHS 258                                                          
						RPPTPPCAVTKTLSASHRTCYLVTQL in AA448259_P8.                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     429 YEMSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHS 478                                                          
						                                                            	                  .         .                                
						                                                            	     259 QRHSSTNLLQEGLGSHRTQVPHLSLGP                        285                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     479 QRHSSTNLLQEGLGSHRTQVPHLSLGP                        505                                                          

						Comparison report between AA448259_P8 and O75906unique head  	Sequence name: O75906                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for AA448259_P8, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 12993 x O75906   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence GLTGPSPT corresponding to    	Alignment segment 1/1:                                       
						amino acids 1 - 8 of AA448259_P8, a second amino acid        	                                                            
						EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPPWGDCSSASLN 	                     Quality: 3022.00                      Escore:       0                                               
						PNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKCGCRMVYMPGDVPVCSPQQYK 	             Matching length:     303                Total length:     303                                               
						NCAHPAIDA                                                    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.67                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:   99.67                                               
						amino acids 229 - 357 of O75906, which also corresponds to   	                        Gaps:       0                        
						amino acids 9 - 137 of AA448259_P8, a bridging amino acid M  	                                                            
						corresponding to amino acid 138 of AA448259_P8, and a third  	Alignment:                                                   
						LRKDSCACPNPCASTRYAKELSMVRIPSRAAARFLARKLNRSEAYIAENVLALDIFFEAL 	                  .         .         .         .         .  
						NYETVEQKKAYEMSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHS 	       9 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 58                                                           
						QRHSSTNLLQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLVTQL        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	     229 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 278                                                          
						corresponding to amino acids 359 - 531 of O75906, which also 	                  .         .         .         .         .  
						corresponds to amino acids 139 - 311 of AA448259_P8, wherein 	      59 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 108                                                          
						said first amino acid sequence, second amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						bridging amino acid and third amino acid sequence are        	     279 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 328                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of AA448259_P8, comprising a 	     109 GCRMVYMPGDVPVCSPQQYKNCAHPAIDAMLRKDSCACPNPCASTRYAKE 158                                                          
						polypeptide being at least 70%, optionally at least about    	         |||||||||||||||||||||||||||||:||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     329 GCRMVYMPGDVPVCSPQQYKNCAHPAIDAILRKDSCACPNPCASTRYAKE 378                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence GLTGPSPT of AA448259_P8.                     	     159 LSMVRIPSRAAARFLARKLNRSEAYIAENVLALDIFFEALNYETVEQKKA 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     379 LSMVRIPSRAAARFLARKLNRSEAYIAENVLALDIFFEALNYETVEQKKA 428                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     209 YEMSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHS 258                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     429 YEMSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHS 478                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     259 QRHSSTNLLQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLV 308                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     479 QRHSSTNLLQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLV 528                                                          
						                                                            	                                                             
						                                                            	     309 TQL                                                311                                                          
						                                                            	         |||                                                 
						                                                            	     529 TQL                                                531                                                          

						Comparison report between AA448259_P8 and Q9UER8unique head  	Sequence name: Q9UER8                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA448259_P8, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 12993 x Q9UER8   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence GLTGPSPT corresponding to amino acids 1 -	Alignment segment 1/1:                                       
						8 of AA448259_P8, and a second amino acid sequence being at  	                                                            
						EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPPWGDCSSASLN 	                     Quality: 3033.00                      Escore:       0                                               
						PNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKCGCRMVYMPGDVPVCSPQQYK 	             Matching length:     303                Total length:     303                                               
						NCAHPAIDAMLRKDSCACPNPCASTRYAKELSMVRIPSRAAARFLARKLNRSEAYIAENV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LALDIFFEALNYETVEQKKAYEMSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKV 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LGYFWNRQHSQRHSSTNLLQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLV 	                        Gaps:       0                        
						TQL                                                          	                                                            
						least 90 % homologous to corresponding to amino acids 229 -  	Alignment:                                                   
						531 of Q9UER8, which also corresponds to amino acids 9 - 311 	                  .         .         .         .         .  
						of AA448259_P8, wherein said first amino acid sequence and   	       9 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 58                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     229 EETPFEVGIRVQIHSQEEPPIIDQLGLGVSPGYQTFVSCQQQQLSFLPPP 278                                                          
						AA448259_P8, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      59 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 108                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence GLTGPSPT of       	     279 WGDCSSASLNPNYEPEPSDPLGSPSPSPSPPYTLMGCRLACETRYVARKC 328                                                          
						AA448259_P8.                                                 	                  .         .         .         .         .  
						                                                            	     109 GCRMVYMPGDVPVCSPQQYKNCAHPAIDAMLRKDSCACPNPCASTRYAKE 158                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     329 GCRMVYMPGDVPVCSPQQYKNCAHPAIDAMLRKDSCACPNPCASTRYAKE 378                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     159 LSMVRIPSRAAARFLARKLNRSEAYIAENVLALDIFFEALNYETVEQKKA 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     379 LSMVRIPSRAAARFLARKLNRSEAYIAENVLALDIFFEALNYETVEQKKA 428                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     209 YEMSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHS 258                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     429 YEMSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHS 478                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     259 QRHSSTNLLQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLV 308                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     479 QRHSSTNLLQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLV 528                                                          
						                                                            	                                                             
						                                                            	     309 TQL                                                311                                                          
						                                                            	         |||                                                 
						                                                            	     529 TQL                                                531                                                          

12991	HMR136_AA448259_9_tr0_r1_1_gPRT		Comparison report between AA448259_P9 and Q9UHC4partial WT   	Sequence name: Q9UHC4                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA448259_P9, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQRHSSTNL     	Alignment of: 12991 x Q9UHC4   ..                            
						corresponding to amino acids 431 - 486 of Q9UHC4, which also 	                                                            
						corresponds to amino acids 1 - 56 of AA448259_P9, and a      	Alignment segment 1/1:                                       
						second amino acid sequence being at least 70%, optionally at 	                                                            
						least 80%, preferably at least 85%, more preferably at least 	                     Quality:  546.00                      Escore:       0                                               
						90% and most preferably at least 95% homologous to a         	             Matching length:      56                Total length:      56                                               
						polypeptide having the sequence                              	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLVTQL corresponding  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						to amino acids 57 - 101 of AA448259_P9, wherein said first   	                        Gaps:       0                        
						amino acid sequence and second amino acid sequence are       	                                                            
						contiguous and in a sequential order.2.An isolated           	Alignment:                                                   
						polypeptide encoding for a tail of AA448259_P9, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	       1 MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQR 50                                                           
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     431 MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQR 480                                                          
						to the sequence LQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLVTQL	                                                             
						in AA448259_P9.                                              	      51 HSSTNL                                             56                                                           
						                                                            	         ||||||                                              
						                                                            	     481 HSSTNL                                             486                                                          

						Comparison report between AA448259_P9 and Q9UHC3partial WT   	Sequence name: Q9UHC3                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA448259_P9, comprising a first     	Sequence documentation:                                      
						MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQRHSSTNLLQEG 	                                                            
						LGSHRTQVPHLSLGP                                              	Alignment of: 12991 x Q9UHC3   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 431 - 505 of Q9UHC3, which also 	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 75 of AA448259_P9, and a      	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality:  732.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:      75                Total length:      75                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence RPPTPPCAVTKTLSASHRTCYLVTQL   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 76 - 101 of AA448259_P9, wherein	                        Gaps:       0                        
						said first amino acid sequence and second amino acid sequence	                                                            
						are contiguous and in a sequential order.2.An isolated       	Alignment:                                                   
						polypeptide encoding for a tail of AA448259_P9, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	       1 MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQR 50                                                           
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     431 MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQR 480                                                          
						to the sequence RPPTPPCAVTKTLSASHRTCYLVTQL in AA448259_P9.   	                  .         .                                
						                                                            	      51 HSSTNLLQEGLGSHRTQVPHLSLGP                          75                                                           
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     481 HSSTNLLQEGLGSHRTQVPHLSLGP                          505                                                          

						Comparison report between AA448259_P9 and O75906partial WT   	Sequence name: O75906                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA448259_P9, comprising a first amino acid      	                                                            
						MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQRHSSTNLLQEG 	Alignment of: 12991 x O75906   ..                            
						LGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLVTQL                    	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 431 - 531 of O75906, which also corresponds to   	                                                            
						amino acids 1 - 101 of AA448259_P9.                          	                     Quality:  993.00                      Escore:       0                                               
						                                                            	             Matching length:     101                Total length:     101                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQR 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     431 MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQR 480                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 HSSTNLLQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLVTQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     481 HSSTNLLQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLVTQ 530                                                          
						                                                            	                                                             
						                                                            	     101 L                                                  101                                                          
						                                                            	         |                                                   
						                                                            	     531 L                                                  531                                                          

						Comparison report between AA448259_P9 and O60263partial WT   	Sequence name: O60263                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for AA448259_P9, comprising a first     	Sequence documentation:                                      
						MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQRHSSTNLLQEG 	                                                            
						LGSHRTQVPHLSLGPRPPTPPCAVTKT                                  	Alignment of: 12991 x O60263   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 432 - 518 of O60263, which also 	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 87 of AA448259_P9, a bridging 	                                                            
						amino acid L corresponding to amino acid 88 of AA448259_P9,  	                     Quality:  985.00                      Escore:       0                                               
						and a second amino acid sequence being at least 90 %         	             Matching length:     101                Total length:     101                                               
						homologous to SASHRTCYLVTQL corresponding to amino acids 520 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.01                                               
						- 532 of O60263, which also corresponds to amino acids 89 -  	    Total Percent Similarity:  100.00      Total Percent Identity:   99.01                                               
						101 of AA448259_P9, wherein said first amino acid sequence,  	                        Gaps:       0                        
						bridging amino acid and second amino acid sequence are       	                                                            
						contiguous and in a sequential order.                        	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQR 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     432 MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQR 481                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 HSSTNLLQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLVTQ 100                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||:||||||||||||  
						                                                            	     482 HSSTNLLQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTFSASHRTCYLVTQ 531                                                          
						                                                            	                                                             
						                                                            	     101 L                                                  101                                                          
						                                                            	         |                                                   
						                                                            	     532 L                                                  532                                                          

						Comparison report between AA448259_P9 and Q9UER8partial WT   	Sequence name: Q9UER8                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA448259_P9, comprising a first amino acid      	                                                            
						MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQRHSSTNLLQEG 	Alignment of: 12991 x Q9UER8   ..                            
						LGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLVTQL                    	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 431 - 531 of Q9UER8, which also corresponds to   	                                                            
						amino acids 1 - 101 of AA448259_P9.                          	                     Quality:  993.00                      Escore:       0                                               
						                                                            	             Matching length:     101                Total length:     101                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQR 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     431 MSELLGDIGGQMGLFIGASLLTILEILDYLCEVFRDKVLGYFWNRQHSQR 480                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 HSSTNLLQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLVTQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     481 HSSTNLLQEGLGSHRTQVPHLSLGPRPPTPPCAVTKTLSASHRTCYLVTQ 530                                                          
						                                                            	                                                             
						                                                            	     101 L                                                  101                                                          
						                                                            	         |                                                   
						                                                            	     531 L                                                  531                                                          

6535	HMR136_AA448947_1_tr0_r1_1_gPRT		Comparison report between AA448947_P1 and Q8TB59unique head  	Sequence name: Q8TB59                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						AA448947_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 6535 x Q8TB59   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						NRALLYVRKLCQGSKGPSIRHRGEWLTPNEFQFVSGRETAKDWKRSIRHKGKSLKTLMSK 	Alignment segment 1/1:                                       
						GILQVHPPICDCPGCRISSPVNRGRLADKRTVALPAARNLKKERTPSFSASDGDSDGSGP 	                                                            
						TCGRRPGLKQEDGPHIRIMKRRVHTHWDVNISFREASCSQDGNLPTLISSVHRSRHLVMP 	                     Quality: 4576.00                      Escore:       0                                               
						EHQSRCEFQRGSLEIGLRPAGDLLGKRLGRSPRISSDCFSEKRARSESPQEALLLPRELG 	             Matching length:     480                Total length:     496                                               
						PS                                                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   96.77      Total Percent Identity:   96.77                                               
						to amino acids 1 - 242 of AA448947_P1, a second amino acid   	                        Gaps:       1                        
						sequence being at least 90 % homologous to                   	                                                            
						MAPEDHYRRLVSALSEASTFEDPQRLYHLG corresponding to amino acids 1	Alignment:                                                   
						- 30 of Q8TB59, which also corresponds to amino acids 243 -  	                  .         .         .         .         .  
						272 of AA448947_P1, a third amino acid sequence being at     	     243 MAPEDHYRRLVSALSEASTFEDPQRLYHLGLPSHGEDPPWHDPPHHLPSH 292                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||                ||||  
						more preferably at least 90% and most preferably at least 95%	       1 MAPEDHYRRLVSALSEASTFEDPQRLYHLG................LPSH 34                                                           
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						LPSHGEDPPWHDPPHH corresponding to amino acids 273 - 288 of   	     293 DLLRVRQEVAAAALRGPSGLEAHLPSSTAGQRRKQGLAQHREGAAPAAAP 342                                                          
						AA448947_P1, and a fourth amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPSHDLLRVRQEVAAAALRGPSGLEAHLPSSTAGQRRKQGLAQHREGAAPAAAPSFSERE 	      35 DLLRVRQEVAAAALRGPSGLEAHLPSSTAGQRRKQGLAQHREGAAPAAAP 84                                                           
						LPQPPPLLSPQNAPHVALGPHLRPPFLGVPSALCQTPGYGFLPPAQAEMFARQQELLRKQ 	                  .         .         .         .         .  
						NLARLELPADLLRQKELESARPQLLAPETALRPNDGAEELQRRGALLVLNHGAAPLLALP 	     343 SFSERELPQPPPLLSPQNAPHVALGPHLRPPFLGVPSALCQTPGYGFLPP 392                                                          
						PQGPPGSGPPTPSRDSARRAPRKGGPGPASARPSESKEMTGARLWAQDGSEDEPPKDSDG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EDPETAAVGCRGPTPGQAPAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDG 	      85 SFSERELPQPPPLLSPQNAPHVALGPHLRPPFLGVPSALCQTPGYGFLPP 134                                                          
						EEAPAPEDVTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLTNMGLKL 	                  .         .         .         .         .  
						GPALKIRAQVARRLGRVFYVASFPVALPLQPPTLRAPERELGTGEQPLSPTTATSPYGGG 	     393 AQAEMFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPN 442                                                          
						HALAGQTSPKQENGTLALLPGAPDPSQPLC                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 31 - 480 of  	     135 AQAEMFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPN 184                                                          
						Q8TB59, which also corresponds to amino acids 289 - 738 of   	                  .         .         .         .         .  
						AA448947_P1, wherein said first amino acid sequence, second  	     443 DGAEELQRRGALLVLNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKG 492                                                          
						amino acid sequence, third amino acid sequence and fourth    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     185 DGAEELQRRGALLVLNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKG 234                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AA448947_P1, comprising a polypeptide being at least 70%,    	     493 GPGPASARPSESKEMTGARLWAQDGSEDEPPKDSDGEDPETAAVGCRGPT 542                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     235 GPGPASARPSESKEMTGARLWAQDGSEDEPPKDSDGEDPETAAVGCRGPT 284                                                          
						NRALLYVRKLCQGSKGPSIRHRGEWLTPNEFQFVSGRETAKDWKRSIRHKGKSLKTLMSK 	                  .         .         .         .         .  
						GILQVHPPICDCPGCRISSPVNRGRLADKRTVALPAARNLKKERTPSFSASDGDSDGSGP 	     543 PGQAPAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDGEEAP 592                                                          
						TCGRRPGLKQEDGPHIRIMKRRVHTHWDVNISFREASCSQDGNLPTLISSVHRSRHLVMP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EHQSRCEFQRGSLEIGLRPAGDLLGKRLGRSPRISSDCFSEKRARSESPQEALLLPRELG 	     285 PGQAPAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDGEEAP 334                                                          
						PS                                                           	                  .         .         .         .         .  
						least about 95% homologous to the sequence of                	     593 APEDVTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLT 642                                                          
						AA448947_P1.3.An isolated polypeptide encoding for an edge   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of AA448947_P1, comprising an amino acid sequence    	     335 APEDVTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLT 384                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .         .         .         .         .  
						at least about 85%, more preferably at least about 90% and   	     643 NMGLKLGPALKIRAQVARRLGRVFYVASFPVALPLQPPTLRAPERELGTG 692                                                          
						most preferably at least about 95% homologous to the sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for LPSHGEDPPWHDPPHH, corresponding to AA448947_P1. 	     385 NMGLKLGPALKIRAQVARRLGRVFYVASFPVALPLQPPTLRAPERELGTG 434                                                          
						                                                            	                  .         .         .         .            
						                                                            	     693 EQPLSPTTATSPYGGGHALAGQTSPKQENGTLALLPGAPDPSQPLC     738                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     435 EQPLSPTTATSPYGGGHALAGQTSPKQENGTLALLPGAPDPSQPLC     480                                                          

						Comparison report between AA448947_P1 and Q8N195unique head  	Sequence name: Q8N195                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA448947_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 6535 x Q8N195   ..                             
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						NRALLYVRKLCQGSKGPSIRHRGEWLTPNEFQFVSGRETAKDWKRSIRHKGKSLKTLMSK 	Alignment segment 1/1:                                       
						GILQVHPPICDCPGCRISSPVNRGRLADKRTVALPAARNLKKERTPSFSASDGDSDGSGP 	                                                            
						TCGRRPGLKQEDGPHIRIMKRRVHTHWDVNISFREASCSQDGNLPTLISSVHRSRHLVMP 	                     Quality: 4861.00                      Escore:       0                                               
						EHQSRCEFQRGSLEIGLRPAGDLLGKRLGRSPRISSDCFSEKRARSESPQEALLLPRELG 	             Matching length:     496                Total length:     496                                               
						PS                                                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 242 of  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AA448947_P1, and a second amino acid sequence being at least 	                        Gaps:       0                        
						MAPEDHYRRLVSALSEASTFEDPQRLYHLGLPSHGEDPPWHDPPHHLPSHDLLRVRQEVA 	                                                            
						AAALRGPSGLEAHLPSSTAGQRRKQGLAQHREGAAPAAAPSFSERELPQPPPLLSPQNAP 	Alignment:                                                   
						HVALGPHLRPPFLGVPSALCQTPGYGFLPPAQAEMFARQQELLRKQNLARLELPADLLRQ 	                  .         .         .         .         .  
						KELESARPQLLAPETALRPNDGAEELQRRGALLVLNHGAAPLLALPPQGPPGSGPPTPSR 	     243 MAPEDHYRRLVSALSEASTFEDPQRLYHLGLPSHGEDPPWHDPPHHLPSH 292                                                          
						DSARRAPRKGGPGPASARPSESKEMTGARLWAQDGSEDEPPKDSDGEDPETAAVGCRGPT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGQAPAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDGEEAPAPEDVTKWTV 	       1 MAPEDHYRRLVSALSEASTFEDPQRLYHLGLPSHGEDPPWHDPPHHLPSH 50                                                           
						DDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLTNMGLKLGPALKIRAQVARRL 	                  .         .         .         .         .  
						GRVFYVASFPVALPLQPPTLRAPERELGTGEQPLSPTTATSPYGGGHALAGQTSPKQENG 	     293 DLLRVRQEVAAAALRGPSGLEAHLPSSTAGQRRKQGLAQHREGAAPAAAP 342                                                          
						TLALLPGAPDPSQPLC                                             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 1 - 496 of   	      51 DLLRVRQEVAAAALRGPSGLEAHLPSSTAGQRRKQGLAQHREGAAPAAAP 100                                                          
						Q8N195, which also corresponds to amino acids 243 - 738 of   	                  .         .         .         .         .  
						AA448947_P1, wherein said first amino acid sequence and      	     343 SFSERELPQPPPLLSPQNAPHVALGPHLRPPFLGVPSALCQTPGYGFLPP 392                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     101 SFSERELPQPPPLLSPQNAPHVALGPHLRPPFLGVPSALCQTPGYGFLPP 150                                                          
						AA448947_P1, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     393 AQAEMFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPN 442                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NRALLYVRKLCQGSKGPSIRHRGEWLTPNEFQFVSGRETAKDWKRSIRHKGKSLKTLMSK 	     151 AQAEMFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPN 200                                                          
						GILQVHPPICDCPGCRISSPVNRGRLADKRTVALPAARNLKKERTPSFSASDGDSDGSGP 	                  .         .         .         .         .  
						TCGRRPGLKQEDGPHIRIMKRRVHTHWDVNISFREASCSQDGNLPTLISSVHRSRHLVMP 	     443 DGAEELQRRGALLVLNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKG 492                                                          
						EHQSRCEFQRGSLEIGLRPAGDLLGKRLGRSPRISSDCFSEKRARSESPQEALLLPRELG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PS                                                           	     201 DGAEELQRRGALLVLNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKG 250                                                          
						least about 95% homologous to the sequence of AA448947_P1.   	                  .         .         .         .         .  
						                                                            	     493 GPGPASARPSESKEMTGARLWAQDGSEDEPPKDSDGEDPETAAVGCRGPT 542                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GPGPASARPSESKEMTGARLWAQDGSEDEPPKDSDGEDPETAAVGCRGPT 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     543 PGQAPAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDGEEAP 592                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PGQAPAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDGEEAP 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     593 APEDVTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLT 642                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 APEDVTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLT 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     643 NMGLKLGPALKIRAQVARRLGRVFYVASFPVALPLQPPTLRAPERELGTG 692                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 NMGLKLGPALKIRAQVARRLGRVFYVASFPVALPLQPPTLRAPERELGTG 450                                                          
						                                                            	                  .         .         .         .            
						                                                            	     693 EQPLSPTTATSPYGGGHALAGQTSPKQENGTLALLPGAPDPSQPLC     738                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||      
						                                                            	     451 EQPLSPTTATSPYGGGHALAGQTSPKQENGTLALLPGAPDPSQPLC     496                                                          

						Comparison report between AA448947_P1 and Q96NU1unique head  	Sequence name: Q96NU1                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for AA448947_P1,      	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 6535 x Q96NU1   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						NRALLYVRKLCQGSKGPSIRHRGEWLTPNEFQFVSGRETAKDWKRSIRHKGKSLKTLMSK 	Alignment segment 1/1:                                       
						GILQVHPPICDCPGCRISSPVNRGRLADKRTVALPAARNLKKERTPSFSASDGDSDGSGP 	                                                            
						TCGRRPGLKQEDGPHIRIMKRRVHTHWDVNISFREASCSQDGNLPTLISSVHRSRHLVMP 	                     Quality: 4761.00                      Escore:       0                                               
						EHQSRCEFQRGSLEIGLRPAGDLLGKRLGRSPRISSDCFSEKRARSESPQEALLLPRELG 	             Matching length:     496                Total length:     529                                               
						PS                                                           	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:   93.76      Total Percent Identity:   93.76                                               
						to amino acids 1 - 242 of AA448947_P1, a second amino acid   	                        Gaps:       1                        
						MAPEDHYRRLVSALSEASTFEDPQRLYHLGLPSHGEDPPWHDPPHHLPSHDLLRVRQEVA 	                                                            
						AAALRGPSGLEAHLPSSTAGQRRKQGLAQHREGAAPAAAPSFSERELPQPPPLLSPQNAP 	Alignment:                                                   
						HVALGPHLRPPFLGVPSALCQTPGYGFLPPAQAEMFARQQELLRKQNLARLELPADLLRQ 	                  .         .         .         .         .  
						KELESARPQLLAPETALRPNDGAEELQRRGALLVLNHGAAPLLALPPQGPPGSGPPTPSR 	     243 MAPEDHYRRLVSALSEASTFEDPQRLYHLGLPSHGEDPPWHDPPHHLPSH 292                                                          
						DSARRAPRKGGPGPASARPSESKEMTGARLWAQDGSEDEPPKDSDGEDPETAAVGCRGPT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGQAPAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDGEEAPAPEDVTKWTV 	       1 MAPEDHYRRLVSALSEASTFEDPQRLYHLGLPSHGEDPPWHDPPHHLPSH 50                                                           
						DDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLTNMGLKLGPALKIRA       	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     293 DLLRVRQEVAAAALRGPSGLEAHLPSSTAGQRRKQGLAQHREGAAPAAAP 342                                                          
						amino acids 1 - 414 of Q96NU1, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 243 - 656 of AA448947_P1, and a third amino acid 	      51 DLLRVRQEVAAAALRGPSGLEAHLPSSTAGQRRKQGLAQHREGAAPAAAP 100                                                          
						QVARRLGRVFYVASFPVALPLQPPTLRAPERELGTGEQPLSPTTATSPYGGGHALAGQTS 	                  .         .         .         .         .  
						PKQENGTLALLPGAPDPSQPLC                                       	     343 SFSERELPQPPPLLSPQNAPHVALGPHLRPPFLGVPSALCQTPGYGFLPP 392                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 448 - 529 of Q96NU1, which also corresponds to   	     101 SFSERELPQPPPLLSPQNAPHVALGPHLRPPFLGVPSALCQTPGYGFLPP 150                                                          
						amino acids 657 - 738 of AA448947_P1, wherein said first     	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence and third    	     393 AQAEMFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPN 442                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     151 AQAEMFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPN 200                                                          
						AA448947_P1, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     443 DGAEELQRRGALLVLNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKG 492                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NRALLYVRKLCQGSKGPSIRHRGEWLTPNEFQFVSGRETAKDWKRSIRHKGKSLKTLMSK 	     201 DGAEELQRRGALLVLNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKG 250                                                          
						GILQVHPPICDCPGCRISSPVNRGRLADKRTVALPAARNLKKERTPSFSASDGDSDGSGP 	                  .         .         .         .         .  
						TCGRRPGLKQEDGPHIRIMKRRVHTHWDVNISFREASCSQDGNLPTLISSVHRSRHLVMP 	     493 GPGPASARPSESKEMTGARLWAQDGSEDEPPKDSDGEDPETAAVGCRGPT 542                                                          
						EHQSRCEFQRGSLEIGLRPAGDLLGKRLGRSPRISSDCFSEKRARSESPQEALLLPRELG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PS                                                           	     251 GPGPASARPSESKEMTGARLWAQDGSEDEPPKDSDGEDPETAAVGCRGPT 300                                                          
						least about 95% homologous to the sequence of                	                  .         .         .         .         .  
						AA448947_P1.3.An isolated chimeric polypeptide encoding for  	     543 PGQAPAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDGEEAP 592                                                          
						an edge portion of AA448947_P1, comprising a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having a length "n", wherein n is at least about 10 amino    	     301 PGQAPAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDGEEAP 350                                                          
						acids in length, optionally at least about 20 amino acids in 	                  .         .         .         .         .  
						length, preferably at least about 30 amino acids in length,  	     593 APEDVTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLT 642                                                          
						more preferably at least about 40 amino acids in length and  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 50 amino acids in length,     	     351 APEDVTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLT 400                                                          
						wherein at least two amino acids comprise AQ, having a       	                  .         .         .         .         .  
						structure as follows: a sequence starting from any of amino  	     643 NMGLKLGPALKIRA.................................QVA 659                                                          
						acid numbers 656-x to 657; and ending at any of amino acid   	         ||||||||||||||                                 |||  
						numbers 657+ ((n-2) - x), in which x varies from 0 to n-2.   	     401 NMGLKLGPALKIRAQVRRWGVRSGSPDHSWAESSGWVCDSPHQAISLQVA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     660 RRLGRVFYVASFPVALPLQPPTLRAPERELGTGEQPLSPTTATSPYGGGH 709                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 RRLGRVFYVASFPVALPLQPPTLRAPERELGTGEQPLSPTTATSPYGGGH 500                                                          
						                                                            	                  .         .                                
						                                                            	     710 ALAGQTSPKQENGTLALLPGAPDPSQPLC                      738                                                          
						                                                            	         |||||||||||||||||||||||||||||                       
						                                                            	     501 ALAGQTSPKQENGTLALLPGAPDPSQPLC                      529                                                          

6537	HMR136_AA448947_5_tr0_r1_1_gPRT		Comparison report between AA448947_P5 and Q8TB59partial WT   	Sequence name: Q8TB59                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA448947_P5, comprising a first amino acid      	                                                            
						MFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPNDGAEELQRRGALLV 	Alignment of: 6537 x Q8TB59   ..                             
						LNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKGGPGPASARPSESKEMTGARLWAQD 	                                                            
						GSEDEPPKDSDGEDPETAAVGCRGPTPGQAPAGGAGAEGKGLFPGSTLPLGFPYAVSPYF 	Alignment segment 1/1:                                       
						HTGAVGGLSMDGEEAPAPEDVTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLT 	                                                            
						EEHLLTNMGLKLGPALKIRAQVARRLGRVFYVASFPVALPLQPPTLRAPERELGTGEQPL 	                     Quality: 3321.00                      Escore:       0                                               
						SPTTATSPYGGGHALAGQTSPKQENGTLALLPGAPDPSQPLC                   	             Matching length:     342                Total length:     342                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 139 - 480 of Q8TB59, which also corresponds to   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 342 of AA448947_P5.                          	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPNDGAE 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     139 MFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPNDGAE 188                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ELQRRGALLVLNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKGGPGP 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     189 ELQRRGALLVLNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKGGPGP 238                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ASARPSESKEMTGARLWAQDGSEDEPPKDSDGEDPETAAVGCRGPTPGQA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     239 ASARPSESKEMTGARLWAQDGSEDEPPKDSDGEDPETAAVGCRGPTPGQA 288                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDGEEAPAPED 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     289 PAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDGEEAPAPED 338                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLTNMGL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     339 VTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLTNMGL 388                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KLGPALKIRAQVARRLGRVFYVASFPVALPLQPPTLRAPERELGTGEQPL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     389 KLGPALKIRAQVARRLGRVFYVASFPVALPLQPPTLRAPERELGTGEQPL 438                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 SPTTATSPYGGGHALAGQTSPKQENGTLALLPGAPDPSQPLC         342                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     439 SPTTATSPYGGGHALAGQTSPKQENGTLALLPGAPDPSQPLC         480                                                          

						Comparison report between AA448947_P5 and Q8N195partial WT   	Sequence name: Q8N195                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA448947_P5, comprising a first amino acid      	                                                            
						MFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPNDGAEELQRRGALLV 	Alignment of: 6537 x Q8N195   ..                             
						LNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKGGPGPASARPSESKEMTGARLWAQD 	                                                            
						GSEDEPPKDSDGEDPETAAVGCRGPTPGQAPAGGAGAEGKGLFPGSTLPLGFPYAVSPYF 	Alignment segment 1/1:                                       
						HTGAVGGLSMDGEEAPAPEDVTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLT 	                                                            
						EEHLLTNMGLKLGPALKIRAQVARRLGRVFYVASFPVALPLQPPTLRAPERELGTGEQPL 	                     Quality: 3321.00                      Escore:       0                                               
						SPTTATSPYGGGHALAGQTSPKQENGTLALLPGAPDPSQPLC                   	             Matching length:     342                Total length:     342                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 155 - 496 of Q8N195, which also corresponds to   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 342 of AA448947_P5.                          	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPNDGAE 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     155 MFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPNDGAE 204                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 ELQRRGALLVLNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKGGPGP 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     205 ELQRRGALLVLNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKGGPGP 254                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ASARPSESKEMTGARLWAQDGSEDEPPKDSDGEDPETAAVGCRGPTPGQA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     255 ASARPSESKEMTGARLWAQDGSEDEPPKDSDGEDPETAAVGCRGPTPGQA 304                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 PAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDGEEAPAPED 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     305 PAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDGEEAPAPED 354                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLTNMGL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     355 VTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLTNMGL 404                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KLGPALKIRAQVARRLGRVFYVASFPVALPLQPPTLRAPERELGTGEQPL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     405 KLGPALKIRAQVARRLGRVFYVASFPVALPLQPPTLRAPERELGTGEQPL 454                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 SPTTATSPYGGGHALAGQTSPKQENGTLALLPGAPDPSQPLC         342                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     455 SPTTATSPYGGGHALAGQTSPKQENGTLALLPGAPDPSQPLC         496                                                          

						Comparison report between AA448947_P5 and Q96NU1partial WT   	Sequence name: Q96NU1                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for AA448947_P5, comprising a first     	Sequence documentation:                                      
						MFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPNDGAEELQRRGALLV 	                                                            
						LNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKGGPGPASARPSESKEMTGARLWAQD 	Alignment of: 6537 x Q96NU1   ..                             
						GSEDEPPKDSDGEDPETAAVGCRGPTPGQAPAGGAGAEGKGLFPGSTLPLGFPYAVSPYF 	                                                            
						HTGAVGGLSMDGEEAPAPEDVTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLT 	Alignment segment 1/1:                                       
						EEHLLTNMGLKLGPALKIRA                                         	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 3221.00                      Escore:       0                                               
						corresponding to amino acids 155 - 414 of Q96NU1, which also 	             Matching length:     342                Total length:     375                                               
						corresponds to amino acids 1 - 260 of AA448947_P5, and a     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QVARRLGRVFYVASFPVALPLQPPTLRAPERELGTGEQPLSPTTATSPYGGGHALAGQTS 	    Total Percent Similarity:   91.20      Total Percent Identity:   91.20                                               
						PKQENGTLALLPGAPDPSQPLC                                       	                        Gaps:       1                        
						second amino acid sequence being at least 90 % homologous to 	                                                            
						corresponding to amino acids 448 - 529 of Q96NU1, which also 	Alignment:                                                   
						corresponds to amino acids 261 - 342 of AA448947_P5, wherein 	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	       1 MFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPNDGAE 50                                                           
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						chimeric polypeptide encoding for an edge portion of         	     155 MFARQQELLRKQNLARLELPADLLRQKELESARPQLLAPETALRPNDGAE 204                                                          
						AA448947_P5, comprising a polypeptide having a length "n",   	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	      51 ELQRRGALLVLNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKGGPGP 100                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     205 ELQRRGALLVLNHGAAPLLALPPQGPPGSGPPTPSRDSARRAPRKGGPGP 254                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     101 ASARPSESKEMTGARLWAQDGSEDEPPKDSDGEDPETAAVGCRGPTPGQA 150                                                          
						at least two amino acids comprise AQ, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     255 ASARPSESKEMTGARLWAQDGSEDEPPKDSDGEDPETAAVGCRGPTPGQA 304                                                          
						260-x to 261; and ending at any of amino acid numbers 261+   	                  .         .         .         .         .  
						((n-2) - x), in which x varies from 0 to n-2.                	     151 PAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDGEEAPAPED 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     305 PAGGAGAEGKGLFPGSTLPLGFPYAVSPYFHTGAVGGLSMDGEEAPAPED 354                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLTNMGL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     355 VTKWTVDDVCSFVGGLSGCGEYTRVFREQGIDGETLPLLTEEHLLTNMGL 404                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KLGPALKIRA.................................QVARRLG 267                                                          
						                                                            	         ||||||||||                                 |||||||  
						                                                            	     405 KLGPALKIRAQVRRWGVRSGSPDHSWAESSGWVCDSPHQAISLQVARRLG 454                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     268 RVFYVASFPVALPLQPPTLRAPERELGTGEQPLSPTTATSPYGGGHALAG 317                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     455 RVFYVASFPVALPLQPPTLRAPERELGTGEQPLSPTTATSPYGGGHALAG 504                                                          
						                                                            	                  .         .                                
						                                                            	     318 QTSPKQENGTLALLPGAPDPSQPLC                          342                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     505 QTSPKQENGTLALLPGAPDPSQPLC                          529                                                          

14121	HMR136_AA449372_0_tr0_r1_1_gPRT		Comparison report between AA449372_P0 and Q9C091partial WT   	Sequence name: Q9C091                                        
						sequence followed by unique insertion and a followed by a    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						AA449372_P0, comprising a first amino acid sequence being at 	                                                            
						MGNSYAGQLKSARFEEALHNSIEASLRCSSVVPRPIFSQLYLDPDQHPFSSADVKPKVED 	Alignment of: 14121 x Q9C091   ..                            
						LDKDLVNRYTQNGSLDFSNNLTVNEMEDDEDDEEMSDSNSPPIPYSQKPAPEGSCTTDGF 	                                                            
						CQAGKDLRLVSLCMEQIDIPAGFLLVGAKSPNLPEHILVCAVDKRFLPDDHGKNALLGFS 	Alignment segment 1/1:                                       
						GNCIGCGERGFRYFTEFSNHINLKLTTQPKKQKHLKYYLVRSSQGVLSKGPLICWKECRS 	                                                            
						RQSSASCHSIKPSSSVSSTVTPENGTTNGYKSGFTQT                        	                     Quality: 6997.00                      Escore:       0                                               
						least 90 % homologous to corresponding to amino acids 2 - 278	             Matching length:     727                Total length:     770                                               
						of Q9C091, which also corresponds to amino acids 1 - 277 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AA449372_P0, a second amino acid sequence being at least 70%,	    Total Percent Similarity:   94.42      Total Percent Identity:   94.42                                               
						optionally at least 80%, preferably at least 85%, more       	                        Gaps:       1                        
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment:                                                   
						DSPILSPANSAINLSGAQDLTRNNNVVKPLALSLQVVGKTFAA corresponding to 	                  .         .         .         .         .  
						amino acids 278 - 320 of AA449372_P0, a third amino acid     	       1 MGNSYAGQLKSARFEEALHNSIEASLRCSSVVPRPIFSQLYLDPDQHPFS 50                                                           
						DAANGNSSHGGKGSASSSTPAHTGNYSLSPRPSYASGDQATMFISGPPKKRHRGWYPGSP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPQPGLVVPVPTVRPLSRTEPLLSAPVPQTPLTGILQPRPIPAGETVIVPENLLSNSGVR 	       2 MGNSYAGQLKSARFEEALHNSIEASLRCSSVVPRPIFSQLYLDPDQHPFS 51                                                           
						PVILIGYGTLPYFYGNVGDIVVSPLLVNCYKIPQLENKDLEKLGLTGSQFLSVENMILLT 	                  .         .         .         .         .  
						IQYLVRLGPDQVPLREEFEQIMLKAMQEFTLRERALQIGAQCVPVSPGQLPWLARLIASV 	      51 SADVKPKVEDLDKDLVNRYTQNGSLDFSNNLTVNEMEDDEDDEEMSDSNS 100                                                          
						SQDLVHVVVTQNSLAEGISETLRTLSEMRHYQRLPDYVVVICASKIRGNEFCVVVLGQHQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SRALAESMLTTSEFLKEISYELITGKVSFLASHFKTTSLGDDLDKLLEKMQQRRGDSVVT 	      52 SADVKPKVEDLDKDLVNRYTQNGSLDFSNNLTVNEMEDDEDDEEMSDSNS 101                                                          
						PFDGDLNECVSPQEAAAMIPTQNLDLDNETFHIYQPQLTVARKLLSQVCAIADSGSQSLD 	                  .         .         .         .         .  
						LGHFSKVDFIIIVPRSEVLVQQTLQRIRQS                               	     101 PPIPYSQKPAPEGSCTTDGFCQAGKDLRLVSLCMEQIDIPAGFLLVGAKS 150                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 279 - 728 of Q9C091, which also corresponds to   	     102 PPIPYSQKPAPEGSCTTDGFCQAGKDLRLVSLCMEQIDIPAGFLLVGAKS 151                                                          
						amino acids 321 - 770 of AA449372_P0, and a fourth amino acid	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     151 PNLPEHILVCAVDKRFLPDDHGKNALLGFSGNCIGCGERGFRYFTEFSNH 200                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     152 PNLPEHILVCAVDKRFLPDDHGKNALLGFSGNCIGCGERGFRYFTEFSNH 201                                                          
						having the sequence VSFQALCHIANPVMG corresponding to amino   	                  .         .         .         .         .  
						acids 771 - 785 of AA449372_P0, wherein said first amino acid	     201 INLKLTTQPKKQKHLKYYLVRSSQGVLSKGPLICWKECRSRQSSASCHSI 250                                                          
						sequence, second amino acid sequence, third amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and fourth amino acid sequence are contiguous and in	     202 INLKLTTQPKKQKHLKYYLVRSSQGVLSKGPLICWKECRSRQSSASCHSI 251                                                          
						a sequential order.2.An isolated polypeptide encoding for an 	                  .         .         .         .         .  
						edge portion of AA449372_P0, comprising an amino acid        	     251 KPSSSVSSTVTPENGTTNGYKSGFTQTDSPILSPANSAINLSGAQDLTRN 300                                                          
						sequence being at least 70%, optionally at least about 80%,  	         |||||||||||||||||||||||||||                         
						preferably at least about 85%, more preferably at least about	     252 KPSSSVSSTVTPENGTTNGYKSGFTQT....................... 278                                                          
						90% and most preferably at least about 95% homologous to the 	                  .         .         .         .         .  
						sequence encoding for                                        	     301 NNVVKPLALSLQVVGKTFAADAANGNSSHGGKGSASSSTPAHTGNYSLSP 350                                                          
						DSPILSPANSAINLSGAQDLTRNNNVVKPLALSLQVVGKTFAA, corresponding to	                             ||||||||||||||||||||||||||||||  
						AA449372_P0.3.An isolated polypeptide encoding for a tail of 	     279 ....................DAANGNSSHGGKGSASSSTPAHTGNYSLSP 308                                                          
						AA449372_P0, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     351 RPSYASGDQATMFISGPPKKRHRGWYPGSPLPQPGLVVPVPTVRPLSRTE 400                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence VSFQALCHIANPVMG in	     309 RPSYASGDQATMFISGPPKKRHRGWYPGSPLPQPGLVVPVPTVRPLSRTE 358                                                          
						AA449372_P0.                                                 	                  .         .         .         .         .  
						                                                            	     401 PLLSAPVPQTPLTGILQPRPIPAGETVIVPENLLSNSGVRPVILIGYGTL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     359 PLLSAPVPQTPLTGILQPRPIPAGETVIVPENLLSNSGVRPVILIGYGTL 408                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 PYFYGNVGDIVVSPLLVNCYKIPQLENKDLEKLGLTGSQFLSVENMILLT 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     409 PYFYGNVGDIVVSPLLVNCYKIPQLENKDLEKLGLTGSQFLSVENMILLT 458                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 IQYLVRLGPDQVPLREEFEQIMLKAMQEFTLRERALQIGAQCVPVSPGQL 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     459 IQYLVRLGPDQVPLREEFEQIMLKAMQEFTLRERALQIGAQCVPVSPGQL 508                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 PWLARLIASVSQDLVHVVVTQNSLAEGISETLRTLSEMRHYQRLPDYVVV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     509 PWLARLIASVSQDLVHVVVTQNSLAEGISETLRTLSEMRHYQRLPDYVVV 558                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 ICASKIRGNEFCVVVLGQHQSRALAESMLTTSEFLKEISYELITGKVSFL 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     559 ICASKIRGNEFCVVVLGQHQSRALAESMLTTSEFLKEISYELITGKVSFL 608                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 ASHFKTTSLGDDLDKLLEKMQQRRGDSVVTPFDGDLNECVSPQEAAAMIP 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     609 ASHFKTTSLGDDLDKLLEKMQQRRGDSVVTPFDGDLNECVSPQEAAAMIP 658                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 TQNLDLDNETFHIYQPQLTVARKLLSQVCAIADSGSQSLDLGHFSKVDFI 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     659 TQNLDLDNETFHIYQPQLTVARKLLSQVCAIADSGSQSLDLGHFSKVDFI 708                                                          
						                                                            	                  .         .                                
						                                                            	     751 IIVPRSEVLVQQTLQRIRQS                               770                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	     709 IIVPRSEVLVQQTLQRIRQS                               728                                                          

14117	HMR136_AA449372_1_tr0_r1_1_gPRT		Comparison report between AA449372_P1 and Q9C091partial WT   	Sequence name: Q9C091                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA449372_P1, comprising a first     	Sequence documentation:                                      
						MGNSYAGQLKSARFEEALHNSIEASLRCSSVVPRPIFSQLYLDPDQHPFSSADVKPKVED 	                                                            
						LDKDLVNRYTQNGSLDFSNNLTVNEMEDDEDDEEMSDSNSPPIPYSQKPAPEGSCTTDGF 	Alignment of: 14117 x Q9C091   ..                            
						CQAGKDLRLVSLCMEQIDIPAGFLLVGAKSPNLPEHILVCAVDKRFLPDDHGKNALLGFS 	                                                            
						GNCIGCGERGFRYFTEFSNHINLKLTTQPKKQKHLKYYLVRSSQGVLSKGPLICWKECRS 	Alignment segment 1/1:                                       
						RQSSASCHSIKPSSSVSSTVTPENGTTNGYKSGFTQTDAANGNSSHGGKGSASSSTPAHT 	                                                            
						GNYSLSPRPSYASGDQATMFISGPPKKRHRGWYPGSPLPQPGLVVPVPTVRPLSRTEPLL 	                     Quality: 7097.00                      Escore:       0                                               
						SAPVPQTPLTGILQPRPIPAGETVIVPENLLSNSGVRPVILIGYGTLPYFYGNVGDIVVS 	             Matching length:     727                Total length:     727                                               
						PLLVNCYKIPQLENKDLEKLGLTGSQFLSVENMILLTIQYLVRLGPDQVPLREEFEQIML 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KAMQEFTLRERALQIGAQCVPVSPGQLPWLARLIASVSQDLVHVVVTQNSLAEGISETLR 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TLSEMRHYQRLPDYVVVICASKIRGNEFCVVVLGQHQSRALAESMLTTSEFLKEISYELI 	                        Gaps:       0                        
						TGKVSFLASHFKTTSLGDDLDKLLEKMQQRRGDSVVTPFDGDLNECVSPQEAAAMIPTQN 	                                                            
						LDLDNETFHIYQPQLTVARKLLSQVCAIADSGSQSLDLGHFSKVDFIIIVPRSEVLVQQT 	Alignment:                                                   
						LQRIRQS                                                      	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MGNSYAGQLKSARFEEALHNSIEASLRCSSVVPRPIFSQLYLDPDQHPFS 50                                                           
						corresponding to amino acids 2 - 728 of Q9C091, which also   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 1 - 727 of AA449372_P1, and a     	       2 MGNSYAGQLKSARFEEALHNSIEASLRCSSVVPRPIFSQLYLDPDQHPFS 51                                                           
						second amino acid sequence being at least 70%, optionally at 	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	      51 SADVKPKVEDLDKDLVNRYTQNGSLDFSNNLTVNEMEDDEDDEEMSDSNS 100                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence VSFQALCHIANPVMG corresponding	      52 SADVKPKVEDLDKDLVNRYTQNGSLDFSNNLTVNEMEDDEDDEEMSDSNS 101                                                          
						to amino acids 728 - 742 of AA449372_P1, wherein said first  	                  .         .         .         .         .  
						amino acid sequence and second amino acid sequence are       	     101 PPIPYSQKPAPEGSCTTDGFCQAGKDLRLVSLCMEQIDIPAGFLLVGAKS 150                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of AA449372_P1, comprising a 	     102 PPIPYSQKPAPEGSCTTDGFCQAGKDLRLVSLCMEQIDIPAGFLLVGAKS 151                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     151 PNLPEHILVCAVDKRFLPDDHGKNALLGFSGNCIGCGERGFRYFTEFSNH 200                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence VSFQALCHIANPVMG in AA449372_P1.              	     152 PNLPEHILVCAVDKRFLPDDHGKNALLGFSGNCIGCGERGFRYFTEFSNH 201                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 INLKLTTQPKKQKHLKYYLVRSSQGVLSKGPLICWKECRSRQSSASCHSI 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     202 INLKLTTQPKKQKHLKYYLVRSSQGVLSKGPLICWKECRSRQSSASCHSI 251                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KPSSSVSSTVTPENGTTNGYKSGFTQTDAANGNSSHGGKGSASSSTPAHT 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     252 KPSSSVSSTVTPENGTTNGYKSGFTQTDAANGNSSHGGKGSASSSTPAHT 301                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GNYSLSPRPSYASGDQATMFISGPPKKRHRGWYPGSPLPQPGLVVPVPTV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     302 GNYSLSPRPSYASGDQATMFISGPPKKRHRGWYPGSPLPQPGLVVPVPTV 351                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RPLSRTEPLLSAPVPQTPLTGILQPRPIPAGETVIVPENLLSNSGVRPVI 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     352 RPLSRTEPLLSAPVPQTPLTGILQPRPIPAGETVIVPENLLSNSGVRPVI 401                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LIGYGTLPYFYGNVGDIVVSPLLVNCYKIPQLENKDLEKLGLTGSQFLSV 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     402 LIGYGTLPYFYGNVGDIVVSPLLVNCYKIPQLENKDLEKLGLTGSQFLSV 451                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ENMILLTIQYLVRLGPDQVPLREEFEQIMLKAMQEFTLRERALQIGAQCV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     452 ENMILLTIQYLVRLGPDQVPLREEFEQIMLKAMQEFTLRERALQIGAQCV 501                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 PVSPGQLPWLARLIASVSQDLVHVVVTQNSLAEGISETLRTLSEMRHYQR 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     502 PVSPGQLPWLARLIASVSQDLVHVVVTQNSLAEGISETLRTLSEMRHYQR 551                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 LPDYVVVICASKIRGNEFCVVVLGQHQSRALAESMLTTSEFLKEISYELI 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     552 LPDYVVVICASKIRGNEFCVVVLGQHQSRALAESMLTTSEFLKEISYELI 601                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 TGKVSFLASHFKTTSLGDDLDKLLEKMQQRRGDSVVTPFDGDLNECVSPQ 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     602 TGKVSFLASHFKTTSLGDDLDKLLEKMQQRRGDSVVTPFDGDLNECVSPQ 651                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 EAAAMIPTQNLDLDNETFHIYQPQLTVARKLLSQVCAIADSGSQSLDLGH 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     652 EAAAMIPTQNLDLDNETFHIYQPQLTVARKLLSQVCAIADSGSQSLDLGH 701                                                          
						                                                            	                  .         .                                
						                                                            	     701 FSKVDFIIIVPRSEVLVQQTLQRIRQS                        727                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     702 FSKVDFIIIVPRSEVLVQQTLQRIRQS                        728                                                          

14115	HMR136_AA449372_3_tr0_r1_1_gPRT		Comparison report between AA449372_P3 and Q9C091partial WT   	Sequence name: Q9C091                                        
						sequence followed by unique insertion and a followed by a    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						AA449372_P3, comprising a first amino acid sequence being at 	                                                            
						MGNSYAGQLKSARFEEALHNSIEASLRCSSVVPRPIFSQLYLDPDQHPFSSADVKPKVED 	Alignment of: 14115 x Q9C091   ..                            
						LDKDLVNRYTQNGSLDFSNNLTVNEMEDDEDDEEMSDSNSPPIPYSQKPAPEGSCTTDGF 	                                                            
						CQAGKDLRLVSLCMEQIDIPAGFLLVGAKSPNLPEHILVCAVDKRFLPDDHGKNALLGFS 	Alignment segment 1/1:                                       
						GNCIGCGERGFRYFTEFSNHINLKLTTQPKKQKHLKYYLVRSSQGVLSKGPLICWKECRS 	                                                            
						RQSSASCHSIKPSSSVSSTVTPENGTTNGYKSGFTQT                        	                     Quality: 6367.00                      Escore:       0                                               
						least 90 % homologous to corresponding to amino acids 2 - 278	             Matching length:     661                Total length:     704                                               
						of Q9C091, which also corresponds to amino acids 1 - 277 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AA449372_P3, a second amino acid sequence being at least 70%,	    Total Percent Similarity:   93.89      Total Percent Identity:   93.89                                               
						optionally at least 80%, preferably at least 85%, more       	                        Gaps:       1                        
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment:                                                   
						DSPILSPANSAINLSGAQDLTRNNNVVKPLALSLQVVGKTFAA corresponding to 	                  .         .         .         .         .  
						amino acids 278 - 320 of AA449372_P3, a third amino acid     	       1 MGNSYAGQLKSARFEEALHNSIEASLRCSSVVPRPIFSQLYLDPDQHPFS 50                                                           
						DAANGNSSHGGKGSASSSTPAHTGNYSLSPRPSYASGDQATMFISGPPKKRHRGWYPGSP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPQPGLVVPVPTVRPLSRTEPLLSAPVPQTPLTGILQPRPIPAGETVIVPENLLSNSGVR 	       2 MGNSYAGQLKSARFEEALHNSIEASLRCSSVVPRPIFSQLYLDPDQHPFS 51                                                           
						PVILIGYGTLPYFYGNVGDIVVSPLLVNCYKIPQLENKDLEKLGLTGSQFLSVENMILLT 	                  .         .         .         .         .  
						IQYLVRLGPDQVPLREEFEQIMLKAMQEFTLRERALQIGAQCVPVSPGQLPWLARLIASV 	      51 SADVKPKVEDLDKDLVNRYTQNGSLDFSNNLTVNEMEDDEDDEEMSDSNS 100                                                          
						SQDLVHVVVTQNSLAEGISETLRTLSEMRHYQRLPDYVVVICASKIRGNEFCVVVLGQHQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SRALAESMLTTSEFLKEISYELITGKVSFLASHFKTTSLGDDLDKLLEKMQQRRGDSVVT 	      52 SADVKPKVEDLDKDLVNRYTQNGSLDFSNNLTVNEMEDDEDDEEMSDSNS 101                                                          
						PFDGDLNECVSPQEAAAMIPTQNL                                     	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     101 PPIPYSQKPAPEGSCTTDGFCQAGKDLRLVSLCMEQIDIPAGFLLVGAKS 150                                                          
						amino acids 279 - 662 of Q9C091, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 321 - 704 of AA449372_P3, and a fourth amino acid	     102 PPIPYSQKPAPEGSCTTDGFCQAGKDLRLVSLCMEQIDIPAGFLLVGAKS 151                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     151 PNLPEHILVCAVDKRFLPDDHGKNALLGFSGNCIGCGERGFRYFTEFSNH 200                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence GNVISDQEEEVSPWDRHCKN corresponding to    	     152 PNLPEHILVCAVDKRFLPDDHGKNALLGFSGNCIGCGERGFRYFTEFSNH 201                                                          
						amino acids 705 - 724 of AA449372_P3, wherein said first     	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence, third amino 	     201 INLKLTTQPKKQKHLKYYLVRSSQGVLSKGPLICWKECRSRQSSASCHSI 250                                                          
						acid sequence and fourth amino acid sequence are contiguous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.2.An isolated polypeptide encoding 	     202 INLKLTTQPKKQKHLKYYLVRSSQGVLSKGPLICWKECRSRQSSASCHSI 251                                                          
						for an edge portion of AA449372_P3, comprising an amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least about 80%,  	     251 KPSSSVSSTVTPENGTTNGYKSGFTQTDSPILSPANSAINLSGAQDLTRN 300                                                          
						preferably at least about 85%, more preferably at least about	         |||||||||||||||||||||||||||                         
						90% and most preferably at least about 95% homologous to the 	     252 KPSSSVSSTVTPENGTTNGYKSGFTQT....................... 278                                                          
						sequence encoding for                                        	                  .         .         .         .         .  
						DSPILSPANSAINLSGAQDLTRNNNVVKPLALSLQVVGKTFAA, corresponding to	     301 NNVVKPLALSLQVVGKTFAADAANGNSSHGGKGSASSSTPAHTGNYSLSP 350                                                          
						AA449372_P3.3.An isolated polypeptide encoding for a tail of 	                             ||||||||||||||||||||||||||||||  
						AA449372_P3, comprising a polypeptide being at least 70%,    	     279 ....................DAANGNSSHGGKGSASSSTPAHTGNYSLSP 308                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     351 RPSYASGDQATMFISGPPKKRHRGWYPGSPLPQPGLVVPVPTVRPLSRTE 400                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GNVISDQEEEVSPWDRHCKN in AA449372_P3.                         	     309 RPSYASGDQATMFISGPPKKRHRGWYPGSPLPQPGLVVPVPTVRPLSRTE 358                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 PLLSAPVPQTPLTGILQPRPIPAGETVIVPENLLSNSGVRPVILIGYGTL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     359 PLLSAPVPQTPLTGILQPRPIPAGETVIVPENLLSNSGVRPVILIGYGTL 408                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 PYFYGNVGDIVVSPLLVNCYKIPQLENKDLEKLGLTGSQFLSVENMILLT 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     409 PYFYGNVGDIVVSPLLVNCYKIPQLENKDLEKLGLTGSQFLSVENMILLT 458                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 IQYLVRLGPDQVPLREEFEQIMLKAMQEFTLRERALQIGAQCVPVSPGQL 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     459 IQYLVRLGPDQVPLREEFEQIMLKAMQEFTLRERALQIGAQCVPVSPGQL 508                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 PWLARLIASVSQDLVHVVVTQNSLAEGISETLRTLSEMRHYQRLPDYVVV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     509 PWLARLIASVSQDLVHVVVTQNSLAEGISETLRTLSEMRHYQRLPDYVVV 558                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 ICASKIRGNEFCVVVLGQHQSRALAESMLTTSEFLKEISYELITGKVSFL 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     559 ICASKIRGNEFCVVVLGQHQSRALAESMLTTSEFLKEISYELITGKVSFL 608                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 ASHFKTTSLGDDLDKLLEKMQQRRGDSVVTPFDGDLNECVSPQEAAAMIP 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     609 ASHFKTTSLGDDLDKLLEKMQQRRGDSVVTPFDGDLNECVSPQEAAAMIP 658                                                          
						                                                            	                                                             
						                                                            	     701 TQNL                                               704                                                          
						                                                            	         ||||                                                
						                                                            	     659 TQNL                                               662                                                          

14119	HMR136_AA449372_4_tr0_r1_1_gPRT		Comparison report between AA449372_P4 and Q9C091partial WT   	Sequence name: Q9C091                                        
						sequence followed by unique insertion and a followed by a    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						AA449372_P4, comprising a first amino acid sequence being at 	                                                            
						MGNSYAGQLKSARFEEALHNSIEASLRCSSVVPRPIFSQLYLDPDQHPFSSADVKPKVED 	Alignment of: 14119 x Q9C091   ..                            
						LDKDLVNRYTQNGSLDFSNNLTVNEMEDDEDDEEMSDSNSPPIPYSQKPAPEGSCTTDGF 	                                                            
						CQAGKDLRLVSLCMEQIDIPAGFLLVGAKSPNLPEHILVCAVDKRFLPDDHGKNALLGFS 	Alignment segment 1/1:                                       
						GNCIGCGERGFRYFTEFSNHINLKLTTQPKKQKHLKYYLVRSSQGVLSKGPLICWKECRS 	                                                            
						RQSSASCHSIKPSSSVSSTVTPENGTTNGYKSGFTQT                        	                     Quality: 5938.00                      Escore:       0                                               
						least 90 % homologous to corresponding to amino acids 2 - 278	             Matching length:     618                Total length:     661                                               
						of Q9C091, which also corresponds to amino acids 1 - 277 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.84                                               
						AA449372_P4, a second amino acid sequence being at least 70%,	    Total Percent Similarity:   93.49      Total Percent Identity:   93.34                                               
						optionally at least 80%, preferably at least 85%, more       	                        Gaps:       1                        
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment:                                                   
						DSPILSPANSAINLSGAQDLTRNNNVVKPLALSLQVVGKTFAA corresponding to 	                  .         .         .         .         .  
						amino acids 278 - 320 of AA449372_P4, a third amino acid     	       1 MGNSYAGQLKSARFEEALHNSIEASLRCSSVVPRPIFSQLYLDPDQHPFS 50                                                           
						DAANGNSSHGGKGSASSSTPAHTGNYSLSPRPSYASGDQATMFISGPPKKRHRGWYPGSP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPQPGLVVPVPTVRPLSRTEPLLSAPVPQTPLTGILQPRPIPAGETVIVPENLLSNSGVR 	       2 MGNSYAGQLKSARFEEALHNSIEASLRCSSVVPRPIFSQLYLDPDQHPFS 51                                                           
						PVILIGYGTLPYFYGNVGDIVVSPLLVNCYKIPQLENKDLEKLGLTGSQFLSVENMILLT 	                  .         .         .         .         .  
						IQYLVRLGPDQVPLREEFEQIMLKAMQEFTLRERALQIGAQCVPVSPGQLPWLARLIASV 	      51 SADVKPKVEDLDKDLVNRYTQNGSLDFSNNLTVNEMEDDEDDEEMSDSNS 100                                                          
						SQDLVHVVVTQNSLAEGISETLRTLSEMRHYQRLPDYVVVICASKIRGNEFCVVVLGQHQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SRALAESMLTTSEFLKEISYELITGKVSFLASHFKTTSLG                     	      52 SADVKPKVEDLDKDLVNRYTQNGSLDFSNNLTVNEMEDDEDDEEMSDSNS 101                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 279 - 618 of Q9C091, which also corresponds to   	     101 PPIPYSQKPAPEGSCTTDGFCQAGKDLRLVSLCMEQIDIPAGFLLVGAKS 150                                                          
						amino acids 321 - 660 of AA449372_P4, and a fourth amino acid	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     102 PPIPYSQKPAPEGSCTTDGFCQAGKDLRLVSLCMEQIDIPAGFLLVGAKS 151                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     151 PNLPEHILVCAVDKRFLPDDHGKNALLGFSGNCIGCGERGFRYFTEFSNH 200                                                          
						having the sequence EWL corresponding to amino acids 661 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						663 of AA449372_P4, wherein said first amino acid sequence,  	     152 PNLPEHILVCAVDKRFLPDDHGKNALLGFSGNCIGCGERGFRYFTEFSNH 201                                                          
						second amino acid sequence, third amino acid sequence and    	                  .         .         .         .         .  
						fourth amino acid sequence are contiguous and in a sequential	     201 INLKLTTQPKKQKHLKYYLVRSSQGVLSKGPLICWKECRSRQSSASCHSI 250                                                          
						order.2.An isolated polypeptide encoding for an edge portion 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of AA449372_P4, comprising an amino acid sequence being at   	     202 INLKLTTQPKKQKHLKYYLVRSSQGVLSKGPLICWKECRSRQSSASCHSI 251                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	     251 KPSSSVSSTVTPENGTTNGYKSGFTQTDSPILSPANSAINLSGAQDLTRN 300                                                          
						preferably at least about 95% homologous to the sequence     	         |||||||||||||||||||||||||||                         
						encoding for DSPILSPANSAINLSGAQDLTRNNNVVKPLALSLQVVGKTFAA,    	     252 KPSSSVSSTVTPENGTTNGYKSGFTQT....................... 278                                                          
						corresponding to AA449372_P4.3.An isolated polypeptide       	                  .         .         .         .         .  
						encoding for a tail of AA449372_P4, comprising a polypeptide 	     301 NNVVKPLALSLQVVGKTFAADAANGNSSHGGKGSASSSTPAHTGNYSLSP 350                                                          
						being at least 70%, optionally at least about 80%, preferably	                             ||||||||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     279 ....................DAANGNSSHGGKGSASSSTPAHTGNYSLSP 308                                                          
						most preferably at least about 95% homologous to the sequence	                  .         .         .         .         .  
						EWL in AA449372_P4.                                          	     351 RPSYASGDQATMFISGPPKKRHRGWYPGSPLPQPGLVVPVPTVRPLSRTE 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     309 RPSYASGDQATMFISGPPKKRHRGWYPGSPLPQPGLVVPVPTVRPLSRTE 358                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 PLLSAPVPQTPLTGILQPRPIPAGETVIVPENLLSNSGVRPVILIGYGTL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     359 PLLSAPVPQTPLTGILQPRPIPAGETVIVPENLLSNSGVRPVILIGYGTL 408                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 PYFYGNVGDIVVSPLLVNCYKIPQLENKDLEKLGLTGSQFLSVENMILLT 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     409 PYFYGNVGDIVVSPLLVNCYKIPQLENKDLEKLGLTGSQFLSVENMILLT 458                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 IQYLVRLGPDQVPLREEFEQIMLKAMQEFTLRERALQIGAQCVPVSPGQL 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     459 IQYLVRLGPDQVPLREEFEQIMLKAMQEFTLRERALQIGAQCVPVSPGQL 508                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 PWLARLIASVSQDLVHVVVTQNSLAEGISETLRTLSEMRHYQRLPDYVVV 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     509 PWLARLIASVSQDLVHVVVTQNSLAEGISETLRTLSEMRHYQRLPDYVVV 558                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 ICASKIRGNEFCVVVLGQHQSRALAESMLTTSEFLKEISYELITGKVSFL 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     559 ICASKIRGNEFCVVVLGQHQSRALAESMLTTSEFLKEISYELITGKVSFL 608                                                          
						                                                            	                  .                                          
						                                                            	     651 ASHFKTTSLGE                                        661                                                          
						                                                            	         ||||||||||:                                         
						                                                            	     609 ASHFKTTSLGD                                        619                                                          

15614	HMR136_AA451835_2_tr0_r1_1_gPRT		Comparison report between AA451835_P2 and Q9H8H4unique head  	Sequence name: Q9H8H4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA451835_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 15614 x Q9H8H4   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						FRRAAGGHVGAAEAAQRCQALVCGYPGRSAVPNAMSVVVQHVEEKAVHSWSRISTAGKKA 	Alignment segment 1/1:                                       
						LEEALLVFNPMSQDLSATEAQLVAFLQGLRDDGFQPTILRSGDVYGYSSCTANPPSQTKL 	                                                            
						QARAPNPTATSPPASAPRTAMRLPAGRATLLPMPLSGRLAKASTPALAKHATTNLLLSSL 	                     Quality: 1854.00                      Escore:       0                                               
						KQSSASHARGAAVGFPTHLYPGVYPAMRLSVVLEALVPLKTPMPCLGAKHKAQSLQLSLA 	             Matching length:     198                Total length:     198                                               
						DSPLKLRKSSGKGPGNPRPKAPRKTTSKGPKCLTRKGPGAGPRRGSGHQSKTNRATGSPS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VRR                                                          	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 303 of  	                        Gaps:       0                        
						AA451835_P2, and a second amino acid sequence being at least 	                                                            
						MKGGSALGTKTAQAKVARTLAKAARAQAKVARTQAKAAKARAKAKAALVKAKAKAKAAQV 	Alignment:                                                   
						KAKAKVMAARAKAKAKAKAVRAKAKVARTQPRGRGRPKGSAKARTTRKGQKNRPETVGQK 	                  .         .         .         .         .  
						RKRAEEAKDLPPKKRTRLGPRSPKAWLGPGTAKLLKFRAIKVDRRSSDDEVRQRAQRILR 	     304 MKGGSALGTKTAQAKVARTLAKAARAQAKVARTQAKAAKARAKAKAALVK 353                                                          
						VNLSPVIRLQPLLPYSAV                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 1 - 198 of   	       1 MKGGSALGTKTAQAKVARTLAKAARAQAKVARTQAKAAKARAKAKAALVK 50                                                           
						Q9H8H4, which also corresponds to amino acids 304 - 501 of   	                  .         .         .         .         .  
						AA451835_P2, wherein said first amino acid sequence and      	     354 AKAKAKAAQVKAKAKVMAARAKAKAKAKAVRAKAKVARTQPRGRGRPKGS 403                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      51 AKAKAKAAQVKAKAKVMAARAKAKAKAKAVRAKAKVARTQPRGRGRPKGS 100                                                          
						AA451835_P2, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     404 AKARTTRKGQKNRPETVGQKRKRAEEAKDLPPKKRTRLGPRSPKAWLGPG 453                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FRRAAGGHVGAAEAAQRCQALVCGYPGRSAVPNAMSVVVQHVEEKAVHSWSRISTAGKKA 	     101 AKARTTRKGQKNRPETVGQKRKRAEEAKDLPPKKRTRLGPRSPKAWLGPG 150                                                          
						LEEALLVFNPMSQDLSATEAQLVAFLQGLRDDGFQPTILRSGDVYGYSSCTANPPSQTKL 	                  .         .         .         .            
						QARAPNPTATSPPASAPRTAMRLPAGRATLLPMPLSGRLAKASTPALAKHATTNLLLSSL 	     454 TAKLLKFRAIKVDRRSSDDEVRQRAQRILRVNLSPVIRLQPLLPYSAV   501                                                          
						KQSSASHARGAAVGFPTHLYPGVYPAMRLSVVLEALVPLKTPMPCLGAKHKAQSLQLSLA 	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						DSPLKLRKSSGKGPGNPRPKAPRKTTSKGPKCLTRKGPGAGPRRGSGHQSKTNRATGSPS 	     151 TAKLLKFRAIKVDRRSSDDEVRQRAQRILRVNLSPVIRLQPLLPYSAV   198                                                          
						VRR                                                          	                                                            
						least about 95% homologous to the sequence of AA451835_P2.   	                                                            

						Comparison report between AA451835_P2 and Q8IV32unique head  	Sequence name: Q8IV32                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA451835_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 15614 x Q8IV32   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence FRRAAGGHVGAAEAAQRCQALVCGYPGRSAVPNA       	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 34 of AA451835_P2, and a    	                                                            
						MSVVVQHVEEKAVHSWSRISTAGKKALEEALLVFNPMSQDLSATEAQLVAFLQGLRDDGF 	                     Quality: 4451.00                      Escore:       0                                               
						QPTILRSGDVYGYSSCTANPPSQTKLQARAPNPTATSPPASAPRTAMRLPAGRATLLPMP 	             Matching length:     467                Total length:     467                                               
						LSGRLAKASTPALAKHATTNLLLSSLKQSSASHARGAAVGFPTHLYPGVYPAMRLSVVLE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ALVPLKTPMPCLGAKHKAQSLQLSLADSPLKLRKSSGKGPGNPRPKAPRKTTSKGPKCLT 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RKGPGAGPRRGSGHQSKTNRATGSPSVRRMKGGSALGTKTAQAKVARTLAKAARAQAKVA 	                        Gaps:       0                        
						RTQAKAAKARAKAKAALVKAKAKAKAAQVKAKAKVMAARAKAKAKAKAVRAKAKVARTQP 	                                                            
						RGRGRPKGSAKARTTRKGQKNRPETVGQKRKRAEEAKDLPPKKRTRLGPRSPKAWLGPGT 	Alignment:                                                   
						AKLLKFRAIKVDRRSSDDEVRQRAQRILRVNLSPVIRLQPLLPYSAV              	                  .         .         .         .         .  
						second amino acid sequence being at least 90 % homologous to 	      35 MSVVVQHVEEKAVHSWSRISTAGKKALEEALLVFNPMSQDLSATEAQLVA 84                                                           
						corresponding to amino acids 1 - 467 of Q8IV32, which also   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 35 - 501 of AA451835_P2, wherein  	       1 MSVVVQHVEEKAVHSWSRISTAGKKALEEALLVFNPMSQDLSATEAQLVA 50                                                           
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	      85 FLQGLRDDGFQPTILRSGDVYGYSSCTANPPSQTKLQARAPNPTATSPPA 134                                                          
						polypeptide encoding for a head of AA451835_P2, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	      51 FLQGLRDDGFQPTILRSGDVYGYSSCTANPPSQTKLQARAPNPTATSPPA 100                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     135 SAPRTAMRLPAGRATLLPMPLSGRLAKASTPALAKHATTNLLLSSLKQSS 184                                                          
						to the sequence FRRAAGGHVGAAEAAQRCQALVCGYPGRSAVPNA of        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA451835_P2.                                                 	     101 SAPRTAMRLPAGRATLLPMPLSGRLAKASTPALAKHATTNLLLSSLKQSS 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     185 ASHARGAAVGFPTHLYPGVYPAMRLSVVLEALVPLKTPMPCLGAKHKAQS 234                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ASHARGAAVGFPTHLYPGVYPAMRLSVVLEALVPLKTPMPCLGAKHKAQS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     235 LQLSLADSPLKLRKSSGKGPGNPRPKAPRKTTSKGPKCLTRKGPGAGPRR 284                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LQLSLADSPLKLRKSSGKGPGNPRPKAPRKTTSKGPKCLTRKGPGAGPRR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     285 GSGHQSKTNRATGSPSVRRMKGGSALGTKTAQAKVARTLAKAARAQAKVA 334                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GSGHQSKTNRATGSPSVRRMKGGSALGTKTAQAKVARTLAKAARAQAKVA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     335 RTQAKAAKARAKAKAALVKAKAKAKAAQVKAKAKVMAARAKAKAKAKAVR 384                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 RTQAKAAKARAKAKAALVKAKAKAKAAQVKAKAKVMAARAKAKAKAKAVR 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     385 AKAKVARTQPRGRGRPKGSAKARTTRKGQKNRPETVGQKRKRAEEAKDLP 434                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 AKAKVARTQPRGRGRPKGSAKARTTRKGQKNRPETVGQKRKRAEEAKDLP 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     435 PKKRTRLGPRSPKAWLGPGTAKLLKFRAIKVDRRSSDDEVRQRAQRILRV 484                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 PKKRTRLGPRSPKAWLGPGTAKLLKFRAIKVDRRSSDDEVRQRAQRILRV 450                                                          
						                                                            	                  .                                          
						                                                            	     485 NLSPVIRLQPLLPYSAV                                  501                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     451 NLSPVIRLQPLLPYSAV                                  467                                                          

16108	HMR136_AA452277_1_tr0_r1_1_gPRT		Comparison report between AA452277_P1 and Q9BPU9partial WT   	Sequence name: Q9BPU9                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for AA452277_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MAEVHVIGQI corresponding to amino acids 1 - 10 of Q9BPU9,    	Alignment of: 16108 x Q9BPU9   ..                            
						which also corresponds to amino acids 1 - 10 of AA452277_P1, 	                                                            
						a bridging amino acid I corresponding to amino acid 11 of    	Alignment segment 1/1:                                       
						AA452277_P1, and a second amino acid sequence being at least 	                                                            
						GASGFSESSLFCKWGIHTGAAWKLLSGVREGQTQVDTPQIGDMAYWSHPIDLHFATKGLQ 	                     Quality: 1753.00                      Escore:       0                                               
						GWPRLHFQVWSQDSFGRCQLAGYGFCHVPSSPGTHQLACPTWRPLGSWREQLARAFVGGG 	             Matching length:     175                Total length:     175                                               
						PQLLHGDTIYSGADRYRLHTAAGGTVHLEIGLLLRNFDRYGVEC                 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.43                                               
						90 % homologous to corresponding to amino acids 12 - 175 of  	    Total Percent Similarity:  100.00      Total Percent Identity:   99.43                                               
						Q9BPU9, which also corresponds to amino acids 12 - 175 of    	                        Gaps:       0                        
						AA452277_P1, wherein said first amino acid sequence, bridging	                                                            
						amino acid and second amino acid sequence are contiguous and 	Alignment:                                                   
						in a sequential order.                                       	                  .         .         .         .         .  
						                                                            	       1 MAEVHVIGQIIGASGFSESSLFCKWGIHTGAAWKLLSGVREGQTQVDTPQ 50                                                           
						                                                            	         ||||||||||:|||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MAEVHVIGQIMGASGFSESSLFCKWGIHTGAAWKLLSGVREGQTQVDTPQ 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 IGDMAYWSHPIDLHFATKGLQGWPRLHFQVWSQDSFGRCQLAGYGFCHVP 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 IGDMAYWSHPIDLHFATKGLQGWPRLHFQVWSQDSFGRCQLAGYGFCHVP 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SSPGTHQLACPTWRPLGSWREQLARAFVGGGPQLLHGDTIYSGADRYRLH 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 SSPGTHQLACPTWRPLGSWREQLARAFVGGGPQLLHGDTIYSGADRYRLH 150                                                          
						                                                            	                  .         .                                
						                                                            	     151 TAAGGTVHLEIGLLLRNFDRYGVEC                          175                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     151 TAAGGTVHLEIGLLLRNFDRYGVEC                          175                                                          

16106	HMR136_AA452277_2_tr0_r1_1_gPRT		Comparison report between AA452277_P2 and Q9BPU9partial WT   	Sequence name: Q9BPU9                                        
						sequence followed by mismatch and a featuring a skipped      	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA452277_P2, comprising a first amino acid sequence being at 	                                                            
						least 90 % homologous to MAEVHVIGQI corresponding to amino   	Alignment of: 16106 x Q9BPU9   ..                            
						acids 1 - 10 of Q9BPU9, which also corresponds to amino acids	                                                            
						1 - 10 of AA452277_P2, a bridging amino acid I corresponding 	Alignment segment 1/1:                                       
						to amino acid 11 of AA452277_P2, a second amino acid sequence	                                                            
						being at least 90 % homologous to GASGFSESSLFCKWGIHT         	                     Quality: 1576.00                      Escore:       0                                               
						corresponding to amino acids 12 - 29 of Q9BPU9, which also   	             Matching length:     167                Total length:     175                                               
						corresponds to amino acids 12 - 29 of AA452277_P2, and a     	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.40                                               
						GVREGQTQVDTPQIGDMAYWSHPIDLHFATKGLQGWPRLHFQVWSQDSFGRCQLAGYGFC 	    Total Percent Similarity:   95.43      Total Percent Identity:   94.86                                               
						HVPSSPGTHQLACPTWRPLGSWREQLARAFVGGGPQLLHGDTIYSGADRYRLHTAAGGTV 	                        Gaps:       1                        
						HLEIGLLLRNFDRYGVEC                                           	                                                            
						third amino acid sequence being at least 90 % homologous to  	Alignment:                                                   
						corresponding to amino acids 38 - 175 of Q9BPU9, which also  	                  .         .         .         .         .  
						corresponds to amino acids 30 - 167 of AA452277_P2, wherein  	       1 MAEVHVIGQIIGASGFSESSLFCKWGIHT........GVREGQTQVDTPQ 42                                                           
						said first amino acid sequence, bridging amino acid, second  	         ||||||||||:||||||||||||||||||        |||||||||||||  
						amino acid sequence and third amino acid sequence are        	       1 MAEVHVIGQIMGASGFSESSLFCKWGIHTGAAWKLLSGVREGQTQVDTPQ 50                                                           
						contiguous and in a sequential order.2.An isolated chimeric  	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of AA452277_P2,     	      43 IGDMAYWSHPIDLHFATKGLQGWPRLHFQVWSQDSFGRCQLAGYGFCHVP 92                                                           
						comprising a polypeptide having a length "n", wherein n is at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 10 amino acids in length, optionally at least    	      51 IGDMAYWSHPIDLHFATKGLQGWPRLHFQVWSQDSFGRCQLAGYGFCHVP 100                                                          
						about 20 amino acids in length, preferably at least about 30 	                  .         .         .         .         .  
						amino acids in length, more preferably at least about 40     	      93 SSPGTHQLACPTWRPLGSWREQLARAFVGGGPQLLHGDTIYSGADRYRLH 142                                                          
						amino acids in length and most preferably at least about 50  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, wherein at least two amino acids      	     101 SSPGTHQLACPTWRPLGSWREQLARAFVGGGPQLLHGDTIYSGADRYRLH 150                                                          
						comprise TG, having a structure as follows: a sequence       	                  .         .                                
						starting from any of amino acid numbers 29-x to 30; and      	     143 TAAGGTVHLEIGLLLRNFDRYGVEC                          167                                                          
						ending at any of amino acid numbers 30+ ((n-2) - x), in which	         |||||||||||||||||||||||||                           
						x varies from 0 to n-2.                                      	     151 TAAGGTVHLEIGLLLRNFDRYGVEC                          175                                                          

20305	HMR136_AA453413_0_tr0_r1_1_gPRT		Comparison report between AA453413_P0 and Q8N8G2partial WT   	Sequence name: Q8N8G2                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA453413_P0, comprising a first     	Sequence documentation:                                      
						MSQRSFPASFWNSAYQAPVPPPLGSPLATAHSELPFAAADPYSPAALHGHLHQGATEPWH 	                                                            
						HAHPHHAHPHHPYALGGALGAQAAPYPRPAAVHEVYAPHFDPRYGPLLMPAASGRPARLA 	Alignment of: 20305 x Q8N8G2   ..                            
						TAPAPAPGSPPCELSGKGEPAGAAWAGPGGPFASPSGDVAQGLGLSVDS            	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 136 - 304 of Q8N8G2, which also 	                                                            
						corresponds to amino acids 1 - 169 of AA453413_P0, and a     	                     Quality: 1707.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     171                Total length:     171                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:   99.42   Matching Percent Identity:   98.83                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:   99.42      Total Percent Identity:   98.83                                               
						polypeptide having the sequence GKQRKKFGLRGAARPRTRPWA        	                        Gaps:       0                        
						corresponding to amino acids 170 - 190 of AA453413_P0,       	                                                            
						wherein said first amino acid sequence and second amino acid 	Alignment:                                                   
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of AA453413_P0,     	       1 MSQRSFPASFWNSAYQAPVPPPLGSPLATAHSELPFAAADPYSPAALHGH 50                                                           
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     136 MSQRSFPASFWNSAYQAPVPPPLGSPLATAHSELPFAAADPYSPAALHGH 185                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence GKQRKKFGLRGAARPRTRPWA in	      51 LHQGATEPWHHAHPHHAHPHHPYALGGALGAQAAPYPRPAAVHEVYAPHF 100                                                          
						AA453413_P0.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     186 LHQGATEPWHHAHPHHAHPHHPYALGGALGAQAAPYPRPAAVHEVYAPHF 235                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 DPRYGPLLMPAASGRPARLATAPAPAPGSPPCELSGKGEPAGAAWAGPGG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     236 DPRYGPLLMPAASGRPARLATAPAPAPGSPPCELSGKGEPAGAAWAGPGG 285                                                          
						                                                            	                  .         .                                
						                                                            	     151 PFASPSGDVAQGLGLSVDSGK                              171                                                          
						                                                            	         ||||||||||||||||||| :                               
						                                                            	     286 PFASPSGDVAQGLGLSVDSAR                              306                                                          

10656	HMR136_AA455011_0_tr0_r1_1_gPRT		Comparison report between AA455011_P0 and SCEL_HUMANpartial  	Sequence name: SCEL_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA455011_P0, comprising a first     	Sequence documentation:                                      
						MSNVTLRKMSPTGNEMKSTTQGTTRKQQDFHEVNKRRTFLQDNSWIKKRPEEEKDENYGR 	                                                            
						VVLNRHNSHDALDRKVNERDVPKATISRYSSDDTLD                         	Alignment of: 10656 x SCEL_HUMAN   ..                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 96 of SCEL_HUMAN, which also	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 96 of AA455011_P0, and a      	                                                            
						RSMSMFRSLEVTKLQPGGSLNANTSNTIASTSATTPVKKKRQSWFPPPPPGYNASSSTGT 	                     Quality: 2703.00                      Escore:       0                                               
						RRREPGVHPPIPPKPSSPVSSPNQLRQDNRQIHPPKPGVYTETNRSAERNISEELDNLIK 	             Matching length:     283                Total length:     306                                               
						MNKSLNRNQGLDSLFRANPKVEEREKRAKSLESLIYMSTRTDKDGKGIQSLGSPIKVNQR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TDKNEKG                                                      	    Total Percent Similarity:   92.48      Total Percent Identity:   92.48                                               
						second amino acid sequence being at least 90 % homologous to 	                        Gaps:       1                        
						corresponding to amino acids 120 - 306 of SCEL_HUMAN, which  	                                                            
						also corresponds to amino acids 97 - 283 of AA455011_P0,     	Alignment:                                                   
						wherein said first amino acid sequence and second amino acid 	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	       1 MSNVTLRKMSPTGNEMKSTTQGTTRKQQDFHEVNKRRTFLQDNSWIKKRP 50                                                           
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA455011_P0, comprising a polypeptide having a length "n",   	       1 MSNVTLRKMSPTGNEMKSTTQGTTRKQQDFHEVNKRRTFLQDNSWIKKRP 50                                                           
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	      51 EEEKDENYGRVVLNRHNSHDALDRKVNERDVPKATISRYSSDDTLD.... 96                                                           
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||      
						preferably at least about 40 amino acids in length and most  	      51 EEEKDENYGRVVLNRHNSHDALDRKVNERDVPKATISRYSSDDTLDRISD 100                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise DR, having a structure as  	      97 ...................RSMSMFRSLEVTKLQPGGSLNANTSNTIAST 127                                                          
						follows: a sequence starting from any of amino acid numbers  	                            |||||||||||||||||||||||||||||||  
						96-x to 97; and ending at any of amino acid numbers 97+      	     101 RNDAAKTYKANTLDNQLTNRSMSMFRSLEVTKLQPGGSLNANTSNTIAST 150                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     128 SATTPVKKKRQSWFPPPPPGYNASSSTGTRRREPGVHPPIPPKPSSPVSS 177                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 SATTPVKKKRQSWFPPPPPGYNASSSTGTRRREPGVHPPIPPKPSSPVSS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     178 PNQLRQDNRQIHPPKPGVYTETNRSAERNISEELDNLIKMNKSLNRNQGL 227                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PNQLRQDNRQIHPPKPGVYTETNRSAERNISEELDNLIKMNKSLNRNQGL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     228 DSLFRANPKVEEREKRAKSLESLIYMSTRTDKDGKGIQSLGSPIKVNQRT 277                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 DSLFRANPKVEEREKRAKSLESLIYMSTRTDKDGKGIQSLGSPIKVNQRT 300                                                          
						                                                            	                                                             
						                                                            	     278 DKNEKG                                             283                                                          
						                                                            	         ||||||                                              
						                                                            	     301 DKNEKG                                             306                                                          

10654	HMR136_AA455011_5_tr0_r1_1_gPRT		Comparison report between AA455011_P5 and Q8WW87partial WT   	Sequence name: Q8WW87                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA455011_P5, comprising a first amino acid sequence being at 	                                                            
						MSNVTLRKMSPTGNEMKSTTQGTTRKQQDFHEVNKRRTFLQDNSWIKKRPEEEKDENYGR 	Alignment of: 10654 x Q8WW87   ..                            
						VVLNRHNSHDALDRKVNERDVPKATISRYSSDDTLDRSMSMFRSLEVTKLQPGGSLNANT 	                                                            
						SNTIASTSATTPVKKKRQSWFPPPPPGYNASSSTGTRRREPGVHPPIPPKPSSPVSSPNQ 	Alignment segment 1/1:                                       
						LRQDNRQIHPPKPGVYTETNRSAERNISEELDNLIKMNKSLNRNQGLDSLFRANPKVEER 	                                                            
						EK                                                           	                     Quality: 2796.00                      Escore:       0                                               
						least 90 % homologous to corresponding to amino acids 1 - 242	             Matching length:     283                Total length:     283                                               
						of Q8WW87, which also corresponds to amino acids 1 - 242 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						AA455011_P5, a bridging amino acid R corresponding to amino  	    Total Percent Similarity:  100.00      Total Percent Identity:   99.65                                               
						acid 243 of AA455011_P5, a second amino acid sequence being  	                        Gaps:       0                        
						at least 90 % homologous to                                  	                                                            
						AKSLESLIYMSTRTDKDGKGIQSLGSPIKVNQRTDKNEKG corresponding to    	Alignment:                                                   
						amino acids 244 - 283 of Q8WW87, which also corresponds to   	                  .         .         .         .         .  
						amino acids 244 - 283 of AA455011_P5, and a third amino acid 	       1 MSNVTLRKMSPTGNEMKSTTQGTTRKQQDFHEVNKRRTFLQDNSWIKKRP 50                                                           
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	       1 MSNVTLRKMSPTGNEMKSTTQGTTRKQQDFHEVNKRRTFLQDNSWIKKRP 50                                                           
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						RQNLESVAKVNARMNKTSRRSEDLDNATEVNPKGHENTTGGQSLDNLIKVTPEVKRSNQG 	      51 EEEKDENYGRVVLNRHNSHDALDRKVNERDVPKATISRYSSDDTLDRSMS 100                                                          
						SKDLNNFIKVYPGTEKSTEGGQSLDSLIKVTPERNRTNQGNQDLENLIKVIPSANKSSEQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GLDEHINVSPKAVKNTDGKQDLDKLIKVNPEIFTNNQRNQDLANLIKVNPAVIRNNQSQD 	      51 EEEKDENYGRVVLNRHNSHDALDRKVNERDVPKATISRYSSDDTLDRSMS 100                                                          
						LDNLIKVKPSALRNTNRDQNLENLIEVNSHVSENKNGRLDAQVNGFTNALHNQSTRIASH 	                  .         .         .         .         .  
						SYEARNNLSSNTGAKQAGPQDTVVYTRTYVENSKSPKDGYQENISGKYIQTVYSTSDRSV 	     101 MFRSLEVTKLQPGGSLNANTSNTIASTSATTPVKKKRQSWFPPPPPGYNA 150                                                          
						IERDMCTYCRKPLGVETKMILDELQICCHSTCFKCEICKQPLENLQAGDSIWIYRQTIHC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EPCYSKIMAKWIP                                                	     101 MFRSLEVTKLQPGGSLNANTSNTIASTSATTPVKKKRQSWFPPPPPGYNA 150                                                          
						having the sequence corresponding to amino acids 284 - 656 of	                  .         .         .         .         .  
						AA455011_P5, wherein said first amino acid sequence, bridging	     151 SSSTGTRRREPGVHPPIPPKPSSPVSSPNQLRQDNRQIHPPKPGVYTETN 200                                                          
						amino acid, second amino acid sequence and third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     151 SSSTGTRRREPGVHPPIPPKPSSPVSSPNQLRQDNRQIHPPKPGVYTETN 200                                                          
						isolated polypeptide encoding for a tail of AA455011_P5,     	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     201 RSAERNISEELDNLIKMNKSLNRNQGLDSLFRANPKVEEREKRAKSLESL 250                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||:|||||||  
						preferably at least about 90% and most preferably at least   	     201 RSAERNISEELDNLIKMNKSLNRNQGLDSLFRANPKVEEREKKAKSLESL 250                                                          
						RQNLESVAKVNARMNKTSRRSEDLDNATEVNPKGHENTTGGQSLDNLIKVTPEVKRSNQG 	                  .         .         .                      
						SKDLNNFIKVYPGTEKSTEGGQSLDSLIKVTPERNRTNQGNQDLENLIKVIPSANKSSEQ 	     251 IYMSTRTDKDGKGIQSLGSPIKVNQRTDKNEKG                  283                                                          
						GLDEHINVSPKAVKNTDGKQDLDKLIKVNPEIFTNNQRNQDLANLIKVNPAVIRNNQSQD 	         |||||||||||||||||||||||||||||||||                   
						LDNLIKVKPSALRNTNRDQNLENLIEVNSHVSENKNGRLDAQVNGFTNALHNQSTRIASH 	     251 IYMSTRTDKDGKGIQSLGSPIKVNQRTDKNEKG                  283                                                          
						SYEARNNLSSNTGAKQAGPQDTVVYTRTYVENSKSPKDGYQENISGKYIQTVYSTSDRSV 	                                                            
						IERDMCTYCRKPLGVETKMILDELQICCHSTCFKCEICKQPLENLQAGDSIWIYRQTIHC 	                                                            
						EPCYSKIMAKWIP                                                	                                                            
						about 95% homologous to the sequence in AA455011_P5.         	                                                            

10658	HMR136_AA455011_6_tr0_r1_1_gPRT		Comparison report between AA455011_P6 and SCEL_HUMANpartial  	Sequence name: SCEL_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						AA455011_P6, comprising a first amino acid sequence being at 	                                                            
						MSNVTLRKMSPTGNEMKSTTQGTTRKQQDFHEVNKRRTFLQDNSWIKKRPEEEKDENYGR 	Alignment of: 10658 x SCEL_HUMAN   ..                        
						VVLNRHNSHDALDRKVNERDVPKATISRYSSDDTLD                         	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 96 	Alignment segment 1/1:                                       
						of SCEL_HUMAN, which also corresponds to amino acids 1 - 96  	                                                            
						of AA455011_P6, a second amino acid sequence being at least  	                     Quality: 5583.00                      Escore:       0                                               
						RSMSMFRSLEVTKLQPGGSLNANTSNTIASTSATTPVKKKRQSWFPPPPPGYNASSSTGT 	             Matching length:     605                Total length:     699                                               
						RRREPGVHPPIPPKPSSPVSSPNQLRQDNRQIHPPKPGVYTETNRSAERNISEELDNLIK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MNKSLNRNQGLDSLFRANPKVEEREKRAKSLESLIYMSTRTDKDGKGIQSLGSPIKVNQR 	    Total Percent Similarity:   86.55      Total Percent Identity:   86.55                                               
						TDKNEKG                                                      	                        Gaps:       4                        
						90 % homologous to corresponding to amino acids 120 - 306 of 	                                                            
						SCEL_HUMAN, which also corresponds to amino acids 97 - 283 of	Alignment:                                                   
						AA455011_P6, a third amino acid sequence being at least 90 % 	                  .         .         .         .         .  
						homologous to SEDLDNATEVNPKGHENTTG corresponding to amino    	       1 MSNVTLRKMSPTGNEMKSTTQGTTRKQQDFHEVNKRRTFLQDNSWIKKRP 50                                                           
						acids 327 - 346 of SCEL_HUMAN, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 284 - 303 of AA455011_P6, a fourth amino acid    	       1 MSNVTLRKMSPTGNEMKSTTQGTTRKQQDFHEVNKRRTFLQDNSWIKKRP 50                                                           
						GQSLDNLIKVTPEVKRSNQGSKDLNNFIKVYPGTEKSTEGGQSLDSLIKVTPERNRTNQG 	                  .         .         .         .         .  
						NQDLENLIKVIPSANKSSEQGLDEHINVSPKAVKNTDGKQDLDKLIKVNPEIFTNNQRNQ 	      51 EEEKDENYGRVVLNRHNSHDALDRKVNERDVPKATISRYSSDDTLD.... 96                                                           
						DLANLIKVNPAVIRNNQSQDLDNLIKVKPSALRNTNRDQNLENLIEVNSHVSENKNG    	         ||||||||||||||||||||||||||||||||||||||||||||||      
						sequence being at least 90 % homologous to corresponding to  	      51 EEEKDENYGRVVLNRHNSHDALDRKVNERDVPKATISRYSSDDTLDRISD 100                                                          
						amino acids 367 - 543 of SCEL_HUMAN, which also corresponds  	                  .         .         .         .         .  
						to amino acids 304 - 480 of AA455011_P6, a fifth amino acid  	      97 ...................RSMSMFRSLEVTKLQPGGSLNANTSNTIAST 127                                                          
						sequence being at least 70%, optionally at least 80%,        	                            |||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 RNDAAKTYKANTLDNQLTNRSMSMFRSLEVTKLQPGGSLNANTSNTIAST 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						having the sequence RLDAQVNGFTNALHNQSTRIASHSYEARNNL          	     128 SATTPVKKKRQSWFPPPPPGYNASSSTGTRRREPGVHPPIPPKPSSPVSS 177                                                          
						corresponding to amino acids 481 - 511 of AA455011_P6, and a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSNTGAKQAGPQDTVVYTRTYVENSKSPKDGYQENISGKYIQTVYSTSDRSVIERDMCTY 	     151 SATTPVKKKRQSWFPPPPPGYNASSSTGTRRREPGVHPPIPPKPSSPVSS 200                                                          
						CRKPLGVETKMILDELQICCHSTCFKCEICKQPLENLQAGDSIWIYRQTIHCEPCYSKIM 	                  .         .         .         .         .  
						AKWIP                                                        	     178 PNQLRQDNRQIHPPKPGVYTETNRSAERNISEELDNLIKMNKSLNRNQGL 227                                                          
						sixth amino acid sequence being at least 90 % homologous to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 544 - 668 of SCEL_HUMAN, which  	     201 PNQLRQDNRQIHPPKPGVYTETNRSAERNISEELDNLIKMNKSLNRNQGL 250                                                          
						also corresponds to amino acids 512 - 636 of AA455011_P6,    	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     228 DSLFRANPKVEEREKRAKSLESLIYMSTRTDKDGKGIQSLGSPIKVNQRT 277                                                          
						sequence, third amino acid sequence, fourth amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, fifth amino acid sequence and sixth amino acid     	     251 DSLFRANPKVEEREKRAKSLESLIYMSTRTDKDGKGIQSLGSPIKVNQRT 300                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	     278 DKNEKG....................SEDLDNATEVNPKGHENTTG.... 303                                                          
						AA455011_P6, comprising a polypeptide having a length "n",   	         ||||||                    ||||||||||||||||||||      
						wherein n is at least about 10 amino acids in length,        	     301 DKNEKGRQNLESVAKVDARTNKTSRRSEDLDNATEVNPKGHENTTGKKDL 350                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     304 ................GQSLDNLIKVTPEVKRSNQGSKDLNNFIKVYPGT 337                                                          
						preferably at least about 40 amino acids in length and most  	                         ||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     351 DGLIKVDPETNKNITRGQSLDNLIKVTPEVKRSNQGSKDLNNFIKVYPGT 400                                                          
						at least two amino acids comprise DR, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     338 EKSTEGGQSLDSLIKVTPERNRTNQGNQDLENLIKVIPSANKSSEQGLDE 387                                                          
						96-x to 97; and ending at any of amino acid numbers 97+      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	     401 EKSTEGGQSLDSLIKVTPERNRTNQGNQDLENLIKVIPSANKSSEQGLDE 450                                                          
						chimeric polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						AA455011_P6, comprising a polypeptide having a length "n",   	     388 HINVSPKAVKNTDGKQDLDKLIKVNPEIFTNNQRNQDLANLIKVNPAVIR 437                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     451 HINVSPKAVKNTDGKQDLDKLIKVNPEIFTNNQRNQDLANLIKVNPAVIR 500                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     438 NNQSQDLDNLIKVKPSALRNTNRDQNLENLIEVNSHVSENKNGRLDAQVN 487                                                          
						preferably at least about 50 amino acids in length, wherein  	         |||||||||||||||||||||||||||||||||||||||||||         
						at least two amino acids comprise GS, having a structure as  	     501 NNQSQDLDNLIKVKPSALRNTNRDQNLENLIEVNSHVSENKNG....... 543                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						283-x to 284; and ending at any of amino acid numbers 284+   	     488 GFTNALHNQSTRIASHSYEARNNLSSNTGAKQAGPQDTVVYTRTYVENSK 537                                                          
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	                                 ||||||||||||||||||||||||||  
						chimeric polypeptide encoding for an edge portion of         	     544 ........................SSNTGAKQAGPQDTVVYTRTYVENSK 569                                                          
						AA455011_P6, comprising a polypeptide having a length "n",   	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     538 SPKDGYQENISGKYIQTVYSTSDRSVIERDMCTYCRKPLGVETKMILDEL 587                                                          
						optionally at least about 20 amino acids in length,          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     570 SPKDGYQENISGKYIQTVYSTSDRSVIERDMCTYCRKPLGVETKMILDEL 619                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .            
						preferably at least about 50 amino acids in length, wherein  	     588 QICCHSTCFKCEICKQPLENLQAGDSIWIYRQTIHCEPCYSKIMAKWIP  636                                                          
						at least two amino acids comprise GG, having a structure as  	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						follows: a sequence starting from any of amino acid numbers  	     620 QICCHSTCFKCEICKQPLENLQAGDSIWIYRQTIHCEPCYSKIMAKWIP  668                                                          
						303-x to 304; and ending at any of amino acid numbers 304+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.5.An isolated   	                                                            
						polypeptide encoding for an edge portion of AA455011_P6,     	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for      	                                                            
						RLDAQVNGFTNALHNQSTRIASHSYEARNNL, corresponding to            	                                                            
						AA455011_P6.                                                 	                                                            

10660	HMR136_AA455011_7_tr0_r1_1_gPRT		Comparison report between AA455011_P7 and AAH47536short      	Sequence name: AAH47536                                      
						unique head followed by partial WT sequence a mismatch,      	                                                            
						featuring a skipped exon and a followed by a unique          	Sequence documentation:                                      
						insertion.1.An isolated chimeric polypeptide encoding for    	                                                            
						AA455011_P7, comprising a first amino acid sequence being at 	Alignment of: 10660 x AAH47536   ..                          
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence M            	                                                            
						corresponding to amino acids 1 - 1 of AA455011_P7, a second  	                     Quality: 4952.00                      Escore:       0                                               
						FRSLEVTKLQPGGSLNANTSNTIASTSATTPVKKKRQSWFPPPPPGYNASSSTGTRRREP 	             Matching length:     524                Total length:     575                                               
						GVHPPIPPKPSSPVSS                                             	 Matching Percent Similarity:   99.81   Matching Percent Identity:   99.81                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:   90.96      Total Percent Identity:   90.96                                               
						corresponding to amino acids 125 - 200 of AAH47536, which    	                        Gaps:       2                        
						also corresponds to amino acids 2 - 77 of AA455011_P7, a     	                                                            
						bridging amino acid P corresponding to amino acid 78 of      	Alignment:                                                   
						AA455011_P7, a third amino acid sequence being at least 90 % 	                  .         .         .         .         .  
						NQLRQDNRQIHPPKPGVYTETNRSAERNISEELDNLIKMNKSLNRNQGLDSLFRANPKVE 	       2 FRSLEVTKLQPGGSLNANTSNTIASTSATTPVKKKRQSWFPPPPPGYNAS 51                                                           
						EREKRAKSLESLIYMSTRTDKDGKGIQSLGSPIKVNQRTDKNEKGRQNLESVAKVNARMN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KTSRRSEDLDNATEVNPKGHENTTG                                    	     125 FRSLEVTKLQPGGSLNANTSNTIASTSATTPVKKKRQSWFPPPPPGYNAS 174                                                          
						homologous to corresponding to amino acids 202 - 346 of      	                  .         .         .         .         .  
						AAH47536, which also corresponds to amino acids 79 - 223 of  	      52 SSTGTRRREPGVHPPIPPKPSSPVSSPNQLRQDNRQIHPPKPGVYTETNR 101                                                          
						AA455011_P7, a fourth amino acid sequence being at least 90 %	         |||||||||||||||||||||||||| |||||||||||||||||||||||  
						GQSLDNLIKVTPEVKRSNQGSKDLNNFIKVYPGTEKSTEGGQSLDSLIKVTPERNRTNQG 	     175 SSTGTRRREPGVHPPIPPKPSSPVSSTNQLRQDNRQIHPPKPGVYTETNR 224                                                          
						NQDLENLIKVIPSANKSSEQGLDEHINVSPKAVKNTDGKQDLDKLIKVNPEIFTNNQRNQ 	                  .         .         .         .         .  
						DLANLIKVNPAVIRNNQSQDLDNLIKVKPSALRNTNRDQNLENLIEVNSHVSENKNG    	     102 SAERNISEELDNLIKMNKSLNRNQGLDSLFRANPKVEEREKRAKSLESLI 151                                                          
						homologous to corresponding to amino acids 367 - 543 of      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AAH47536, which also corresponds to amino acids 224 - 400 of 	     225 SAERNISEELDNLIKMNKSLNRNQGLDSLFRANPKVEEREKRAKSLESLI 274                                                          
						AA455011_P7, a fifth amino acid sequence being at least 70%, 	                  .         .         .         .         .  
						optionally at least 80%, preferably at least 85%, more       	     152 YMSTRTDKDGKGIQSLGSPIKVNQRTDKNEKGRQNLESVAKVNARMNKTS 201                                                          
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	     275 YMSTRTDKDGKGIQSLGSPIKVNQRTDKNEKGRQNLESVAKVNARMNKTS 324                                                          
						RLDAQVNGFTNALHNQSTRIASHSYEARNNL corresponding to amino acids 	                  .         .         .         .         .  
						401 - 431 of AA455011_P7, and a sixth amino acid sequence    	     202 RRSEDLDNATEVNPKGHENTTG....................GQSLDNLI 231                                                          
						SSNTGAKQAGPQDTVVYTRTYVENSKSPKDGYQENISGKYIQTVYSTSDRSVIERDMCTY 	         ||||||||||||||||||||||                    ||||||||  
						CRKPLGVETKMILDELQICCHSTCFKCEICKQPLENLQAGDSIWIYRQTIHCEPCYSKIM 	     325 RRSEDLDNATEVNPKGHENTTGKKDLDGLIKVDPETNKNITRGQSLDNLI 374                                                          
						AKWIP                                                        	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	     232 KVTPEVKRSNQGSKDLNNFIKVYPGTEKSTEGGQSLDSLIKVTPERNRTN 281                                                          
						acids 544 - 668 of AAH47536, which also corresponds to amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 432 - 556 of AA455011_P7, wherein said first amino acid	     375 KVTPEVKRSNQGSKDLNNFIKVYPGTEKSTEGGQSLDSLIKVTPERNRTN 424                                                          
						sequence, second amino acid sequence, bridging amino acid,   	                  .         .         .         .         .  
						third amino acid sequence, fourth amino acid sequence, fifth 	     282 QGNQDLENLIKVIPSANKSSEQGLDEHINVSPKAVKNTDGKQDLDKLIKV 331                                                          
						amino acid sequence and sixth amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated chimeric  	     425 QGNQDLENLIKVIPSANKSSEQGLDEHINVSPKAVKNTDGKQDLDKLIKV 474                                                          
						polypeptide encoding for an edge portion of AA455011_P7,     	                  .         .         .         .         .  
						comprising a polypeptide having a length "n", wherein n is at	     332 NPEIFTNNQRNQDLANLIKVNPAVIRNNQSQDLDNLIKVKPSALRNTNRD 381                                                          
						least about 10 amino acids in length, optionally at least    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 20 amino acids in length, preferably at least about 30 	     475 NPEIFTNNQRNQDLANLIKVNPAVIRNNQSQDLDNLIKVKPSALRNTNRD 524                                                          
						amino acids in length, more preferably at least about 40     	                  .         .         .         .         .  
						amino acids in length and most preferably at least about 50  	     382 QNLENLIEVNSHVSENKNGRLDAQVNGFTNALHNQSTRIASHSYEARNNL 431                                                          
						amino acids in length, wherein at least two amino acids      	         |||||||||||||||||||                                 
						comprise GG, having a structure as follows: a sequence       	     525 QNLENLIEVNSHVSENKNG............................... 543                                                          
						starting from any of amino acid numbers 223-x to 224; and    	                  .         .         .         .         .  
						ending at any of amino acid numbers 224+ ((n-2) - x), in     	     432 SSNTGAKQAGPQDTVVYTRTYVENSKSPKDGYQENISGKYIQTVYSTSDR 481                                                          
						which x varies from 0 to n-2.3.An isolated polypeptide       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for an edge portion of AA455011_P7, comprising an   	     544 SSNTGAKQAGPQDTVVYTRTYVENSKSPKDGYQENISGKYIQTVYSTSDR 593                                                          
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						about 80%, preferably at least about 85%, more preferably at 	     482 SVIERDMCTYCRKPLGVETKMILDELQICCHSTCFKCEICKQPLENLQAG 531                                                          
						least about 90% and most preferably at least about 95%       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to the sequence encoding for                      	     594 SVIERDMCTYCRKPLGVETKMILDELQICCHSTCFKCEICKQPLENLQAG 643                                                          
						RLDAQVNGFTNALHNQSTRIASHSYEARNNL, corresponding to            	                  .         .                                
						AA455011_P7.                                                 	     532 DSIWIYRQTIHCEPCYSKIMAKWIP                          556                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     644 DSIWIYRQTIHCEPCYSKIMAKWIP                          668                                                          

						Comparison report between AA455011_P7 and Q8WW87partial WT   	Sequence name: Q8WW87                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA455011_P7, comprising a first amino acid sequence being at 	                                                            
						MFRSLEVTKLQPGGSLNANTSNTIASTSATTPVKKKRQSWFPPPPPGYNASSSTGTRRRE 	Alignment of: 10660 x Q8WW87   ..                            
						PGVHPPIPPKPSSPVSSPNQLRQDNRQIHPPKPGVYTETNRSAERNISEELDNLIKMNKS 	                                                            
						LNRNQGLDSLFRANPKVEEREK                                       	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 101 -  	                                                            
						242 of Q8WW87, which also corresponds to amino acids 1 - 142 	                     Quality: 1800.00                      Escore:       0                                               
						of AA455011_P7, a bridging amino acid R corresponding to     	             Matching length:     183                Total length:     183                                               
						amino acid 143 of AA455011_P7, a second amino acid sequence  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.45                                               
						being at least 90 % homologous to                            	    Total Percent Similarity:  100.00      Total Percent Identity:   99.45                                               
						AKSLESLIYMSTRTDKDGKGIQSLGSPIKVNQRTDKNEKG corresponding to    	                        Gaps:       0                        
						amino acids 244 - 283 of Q8WW87, which also corresponds to   	                                                            
						amino acids 144 - 183 of AA455011_P7, and a third amino acid 	Alignment:                                                   
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	       1 MFRSLEVTKLQPGGSLNANTSNTIASTSATTPVKKKRQSWFPPPPPGYNA 50                                                           
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RQNLESVAKVNARMNKTSRRSEDLDNATEVNPKGHENTTGGQSLDNLIKVTPEVKRSNQG 	     101 MFRSLEVTKLQPGGSLNANTSNTIASTSATTPVKKKRQSWFPPPPPGYNA 150                                                          
						SKDLNNFIKVYPGTEKSTEGGQSLDSLIKVTPERNRTNQGNQDLENLIKVIPSANKSSEQ 	                  .         .         .         .         .  
						GLDEHINVSPKAVKNTDGKQDLDKLIKVNPEIFTNNQRNQDLANLIKVNPAVIRNNQSQD 	      51 SSSTGTRRREPGVHPPIPPKPSSPVSSPNQLRQDNRQIHPPKPGVYTETN 100                                                          
						LDNLIKVKPSALRNTNRDQNLENLIEVNSHVSENKNGRLDAQVNGFTNALHNQSTRIASH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SYEARNNLSSNTGAKQAGPQDTVVYTRTYVENSKSPKDGYQENISGKYIQTVYSTSDRSV 	     151 SSSTGTRRREPGVHPPIPPKPSSPVSSPNQLRQDNRQIHPPKPGVYTETN 200                                                          
						IERDMCTYCRKPLGVETKMILDELQICCHSTCFKCEICKQPLENLQAGDSIWIYRQTIHC 	                  .         .         .         .         .  
						EPCYSKIMAKWIP                                                	     101 RSAERNISEELDNLIKMNKSLNRNQGLDSLFRANPKVEEREKRAKSLESL 150                                                          
						having the sequence corresponding to amino acids 184 - 556 of	         ||||||||||||||||||||||||||||||||||||||||||:|||||||  
						AA455011_P7, wherein said first amino acid sequence, bridging	     201 RSAERNISEELDNLIKMNKSLNRNQGLDSLFRANPKVEEREKKAKSLESL 250                                                          
						amino acid, second amino acid sequence and third amino acid  	                  .         .         .                      
						sequence are contiguous and in a sequential order.2.An       	     151 IYMSTRTDKDGKGIQSLGSPIKVNQRTDKNEKG                  183                                                          
						isolated polypeptide encoding for a tail of AA455011_P7,     	         |||||||||||||||||||||||||||||||||                   
						comprising a polypeptide being at least 70%, optionally at   	     251 IYMSTRTDKDGKGIQSLGSPIKVNQRTDKNEKG                  283                                                          
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						RQNLESVAKVNARMNKTSRRSEDLDNATEVNPKGHENTTGGQSLDNLIKVTPEVKRSNQG 	                                                            
						SKDLNNFIKVYPGTEKSTEGGQSLDSLIKVTPERNRTNQGNQDLENLIKVIPSANKSSEQ 	                                                            
						GLDEHINVSPKAVKNTDGKQDLDKLIKVNPEIFTNNQRNQDLANLIKVNPAVIRNNQSQD 	                                                            
						LDNLIKVKPSALRNTNRDQNLENLIEVNSHVSENKNGRLDAQVNGFTNALHNQSTRIASH 	                                                            
						SYEARNNLSSNTGAKQAGPQDTVVYTRTYVENSKSPKDGYQENISGKYIQTVYSTSDRSV 	                                                            
						IERDMCTYCRKPLGVETKMILDELQICCHSTCFKCEICKQPLENLQAGDSIWIYRQTIHC 	                                                            
						EPCYSKIMAKWIP                                                	                                                            
						about 95% homologous to the sequence in AA455011_P7.         	                                                            

10652	HMR136_AA455011_8_tr0_r1_1_gPRT		Comparison report between AA455011_P8 and SCEL_HUMANunique   	Sequence name: SCEL_HUMAN                                    
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA455011_P8, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 10652 x SCEL_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MNKSLN       	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 6 of AA455011_P8, a second  	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 1351.00                      Escore:       0                                               
						RAKSLESLIYMSTRTDKDGKGIQSLGSPIKVNQRTDKNEKG corresponding to   	             Matching length:     151                Total length:     211                                               
						amino acids 266 - 306 of SCEL_HUMAN, which also corresponds  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						to amino acids 7 - 47 of AA455011_P8, and a third amino acid 	    Total Percent Similarity:   71.56      Total Percent Identity:   71.56                                               
						GQSLDNLIKVTPEVKRSNQGSKDLNNFIKVYPGTEKSTEGGQSLDSLIKVTPERNRTNQG 	                        Gaps:       1                        
						NQDLENLIKVIPSANKSSEQGLDEHINVSPKAVKNTDGKQDLDKLIKVNP           	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 367 - 476 of SCEL_HUMAN, which also corresponds  	                  .         .         .         .         .  
						to amino acids 48 - 157 of AA455011_P8, wherein said first   	       7 RAKSLESLIYMSTRTDKDGKGIQSLGSPIKVNQRTDKNEKG......... 47                                                           
						amino acid sequence, second amino acid sequence and third    	         |||||||||||||||||||||||||||||||||||||||||           
						amino acid sequence are contiguous and in a sequential       	     266 RAKSLESLIYMSTRTDKDGKGIQSLGSPIKVNQRTDKNEKGRQNLESVAK 315                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AA455011_P8, comprising a polypeptide being at least 70%,    	      47 .................................................. 47                                                           
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	     316 VDARTNKTSRRSEDLDNATEVNPKGHENTTGKKDLDGLIKVDPETNKNIT 365                                                          
						least about 95% homologous to the sequence MNKSLN of         	                  .         .         .         .         .  
						AA455011_P8.3.An isolated chimeric polypeptide encoding for  	      48 .GQSLDNLIKVTPEVKRSNQGSKDLNNFIKVYPGTEKSTEGGQSLDSLIK 96                                                           
						an edge portion of AA455011_P8, comprising a polypeptide     	          |||||||||||||||||||||||||||||||||||||||||||||||||  
						having a length "n", wherein n is at least about 10 amino    	     366 RGQSLDNLIKVTPEVKRSNQGSKDLNNFIKVYPGTEKSTEGGQSLDSLIK 415                                                          
						acids in length, optionally at least about 20 amino acids in 	                  .         .         .         .         .  
						length, preferably at least about 30 amino acids in length,  	      97 VTPERNRTNQGNQDLENLIKVIPSANKSSEQGLDEHINVSPKAVKNTDGK 146                                                          
						more preferably at least about 40 amino acids in length and  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 50 amino acids in length,     	     416 VTPERNRTNQGNQDLENLIKVIPSANKSSEQGLDEHINVSPKAVKNTDGK 465                                                          
						wherein at least two amino acids comprise GG, having a       	                  .                                          
						structure as follows: a sequence starting from any of amino  	     147 QDLDKLIKVNP                                        157                                                          
						acid numbers 47-x to 48; and ending at any of amino acid     	         |||||||||||                                         
						numbers 48+ ((n-2) - x), in which x varies from 0 to n-2.    	     466 QDLDKLIKVNP                                        476                                                          

16563	HMR136_AA455897_0_tr0_r1_1_gPRT		Comparison report between AA455897_P0 and Q8N434unique head  	Sequence name: Q8N434                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for AA455897_P0, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 16563 x Q8N434   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MATKPTEPVTILSLRKLSLGTAEPQVKEPKTFTVEDAVETIGFGRFHIALFLIMGSTGVV 	Alignment segment 1/1:                                       
						EAMEIMLIAVVSPVIRCEWQLENWQVALVTTMVFFGYMVFSILFGLLADRYGRWKILLIS 	                                                            
						FLWGAYFSLLTSFAPSYIWFVFLRTMVGCGVSGHSQG                        	                     Quality: 3169.00                      Escore:       0                                               
						polypeptide having the sequence corresponding to amino acids 	             Matching length:     335                Total length:     335                                               
						1 - 157 of AA455897_P0, a second amino acid sequence being at	 Matching Percent Similarity:   99.70   Matching Percent Identity:   99.70                                               
						LIIKTEFLPTKYRGYMLPLSQVFWLAGSLLIIGLASVIIPTIGWRWLIRVASIPGIILIV 	    Total Percent Similarity:   99.70      Total Percent Identity:   99.70                                               
						AFKFIPESARFNVSTGNTRAALATLERVAKMNRSVMPEGKLVEPVLEKRGRFADLLDAKY 	                        Gaps:       0                        
						LRTTLQIWVIWLGISFAYYGVILASAELLERDLVCGSKSDSAVVVTGGDSGESQSPCYCH 	                                                            
						MFAPSDYRTMIISTIGEIALNPLNILGINFLGRRLSLSITMGCTALF              	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 6 - 232	                  .         .         .         .         .  
						of Q8N434, which also corresponds to amino acids 158 - 384 of	     158 LIIKTEFLPTKYRGYMLPLSQVFWLAGSLLIIGLASVIIPTIGWRWLIRV 207                                                          
						AA455897_P0, a bridging amino acid C corresponding to amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid 385 of AA455897_P0, and a third amino acid sequence     	       6 LIIKTEFLPTKYRGYMLPLSQVFWLAGSLLIIGLASVIIPTIGWRWLIRV 55                                                           
						LLLNICTSSAGLIGFLFMLRALVAANFNTVYIYTAEVYPTTMRALGMGTSGSLCRIGAMV 	                  .         .         .         .         .  
						APFISQVLMSASILGALCLFSSVCVVCAISAFTLPIETKGRALQQIK              	     208 ASIPGIILIVAFKFIPESARFNVSTGNTRAALATLERVAKMNRSVMPEGK 257                                                          
						being at least 90 % homologous to corresponding to amino     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 234 - 340 of Q8N434, which also corresponds to amino   	      56 ASIPGIILIVAFKFIPESARFNVSTGNTRAALATLERVAKMNRSVMPEGK 105                                                          
						acids 386 - 492 of AA455897_P0, wherein said first amino acid	                  .         .         .         .         .  
						sequence, second amino acid sequence, bridging amino acid and	     258 LVEPVLEKRGRFADLLDAKYLRTTLQIWVIWLGISFAYYGVILASAELLE 307                                                          
						third amino acid sequence are contiguous and in a sequential 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     106 LVEPVLEKRGRFADLLDAKYLRTTLQIWVIWLGISFAYYGVILASAELLE 155                                                          
						AA455897_P0, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     308 RDLVCGSKSDSAVVVTGGDSGESQSPCYCHMFAPSDYRTMIISTIGEIAL 357                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MATKPTEPVTILSLRKLSLGTAEPQVKEPKTFTVEDAVETIGFGRFHIALFLIMGSTGVV 	     156 RDLVCGSKSDSAVVVTGGDSGESQSPCYCHMFAPSDYRTMIISTIGEIAL 205                                                          
						EAMEIMLIAVVSPVIRCEWQLENWQVALVTTMVFFGYMVFSILFGLLADRYGRWKILLIS 	                  .         .         .         .         .  
						FLWGAYFSLLTSFAPSYIWFVFLRTMVGCGVSGHSQG                        	     358 NPLNILGINFLGRRLSLSITMGCTALFCLLLNICTSSAGLIGFLFMLRAL 407                                                          
						least about 95% homologous to the sequence of AA455897_P0.   	         ||||||||||||||||||||||||||| ||||||||||||||||||||||  
						                                                            	     206 NPLNILGINFLGRRLSLSITMGCTALFFLLLNICTSSAGLIGFLFMLRAL 255                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     408 VAANFNTVYIYTAEVYPTTMRALGMGTSGSLCRIGAMVAPFISQVLMSAS 457                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     256 VAANFNTVYIYTAEVYPTTMRALGMGTSGSLCRIGAMVAPFISQVLMSAS 305                                                          
						                                                            	                  .         .         .                      
						                                                            	     458 ILGALCLFSSVCVVCAISAFTLPIETKGRALQQIK                492                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     306 ILGALCLFSSVCVVCAISAFTLPIETKGRALQQIK                340                                                          

16565	HMR136_AA455897_1_tr0_r1_1_gPRT		Comparison report between AA455897_P1 and Q8N434unique head  	Sequence name: Q8N434                                        
						followed by partial WT sequence a mismatch and a featuring a 	                                                            
						skipped exon.1.An isolated chimeric polypeptide encoding for 	Sequence documentation:                                      
						AA455897_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16565 x Q8N434   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MATKPTEPVTILSLRKLSLGTAEPQVKEPKTFTVEDAVETIGFGRFHIALFLIMGSTGVV 	Alignment segment 1/1:                                       
						EAMEIMLIAVVSPVIRCEWQLENWQVALVTTMVFFGYMVFSILFGLLADRYGRWKILLIS 	                                                            
						FLWGAYFSLLTSFAPSYIWFVFLRTMVGCGVSGHSQG                        	                     Quality: 2779.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     305                Total length:     335                                               
						to amino acids 1 - 157 of AA455897_P1, a second amino acid   	 Matching Percent Similarity:   99.67   Matching Percent Identity:   99.67                                               
						LIIKTEFLPTKYRGYMLPLSQVFWLAGSLLIIGLASVIIPTIGWRWLIRVASIPGIILIV 	    Total Percent Similarity:   90.75      Total Percent Identity:   90.75                                               
						AFKFIPESARFNVSTGNTRAALATLERVAKMNRSVMPEGKLVEPVLEKRGRFADLLDAKY 	                        Gaps:       1                        
						LRTTLQIWVIWLGISFAYYGVILASAELLERDLVCGSKSDSAVVVTGGDSGESQSPCYCH 	                                                            
						MFAPSDYRTMIISTIGEIALNPLNILGINFLGRRLSLSITMGCTALF              	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 6 - 232 of Q8N434, which also corresponds to     	     158 LIIKTEFLPTKYRGYMLPLSQVFWLAGSLLIIGLASVIIPTIGWRWLIRV 207                                                          
						amino acids 158 - 384 of AA455897_P1, a bridging amino acid C	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acid 385 of AA455897_P1, a third amino	       6 LIIKTEFLPTKYRGYMLPLSQVFWLAGSLLIIGLASVIIPTIGWRWLIRV 55                                                           
						acid sequence being at least 90 % homologous to              	                  .         .         .         .         .  
						LLLNICTSSAGLIGFLFMLRALVAANFNTVYIYTAE corresponding to amino  	     208 ASIPGIILIVAFKFIPESARFNVSTGNTRAALATLERVAKMNRSVMPEGK 257                                                          
						acids 234 - 269 of Q8N434, which also corresponds to amino   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 386 - 421 of AA455897_P1, and a fourth amino acid      	      56 ASIPGIILIVAFKFIPESARFNVSTGNTRAALATLERVAKMNRSVMPEGK 105                                                          
						sequence being at least 90 % homologous to                   	                  .         .         .         .         .  
						VLMSASILGALCLFSSVCVVCAISAFTLPIETKGRALQQIK corresponding to   	     258 LVEPVLEKRGRFADLLDAKYLRTTLQIWVIWLGISFAYYGVILASAELLE 307                                                          
						amino acids 300 - 340 of Q8N434, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 422 - 462 of AA455897_P1, wherein said first     	     106 LVEPVLEKRGRFADLLDAKYLRTTLQIWVIWLGISFAYYGVILASAELLE 155                                                          
						amino acid sequence, second amino acid sequence, bridging    	                  .         .         .         .         .  
						amino acid, third amino acid sequence and fourth amino acid  	     308 RDLVCGSKSDSAVVVTGGDSGESQSPCYCHMFAPSDYRTMIISTIGEIAL 357                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of AA455897_P1,     	     156 RDLVCGSKSDSAVVVTGGDSGESQSPCYCHMFAPSDYRTMIISTIGEIAL 205                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     358 NPLNILGINFLGRRLSLSITMGCTALFCLLLNICTSSAGLIGFLFMLRAL 407                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||| ||||||||||||||||||||||  
						MATKPTEPVTILSLRKLSLGTAEPQVKEPKTFTVEDAVETIGFGRFHIALFLIMGSTGVV 	     206 NPLNILGINFLGRRLSLSITMGCTALFFLLLNICTSSAGLIGFLFMLRAL 255                                                          
						EAMEIMLIAVVSPVIRCEWQLENWQVALVTTMVFFGYMVFSILFGLLADRYGRWKILLIS 	                  .         .         .         .         .  
						FLWGAYFSLLTSFAPSYIWFVFLRTMVGCGVSGHSQG                        	     408 VAANFNTVYIYTAE..............................VLMSAS 427                                                          
						about 95% homologous to the sequence of AA455897_P1.3.An     	         ||||||||||||||                              ||||||  
						isolated chimeric polypeptide encoding for an edge portion of	     256 VAANFNTVYIYTAEVYPTTMRALGMGTSGSLCRIGAMVAPFISQVLMSAS 305                                                          
						AA455897_P1, comprising a polypeptide having a length "n",   	                  .         .         .                      
						wherein n is at least about 10 amino acids in length,        	     428 ILGALCLFSSVCVVCAISAFTLPIETKGRALQQIK                462                                                          
						optionally at least about 20 amino acids in length,          	         |||||||||||||||||||||||||||||||||||                 
						preferably at least about 30 amino acids in length, more     	     306 ILGALCLFSSVCVVCAISAFTLPIETKGRALQQIK                340                                                          
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise EV, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						421-x to 422; and ending at any of amino acid numbers 422+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

16561	HMR136_AA455897_2_tr0_r1_1_gPRT		Comparison report between AA455897_P2 and Q8N434partial WT   	Sequence name: Q8N434                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for AA455897_P2, comprising a first     	Sequence documentation:                                      
						MAAGRLIIKTEFLPTKYRGYMLPLSQVFWLAGSLLIIGLASVIIPTIGWRWLIRVASIPG 	                                                            
						IILIVAFKFIPESARFNVSTGNTRAALATLERVAKMNRSVMPEGKLVEPVLEKRGRFADL 	Alignment of: 16561 x Q8N434   ..                            
						LDAKYLRTTLQIWVIWLGISFAYYGVILASAELLERDLVCGSKSDSAVVVTGGDSGESQS 	                                                            
						PCYCHMFAPSDYRTMIISTIGEIALNPLNILGINFLGRRLSLSITMGCTALF         	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 232 of Q8N434, which also   	                     Quality: 3216.00                      Escore:       0                                               
						corresponds to amino acids 1 - 232 of AA455897_P2, a bridging	             Matching length:     340                Total length:     340                                               
						amino acid C corresponding to amino acid 233 of AA455897_P2, 	 Matching Percent Similarity:   99.71   Matching Percent Identity:   99.71                                               
						and a second amino acid sequence being at least 90 %         	    Total Percent Similarity:   99.71      Total Percent Identity:   99.71                                               
						LLLNICTSSAGLIGFLFMLRALVAANFNTVYIYTAEVYPTTMRALGMGTSGSLCRIGAMV 	                        Gaps:       0                        
						APFISQVLMSASILGALCLFSSVCVVCAISAFTLPIETKGRALQQIK              	                                                            
						homologous to corresponding to amino acids 234 - 340 of      	Alignment:                                                   
						Q8N434, which also corresponds to amino acids 234 - 340 of   	                  .         .         .         .         .  
						AA455897_P2, wherein said first amino acid sequence, bridging	       1 MAAGRLIIKTEFLPTKYRGYMLPLSQVFWLAGSLLIIGLASVIIPTIGWR 50                                                           
						amino acid and second amino acid sequence are contiguous and 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						in a sequential order.                                       	       1 MAAGRLIIKTEFLPTKYRGYMLPLSQVFWLAGSLLIIGLASVIIPTIGWR 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 WLIRVASIPGIILIVAFKFIPESARFNVSTGNTRAALATLERVAKMNRSV 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 WLIRVASIPGIILIVAFKFIPESARFNVSTGNTRAALATLERVAKMNRSV 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 MPEGKLVEPVLEKRGRFADLLDAKYLRTTLQIWVIWLGISFAYYGVILAS 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 MPEGKLVEPVLEKRGRFADLLDAKYLRTTLQIWVIWLGISFAYYGVILAS 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 AELLERDLVCGSKSDSAVVVTGGDSGESQSPCYCHMFAPSDYRTMIISTI 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 AELLERDLVCGSKSDSAVVVTGGDSGESQSPCYCHMFAPSDYRTMIISTI 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GEIALNPLNILGINFLGRRLSLSITMGCTALFCLLLNICTSSAGLIGFLF 250                                                          
						                                                            	         |||||||||||||||||||||||||||||||| |||||||||||||||||  
						                                                            	     201 GEIALNPLNILGINFLGRRLSLSITMGCTALFFLLLNICTSSAGLIGFLF 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MLRALVAANFNTVYIYTAEVYPTTMRALGMGTSGSLCRIGAMVAPFISQV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MLRALVAANFNTVYIYTAEVYPTTMRALGMGTSGSLCRIGAMVAPFISQV 300                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 LMSASILGALCLFSSVCVVCAISAFTLPIETKGRALQQIK           340                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     301 LMSASILGALCLFSSVCVVCAISAFTLPIETKGRALQQIK           340                                                          

17745	HMR136_AA458488_7_tr0_r1_1_gPRT		Comparison report between AA458488_P7 and Q8N4T4unique head  	Sequence name: Q8N4T4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA458488_P7, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 17745 x Q8N4T4   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						MSGMTLSSTDMYTVSLLLCLFFKKSDPDPGPFQNNLFHNHGTQSQSCMGSKVGDVIPG   	                                                            
						corresponding to amino acids 1 - 58 of AA458488_P7, and a    	                     Quality: 1527.00                      Escore:       0                                               
						AARLISETAQRVHTIGQKQKNDQHLRRVQALLSGRQAKGLTSGRWFLRQGWLLVVPPHGE 	             Matching length:     153                Total length:     153                                               
						PRPRMFFLFTDVLLMAKPRPPLHLLRSGTFACKALYPMAQCHLSRVFGHSGGPCGGLLSL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SFPHEKLLLMSTDQEELSRWYHSLTWAISSQKN                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 90 % homologous to 	                        Gaps:       0                        
						corresponding to amino acids 183 - 335 of Q8N4T4, which also 	                                                            
						corresponds to amino acids 59 - 211 of AA458488_P7, wherein  	Alignment:                                                   
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	      59 AARLISETAQRVHTIGQKQKNDQHLRRVQALLSGRQAKGLTSGRWFLRQG 108                                                          
						polypeptide encoding for a head of AA458488_P7, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     183 AARLISETAQRVHTIGQKQKNDQHLRRVQALLSGRQAKGLTSGRWFLRQG 232                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     109 WLLVVPPHGEPRPRMFFLFTDVLLMAKPRPPLHLLRSGTFACKALYPMAQ 158                                                          
						to the sequence                                              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MSGMTLSSTDMYTVSLLLCLFFKKSDPDPGPFQNNLFHNHGTQSQSCMGSKVGDVIPG of	     233 WLLVVPPHGEPRPRMFFLFTDVLLMAKPRPPLHLLRSGTFACKALYPMAQ 282                                                          
						AA458488_P7.                                                 	                  .         .         .         .         .  
						                                                            	     159 CHLSRVFGHSGGPCGGLLSLSFPHEKLLLMSTDQEELSRWYHSLTWAISS 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     283 CHLSRVFGHSGGPCGGLLSLSFPHEKLLLMSTDQEELSRWYHSLTWAISS 332                                                          
						                                                            	                                                             
						                                                            	     209 QKN                                                211                                                          
						                                                            	         |||                                                 
						                                                            	     333 QKN                                                335                                                          

19314	HMR136_AA459886_4_tr0_r1_1_gPRT		Comparison report between AA459886_P4 and PUR4_HUMANpartial  	Sequence name: PUR4_HUMAN                                    
						WT sequence followed by mismatch.1.An isolated chimeric      	                                                            
						polypeptide encoding for AA459886_P4, comprising a first     	Sequence documentation:                                      
						MWAAKLPGEGAALADACEAMVAVMAALGVAVDGGKDSLSMAARVGTETVRAPGSLVISAY 	                                                            
						AVCPDITATVTPDLKHPEGRGHLLYVALSPGQHRLGGTALAQCFSQLGEHPPDLDLPENL 	Alignment of: 19314 x PUR4_HUMAN   ..                        
						VRAFSITQGLLKDRLLCSGHDVSDGGLVTCLLEMAFAGNCGLQVDVPVPRVDVLSVLFAE 	                                                            
						EPGLVLEVQEPDLAQVLKRYRDAGLHCLELGHTGEAGPHAMVRVSVNGAVVLEEPVGELR 	Alignment segment 1/1:                                       
						ALWEETSFQLDRLQAEPRCVAEEERGLRERMGPSYCLPPTFPKASVPREPGGPSPRVAIL 	                                                            
						REEGSNGDREMADAFHLAGFEVWDVTMQDLCSGAIGLDTFRGVAFVGGFSYADVLGSAKG 	                     Quality: 5576.00                      Escore:       0                                               
						WAAAVTFHPRAGAELRRFRKRPDTFSLGVCNGCQLLALLGWVGGDPNEDAAEMGPDSQPA 	             Matching length:     570                Total length:     570                                               
						RPGLLLRHNLSGRYESRWASVRVGPGPALMLRGMEGAVLPVWSAHGEGYVAFSSPELQAQ 	 Matching Percent Similarity:   99.82   Matching Percent Identity:   99.82                                               
						IEARGLAPLHWADDDGNPTEQYPLNPNGSPGGVAGICSCDGRHLAVMPHPERAVRPWQWA 	    Total Percent Similarity:   99.82      Total Percent Identity:   99.82                                               
						WRPPPFDTLTTSPWLQL                                            	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 769 - 1325 of PUR4_HUMAN, which 	Alignment:                                                   
						also corresponds to amino acids 1 - 557 of AA459886_P4, a    	                  .         .         .         .         .  
						bridging amino acid F corresponding to amino acid 558 of     	       1 MWAAKLPGEGAALADACEAMVAVMAALGVAVDGGKDSLSMAARVGTETVR 50                                                           
						AA459886_P4, and a second amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to INARNWTLEGSC corresponding to amino acids 	     769 MWAAKLPGEGAALADACEAMVAVMAALGVAVDGGKDSLSMAARVGTETVR 818                                                          
						1327 - 1338 of PUR4_HUMAN, which also corresponds to amino   	                  .         .         .         .         .  
						acids 559 - 570 of AA459886_P4, wherein said first amino acid	      51 APGSLVISAYAVCPDITATVTPDLKHPEGRGHLLYVALSPGQHRLGGTAL 100                                                          
						sequence, bridging amino acid and second amino acid sequence 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						are contiguous and in a sequential order.                    	     819 APGSLVISAYAVCPDITATVTPDLKHPEGRGHLLYVALSPGQHRLGGTAL 868                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 AQCFSQLGEHPPDLDLPENLVRAFSITQGLLKDRLLCSGHDVSDGGLVTC 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     869 AQCFSQLGEHPPDLDLPENLVRAFSITQGLLKDRLLCSGHDVSDGGLVTC 918                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LLEMAFAGNCGLQVDVPVPRVDVLSVLFAEEPGLVLEVQEPDLAQVLKRY 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     919 LLEMAFAGNCGLQVDVPVPRVDVLSVLFAEEPGLVLEVQEPDLAQVLKRY 968                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 RDAGLHCLELGHTGEAGPHAMVRVSVNGAVVLEEPVGELRALWEETSFQL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     969 RDAGLHCLELGHTGEAGPHAMVRVSVNGAVVLEEPVGELRALWEETSFQL 1018                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     251 DRLQAEPRCVAEEERGLRERMGPSYCLPPTFPKASVPREPGGPSPRVAIL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1019 DRLQAEPRCVAEEERGLRERMGPSYCLPPTFPKASVPREPGGPSPRVAIL 1068                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     301 REEGSNGDREMADAFHLAGFEVWDVTMQDLCSGAIGLDTFRGVAFVGGFS 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1069 REEGSNGDREMADAFHLAGFEVWDVTMQDLCSGAIGLDTFRGVAFVGGFS 1118                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     351 YADVLGSAKGWAAAVTFHPRAGAELRRFRKRPDTFSLGVCNGCQLLALLG 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1119 YADVLGSAKGWAAAVTFHPRAGAELRRFRKRPDTFSLGVCNGCQLLALLG 1168                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     401 WVGGDPNEDAAEMGPDSQPARPGLLLRHNLSGRYESRWASVRVGPGPALM 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1169 WVGGDPNEDAAEMGPDSQPARPGLLLRHNLSGRYESRWASVRVGPGPALM 1218                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     451 LRGMEGAVLPVWSAHGEGYVAFSSPELQAQIEARGLAPLHWADDDGNPTE 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1219 LRGMEGAVLPVWSAHGEGYVAFSSPELQAQIEARGLAPLHWADDDGNPTE 1268                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     501 QYPLNPNGSPGGVAGICSCDGRHLAVMPHPERAVRPWQWAWRPPPFDTLT 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1269 QYPLNPNGSPGGVAGICSCDGRHLAVMPHPERAVRPWQWAWRPPPFDTLT 1318                                                         
						                                                            	                  .         .                                
						                                                            	     551 TSPWLQLFINARNWTLEGSC                               570                                                          
						                                                            	         ||||||| ||||||||||||                                
						                                                            	    1319 TSPWLQLSINARNWTLEGSC                               1338                                                         

20180	HMR136_AA460330_3_tr0_r1_1_gPRT		Comparison report between AA460330_P3 and Q9HB10partial WT   	Sequence name: Q9HB10                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA460330_P3, comprising a first     	Sequence documentation:                                      
						MAFSGRARPCIIPENEEIPRAALNTVHEANGTEDERAVSKLQRRHSDVKVYKEFCDFYAK 	                                                            
						FNMANALASATCERCKGGFAPAETIVNSNGELYHEQCFVCAQCFQQFPEGLFYE       	Alignment of: 20180 x Q9HB10   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 114 of Q9HB10, which also   	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 114 of AA460330_P3, and a     	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality: 1147.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:     114                Total length:     114                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FEGRKYCEHDFQMLFAPCCHQCGEFIIGRVIKAMNNSWHPECFRCDLCQEVLADIGFVKN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AGRKDLTADAQELKGELYCLPCHDKMGVPICGACRRPIEGRVVNAMGKQWHVEHFVCAKC 	                        Gaps:       0                        
						EKPFLGHRHYERKGLAYCETHYNQLFGDVCFHCNRVIEGDVVSALNKAWCVNCFACSTCN 	                                                            
						TKLTLKDKFVEIDLKPVCKHCYEKMPEEFKRRLAKREREAKDKDKQKKKKP          	Alignment:                                                   
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						115 - 345 of AA460330_P3, wherein said first amino acid      	       1 MAFSGRARPCIIPENEEIPRAALNTVHEANGTEDERAVSKLQRRHSDVKV 50                                                           
						sequence and second amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	       1 MAFSGRARPCIIPENEEIPRAALNTVHEANGTEDERAVSKLQRRHSDVKV 50                                                           
						tail of AA460330_P3, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	      51 YKEFCDFYAKFNMANALASATCERCKGGFAPAETIVNSNGELYHEQCFVC 100                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FEGRKYCEHDFQMLFAPCCHQCGEFIIGRVIKAMNNSWHPECFRCDLCQEVLADIGFVKN 	      51 YKEFCDFYAKFNMANALASATCERCKGGFAPAETIVNSNGELYHEQCFVC 100                                                          
						AGRKDLTADAQELKGELYCLPCHDKMGVPICGACRRPIEGRVVNAMGKQWHVEHFVCAKC 	                  .                                          
						EKPFLGHRHYERKGLAYCETHYNQLFGDVCFHCNRVIEGDVVSALNKAWCVNCFACSTCN 	     101 AQCFQQFPEGLFYE                                     114                                                          
						TKLTLKDKFVEIDLKPVCKHCYEKMPEEFKRRLAKREREAKDKDKQKKKKP          	         ||||||||||||||                                      
						at least about 95% homologous to the sequence in AA460330_P3.	     101 AQCFQQFPEGLFYE                                     114                                                          

20971	HMR136_AA461009_2_tr0_r1_1_gPRT		Comparison report between AA461009_P2 and O14492unique head  	Sequence name: O14492                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA461009_P2, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 20971 x O14492   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MDPSYCPAHGFPSQDALWPLSSQQWSSAHYSEPAAGGCYGTEA corresponding to 	                                                            
						amino acids 1 - 43 of AA461009_P2, a second amino acid       	                     Quality: 5063.00                      Escore:       0                                               
						MNGAGPGPAAAAPVPVPVPVPDWRQFCELHAQAAAVDFAHKFCRFLRDNPAYDTPDAGAS 	             Matching length:     531                Total length:     531                                               
						FSRHFAANFLDVFGEEVRRVLVAGPTTRGAAVSAEAMEPELADTSALKAASYGHSRSSED 	 Matching Percent Similarity:   98.31   Matching Percent Identity:   98.31                                               
						VSTHAATKARVRKGFSLRNMSLCVVDGVRDMWHRRASPEPDAAAAPRTAEPRDKWTRRLR 	    Total Percent Similarity:   98.31      Total Percent Identity:   98.31                                               
						LSRTLAAKVELVDIQREGALRFMVADDAAAGSGGSAQWQKCRLLLRRAVAEERFRLEFFV 	                        Gaps:       0                        
						PPKASRPKVSIPLSAIIEVRTTMPLEMPEKDNTFVLKVENGAEYILETIDSLQKHSWVAD 	                                                            
						IQGCVDPGDSEEDTELSCTRGGCLASRVASCSCELLTDAVDLPRPPETTAVGAVVTAPHS 	Alignment:                                                   
						RGRDAVRESLIHVPLETFLQTLESPGGSGSDSNNTGEQGAETDPEAEPELELSDYPWFHG 	                  .         .         .         .         .  
						TLSRVKAAQLVLAGGPRNHGLFVIRQSETRPGEYVLTFNFQGKAKHLRLSLNGHGQCHVQ 	      44 MNGAGPGPAAAAPVPVPVPVPDWRQFCELHAQAAAVDFAHKFCRFLRDNP 93                                                           
						HLWFQSVLDMLRHFHTHPIPLESGGSADITLRSY                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 MNGAGPGPAAAAPVPVPVPVPDWRQFCELHAQAAAVDFAHKFCRFLRDNP 50                                                           
						amino acids 1 - 514 of O14492, which also corresponds to     	                  .         .         .         .         .  
						amino acids 44 - 557 of AA461009_P2, and a third amino acid  	      94 AYDTPDAGASFSRHFAANFLDVFGEEVRRVLVAGPTTRGAAVSAEAMEPE 143                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	      51 AYDTPDAGASFSRHFAANFLDVFGEEVRRVLVAGPTTRGAAVSAEAMEPE 100                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						SRAPRPLPRPRPRPAGATRPASTTSPASPRPPARLPRPPTPPAPPRLPPRRPLPRRGPPP 	     144 LADTSALKAASYGHSRSSEDVSTHAATKARVRKGFSLRNMSLCVVDGVRD 193                                                          
						RAPSRASSARGAAATAPSACWRPWPPPPPRSPRRPRPAARAPWRTSTPSTSPRRRPGGTR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QALQ                                                         	     101 LADTSALKAASYGHSRSSEDVSTHAATKARVRKGFSLRNMSLCVVDGVRD 150                                                          
						having the sequence corresponding to amino acids 558 - 681 of	                  .         .         .         .         .  
						AA461009_P2, wherein said first amino acid sequence, second  	     194 MWHRRASPEPDAAAAPRTAEPRDKWTRRLRLSRTLAAKVELVDIQREGAL 243                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     151 MWHRRASPEPDAAAAPRTAEPRDKWTRRLRLSRTLAAKVELVDIQREGAL 200                                                          
						polypeptide encoding for a head of AA461009_P2, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     244 RFMVADDAAAGSGGSAQWQKCRLLLRRAVAEERFRLEFFVPPKASRPKVS 293                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     201 RFMVADDAAAGSGGSAQWQKCRLLLRRAVAEERFRLEFFVPPKASRPKVS 250                                                          
						to the sequence MDPSYCPAHGFPSQDALWPLSSQQWSSAHYSEPAAGGCYGTEA  	                  .         .         .         .         .  
						of AA461009_P2.3.An isolated polypeptide encoding for a tail 	     294 IPLSAIIEVRTTMPLEMPEKDNTFVLKVENGAEYILETIDSLQKHSWVAD 343                                                          
						of AA461009_P2, comprising a polypeptide being at least 70%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     251 IPLSAIIEVRTTMPLEMPEKDNTFVLKVENGAEYILETIDSLQKHSWVAD 300                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						SRAPRPLPRPRPRPAGATRPASTTSPASPRPPARLPRPPTPPAPPRLPPRRPLPRRGPPP 	     344 IQGCVDPGDSEEDTELSCTRGGCLASRVASCSCELLTDAVDLPRPPETTA 393                                                          
						RAPSRASSARGAAATAPSACWRPWPPPPPRSPRRPRPAARAPWRTSTPSTSPRRRPGGTR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QALQ                                                         	     301 IQGCVDPGDSEEDTELSCTRGGCLASRVASCSCELLTDAVDLPRPPETTA 350                                                          
						least about 95% homologous to the sequence in AA461009_P2.   	                  .         .         .         .         .  
						                                                            	     394 VGAVVTAPHSRGRDAVRESLIHVPLETFLQTLESPGGSGSDSNNTGEQGA 443                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 VGAVVTAPHSRGRDAVRESLIHVPLETFLQTLESPGGSGSDSNNTGEQGA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     444 ETDPEAEPELELSDYPWFHGTLSRVKAAQLVLAGGPRNHGLFVIRQSETR 493                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 ETDPEAEPELELSDYPWFHGTLSRVKAAQLVLAGGPRNHGLFVIRQSETR 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     494 PGEYVLTFNFQGKAKHLRLSLNGHGQCHVQHLWFQSVLDMLRHFHTHPIP 543                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 PGEYVLTFNFQGKAKHLRLSLNGHGQCHVQHLWFQSVLDMLRHFHTHPIP 500                                                          
						                                                            	                  .         .         .                      
						                                                            	     544 LESGGSADITLRSYSRAPRPLPRPRPRPAGA                    574                                                          
						                                                            	         |||||||||||||| ||  | | | | |  |                     
						                                                            	     501 LESGGSADITLRSYVRAQDPPPEPGPTPPAA                    531                                                          

23806	HMR136_AA465572_4_tr0_r1_1_gPRT		Comparison report between AA465572_P4 and Q8WUX2partial WT   	Sequence name: Q8WUX2                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for AA465572_P4, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MWVFGYGSLIWKVDFPYQDKLVGYITNYSRRFWQGSTDHRGVPGK corresponding  	Alignment of: 23806 x Q8WUX2   ..                            
						to amino acids 1 - 45 of Q8WUX2, which also corresponds to   	                                                            
						amino acids 1 - 45 of AA465572_P4, and a second amino acid   	Alignment segment 1/1:                                       
						GCVWGVAYRLPVGKEEEVKAYLDFREKGGYRTTTVIFYPKDPTTKPFSVLLYIGTCDNPD 	                                                            
						YLGPAPLEDIAEQIFNAAGPSGRNTEYLFELANSIRNLVPEEADEHLFALEKLVKERLEG 	                     Quality: 1612.00                      Escore:       0                                               
						KQNLNCI                                                      	             Matching length:     172                Total length:     184                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 58 - 184 of Q8WUX2, which also corresponds to    	    Total Percent Similarity:   93.48      Total Percent Identity:   93.48                                               
						amino acids 46 - 172 of AA465572_P4, wherein said first amino	                        Gaps:       1                        
						acid sequence and second amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated chimeric polypeptide 	Alignment:                                                   
						encoding for an edge portion of AA465572_P4, comprising a    	                  .         .         .         .         .  
						polypeptide having a length "n", wherein n is at least about 	       1 MWVFGYGSLIWKVDFPYQDKLVGYITNYSRRFWQGSTDHRGVPGK..... 45                                                           
						10 amino acids in length, optionally at least about 20 amino 	         |||||||||||||||||||||||||||||||||||||||||||||       
						acids in length, preferably at least about 30 amino acids in 	       1 MWVFGYGSLIWKVDFPYQDKLVGYITNYSRRFWQGSTDHRGVPGKPGRVV 50                                                           
						length, more preferably at least about 40 amino acids in     	                  .         .         .         .         .  
						length and most preferably at least about 50 amino acids in  	      46 .......GCVWGVAYRLPVGKEEEVKAYLDFREKGGYRTTTVIFYPKDPT 88                                                           
						length, wherein at least two amino acids comprise KG, having 	                |||||||||||||||||||||||||||||||||||||||||||  
						a structure as follows: a sequence starting from any of amino	      51 TLVEDPAGCVWGVAYRLPVGKEEEVKAYLDFREKGGYRTTTVIFYPKDPT 100                                                          
						acid numbers 45-x to 46; and ending at any of amino acid     	                  .         .         .         .         .  
						numbers 46+ ((n-2) - x), in which x varies from 0 to n-2.    	      89 TKPFSVLLYIGTCDNPDYLGPAPLEDIAEQIFNAAGPSGRNTEYLFELAN 138                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 TKPFSVLLYIGTCDNPDYLGPAPLEDIAEQIFNAAGPSGRNTEYLFELAN 150                                                          
						                                                            	                  .         .         .                      
						                                                            	     139 SIRNLVPEEADEHLFALEKLVKERLEGKQNLNCI                 172                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||                  
						                                                            	     151 SIRNLVPEEADEHLFALEKLVKERLEGKQNLNCI                 184                                                          

						Comparison report between AA465572_P4 and Q8WVI8partial WT   	Sequence name: Q8WVI8                                        
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for AA465572_P4, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 90 % homologous to  	                                                            
						MWVFGYGSLIWKVDFPYQDKLVGYITNYSRRFWQGSTDHRGVPGK corresponding  	Alignment of: 23806 x Q8WVI8   ..                            
						to amino acids 1 - 45 of Q8WVI8, which also corresponds to   	                                                            
						amino acids 1 - 45 of AA465572_P4, a second amino acid       	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to                   	                                                            
						GCVWGVAYRLPVGKEEEVKAYLDF corresponding to amino acids 58 - 81	                     Quality: 1596.00                      Escore:       0                                               
						of Q8WVI8, which also corresponds to amino acids 46 - 69 of  	             Matching length:     172                Total length:     184                                               
						AA465572_P4, a bridging amino acid R corresponding to amino  	 Matching Percent Similarity:   99.42   Matching Percent Identity:   99.42                                               
						acid 70 of AA465572_P4, and a third amino acid sequence being	    Total Percent Similarity:   92.93      Total Percent Identity:   92.93                                               
						EKGGYRTTTVIFYPKDPTTKPFSVLLYIGTCDNPDYLGPAPLEDIAEQIFNAAGPSGRNT 	                        Gaps:       1                        
						EYLFELANSIRNLVPEEADEHLFALEKLVKERLEGKQNLNCI                   	                                                            
						at least 90 % homologous to corresponding to amino acids 83 -	Alignment:                                                   
						184 of Q8WVI8, which also corresponds to amino acids 71 - 172	                  .         .         .         .         .  
						of AA465572_P4, wherein said first amino acid sequence,      	       1 MWVFGYGSLIWKVDFPYQDKLVGYITNYSRRFWQGSTDHRGVPGK..... 45                                                           
						second amino acid sequence, bridging amino acid and third    	         |||||||||||||||||||||||||||||||||||||||||||||       
						amino acid sequence are contiguous and in a sequential       	       1 MWVFGYGSLIWKVDFPYQDKLVGYITNYSRRFWQGSTDHRGVPGKPGRVV 50                                                           
						order.2.An isolated chimeric polypeptide encoding for an edge	                  .         .         .         .         .  
						portion of AA465572_P4, comprising a polypeptide having a    	      46 .......GCVWGVAYRLPVGKEEEVKAYLDFREKGGYRTTTVIFYPKDPT 88                                                           
						length "n", wherein n is at least about 10 amino acids in    	                |||||||||||||||||||||||| ||||||||||||||||||  
						length, optionally at least about 20 amino acids in length,  	      51 TLVEDPAGCVWGVAYRLPVGKEEEVKAYLDFGEKGGYRTTTVIFYPKDPT 100                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	      89 TKPFSVLLYIGTCDNPDYLGPAPLEDIAEQIFNAAGPSGRNTEYLFELAN 138                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise KG, having a structure as  	     101 TKPFSVLLYIGTCDNPDYLGPAPLEDIAEQIFNAAGPSGRNTEYLFELAN 150                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .                      
						45-x to 46; and ending at any of amino acid numbers 46+      	     139 SIRNLVPEEADEHLFALEKLVKERLEGKQNLNCI                 172                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||                  
						                                                            	     151 SIRNLVPEEADEHLFALEKLVKERLEGKQNLNCI                 184                                                          

24302	HMR136_AA469162_3_tr0_r1_1_gPRT		Comparison report between AA469162_P3 and Q9P2H6unique head  	Sequence name: Q9P2H6                                        
						followed by partial WT sequence followed by a short unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA469162_P3, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 24302 x Q9P2H6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						DLIQDWSSDSPPDIFSFVPYTWNFKIMFHQFEMIWAANQHNWIDCSTKQQENVYLAACGE 	Alignment segment 1/1:                                       
						TLNIDFSLPFTDFVPATCNTKFSLRGEDVD                               	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 2844.00                      Escore:       0                                               
						to amino acids 1 - 90 of AA469162_P3, a second amino acid    	             Matching length:     284                Total length:     284                                               
						LHLFLPDCHPSKYSLFMLVKNCHPNKMIHDTGIPAECQSGQKTVKPKWRNVTQEKSGWVE 	 Matching Percent Similarity:   99.65   Matching Percent Identity:   99.65                                               
						CWTVPSVMLTIDYTWHPIYPQKADEQLKQSLSEMEETMLSVLRPSQKTSDRVVSSPSTSS 	    Total Percent Similarity:   99.65      Total Percent Identity:   99.65                                               
						RPPIDPSELPPDKLHVEMELSPDSQITLYGPLLNAFLCIKENYFGEDDMYMDFEEVISSP 	                        Gaps:       0                        
						VLSLSTSSSSGWTAVGMENDKKENEGSAKSIHPLALRPWDITVLVNLYKVHGRLPVHGTT 	                                                            
						DGPECPTAFLERLCFEMKKGFRETMLQLILSPLNVFVSDNYQ                   	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 282 of Q9P2H6, which also corresponds to     	      91 LHLFLPDCHPSKYSLFMLVKNCHPNKMIHDTGIPAECQSGQKTVKPKWRN 140                                                          
						amino acids 91 - 372 of AA469162_P3, and a third amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	       1 LHLFLPDCHPSKYSLFMLVKNCHPNKMIHDTGIPAECQSGQKTVKPKWRN 50                                                           
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     141 VTQEKSGWVECWTVPSVMLTIDYTWHPIYPQKADEQLKQSLSEMEETMLS 190                                                          
						having the sequence VR corresponding to amino acids 373 - 374	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of AA469162_P3, wherein said first amino acid sequence,      	      51 VTQEKSGWVECWTVPSVMLTIDYTWHPIYPQKADEQLKQSLSEMEETMLS 100                                                          
						second amino acid sequence and third amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     191 VLRPSQKTSDRVVSSPSTSSRPPIDPSELPPDKLHVEMELSPDSQITLYG 240                                                          
						polypeptide encoding for a head of AA469162_P3, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     101 VLRPSQKTSDRVVSSPSTSSRPPIDPSELPPDKLHVEMELSPDSQITLYG 150                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     241 PLLNAFLCIKENYFGEDDMYMDFEEVISSPVLSLSTSSSSGWTAVGMEND 290                                                          
						DLIQDWSSDSPPDIFSFVPYTWNFKIMFHQFEMIWAANQHNWIDCSTKQQENVYLAACGE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TLNIDFSLPFTDFVPATCNTKFSLRGEDVD                               	     151 PLLNAFLCIKENYFGEDDMYMDFEEVISSPVLSLSTSSSSGWTAVGMEND 200                                                          
						to the sequence of AA469162_P3.                              	                  .         .         .         .         .  
						                                                            	     291 KKENEGSAKSIHPLALRPWDITVLVNLYKVHGRLPVHGTTDGPECPTAFL 340                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 KKENEGSAKSIHPLALRPWDITVLVNLYKVHGRLPVHGTTDGPECPTAFL 250                                                          
						                                                            	                  .         .         .                      
						                                                            	     341 ERLCFEMKKGFRETMLQLILSPLNVFVSDNYQVR                 374                                                          
						                                                            	         |||||||||||||||||||||||||||||||| |                  
						                                                            	     251 ERLCFEMKKGFRETMLQLILSPLNVFVSDNYQQR                 284                                                          

26095	HMR136_AA476827_4_tr0_r1_1_gPRT		Comparison report between AA476827_P4 and Q9H6E4unique head  	Sequence name: Q9H6E4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA476827_P4, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 26095 x Q9H6E4   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MSCSRGSLSHSALAGFPQ corresponding to amino	Alignment segment 1/1:                                       
						acids 1 - 18 of AA476827_P4, and a second amino acid sequence	                                                            
						VLEDSRTVLTAADVLPDGPFPQDEKLKDAFSHVVENTAFFGDVVLRFPRIVHYYFDHNSN 	                     Quality: 1536.00                      Escore:       0                                               
						WNLLIRWGISFCNQTGVFNQGPHSPILSLMAQELGISEKDSNFQNPFKIDRTEFIPSTDP 	             Matching length:     160                Total length:     160                                               
						FQKALREEEKRRKKEEKRKEIRKGPRISRSQSEL                           	 Matching Percent Similarity:   98.75   Matching Percent Identity:   97.50                                               
						being at least 90 % homologous to corresponding to amino     	    Total Percent Similarity:   98.75      Total Percent Identity:   97.50                                               
						acids 76 - 229 of Q9H6E4, which also corresponds to amino    	                        Gaps:       0                        
						acids 19 - 172 of AA476827_P4, wherein said first amino acid 	                                                            
						sequence and second amino acid sequence are contiguous and in	Alignment:                                                   
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of AA476827_P4, comprising a polypeptide being at least 	      13 LAGFPQVLEDSRTVLTAADVLPDGPFPQDEKLKDAFSHVVENTAFFGDVV 62                                                           
						70%, optionally at least about 80%, preferably at least about	         | |: :||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	      70 LKGLFKVLEDSRTVLTAADVLPDGPFPQDEKLKDAFSHVVENTAFFGDVV 119                                                          
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						MSCSRGSLSHSALAGFPQ of AA476827_P4.                           	      63 LRFPRIVHYYFDHNSNWNLLIRWGISFCNQTGVFNQGPHSPILSLMAQEL 112                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     120 LRFPRIVHYYFDHNSNWNLLIRWGISFCNQTGVFNQGPHSPILSLMAQEL 169                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     113 GISEKDSNFQNPFKIDRTEFIPSTDPFQKALREEEKRRKKEEKRKEIRKG 162                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     170 GISEKDSNFQNPFKIDRTEFIPSTDPFQKALREEEKRRKKEEKRKEIRKG 219                                                          
						                                                            	                  .                                          
						                                                            	     163 PRISRSQSEL                                         172                                                          
						                                                            	         ||||||||||                                          
						                                                            	     220 PRISRSQSEL                                         229                                                          

26093	HMR136_AA476827_5_tr0_r1_1_gPRT		Comparison report between AA476827_P5 and Q9H6E4partial WT   	Sequence name: Q9H6E4                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA476827_P5, comprising a first amino acid      	                                                            
						MAQELGISEKDSNFQNPFKIDRTEFIPSTDPFQKALREEEKRRKKEEKRKEIRKGPRISR 	Alignment of: 26093 x Q9H6E4   ..                            
						SQSEL                                                        	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 165 - 229 of Q9H6E4, which also corresponds to   	                                                            
						amino acids 1 - 65 of AA476827_P5.                           	                     Quality:  640.00                      Escore:       0                                               
						                                                            	             Matching length:      65                Total length:      65                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAQELGISEKDSNFQNPFKIDRTEFIPSTDPFQKALREEEKRRKKEEKRK 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     165 MAQELGISEKDSNFQNPFKIDRTEFIPSTDPFQKALREEEKRRKKEEKRK 214                                                          
						                                                            	                  .                                          
						                                                            	      51 EIRKGPRISRSQSEL                                    65                                                           
						                                                            	         |||||||||||||||                                     
						                                                            	     215 EIRKGPRISRSQSEL                                    229                                                          

26741	HMR136_AA478318_10_tr0_r1_1_gPRT		Comparison report between AA478318_P10 and SL11_HUMANpartial 	Sequence name: SL11_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for AA478318_P10, comprising a first    	                                                            
						MAQIQSLSLRAVSGAMGLGFLLSMLFFIEQNLVAALVNAPENRLVKGTAYHWDLLLLAII 	Alignment of: 26741 x SL11_HUMAN   ..                        
						NTGLSLFGLPWIHAAYPHSPLHVRALALVEERVENGHIYDTIVNVKETRLTSLGASVLVG 	                                                            
						LSLLLLPVPLQWIPKPVLYGLFLYIALTSLDGNQLVQRVALLLKEQTAYPPTHYIRRVPQ 	Alignment segment 1/1:                                       
						RKIHYFTGLQVLQLLLLCAFGMSSLPYMKMIFPLIMIAMIPIRYILLPRIIEAKYLDVMD 	                                                            
						AEHRP                                                        	                     Quality: 2352.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     245                Total length:     245                                               
						corresponding to amino acids 647 - 891 of SL11_HUMAN, which  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						also corresponds to amino acids 1 - 245 of AA478318_P10.     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAQIQSLSLRAVSGAMGLGFLLSMLFFIEQNLVAALVNAPENRLVKGTAY 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     647 MAQIQSLSLRAVSGAMGLGFLLSMLFFIEQNLVAALVNAPENRLVKGTAY 696                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 HWDLLLLAIINTGLSLFGLPWIHAAYPHSPLHVRALALVEERVENGHIYD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     697 HWDLLLLAIINTGLSLFGLPWIHAAYPHSPLHVRALALVEERVENGHIYD 746                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 TIVNVKETRLTSLGASVLVGLSLLLLPVPLQWIPKPVLYGLFLYIALTSL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     747 TIVNVKETRLTSLGASVLVGLSLLLLPVPLQWIPKPVLYGLFLYIALTSL 796                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DGNQLVQRVALLLKEQTAYPPTHYIRRVPQRKIHYFTGLQVLQLLLLCAF 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     797 DGNQLVQRVALLLKEQTAYPPTHYIRRVPQRKIHYFTGLQVLQLLLLCAF 846                                                          
						                                                            	                  .         .         .         .            
						                                                            	     201 GMSSLPYMKMIFPLIMIAMIPIRYILLPRIIEAKYLDVMDAEHRP      245                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     847 GMSSLPYMKMIFPLIMIAMIPIRYILLPRIIEAKYLDVMDAEHRP      891                                                          

26739	HMR136_AA478318_3_tr0_r1_1_gPRT		Comparison report between AA478318_P3 and SL11_HUMANunique   	Sequence name: SL11_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA478318_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 26739 x SL11_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence ARVVLSLGSPQ corresponding to amino acids 	Alignment segment 1/1:                                       
						1 - 11 of AA478318_P3, and a second amino acid sequence being	                                                            
						YLKLKNFKEEIRAHRDLDGFLAQASIVLNETATSLDNVLRTMLRRFARDPDNNEPNCNLD 	                     Quality: 7532.00                      Escore:       0                                               
						LLMAMLFTDAGAPMRGKVHLLSDTIQGVTATVTGVRYQQSWLCIICTMKALQKRHVCISR 	             Matching length:     781                Total length:     781                                               
						LVRPQNWGENSCEVRFVILVLAPPKMKSTKTAMEVARTFATMFSDIAFRQKLLETRTEEE 	 Matching Percent Similarity:   99.87   Matching Percent Identity:   99.74                                               
						FKEALVHQRQLLTMVSHGPVAPRTKERSTVSLPAHRHPEPPKCKDFVPFGKGIREDIARR 	    Total Percent Similarity:   99.87      Total Percent Identity:   99.74                                               
						FPLYPLDFTDGIIGKNKAVGKYITTTLFLYFACLLPTIAFGSLNDENTDGAIDVQKTIAG 	                        Gaps:       0                        
						QSIGGLLYALFSGQPLVILLTTAPLALYIQVIRVICDDYDLDFNSFYAWTGLWNSFFLAL 	                                                            
						YAFFNLSLVMSLFKRSTEEIIALFISITFVLDAVKGTVKIFWKYYYGHYLDDYHTKRTSS 	Alignment:                                                   
						LVSLSGLGASLNASLHTALNASFLASPTELPSATHSGQATAVLSLLIMLGTLWLGYTLYQ 	                  .         .         .         .         .  
						FKKSPYLHPCVREILSDCALPIAVLAFSLISSHGFREIEMSKFRYNPSESPFAMAQIQSL 	       9 SPQYLKLKNFKEEIRAHRDLDGFLAQASIVLNETATSLDNVLRTMLRRFA 58                                                           
						SLRAVSGAMGLGFLLSMLFFIEQNLVAALVNAPENRLVKGTAYHWDLLLLAIINTGLSLF 	         | :|||||||||||||||||||||||||||||||||||||||||||||||  
						GLPWIHAAYPHSPLHVRALALVEERVENGHIYDTIVNVKETRLTSLGASVLVGLSLLLLP 	     111 SRKYLKLKNFKEEIRAHRDLDGFLAQASIVLNETATSLDNVLRTMLRRFA 160                                                          
						VPLQWIPKPVLYGLFLYIALTSLDGNQLVQRVALLLKEQTAYPPTHYIRRVPQRKIHYFT 	                  .         .         .         .         .  
						GLQVLQLLLLCAFGMSSLPYMKMIFPLIMIAMIPIRYILLPRIIEAKYLDVMDAEHRP   	      59 RDPDNNEPNCNLDLLMAMLFTDAGAPMRGKVHLLSDTIQGVTATVTGVRY 108                                                          
						at least 90 % homologous to corresponding to amino acids 114 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 891 of SL11_HUMAN, which also corresponds to amino acids 12	     161 RDPDNNEPNCNLDLLMAMLFTDAGAPMRGKVHLLSDTIQGVTATVTGVRY 210                                                          
						- 789 of AA478318_P3, wherein said first amino acid sequence 	                  .         .         .         .         .  
						and second amino acid sequence are contiguous and in a       	     109 QQSWLCIICTMKALQKRHVCISRLVRPQNWGENSCEVRFVILVLAPPKMK 158                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of AA478318_P3, comprising a polypeptide being at least 	     211 QQSWLCIICTMKALQKRHVCISRLVRPQNWGENSCEVRFVILVLAPPKMK 260                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     159 STKTAMEVARTFATMFSDIAFRQKLLETRTEEEFKEALVHQRQLLTMVSH 208                                                          
						at least about 95% homologous to the sequence ARVVLSLGSPQ of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA478318_P3.                                                 	     261 STKTAMEVARTFATMFSDIAFRQKLLETRTEEEFKEALVHQRQLLTMVSH 310                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     209 GPVAPRTKERSTVSLPAHRHPEPPKCKDFVPFGKGIREDIARRFPLYPLD 258                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     311 GPVAPRTKERSTVSLPAHRHPEPPKCKDFVPFGKGIREDIARRFPLYPLD 360                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     259 FTDGIIGKNKAVGKYITTTLFLYFACLLPTIAFGSLNDENTDGAIDVQKT 308                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     361 FTDGIIGKNKAVGKYITTTLFLYFACLLPTIAFGSLNDENTDGAIDVQKT 410                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     309 IAGQSIGGLLYALFSGQPLVILLTTAPLALYIQVIRVICDDYDLDFNSFY 358                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     411 IAGQSIGGLLYALFSGQPLVILLTTAPLALYIQVIRVICDDYDLDFNSFY 460                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     359 AWTGLWNSFFLALYAFFNLSLVMSLFKRSTEEIIALFISITFVLDAVKGT 408                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     461 AWTGLWNSFFLALYAFFNLSLVMSLFKRSTEEIIALFISITFVLDAVKGT 510                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     409 VKIFWKYYYGHYLDDYHTKRTSSLVSLSGLGASLNASLHTALNASFLASP 458                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     511 VKIFWKYYYGHYLDDYHTKRTSSLVSLSGLGASLNASLHTALNASFLASP 560                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     459 TELPSATHSGQATAVLSLLIMLGTLWLGYTLYQFKKSPYLHPCVREILSD 508                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     561 TELPSATHSGQATAVLSLLIMLGTLWLGYTLYQFKKSPYLHPCVREILSD 610                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     509 CALPIAVLAFSLISSHGFREIEMSKFRYNPSESPFAMAQIQSLSLRAVSG 558                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     611 CALPIAVLAFSLISSHGFREIEMSKFRYNPSESPFAMAQIQSLSLRAVSG 660                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     559 AMGLGFLLSMLFFIEQNLVAALVNAPENRLVKGTAYHWDLLLLAIINTGL 608                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     661 AMGLGFLLSMLFFIEQNLVAALVNAPENRLVKGTAYHWDLLLLAIINTGL 710                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     609 SLFGLPWIHAAYPHSPLHVRALALVEERVENGHIYDTIVNVKETRLTSLG 658                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     711 SLFGLPWIHAAYPHSPLHVRALALVEERVENGHIYDTIVNVKETRLTSLG 760                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     659 ASVLVGLSLLLLPVPLQWIPKPVLYGLFLYIALTSLDGNQLVQRVALLLK 708                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     761 ASVLVGLSLLLLPVPLQWIPKPVLYGLFLYIALTSLDGNQLVQRVALLLK 810                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     709 EQTAYPPTHYIRRVPQRKIHYFTGLQVLQLLLLCAFGMSSLPYMKMIFPL 758                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     811 EQTAYPPTHYIRRVPQRKIHYFTGLQVLQLLLLCAFGMSSLPYMKMIFPL 860                                                          
						                                                            	                  .         .         .                      
						                                                            	     759 IMIAMIPIRYILLPRIIEAKYLDVMDAEHRP                    789                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     861 IMIAMIPIRYILLPRIIEAKYLDVMDAEHRP                    891                                                          

26743	HMR136_AA478318_5_tr0_r1_1_gPRT		Comparison report between AA478318_P5 and SL11_HUMANunique   	Sequence name: SL11_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA478318_P5, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 26743 x SL11_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MGVYGPQDRSESEKRDVQRDPPPWHPRREGERPARARSLPLAAAGQGFLRKTWISEH    	                                                            
						corresponding to amino acids 1 - 57 of AA478318_P5, a second 	                     Quality: 4014.00                      Escore:       0                                               
						ENSPTMSQNGYFEDSSYYKCDTDDTFEAREEILGDEAFDTANSSIVSGESIRFFVNVNLE 	             Matching length:     413                Total length:     413                                               
						MQATNTENEATSGGCVLLHTSRKYLKLKNFKEEIRAHRDLDGFLAQASIVLNETATSLDN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VLRTMLRRFARDPDNNEPNCNLDLLMAMLFTDAGAPMRGKVHLLSDTIQGVTATVTGVRY 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						QQSWLCIICTMKALQKRHVCISRLVRPQNWGENSCEVRFVILVLAPPKMKSTKTAMEVAR 	                        Gaps:       0                        
						TFATMFSDIAFRQKLLETRTEEEFKEALVHQRQLLTMVSHGPVAPRTKERSTVSLPAHRH 	                                                            
						PEPPKCKDFVPFGKGIREDIARRFPLYPLDFTDGIIGKNKAVGKYITTTLFLYFACLLPT 	Alignment:                                                   
						IAFGSLNDENTDGAIDVQKTIAGQSIGGLLYALFSGQPLVILLTTAPLALYIQ        	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      58 ENSPTMSQNGYFEDSSYYKCDTDDTFEAREEILGDEAFDTANSSIVSGES 107                                                          
						corresponding to amino acids 31 - 443 of SL11_HUMAN, which   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 58 - 470 of AA478318_P5, and 	      31 ENSPTMSQNGYFEDSSYYKCDTDDTFEAREEILGDEAFDTANSSIVSGES 80                                                           
						a third amino acid sequence being at least 70%, optionally at	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     108 IRFFVNVNLEMQATNTENEATSGGCVLLHTSRKYLKLKNFKEEIRAHRDL 157                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence GAVGAEAGDGA corresponding to 	      81 IRFFVNVNLEMQATNTENEATSGGCVLLHTSRKYLKLKNFKEEIRAHRDL 130                                                          
						amino acids 471 - 481 of AA478318_P5, wherein said first     	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence and third    	     158 DGFLAQASIVLNETATSLDNVLRTMLRRFARDPDNNEPNCNLDLLMAMLF 207                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     131 DGFLAQASIVLNETATSLDNVLRTMLRRFARDPDNNEPNCNLDLLMAMLF 180                                                          
						AA478318_P5, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     208 TDAGAPMRGKVHLLSDTIQGVTATVTGVRYQQSWLCIICTMKALQKRHVC 257                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence                   	     181 TDAGAPMRGKVHLLSDTIQGVTATVTGVRYQQSWLCIICTMKALQKRHVC 230                                                          
						MGVYGPQDRSESEKRDVQRDPPPWHPRREGERPARARSLPLAAAGQGFLRKTWISEH of 	                  .         .         .         .         .  
						AA478318_P5.3.An isolated polypeptide encoding for a tail of 	     258 ISRLVRPQNWGENSCEVRFVILVLAPPKMKSTKTAMEVARTFATMFSDIA 307                                                          
						AA478318_P5, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     231 ISRLVRPQNWGENSCEVRFVILVLAPPKMKSTKTAMEVARTFATMFSDIA 280                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence GAVGAEAGDGA in    	     308 FRQKLLETRTEEEFKEALVHQRQLLTMVSHGPVAPRTKERSTVSLPAHRH 357                                                          
						AA478318_P5.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     281 FRQKLLETRTEEEFKEALVHQRQLLTMVSHGPVAPRTKERSTVSLPAHRH 330                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     358 PEPPKCKDFVPFGKGIREDIARRFPLYPLDFTDGIIGKNKAVGKYITTTL 407                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     331 PEPPKCKDFVPFGKGIREDIARRFPLYPLDFTDGIIGKNKAVGKYITTTL 380                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     408 FLYFACLLPTIAFGSLNDENTDGAIDVQKTIAGQSIGGLLYALFSGQPLV 457                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     381 FLYFACLLPTIAFGSLNDENTDGAIDVQKTIAGQSIGGLLYALFSGQPLV 430                                                          
						                                                            	                  .                                          
						                                                            	     458 ILLTTAPLALYIQ                                      470                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     431 ILLTTAPLALYIQ                                      443                                                          

26745	HMR136_AA478318_6_tr0_r1_1_gPRT		Comparison report between AA478318_P6 and SL11_HUMANunique   	Sequence name: SL11_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA478318_P6, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 26745 x SL11_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MGVYGPQDRSESEKRDVQRDPPPWHPRREGERPARARSLPLAAAGQGFLRKTWISEH    	                                                            
						corresponding to amino acids 1 - 57 of AA478318_P6, a second 	                     Quality: 4014.00                      Escore:       0                                               
						ENSPTMSQNGYFEDSSYYKCDTDDTFEAREEILGDEAFDTANSSIVSGESIRFFVNVNLE 	             Matching length:     413                Total length:     413                                               
						MQATNTENEATSGGCVLLHTSRKYLKLKNFKEEIRAHRDLDGFLAQASIVLNETATSLDN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VLRTMLRRFARDPDNNEPNCNLDLLMAMLFTDAGAPMRGKVHLLSDTIQGVTATVTGVRY 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						QQSWLCIICTMKALQKRHVCISRLVRPQNWGENSCEVRFVILVLAPPKMKSTKTAMEVAR 	                        Gaps:       0                        
						TFATMFSDIAFRQKLLETRTEEEFKEALVHQRQLLTMVSHGPVAPRTKERSTVSLPAHRH 	                                                            
						PEPPKCKDFVPFGKGIREDIARRFPLYPLDFTDGIIGKNKAVGKYITTTLFLYFACLLPT 	Alignment:                                                   
						IAFGSLNDENTDGAIDVQKTIAGQSIGGLLYALFSGQPLVILLTTAPLALYIQ        	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      58 ENSPTMSQNGYFEDSSYYKCDTDDTFEAREEILGDEAFDTANSSIVSGES 107                                                          
						corresponding to amino acids 31 - 443 of SL11_HUMAN, which   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 58 - 470 of AA478318_P6, and 	      31 ENSPTMSQNGYFEDSSYYKCDTDDTFEAREEILGDEAFDTANSSIVSGES 80                                                           
						a third amino acid sequence being at least 70%, optionally at	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	     108 IRFFVNVNLEMQATNTENEATSGGCVLLHTSRKYLKLKNFKEEIRAHRDL 157                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence GAVGAEAGDGA corresponding to 	      81 IRFFVNVNLEMQATNTENEATSGGCVLLHTSRKYLKLKNFKEEIRAHRDL 130                                                          
						amino acids 471 - 481 of AA478318_P6, wherein said first     	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence and third    	     158 DGFLAQASIVLNETATSLDNVLRTMLRRFARDPDNNEPNCNLDLLMAMLF 207                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     131 DGFLAQASIVLNETATSLDNVLRTMLRRFARDPDNNEPNCNLDLLMAMLF 180                                                          
						AA478318_P6, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     208 TDAGAPMRGKVHLLSDTIQGVTATVTGVRYQQSWLCIICTMKALQKRHVC 257                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence                   	     181 TDAGAPMRGKVHLLSDTIQGVTATVTGVRYQQSWLCIICTMKALQKRHVC 230                                                          
						MGVYGPQDRSESEKRDVQRDPPPWHPRREGERPARARSLPLAAAGQGFLRKTWISEH of 	                  .         .         .         .         .  
						AA478318_P6.3.An isolated polypeptide encoding for a tail of 	     258 ISRLVRPQNWGENSCEVRFVILVLAPPKMKSTKTAMEVARTFATMFSDIA 307                                                          
						AA478318_P6, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     231 ISRLVRPQNWGENSCEVRFVILVLAPPKMKSTKTAMEVARTFATMFSDIA 280                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence GAVGAEAGDGA in    	     308 FRQKLLETRTEEEFKEALVHQRQLLTMVSHGPVAPRTKERSTVSLPAHRH 357                                                          
						AA478318_P6.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     281 FRQKLLETRTEEEFKEALVHQRQLLTMVSHGPVAPRTKERSTVSLPAHRH 330                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     358 PEPPKCKDFVPFGKGIREDIARRFPLYPLDFTDGIIGKNKAVGKYITTTL 407                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     331 PEPPKCKDFVPFGKGIREDIARRFPLYPLDFTDGIIGKNKAVGKYITTTL 380                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     408 FLYFACLLPTIAFGSLNDENTDGAIDVQKTIAGQSIGGLLYALFSGQPLV 457                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     381 FLYFACLLPTIAFGSLNDENTDGAIDVQKTIAGQSIGGLLYALFSGQPLV 430                                                          
						                                                            	                  .                                          
						                                                            	     458 ILLTTAPLALYIQ                                      470                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     431 ILLTTAPLALYIQ                                      443                                                          

26747	HMR136_AA478318_9_tr0_r1_1_gPRT		Comparison report between AA478318_P9 and SL11_HUMANunique   	Sequence name: SL11_HUMAN                                    
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA478318_P9, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 26747 x SL11_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MGVYGPQDRSESEKRDVQRDPPPWHPRREGERPARARSLPLAAAGQGFLRKTWISEH    	                                                            
						corresponding to amino acids 1 - 57 of AA478318_P9, a second 	                     Quality: 4016.00                      Escore:       0                                               
						ENSPTMSQNGYFEDSSYYKCDTDDTFEAREEILGDEAFDTANSSIVSGESIRFFVNVNLE 	             Matching length:     420                Total length:     458                                               
						MQATNTENEATSGGCVLLHTSRKYLKLKNFKEEIRAHRDLDGFLAQASIVLNETATSLDN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VLRTMLRRFARDPDNNEPNCNLDLLMAMLFTDAGAPMRGKVHLLSDTIQGVTATVTGVRY 	    Total Percent Similarity:   91.70      Total Percent Identity:   91.70                                               
						QQSWLCIICTMKALQKRHVCISRLVRPQNWGENSCEVRFVILVLAPPKMKSTKTAMEVAR 	                        Gaps:       1                        
						TFATMFSDIAFRQKLLETRTEEEFKEALVHQRQLLTMVSHGPVAPRTKERSTVSLPAHRH 	                                                            
						PEPPKCKDFVPFGKGIREDIARRFPLYPLDFTDGIIGKNKAVGKYITTTLFLYFACLLPT 	Alignment:                                                   
						IAFGSLNDENTDGAI                                              	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      58 ENSPTMSQNGYFEDSSYYKCDTDDTFEAREEILGDEAFDTANSSIVSGES 107                                                          
						corresponding to amino acids 31 - 405 of SL11_HUMAN, which   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 58 - 432 of AA478318_P9, and 	      31 ENSPTMSQNGYFEDSSYYKCDTDDTFEAREEILGDEAFDTANSSIVSGES 80                                                           
						a third amino acid sequence being at least 90 % homologous to	                  .         .         .         .         .  
						VIRVICDDYDLDFNSFYAWTGLWNSFFLALYAFFNLSLVMSLFKR corresponding  	     108 IRFFVNVNLEMQATNTENEATSGGCVLLHTSRKYLKLKNFKEEIRAHRDL 157                                                          
						to amino acids 444 - 488 of SL11_HUMAN, which also           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 433 - 477 of AA478318_P9, wherein 	      81 IRFFVNVNLEMQATNTENEATSGGCVLLHTSRKYLKLKNFKEEIRAHRDL 130                                                          
						said first amino acid sequence, second amino acid sequence   	                  .         .         .         .         .  
						and third amino acid sequence are contiguous and in a        	     158 DGFLAQASIVLNETATSLDNVLRTMLRRFARDPDNNEPNCNLDLLMAMLF 207                                                          
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of AA478318_P9, comprising a polypeptide being at least 	     131 DGFLAQASIVLNETATSLDNVLRTMLRRFARDPDNNEPNCNLDLLMAMLF 180                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     208 TDAGAPMRGKVHLLSDTIQGVTATVTGVRYQQSWLCIICTMKALQKRHVC 257                                                          
						at least about 95% homologous to the sequence                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MGVYGPQDRSESEKRDVQRDPPPWHPRREGERPARARSLPLAAAGQGFLRKTWISEH of 	     181 TDAGAPMRGKVHLLSDTIQGVTATVTGVRYQQSWLCIICTMKALQKRHVC 230                                                          
						AA478318_P9.3.An isolated chimeric polypeptide encoding for  	                  .         .         .         .         .  
						an edge portion of AA478318_P9, comprising a polypeptide     	     258 ISRLVRPQNWGENSCEVRFVILVLAPPKMKSTKTAMEVARTFATMFSDIA 307                                                          
						having a length "n", wherein n is at least about 10 amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, optionally at least about 20 amino acids in 	     231 ISRLVRPQNWGENSCEVRFVILVLAPPKMKSTKTAMEVARTFATMFSDIA 280                                                          
						length, preferably at least about 30 amino acids in length,  	                  .         .         .         .         .  
						more preferably at least about 40 amino acids in length and  	     308 FRQKLLETRTEEEFKEALVHQRQLLTMVSHGPVAPRTKERSTVSLPAHRH 357                                                          
						most preferably at least about 50 amino acids in length,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein at least two amino acids comprise IV, having a       	     281 FRQKLLETRTEEEFKEALVHQRQLLTMVSHGPVAPRTKERSTVSLPAHRH 330                                                          
						structure as follows: a sequence starting from any of amino  	                  .         .         .         .         .  
						acid numbers 432-x to 433; and ending at any of amino acid   	     358 PEPPKCKDFVPFGKGIREDIARRFPLYPLDFTDGIIGKNKAVGKYITTTL 407                                                          
						numbers 433+ ((n-2) - x), in which x varies from 0 to n-2.   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     331 PEPPKCKDFVPFGKGIREDIARRFPLYPLDFTDGIIGKNKAVGKYITTTL 380                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     408 FLYFACLLPTIAFGSLNDENTDGAI......................... 432                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     381 FLYFACLLPTIAFGSLNDENTDGAIDVQKTIAGQSIGGLLYALFSGQPLV 430                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     433 .............VIRVICDDYDLDFNSFYAWTGLWNSFFLALYAFFNLS 469                                                          
						                                                            	                      |||||||||||||||||||||||||||||||||||||  
						                                                            	     431 ILLTTAPLALYIQVIRVICDDYDLDFNSFYAWTGLWNSFFLALYAFFNLS 480                                                          
						                                                            	                                                             
						                                                            	     470 LVMSLFKR                                           477                                                          
						                                                            	         ||||||||                                            
						                                                            	     481 LVMSLFKR                                           488                                                          

27159	HMR136_AA479483_1_tr0_r1_1_gPRT		Comparison report between AA479483_P1 and AAH47416unique     	Sequence name: AAH47416                                      
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA479483_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27159 x AAH47416   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						NRRAKMAAEEGVASAASAGGSWGTAA corresponding to amino acids 1 -  	                                                            
						26 of AA479483_P1, a second amino acid sequence being at     	                     Quality: 7369.00                      Escore:       0                                               
						MGRVLPMLLVPVPAEAMGQLGSRAQLRTQPEALGSLTAAGSLQVLSLTPGSRGGGRCCLE 	             Matching length:     752                Total length:     752                                               
						GPFWHFLWEDSRNSSTPTEKPKLLALGENYELLIYEFNLKDGRCDATILYSCSREALQKL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						IDDQDISISLLSLRILSFHNNTSLLFINKCVILHIIFPERDAAIRVLNCFTLPLPAQAVD 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MIIDTQLCRGILFVLSSLGWIYIFDVVDGTYVAHVDLALHKEDMCNEQQQEPAKISSFTS 	                        Gaps:       0                        
						LKVSQDLDVAVIVSSSNSAVALNLNLYFRQHPGHLLCERILEDLPIQGPKGVDEDDPVNS 	                                                            
						AYNMKLAKFSFQIDRSWKAQLSSLDETIKNSKLEVSCCAPWFQDILHLESPESGNHSTSV 	Alignment:                                                   
						QSWAFIPQDIMHGQYNVLQKDHAKTSDPGRSWKIMHISEQEEPIELKCVSVTGFTALFTW 	                  .         .         .         .         .  
						EVERMGYTITLWDLETQGMQCFSLGTKCIPVDSSGDQQLCFVLTENGLSLILFGLTQEEF 	      27 MGRVLPMLLVPVPAEAMGQLGSRAQLRTQPEALGSLTAAGSLQVLSLTPG 76                                                           
						LNRLMIHGSASTVDTLCHLNGWGRCSIPIHALEAGIENRQLDTVNFFLKSKENLFNPSSK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSVSDQFDHLSSHLYLRNVEELIPALDLLCSAIRESYSEPQSKHFSEQLLNLTLSFLNNQ 	       1 MGRVLPMLLVPVPAEAMGQLGSRAQLRTQPEALGSLTAAGSLQVLSLTPG 50                                                           
						IKELFIHTEELDEHLQKGVNILTSYINELRTFMIKFPWKLTDAIDEYDVHENVPKVKESN 	                  .         .         .         .         .  
						IWKKLSFEEVIASAILNNKIPEAQTFFRIDSHSAQKLEELIGIGLNLVFDNLKKNNIKEA 	      77 SRGGGRCCLEGPFWHFLWEDSRNSSTPTEKPKLLALGENYELLIYEFNLK 126                                                          
						SELLKNMGFDVKGQLLKICFYTTNKNIRDFLV                             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 1 - 752	      51 SRGGGRCCLEGPFWHFLWEDSRNSSTPTEKPKLLALGENYELLIYEFNLK 100                                                          
						of AAH47416, which also corresponds to amino acids 27 - 778  	                  .         .         .         .         .  
						of AA479483_P1, and a third amino acid sequence being at     	     127 DGRCDATILYSCSREALQKLIDDQDISISLLSLRILSFHNNTSLLFINKC 176                                                          
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	     101 DGRCDATILYSCSREALQKLIDDQDISISLLSLRILSFHNNTSLLFINKC 150                                                          
						homologous to a polypeptide having the sequence EILKEKNYFSEKEKRTIDFVHQVEKLYLGHFQENMQIQSFPRYWIKEQDFFKHKSVLDSF             	                  .         .         .         .         .  
						corresponding to amino acids 779 - 838 of AA479483_P1,       	     177 VILHIIFPERDAAIRVLNCFTLPLPAQAVDMIIDTQLCRGILFVLSSLGW 226                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     151 VILHIIFPERDAAIRVLNCFTLPLPAQAVDMIIDTQLCRGILFVLSSLGW 200                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of AA479483_P1, comprising a polypeptide being at least 	     227 IYIFDVVDGTYVAHVDLALHKEDMCNEQQQEPAKISSFTSLKVSQDLDVA 276                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     201 IYIFDVVDGTYVAHVDLALHKEDMCNEQQQEPAKISSFTSLKVSQDLDVA 250                                                          
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						NRRAKMAAEEGVASAASAGGSWGTAA of AA479483_P1.3.An isolated      	     277 VIVSSSNSAVALNLNLYFRQHPGHLLCERILEDLPIQGPKGVDEDDPVNS 326                                                          
						polypeptide encoding for a tail of AA479483_P1, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     251 VIVSSSNSAVALNLNLYFRQHPGHLLCERILEDLPIQGPKGVDEDDPVNS 300                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     327 AYNMKLAKFSFQIDRSWKAQLSSLDETIKNSKLEVSCCAPWFQDILHLES 376                                                          
						to the sequence EILKEKNYFSEKEKRTIDFVHQVEKLYLGHFQENMQIQSFPRYWIKEQDFFKHKSVLDSF                                             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						in AA479483_P1.                                              	     301 AYNMKLAKFSFQIDRSWKAQLSSLDETIKNSKLEVSCCAPWFQDILHLES 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     377 PESGNHSTSVQSWAFIPQDIMHGQYNVLQKDHAKTSDPGRSWKIMHISEQ 426                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PESGNHSTSVQSWAFIPQDIMHGQYNVLQKDHAKTSDPGRSWKIMHISEQ 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     427 EEPIELKCVSVTGFTALFTWEVERMGYTITLWDLETQGMQCFSLGTKCIP 476                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 EEPIELKCVSVTGFTALFTWEVERMGYTITLWDLETQGMQCFSLGTKCIP 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     477 VDSSGDQQLCFVLTENGLSLILFGLTQEEFLNRLMIHGSASTVDTLCHLN 526                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 VDSSGDQQLCFVLTENGLSLILFGLTQEEFLNRLMIHGSASTVDTLCHLN 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     527 GWGRCSIPIHALEAGIENRQLDTVNFFLKSKENLFNPSSKSSVSDQFDHL 576                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 GWGRCSIPIHALEAGIENRQLDTVNFFLKSKENLFNPSSKSSVSDQFDHL 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     577 SSHLYLRNVEELIPALDLLCSAIRESYSEPQSKHFSEQLLNLTLSFLNNQ 626                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 SSHLYLRNVEELIPALDLLCSAIRESYSEPQSKHFSEQLLNLTLSFLNNQ 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     627 IKELFIHTEELDEHLQKGVNILTSYINELRTFMIKFPWKLTDAIDEYDVH 676                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 IKELFIHTEELDEHLQKGVNILTSYINELRTFMIKFPWKLTDAIDEYDVH 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     677 ENVPKVKESNIWKKLSFEEVIASAILNNKIPEAQTFFRIDSHSAQKLEEL 726                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 ENVPKVKESNIWKKLSFEEVIASAILNNKIPEAQTFFRIDSHSAQKLEEL 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     727 IGIGLNLVFDNLKKNNIKEASELLKNMGFDVKGQLLKICFYTTNKNIRDF 776                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 IGIGLNLVFDNLKKNNIKEASELLKNMGFDVKGQLLKICFYTTNKNIRDF 750                                                          
						                                                            	                                                             
						                                                            	     777 LV                                                 778                                                          
						                                                            	         ||                                                  
						                                                            	     751 LV                                                 752                                                          

27421	HMR136_AA480077_2_tr0_r1_1_gPRT		Comparison report between AA480077_P2 and ENP2_HUMANunique   	Sequence name: ENP2_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA480077_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 27421 x ENP2_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MPRTGASGCAQRETRGHTPLPGSHSGYAPAQ          	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 31 of AA480077_P2, and a    	                                                            
						YGWVGRWFRPRKGTLGAMDLGGASTQITFETTSPAEDRASEVQLHLYGQHYRVYTHSFLC 	                     Quality: 3074.00                      Escore:       0                                               
						YGRDQVLQRLLASALQTHGFHPCWPRGFSTQVLLGDVYQSPCTMAQRPQNFNSSARVSLS 	             Matching length:     314                Total length:     314                                               
						GSSDPHLCRDLVSGLFSFSSCPFSRCSFNGVFQPPVAGNFVAFSAFFYTVDFLRTSMGLP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.68                                               
						VATLQQLEAAAVNVCNQTWAQLQARVPGQRARLADYCAGAMFVQQLLSRGYGFDERAFGG 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.68                                               
						VIFQKKAADTAVGWALGYMLNLTNLIPADPPGLRKGTDFSSWVVLLLLFASALLAALVLL 	                        Gaps:       0                        
						LRQVHSAKLPSTI                                                	                                                            
						second amino acid sequence being at least 90 % homologous to 	Alignment:                                                   
						corresponding to amino acids 183 - 495 of ENP2_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 32 - 344 of AA480077_P2,     	      31 QYGWVGRWFRPRKGTLGAMDLGGASTQITFETTSPAEDRASEVQLHLYGQ 80                                                           
						wherein said first amino acid sequence and second amino acid 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     182 KYGWVGRWFRPRKGTLGAMDLGGASTQITFETTSPAEDRASEVQLHLYGQ 231                                                          
						isolated polypeptide encoding for a head of AA480077_P2,     	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	      81 HYRVYTHSFLCYGRDQVLQRLLASALQTHGFHPCWPRGFSTQVLLGDVYQ 130                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     232 HYRVYTHSFLCYGRDQVLQRLLASALQTHGFHPCWPRGFSTQVLLGDVYQ 281                                                          
						about 95% homologous to the sequence                         	                  .         .         .         .         .  
						MPRTGASGCAQRETRGHTPLPGSHSGYAPAQ of AA480077_P2.              	     131 SPCTMAQRPQNFNSSARVSLSGSSDPHLCRDLVSGLFSFSSCPFSRCSFN 180                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     282 SPCTMAQRPQNFNSSARVSLSGSSDPHLCRDLVSGLFSFSSCPFSRCSFN 331                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     181 GVFQPPVAGNFVAFSAFFYTVDFLRTSMGLPVATLQQLEAAAVNVCNQTW 230                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     332 GVFQPPVAGNFVAFSAFFYTVDFLRTSMGLPVATLQQLEAAAVNVCNQTW 381                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     231 AQLQARVPGQRARLADYCAGAMFVQQLLSRGYGFDERAFGGVIFQKKAAD 280                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     382 AQLQARVPGQRARLADYCAGAMFVQQLLSRGYGFDERAFGGVIFQKKAAD 431                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     281 TAVGWALGYMLNLTNLIPADPPGLRKGTDFSSWVVLLLLFASALLAALVL 330                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     432 TAVGWALGYMLNLTNLIPADPPGLRKGTDFSSWVVLLLLFASALLAALVL 481                                                          
						                                                            	                  .                                          
						                                                            	     331 LLRQVHSAKLPSTI                                     344                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     482 LLRQVHSAKLPSTI                                     495                                                          

28764	HMR136_AA483038_1_tr0_r1_1_gPRT		Comparison report between AA483038_P1 and Q8IVZ5unique head  	Sequence name: Q8IVZ5                                        
						followed by partial WT sequence followed by a short unique   	                                                            
						deletion and a followed by a unique insertion.1.An isolated  	Sequence documentation:                                      
						chimeric polypeptide encoding for AA483038_P1, comprising a  	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 28764 x Q8IVZ5   ..                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						MNKNTSTVVSPSLLEKDPAFQMITIAKETGLGLKVLGGINRNEGPLVYIQEIIPGGDCYK 	                                                            
						DGRLKPGDQLVSVNKES                                            	                     Quality: 2158.00                      Escore:       0                                               
						polypeptide having the sequence corresponding to amino acids 	             Matching length:     243                Total length:     248                                               
						1 - 77 of AA483038_P1, a second amino acid sequence being at 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 90 % homologous to MIGVSFEEAKSIITGAKL corresponding to 	    Total Percent Similarity:   97.98      Total Percent Identity:   97.98                                               
						amino acids 1 - 18 of Q8IVZ5, which also corresponds to amino	                        Gaps:       2                        
						acids 78 - 95 of AA483038_P1, a third amino acid sequence    	                                                            
						RLESAWEIAFIRQKSDNIQPENLSCTSLIEASGEYGPQASTLSLFSSPPEILIPKTSSTP 	Alignment:                                                   
						KTNNDILSSCE                                                  	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	      78 MIGVSFEEAKSIITGAKL..RLESAWEIAFIRQKSDNIQPENLSCTSLIE 125                                                          
						acids 21 - 91 of Q8IVZ5, which also corresponds to amino     	         ||||||||||||||||||  ||||||||||||||||||||||||||||||  
						acids 96 - 166 of AA483038_P1, a fourth amino acid sequence  	       1 MIGVSFEEAKSIITGAKLSTRLESAWEIAFIRQKSDNIQPENLSCTSLIE 50                                                           
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	     126 ASGEYGPQASTLSLFSSPPEILIPKTSSTPKTNNDILSSCEVSQIKTGYN 175                                                          
						at least 95% homologous to a polypeptide having the sequence 	         |||||||||||||||||||||||||||||||||||||||||   ||||||  
						VSQ corresponding to amino acids 167 - 169 of AA483038_P1,   	      51 ASGEYGPQASTLSLFSSPPEILIPKTSSTPKTNNDILSSCE...IKTGYN 97                                                           
						and a fifth amino acid sequence being at least 90 %          	                  .         .         .         .         .  
						IKTGYNKTVQIPITSENSTVGLSNTDVASAWTENYGLQEKISLNPSVRFKAEKLEMALNY 	     176 KTVQIPITSENSTVGLSNTDVASAWTENYGLQEKISLNPSVRFKAEKLEM 225                                                          
						LGIQPTKEQHQALRQQVQADSKGTVSFGDFVQVARNLFCLQLDEVNVGAHEISNILDSQL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPCDSSEADEMERLKCERDDALKEVNTLKWPGQN                           	      98 KTVQIPITSENSTVGLSNTDVASAWTENYGLQEKISLNPSVRFKAEKLEM 147                                                          
						homologous to corresponding to amino acids 92 - 245 of       	                  .         .         .         .         .  
						Q8IVZ5, which also corresponds to amino acids 170 - 323 of   	     226 ALNYLGIQPTKEQHQALRQQVQADSKGTVSFGDFVQVARNLFCLQLDEVN 275                                                          
						AA483038_P1, wherein said first amino acid sequence, second  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, third amino acid sequence, fourth amino 	     148 ALNYLGIQPTKEQHQALRQQVQADSKGTVSFGDFVQVARNLFCLQLDEVN 197                                                          
						acid sequence and fifth amino acid sequence are contiguous   	                  .         .         .         .            
						and in a sequential order.2.An isolated polypeptide encoding 	     276 VGAHEISNILDSQLLPCDSSEADEMERLKCERDDALKEVNTLKWPGQN   323                                                          
						for a head of AA483038_P1, comprising a polypeptide being at 	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						least 70%, optionally at least about 80%, preferably at least	     198 VGAHEISNILDSQLLPCDSSEADEMERLKCERDDALKEVNTLKWPGQN   245                                                          
						about 85%, more preferably at least about 90% and most       	                                                            
						MNKNTSTVVSPSLLEKDPAFQMITIAKETGLGLKVLGGINRNEGPLVYIQEIIPGGDCYK 	                                                            
						DGRLKPGDQLVSVNKES                                            	                                                            
						preferably at least about 95% homologous to the sequence of  	                                                            
						AA483038_P1.3.An isolated chimeric polypeptide encoding for  	                                                            
						an edge portion of AA483038_P1, comprising a polypeptide     	                                                            
						having a length "n", wherein n is at least about 10 amino    	                                                            
						acids in length, optionally at least about 20 amino acids in 	                                                            
						length, preferably at least about 30 amino acids in length,  	                                                            
						more preferably at least about 40 amino acids in length and  	                                                            
						most preferably at least about 50 amino acids in length,     	                                                            
						wherein at least two amino acids comprise LR, having a       	                                                            
						structure as follows: a sequence starting from any of amino  	                                                            
						acid numbers 95-x to 96; and ending at any of amino acid     	                                                            
						numbers 96+ ((n-2) - x), in which x varies from 0 to n-2.4.An	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						AA483038_P1, comprising an amino acid sequence being at least	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						VSQ, corresponding to AA483038_P1.                           	                                                            

28762	HMR136_AA483038_2_tr0_r1_1_gPRT		Comparison report between AA483038_P2 and Q8IVZ5unique head  	Sequence name: Q8IVZ5                                        
						followed by partial WT sequence followed by a short unique   	                                                            
						deletion, followed by a unique insertion and a followed by a 	Sequence documentation:                                      
						unique tail.1.An isolated chimeric polypeptide encoding for  	                                                            
						AA483038_P2, comprising a first amino acid sequence being at 	Alignment of: 28762 x Q8IVZ5   ..                            
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						MNKNTSTVVSPSLLEKDPAFQMITIAKETGLGLKVLGGINRNEGPLVYIQEIIPGGDCYK 	                                                            
						DGRLKPGDQLVSVNKES                                            	                     Quality: 1196.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     145                Total length:     150                                               
						to amino acids 1 - 77 of AA483038_P2, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to MIGVSFEEAKSIITGAKL	    Total Percent Similarity:   96.67      Total Percent Identity:   96.67                                               
						corresponding to amino acids 1 - 18 of Q8IVZ5, which also    	                        Gaps:       2                        
						corresponds to amino acids 78 - 95 of AA483038_P2, a third   	                                                            
						RLESAWEIAFIRQKSDNIQPENLSCTSLIEASGEYGPQASTLSLFSSPPEILIPKTSSTP 	Alignment:                                                   
						KTNNDILSSCE                                                  	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      78 MIGVSFEEAKSIITGAKL..RLESAWEIAFIRQKSDNIQPENLSCTSLIE 125                                                          
						corresponding to amino acids 21 - 91 of Q8IVZ5, which also   	         ||||||||||||||||||  ||||||||||||||||||||||||||||||  
						corresponds to amino acids 96 - 166 of AA483038_P2, a fourth 	       1 MIGVSFEEAKSIITGAKLSTRLESAWEIAFIRQKSDNIQPENLSCTSLIE 50                                                           
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	     126 ASGEYGPQASTLSLFSSPPEILIPKTSSTPKTNNDILSSCEVSQIKTGYN 175                                                          
						and most preferably at least 95% homologous to a polypeptide 	         |||||||||||||||||||||||||||||||||||||||||   ||||||  
						having the sequence VSQ corresponding to amino acids 167 -   	      51 ASGEYGPQASTLSLFSSPPEILIPKTSSTPKTNNDILSSCE...IKTGYN 97                                                           
						169 of AA483038_P2, a fifth amino acid sequence being at     	                  .         .         .         .         .  
						least 90 % homologous to                                     	     176 KTVQIPITSENSTVGLSNTDVASAWTENYGLQEKISLNPSVRFKAEKLEM 225                                                          
						IKTGYNKTVQIPITSENSTVGLSNTDVASAWTENYGLQEKISLNPSVRFKAEKLEM     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 92 - 147 of Q8IVZ5, which also  	      98 KTVQIPITSENSTVGLSNTDVASAWTENYGLQEKISLNPSVRFKAEKLEM 147                                                          
						corresponds to amino acids 170 - 225 of AA483038_P2, and a   	                                                            
						sixth amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence VKPLNFHFSSIRQKQERSILLL       	                                                            
						corresponding to amino acids 226 - 247 of AA483038_P2,       	                                                            
						wherein said first amino acid sequence, second amino acid    	                                                            
						sequence, third amino acid sequence, fourth amino acid       	                                                            
						sequence, fifth amino acid sequence and sixth amino acid     	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of AA483038_P2,     	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MNKNTSTVVSPSLLEKDPAFQMITIAKETGLGLKVLGGINRNEGPLVYIQEIIPGGDCYK 	                                                            
						DGRLKPGDQLVSVNKES                                            	                                                            
						about 95% homologous to the sequence of AA483038_P2.3.An     	                                                            
						isolated chimeric polypeptide encoding for an edge portion of	                                                            
						AA483038_P2, comprising a polypeptide having a length "n",   	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise LR, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						95-x to 96; and ending at any of amino acid numbers 96+      	                                                            
						((n-2) - x), in which x varies from 0 to n-2.4.An isolated   	                                                            
						polypeptide encoding for an edge portion of AA483038_P2,     	                                                            
						comprising an amino acid sequence being at least 70%,        	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence encoding for VSQ, 	                                                            
						corresponding to AA483038_P2.5.An isolated polypeptide       	                                                            
						encoding for a tail of AA483038_P2, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						VKPLNFHFSSIRQKQERSILLL in AA483038_P2.                       	                                                            

28766	HMR136_AA483038_3_tr0_r1_1_gPRT		Comparison report between AA483038_P3 and Q8IVZ5unique head  	Sequence name: Q8IVZ5                                        
						followed by partial WT sequence followed by a short unique   	                                                            
						deletion, followed by a unique insertion and a followed by a 	Sequence documentation:                                      
						unique tail.1.An isolated chimeric polypeptide encoding for  	                                                            
						AA483038_P3, comprising a first amino acid sequence being at 	Alignment of: 28766 x Q8IVZ5   ..                            
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						MNKNTSTVVSPSLLEKDPAFQMITIAKETGLGLKVLGGINRNEGPLVYIQEIIPGGDCYK 	                                                            
						DGRLKPGDQLVSVNKES                                            	                     Quality:  894.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     120                Total length:     125                                               
						to amino acids 1 - 77 of AA483038_P3, a second amino acid    	 Matching Percent Similarity:   96.67   Matching Percent Identity:   95.83                                               
						sequence being at least 90 % homologous to MIGVSFEEAKSIITGAKL	    Total Percent Similarity:   92.80      Total Percent Identity:   92.00                                               
						corresponding to amino acids 1 - 18 of Q8IVZ5, which also    	                        Gaps:       2                        
						corresponds to amino acids 78 - 95 of AA483038_P3, a third   	                                                            
						RLESAWEIAFIRQKSDNIQPENLSCTSLIEASGEYGPQASTLSLFSSPPEILIPKTSSTP 	Alignment:                                                   
						KTNNDILSSCE                                                  	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      78 MIGVSFEEAKSIITGAKL..RLESAWEIAFIRQKSDNIQPENLSCTSLIE 125                                                          
						corresponding to amino acids 21 - 91 of Q8IVZ5, which also   	         ||||||||||||||||||  ||||||||||||||||||||||||||||||  
						corresponds to amino acids 96 - 166 of AA483038_P3, a fourth 	       1 MIGVSFEEAKSIITGAKLSTRLESAWEIAFIRQKSDNIQPENLSCTSLIE 50                                                           
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	     126 ASGEYGPQASTLSLFSSPPEILIPKTSSTPKTNNDILSSCEVSQIKTGYN 175                                                          
						and most preferably at least 95% homologous to a polypeptide 	         |||||||||||||||||||||||||||||||||||||||||   ||||||  
						having the sequence VSQ corresponding to amino acids 167 -   	      51 ASGEYGPQASTLSLFSSPPEILIPKTSSTPKTNNDILSSCE...IKTGYN 97                                                           
						169 of AA483038_P3, a fifth amino acid sequence being at     	                  .         .                                
						least 90 % homologous to IKTGYNKTVQIPITSENSTVGLSNT           	     176 KTVQIPITSENSTVGLSNTGSKLSW                          200                                                          
						corresponding to amino acids 92 - 116 of Q8IVZ5, which also  	         |||||||||||||||||||    :|                           
						corresponds to amino acids 170 - 194 of AA483038_P3, and a   	      98 KTVQIPITSENSTVGLSNTDVASAW                          122                                                          
						sixth amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence                              	                                                            
						GSKLSWYSAHKGTTPSPETASTSRLKRDSVFWRFCPGCQKLVLLAVG corresponding	                                                            
						to amino acids 195 - 241 of AA483038_P3, wherein said first  	                                                            
						amino acid sequence, second amino acid sequence, third amino 	                                                            
						acid sequence, fourth amino acid sequence, fifth amino acid  	                                                            
						sequence and sixth amino acid sequence are contiguous and in 	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	                                                            
						head of AA483038_P3, comprising a polypeptide being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						MNKNTSTVVSPSLLEKDPAFQMITIAKETGLGLKVLGGINRNEGPLVYIQEIIPGGDCYK 	                                                            
						DGRLKPGDQLVSVNKES                                            	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						AA483038_P3.3.An isolated chimeric polypeptide encoding for  	                                                            
						an edge portion of AA483038_P3, comprising a polypeptide     	                                                            
						having a length "n", wherein n is at least about 10 amino    	                                                            
						acids in length, optionally at least about 20 amino acids in 	                                                            
						length, preferably at least about 30 amino acids in length,  	                                                            
						more preferably at least about 40 amino acids in length and  	                                                            
						most preferably at least about 50 amino acids in length,     	                                                            
						wherein at least two amino acids comprise LR, having a       	                                                            
						structure as follows: a sequence starting from any of amino  	                                                            
						acid numbers 95-x to 96; and ending at any of amino acid     	                                                            
						numbers 96+ ((n-2) - x), in which x varies from 0 to n-2.4.An	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						AA483038_P3, comprising an amino acid sequence being at least	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence encoding for   	                                                            
						VSQ, corresponding to AA483038_P3.5.An isolated polypeptide  	                                                            
						encoding for a tail of AA483038_P3, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						GSKLSWYSAHKGTTPSPETASTSRLKRDSVFWRFCPGCQKLVLLAVG in           	                                                            
						AA483038_P3.                                                 	                                                            

11186	HMR136_AA493404_1_tr0_r1_1_gPRT		Comparison report between AA493404_P1 and Q96CN5partial WT   	Sequence name: Q96CN5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA493404_P1, comprising a first     	Sequence documentation:                                      
						MEEFRRSYSRLCRESGAEPQEAVLQQLHQLPRGRLDLATQSLTVETCRALGKLLPRETLC 	                                                            
						TELVLSDCMLSEEGATLLLRGLCANTVLRFLDLKGNNLRAAGAEALGKLLQQNKSIQSLT 	Alignment of: 11186 x Q96CN5   ..                            
						LEWNSLGTWDDAFATFCGGLAANGALQRLDLRNNQISHKGAEELALALKGNTTLQQLDLR 	                                                            
						WNNVGLLGGRALMNCLPSNRTLWRLDLAGNNIPGDVLRAVEQAMGHSQDRLTTFQENQAR 	Alignment segment 1/1:                                       
						THVLSKEVQHLREEKSKQFLDLMETIDKQREEMAKSSRASAARVGQLQEALNERHSIINA 	                                                            
						LKAKLQMTEAALALSEQKAQDLGELLATAEQEQLSLSQRQAKELKLEQQEAAERESKLLR 	                     Quality: 3959.00                      Escore:       0                                               
						DLSAANEKNLLLQNQVDELERKFRCQQEQLFQTRQEMTSMSAELKMRAIQAE         	             Matching length:     412                Total length:     412                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 412 of Q96CN5, which also   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 412 of AA493404_P1, and a     	                        Gaps:       0                        
						second amino acid sequence being at least 70%, optionally at 	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence GGAYDPSPGGE corresponding to 	       1 MEEFRRSYSRLCRESGAEPQEAVLQQLHQLPRGRLDLATQSLTVETCRAL 50                                                           
						amino acids 413 - 423 of AA493404_P1, wherein said first     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and second amino acid sequence are       	       1 MEEFRRSYSRLCRESGAEPQEAVLQQLHQLPRGRLDLATQSLTVETCRAL 50                                                           
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of AA493404_P1, comprising a 	      51 GKLLPRETLCTELVLSDCMLSEEGATLLLRGLCANTVLRFLDLKGNNLRA 100                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	      51 GKLLPRETLCTELVLSDCMLSEEGATLLLRGLCANTVLRFLDLKGNNLRA 100                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence GGAYDPSPGGE in AA493404_P1.                  	     101 AGAEALGKLLQQNKSIQSLTLEWNSLGTWDDAFATFCGGLAANGALQRLD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 AGAEALGKLLQQNKSIQSLTLEWNSLGTWDDAFATFCGGLAANGALQRLD 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LRNNQISHKGAEELALALKGNTTLQQLDLRWNNVGLLGGRALMNCLPSNR 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 LRNNQISHKGAEELALALKGNTTLQQLDLRWNNVGLLGGRALMNCLPSNR 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 TLWRLDLAGNNIPGDVLRAVEQAMGHSQDRLTTFQENQARTHVLSKEVQH 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 TLWRLDLAGNNIPGDVLRAVEQAMGHSQDRLTTFQENQARTHVLSKEVQH 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LREEKSKQFLDLMETIDKQREEMAKSSRASAARVGQLQEALNERHSIINA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LREEKSKQFLDLMETIDKQREEMAKSSRASAARVGQLQEALNERHSIINA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LKAKLQMTEAALALSEQKAQDLGELLATAEQEQLSLSQRQAKELKLEQQE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LKAKLQMTEAALALSEQKAQDLGELLATAEQEQLSLSQRQAKELKLEQQE 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 AAERESKLLRDLSAANEKNLLLQNQVDELERKFRCQQEQLFQTRQEMTSM 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 AAERESKLLRDLSAANEKNLLLQNQVDELERKFRCQQEQLFQTRQEMTSM 400                                                          
						                                                            	                  .                                          
						                                                            	     401 SAELKMRAIQAE                                       412                                                          
						                                                            	         ||||||||||||                                        
						                                                            	     401 SAELKMRAIQAE                                       412                                                          

11188	HMR136_AA493404_5_tr0_r1_1_gPRT		Comparison report between AA493404_P5 and Q96CN5partial WT   	Sequence name: Q96CN5                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for AA493404_P5, comprising a first     	Sequence documentation:                                      
						MEEFRRSYSRLCRESGAEPQEAVLQQLHQLPRGRLDLATQSLTVETCRALGKLLPRETLC 	                                                            
						TELVLSDCMLSEEGATLLLRGLCANTVLRFLDLKGNNLRAAGAEALGKLLQQNKSIQSLT 	Alignment of: 11188 x Q96CN5   ..                            
						LEWNSLGTWDDAFATFCGGLAANGALQRLDLRNNQISHKGAEELALALKGNTTLQQLDLR 	                                                            
						WNNVGLLGGRALMNCLPSNRTLWRLDLAGNNIPGDVLRAVEQAMGHSQDRLTTFQENQAR 	Alignment segment 1/1:                                       
						THVLSKEVQHLREEKSKQFLDLMETIDKQREEMAKSSR                       	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 6058.00                      Escore:       0                                               
						corresponding to amino acids 1 - 278 of Q96CN5, which also   	             Matching length:     644                Total length:     670                                               
						corresponds to amino acids 1 - 278 of AA493404_P5, and a     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LQMTEAALALSEQKAQDLGELLATAEQEQLSLSQRQAKELKLEQQEAAERESKLLRDLSA 	    Total Percent Similarity:   96.12      Total Percent Identity:   96.12                                               
						ANEKNLLLQNQVDELERKFRCQQEQLFQTRQEMTSMSAELKMRAIQAEERLDMEKRRCRQ 	                        Gaps:       1                        
						SLEDSESLRIKEVEHMTRHLEESEKAMQERVQRLEAARLSLEEELSRVKAAALSERGQAE 	                                                            
						EELIKAKSQARLEEQQRLAHLEDKLRLLAQARDEAQGACLQQKQVVAEAQTRVSQLGLQV 	Alignment:                                                   
						EGLRRRLEELQQELSLKDQERVAEVSRVRVELQEQNGRLQAELAAQEALREKAAALERQL 	                  .         .         .         .         .  
						KVMASDHREALLDRESENASLREKLRLREAEIARIRDEEAQRASFLQNAVLAYVQASPVR 	       1 MEEFRRSYSRLCRESGAEPQEAVLQQLHQLPRGRLDLATQSLTVETCRAL 50                                                           
						TLSPPK                                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence being at least 90 % homologous to 	       1 MEEFRRSYSRLCRESGAEPQEAVLQQLHQLPRGRLDLATQSLTVETCRAL 50                                                           
						corresponding to amino acids 305 - 670 of Q96CN5, which also 	                  .         .         .         .         .  
						corresponds to amino acids 279 - 644 of AA493404_P5, wherein 	      51 GKLLPRETLCTELVLSDCMLSEEGATLLLRGLCANTVLRFLDLKGNNLRA 100                                                          
						said first amino acid sequence and second amino acid sequence	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						are contiguous and in a sequential order.2.An isolated       	      51 GKLLPRETLCTELVLSDCMLSEEGATLLLRGLCANTVLRFLDLKGNNLRA 100                                                          
						chimeric polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						AA493404_P5, comprising a polypeptide having a length "n",   	     101 AGAEALGKLLQQNKSIQSLTLEWNSLGTWDDAFATFCGGLAANGALQRLD 150                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     101 AGAEALGKLLQQNKSIQSLTLEWNSLGTWDDAFATFCGGLAANGALQRLD 150                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     151 LRNNQISHKGAEELALALKGNTTLQQLDLRWNNVGLLGGRALMNCLPSNR 200                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise RL, having a structure as  	     151 LRNNQISHKGAEELALALKGNTTLQQLDLRWNNVGLLGGRALMNCLPSNR 200                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						278-x to 279; and ending at any of amino acid numbers 279+   	     201 TLWRLDLAGNNIPGDVLRAVEQAMGHSQDRLTTFQENQARTHVLSKEVQH 250                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 TLWRLDLAGNNIPGDVLRAVEQAMGHSQDRLTTFQENQARTHVLSKEVQH 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LREEKSKQFLDLMETIDKQREEMAKSSR...................... 278                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     251 LREEKSKQFLDLMETIDKQREEMAKSSRASAARVGQLQEALNERHSIINA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     279 ....LQMTEAALALSEQKAQDLGELLATAEQEQLSLSQRQAKELKLEQQE 324                                                          
						                                                            	             ||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LKAKLQMTEAALALSEQKAQDLGELLATAEQEQLSLSQRQAKELKLEQQE 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     325 AAERESKLLRDLSAANEKNLLLQNQVDELERKFRCQQEQLFQTRQEMTSM 374                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 AAERESKLLRDLSAANEKNLLLQNQVDELERKFRCQQEQLFQTRQEMTSM 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     375 SAELKMRAIQAEERLDMEKRRCRQSLEDSESLRIKEVEHMTRHLEESEKA 424                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 SAELKMRAIQAEERLDMEKRRCRQSLEDSESLRIKEVEHMTRHLEESEKA 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     425 MQERVQRLEAARLSLEEELSRVKAAALSERGQAEEELIKAKSQARLEEQQ 474                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 MQERVQRLEAARLSLEEELSRVKAAALSERGQAEEELIKAKSQARLEEQQ 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     475 RLAHLEDKLRLLAQARDEAQGACLQQKQVVAEAQTRVSQLGLQVEGLRRR 524                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 RLAHLEDKLRLLAQARDEAQGACLQQKQVVAEAQTRVSQLGLQVEGLRRR 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     525 LEELQQELSLKDQERVAEVSRVRVELQEQNGRLQAELAAQEALREKAAAL 574                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 LEELQQELSLKDQERVAEVSRVRVELQEQNGRLQAELAAQEALREKAAAL 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     575 ERQLKVMASDHREALLDRESENASLREKLRLREAEIARIRDEEAQRASFL 624                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 ERQLKVMASDHREALLDRESENASLREKLRLREAEIARIRDEEAQRASFL 650                                                          
						                                                            	                  .         .                                
						                                                            	     625 QNAVLAYVQASPVRTLSPPK                               644                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	     651 QNAVLAYVQASPVRTLSPPK                               670                                                          

15013	HMR136_AA504218_0_tr0_r1_1_gPRT		Comparison report between AA504218_P0 and Q8N3K0partial WT   	Sequence name: Q8N3K0                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA504218_P0, comprising a first amino acid      	                                                            
						MQSLDDATKQLDFTRKTLAEKKQELDKLRNEWASHTAALTNKHSQELTNEKEKALQAQVQ 	Alignment of: 15013 x Q8N3K0   ..                            
						YQQQHEQQKKDLEILHQQNIHQLQNRLSELEAANKDLTERKYKGDSTIRELKAKLSGVEE 	                                                            
						ELQRTKQEVLSLRRENSTLDVECHEKEKHVNQLQTKVAVLEQEIKDKDQLVLRTKEAFDT 	Alignment segment 1/1:                                       
						IQEQKVVLEENGEKNQVQLGKLEATIKSLSAELLKANEIIKKLQGDLKTLMGKLKLKNTV 	                                                            
						TIQQEKLLAEKEEKLQKEQKELQDVGQSLRIKEQEVCKLQEQLEATVKKLEESKQLLKNN 	                     Quality: 4744.00                      Escore:       0                                               
						EKLITWLNKELNENQLVRKQDVLGPSTTPPAHSSSNTIRSGISPNLNVVDGRLTYPTCGI 	             Matching length:     490                Total length:     490                                               
						GYPVSSAFAFQNTFPHSISAKNTSHPGSGTKVQFNLQFTKPNASLGDVQSGATISMPCST 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DKENGENVGLESKYLKKREDSIPLRGLSQNLFSNSDHQRDGTLGALHTSSKPTALPSASS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AYFPGQLPNS                                                   	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 16 - 505 of Q8N3K0, which also corresponds to    	Alignment:                                                   
						amino acids 1 - 490 of AA504218_P0.                          	                  .         .         .         .         .  
						                                                            	       1 MQSLDDATKQLDFTRKTLAEKKQELDKLRNEWASHTAALTNKHSQELTNE 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      16 MQSLDDATKQLDFTRKTLAEKKQELDKLRNEWASHTAALTNKHSQELTNE 65                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 KEKALQAQVQYQQQHEQQKKDLEILHQQNIHQLQNRLSELEAANKDLTER 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      66 KEKALQAQVQYQQQHEQQKKDLEILHQQNIHQLQNRLSELEAANKDLTER 115                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KYKGDSTIRELKAKLSGVEEELQRTKQEVLSLRRENSTLDVECHEKEKHV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     116 KYKGDSTIRELKAKLSGVEEELQRTKQEVLSLRRENSTLDVECHEKEKHV 165                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NQLQTKVAVLEQEIKDKDQLVLRTKEAFDTIQEQKVVLEENGEKNQVQLG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     166 NQLQTKVAVLEQEIKDKDQLVLRTKEAFDTIQEQKVVLEENGEKNQVQLG 215                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KLEATIKSLSAELLKANEIIKKLQGDLKTLMGKLKLKNTVTIQQEKLLAE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     216 KLEATIKSLSAELLKANEIIKKLQGDLKTLMGKLKLKNTVTIQQEKLLAE 265                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KEEKLQKEQKELQDVGQSLRIKEQEVCKLQEQLEATVKKLEESKQLLKNN 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     266 KEEKLQKEQKELQDVGQSLRIKEQEVCKLQEQLEATVKKLEESKQLLKNN 315                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EKLITWLNKELNENQLVRKQDVLGPSTTPPAHSSSNTIRSGISPNLNVVD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     316 EKLITWLNKELNENQLVRKQDVLGPSTTPPAHSSSNTIRSGISPNLNVVD 365                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 GRLTYPTCGIGYPVSSAFAFQNTFPHSISAKNTSHPGSGTKVQFNLQFTK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     366 GRLTYPTCGIGYPVSSAFAFQNTFPHSISAKNTSHPGSGTKVQFNLQFTK 415                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 PNASLGDVQSGATISMPCSTDKENGENVGLESKYLKKREDSIPLRGLSQN 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     416 PNASLGDVQSGATISMPCSTDKENGENVGLESKYLKKREDSIPLRGLSQN 465                                                          
						                                                            	                  .         .         .         .            
						                                                            	     451 LFSNSDHQRDGTLGALHTSSKPTALPSASSAYFPGQLPNS           490                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     466 LFSNSDHQRDGTLGALHTSSKPTALPSASSAYFPGQLPNS           505                                                          

15011	HMR136_AA504218_1_tr0_r1_1_gPRT		Comparison report between AA504218_P1 and Q8N3K0partial WT   	Sequence name: Q8N3K0                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA504218_P1, comprising a first amino acid      	                                                            
						MQSLDDATKQLDFTRKTLAEKKQELDKLRNEWASHTAALTNKHSQELTNEKEKALQAQVQ 	Alignment of: 15011 x Q8N3K0   ..                            
						YQQQHEQQKKDLEILHQQNIHQLQNRLSELEAANKDLTERKYKGDSTIRELKAKLSGVEE 	                                                            
						ELQRTKQEVLSLRRENSTLDVECHEKEKHVNQLQTKVAVLEQEIKDKDQLVLRTKEAFDT 	Alignment segment 1/1:                                       
						IQEQKVVLEENGEKNQVQLGKLEATIKSLSAELLKANEIIKKLQGDLKTLMGKLKLKNTV 	                                                            
						TIQQEKLLAEKEEKLQKEQKELQDVGQSLRIKEQEVCKLQEQLEATVKKLEESKQLLKNN 	                     Quality: 4744.00                      Escore:       0                                               
						EKLITWLNKELNENQLVRKQDVLGPSTTPPAHSSSNTIRSGISPNLNVVDGRLTYPTCGI 	             Matching length:     490                Total length:     490                                               
						GYPVSSAFAFQNTFPHSISAKNTSHPGSGTKVQFNLQFTKPNASLGDVQSGATISMPCST 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DKENGENVGLESKYLKKREDSIPLRGLSQNLFSNSDHQRDGTLGALHTSSKPTALPSASS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AYFPGQLPNS                                                   	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 16 - 505 of Q8N3K0, which also corresponds to    	Alignment:                                                   
						amino acids 1 - 490 of AA504218_P1.                          	                  .         .         .         .         .  
						                                                            	       1 MQSLDDATKQLDFTRKTLAEKKQELDKLRNEWASHTAALTNKHSQELTNE 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      16 MQSLDDATKQLDFTRKTLAEKKQELDKLRNEWASHTAALTNKHSQELTNE 65                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 KEKALQAQVQYQQQHEQQKKDLEILHQQNIHQLQNRLSELEAANKDLTER 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      66 KEKALQAQVQYQQQHEQQKKDLEILHQQNIHQLQNRLSELEAANKDLTER 115                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KYKGDSTIRELKAKLSGVEEELQRTKQEVLSLRRENSTLDVECHEKEKHV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     116 KYKGDSTIRELKAKLSGVEEELQRTKQEVLSLRRENSTLDVECHEKEKHV 165                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NQLQTKVAVLEQEIKDKDQLVLRTKEAFDTIQEQKVVLEENGEKNQVQLG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     166 NQLQTKVAVLEQEIKDKDQLVLRTKEAFDTIQEQKVVLEENGEKNQVQLG 215                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KLEATIKSLSAELLKANEIIKKLQGDLKTLMGKLKLKNTVTIQQEKLLAE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     216 KLEATIKSLSAELLKANEIIKKLQGDLKTLMGKLKLKNTVTIQQEKLLAE 265                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 KEEKLQKEQKELQDVGQSLRIKEQEVCKLQEQLEATVKKLEESKQLLKNN 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     266 KEEKLQKEQKELQDVGQSLRIKEQEVCKLQEQLEATVKKLEESKQLLKNN 315                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 EKLITWLNKELNENQLVRKQDVLGPSTTPPAHSSSNTIRSGISPNLNVVD 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     316 EKLITWLNKELNENQLVRKQDVLGPSTTPPAHSSSNTIRSGISPNLNVVD 365                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 GRLTYPTCGIGYPVSSAFAFQNTFPHSISAKNTSHPGSGTKVQFNLQFTK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     366 GRLTYPTCGIGYPVSSAFAFQNTFPHSISAKNTSHPGSGTKVQFNLQFTK 415                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 PNASLGDVQSGATISMPCSTDKENGENVGLESKYLKKREDSIPLRGLSQN 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     416 PNASLGDVQSGATISMPCSTDKENGENVGLESKYLKKREDSIPLRGLSQN 465                                                          
						                                                            	                  .         .         .         .            
						                                                            	     451 LFSNSDHQRDGTLGALHTSSKPTALPSASSAYFPGQLPNS           490                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     466 LFSNSDHQRDGTLGALHTSSKPTALPSASSAYFPGQLPNS           505                                                          

15009	HMR136_AA504218_2_tr0_r1_1_gPRT		Comparison report between AA504218_P2 and Q8N3K0partial WT   	Sequence name: Q8N3K0                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA504218_P2, comprising a first     	Sequence documentation:                                      
						MQSLDDATKQLDFTRKTLAEKKQELDKLRNEWASHTAALTNKHSQELTNEKEKALQAQVQ 	                                                            
						YQQQHEQQKKDLEILHQQNIHQLQNRLSELEAANKDLTERKYKGDSTIRELKAKLSGVEE 	Alignment of: 15009 x Q8N3K0   ..                            
						ELQRTKQEVLSLRRENSTLDVECHEKEKHVNQLQTKVAVLEQEIKDKDQLVLRTKEAFDT 	                                                            
						IQEQKVVLEENGEKNQVQLGKLEATIKSLSAELLKANEIIKKLQGDLKTLMGKLKLKNTV 	Alignment segment 1/1:                                       
						TIQQEKLLAEKEEKLQKEQKELQDVGQSLRIKEQEV                         	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2653.00                      Escore:       0                                               
						corresponding to amino acids 16 - 291 of Q8N3K0, which also  	             Matching length:     276                Total length:     276                                               
						corresponds to amino acids 1 - 276 of AA504218_P2, and a     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 80%, preferably at least 85%, more preferably at least 	                        Gaps:       0                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence                              	Alignment:                                                   
						MPNSPSTQLEASQLQQTPCTQQPNNVLNTHIMQTVNHVVK corresponding to    	                  .         .         .         .         .  
						amino acids 277 - 316 of AA504218_P2, wherein said first     	       1 MQSLDDATKQLDFTRKTLAEKKQELDKLRNEWASHTAALTNKHSQELTNE 50                                                           
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	      16 MQSLDDATKQLDFTRKTLAEKKQELDKLRNEWASHTAALTNKHSQELTNE 65                                                           
						polypeptide encoding for a tail of AA504218_P2, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      51 KEKALQAQVQYQQQHEQQKKDLEILHQQNIHQLQNRLSELEAANKDLTER 100                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      66 KEKALQAQVQYQQQHEQQKKDLEILHQQNIHQLQNRLSELEAANKDLTER 115                                                          
						to the sequence MPNSPSTQLEASQLQQTPCTQQPNNVLNTHIMQTVNHVVK in  	                  .         .         .         .         .  
						AA504218_P2.                                                 	     101 KYKGDSTIRELKAKLSGVEEELQRTKQEVLSLRRENSTLDVECHEKEKHV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     116 KYKGDSTIRELKAKLSGVEEELQRTKQEVLSLRRENSTLDVECHEKEKHV 165                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NQLQTKVAVLEQEIKDKDQLVLRTKEAFDTIQEQKVVLEENGEKNQVQLG 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     166 NQLQTKVAVLEQEIKDKDQLVLRTKEAFDTIQEQKVVLEENGEKNQVQLG 215                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KLEATIKSLSAELLKANEIIKKLQGDLKTLMGKLKLKNTVTIQQEKLLAE 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     216 KLEATIKSLSAELLKANEIIKKLQGDLKTLMGKLKLKNTVTIQQEKLLAE 265                                                          
						                                                            	                  .         .                                
						                                                            	     251 KEEKLQKEQKELQDVGQSLRIKEQEV                         276                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     266 KEEKLQKEQKELQDVGQSLRIKEQEV                         291                                                          

85	HMR136_AA522500_3_tr0_r1_1_gPRT		Comparison report between AA522500_P3 and Q9H6A4short unique 	Sequence name: Q9H6A4                                        
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA522500_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 85 x Q9H6A4   ..                               
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MG corresponding to amino acids 1 - 2 of 	Alignment segment 1/1:                                       
						AA522500_P3, and a second amino acid sequence being at least 	                                                            
						DYGPKVNFRKQKLKTEGFCGLPSFSREVVRRMGLYPGLEGFRPVEQCNLDYCPERGSAID 	                     Quality: 1912.00                      Escore:       0                                               
						PHLDDAWLWGERLVSLNLLSPTVLSMCREAPGSLLLCSAPSAAPEALVDSVIAPSRSVLC 	             Matching length:     195                Total length:     195                                               
						QEVEVAIPLPARSLLVLTGAARHQWKHAIHRRHIEARRVCVTFRELSAEFGPGGRQQELG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QELLRIALSFQGRPV                                              	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						90 % homologous to corresponding to amino acids 35 - 229 of  	                        Gaps:       0                        
						Q9H6A4, which also corresponds to amino acids 3 - 197 of     	                                                            
						AA522500_P3, wherein said first amino acid sequence and      	Alignment:                                                   
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.                                                       	       3 DYGPKVNFRKQKLKTEGFCGLPSFSREVVRRMGLYPGLEGFRPVEQCNLD 52                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      35 DYGPKVNFRKQKLKTEGFCGLPSFSREVVRRMGLYPGLEGFRPVEQCNLD 84                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      53 YCPERGSAIDPHLDDAWLWGERLVSLNLLSPTVLSMCREAPGSLLLCSAP 102                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      85 YCPERGSAIDPHLDDAWLWGERLVSLNLLSPTVLSMCREAPGSLLLCSAP 134                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     103 SAAPEALVDSVIAPSRSVLCQEVEVAIPLPARSLLVLTGAARHQWKHAIH 152                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     135 SAAPEALVDSVIAPSRSVLCQEVEVAIPLPARSLLVLTGAARHQWKHAIH 184                                                          
						                                                            	                  .         .         .         .            
						                                                            	     153 RRHIEARRVCVTFRELSAEFGPGGRQQELGQELLRIALSFQGRPV      197                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     185 RRHIEARRVCVTFRELSAEFGPGGRQQELGQELLRIALSFQGRPV      229                                                          

						Comparison report between AA522500_P3 and Q9NXW9short unique 	Sequence name: Q9NXW9                                        
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA522500_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 85 x Q9NXW9   ..                               
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MG corresponding to amino acids 1 - 2 of 	Alignment segment 1/1:                                       
						AA522500_P3, and a second amino acid sequence being at least 	                                                            
						DYGPKVNFRKQKLKTEGFCGLPSFSREVVRRMGLYPGLEGFRPVEQCNLDYCPERGSAID 	                     Quality: 1912.00                      Escore:       0                                               
						PHLDDAWLWGERLVSLNLLSPTVLSMCREAPGSLLLCSAPSAAPEALVDSVIAPSRSVLC 	             Matching length:     195                Total length:     195                                               
						QEVEVAIPLPARSLLVLTGAARHQWKHAIHRRHIEARRVCVTFRELSAEFGPGGRQQELG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QELLRIALSFQGRPV                                              	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						90 % homologous to corresponding to amino acids 108 - 302 of 	                        Gaps:       0                        
						Q9NXW9, which also corresponds to amino acids 3 - 197 of     	                                                            
						AA522500_P3, wherein said first amino acid sequence and      	Alignment:                                                   
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.                                                       	       3 DYGPKVNFRKQKLKTEGFCGLPSFSREVVRRMGLYPGLEGFRPVEQCNLD 52                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     108 DYGPKVNFRKQKLKTEGFCGLPSFSREVVRRMGLYPGLEGFRPVEQCNLD 157                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      53 YCPERGSAIDPHLDDAWLWGERLVSLNLLSPTVLSMCREAPGSLLLCSAP 102                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     158 YCPERGSAIDPHLDDAWLWGERLVSLNLLSPTVLSMCREAPGSLLLCSAP 207                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     103 SAAPEALVDSVIAPSRSVLCQEVEVAIPLPARSLLVLTGAARHQWKHAIH 152                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     208 SAAPEALVDSVIAPSRSVLCQEVEVAIPLPARSLLVLTGAARHQWKHAIH 257                                                          
						                                                            	                  .         .         .         .            
						                                                            	     153 RRHIEARRVCVTFRELSAEFGPGGRQQELGQELLRIALSFQGRPV      197                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     258 RRHIEARRVCVTFRELSAEFGPGGRQQELGQELLRIALSFQGRPV      302                                                          

83	HMR136_AA522500_4_tr0_r1_1_gPRT		Comparison report between AA522500_P4 and Q9H6A4unique head  	Sequence name: Q9H6A4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA522500_P4, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 83 x Q9H6A4   ..                               
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						PRPRLRTGHADGAMAAAAAETPEVLRECGCKGIRTCLICERQRGSDPPWELPPA       	                                                            
						corresponding to amino acids 1 - 54 of AA522500_P4, and a    	                     Quality: 2152.00                      Escore:       0                                               
						EEAELVRLMDRDPWKLSQSGRRKQDYGPKVNFRKQKLKTEGFCGLPSFSREVVRRMGLYP 	             Matching length:     219                Total length:     219                                               
						GLEGFRPVEQCNLDYCPERGSAIDPHLDDAWLWGERLVSLNLLSPTVLSMCREAPGSLLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						CSAPSAAPEALVDSVIAPSRSVLCQEVEVAIPLPARSLLVLTGAARHQWKHAIHRRHIEA 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RRVCVTFRELSAEFGPGGRQQELGQELLRIALSFQGRPV                      	                        Gaps:       0                        
						second amino acid sequence being at least 90 % homologous to 	                                                            
						corresponding to amino acids 11 - 229 of Q9H6A4, which also  	Alignment:                                                   
						corresponds to amino acids 55 - 273 of AA522500_P4, wherein  	                  .         .         .         .         .  
						said first amino acid sequence and second amino acid sequence	      55 EEAELVRLMDRDPWKLSQSGRRKQDYGPKVNFRKQKLKTEGFCGLPSFSR 104                                                          
						are contiguous and in a sequential order.2.An isolated       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of AA522500_P4, comprising a 	      11 EEAELVRLMDRDPWKLSQSGRRKQDYGPKVNFRKQKLKTEGFCGLPSFSR 60                                                           
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     105 EVVRRMGLYPGLEGFRPVEQCNLDYCPERGSAIDPHLDDAWLWGERLVSL 154                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence                                              	      61 EVVRRMGLYPGLEGFRPVEQCNLDYCPERGSAIDPHLDDAWLWGERLVSL 110                                                          
						PRPRLRTGHADGAMAAAAAETPEVLRECGCKGIRTCLICERQRGSDPPWELPPA of    	                  .         .         .         .         .  
						AA522500_P4.                                                 	     155 NLLSPTVLSMCREAPGSLLLCSAPSAAPEALVDSVIAPSRSVLCQEVEVA 204                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     111 NLLSPTVLSMCREAPGSLLLCSAPSAAPEALVDSVIAPSRSVLCQEVEVA 160                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     205 IPLPARSLLVLTGAARHQWKHAIHRRHIEARRVCVTFRELSAEFGPGGRQ 254                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     161 IPLPARSLLVLTGAARHQWKHAIHRRHIEARRVCVTFRELSAEFGPGGRQ 210                                                          
						                                                            	                  .                                          
						                                                            	     255 QELGQELLRIALSFQGRPV                                273                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     211 QELGQELLRIALSFQGRPV                                229                                                          

						Comparison report between AA522500_P4 and Q9NXW9unique head  	Sequence name: Q9NXW9                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for AA522500_P4,      	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 83 x Q9NXW9   ..                               
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence PRPRLRTGHADGA	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 13 of AA522500_P4, a second 	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2468.00                      Escore:       0                                               
						MAAAAAETPEVLRECGCKGIRTCLICERQRGSDPPWELPPA corresponding to   	             Matching length:     260                Total length:     302                                               
						amino acids 1 - 41 of Q9NXW9, which also corresponds to amino	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						acids 14 - 54 of AA522500_P4, and a third amino acid sequence	    Total Percent Similarity:   86.09      Total Percent Identity:   86.09                                               
						EEAELVRLMDRDPWKLSQSGRRKQDYGPKVNFRKQKLKTEGFCGLPSFSREVVRRMGLYP 	                        Gaps:       1                        
						GLEGFRPVEQCNLDYCPERGSAIDPHLDDAWLWGERLVSLNLLSPTVLSMCREAPGSLLL 	                                                            
						CSAPSAAPEALVDSVIAPSRSVLCQEVEVAIPLPARSLLVLTGAARHQWKHAIHRRHIEA 	Alignment:                                                   
						RRVCVTFRELSAEFGPGGRQQELGQELLRIALSFQGRPV                      	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	      14 MAAAAAETPEVLRECGCKGIRTCLICERQRGSDPPWELPPA......... 54                                                           
						acids 84 - 302 of Q9NXW9, which also corresponds to amino    	         |||||||||||||||||||||||||||||||||||||||||           
						acids 55 - 273 of AA522500_P4, wherein said first amino acid 	       1 MAAAAAETPEVLRECGCKGIRTCLICERQRGSDPPWELPPAKTYRFIYCS 50                                                           
						sequence, second amino acid sequence and third amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	      55 .................................EEAELVRLMDRDPWKLS 71                                                           
						isolated polypeptide encoding for a head of AA522500_P4,     	                                          |||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	      51 DTGWAVGTEESDFEGWAFPFPGVMLIEDFVTREEEAELVRLMDRDPWKLS 100                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	      72 QSGRRKQDYGPKVNFRKQKLKTEGFCGLPSFSREVVRRMGLYPGLEGFRP 121                                                          
						about 95% homologous to the sequence PRPRLRTGHADGA of        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA522500_P4.3.An isolated chimeric polypeptide encoding for  	     101 QSGRRKQDYGPKVNFRKQKLKTEGFCGLPSFSREVVRRMGLYPGLEGFRP 150                                                          
						an edge portion of AA522500_P4, comprising a polypeptide     	                  .         .         .         .         .  
						having a length "n", wherein n is at least about 10 amino    	     122 VEQCNLDYCPERGSAIDPHLDDAWLWGERLVSLNLLSPTVLSMCREAPGS 171                                                          
						acids in length, optionally at least about 20 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, preferably at least about 30 amino acids in length,  	     151 VEQCNLDYCPERGSAIDPHLDDAWLWGERLVSLNLLSPTVLSMCREAPGS 200                                                          
						more preferably at least about 40 amino acids in length and  	                  .         .         .         .         .  
						most preferably at least about 50 amino acids in length,     	     172 LLLCSAPSAAPEALVDSVIAPSRSVLCQEVEVAIPLPARSLLVLTGAARH 221                                                          
						wherein at least two amino acids comprise AE, having a       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						structure as follows: a sequence starting from any of amino  	     201 LLLCSAPSAAPEALVDSVIAPSRSVLCQEVEVAIPLPARSLLVLTGAARH 250                                                          
						acid numbers 54-x to 55; and ending at any of amino acid     	                  .         .         .         .         .  
						numbers 55+ ((n-2) - x), in which x varies from 0 to n-2.    	     222 QWKHAIHRRHIEARRVCVTFRELSAEFGPGGRQQELGQELLRIALSFQGR 271                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QWKHAIHRRHIEARRVCVTFRELSAEFGPGGRQQELGQELLRIALSFQGR 300                                                          
						                                                            	                                                             
						                                                            	     272 PV                                                 273                                                          
						                                                            	         ||                                                  
						                                                            	     301 PV                                                 302                                                          

18191	HMR136_AA525172_1_tr0_r1_1_gPRT		Comparison report between AA525172_P1 and Q9H8Z7unique head  	Sequence name: Q9H8Z7                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AA525172_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 18191 x Q9H8Z7   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MAAGA        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 5 of AA525172_P1, a second  	                                                            
						MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCEIQVHSVDNTR 	                     Quality: 3625.00                      Escore:       0                                               
						MDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRTQKEKEFAENTENLKTKMSEL 	             Matching length:     369                Total length:     369                                               
						RLYCDLLVQQVDKTKEVTTTGVSNSEEGIDVGTLLKSTCNTFLKTLEECMQIANAAFTSE 	 Matching Percent Similarity:   99.73   Matching Percent Identity:   99.73                                               
						LLYRTPPGSPQLAMLKSSKMKHPIIPIHNSLERQMELSTCENGSLNMEING          	    Total Percent Similarity:   99.73      Total Percent Identity:   99.73                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 1 - 231 of Q9H8Z7, which also   	                                                            
						corresponds to amino acids 6 - 236 of AA525172_P1, a bridging	Alignment:                                                   
						amino acid E corresponding to amino acid 237 of AA525172_P1, 	                  .         .         .         .         .  
						EEILMKNKNSLYLKSAEIDCSISSEENTDDNITVQGEIRKEDGMENLKNHDNNLTQSGSD 	       6 MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCE 55                                                           
						SSCSPECLWEEGKEVIPTFFSTMNTSFSDIELLEDSGIPTEAFLASCYAVVPVLDKLGPT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VFAPVKMDLVGNIKKVN                                            	       1 MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCE 50                                                           
						a third amino acid sequence being at least 90 % homologous to	                  .         .         .         .         .  
						corresponding to amino acids 233 - 369 of Q9H8Z7, which also 	      56 IQVHSVDNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRT 105                                                          
						corresponds to amino acids 238 - 374 of AA525172_P1, and a   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence being at least 70%, optionally at 	      51 IQVHSVDNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRT 100                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     106 QKEKEFAENTENLKTKMSELRLYCDLLVQQVDKTKEVTTTGVSNSEEGID 155                                                          
						QKYITNKEEFTTLQKIVLHEVEADVAQVRNSATEALLWLKRGLKFLKGFLTEVKNGEKDI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QTALNNAYGKTLRQHHGWVVRGVFALALRAAPSYEDFVAALTVKEGDHQKEAFSIGMQRD 	     101 QKEKEFAENTENLKTKMSELRLYCDLLVQQVDKTKEVTTTGVSNSEEGID 150                                                          
						LSLYLPAMEKQLAILDTLYEVHGLESDEVV                               	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	     156 VGTLLKSTCNTFLKTLEECMQIANAAFTSELLYRTPPGSPQLAMLKSSKM 205                                                          
						375 - 524 of AA525172_P1, wherein said first amino acid      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, bridging amino acid,   	     151 VGTLLKSTCNTFLKTLEECMQIANAAFTSELLYRTPPGSPQLAMLKSSKM 200                                                          
						third amino acid sequence and fourth amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     206 KHPIIPIHNSLERQMELSTCENGSLNMEINGEEEILMKNKNSLYLKSAEI 255                                                          
						polypeptide encoding for a head of AA525172_P1, comprising a 	         ||||||||||||||||||||||||||||||| ||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     201 KHPIIPIHNSLERQMELSTCENGSLNMEINGGEEILMKNKNSLYLKSAEI 250                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     256 DCSISSEENTDDNITVQGEIRKEDGMENLKNHDNNLTQSGSDSSCSPECL 305                                                          
						to the sequence MAAGA of AA525172_P1.3.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of AA525172_P1, comprising a 	     251 DCSISSEENTDDNITVQGEIRKEDGMENLKNHDNNLTQSGSDSSCSPECL 300                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     306 WEEGKEVIPTFFSTMNTSFSDIELLEDSGIPTEAFLASCYAVVPVLDKLG 355                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QKYITNKEEFTTLQKIVLHEVEADVAQVRNSATEALLWLKRGLKFLKGFLTEVKNGEKDI 	     301 WEEGKEVIPTFFSTMNTSFSDIELLEDSGIPTEAFLASCYAVVPVLDKLG 350                                                          
						QTALNNAYGKTLRQHHGWVVRGVFALALRAAPSYEDFVAALTVKEGDHQKEAFSIGMQRD 	                  .                                          
						LSLYLPAMEKQLAILDTLYEVHGLESDEVV                               	     356 PTVFAPVKMDLVGNIKKVN                                374                                                          
						to the sequence in AA525172_P1.                              	         |||||||||||||||||||                                 
						                                                            	     351 PTVFAPVKMDLVGNIKKVN                                369                                                          

						Comparison report between AA525172_P1 and Q9H274short unique 	Sequence name: Q9H274                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA525172_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 18191 x Q9H274   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence M            	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 1 of AA525172_P1, a second  	                                                            
						AAGAMEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCEIQVHSV 	                     Quality: 3569.00                      Escore:       0                                               
						DNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRTQKEKEFAENTENLKTK 	             Matching length:     362                Total length:     362                                               
						MSELRLYCDLLVQQVDKTKEVTTTGVSNSEEGIDVGTLLKSTCNTFLKTLEECMQIANAA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FTSELLYRTPPGSPQLAMLKSSKMKHPIIPIHNSLERQMELSTCENGSLNMEINGEEEIL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MKNKNSLYLKSAEIDCSISSEENTDDNITVQGEIRKEDGMENLKNHDNNLTQSGSDSSCS 	                        Gaps:       0                        
						PECLWEEGKEVIPTFFSTMNTSFSDIELLEDSGIPTEAFLASCYAVVPVLDKLGPTVFAP 	                                                            
						VK                                                           	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 23 - 384 of Q9H274, which also  	       2 AAGAMEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQM 51                                                           
						corresponds to amino acids 2 - 363 of AA525172_P1, and a     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence being at least 70%, optionally at  	      23 AAGAMEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQM 72                                                           
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	      52 AVCEIQVHSVDNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLT 101                                                          
						MDLVGNIKKVNQKYITNKEEFTTLQKIVLHEVEADVAQVRNSATEALLWLKRGLKFLKGF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LTEVKNGEKDIQTALNNAYGKTLRQHHGWVVRGVFALALRAAPSYEDFVAALTVKEGDHQ 	      73 AVCEIQVHSVDNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLT 122                                                          
						KEAFSIGMQRDLSLYLPAMEKQLAILDTLYEVHGLESDEVV                    	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	     102 DSRTQKEKEFAENTENLKTKMSELRLYCDLLVQQVDKTKEVTTTGVSNSE 151                                                          
						364 - 524 of AA525172_P1, wherein said first amino acid      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence and third amino acid    	     123 DSRTQKEKEFAENTENLKTKMSELRLYCDLLVQQVDKTKEVTTTGVSNSE 172                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of AA525172_P1,     	     152 EGIDVGTLLKSTCNTFLKTLEECMQIANAAFTSELLYRTPPGSPQLAMLK 201                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     173 EGIDVGTLLKSTCNTFLKTLEECMQIANAAFTSELLYRTPPGSPQLAMLK 222                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						MDLVGNIKKVNQKYITNKEEFTTLQKIVLHEVEADVAQVRNSATEALLWLKRGLKFLKGF 	     202 SSKMKHPIIPIHNSLERQMELSTCENGSLNMEINGEEEILMKNKNSLYLK 251                                                          
						LTEVKNGEKDIQTALNNAYGKTLRQHHGWVVRGVFALALRAAPSYEDFVAALTVKEGDHQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KEAFSIGMQRDLSLYLPAMEKQLAILDTLYEVHGLESDEVV                    	     223 SSKMKHPIIPIHNSLERQMELSTCENGSLNMEINGEEEILMKNKNSLYLK 272                                                          
						about 95% homologous to the sequence in AA525172_P1.         	                  .         .         .         .         .  
						                                                            	     252 SAEIDCSISSEENTDDNITVQGEIRKEDGMENLKNHDNNLTQSGSDSSCS 301                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     273 SAEIDCSISSEENTDDNITVQGEIRKEDGMENLKNHDNNLTQSGSDSSCS 322                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     302 PECLWEEGKEVIPTFFSTMNTSFSDIELLEDSGIPTEAFLASCYAVVPVL 351                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     323 PECLWEEGKEVIPTFFSTMNTSFSDIELLEDSGIPTEAFLASCYAVVPVL 372                                                          
						                                                            	                  .                                          
						                                                            	     352 DKLGPTVFAPVK                                       363                                                          
						                                                            	         ||||||||||||                                        
						                                                            	     373 DKLGPTVFAPVK                                       384                                                          

						Comparison report between AA525172_P1 and Q9BU78unique head  	Sequence name: Q9BU78                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA525172_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 18191 x Q9BU78   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MAAGA        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 5 of AA525172_P1, a second  	                                                            
						MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCEIQVHSVDNTR 	                     Quality: 4258.00                      Escore:       0                                               
						MDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRTQKEKEFAENTENLKTKMSEL 	             Matching length:     435                Total length:     435                                               
						RLYCDLLVQQVDKTKEVTTTGVSNSEEGIDVGTLLKSTCNTFLKTLEECMQIANAAFTSE 	 Matching Percent Similarity:   99.77   Matching Percent Identity:   99.77                                               
						LLYRTPPGSPQLAMLKSSKMKHPIIPIHNSLERQMELSTCENGSLNMEINGEEEILMKNK 	    Total Percent Similarity:   99.77      Total Percent Identity:   99.77                                               
						NSLYLKSAEIDCSISSEENTDDNITVQGEIRKEDGMENLKNHDNNLTQSGSDSSCSPECL 	                        Gaps:       0                        
						WEEGKEVIPTFFSTMNTSFSDIELLEDSGIPTEAFLASCYAVVPVLDKLGPTVFAPVKMD 	                                                            
						LVGNIKKVNQKYITNKEEFTTLQKIVLHEVEADVAQVRNSATEALLWLKRGLKFLKGFLT 	Alignment:                                                   
						EVKNGEKDIQTAL                                                	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       6 MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCE 55                                                           
						corresponding to amino acids 1 - 433 of Q9BU78, which also   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 6 - 438 of AA525172_P1, and a     	       1 MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCE 50                                                           
						third amino acid sequence being at least 70%, optionally at  	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	      56 IQVHSVDNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRT 105                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NNAYGKTLRQHHGWVVRGVFALALRAAPSYEDFVAALTVKEGDHQKEAFSIGMQRDLSLY 	      51 IQVHSVDNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRT 100                                                          
						LPAMEKQLAILDTLYEVHGLESDEVV                                   	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	     106 QKEKEFAENTENLKTKMSELRLYCDLLVQQVDKTKEVTTTGVSNSEEGID 155                                                          
						439 - 524 of AA525172_P1, wherein said first amino acid      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence and third amino acid    	     101 QKEKEFAENTENLKTKMSELRLYCDLLVQQVDKTKEVTTTGVSNSEEGID 150                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of AA525172_P1,     	     156 VGTLLKSTCNTFLKTLEECMQIANAAFTSELLYRTPPGSPQLAMLKSSKM 205                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     151 VGTLLKSTCNTFLKTLEECMQIANAAFTSELLYRTPPGSPQLAMLKSSKM 200                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence MAAGA of                	     206 KHPIIPIHNSLERQMELSTCENGSLNMEINGEEEILMKNKNSLYLKSAEI 255                                                          
						AA525172_P1.3.An isolated polypeptide encoding for a tail of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA525172_P1, comprising a polypeptide being at least 70%,    	     201 KHPIIPIHNSLERQMELSTCENGSLNMEINGEEEILMKNKNSLYLKSAEI 250                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     256 DCSISSEENTDDNITVQGEIRKEDGMENLKNHDNNLTQSGSDSSCSPECL 305                                                          
						NNAYGKTLRQHHGWVVRGVFALALRAAPSYEDFVAALTVKEGDHQKEAFSIGMQRDLSLY 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPAMEKQLAILDTLYEVHGLESDEVV                                   	     251 DCSISSEENTDDNITVQGEIRKEDGMENLKNHDNNLTQSGSDSSCSPECL 300                                                          
						least about 95% homologous to the sequence in AA525172_P1.   	                  .         .         .         .         .  
						                                                            	     306 WEEGKEVIPTFFSTMNTSFSDIELLEDSGIPTEAFLASCYAVVPVLDKLG 355                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 WEEGKEVIPTFFSTMNTSFSDIELLEDSGIPTEAFLASCYAVVPVLDKLG 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     356 PTVFAPVKMDLVGNIKKVNQKYITNKEEFTTLQKIVLHEVEADVAQVRNS 405                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 PTVFAPVKMDLVGNIKKVNQKYITNKEEFTTLQKIVLHEVEADVAQVRNS 400                                                          
						                                                            	                  .         .         .                      
						                                                            	     406 ATEALLWLKRGLKFLKGFLTEVKNGEKDIQTALNN                440                                                          
						                                                            	         ||||||||||||||||||||||||||||||||| |                 
						                                                            	     401 ATEALLWLKRGLKFLKGFLTEVKNGEKDIQTALRN                435                                                          

18189	HMR136_AA525172_8_tr0_r1_1_gPRT		Comparison report between AA525172_P8 and Q9H8Z7unique head  	Sequence name: Q9H8Z7                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA525172_P8, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 18189 x Q9H8Z7   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MAAGA        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 5 of AA525172_P8, a second  	                                                            
						MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCEIQVHSVDNTR 	                     Quality: 1456.00                      Escore:       0                                               
						MDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRTQKEKEFAENTENLKTKMSEL 	             Matching length:     146                Total length:     146                                               
						RLYCDLLVQQVDKTKEVTTTGVSNSE                                   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 146 of Q9H8Z7, which also   	                        Gaps:       0                        
						corresponds to amino acids 6 - 151 of AA525172_P8, and a     	                                                            
						third amino acid sequence being at least 70%, optionally at  	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       6 MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCE 55                                                           
						polypeptide having the sequence VKESSTLVVS corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 152 - 161 of AA525172_P8, wherein said first     	       1 MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCE 50                                                           
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	      56 IQVHSVDNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRT 105                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA525172_P8, comprising a polypeptide being at least 70%,    	      51 IQVHSVDNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRT 100                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .            
						more preferably at least about 90% and most preferably at    	     106 QKEKEFAENTENLKTKMSELRLYCDLLVQQVDKTKEVTTTGVSNSE     151                                                          
						least about 95% homologous to the sequence MAAGA of          	         ||||||||||||||||||||||||||||||||||||||||||||||      
						AA525172_P8.3.An isolated polypeptide encoding for a tail of 	     101 QKEKEFAENTENLKTKMSELRLYCDLLVQQVDKTKEVTTTGVSNSE     146                                                          
						AA525172_P8, comprising a polypeptide being at least 70%,    	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence VKESSTLVVS in     	                                                            
						AA525172_P8.                                                 	                                                            

						Comparison report between AA525172_P8 and Q9H274short unique 	Sequence name: Q9H274                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA525172_P8, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 18189 x Q9H274   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence M            	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 1 of AA525172_P8, a second  	                                                            
						AAGAMEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCEIQVHSV 	                     Quality: 1489.00                      Escore:       0                                               
						DNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRTQKEKEFAENTENLKTK 	             Matching length:     150                Total length:     150                                               
						MSELRLYCDLLVQQVDKTKEVTTTGVSNSE                               	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 23 - 172 of Q9H274, which also  	                        Gaps:       0                        
						corresponds to amino acids 2 - 151 of AA525172_P8, and a     	                                                            
						third amino acid sequence being at least 70%, optionally at  	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       2 AAGAMEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQM 51                                                           
						polypeptide having the sequence VKESSTLVVS corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 152 - 161 of AA525172_P8, wherein said first     	      23 AAGAMEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQM 72                                                           
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	      52 AVCEIQVHSVDNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLT 101                                                          
						order.2.An isolated polypeptide encoding for a tail of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA525172_P8, comprising a polypeptide being at least 70%,    	      73 AVCEIQVHSVDNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLT 122                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     102 DSRTQKEKEFAENTENLKTKMSELRLYCDLLVQQVDKTKEVTTTGVSNSE 151                                                          
						least about 95% homologous to the sequence VKESSTLVVS in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA525172_P8.                                                 	     123 DSRTQKEKEFAENTENLKTKMSELRLYCDLLVQQVDKTKEVTTTGVSNSE 172                                                          

						Comparison report between AA525172_P8 and Q9BU78unique head  	Sequence name: Q9BU78                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA525172_P8, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 18189 x Q9BU78   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MAAGA        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 5 of AA525172_P8, a second  	                                                            
						MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCEIQVHSVDNTR 	                     Quality: 1456.00                      Escore:       0                                               
						MDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRTQKEKEFAENTENLKTKMSEL 	             Matching length:     146                Total length:     146                                               
						RLYCDLLVQQVDKTKEVTTTGVSNSE                                   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 146 of Q9BU78, which also   	                        Gaps:       0                        
						corresponds to amino acids 6 - 151 of AA525172_P8, and a     	                                                            
						third amino acid sequence being at least 70%, optionally at  	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       6 MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCE 55                                                           
						polypeptide having the sequence VKESSTLVVS corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 152 - 161 of AA525172_P8, wherein said first     	       1 MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCE 50                                                           
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	      56 IQVHSVDNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRT 105                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA525172_P8, comprising a polypeptide being at least 70%,    	      51 IQVHSVDNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRT 100                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .            
						more preferably at least about 90% and most preferably at    	     106 QKEKEFAENTENLKTKMSELRLYCDLLVQQVDKTKEVTTTGVSNSE     151                                                          
						least about 95% homologous to the sequence MAAGA of          	         ||||||||||||||||||||||||||||||||||||||||||||||      
						AA525172_P8.3.An isolated polypeptide encoding for a tail of 	     101 QKEKEFAENTENLKTKMSELRLYCDLLVQQVDKTKEVTTTGVSNSE     146                                                          
						AA525172_P8, comprising a polypeptide being at least 70%,    	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence VKESSTLVVS in     	                                                            
						AA525172_P8.                                                 	                                                            

						Comparison report between AA525172_P8 and Q96JA3unique head  	Sequence name: Q96JA3                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA525172_P8, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 18189 x Q96JA3   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MAAGA        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 5 of AA525172_P8, a second  	                                                            
						MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCEIQVHSVDNTR 	                     Quality: 1456.00                      Escore:       0                                               
						MDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRTQKEKEFAENTENLKTKMSEL 	             Matching length:     146                Total length:     146                                               
						RLYCDLLVQQVDKTKEVTTTGVSNSE                                   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 146 of Q96JA3, which also   	                        Gaps:       0                        
						corresponds to amino acids 6 - 151 of AA525172_P8, and a     	                                                            
						third amino acid sequence being at least 70%, optionally at  	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       6 MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCE 55                                                           
						polypeptide having the sequence VKESSTLVVS corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 152 - 161 of AA525172_P8, wherein said first     	       1 MEGVLYKWTNYLSGWQPRWFLLCGGILSYYDSPEDAWKGCKGSIQMAVCE 50                                                           
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	      56 IQVHSVDNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRT 105                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA525172_P8, comprising a polypeptide being at least 70%,    	      51 IQVHSVDNTRMDLIIPGEQYFYLKARSVAERQRWLVALGSAKACLTDSRT 100                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .            
						more preferably at least about 90% and most preferably at    	     106 QKEKEFAENTENLKTKMSELRLYCDLLVQQVDKTKEVTTTGVSNSE     151                                                          
						least about 95% homologous to the sequence MAAGA of          	         ||||||||||||||||||||||||||||||||||||||||||||||      
						AA525172_P8.3.An isolated polypeptide encoding for a tail of 	     101 QKEKEFAENTENLKTKMSELRLYCDLLVQQVDKTKEVTTTGVSNSE     146                                                          
						AA525172_P8, comprising a polypeptide being at least 70%,    	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence VKESSTLVVS in     	                                                            
						AA525172_P8.                                                 	                                                            

18523	HMR136_AA525310_1_tr0_r1_1_gPRT		Comparison report between AA525310_P1 and Q9P225partial WT   	Sequence name: Q9P225                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA525310_P1, comprising a first     	Sequence documentation:                                      
						MSSKAEKKQRLSGRGSSQASWSGRATRAAVATQEQGNAPAVSEPELQAELPKEEPEPRLE 	                                                            
						GPQAQSEESVEPEADVKPLFLSRAALTGLADAVWTQEHDAILEHFAQDPTESILTIFIDP 	Alignment of: 18523 x Q9P225   ..                            
						CFGLKLELGMPVQTQNQLVYFIRQAPVPITWENFEATVQFGTVRGPYIPALLRLLGGVFA 	                                                            
						PQIFANTGWPESIRNHFASHLHKFLACLTDTRYKLEGHTVLYIPAEAMNMKPEMVIKDKE 	Alignment segment 1/1:                                       
						LVQRLETSMIHWTRQIKEMLSAQETVETGENLGPLEEIEFWRNRCMDLSGISKQLVKKGV 	                                                            
						KHVESILHLAKSSYLAPFMKLAQQIQDGSRQAQSNLTFLSILKEPYQELAFMKPKDISSK 	                     Quality: 3832.00                      Escore:       0                                               
						LPKLISLIRIIWVNSPHYNTRERLTSLFRKV                              	             Matching length:     391                Total length:     391                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 38 - 428 of Q9P225, which also  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 391 of AA525310_P1, and a     	                        Gaps:       0                        
						second amino acid sequence being at least 70%, optionally at 	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence LQSGLGPRSDQHLCSG             	       1 MSSKAEKKQRLSGRGSSQASWSGRATRAAVATQEQGNAPAVSEPELQAEL 50                                                           
						corresponding to amino acids 392 - 407 of AA525310_P1,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence and second amino acid 	      38 MSSKAEKKQRLSGRGSSQASWSGRATRAAVATQEQGNAPAVSEPELQAEL 87                                                           
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of AA525310_P1,     	      51 PKEEPEPRLEGPQAQSEESVEPEADVKPLFLSRAALTGLADAVWTQEHDA 100                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	      88 PKEEPEPRLEGPQAQSEESVEPEADVKPLFLSRAALTGLADAVWTQEHDA 137                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence LQSGLGPRSDQHLCSG in     	     101 ILEHFAQDPTESILTIFIDPCFGLKLELGMPVQTQNQLVYFIRQAPVPIT 150                                                          
						AA525310_P1.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     138 ILEHFAQDPTESILTIFIDPCFGLKLELGMPVQTQNQLVYFIRQAPVPIT 187                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 WENFEATVQFGTVRGPYIPALLRLLGGVFAPQIFANTGWPESIRNHFASH 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     188 WENFEATVQFGTVRGPYIPALLRLLGGVFAPQIFANTGWPESIRNHFASH 237                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LHKFLACLTDTRYKLEGHTVLYIPAEAMNMKPEMVIKDKELVQRLETSMI 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     238 LHKFLACLTDTRYKLEGHTVLYIPAEAMNMKPEMVIKDKELVQRLETSMI 287                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 HWTRQIKEMLSAQETVETGENLGPLEEIEFWRNRCMDLSGISKQLVKKGV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     288 HWTRQIKEMLSAQETVETGENLGPLEEIEFWRNRCMDLSGISKQLVKKGV 337                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 KHVESILHLAKSSYLAPFMKLAQQIQDGSRQAQSNLTFLSILKEPYQELA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     338 KHVESILHLAKSSYLAPFMKLAQQIQDGSRQAQSNLTFLSILKEPYQELA 387                                                          
						                                                            	                  .         .         .         .            
						                                                            	     351 FMKPKDISSKLPKLISLIRIIWVNSPHYNTRERLTSLFRKV          391                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||           
						                                                            	     388 FMKPKDISSKLPKLISLIRIIWVNSPHYNTRERLTSLFRKV          428                                                          

20670	HMR136_AA527539_7_tr0_r1_1_gPRT		Comparison report between AA527539_P7 and Q8N990partial WT   	Sequence name: Q8N990                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA527539_P7, comprising a first amino acid sequence being at 	                                                            
						least 90 % homologous to MDEADFSEHTTYKQEDLPYDGDLSQIKIGNDYSFTSKKDGLEVLNQIIFIADDPQEKAMH                                    	Alignment of: 20670 x Q8N990   ..                            
						corresponding to amino acids 1 - 60 of Q8N990, which also    	                                                            
						corresponds to amino acids 1 - 60 of AA527539_P7, a bridging 	Alignment segment 1/1:                                       
						amino acid S corresponding to amino acid 61 of AA527539_P7, a	                                                            
						ETCGNTAVTIPLGKITENAANKKDEKEKQCTAALHIPANEGDASKSSISDILLHHLSKEP 	                     Quality: 4085.00                      Escore:       0                                               
						FLRGQGIDCETLPEISNADSFEEEAIIKSIISCYNKNSWPKEQTPELTDQLNPKRDGENS 	             Matching length:     417                Total length:     417                                               
						NKPGSATTTEENTSDLEGPVAAGDSSHQENVNVLTKTKGPGDKQKSYQGQSPQKQQTEKA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.52                                               
						NSGNTFKYGQGQVHYQLPDFSKIAPKVKIPKNKIINKPLAIAKQASFSSKSRDKPTLVQD 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.52                                               
						SLETTPESNCVEKQHQEQKGKITEPSQQIQMEPIVHIHQELLTGIESEASLSKLSPTSQK 	                        Gaps:       0                        
						GTSSSSSYIFQKISQGKQMCQKLKEQTDQLKTKVQEFSKRIKQDSPYHLQDKKLV      	                                                            
						second amino acid sequence being at least 90 % homologous to 	Alignment:                                                   
						corresponding to amino acids 62 - 416 of Q8N990, which also  	                  .         .         .         .         .  
						corresponds to amino acids 62 - 416 of AA527539_P7, and a    	       1 MDEADFSEHTTYKQEDLPYDGDLSQIKIGNDYSFTSKKDGLEVLNQIIFI 50                                                           
						third amino acid sequence being at least 70%, optionally at  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	       1 MDEADFSEHTTYKQEDLPYDGDLSQIKIGNDYSFTSKKDGLEVLNQIIFI 50                                                           
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence MNFIPFLKS corresponding to   	      51 ADDPQEKAMHSETCGNTAVTIPLGKITENAANKKDEKEKQCTAALHIPAN 100                                                          
						amino acids 417 - 425 of AA527539_P7, wherein said first     	         ||||||||||:|||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, bridging amino acid, second amino acid  	      51 ADDPQEKAMHNETCGNTAVTIPLGKITENAANKKDEKEKQCTAALHIPAN 100                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     101 EGDASKSSISDILLHHLSKEPFLRGQGIDCETLPEISNADSFEEEAIIKS 150                                                          
						tail of AA527539_P7, comprising a polypeptide being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     101 EGDASKSSISDILLHHLSKEPFLRGQGIDCETLPEISNADSFEEEAIIKS 150                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence MNFIPFLKS in   	     151 IISCYNKNSWPKEQTPELTDQLNPKRDGENSNKPGSATTTEENTSDLEGP 200                                                          
						AA527539_P7.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 IISCYNKNSWPKEQTPELTDQLNPKRDGENSNKPGSATTTEENTSDLEGP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VAAGDSSHQENVNVLTKTKGPGDKQKSYQGQSPQKQQTEKANSGNTFKYG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VAAGDSSHQENVNVLTKTKGPGDKQKSYQGQSPQKQQTEKANSGNTFKYG 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 QGQVHYQLPDFSKIAPKVKIPKNKIINKPLAIAKQASFSSKSRDKPTLVQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QGQVHYQLPDFSKIAPKVKIPKNKIINKPLAIAKQASFSSKSRDKPTLVQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 DSLETTPESNCVEKQHQEQKGKITEPSQQIQMEPIVHIHQELLTGIESEA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 DSLETTPESNCVEKQHQEQKGKITEPSQQIQMEPIVHIHQELLTGIESEA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SLSKLSPTSQKGTSSSSSYIFQKISQGKQMCQKLKEQTDQLKTKVQEFSK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 SLSKLSPTSQKGTSSSSSYIFQKISQGKQMCQKLKEQTDQLKTKVQEFSK 400                                                          
						                                                            	                  .                                          
						                                                            	     401 RIKQDSPYHLQDKKLVM                                  417                                                          
						                                                            	         ||||||||||||||||:                                   
						                                                            	     401 RIKQDSPYHLQDKKLVL                                  417                                                          

						Comparison report between AA527539_P7 and Q8NCN9partial WT   	Sequence name: Q8NCN9                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA527539_P7, comprising a first amino acid sequence being at 	                                                            
						MDEADFSEHTTYKQEDLPYDGDLSQIKIGNDYSFTSKKDGLEVLNQIIFIADDPQEKAMH 	Alignment of: 20670 x Q8NCN9   ..                            
						SETCGNTAVTIPLGKITENAANKKDEKEKQCTAALHIPANEGDASKSSISDILLHHLSKE 	                                                            
						PFLRGQGIDCETLPEISNADSFEEEAIIKSIISCYNKNSWPKEQTP               	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 166	                                                            
						of Q8NCN9, which also corresponds to amino acids 1 - 166 of  	                     Quality: 4067.00                      Escore:       0                                               
						AA527539_P7, a bridging amino acid E corresponding to amino  	             Matching length:     415                Total length:     415                                               
						acid 167 of AA527539_P7, a second amino acid sequence being  	 Matching Percent Similarity:   99.76   Matching Percent Identity:   99.76                                               
						LTDQLNPKRDGENSNKPGSATTTEENTSDLEGPVAAGDSSHQENVNVLTKTKGPGDKQKS 	    Total Percent Similarity:   99.76      Total Percent Identity:   99.76                                               
						YQGQSPQKQQTEKANSGNTFKYGQGQVHYQLPDFSKIAPKVKIPKNKIINKPLAIAKQAS 	                        Gaps:       0                        
						FSSKSRDKPTLVQDSLETTPESNCVEKQHQEQKGKITEPSQQIQMEPIVHIHQELLTGIE 	                                                            
						SEASLSKLSPTSQKGTSSSSSYIFQKISQGKQMCQKLKEQTDQLKTKVQEFSKRIKQDSP 	Alignment:                                                   
						YHLQDKKL                                                     	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 168 	       1 MDEADFSEHTTYKQEDLPYDGDLSQIKIGNDYSFTSKKDGLEVLNQIIFI 50                                                           
						- 415 of Q8NCN9, which also corresponds to amino acids 168 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						415 of AA527539_P7, and a third amino acid sequence being at 	       1 MDEADFSEHTTYKQEDLPYDGDLSQIKIGNDYSFTSKKDGLEVLNQIIFI 50                                                           
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	      51 ADDPQEKAMHSETCGNTAVTIPLGKITENAANKKDEKEKQCTAALHIPAN 100                                                          
						homologous to a polypeptide having the sequence VMNFIPFLKS   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 416 - 425 of AA527539_P7,       	      51 ADDPQEKAMHSETCGNTAVTIPLGKITENAANKKDEKEKQCTAALHIPAN 100                                                          
						wherein said first amino acid sequence, bridging amino acid, 	                  .         .         .         .         .  
						second amino acid sequence and third amino acid sequence are 	     101 EGDASKSSISDILLHHLSKEPFLRGQGIDCETLPEISNADSFEEEAIIKS 150                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of AA527539_P7, comprising a 	     101 EGDASKSSISDILLHHLSKEPFLRGQGIDCETLPEISNADSFEEEAIIKS 150                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     151 IISCYNKNSWPKEQTPELTDQLNPKRDGENSNKPGSATTTEENTSDLEGP 200                                                          
						about 90% and most preferably at least about 95% homologous  	         |||||||||||||||| |||||||||||||||||||||||||||||||||  
						to the sequence VMNFIPFLKS in AA527539_P7.                   	     151 IISCYNKNSWPKEQTPGLTDQLNPKRDGENSNKPGSATTTEENTSDLEGP 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VAAGDSSHQENVNVLTKTKGPGDKQKSYQGQSPQKQQTEKANSGNTFKYG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VAAGDSSHQENVNVLTKTKGPGDKQKSYQGQSPQKQQTEKANSGNTFKYG 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 QGQVHYQLPDFSKIAPKVKIPKNKIINKPLAIAKQASFSSKSRDKPTLVQ 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 QGQVHYQLPDFSKIAPKVKIPKNKIINKPLAIAKQASFSSKSRDKPTLVQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 DSLETTPESNCVEKQHQEQKGKITEPSQQIQMEPIVHIHQELLTGIESEA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 DSLETTPESNCVEKQHQEQKGKITEPSQQIQMEPIVHIHQELLTGIESEA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SLSKLSPTSQKGTSSSSSYIFQKISQGKQMCQKLKEQTDQLKTKVQEFSK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 SLSKLSPTSQKGTSSSSSYIFQKISQGKQMCQKLKEQTDQLKTKVQEFSK 400                                                          
						                                                            	                  .                                          
						                                                            	     401 RIKQDSPYHLQDKKL                                    415                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     401 RIKQDSPYHLQDKKL                                    415                                                          

20843	HMR136_AA528179_4_tr0_r1_1_gPRT		Comparison report between AA528179_P4 and TMS3_HUMANunique   	Sequence name: TMS3_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA528179_P4, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 20843 x TMS3_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MAAPEMEVEVEAEPDVRGPEIVT corresponding to 	Alignment segment 1/1:                                       
						amino acids 1 - 23 of AA528179_P4, and a second amino acid   	                                                            
						MGENDPPAVEAPFSFRSLFGLDDLKISPVAPDADAVAAQILSLLPLKFFPIIVIGIIALI 	                     Quality: 4487.00                      Escore:       0                                               
						LALAIGLGIHFDCSGKYRCRSSFKCIELIARCDGVSDCKDGEDEYRCVRVGGQNAVLQVF 	             Matching length:     454                Total length:     454                                               
						TAASWKTMCSDDWKGHYANVACAQLGFPSYVSSDNLRVSSLEGQFREEFVSIDHLLPDDK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VTALHHSVYVREGCASGHVVTLQCTACGHRRGYSSRIVGGNMSLLSQWPWQASLQFQGYH 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LCGGSVITPLWIITAAHCVYDLYLPKSWTIQVGLVSLLDNPAPSHLVEKIVYHSKYKPKR 	                        Gaps:       0                        
						LGNDIALMKLAGPLTFNEMIQPVCLPNSEENFPDGKVCWTSGWGATEDGAGDASPVLNHA 	                                                            
						AVPLISNKICNHRDVYGGIISPSMLCAGYLTGGVDSCQGDSGGPLVCQERRLWKLVGATS 	Alignment:                                                   
						FGIGCAEVNKPGVYTRVTSFLDWIHEQMERDLKT                           	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	      24 MGENDPPAVEAPFSFRSLFGLDDLKISPVAPDADAVAAQILSLLPLKFFP 73                                                           
						amino acids 1 - 454 of TMS3_HUMAN, which also corresponds to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 24 - 477 of AA528179_P4, wherein said first amino	       1 MGENDPPAVEAPFSFRSLFGLDDLKISPVAPDADAVAAQILSLLPLKFFP 50                                                           
						acid sequence and second amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated polypeptide encoding 	      74 IIVIGIIALILALAIGLGIHFDCSGKYRCRSSFKCIELIARCDGVSDCKD 123                                                          
						for a head of AA528179_P4, comprising a polypeptide being at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	      51 IIVIGIIALILALAIGLGIHFDCSGKYRCRSSFKCIELIARCDGVSDCKD 100                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     124 GEDEYRCVRVGGQNAVLQVFTAASWKTMCSDDWKGHYANVACAQLGFPSY 173                                                          
						MAAPEMEVEVEAEPDVRGPEIVT of AA528179_P4.                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 GEDEYRCVRVGGQNAVLQVFTAASWKTMCSDDWKGHYANVACAQLGFPSY 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     174 VSSDNLRVSSLEGQFREEFVSIDHLLPDDKVTALHHSVYVREGCASGHVV 223                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VSSDNLRVSSLEGQFREEFVSIDHLLPDDKVTALHHSVYVREGCASGHVV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     224 TLQCTACGHRRGYSSRIVGGNMSLLSQWPWQASLQFQGYHLCGGSVITPL 273                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 TLQCTACGHRRGYSSRIVGGNMSLLSQWPWQASLQFQGYHLCGGSVITPL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     274 WIITAAHCVYDLYLPKSWTIQVGLVSLLDNPAPSHLVEKIVYHSKYKPKR 323                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 WIITAAHCVYDLYLPKSWTIQVGLVSLLDNPAPSHLVEKIVYHSKYKPKR 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     324 LGNDIALMKLAGPLTFNEMIQPVCLPNSEENFPDGKVCWTSGWGATEDGA 373                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 LGNDIALMKLAGPLTFNEMIQPVCLPNSEENFPDGKVCWTSGWGATEDGA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     374 GDASPVLNHAAVPLISNKICNHRDVYGGIISPSMLCAGYLTGGVDSCQGD 423                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 GDASPVLNHAAVPLISNKICNHRDVYGGIISPSMLCAGYLTGGVDSCQGD 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     424 SGGPLVCQERRLWKLVGATSFGIGCAEVNKPGVYTRVTSFLDWIHEQMER 473                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 SGGPLVCQERRLWKLVGATSFGIGCAEVNKPGVYTRVTSFLDWIHEQMER 450                                                          
						                                                            	                                                             
						                                                            	     474 DLKT                                               477                                                          
						                                                            	         ||||                                                
						                                                            	     451 DLKT                                               454                                                          

21465	HMR136_AA530994_6_tr0_r1_1_gPRT		Comparison report between AA530994_P6 and GHRL_HUMANpartial  	Sequence name: GHRL_HUMAN                                    
						WT sequence featuring skipped exon and a followed by a unique	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA530994_P6, comprising a first amino acid sequence being at 	                                                            
						least 90 % homologous to MPSPGTVCSLLLLGMLWLDLAMAGSSFLSPEHQRVQ	Alignment of: 21465 x GHRL_HUMAN   ..                        
						corresponding to amino acids 1 - 36 of GHRL_HUMAN, which also	                                                            
						corresponds to amino acids 1 - 36 of AA530994_P6, a second   	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						FNAPFDVGIKLSGVQYQQHSQALGKFLQDILWEEAK corresponding to amino  	                     Quality:  612.00                      Escore:       0                                               
						acids 76 - 111 of GHRL_HUMAN, which also corresponds to amino	             Matching length:      72                Total length:     111                                               
						acids 37 - 72 of AA530994_P6, and a third amino acid sequence	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						being at least 70%, optionally at least 80%, preferably at   	    Total Percent Similarity:   64.86      Total Percent Identity:   64.86                                               
						least 85%, more preferably at least 90% and most preferably  	                        Gaps:       1                        
						at least 95% homologous to a polypeptide having the sequence 	                                                            
						GESCLDWVCSVSLQPHMGVHSVGDEFSPTSASPKELLISLSQRSAG corresponding 	Alignment:                                                   
						to amino acids 73 - 118 of AA530994_P6, wherein said first   	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence and third    	       1 MPSPGTVCSLLLLGMLWLDLAMAGSSFLSPEHQRVQ.............. 36                                                           
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||                
						order.2.An isolated chimeric polypeptide encoding for an edge	       1 MPSPGTVCSLLLLGMLWLDLAMAGSSFLSPEHQRVQQRKESKKPPAKLQP 50                                                           
						portion of AA530994_P6, comprising a polypeptide having a    	                  .         .         .         .         .  
						length "n", wherein n is at least about 10 amino acids in    	      37 .........................FNAPFDVGIKLSGVQYQQHSQALGK 61                                                           
						length, optionally at least about 20 amino acids in length,  	                                  |||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	      51 RALAGWLRPEDGGQAEGAEDELEVRFNAPFDVGIKLSGVQYQQHSQALGK 100                                                          
						preferably at least about 40 amino acids in length and most  	                  .                                          
						preferably at least about 50 amino acids in length, wherein  	      62 FLQDILWEEAK                                        72                                                           
						at least two amino acids comprise QF, having a structure as  	         |||||||||||                                         
						follows: a sequence starting from any of amino acid numbers  	     101 FLQDILWEEAK                                        111                                                          
						36-x to 37; and ending at any of amino acid numbers 37+      	                                                            
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	                                                            
						polypeptide encoding for a tail of AA530994_P6, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence                                              	                                                            
						GESCLDWVCSVSLQPHMGVHSVGDEFSPTSASPKELLISLSQRSAG in            	                                                            
						AA530994_P6.                                                 	                                                            

1948	HMR136_AA533512_2_tr0_r1_1_gPRT		Comparison report between AA533512_P2 and O96030partial WT   	Sequence name: O96030                                        
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for AA533512_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MELGLGGLSTLSHCPWPRR corresponding to amino acids 1 - 19 of   	Alignment of: 1948 x O96030   ..                             
						O96030, which also corresponds to amino acids 1 - 19 of      	                                                            
						AA533512_P2, a second amino acid sequence being at least 70%,	Alignment segment 1/1:                                       
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	                     Quality: 2073.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence QAPLGLSA     	             Matching length:     220                Total length:     228                                               
						corresponding to amino acids 20 - 27 of AA533512_P2, and a   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QPALWPTLAALALLSSVAEASLGSAPRSPAPREGPPPVLASPAGHLPGGRTARWCSGRAR 	    Total Percent Similarity:   96.49      Total Percent Identity:   96.49                                               
						RPPPQPSRPAPPPPAPPSALPRGGRAARAGGPGSRARAAGARGCRLRSQLVPVRALGLGH 	                        Gaps:       1                        
						RSDELVRFRFCSGSCRRARSPHDLSLASLLGAGALRPPPGSRPVSQPCCRPTRYEAVSFM 	                                                            
						DVNSTWRTVDRLSATACGCLG                                        	Alignment:                                                   
						third amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 20 - 220 of O96030, which also  	       1 MELGLGGLSTLSHCPWPRRQAPLGLSAQPALWPTLAALALLSSVAEASLG 50                                                           
						corresponds to amino acids 28 - 228 of AA533512_P2, wherein  	         |||||||||||||||||||        |||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence   	       1 MELGLGGLSTLSHCPWPRR........QPALWPTLAALALLSSVAEASLG 42                                                           
						and third amino acid sequence are contiguous and in a        	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for an   	      51 SAPRSPAPREGPPPVLASPAGHLPGGRTARWCSGRARRPPPQPSRPAPPP 100                                                          
						edge portion of AA533512_P2, comprising an amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least about 80%,  	      43 SAPRSPAPREGPPPVLASPAGHLPGGRTARWCSGRARRPPPQPSRPAPPP 92                                                           
						preferably at least about 85%, more preferably at least about	                  .         .         .         .         .  
						90% and most preferably at least about 95% homologous to the 	     101 PAPPSALPRGGRAARAGGPGSRARAAGARGCRLRSQLVPVRALGLGHRSD 150                                                          
						sequence encoding for QAPLGLSA, corresponding to AA533512_P2.	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      93 PAPPSALPRGGRAARAGGPGSRARAAGARGCRLRSQLVPVRALGLGHRSD 142                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ELVRFRFCSGSCRRARSPHDLSLASLLGAGALRPPPGSRPVSQPCCRPTR 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     143 ELVRFRFCSGSCRRARSPHDLSLASLLGAGALRPPPGSRPVSQPCCRPTR 192                                                          
						                                                            	                  .         .                                
						                                                            	     201 YEAVSFMDVNSTWRTVDRLSATACGCLG                       228                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     193 YEAVSFMDVNSTWRTVDRLSATACGCLG                       220                                                          

23561	HMR136_AA535099_0_tr0_r1_1_gPRT		Comparison report between AA535099_P0 and Q8N1H2unique head  	Sequence name: Q8N1H2                                        
						followed by partial WT sequence featuring a skipped exon plus	                                                            
						extra amino acids, a mismatch and a followed by a unique     	Sequence documentation:                                      
						tail.1.An isolated chimeric polypeptide encoding for         	                                                            
						AA535099_P0, comprising a first amino acid sequence being at 	Alignment of: 23561 x Q8N1H2   ..                            
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence              	                                                            
						MGILSITDQPPLVQAIFSRDVEEVRSLLSQKENINVL corresponding to amino 	                     Quality: 2352.00                      Escore:       0                                               
						acids 1 - 37 of AA535099_P0, a second amino acid sequence    	             Matching length:     260                Total length:     279                                               
						being at least 90 % homologous to DQERRTPLHAAAYVGDVPILQLLL   	 Matching Percent Similarity:   99.62   Matching Percent Identity:   98.85                                               
						corresponding to amino acids 37 - 60 of Q8N1H2, which also   	    Total Percent Similarity:   92.83      Total Percent Identity:   92.11                                               
						corresponds to amino acids 38 - 61 of AA535099_P0, a third   	                        Gaps:       1                        
						amino acid sequence bridging amino acid sequence comprising  	                                                            
						of MS, a fourth amino acid sequence being at least 90 %      	Alignment:                                                   
						homologous to GANVNAKDTLWL corresponding to amino acids 82 - 	                  .         .         .         .         .  
						93 of Q8N1H2, which also corresponds to amino acids 64 - 75  	      38 DQERRTPLHAAAYVGDVPILQLLLM...................SGANVN 68                                                           
						of AA535099_P0, a bridging amino acid T corresponding to     	         ||||||||||||||||||||||||:                   :|||||  
						amino acid 76 of AA535099_P0, a fifth amino acid sequence    	      37 DQERRTPLHAAAYVGDVPILQLLLITGFLHTSSPPSIKIGNYIPTGANVN 86                                                           
						PLHRAAASRNEKVLGLLLAHSADVNARDKLWQTPLHVAAANRATKCAEALAPLLSSLNVA 	                  .         .         .         .         .  
						DRSGRSALHHAVHSGHLETVNLLLNKGASLNVCDKKERQPLHWAAFLGHLEVLKLLVARG 	      69 AKDTLWLTPLHRAAASRNEKVLGLLLAHSADVNARDKLWQTPLHVAAANR 118                                                          
						ADLGCKDRKGYGLLHTAAASGQIEVVKYLLRMGAEIDEPNAFGNTALHIACYLGQDAVAI 	         ||||||| ||||||||||||||||||||||||||||||||||||||||||  
						ELVNAGANVNQPNDKGFTPLHVAAVSTNGALCLELLVNNGA                    	      87 AKDTLWLAPLHRAAASRNEKVLGLLLAHSADVNARDKLWQTPLHVAAANR 136                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 95 - 315 of Q8N1H2, which also corresponds to amino    	     119 ATKCAEALAPLLSSLNVADRSGRSALHHAVHSGHLETVNLLLNKGASLNV 168                                                          
						acids 77 - 297 of AA535099_P0, and a sixth amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     137 ATKCAEALAPLLSSLNVADRSGRSALHHAVHSGHLETVNLLLNKGASLNV 186                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     169 CDKKERQPLHWAAFLGHLEVLKLLVARGADLGCKDRKGYGLLHTAAASGQ 218                                                          
						DVNYQSKEGKSPLHMAAIHGRFTRSQILIQNGSEIDCADKFGNTPLHVAARYGHELLIST 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LMTNGADTARRGIHDMFPLHLAVLFGFSDCCRKLLSSGQLYSIVSSLSNEHVLSAGFDIN 	     187 CDKKERQPLHWAAFLGHLEVLKLLVARGADLGCKDRKGYGLLHTAAASGQ 236                                                          
						TPDNLGRTCLHAAASGGNVECLNLLLSSGADLRRRDKFGRTPLHYAAANGSYQCAVTLVT 	                  .         .         .         .         .  
						AGAGVNEADCKGCSPLHYAAASDTYRRAEPHTPSSHDAEEDEPLKESRRKEAFFCLEFLL 	     219 IEVVKYLLRMGAEIDEPNAFGNTALHIACYLGQDAVAIELVNAGANVNQP 268                                                          
						DNGADPSLRDRQGYTAVHYAAAYGNRQNLELLLEMSFNCLEDVESTIPVSPLHLAAYNGH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CEALKTLAETLVNLDVRDHKGRTALFLATERGSTECVEVLTAHGASALIKERKRKWTPLH 	     237 IEVVKYLLRMGAEIDEPNAFGNTALHIACYLGQDAVAIELVNAGANVNQP 286                                                          
						AAAASGHTDSLHLLIDSGERADITDVMDAYGQTPLMLAIMNGHVDCVHLLLEKGSTADAA 	                  .         .                                
						DLRGRTALHRGAVTGCEDCLAALLDHDAFVLCRDFKGRTPIHLASACGHTAVLRTLLQAA 	     269 NDKGFTPLHVAAVSTNGALCLELLVNNGA                      297                                                          
						LSTDPLDAGVDYSGYSPMHWASYTGHEDCLELLLEHSPFSYLEGNPFTPLHCAVINNQDS 	         |||||||||||||||||||||||||||||                       
						TTEMLLGALGAKIVNSRDAKGRTPLHAAAFADNVSGLRMLLQHQAEVNATDHTGRTALMT 	     287 NDKGFTPLHVAAVSTNGALCLELLVNNGA                      315                                                          
						AAENGQTAAVEFLLYRGKADLTVLDENKNTALHLACSKGHEKCALMILAETQDLGLINAT 	                                                            
						NSALQMPLHIAARNGLASVVQALLSHGATVLAVDEEGHTPALACAPNKDVADCLALILST 	                                                            
						MKPFPPKDAVSPFSFSLLKNCSIAAAKTVGGCGALPHGASCPYSQERPGAIGLDGCYSE  	                                                            
						having the sequence corresponding to amino acids 298 - 1076  	                                                            
						of AA535099_P0, wherein said first amino acid sequence,      	                                                            
						second amino acid sequence, third amino acid sequence, fourth	                                                            
						amino acid sequence, bridging amino acid, fifth amino acid   	                                                            
						sequence and sixth amino acid sequence are contiguous and in 	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	                                                            
						head of AA535099_P0, comprising a polypeptide being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						MGILSITDQPPLVQAIFSRDVEEVRSLLSQKENINVL of AA535099_P0.3.An    	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						AA535099_P0, comprising a polypeptide having a length "n",   	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise LMSG having a structure as 	                                                            
						follows (numbering according to AA535099_P0): a sequence     	                                                            
						starting from any of amino acid numbers 61-x to 61; and      	                                                            
						ending at any of amino acid numbers 64 + ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for a tail of AA535099_P0, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						DVNYQSKEGKSPLHMAAIHGRFTRSQILIQNGSEIDCADKFGNTPLHVAARYGHELLIST 	                                                            
						LMTNGADTARRGIHDMFPLHLAVLFGFSDCCRKLLSSGQLYSIVSSLSNEHVLSAGFDIN 	                                                            
						TPDNLGRTCLHAAASGGNVECLNLLLSSGADLRRRDKFGRTPLHYAAANGSYQCAVTLVT 	                                                            
						AGAGVNEADCKGCSPLHYAAASDTYRRAEPHTPSSHDAEEDEPLKESRRKEAFFCLEFLL 	                                                            
						DNGADPSLRDRQGYTAVHYAAAYGNRQNLELLLEMSFNCLEDVESTIPVSPLHLAAYNGH 	                                                            
						CEALKTLAETLVNLDVRDHKGRTALFLATERGSTECVEVLTAHGASALIKERKRKWTPLH 	                                                            
						AAAASGHTDSLHLLIDSGERADITDVMDAYGQTPLMLAIMNGHVDCVHLLLEKGSTADAA 	                                                            
						DLRGRTALHRGAVTGCEDCLAALLDHDAFVLCRDFKGRTPIHLASACGHTAVLRTLLQAA 	                                                            
						LSTDPLDAGVDYSGYSPMHWASYTGHEDCLELLLEHSPFSYLEGNPFTPLHCAVINNQDS 	                                                            
						TTEMLLGALGAKIVNSRDAKGRTPLHAAAFADNVSGLRMLLQHQAEVNATDHTGRTALMT 	                                                            
						AAENGQTAAVEFLLYRGKADLTVLDENKNTALHLACSKGHEKCALMILAETQDLGLINAT 	                                                            
						NSALQMPLHIAARNGLASVVQALLSHGATVLAVDEEGHTPALACAPNKDVADCLALILST 	                                                            
						MKPFPPKDAVSPFSFSLLKNCSIAAAKTVGGCGALPHGASCPYSQERPGAIGLDGCYSE  	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA535099_P0.                                              	                                                            

23565	HMR136_AA535099_2_tr0_r1_1_gPRT		Comparison report between AA535099_P2 and Q8N1H2unique head  	Sequence name: Q8N1H2                                        
						followed by partial WT sequence featuring a skipped exon plus	                                                            
						extra amino acids, a mismatch and a followed by a unique     	Sequence documentation:                                      
						tail.1.An isolated chimeric polypeptide encoding for         	                                                            
						AA535099_P2, comprising a first amino acid sequence being at 	Alignment of: 23565 x Q8N1H2   ..                            
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence              	                                                            
						MGILSITDQPPLVQAIFSRDVEEVRSLLSQKENINVL corresponding to amino 	                     Quality: 2352.00                      Escore:       0                                               
						acids 1 - 37 of AA535099_P2, a second amino acid sequence    	             Matching length:     260                Total length:     279                                               
						being at least 90 % homologous to DQERRTPLHAAAYVGDVPILQLLL   	 Matching Percent Similarity:   99.62   Matching Percent Identity:   98.85                                               
						corresponding to amino acids 37 - 60 of Q8N1H2, which also   	    Total Percent Similarity:   92.83      Total Percent Identity:   92.11                                               
						corresponds to amino acids 38 - 61 of AA535099_P2, a third   	                        Gaps:       1                        
						amino acid sequence bridging amino acid sequence comprising  	                                                            
						of MS, a fourth amino acid sequence being at least 90 %      	Alignment:                                                   
						homologous to GANVNAKDTLWL corresponding to amino acids 82 - 	                  .         .         .         .         .  
						93 of Q8N1H2, which also corresponds to amino acids 64 - 75  	      38 DQERRTPLHAAAYVGDVPILQLLLM...................SGANVN 68                                                           
						of AA535099_P2, a bridging amino acid T corresponding to     	         ||||||||||||||||||||||||:                   :|||||  
						amino acid 76 of AA535099_P2, a fifth amino acid sequence    	      37 DQERRTPLHAAAYVGDVPILQLLLITGFLHTSSPPSIKIGNYIPTGANVN 86                                                           
						PLHRAAASRNEKVLGLLLAHSADVNARDKLWQTPLHVAAANRATKCAEALAPLLSSLNVA 	                  .         .         .         .         .  
						DRSGRSALHHAVHSGHLETVNLLLNKGASLNVCDKKERQPLHWAAFLGHLEVLKLLVARG 	      69 AKDTLWLTPLHRAAASRNEKVLGLLLAHSADVNARDKLWQTPLHVAAANR 118                                                          
						ADLGCKDRKGYGLLHTAAASGQIEVVKYLLRMGAEIDEPNAFGNTALHIACYLGQDAVAI 	         ||||||| ||||||||||||||||||||||||||||||||||||||||||  
						ELVNAGANVNQPNDKGFTPLHVAAVSTNGALCLELLVNNGA                    	      87 AKDTLWLAPLHRAAASRNEKVLGLLLAHSADVNARDKLWQTPLHVAAANR 136                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 95 - 315 of Q8N1H2, which also corresponds to amino    	     119 ATKCAEALAPLLSSLNVADRSGRSALHHAVHSGHLETVNLLLNKGASLNV 168                                                          
						acids 77 - 297 of AA535099_P2, and a sixth amino acid        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     137 ATKCAEALAPLLSSLNVADRSGRSALHHAVHSGHLETVNLLLNKGASLNV 186                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     169 CDKKERQPLHWAAFLGHLEVLKLLVARGADLGCKDRKGYGLLHTAAASGQ 218                                                          
						DVNYQSKEGKSPLHMAAIHGRFTRSQILIQNGSEIDCADKFGNTPLHVAARYGHELLIST 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LMTNGADTARRGIHDMFPLHLAVLFGFSDCCRKLLSSGQLYSIVSSLSNEHVLSAGFDIN 	     187 CDKKERQPLHWAAFLGHLEVLKLLVARGADLGCKDRKGYGLLHTAAASGQ 236                                                          
						TPDNLGRTCLHAAASGGNVECLNLLLSSGADLRRRDKFGRTPLHYAAANGSYQCAVTLVT 	                  .         .         .         .         .  
						AGAGVNEADCKGCSPLHYAAASDTYRRAEPHTPSSHDAEEDEPLKESRRKEAFL       	     219 IEVVKYLLRMGAEIDEPNAFGNTALHIACYLGQDAVAIELVNAGANVNQP 268                                                          
						having the sequence corresponding to amino acids 298 - 531 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA535099_P2, wherein said first amino acid sequence, second  	     237 IEVVKYLLRMGAEIDEPNAFGNTALHIACYLGQDAVAIELVNAGANVNQP 286                                                          
						amino acid sequence, third amino acid sequence, fourth amino 	                  .         .                                
						acid sequence, bridging amino acid, fifth amino acid sequence	     269 NDKGFTPLHVAAVSTNGALCLELLVNNGA                      297                                                          
						and sixth amino acid sequence are contiguous and in a        	         |||||||||||||||||||||||||||||                       
						sequential order.2.An isolated polypeptide encoding for a    	     287 NDKGFTPLHVAAVSTNGALCLELLVNNGA                      315                                                          
						head of AA535099_P2, comprising a polypeptide being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						MGILSITDQPPLVQAIFSRDVEEVRSLLSQKENINVL of AA535099_P2.3.An    	                                                            
						isolated polypeptide encoding for an edge portion of         	                                                            
						AA535099_P2, comprising a polypeptide having a length "n",   	                                                            
						wherein n is at least about 10 amino acids in length,        	                                                            
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise LMSG having a structure as 	                                                            
						follows (numbering according to AA535099_P2): a sequence     	                                                            
						starting from any of amino acid numbers 61-x to 61; and      	                                                            
						ending at any of amino acid numbers 64 + ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for a tail of AA535099_P2, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						DVNYQSKEGKSPLHMAAIHGRFTRSQILIQNGSEIDCADKFGNTPLHVAARYGHELLIST 	                                                            
						LMTNGADTARRGIHDMFPLHLAVLFGFSDCCRKLLSSGQLYSIVSSLSNEHVLSAGFDIN 	                                                            
						TPDNLGRTCLHAAASGGNVECLNLLLSSGADLRRRDKFGRTPLHYAAANGSYQCAVTLVT 	                                                            
						AGAGVNEADCKGCSPLHYAAASDTYRRAEPHTPSSHDAEEDEPLKESRRKEAFL       	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA535099_P2.                                              	                                                            

23559	HMR136_AA535099_4_tr0_r1_1_gPRT		Comparison report between AA535099_P4 and Q8N1H2unique head  	Sequence name: Q8N1H2                                        
						followed by partial WT sequence featuring a skipped exon plus	                                                            
						extra amino acids, a mismatch and a followed by a unique     	Sequence documentation:                                      
						tail.1.An isolated chimeric polypeptide encoding for         	                                                            
						AA535099_P4, comprising a first amino acid sequence being at 	Alignment of: 23559 x Q8N1H2   ..                            
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence              	                                                            
						MGILSITDQPPLVQAIFSRDVEEVRSLLSQKENINVL corresponding to amino 	                     Quality:  989.00                      Escore:       0                                               
						acids 1 - 37 of AA535099_P4, a second amino acid sequence    	             Matching length:     117                Total length:     136                                               
						being at least 90 % homologous to DQERRTPLHAAAYVGDVPILQLLL   	 Matching Percent Similarity:   99.15   Matching Percent Identity:   97.44                                               
						corresponding to amino acids 37 - 60 of Q8N1H2, which also   	    Total Percent Similarity:   85.29      Total Percent Identity:   83.82                                               
						corresponds to amino acids 38 - 61 of AA535099_P4, a third   	                        Gaps:       1                        
						amino acid sequence bridging amino acid sequence comprising  	                                                            
						of MS, a fourth amino acid sequence being at least 90 %      	Alignment:                                                   
						homologous to GANVNAKDTLWL corresponding to amino acids 82 - 	                  .         .         .         .         .  
						93 of Q8N1H2, which also corresponds to amino acids 64 - 75  	      38 DQERRTPLHAAAYVGDVPILQLLLM...................SGANVN 68                                                           
						of AA535099_P4, a bridging amino acid T corresponding to     	         ||||||||||||||||||||||||:                   :|||||  
						amino acid 76 of AA535099_P4, a fifth amino acid sequence    	      37 DQERRTPLHAAAYVGDVPILQLLLITGFLHTSSPPSIKIGNYIPTGANVN 86                                                           
						PLHRAAASRNEKVLGLLLAHSADVNARDKLWQTPLHVAAANRATKCAEALAPLLSSLNVA 	                  .         .         .         .         .  
						DRSGRSALHHAVHSGHLE                                           	      69 AKDTLWLTPLHRAAASRNEKVLGLLLAHSADVNARDKLWQTPLHVAAANR 118                                                          
						being at least 90 % homologous to corresponding to amino     	         ||||||| ||||||||||||||||||||||||||||||||||||||||||  
						acids 95 - 172 of Q8N1H2, which also corresponds to amino    	      87 AKDTLWLAPLHRAAASRNEKVLGLLLAHSADVNARDKLWQTPLHVAAANR 136                                                          
						acids 77 - 154 of AA535099_P4, and a sixth amino acid        	                  .         .         .                      
						sequence being at least 70%, optionally at least 80%,        	     119 ATKCAEALAPLLSSLNVADRSGRSALHHAVHSGHLE               154                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||                
						most preferably at least 95% homologous to a polypeptide     	     137 ATKCAEALAPLLSSLNVADRSGRSALHHAVHSGHLE               172                                                          
						having the sequence                                          	                                                            
						VRTVPIQAQLGLSLFLPSYSRFPASGPSSLKEKQPGWLYKHLS corresponding to 	                                                            
						amino acids 155 - 197 of AA535099_P4, wherein said first     	                                                            
						amino acid sequence, second amino acid sequence, third amino 	                                                            
						acid sequence, fourth amino acid sequence, bridging amino    	                                                            
						acid, fifth amino acid sequence and sixth amino acid sequence	                                                            
						are contiguous and in a sequential order.2.An isolated       	                                                            
						polypeptide encoding for a head of AA535099_P4, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence MGILSITDQPPLVQAIFSRDVEEVRSLLSQKENINVL of     	                                                            
						AA535099_P4.3.An isolated polypeptide encoding for an edge   	                                                            
						portion of AA535099_P4, comprising a polypeptide having a    	                                                            
						length "n", wherein n is at least about 10 amino acids in    	                                                            
						length, optionally at least about 20 amino acids in length,  	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise LMSG having a structure as 	                                                            
						follows (numbering according to AA535099_P4): a sequence     	                                                            
						starting from any of amino acid numbers 61-x to 61; and      	                                                            
						ending at any of amino acid numbers 64 + ((n-2) - x), in     	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for a tail of AA535099_P4, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						VRTVPIQAQLGLSLFLPSYSRFPASGPSSLKEKQPGWLYKHLS in AA535099_P4.  	                                                            

24020	HMR136_AA536130_2_tr0_r1_1_gPRT		Comparison report between AA536130_P2 and Q9BQP3short unique 	Sequence name: Q9BQP3                                        
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA536130_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 24020 x Q9BQP3   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence M corresponding to amino acids 1 - 1 of  	Alignment segment 1/1:                                       
						AA536130_P2, and a second amino acid sequence being at least 	                                                            
						EFGGECPADPLPCEELCDGDASCPQGHKCCSTGCGRTCLGDIEGGRGGDCPKVLVGLCIV 	                     Quality: 1150.00                      Escore:       0                                               
						GCVMDENCQAGEKCCKSGCGRFCVPPVLPPKLTMNPNWTVRSDSELEIPVP          	             Matching length:     111                Total length:     111                                               
						90 % homologous to corresponding to amino acids 114 - 224 of 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						Q9BQP3, which also corresponds to amino acids 2 - 112 of     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AA536130_P2, wherein said first amino acid sequence and      	                        Gaps:       0                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.                                                       	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       2 EFGGECPADPLPCEELCDGDASCPQGHKCCSTGCGRTCLGDIEGGRGGDC 51                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     114 EFGGECPADPLPCEELCDGDASCPQGHKCCSTGCGRTCLGDIEGGRGGDC 163                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      52 PKVLVGLCIVGCVMDENCQAGEKCCKSGCGRFCVPPVLPPKLTMNPNWTV 101                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     164 PKVLVGLCIVGCVMDENCQAGEKCCKSGCGRFCVPPVLPPKLTMNPNWTV 213                                                          
						                                                            	                  .                                          
						                                                            	     102 RSDSELEIPVP                                        112                                                          
						                                                            	         |||||||||||                                         
						                                                            	     214 RSDSELEIPVP                                        224                                                          

						Comparison report between AA536130_P2 and Q8TC52unique head  	Sequence name: Q8TC52                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA536130_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 24020 x Q8TC52   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						MEFGGECPADPLPCEELCDGDASCPQGHKCCSTGCGRTCLGDIEG corresponding  	                                                            
						to amino acids 1 - 45 of AA536130_P2, and a second amino acid	                     Quality:  689.00                      Escore:       0                                               
						GRGGDCPKVLVGLCIVGCVMDENCQAGEKCCKSGCGRFCVPPVLPPKLTMNPNWTVRSDS 	             Matching length:      67                Total length:      67                                               
						ELEIPVP                                                      	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 73 - 139 of Q8TC52, which also corresponds to    	                        Gaps:       0                        
						amino acids 46 - 112 of AA536130_P2, wherein said first amino	                                                            
						acid sequence and second amino acid sequence are contiguous  	Alignment:                                                   
						and in a sequential order.2.An isolated polypeptide encoding 	                  .         .         .         .         .  
						for a head of AA536130_P2, comprising a polypeptide being at 	      46 GRGGDCPKVLVGLCIVGCVMDENCQAGEKCCKSGCGRFCVPPVLPPKLTM 95                                                           
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	      73 GRGGDCPKVLVGLCIVGCVMDENCQAGEKCCKSGCGRFCVPPVLPPKLTM 122                                                          
						preferably at least about 95% homologous to the sequence     	                  .                                          
						MEFGGECPADPLPCEELCDGDASCPQGHKCCSTGCGRTCLGDIEG of AA536130_P2.	      96 NPNWTVRSDSELEIPVP                                  112                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     123 NPNWTVRSDSELEIPVP                                  139                                                          

						Comparison report between AA536130_P2 and Q8IUB2short unique 	Sequence name: Q8IUB2                                        
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA536130_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 24020 x Q8IUB2   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence M corresponding to amino acids 1 - 1 of  	Alignment segment 1/1:                                       
						AA536130_P2, and a second amino acid sequence being at least 	                                                            
						EFGGECPADPLPCEELCDGDASCPQGHKCCSTGCGRTCLGDIEGGRGGDCPKVLVGLCIV 	                     Quality: 1150.00                      Escore:       0                                               
						GCVMDENCQAGEKCCKSGCGRFCVPPVLPPKLTMNPNWTVRSDSELEIPVP          	             Matching length:     111                Total length:     111                                               
						90 % homologous to corresponding to amino acids 121 - 231 of 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						Q8IUB2, which also corresponds to amino acids 2 - 112 of     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AA536130_P2, wherein said first amino acid sequence and      	                        Gaps:       0                        
						second amino acid sequence are contiguous and in a sequential	                                                            
						order.                                                       	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       2 EFGGECPADPLPCEELCDGDASCPQGHKCCSTGCGRTCLGDIEGGRGGDC 51                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     121 EFGGECPADPLPCEELCDGDASCPQGHKCCSTGCGRTCLGDIEGGRGGDC 170                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      52 PKVLVGLCIVGCVMDENCQAGEKCCKSGCGRFCVPPVLPPKLTMNPNWTV 101                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     171 PKVLVGLCIVGCVMDENCQAGEKCCKSGCGRFCVPPVLPPKLTMNPNWTV 220                                                          
						                                                            	                  .                                          
						                                                            	     102 RSDSELEIPVP                                        112                                                          
						                                                            	         |||||||||||                                         
						                                                            	     221 RSDSELEIPVP                                        231                                                          

24308	HMR136_AA541340_4_tr0_r1_1_gPRT		Comparison report between AA541340_P4 and KLFF_HUMANpartial  	Sequence name: KLFF_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for AA541340_P4, comprising a first     	Sequence documentation:                                      
						MVDHLLPVDENFSSPKCPVGYLGDRLVGRRAYHMLPSPVSEDDSDASSPCSCSSPDSQAL 	                                                            
						CSCYGGGLGTESQDSILDFLLSQATLGSGGGSGSSIGASSGPVAWGPWRRAAAPVKGEHF 	Alignment of: 24308 x KLFF_HUMAN   ..                        
						CLPEFPLGDPDDVPRPFQPTLEEIEEFLEENMEPGVKEVPEGNSKDLDACSQLSAGPHKS 	                                                            
						HLHPGSSGRERCSPPPGGASAGGAQGPGGGPTPDGPIPVLLQIQPVPVKQESGTGPASPG 	Alignment segment 1/1:                                       
						QAPENVKVAQLLVNIQGQTFALVPQVVPSSNLNLPSKFVRIAPVPIAAKPVGSGPLGPGP 	                                                            
						AGLLMGQKFPKNPAAELIKMHKCTFPGCSKMYTKSSHLKAHLRRHTGEKPFACTWPGCGW 	                     Quality: 3595.00                      Escore:       0                                               
						R                                                            	             Matching length:     361                Total length:     361                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 361 of KLFF_HUMAN, which    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						also corresponds to amino acids 1 - 361 of AA541340_P4, and a	                        Gaps:       0                        
						second amino acid sequence being at least 70%, optionally at 	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence ARPR corresponding to amino  	       1 MVDHLLPVDENFSSPKCPVGYLGDRLVGRRAYHMLPSPVSEDDSDASSPC 50                                                           
						acids 362 - 365 of AA541340_P4, wherein said first amino acid	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	       1 MVDHLLPVDENFSSPKCPVGYLGDRLVGRRAYHMLPSPVSEDDSDASSPC 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of AA541340_P4, comprising a polypeptide being at least 	      51 SCSSPDSQALCSCYGGGLGTESQDSILDFLLSQATLGSGGGSGSSIGASS 100                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	      51 SCSSPDSQALCSCYGGGLGTESQDSILDFLLSQATLGSGGGSGSSIGASS 100                                                          
						at least about 95% homologous to the sequence ARPR in        	                  .         .         .         .         .  
						AA541340_P4.                                                 	     101 GPVAWGPWRRAAAPVKGEHFCLPEFPLGDPDDVPRPFQPTLEEIEEFLEE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 GPVAWGPWRRAAAPVKGEHFCLPEFPLGDPDDVPRPFQPTLEEIEEFLEE 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NMEPGVKEVPEGNSKDLDACSQLSAGPHKSHLHPGSSGRERCSPPPGGAS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 NMEPGVKEVPEGNSKDLDACSQLSAGPHKSHLHPGSSGRERCSPPPGGAS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AGGAQGPGGGPTPDGPIPVLLQIQPVPVKQESGTGPASPGQAPENVKVAQ 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 AGGAQGPGGGPTPDGPIPVLLQIQPVPVKQESGTGPASPGQAPENVKVAQ 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LLVNIQGQTFALVPQVVPSSNLNLPSKFVRIAPVPIAAKPVGSGPLGPGP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LLVNIQGQTFALVPQVVPSSNLNLPSKFVRIAPVPIAAKPVGSGPLGPGP 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AGLLMGQKFPKNPAAELIKMHKCTFPGCSKMYTKSSHLKAHLRRHTGEKP 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 AGLLMGQKFPKNPAAELIKMHKCTFPGCSKMYTKSSHLKAHLRRHTGEKP 350                                                          
						                                                            	                  .                                          
						                                                            	     351 FACTWPGCGWR                                        361                                                          
						                                                            	         |||||||||||                                         
						                                                            	     351 FACTWPGCGWR                                        361                                                          

26097	HMR136_AA551373_3_tr0_r1_1_gPRT		Comparison report between AA551373_P3 and 5H4_HUMANpartial   	Sequence name: 5H4_HUMAN                                     
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for AA551373_P3, comprising a first     	Sequence documentation:                                      
						MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIV 	                                                            
						SLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYY 	Alignment of: 26097 x 5H4_HUMAN   ..                         
						AICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSN 	                                                            
						STYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRP 	Alignment segment 1/1:                                       
						QSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 	                                                            
						GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVL   	                     Quality: 3530.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     358                Total length:     358                                               
						corresponding to amino acids 1 - 358 of 5H4_HUMAN, which also	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 358 of AA551373_P3, and a     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						polypeptide having the sequence SFLLLFCNRPVPV corresponding  	                  .         .         .         .         .  
						to amino acids 359 - 371 of AA551373_P3, wherein said first  	       1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQL 50                                                           
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	       1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQL 50                                                           
						polypeptide encoding for a tail of AA551373_P3, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      51 RKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLD 100                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      51 RKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLD 100                                                          
						to the sequence SFLLLFCNRPVPV in AA551373_P3.                	                  .         .         .         .         .  
						                                                            	     101 VLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 VLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 FISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVA 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 FYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTT 350                                                          
						                                                            	                                                             
						                                                            	     351 INGSTHVL                                           358                                                          
						                                                            	         ||||||||                                            
						                                                            	     351 INGSTHVL                                           358                                                          

						Comparison report between AA551373_P3 and CAC20411partial WT 	Sequence name: CAC20411                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA551373_P3, comprising a first     	Sequence documentation:                                      
						MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIV 	                                                            
						SLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYY 	Alignment of: 26097 x CAC20411   ..                          
						AICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSN 	                                                            
						STYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRP 	Alignment segment 1/1:                                       
						QSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 	                                                            
						GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVL   	                     Quality: 3530.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     358                Total length:     358                                               
						corresponding to amino acids 1 - 358 of CAC20411, which also 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 358 of AA551373_P3, and a     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						polypeptide having the sequence SFLLLFCNRPVPV corresponding  	                  .         .         .         .         .  
						to amino acids 359 - 371 of AA551373_P3, wherein said first  	       1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQL 50                                                           
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	       1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQL 50                                                           
						polypeptide encoding for a tail of AA551373_P3, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      51 RKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLD 100                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      51 RKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLD 100                                                          
						to the sequence SFLLLFCNRPVPV in AA551373_P3.                	                  .         .         .         .         .  
						                                                            	     101 VLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 VLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 FISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVA 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 FYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTT 350                                                          
						                                                            	                                                             
						                                                            	     351 INGSTHVL                                           358                                                          
						                                                            	         ||||||||                                            
						                                                            	     351 INGSTHVL                                           358                                                          

						Comparison report between AA551373_P3 and CAC22249partial WT 	Sequence name: CAC22249                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA551373_P3, comprising a first     	Sequence documentation:                                      
						MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIV 	                                                            
						SLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYY 	Alignment of: 26097 x CAC22249   ..                          
						AICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSN 	                                                            
						STYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRP 	Alignment segment 1/1:                                       
						QSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 	                                                            
						GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVL   	                     Quality: 3530.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     358                Total length:     358                                               
						corresponding to amino acids 1 - 358 of CAC22249, which also 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 358 of AA551373_P3, and a     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						polypeptide having the sequence SFLLLFCNRPVPV corresponding  	                  .         .         .         .         .  
						to amino acids 359 - 371 of AA551373_P3, wherein said first  	       1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQL 50                                                           
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	       1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQL 50                                                           
						polypeptide encoding for a tail of AA551373_P3, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      51 RKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLD 100                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      51 RKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLD 100                                                          
						to the sequence SFLLLFCNRPVPV in AA551373_P3.                	                  .         .         .         .         .  
						                                                            	     101 VLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 VLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 FISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVA 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 FYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTT 350                                                          
						                                                            	                                                             
						                                                            	     351 INGSTHVL                                           358                                                          
						                                                            	         ||||||||                                            
						                                                            	     351 INGSTHVL                                           358                                                          

						Comparison report between AA551373_P3 and Q96KH9partial WT   	Sequence name: Q96KH9                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for AA551373_P3, comprising a first     	Sequence documentation:                                      
						MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIV 	                                                            
						SLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYY 	Alignment of: 26097 x Q96KH9   ..                            
						AICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSN 	                                                            
						STYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRP 	Alignment segment 1/1:                                       
						QSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 	                                                            
						GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVL   	                     Quality: 3560.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     371                Total length:     378                                               
						corresponding to amino acids 1 - 358 of Q96KH9, which also   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 358 of AA551373_P3, and a     	    Total Percent Similarity:   98.15      Total Percent Identity:   98.15                                               
						second amino acid sequence being at least 90 % homologous to 	                        Gaps:       1                        
						SFLLLFCNRPVPV corresponding to amino acids 366 - 378 of      	                                                            
						Q96KH9, which also corresponds to amino acids 359 - 371 of   	Alignment:                                                   
						AA551373_P3, wherein said first amino acid sequence and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	       1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQL 50                                                           
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of AA551373_P3, comprising a polypeptide having a    	       1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQL 50                                                           
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	      51 RKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLD 100                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	      51 RKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLD 100                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise LS, having a structure as  	     101 VLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPT 150                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						358-x to 359; and ending at any of amino acid numbers 359+   	     101 VLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPT 150                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     151 FISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 FISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVA 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 FYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTT 350                                                          
						                                                            	                  .         .                                
						                                                            	     351 INGSTHVL.......SFLLLFCNRPVPV                       371                                                          
						                                                            	         ||||||||       |||||||||||||                        
						                                                            	     351 INGSTHVLSGCSPVSSFLLLFCNRPVPV                       378                                                          

						Comparison report between AA551373_P3 and Q96KI0partial WT   	Sequence name: Q96KI0                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA551373_P3, comprising a first     	Sequence documentation:                                      
						MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIV 	                                                            
						SLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYY 	Alignment of: 26097 x Q96KI0   ..                            
						AICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSN 	                                                            
						STYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRP 	Alignment segment 1/1:                                       
						QSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 	                                                            
						GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVL   	                     Quality: 3535.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     363                Total length:     363                                               
						corresponding to amino acids 1 - 358 of Q96KI0, which also   	 Matching Percent Similarity:   99.45   Matching Percent Identity:   98.90                                               
						corresponds to amino acids 1 - 358 of AA551373_P3, and a     	    Total Percent Similarity:   99.45      Total Percent Identity:   98.90                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						polypeptide having the sequence SFLLLFCNRPVPV corresponding  	                  .         .         .         .         .  
						to amino acids 359 - 371 of AA551373_P3, wherein said first  	       1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQL 50                                                           
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	       1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQL 50                                                           
						polypeptide encoding for a tail of AA551373_P3, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      51 RKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLD 100                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      51 RKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLD 100                                                          
						to the sequence SFLLLFCNRPVPV in AA551373_P3.                	                  .         .         .         .         .  
						                                                            	     101 VLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 VLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 FISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVA 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 FYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTT 350                                                          
						                                                            	                  .                                          
						                                                            	     351 INGSTHVLSFLLL                                      363                                                          
						                                                            	         |||||||| : :|                                       
						                                                            	     351 INGSTHVLRYTVL                                      363                                                          

						Comparison report between AA551373_P3 and Q8IXH9partial WT   	Sequence name: Q8IXH9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA551373_P3, comprising a first     	Sequence documentation:                                      
						MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIV 	                                                            
						SLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYY 	Alignment of: 26097 x Q8IXH9   ..                            
						AICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSN 	                                                            
						STYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRP 	Alignment segment 1/1:                                       
						QSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 	                                                            
						GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVL   	                     Quality: 3530.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     358                Total length:     358                                               
						corresponding to amino acids 1 - 358 of Q8IXH9, which also   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 358 of AA551373_P3, and a     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						polypeptide having the sequence SFLLLFCNRPVPV corresponding  	                  .         .         .         .         .  
						to amino acids 359 - 371 of AA551373_P3, wherein said first  	       1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQL 50                                                           
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	       1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQL 50                                                           
						polypeptide encoding for a tail of AA551373_P3, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      51 RKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLD 100                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      51 RKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLD 100                                                          
						to the sequence SFLLLFCNRPVPV in AA551373_P3.                	                  .         .         .         .         .  
						                                                            	     101 VLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPT 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 VLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPT 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 FISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVA 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 FYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHR 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 FYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHR 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWL 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTT 350                                                          
						                                                            	                                                             
						                                                            	     351 INGSTHVL                                           358                                                          
						                                                            	         ||||||||                                            
						                                                            	     351 INGSTHVL                                           358                                                          

26296	HMR136_AA551387_3_tr0_r1_1_gPRT		Comparison report between AA551387_P3 and GLP2_HUMANunique   	Sequence name: GLP2_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA551387_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 26296 x GLP2_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						MLREPQLQAKRGSLCLAVNLAADVHRGILLLSYLPLPGSHPPLVSS corresponding 	                                                            
						to amino acids 1 - 46 of AA551387_P3, and a second amino acid	                     Quality: 2948.00                      Escore:       0                                               
						MSTSCRSVQVLLHYFVGANYLWLLVEGLYLHTLLEPTVLPERRLWPRYLLLGWAFPVLFV 	             Matching length:     300                Total length:     300                                               
						VPWGFARAHLENTGCWTTNGNKKIWWIIRGPMMLCVTVNFFIFLKILKLLISKLKAHQMC 	 Matching Percent Similarity:   99.67   Matching Percent Identity:   99.67                                               
						FRDYKYRLAKSTLVLIPLLGVHEILFSFITDDQVEGFAKLIRLFIQLTLSSFHGFLVALQ 	    Total Percent Similarity:   99.67      Total Percent Identity:   99.67                                               
						YGFANGEVKAELRKYWVRFLLARHSGCRACVLGKDFRFLGKCPKKLSEGDGAEKLRKLQP 	                        Gaps:       0                        
						SLNSGRLLHLAMRGLGELGAQPQQDHARWPRGSSLSECSEGDVTMANTMEEILEESEI   	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 256 - 553 of GLP2_HUMAN, which also corresponds  	                  .         .         .         .         .  
						to amino acids 47 - 344 of AA551387_P3, wherein said first   	      45 SSMSTSCRSVQVLLHYFVGANYLWLLVEGLYLHTLLEPTVLPERRLWPRY 94                                                           
						amino acid sequence and second amino acid sequence are       	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     254 SEMSTSCRSVQVLLHYFVGANYLWLLVEGLYLHTLLEPTVLPERRLWPRY 303                                                          
						polypeptide encoding for a head of AA551387_P3, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      95 LLLGWAFPVLFVVPWGFARAHLENTGCWTTNGNKKIWWIIRGPMMLCVTV 144                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     304 LLLGWAFPVLFVVPWGFARAHLENTGCWTTNGNKKIWWIIRGPMMLCVTV 353                                                          
						to the sequence                                              	                  .         .         .         .         .  
						MLREPQLQAKRGSLCLAVNLAADVHRGILLLSYLPLPGSHPPLVSS of            	     145 NFFIFLKILKLLISKLKAHQMCFRDYKYRLAKSTLVLIPLLGVHEILFSF 194                                                          
						AA551387_P3.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     354 NFFIFLKILKLLISKLKAHQMCFRDYKYRLAKSTLVLIPLLGVHEILFSF 403                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     195 ITDDQVEGFAKLIRLFIQLTLSSFHGFLVALQYGFANGEVKAELRKYWVR 244                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     404 ITDDQVEGFAKLIRLFIQLTLSSFHGFLVALQYGFANGEVKAELRKYWVR 453                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     245 FLLARHSGCRACVLGKDFRFLGKCPKKLSEGDGAEKLRKLQPSLNSGRLL 294                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     454 FLLARHSGCRACVLGKDFRFLGKCPKKLSEGDGAEKLRKLQPSLNSGRLL 503                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     295 HLAMRGLGELGAQPQQDHARWPRGSSLSECSEGDVTMANTMEEILEESEI 344                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     504 HLAMRGLGELGAQPQQDHARWPRGSSLSECSEGDVTMANTMEEILEESEI 553                                                          

28141	HMR136_AA553584_1_tr0_r1_1_gPRT		Comparison report between AA553584_P1 and Q9ULE6partial WT   	Sequence name: Q9ULE6                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA553584_P1, comprising a first amino acid sequence being at 	                                                            
						MGTTASTAQQTVSAGTPFEGLQGSGTMDSRHSVSIHSFQSTSLHNSKAKSIIPNKVAPVV 	Alignment of: 28141 x Q9ULE6   ..                            
						ITYNCKEEFQIHDELLKAHYTLGRLSDNTPEHYLVQGRYFLVRDVTEKMDVLGTVGSCGA 	                                                            
						PNFRQVQGGLTVFGMGQPSL                                         	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 6 - 145	                                                            
						of Q9ULE6, which also corresponds to amino acids 1 - 140 of  	                     Quality: 4328.00                      Escore:       0                                               
						AA553584_P1, a bridging amino acid S corresponding to amino  	             Matching length:     442                Total length:     442                                               
						acid 141 of AA553584_P1, a second amino acid sequence being  	 Matching Percent Similarity:   99.77   Matching Percent Identity:   99.55                                               
						GFRRVLQKLQKDGHRECVIFCVREEPVLFLRADEDFVSYTPRDKQNLHENLQGLGPGVRV 	    Total Percent Similarity:   99.77      Total Percent Identity:   99.55                                               
						ESLELAIRKEIHDFAQLSENTYHVYHNTEDLWGEPHAVAIHGEDDLHVTEEVYKRPLFLQ 	                        Gaps:       0                        
						PTYRYHRLPLPEQGSPLEAQLDAFVSVLRETPSLLQLRDAHGPPPALVFSCQMGVGRTNL 	                                                            
						GMVLGTLILLHRSGTTSQPEAAPTQAKPLPMEQFQVIQSFLRMVPQGRRMVEEVDRAITA 	Alignment:                                                   
						CAELHDLKEVVLENQKKLEGIRPESPAQGSGSRHSVWQRALWSLERYFYLILFNYYLHEQ 	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 147 	       1 MGTTASTAQQTVSAGTPFEGLQGSGTMDSRHSVSIHSFQSTSLHNSKAKS 50                                                           
						- 446 of Q9ULE6, which also corresponds to amino acids 142 - 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						441 of AA553584_P1, and a third amino acid sequence being at 	       6 MGTTASTAQQTVSAGTPFEGLQGSGTMDSRHSVSIHSFQSTSLHNSKAKS 55                                                           
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	      51 IIPNKVAPVVITYNCKEEFQIHDELLKAHYTLGRLSDNTPEHYLVQGRYF 100                                                          
						homologous to a polypeptide having the sequence FQPLAVCPP    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 442 - 450 of AA553584_P1,       	      56 IIPNKVAPVVITYNCKEEFQIHDELLKAHYTLGRLSDNTPEHYLVQGRYF 105                                                          
						wherein said first amino acid sequence, bridging amino acid, 	                  .         .         .         .         .  
						second amino acid sequence and third amino acid sequence are 	     101 LVRDVTEKMDVLGTVGSCGAPNFRQVQGGLTVFGMGQPSLSGFRRVLQKL 150                                                          
						contiguous and in a sequential order.2.An isolated           	         |||||||||||||||||||||||||||||||||||||||| |||||||||  
						polypeptide encoding for a tail of AA553584_P1, comprising a 	     106 LVRDVTEKMDVLGTVGSCGAPNFRQVQGGLTVFGMGQPSLLGFRRVLQKL 155                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     151 QKDGHRECVIFCVREEPVLFLRADEDFVSYTPRDKQNLHENLQGLGPGVR 200                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence FQPLAVCPP in AA553584_P1.                    	     156 QKDGHRECVIFCVREEPVLFLRADEDFVSYTPRDKQNLHENLQGLGPGVR 205                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VESLELAIRKEIHDFAQLSENTYHVYHNTEDLWGEPHAVAIHGEDDLHVT 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     206 VESLELAIRKEIHDFAQLSENTYHVYHNTEDLWGEPHAVAIHGEDDLHVT 255                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEVYKRPLFLQPTYRYHRLPLPEQGSPLEAQLDAFVSVLRETPSLLQLRD 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     256 EEVYKRPLFLQPTYRYHRLPLPEQGSPLEAQLDAFVSVLRETPSLLQLRD 305                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 AHGPPPALVFSCQMGVGRTNLGMVLGTLILLHRSGTTSQPEAAPTQAKPL 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     306 AHGPPPALVFSCQMGVGRTNLGMVLGTLILLHRSGTTSQPEAAPTQAKPL 355                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 PMEQFQVIQSFLRMVPQGRRMVEEVDRAITACAELHDLKEVVLENQKKLE 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     356 PMEQFQVIQSFLRMVPQGRRMVEEVDRAITACAELHDLKEVVLENQKKLE 405                                                          
						                                                            	                  .         .         .         .            
						                                                            	     401 GIRPESPAQGSGSRHSVWQRALWSLERYFYLILFNYYLHEQF         442                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||:          
						                                                            	     406 GIRPESPAQGSGSRHSVWQRALWSLERYFYLILFNYYLHEQY         447                                                          

7918	HMR136_AA558949_2_tr0_r1_1_gPRT		Comparison report between AA558949_P2 and Q9UQP3unique head  	Sequence name: Q9UQP3                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for AA558949_P2,      	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 7918 x Q9UQP3   ..                             
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence MCPSLPWFRLT  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 11 of AA558949_P2, a second 	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 7086.00                      Escore:       0                                               
						TKEMAVHKDESSTVLTGLKPGEAYKVYVWAERGNQGSKKADTNAL corresponding  	             Matching length:     727                Total length:     816                                               
						to amino acids 479 - 523 of Q9UQP3, which also corresponds to	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 12 - 56 of AA558949_P2, and a third amino acid   	    Total Percent Similarity:   89.09      Total Percent Identity:   89.09                                               
						TDIDSPKNLVTDRVTENMATVSWDPVQAAIDKYVVRYTSAGGETREVPVGKEQSSTVLTG 	                        Gaps:       1                        
						LRPGMEYMVHVWAQKGDQESKKADTKAQTDIDSPQNLVTDRVTENMATVSWDPVRATIDR 	                                                            
						YVVRYTSAKDGETREVPVGKEQSSTVLTGLRPGVEYTVHVWAQKGAQESKKADTKAQTDI 	Alignment:                                                   
						DSPQNLVTDWVTENTATVSWDPVQATIDRYVVHYTSANGETREVPVGKEQSSTVLTGLRP 	                  .         .         .         .         .  
						GMEYTVHVWAQKGNQESKKADTKAQTEIDGPKNLVTDWVTENMATVSWDPVQATIDKYMV 	      12 TKEMAVHKDESSTVLTGLKPGEAYKVYVWAERGNQGSKKADTNAL..... 56                                                           
						RYTSADGETREVPVGKEHSSTVLTGLRPGMEYMVHVWAQKGAQESKKADTKAQTELDPPR 	         |||||||||||||||||||||||||||||||||||||||||||||       
						NLRPSAVTQSGGILTWTPPSAQIHGYILTYQFPDGTVKEMQLGREDQRFALQGLEQGATY 	     479 TKEMAVHKDESSTVLTGLKPGEAYKVYVWAERGNQGSKKADTNALTEIDS 528                                                          
						PVSLVAFKGGRRSRNVSTTLSTVGARFPHPSDCSQVQQNSNAASGLYTIYLHGDASRPLQ 	                  .         .         .         .         .  
						VYCDMETDGGGWIVFQRRNTGQLDFFKRWRSYVEGFGDPMKEFWLGLDKLHNLTTGTPAR 	      56 .................................................. 56                                                           
						YEVRVDLQTANESAYAIYDFFQVASSKERYKLTVGKYRGTAGDALTYHNGWKFTTFDRDN 	                                                            
						DIALSNCALTHHGGWWYKNCHLANPNGRYGETKHSEGVNWEPWKGHEFSIPYVELKIRPH 	     529 PANLVTDRVTENTATISWDPVQATIDKYVVRYTSADDQETREVLVGKEQS 578                                                          
						GYSREPVLGRKKRTLRGRLRTF                                       	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	      57 ..................................TDIDSPKNLVTDRVTE 72                                                           
						amino acids 613 - 1294 of Q9UQP3, which also corresponds to  	                                           ||||||||||||||||  
						amino acids 57 - 738 of AA558949_P2, wherein said first amino	     579 STVLTGLRPGVEYTVHVWAQKGDRESKKADTNAPTDIDSPKNLVTDRVTE 628                                                          
						acid sequence, second amino acid sequence and third amino    	                  .         .         .         .         .  
						acid sequence are contiguous and in a sequential order.2.An  	      73 NMATVSWDPVQAAIDKYVVRYTSAGGETREVPVGKEQSSTVLTGLRPGME 122                                                          
						isolated polypeptide encoding for a head of AA558949_P2,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	     629 NMATVSWDPVQAAIDKYVVRYTSAGGETREVPVGKEQSSTVLTGLRPGME 678                                                          
						least about 80%, preferably at least about 85%, more         	                  .         .         .         .         .  
						preferably at least about 90% and most preferably at least   	     123 YMVHVWAQKGDQESKKADTKAQTDIDSPQNLVTDRVTENMATVSWDPVRA 172                                                          
						about 95% homologous to the sequence MCPSLPWFRLT of          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA558949_P2.3.An isolated chimeric polypeptide encoding for  	     679 YMVHVWAQKGDQESKKADTKAQTDIDSPQNLVTDRVTENMATVSWDPVRA 728                                                          
						an edge portion of AA558949_P2, comprising a polypeptide     	                  .         .         .         .         .  
						having a length "n", wherein n is at least about 10 amino    	     173 TIDRYVVRYTSAKDGETREVPVGKEQSSTVLTGLRPGVEYTVHVWAQKGA 222                                                          
						acids in length, optionally at least about 20 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, preferably at least about 30 amino acids in length,  	     729 TIDRYVVRYTSAKDGETREVPVGKEQSSTVLTGLRPGVEYTVHVWAQKGA 778                                                          
						more preferably at least about 40 amino acids in length and  	                  .         .         .         .         .  
						most preferably at least about 50 amino acids in length,     	     223 QESKKADTKAQTDIDSPQNLVTDWVTENTATVSWDPVQATIDRYVVHYTS 272                                                          
						wherein at least two amino acids comprise LT, having a       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						structure as follows: a sequence starting from any of amino  	     779 QESKKADTKAQTDIDSPQNLVTDWVTENTATVSWDPVQATIDRYVVHYTS 828                                                          
						acid numbers 56-x to 57; and ending at any of amino acid     	                  .         .         .         .         .  
						numbers 57+ ((n-2) - x), in which x varies from 0 to n-2.    	     273 ANGETREVPVGKEQSSTVLTGLRPGMEYTVHVWAQKGNQESKKADTKAQT 322                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     829 ANGETREVPVGKEQSSTVLTGLRPGMEYTVHVWAQKGNQESKKADTKAQT 878                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     323 EIDGPKNLVTDWVTENMATVSWDPVQATIDKYMVRYTSADGETREVPVGK 372                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     879 EIDGPKNLVTDWVTENMATVSWDPVQATIDKYMVRYTSADGETREVPVGK 928                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     373 EHSSTVLTGLRPGMEYMVHVWAQKGAQESKKADTKAQTELDPPRNLRPSA 422                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     929 EHSSTVLTGLRPGMEYMVHVWAQKGAQESKKADTKAQTELDPPRNLRPSA 978                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     423 VTQSGGILTWTPPSAQIHGYILTYQFPDGTVKEMQLGREDQRFALQGLEQ 472                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     979 VTQSGGILTWTPPSAQIHGYILTYQFPDGTVKEMQLGREDQRFALQGLEQ 1028                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     473 GATYPVSLVAFKGGRRSRNVSTTLSTVGARFPHPSDCSQVQQNSNAASGL 522                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1029 GATYPVSLVAFKGGRRSRNVSTTLSTVGARFPHPSDCSQVQQNSNAASGL 1078                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     523 YTIYLHGDASRPLQVYCDMETDGGGWIVFQRRNTGQLDFFKRWRSYVEGF 572                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1079 YTIYLHGDASRPLQVYCDMETDGGGWIVFQRRNTGQLDFFKRWRSYVEGF 1128                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     573 GDPMKEFWLGLDKLHNLTTGTPARYEVRVDLQTANESAYAIYDFFQVASS 622                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1129 GDPMKEFWLGLDKLHNLTTGTPARYEVRVDLQTANESAYAIYDFFQVASS 1178                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     623 KERYKLTVGKYRGTAGDALTYHNGWKFTTFDRDNDIALSNCALTHHGGWW 672                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1179 KERYKLTVGKYRGTAGDALTYHNGWKFTTFDRDNDIALSNCALTHHGGWW 1228                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     673 YKNCHLANPNGRYGETKHSEGVNWEPWKGHEFSIPYVELKIRPHGYSREP 722                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1229 YKNCHLANPNGRYGETKHSEGVNWEPWKGHEFSIPYVELKIRPHGYSREP 1278                                                         
						                                                            	                  .                                          
						                                                            	     723 VLGRKKRTLRGRLRTF                                   738                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	    1279 VLGRKKRTLRGRLRTF                                   1294                                                         

4661	HMR136_AA563930_2_tr0_r1_1_gPRT		Comparison report between AA563930_P2 and TC10_HUMANunique   	Sequence name: TC10_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA563930_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 4661 x TC10_HUMAN   ..                         
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						IRFSNGDVKKIKPSRRVIYYHANAQTMRTTYPDGLEVVQFPNKQT corresponding  	                                                            
						to amino acids 1 - 45 of AA563930_P2, and a second amino acid	                     Quality: 1241.00                      Escore:       0                                               
						EKFYPNGSKEIVFPDGTVEHLKDGQEETLFPDGTIVRVERNGDKTIVLSNGQKEIHTARF 	             Matching length:     126                Total length:     126                                               
						KRREYPDGTVKTVYCSGCQETKYASGRVKIKDEAGNVVLDEKQMSPQHAASHGKCQLQIF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AKTDKN                                                       	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 291 - 416 of TC10_HUMAN, which also corresponds  	                                                            
						to amino acids 46 - 171 of AA563930_P2, wherein said first   	Alignment:                                                   
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	      46 EKFYPNGSKEIVFPDGTVEHLKDGQEETLFPDGTIVRVERNGDKTIVLSN 95                                                           
						polypeptide encoding for a head of AA563930_P2, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     291 EKFYPNGSKEIVFPDGTVEHLKDGQEETLFPDGTIVRVERNGDKTIVLSN 340                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	      96 GQKEIHTARFKRREYPDGTVKTVYCSGCQETKYASGRVKIKDEAGNVVLD 145                                                          
						to the sequence IRFSNGDVKKIKPSRRVIYYHANAQTMRTTYPDGLEVVQFPNKQT	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of AA563930_P2.                                              	     341 GQKEIHTARFKRREYPDGTVKTVYCSGCQETKYASGRVKIKDEAGNVVLD 390                                                          
						                                                            	                  .         .                                
						                                                            	     146 EKQMSPQHAASHGKCQLQIFAKTDKN                         171                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     391 EKQMSPQHAASHGKCQLQIFAKTDKN                         416                                                          

12877	HMR136_AA576971_5_tr0_r1_1_gPRT		Comparison report between AA576971_P5 and Q8WYA3partial WT   	Sequence name: Q8WYA3                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for AA576971_P5, comprising a first     	Sequence documentation:                                      
						MAAEEEAAAGGKVLREENQCIAPVVSSRVSPGTRPTAMGSFSSHMTEFPRKRKGSDSDPS 	                                                            
						Q                                                            	Alignment of: 12877 x Q8WYA3   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 61 of Q8WYA3, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 61 of AA576971_P5, and a      	                                                            
						EAHSQTEKRRRDKMNNLIEELSAMIPQCNPMARKLDKLTVLRMAVQHLRSLKGLTNSYVG 	                     Quality: 4082.00                      Escore:       0                                               
						SNYRPSFLQDNELRHLILKTAEGFLFVVGCERGKILFVSKSVSKILNYDQASLTGQSLFD 	             Matching length:     425                Total length:     459                                               
						FLHPKDVAKVKEQLSSFDISPREKLIDAKTGLQVHSNLHAGRTRVYSGSRRSFFCRIKSC 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KISVKEEHGCLPNSKKKEHRKFYTIHCTGYLRSWPPNIVGMEEERNSKKDNSNFTCLVAI 	    Total Percent Similarity:   92.59      Total Percent Identity:   92.59                                               
						GRLQPYIVPQNSGEINVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELLGTSCYEYFH 	                        Gaps:       1                        
						QDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDGSFVTLKSQWFSFTNPWTKELEYIVSVN 	                                                            
						TLVL                                                         	Alignment:                                                   
						second amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 96 - 459 of Q8WYA3, which also  	       1 MAAEEEAAAGGKVLREENQCIAPVVSSRVSPGTRPTAMGSFSSHMTEFPR 50                                                           
						corresponds to amino acids 62 - 425 of AA576971_P5, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence and second amino acid sequence	       1 MAAEEEAAAGGKVLREENQCIAPVVSSRVSPGTRPTAMGSFSSHMTEFPR 50                                                           
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						chimeric polypeptide encoding for an edge portion of         	      51 KRKGSDSDPSQ..................................EAHSQ 66                                                           
						AA576971_P5, comprising a polypeptide having a length "n",   	         |||||||||||                                  |||||  
						wherein n is at least about 10 amino acids in length,        	      51 KRKGSDSDPSQSGIMTEKVVEKLSQNPLTYLLSTRIEISASSGSREAHSQ 100                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	      67 TEKRRRDKMNNLIEELSAMIPQCNPMARKLDKLTVLRMAVQHLRSLKGLT 116                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     101 TEKRRRDKMNNLIEELSAMIPQCNPMARKLDKLTVLRMAVQHLRSLKGLT 150                                                          
						at least two amino acids comprise QE, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     117 NSYVGSNYRPSFLQDNELRHLILKTAEGFLFVVGCERGKILFVSKSVSKI 166                                                          
						61-x to 62; and ending at any of amino acid numbers 62+      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     151 NSYVGSNYRPSFLQDNELRHLILKTAEGFLFVVGCERGKILFVSKSVSKI 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     167 LNYDQASLTGQSLFDFLHPKDVAKVKEQLSSFDISPREKLIDAKTGLQVH 216                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LNYDQASLTGQSLFDFLHPKDVAKVKEQLSSFDISPREKLIDAKTGLQVH 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     217 SNLHAGRTRVYSGSRRSFFCRIKSCKISVKEEHGCLPNSKKKEHRKFYTI 266                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SNLHAGRTRVYSGSRRSFFCRIKSCKISVKEEHGCLPNSKKKEHRKFYTI 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     267 HCTGYLRSWPPNIVGMEEERNSKKDNSNFTCLVAIGRLQPYIVPQNSGEI 316                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 HCTGYLRSWPPNIVGMEEERNSKKDNSNFTCLVAIGRLQPYIVPQNSGEI 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     317 NVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELLGTSCYEYFHQDDHN 366                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 NVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELLGTSCYEYFHQDDHN 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     367 NLTDKHKAVLQSKEKILTDSYKFRAKDGSFVTLKSQWFSFTNPWTKELEY 416                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 NLTDKHKAVLQSKEKILTDSYKFRAKDGSFVTLKSQWFSFTNPWTKELEY 450                                                          
						                                                            	                                                             
						                                                            	     417 IVSVNTLVL                                          425                                                          
						                                                            	         |||||||||                                           
						                                                            	     451 IVSVNTLVL                                          459                                                          

						Comparison report between AA576971_P5 and Q8WYA1partial WT   	Sequence name: Q8WYA1                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA576971_P5, comprising a first amino acid      	                                                            
						MAAEEEAAAGGKVLREENQCIAPVVSSRVSPGTRPTAMGSFSSHMTEFPRKRKGSDSDPS 	Alignment of: 12877 x Q8WYA1   ..                            
						QEAHSQTEKRRRDKMNNLIEELSAMIPQCNPMARKLDKLTVLRMAVQHLRSLKGLTNSYV 	                                                            
						GSNYRPSFLQDNELRHLILKTAEGFLFVVGCERGKILFVSKSVSKILNYDQASLTGQSLF 	Alignment segment 1/1:                                       
						DFLHPKDVAKVKEQLSSFDISPREKLIDAKTGLQVHSNLHAGRTRVYSGSRRSFFCRIKS 	                                                            
						CKISVKEEHGCLPNSKKKEHRKFYTIHCTGYLRSWPPNIVGMEEERNSKKDNSNFTCLVA 	                     Quality: 4182.00                      Escore:       0                                               
						IGRLQPYIVPQNSGEINVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELLGTSCYEYF 	             Matching length:     425                Total length:     425                                               
						HQDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDGSFVTLKSQWFSFTNPWTKELEYIVSV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NTLVL                                                        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 1 - 425 of Q8WYA1, which also corresponds to     	                                                            
						amino acids 1 - 425 of AA576971_P5.                          	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAAEEEAAAGGKVLREENQCIAPVVSSRVSPGTRPTAMGSFSSHMTEFPR 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MAAEEEAAAGGKVLREENQCIAPVVSSRVSPGTRPTAMGSFSSHMTEFPR 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 KRKGSDSDPSQEAHSQTEKRRRDKMNNLIEELSAMIPQCNPMARKLDKLT 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 KRKGSDSDPSQEAHSQTEKRRRDKMNNLIEELSAMIPQCNPMARKLDKLT 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VLRMAVQHLRSLKGLTNSYVGSNYRPSFLQDNELRHLILKTAEGFLFVVG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 VLRMAVQHLRSLKGLTNSYVGSNYRPSFLQDNELRHLILKTAEGFLFVVG 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 CERGKILFVSKSVSKILNYDQASLTGQSLFDFLHPKDVAKVKEQLSSFDI 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 CERGKILFVSKSVSKILNYDQASLTGQSLFDFLHPKDVAKVKEQLSSFDI 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SPREKLIDAKTGLQVHSNLHAGRTRVYSGSRRSFFCRIKSCKISVKEEHG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 SPREKLIDAKTGLQVHSNLHAGRTRVYSGSRRSFFCRIKSCKISVKEEHG 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 CLPNSKKKEHRKFYTIHCTGYLRSWPPNIVGMEEERNSKKDNSNFTCLVA 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 CLPNSKKKEHRKFYTIHCTGYLRSWPPNIVGMEEERNSKKDNSNFTCLVA 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IGRLQPYIVPQNSGEINVKPTEFITRFAVNGKFVYVDQRATAILGYLPQE 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 IGRLQPYIVPQNSGEINVKPTEFITRFAVNGKFVYVDQRATAILGYLPQE 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 LLGTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDGSFVTLK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LLGTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDGSFVTLK 400                                                          
						                                                            	                  .         .                                
						                                                            	     401 SQWFSFTNPWTKELEYIVSVNTLVL                          425                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     401 SQWFSFTNPWTKELEYIVSVNTLVL                          425                                                          

						Comparison report between AA576971_P5 and Q8WYA2unique head  	Sequence name: Q8WYA2                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA576971_P5, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 12877 x Q8WYA2   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MAAEEEAAAG corresponding to amino acids 1	Alignment segment 1/1:                                       
						- 10 of AA576971_P5, and a second amino acid sequence being  	                                                            
						GKVLREENQCIAPVVSSRVSPGTRPTAMGSFSSHMTEFPRKRKGSDSDPSQEAHSQTEKR 	                     Quality: 4110.00                      Escore:       0                                               
						RRDKMNNLIEELSAMIPQCNPMARKLDKLTVLRMAVQHLRSLKGLTNSYVGSNYRPSFLQ 	             Matching length:     420                Total length:     420                                               
						DNELRHLILKTAEGFLFVVGCERGKILFVSKSVSKILNYDQASLTGQSLFDFLHPKDVAK 	 Matching Percent Similarity:   99.52   Matching Percent Identity:   99.52                                               
						VKEQLSSFDISPREKLIDAKTGLQVHSNLHAGRTRVYSGSRRSFFCRIKSCKISVKEEHG 	    Total Percent Similarity:   99.52      Total Percent Identity:   99.52                                               
						CLPNSKKKEHRKFYTIHCTGYLRSWPPNIVGMEEERNSKKDNSNFTCLVAIGRLQPYIVP 	                        Gaps:       0                        
						QNSGEINVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELLGTSCYEYFHQDDHNNLTD 	                                                            
						KHKAVLQSKEKILTDSYKFRAKDGSFVTLKSQWFSFTNPWTKELEYIVSVNTLVL      	Alignment:                                                   
						at least 90 % homologous to corresponding to amino acids 22 -	                  .         .         .         .         .  
						436 of Q8WYA2, which also corresponds to amino acids 11 - 425	       6 EAAAGGKVLREENQCIAPVVSSRVSPGTRPTAMGSFSSHMTEFPRKRKGS 55                                                           
						of AA576971_P5, wherein said first amino acid sequence and   	         || | |||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	      17 EATAPGKVLREENQCIAPVVSSRVSPGTRPTAMGSFSSHMTEFPRKRKGS 66                                                           
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AA576971_P5, comprising a polypeptide being at least 70%,    	      56 DSDPSQEAHSQTEKRRRDKMNNLIEELSAMIPQCNPMARKLDKLTVLRMA 105                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	      67 DSDPSQEAHSQTEKRRRDKMNNLIEELSAMIPQCNPMARKLDKLTVLRMA 116                                                          
						least about 95% homologous to the sequence MAAEEEAAAG of     	                  .         .         .         .         .  
						AA576971_P5.                                                 	     106 VQHLRSLKGLTNSYVGSNYRPSFLQDNELRHLILKTAEGFLFVVGCERGK 155                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     117 VQHLRSLKGLTNSYVGSNYRPSFLQDNELRHLILKTAEGFLFVVGCERGK 166                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     156 ILFVSKSVSKILNYDQASLTGQSLFDFLHPKDVAKVKEQLSSFDISPREK 205                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     167 ILFVSKSVSKILNYDQASLTGQSLFDFLHPKDVAKVKEQLSSFDISPREK 216                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     206 LIDAKTGLQVHSNLHAGRTRVYSGSRRSFFCRIKSCKISVKEEHGCLPNS 255                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     217 LIDAKTGLQVHSNLHAGRTRVYSGSRRSFFCRIKSCKISVKEEHGCLPNS 266                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     256 KKKEHRKFYTIHCTGYLRSWPPNIVGMEEERNSKKDNSNFTCLVAIGRLQ 305                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     267 KKKEHRKFYTIHCTGYLRSWPPNIVGMEEERNSKKDNSNFTCLVAIGRLQ 316                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     306 PYIVPQNSGEINVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELLGTS 355                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     317 PYIVPQNSGEINVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELLGTS 366                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     356 CYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDGSFVTLKSQWFS 405                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     367 CYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDGSFVTLKSQWFS 416                                                          
						                                                            	                  .         .                                
						                                                            	     406 FTNPWTKELEYIVSVNTLVL                               425                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	     417 FTNPWTKELEYIVSVNTLVL                               436                                                          

						Comparison report between AA576971_P5 and Q96J63unique head  	Sequence name: Q96J63                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA576971_P5, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 12877 x Q96J63   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MAAEEEAAAGGKVLREENQCIAPVVSSRVSPGTRPTA    	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 37 of AA576971_P5, and a    	                                                            
						MGSFSSHMTEFPRKRKGSDSDPSQEAHSQTEKRRRDKMNNLIEELSAMIPQCNPMARKLD 	                     Quality: 3832.00                      Escore:       0                                               
						KLTVLRMAVQHLRSLKGLTNSYVGSNYRPSFLQDNELRHLILKTAEGFLFVVGCERGKIL 	             Matching length:     388                Total length:     388                                               
						FVSKSVSKILNYDQASLTGQSLFDFLHPKDVAKVKEQLSSFDISPREKLIDAKTGLQVHS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						NLHAGRTRVYSGSRRSFFCRIKSCKISVKEEHGCLPNSKKKEHRKFYTIHCTGYLRSWPP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						NIVGMEEERNSKKDNSNFTCLVAIGRLQPYIVPQNSGEINVKPTEFITRFAVNGKFVYVD 	                        Gaps:       0                        
						QRATAILGYLPQELLGTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDGSFV 	                                                            
						TLKSQWFSFTNPWTKELEYIVSVNTLVL                                 	Alignment:                                                   
						second amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 1 - 388 of Q96J63, which also   	      38 MGSFSSHMTEFPRKRKGSDSDPSQEAHSQTEKRRRDKMNNLIEELSAMIP 87                                                           
						corresponds to amino acids 38 - 425 of AA576971_P5, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence and second amino acid sequence	       1 MGSFSSHMTEFPRKRKGSDSDPSQEAHSQTEKRRRDKMNNLIEELSAMIP 50                                                           
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a head of AA576971_P5, comprising a 	      88 QCNPMARKLDKLTVLRMAVQHLRSLKGLTNSYVGSNYRPSFLQDNELRHL 137                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	      51 QCNPMARKLDKLTVLRMAVQHLRSLKGLTNSYVGSNYRPSFLQDNELRHL 100                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence MAAEEEAAAGGKVLREENQCIAPVVSSRVSPGTRPTA of     	     138 ILKTAEGFLFVVGCERGKILFVSKSVSKILNYDQASLTGQSLFDFLHPKD 187                                                          
						AA576971_P5.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 ILKTAEGFLFVVGCERGKILFVSKSVSKILNYDQASLTGQSLFDFLHPKD 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     188 VAKVKEQLSSFDISPREKLIDAKTGLQVHSNLHAGRTRVYSGSRRSFFCR 237                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VAKVKEQLSSFDISPREKLIDAKTGLQVHSNLHAGRTRVYSGSRRSFFCR 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     238 IKSCKISVKEEHGCLPNSKKKEHRKFYTIHCTGYLRSWPPNIVGMEEERN 287                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 IKSCKISVKEEHGCLPNSKKKEHRKFYTIHCTGYLRSWPPNIVGMEEERN 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     288 SKKDNSNFTCLVAIGRLQPYIVPQNSGEINVKPTEFITRFAVNGKFVYVD 337                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SKKDNSNFTCLVAIGRLQPYIVPQNSGEINVKPTEFITRFAVNGKFVYVD 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     338 QRATAILGYLPQELLGTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSY 387                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 QRATAILGYLPQELLGTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSY 350                                                          
						                                                            	                  .         .         .                      
						                                                            	     388 KFRAKDGSFVTLKSQWFSFTNPWTKELEYIVSVNTLVL             425                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     351 KFRAKDGSFVTLKSQWFSFTNPWTKELEYIVSVNTLVL             388                                                          

						Comparison report between AA576971_P5 and Q8WYA4partial WT   	Sequence name: Q8WYA4                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for AA576971_P5, comprising a first     	Sequence documentation:                                      
						MAAEEEAAAGGKVLREENQCIAPVVSSRVSPGTRPTAMGSFSSHMTEFPRKRKGSDSDPS 	                                                            
						Q                                                            	Alignment of: 12877 x Q8WYA4   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 61 of Q8WYA4, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 61 of AA576971_P5, and a      	                                                            
						EAHSQTEKRRRDKMNNLIEELSAMIPQCNPMARKLDKLTVLRMAVQHLRSLKGLTNSYVG 	                     Quality: 4082.00                      Escore:       0                                               
						SNYRPSFLQDNELRHLILKTAEGFLFVVGCERGKILFVSKSVSKILNYDQASLTGQSLFD 	             Matching length:     425                Total length:     473                                               
						FLHPKDVAKVKEQLSSFDISPREKLIDAKTGLQVHSNLHAGRTRVYSGSRRSFFCRIKSC 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KISVKEEHGCLPNSKKKEHRKFYTIHCTGYLRSWPPNIVGMEEERNSKKDNSNFTCLVAI 	    Total Percent Similarity:   89.85      Total Percent Identity:   89.85                                               
						GRLQPYIVPQNSGEINVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELLGTSCYEYFH 	                        Gaps:       1                        
						QDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDGSFVTLKSQWFSFTNPWTKELEYIVSVN 	                                                            
						TLVL                                                         	Alignment:                                                   
						second amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 110 - 473 of Q8WYA4, which also 	       1 MAAEEEAAAGGKVLREENQCIAPVVSSRVSPGTRPTAMGSFSSHMTEFPR 50                                                           
						corresponds to amino acids 62 - 425 of AA576971_P5, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence and second amino acid sequence	       1 MAAEEEAAAGGKVLREENQCIAPVVSSRVSPGTRPTAMGSFSSHMTEFPR 50                                                           
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						chimeric polypeptide encoding for an edge portion of         	      51 KRKGSDSDPSQ....................................... 61                                                           
						AA576971_P5, comprising a polypeptide having a length "n",   	         |||||||||||                                         
						wherein n is at least about 10 amino acids in length,        	      51 KRKGSDSDPSQSGIMTEKVVEKLSQNPLTYLLSTRIEISASSGSRVEDGE 100                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	      62 .........EAHSQTEKRRRDKMNNLIEELSAMIPQCNPMARKLDKLTVL 102                                                          
						preferably at least about 40 amino acids in length and most  	                  |||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     101 HQVKMKAFREAHSQTEKRRRDKMNNLIEELSAMIPQCNPMARKLDKLTVL 150                                                          
						at least two amino acids comprise QE, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     103 RMAVQHLRSLKGLTNSYVGSNYRPSFLQDNELRHLILKTAEGFLFVVGCE 152                                                          
						61-x to 62; and ending at any of amino acid numbers 62+      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     151 RMAVQHLRSLKGLTNSYVGSNYRPSFLQDNELRHLILKTAEGFLFVVGCE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     153 RGKILFVSKSVSKILNYDQASLTGQSLFDFLHPKDVAKVKEQLSSFDISP 202                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 RGKILFVSKSVSKILNYDQASLTGQSLFDFLHPKDVAKVKEQLSSFDISP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     203 REKLIDAKTGLQVHSNLHAGRTRVYSGSRRSFFCRIKSCKISVKEEHGCL 252                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 REKLIDAKTGLQVHSNLHAGRTRVYSGSRRSFFCRIKSCKISVKEEHGCL 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     253 PNSKKKEHRKFYTIHCTGYLRSWPPNIVGMEEERNSKKDNSNFTCLVAIG 302                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 PNSKKKEHRKFYTIHCTGYLRSWPPNIVGMEEERNSKKDNSNFTCLVAIG 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     303 RLQPYIVPQNSGEINVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELL 352                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RLQPYIVPQNSGEINVKPTEFITRFAVNGKFVYVDQRATAILGYLPQELL 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     353 GTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDGSFVTLKSQ 402                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GTSCYEYFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAKDGSFVTLKSQ 450                                                          
						                                                            	                  .         .                                
						                                                            	     403 WFSFTNPWTKELEYIVSVNTLVL                            425                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     451 WFSFTNPWTKELEYIVSVNTLVL                            473                                                          

24803	HMR136_AA587760_2_tr0_r1_1_gPRT		Comparison report between AA587760_P2 and Q9P2A7partial WT   	Sequence name: Q9P2A7                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA587760_P2, comprising a first amino acid      	                                                            
						MGDMKTPDFDDLLAAFDIPDIDANEAIHSGPEENEGPGGPGKPEPGVGSESEDTAAASAG 	Alignment of: 24803 x Q9P2A7   ..                            
						DGPGVPAQASDHGLPPPDISVVSVIVKNTVCPEQSEALAGGSAGDGAQAAGVTKEGPVGP 	                                                            
						HRMQNGFGSPEPSLPGTPHSPAPPSGGTWKEKGMEGKTPLDLFAHFGPEPGDHSDPLPPS 	Alignment segment 1/1:                                       
						APSPTREGALTPPPFPSSFELAQENGPGMQPPVSSPPLGALKQESCSPHHPQVLAQQGSG 	                                                            
						SSPKATDIPASASPPPVAGVPFFKQSPGHQSPLASPKVPVCQPLKEEDDDEGPVDKSSPG 	                     Quality: 12229.00                      Escore:       0                                              
						SPQSPSSGAEAADEDSNDSPASSSSRPLKVRIKTIKTSCGNITRTVTQVPSDPDPPAPLA 	             Matching length:    1237                Total length:    1237                                               
						EGAFLAEASLLKLSPATPTSEGPKVVSVQLGDGTRLKGTVLPVATIQNASTAMLMAASVA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RKAVVLPGGTATSPKMIAKNVLGLVPQALPKADGRAGLGTGGQKVNGASVVMVQPSKTAT 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GPSTGGGTVISRTQSSLVEAFNKILNSKNLLPAYRPNLSPPAEAGLALPPTGYRCLECGD 	                        Gaps:       0                        
						AFSLEKSLARHYDRRSMRIEVTCNHCARRLVFFNKCSLLLHAREHKDKGLVMQCSHLVMR 	                                                            
						PVALDQMVGQPDITPLLPVAVPPVSGPLALPALGKGEGAITSSAITTVAAEAPVLPLSTE 	Alignment:                                                   
						PPAAPATSAYTCFRCLECKEQCRDKAGMAAHFQQLGPPAPGATSNVCPTCPMMLPNRCSF 	                  .         .         .         .         .  
						SAHQRMHKNRPPHVCPECGGNFLQANFQTHLREACLHVSRRVGYRCPSCSVVFGGVNSIK 	       1 MGDMKTPDFDDLLAAFDIPDIDANEAIHSGPEENEGPGGPGKPEPGVGSE 50                                                           
						SHIQTSHCEVFHKCPICPMAFKSGPSAHAHLYSQHPSFQTQQAKLIYKCAMCDTVFTHKP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLSSHFDQHLLPQRVSVFKCPSCPLLFAQKRTMLEHLKNTHQSGRLEETAGKGAGGALLT 	      22 MGDMKTPDFDDLLAAFDIPDIDANEAIHSGPEENEGPGGPGKPEPGVGSE 71                                                           
						PKTEPEELAVSQGGAAPATEESSSSSEEEEVPSSPEPPRPAKRPRRELGSKGLKGGGGGP 	                  .         .         .         .         .  
						GGWTCGLCHSWFPERDEYVAHMKKEHGKSVKKFPCRLCERSFCSAPSLRRHVRVNHEGIK 	      51 SEDTAAASAGDGPGVPAQASDHGLPPPDISVVSVIVKNTVCPEQSEALAG 100                                                          
						RVYPCRYCTEGKRTFSSRLILEKHVQVRHGLQLGAQSPGRGTTLARGSSARAQGPGRKRR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QSSDSCSEEPDSTTPPAKSPRGGPGSGGHGPLRYRSSSSTEQSLMMGLRVEDGAQQCLDC 	      72 SEDTAAASAGDGPGVPAQASDHGLPPPDISVVSVIVKNTVCPEQSEALAG 121                                                          
						GLCFASPGSLSRHRFISHKKRRGVGKASALGLGDGEEEAPPSRSDPDGGDSPLPASGGPL 	                  .         .         .         .         .  
						TCKVCGKSCDSPLNLKTHFRTHGMAFIRARQGAVGDN                        	     101 GSAGDGAQAAGVTKEGPVGPHRMQNGFGSPEPSLPGTPHSPAPPSGGTWK 150                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 22 - 1258 of Q9P2A7, which also corresponds to   	     122 GSAGDGAQAAGVTKEGPVGPHRMQNGFGSPEPSLPGTPHSPAPPSGGTWK 171                                                          
						amino acids 1 - 1237 of AA587760_P2.                         	                  .         .         .         .         .  
						                                                            	     151 EKGMEGKTPLDLFAHFGPEPGDHSDPLPPSAPSPTREGALTPPPFPSSFE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     172 EKGMEGKTPLDLFAHFGPEPGDHSDPLPPSAPSPTREGALTPPPFPSSFE 221                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LAQENGPGMQPPVSSPPLGALKQESCSPHHPQVLAQQGSGSSPKATDIPA 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     222 LAQENGPGMQPPVSSPPLGALKQESCSPHHPQVLAQQGSGSSPKATDIPA 271                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SASPPPVAGVPFFKQSPGHQSPLASPKVPVCQPLKEEDDDEGPVDKSSPG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     272 SASPPPVAGVPFFKQSPGHQSPLASPKVPVCQPLKEEDDDEGPVDKSSPG 321                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SPQSPSSGAEAADEDSNDSPASSSSRPLKVRIKTIKTSCGNITRTVTQVP 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     322 SPQSPSSGAEAADEDSNDSPASSSSRPLKVRIKTIKTSCGNITRTVTQVP 371                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SDPDPPAPLAEGAFLAEASLLKLSPATPTSEGPKVVSVQLGDGTRLKGTV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     372 SDPDPPAPLAEGAFLAEASLLKLSPATPTSEGPKVVSVQLGDGTRLKGTV 421                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 LPVATIQNASTAMLMAASVARKAVVLPGGTATSPKMIAKNVLGLVPQALP 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     422 LPVATIQNASTAMLMAASVARKAVVLPGGTATSPKMIAKNVLGLVPQALP 471                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KADGRAGLGTGGQKVNGASVVMVQPSKTATGPSTGGGTVISRTQSSLVEA 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     472 KADGRAGLGTGGQKVNGASVVMVQPSKTATGPSTGGGTVISRTQSSLVEA 521                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 FNKILNSKNLLPAYRPNLSPPAEAGLALPPTGYRCLECGDAFSLEKSLAR 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     522 FNKILNSKNLLPAYRPNLSPPAEAGLALPPTGYRCLECGDAFSLEKSLAR 571                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 HYDRRSMRIEVTCNHCARRLVFFNKCSLLLHAREHKDKGLVMQCSHLVMR 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     572 HYDRRSMRIEVTCNHCARRLVFFNKCSLLLHAREHKDKGLVMQCSHLVMR 621                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 PVALDQMVGQPDITPLLPVAVPPVSGPLALPALGKGEGAITSSAITTVAA 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     622 PVALDQMVGQPDITPLLPVAVPPVSGPLALPALGKGEGAITSSAITTVAA 671                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 EAPVLPLSTEPPAAPATSAYTCFRCLECKEQCRDKAGMAAHFQQLGPPAP 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     672 EAPVLPLSTEPPAAPATSAYTCFRCLECKEQCRDKAGMAAHFQQLGPPAP 721                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GATSNVCPTCPMMLPNRCSFSAHQRMHKNRPPHVCPECGGNFLQANFQTH 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     722 GATSNVCPTCPMMLPNRCSFSAHQRMHKNRPPHVCPECGGNFLQANFQTH 771                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 LREACLHVSRRVGYRCPSCSVVFGGVNSIKSHIQTSHCEVFHKCPICPMA 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     772 LREACLHVSRRVGYRCPSCSVVFGGVNSIKSHIQTSHCEVFHKCPICPMA 821                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 FKSGPSAHAHLYSQHPSFQTQQAKLIYKCAMCDTVFTHKPLLSSHFDQHL 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     822 FKSGPSAHAHLYSQHPSFQTQQAKLIYKCAMCDTVFTHKPLLSSHFDQHL 871                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 LPQRVSVFKCPSCPLLFAQKRTMLEHLKNTHQSGRLEETAGKGAGGALLT 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     872 LPQRVSVFKCPSCPLLFAQKRTMLEHLKNTHQSGRLEETAGKGAGGALLT 921                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     901 PKTEPEELAVSQGGAAPATEESSSSSEEEEVPSSPEPPRPAKRPRRELGS 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     922 PKTEPEELAVSQGGAAPATEESSSSSEEEEVPSSPEPPRPAKRPRRELGS 971                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     951 KGLKGGGGGPGGWTCGLCHSWFPERDEYVAHMKKEHGKSVKKFPCRLCER 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     972 KGLKGGGGGPGGWTCGLCHSWFPERDEYVAHMKKEHGKSVKKFPCRLCER 1021                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 SFCSAPSLRRHVRVNHEGIKRVYPCRYCTEGKRTFSSRLILEKHVQVRHG 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1022 SFCSAPSLRRHVRVNHEGIKRVYPCRYCTEGKRTFSSRLILEKHVQVRHG 1071                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 LQLGAQSPGRGTTLARGSSARAQGPGRKRRQSSDSCSEEPDSTTPPAKSP 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1072 LQLGAQSPGRGTTLARGSSARAQGPGRKRRQSSDSCSEEPDSTTPPAKSP 1121                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 RGGPGSGGHGPLRYRSSSSTEQSLMMGLRVEDGAQQCLDCGLCFASPGSL 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1122 RGGPGSGGHGPLRYRSSSSTEQSLMMGLRVEDGAQQCLDCGLCFASPGSL 1171                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 SRHRFISHKKRRGVGKASALGLGDGEEEAPPSRSDPDGGDSPLPASGGPL 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1172 SRHRFISHKKRRGVGKASALGLGDGEEEAPPSRSDPDGGDSPLPASGGPL 1221                                                         
						                                                            	                  .         .         .                      
						                                                            	    1201 TCKVCGKSCDSPLNLKTHFRTHGMAFIRARQGAVGDN              1237                                                         
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	    1222 TCKVCGKSCDSPLNLKTHFRTHGMAFIRARQGAVGDN              1258                                                         

16567	HMR136_AA594251_5_tr0_r1_1_gPRT		Comparison report between AA594251_P5 and BCA3_HUMANpartial  	Sequence name: BCA3_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for AA594251_P5, comprising a first     	                                                            
						MAEFMDYTSSQCGKYYSSVPEEGGATHVYRYHRGESKLHMCLDIGNGQRKDRKKTSLGPG 	Alignment of: 16567 x BCA3_HUMAN   ..                        
						GSYQISEHAPEASQPAENISKDLYIEVYPGTYSVTVGSNDLTKKTHVVAVDSGQSVDLVF 	                                                            
						PV                                                           	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 89 - 210 of BCA3_HUMAN, which   	                     Quality: 1202.00                      Escore:       0                                               
						also corresponds to amino acids 1 - 122 of AA594251_P5.      	             Matching length:     122                Total length:     122                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MAEFMDYTSSQCGKYYSSVPEEGGATHVYRYHRGESKLHMCLDIGNGQRK 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      89 MAEFMDYTSSQCGKYYSSVPEEGGATHVYRYHRGESKLHMCLDIGNGQRK 138                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 DRKKTSLGPGGSYQISEHAPEASQPAENISKDLYIEVYPGTYSVTVGSND 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     139 DRKKTSLGPGGSYQISEHAPEASQPAENISKDLYIEVYPGTYSVTVGSND 188                                                          
						                                                            	                  .         .                                
						                                                            	     101 LTKKTHVVAVDSGQSVDLVFPV                             122                                                          
						                                                            	         ||||||||||||||||||||||                              
						                                                            	     189 LTKKTHVVAVDSGQSVDLVFPV                             210                                                          

19904	HMR136_AA608725_1_tr0_r1_1_gPRT		Comparison report between AA608725_P1 and Q8NCX0unique head  	Sequence name: Q8NCX0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA608725_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 19904 x Q8NCX0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MNKYLQTKYAQANSELSAKRVHLQQADAHLKE corresponding to amino acids	                                                            
						1 - 32 of AA608725_P1, a second amino acid sequence being at 	                     Quality: 2840.00                      Escore:       0                                               
						VKSILERSKEELSRTVKCRNAALKESQKLKEDLEAVEDRENKKVGNFQRQLAEAKEDNCK 	             Matching length:     295                Total length:     295                                               
						VTIMLENVLASHSKMQGALEKVQIELGRRDSEIAGLKKERDLNQQRVQKLEAEVDQWQAR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MLVMEDQHNSEIESLQKALGVAREDNRKLAMSLEQALQTNNHLQTKLDHIQEQLESKELE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RQNLETFKDRMTEESKVEAELHAERIEALRKQFQTERETTKKVAQREVAELKKALDEANF 	                        Gaps:       0                        
						RSVEVSRTNRELRQKLAELEKILESNKEKIKNQKTQIKLHLSAKANNAQNIERMK      	                                                            
						least 90 % homologous to corresponding to amino acids 110 -  	Alignment:                                                   
						404 of Q8NCX0, which also corresponds to amino acids 33 - 327	                  .         .         .         .         .  
						of AA608725_P1, and a third amino acid sequence being at     	      33 VKSILERSKEELSRTVKCRNAALKESQKLKEDLEAVEDRENKKVGNFQRQ 82                                                           
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	     110 VKSILERSKEELSRTVKCRNAALKESQKLKEDLEAVEDRENKKVGNFQRQ 159                                                          
						QIEKELKQMELIKDQYQKKNYEQSLSIQRFVCEMTNLQKEMQMLAKSQYDASVRNKQQEL 	                  .         .         .         .         .  
						HLEAERKIRQELENRCQELEETVRHLKKCKEATENTLKEASVESEQITANLEEAHRWFKH 	      83 LAEAKEDNCKVTIMLENVLASHSKMQGALEKVQIELGRRDSEIAGLKKER 132                                                          
						RFDGLQLELTKNRLQRPSGEDRWQEKDQDVKHDVMSNQSVLHRWERKQNLRPMPKKYHSE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VQRK                                                         	     160 LAEAKEDNCKVTIMLENVLASHSKMQGALEKVQIELGRRDSEIAGLKKER 209                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 328 - 511 of AA608725_P1, wherein said first  	     133 DLNQQRVQKLEAEVDQWQARMLVMEDQHNSEIESLQKALGVAREDNRKLA 182                                                          
						amino acid sequence, second amino acid sequence and third    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     210 DLNQQRVQKLEAEVDQWQARMLVMEDQHNSEIESLQKALGVAREDNRKLA 259                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AA608725_P1, comprising a polypeptide being at least 70%,    	     183 MSLEQALQTNNHLQTKLDHIQEQLESKELERQNLETFKDRMTEESKVEAE 232                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     260 MSLEQALQTNNHLQTKLDHIQEQLESKELERQNLETFKDRMTEESKVEAE 309                                                          
						least about 95% homologous to the sequence                   	                  .         .         .         .         .  
						MNKYLQTKYAQANSELSAKRVHLQQADAHLKE of AA608725_P1.3.An isolated	     233 LHAERIEALRKQFQTERETTKKVAQREVAELKKALDEANFRSVEVSRTNR 282                                                          
						polypeptide encoding for a tail of AA608725_P1, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     310 LHAERIEALRKQFQTERETTKKVAQREVAELKKALDEANFRSVEVSRTNR 359                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .            
						about 90% and most preferably at least about 95% homologous  	     283 ELRQKLAELEKILESNKEKIKNQKTQIKLHLSAKANNAQNIERMK      327                                                          
						QIEKELKQMELIKDQYQKKNYEQSLSIQRFVCEMTNLQKEMQMLAKSQYDASVRNKQQEL 	         |||||||||||||||||||||||||||||||||||||||||||||       
						HLEAERKIRQELENRCQELEETVRHLKKCKEATENTLKEASVESEQITANLEEAHRWFKH 	     360 ELRQKLAELEKILESNKEKIKNQKTQIKLHLSAKANNAQNIERMK      404                                                          
						RFDGLQLELTKNRLQRPSGEDRWQEKDQDVKHDVMSNQSVLHRWERKQNLRPMPKKYHSE 	                                                            
						VQRK                                                         	                                                            
						to the sequence in AA608725_P1.                              	                                                            

						Comparison report between AA608725_P1 and Q8N8V5unique head  	Sequence name: Q8N8V5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA608725_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 19904 x Q8N8V5   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MNKYLQTKYAQANSELSAKRVHLQQADAHLKEVKSILERSKEELSRTVKCRNAALKESQK 	Alignment segment 1/1:                                       
						LKEDLEAVEDRENKKVGNFQRQLAEAKEDNCKVTI                          	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 1616.00                      Escore:       0                                               
						to amino acids 1 - 95 of AA608725_P1, a second amino acid    	             Matching length:     167                Total length:     167                                               
						MLENVLASHSKMQGALEKVQIELGRRDSEIAGLKKERDLNQQRVQKLEAEVDQWQARMLV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MEDQHNSEIESLQKALGVAREDNRKLAMSLEQALQTNNHLQTKLDHIQEQLESKELERQN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LETFKDRMTEESKVEAELHAERIEALRKQFQTERETTKKVAQREVAE              	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 167 of Q8N8V5, which also corresponds to     	Alignment:                                                   
						amino acids 96 - 262 of AA608725_P1, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	      96 MLENVLASHSKMQGALEKVQIELGRRDSEIAGLKKERDLNQQRVQKLEAE 145                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	       1 MLENVLASHSKMQGALEKVQIELGRRDSEIAGLKKERDLNQQRVQKLEAE 50                                                           
						LKKALDEANFRSVEVSRTNRELRQKLAELEKILESNKEKIKNQKTQIKLHLSAKANNAQN 	                  .         .         .         .         .  
						IERMKQIEKELKQMELIKDQYQKKNYEQSLSIQRFVCEMTNLQKEMQMLAKSQYDASVRN 	     146 VDQWQARMLVMEDQHNSEIESLQKALGVAREDNRKLAMSLEQALQTNNHL 195                                                          
						KQQELHLEAERKIRQELENRCQELEETVRHLKKCKEATENTLKEASVESEQITANLEEAH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RWFKHRFDGLQLELTKNRLQRPSGEDRWQEKDQDVKHDVMSNQSVLHRWERKQNLRPMPK 	      51 VDQWQARMLVMEDQHNSEIESLQKALGVAREDNRKLAMSLEQALQTNNHL 100                                                          
						KYHSEVQRK                                                    	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 263 - 511 of	     196 QTKLDHIQEQLESKELERQNLETFKDRMTEESKVEAELHAERIEALRKQF 245                                                          
						AA608725_P1, wherein said first amino acid sequence, second  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and third amino acid sequence are        	     101 QTKLDHIQEQLESKELERQNLETFKDRMTEESKVEAELHAERIEALRKQF 150                                                          
						contiguous and in a sequential order.2.An isolated           	                  .                                          
						polypeptide encoding for a head of AA608725_P1, comprising a 	     246 QTERETTKKVAQREVAE                                  262                                                          
						polypeptide being at least 70%, optionally at least about    	         |||||||||||||||||                                   
						80%, preferably at least about 85%, more preferably at least 	     151 QTERETTKKVAQREVAE                                  167                                                          
						about 90% and most preferably at least about 95% homologous  	                                                            
						MNKYLQTKYAQANSELSAKRVHLQQADAHLKEVKSILERSKEELSRTVKCRNAALKESQK 	                                                            
						LKEDLEAVEDRENKKVGNFQRQLAEAKEDNCKVTI                          	                                                            
						to the sequence of AA608725_P1.3.An isolated polypeptide     	                                                            
						encoding for a tail of AA608725_P1, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						LKKALDEANFRSVEVSRTNRELRQKLAELEKILESNKEKIKNQKTQIKLHLSAKANNAQN 	                                                            
						IERMKQIEKELKQMELIKDQYQKKNYEQSLSIQRFVCEMTNLQKEMQMLAKSQYDASVRN 	                                                            
						KQQELHLEAERKIRQELENRCQELEETVRHLKKCKEATENTLKEASVESEQITANLEEAH 	                                                            
						RWFKHRFDGLQLELTKNRLQRPSGEDRWQEKDQDVKHDVMSNQSVLHRWERKQNLRPMPK 	                                                            
						KYHSEVQRK                                                    	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA608725_P1.                                              	                                                            

19906	HMR136_AA608725_7_tr0_r1_1_gPRT		Comparison report between AA608725_P7 and Q8NCX0unique head  	Sequence name: Q8NCX0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA608725_P7, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 19906 x Q8NCX0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MNKYLQTKYAQANSELSAKRVHLQQADAHLKE corresponding to amino acids	                                                            
						1 - 32 of AA608725_P7, a second amino acid sequence being at 	                     Quality: 2840.00                      Escore:       0                                               
						VKSILERSKEELSRTVKCRNAALKESQKLKEDLEAVEDRENKKVGNFQRQLAEAKEDNCK 	             Matching length:     295                Total length:     295                                               
						VTIMLENVLASHSKMQGALEKVQIELGRRDSEIAGLKKERDLNQQRVQKLEAEVDQWQAR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MLVMEDQHNSEIESLQKALGVAREDNRKLAMSLEQALQTNNHLQTKLDHIQEQLESKELE 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RQNLETFKDRMTEESKVEAELHAERIEALRKQFQTERETTKKVAQREVAELKKALDEANF 	                        Gaps:       0                        
						RSVEVSRTNRELRQKLAELEKILESNKEKIKNQKTQIKLHLSAKANNAQNIERMK      	                                                            
						least 90 % homologous to corresponding to amino acids 110 -  	Alignment:                                                   
						404 of Q8NCX0, which also corresponds to amino acids 33 - 327	                  .         .         .         .         .  
						of AA608725_P7, and a third amino acid sequence being at     	      33 VKSILERSKEELSRTVKCRNAALKESQKLKEDLEAVEDRENKKVGNFQRQ 82                                                           
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	     110 VKSILERSKEELSRTVKCRNAALKESQKLKEDLEAVEDRENKKVGNFQRQ 159                                                          
						QIEKELKQMELIKDQYQKKNYEQSLSIQRFVCEMTNLQKEMQMLAKSQYDASVRNKQQEL 	                  .         .         .         .         .  
						HLEAERKIRQELENRCQELEETVRHLKKCKEATENTLKEASVESEQITANLEEAHRWFKH 	      83 LAEAKEDNCKVTIMLENVLASHSKMQGALEKVQIELGRRDSEIAGLKKER 132                                                          
						RFDGLQLELTKNRLQRPSGEDRWQEKVCFLSNRTKM                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     160 LAEAKEDNCKVTIMLENVLASHSKMQGALEKVQIELGRRDSEIAGLKKER 209                                                          
						to amino acids 328 - 483 of AA608725_P7, wherein said first  	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence and third    	     133 DLNQQRVQKLEAEVDQWQARMLVMEDQHNSEIESLQKALGVAREDNRKLA 182                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     210 DLNQQRVQKLEAEVDQWQARMLVMEDQHNSEIESLQKALGVAREDNRKLA 259                                                          
						AA608725_P7, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     183 MSLEQALQTNNHLQTKLDHIQEQLESKELERQNLETFKDRMTEESKVEAE 232                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence                   	     260 MSLEQALQTNNHLQTKLDHIQEQLESKELERQNLETFKDRMTEESKVEAE 309                                                          
						MNKYLQTKYAQANSELSAKRVHLQQADAHLKE of AA608725_P7.3.An isolated	                  .         .         .         .         .  
						polypeptide encoding for a tail of AA608725_P7, comprising a 	     233 LHAERIEALRKQFQTERETTKKVAQREVAELKKALDEANFRSVEVSRTNR 282                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     310 LHAERIEALRKQFQTERETTKKVAQREVAELKKALDEANFRSVEVSRTNR 359                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .            
						QIEKELKQMELIKDQYQKKNYEQSLSIQRFVCEMTNLQKEMQMLAKSQYDASVRNKQQEL 	     283 ELRQKLAELEKILESNKEKIKNQKTQIKLHLSAKANNAQNIERMK      327                                                          
						HLEAERKIRQELENRCQELEETVRHLKKCKEATENTLKEASVESEQITANLEEAHRWFKH 	         |||||||||||||||||||||||||||||||||||||||||||||       
						RFDGLQLELTKNRLQRPSGEDRWQEKVCFLSNRTKM                         	     360 ELRQKLAELEKILESNKEKIKNQKTQIKLHLSAKANNAQNIERMK      404                                                          
						to the sequence in AA608725_P7.                              	                                                            

						Comparison report between AA608725_P7 and Q8N8V5unique head  	Sequence name: Q8N8V5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA608725_P7, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 19906 x Q8N8V5   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MNKYLQTKYAQANSELSAKRVHLQQADAHLKEVKSILERSKEELSRTVKCRNAALKESQK 	Alignment segment 1/1:                                       
						LKEDLEAVEDRENKKVGNFQRQLAEAKEDNCKVTI                          	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 1616.00                      Escore:       0                                               
						to amino acids 1 - 95 of AA608725_P7, a second amino acid    	             Matching length:     167                Total length:     167                                               
						MLENVLASHSKMQGALEKVQIELGRRDSEIAGLKKERDLNQQRVQKLEAEVDQWQARMLV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MEDQHNSEIESLQKALGVAREDNRKLAMSLEQALQTNNHLQTKLDHIQEQLESKELERQN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LETFKDRMTEESKVEAELHAERIEALRKQFQTERETTKKVAQREVAE              	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 167 of Q8N8V5, which also corresponds to     	Alignment:                                                   
						amino acids 96 - 262 of AA608725_P7, and a third amino acid  	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	      96 MLENVLASHSKMQGALEKVQIELGRRDSEIAGLKKERDLNQQRVQKLEAE 145                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	       1 MLENVLASHSKMQGALEKVQIELGRRDSEIAGLKKERDLNQQRVQKLEAE 50                                                           
						LKKALDEANFRSVEVSRTNRELRQKLAELEKILESNKEKIKNQKTQIKLHLSAKANNAQN 	                  .         .         .         .         .  
						IERMKQIEKELKQMELIKDQYQKKNYEQSLSIQRFVCEMTNLQKEMQMLAKSQYDASVRN 	     146 VDQWQARMLVMEDQHNSEIESLQKALGVAREDNRKLAMSLEQALQTNNHL 195                                                          
						KQQELHLEAERKIRQELENRCQELEETVRHLKKCKEATENTLKEASVESEQITANLEEAH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RWFKHRFDGLQLELTKNRLQRPSGEDRWQEKVCFLSNRTKM                    	      51 VDQWQARMLVMEDQHNSEIESLQKALGVAREDNRKLAMSLEQALQTNNHL 100                                                          
						having the sequence corresponding to amino acids 263 - 483 of	                  .         .         .         .         .  
						AA608725_P7, wherein said first amino acid sequence, second  	     196 QTKLDHIQEQLESKELERQNLETFKDRMTEESKVEAELHAERIEALRKQF 245                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     101 QTKLDHIQEQLESKELERQNLETFKDRMTEESKVEAELHAERIEALRKQF 150                                                          
						polypeptide encoding for a head of AA608725_P7, comprising a 	                  .                                          
						polypeptide being at least 70%, optionally at least about    	     246 QTERETTKKVAQREVAE                                  262                                                          
						80%, preferably at least about 85%, more preferably at least 	         |||||||||||||||||                                   
						about 90% and most preferably at least about 95% homologous  	     151 QTERETTKKVAQREVAE                                  167                                                          
						MNKYLQTKYAQANSELSAKRVHLQQADAHLKEVKSILERSKEELSRTVKCRNAALKESQK 	                                                            
						LKEDLEAVEDRENKKVGNFQRQLAEAKEDNCKVTI                          	                                                            
						to the sequence of AA608725_P7.3.An isolated polypeptide     	                                                            
						encoding for a tail of AA608725_P7, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						LKKALDEANFRSVEVSRTNRELRQKLAELEKILESNKEKIKNQKTQIKLHLSAKANNAQN 	                                                            
						IERMKQIEKELKQMELIKDQYQKKNYEQSLSIQRFVCEMTNLQKEMQMLAKSQYDASVRN 	                                                            
						KQQELHLEAERKIRQELENRCQELEETVRHLKKCKEATENTLKEASVESEQITANLEEAH 	                                                            
						RWFKHRFDGLQLELTKNRLQRPSGEDRWQEKVCFLSNRTKM                    	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA608725_P7.                                              	                                                            

1440	HMR136_AA609064_2_tr0_r1_1_gPRT		Comparison report between AA609064_P2 and A4E1_HUMANpartial  	Sequence name: A4E1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for AA609064_P2, comprising a first     	Sequence documentation:                                      
						MSDIVEKTLTALPGLFLQNQPGGGPAAAKASFSSRLGSLVRGITALTSKHEEEKLIQQEL 	                                                            
						SSLKATVSAPTTTL                                               	Alignment of: 1440 x A4E1_HUMAN   ..                         
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 74 of A4E1_HUMAN, which also	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 74 of AA609064_P2, and a      	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality:  687.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:      74                Total length:      74                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence VGLHSQCQHI corresponding to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 75 - 84 of AA609064_P2, wherein said first amino 	                        Gaps:       0                        
						acid sequence and second amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	Alignment:                                                   
						for a tail of AA609064_P2, comprising a polypeptide being at 	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	       1 MSDIVEKTLTALPGLFLQNQPGGGPAAAKASFSSRLGSLVRGITALTSKH 50                                                           
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	       1 MSDIVEKTLTALPGLFLQNQPGGGPAAAKASFSSRLGSLVRGITALTSKH 50                                                           
						VGLHSQCQHI in AA609064_P2.                                   	                  .         .                                
						                                                            	      51 EEEKLIQQELSSLKATVSAPTTTL                           74                                                           
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	      51 EEEKLIQQELSSLKATVSAPTTTL                           74                                                           

21342	HMR136_AA609149_5_tr0_r1_1_gPRT		Comparison report between AA609149_P5 and Q8N4H0unique head  	Sequence name: Q8N4H0                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AA609149_P5, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 21342 x Q8N4H0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MGPRPLEKGCFPGCFFRNSK corresponding to amino acids 1 - 20 of  	                                                            
						AA609149_P5, a second amino acid sequence being at least 90 %	                     Quality:  808.00                      Escore:       0                                               
						homologous to EERHESRRPLSTSHEPIFPLNTIKMKL corresponding to   	             Matching length:      81                Total length:      81                                               
						amino acids 144 - 170 of Q8N4H0, which also corresponds to   	 Matching Percent Similarity:  100.00   Matching Percent Identity:   98.77                                               
						amino acids 21 - 47 of AA609149_P5, a bridging amino acid K  	    Total Percent Similarity:  100.00      Total Percent Identity:   98.77                                               
						corresponding to amino acid 48 of AA609149_P5, a third amino 	                        Gaps:       0                        
						acid sequence being at least 90 % homologous to              	                                                            
						ENNLNRLPKGMQARAPSQYSTRHFFQDQPAQLNLGNNFKISGGSKPPFVVRHV        	Alignment:                                                   
						corresponding to amino acids 172 - 224 of Q8N4H0, which also 	                  .         .         .         .         .  
						corresponds to amino acids 49 - 101 of AA609149_P5, and a    	      21 EERHESRRPLSTSHEPIFPLNTIKMKLKENNLNRLPKGMQARAPSQYSTR 70                                                           
						fourth amino acid sequence being at least 70%, optionally at 	         |||||||||||||||||||||||||||:||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     144 EERHESRRPLSTSHEPIFPLNTIKMKLRENNLNRLPKGMQARAPSQYSTR 193                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .                      
						polypeptide having the sequence SLKLFFRAFCNSEDMDEGGRKEG      	      71 HFFQDQPAQLNLGNNFKISGGSKPPFVVRHV                    101                                                          
						corresponding to amino acids 102 - 124 of AA609149_P5,       	         |||||||||||||||||||||||||||||||                     
						wherein said first amino acid sequence, second amino acid    	     194 HFFQDQPAQLNLGNNFKISGGSKPPFVVRHV                    224                                                          
						sequence, bridging amino acid, third amino acid sequence and 	                                                            
						fourth amino acid sequence are contiguous and in a sequential	                                                            
						order.2.An isolated polypeptide encoding for a head of       	                                                            
						AA609149_P5, comprising a polypeptide being at least 70%,    	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence                   	                                                            
						MGPRPLEKGCFPGCFFRNSK of AA609149_P5.3.An isolated polypeptide	                                                            
						encoding for a tail of AA609149_P5, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						SLKLFFRAFCNSEDMDEGGRKEG in AA609149_P5.                      	                                                            

23571	HMR136_AA610143_4_tr0_r1_1_gPRT		Comparison report between AA610143_P4 and Q9UFP1unique head  	Sequence name: Q9UFP1                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AA610143_P4, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23571 x Q9UFP1   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MILSAMAVTRFPPQRPSAGPDPGPMEPQGVTGAPATHIRQALSSSRRQRARNMGFWRSRA 	Alignment segment 1/1:                                       
						LPRNSILVCAEEQGHRARVDRSRESPGGDLRHPGRVRRDITLSGH                	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 2990.00                      Escore:       0                                               
						to amino acids 1 - 105 of AA610143_P4, a second amino acid   	             Matching length:     304                Total length:     304                                               
						PRLSTQHVVLLREDEVGDPGTKDLGHPQHGSPIQETQSEVVTLVSPLPGSDMAALPAWRA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.67                                               
						TSGLTLWPHTAEGRDLLGAENRALTGGQQAEDPTLASGA                      	    Total Percent Similarity:  100.00      Total Percent Identity:   99.67                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 1 - 99 of Q9UFP1, which also corresponds to amino	                                                            
						acids 106 - 204 of AA610143_P4, a bridging amino acid H      	Alignment:                                                   
						corresponding to amino acid 205 of AA610143_P4, a third amino	                  .         .         .         .         .  
						QWPGSVEKLQGSVWCDAETLLSSSRTGGQAPPWLTDHDVQMLRLLAQGEVVDKARVPAHG 	     106 PRLSTQHVVLLREDEVGDPGTKDLGHPQHGSPIQETQSEVVTLVSPLPGS 155                                                          
						QVLQVGFSTEAALQDLSSPRLSQLCSQGLCGLIKRPGDLPEVLSFHVDRVLGLRRSLPAV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ARRFHSPLLPYRYTDGGARPVIWWAPDVQHLSDPDEDQNSLALGWLQYQALLAHSCNWPG 	       1 PRLSTQHVVLLREDEVGDPGTKDLGHPQHGSPIQETQSEVVTLVSPLPGS 50                                                           
						QAPCPGIHHTEWARLALFDFLLQV                                     	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	     156 DMAALPAWRATSGLTLWPHTAEGRDLLGAENRALTGGQQAEDPTLASGAH 205                                                          
						to amino acids 101 - 304 of Q9UFP1, which also corresponds to	         |||||||||||||||||||||||||||||||||||||||||||||||||:  
						amino acids 206 - 409 of AA610143_P4, and a fourth amino acid	      51 DMAALPAWRATSGLTLWPHTAEGRDLLGAENRALTGGQQAEDPTLASGAY 100                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     206 QWPGSVEKLQGSVWCDAETLLSSSRTGGQAPPWLTDHDVQMLRLLAQGEV 255                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence GGVGQQG corresponding to amino acids 410 	     101 QWPGSVEKLQGSVWCDAETLLSSSRTGGQAPPWLTDHDVQMLRLLAQGEV 150                                                          
						- 416 of AA610143_P4, wherein said first amino acid sequence,	                  .         .         .         .         .  
						second amino acid sequence, bridging amino acid, third amino 	     256 VDKARVPAHGQVLQVGFSTEAALQDLSSPRLSQLCSQGLCGLIKRPGDLP 305                                                          
						acid sequence and fourth amino acid sequence are contiguous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.2.An isolated polypeptide encoding 	     151 VDKARVPAHGQVLQVGFSTEAALQDLSSPRLSQLCSQGLCGLIKRPGDLP 200                                                          
						for a head of AA610143_P4, comprising a polypeptide being at 	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	     306 EVLSFHVDRVLGLRRSLPAVARRFHSPLLPYRYTDGGARPVIWWAPDVQH 355                                                          
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MILSAMAVTRFPPQRPSAGPDPGPMEPQGVTGAPATHIRQALSSSRRQRARNMGFWRSRA 	     201 EVLSFHVDRVLGLRRSLPAVARRFHSPLLPYRYTDGGARPVIWWAPDVQH 250                                                          
						LPRNSILVCAEEQGHRARVDRSRESPGGDLRHPGRVRRDITLSGH                	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence of  	     356 LSDPDEDQNSLALGWLQYQALLAHSCNWPGQAPCPGIHHTEWARLALFDF 405                                                          
						AA610143_P4.3.An isolated polypeptide encoding for a tail of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA610143_P4, comprising a polypeptide being at least 70%,    	     251 LSDPDEDQNSLALGWLQYQALLAHSCNWPGQAPCPGIHHTEWARLALFDF 300                                                          
						optionally at least about 80%, preferably at least about 85%,	                                                             
						more preferably at least about 90% and most preferably at    	     406 LLQV                                               409                                                          
						least about 95% homologous to the sequence GGVGQQG in        	         ||||                                                
						AA610143_P4.                                                 	     301 LLQV                                               304                                                          

9659	HMR136_AA628425_2_tr0_r1_1_gPRT		Comparison report between AA628425_P2 and Q96MF2partial WT   	Sequence name: Q96MF2                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA628425_P2, comprising a first     	Sequence documentation:                                      
						MTEKEVLESPKPSFPAETRQSGLQRLKQLLRKGSTGTKEMELPPEPQANGEAVGAGGGPI 	                                                            
						YYIYEEEEEEEEEEEEPPPEPPKLVNDKPHKFKDHFFKKPKFCDVCARMIVLNNKFGLRC 	Alignment of: 9659 x Q96MF2   ..                             
						KNCKTNIHEHCQSYVEMQRCFGKIPPGFHRAYSSPLYSNQQYAC                 	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 164 of Q96MF2, which also   	                                                            
						corresponds to amino acids 1 - 164 of AA628425_P2, and a     	                     Quality: 1682.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     164                Total length:     164                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						polypeptide having the sequence LLPIAMILCLKPCALG             	                        Gaps:       0                        
						corresponding to amino acids 165 - 180 of AA628425_P2,       	                                                            
						wherein said first amino acid sequence and second amino acid 	Alignment:                                                   
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of AA628425_P2,     	       1 MTEKEVLESPKPSFPAETRQSGLQRLKQLLRKGSTGTKEMELPPEPQANG 50                                                           
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	       1 MTEKEVLESPKPSFPAETRQSGLQRLKQLLRKGSTGTKEMELPPEPQANG 50                                                           
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence LLPIAMILCLKPCALG in     	      51 EAVGAGGGPIYYIYEEEEEEEEEEEEPPPEPPKLVNDKPHKFKDHFFKKP 100                                                          
						AA628425_P2.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 EAVGAGGGPIYYIYEEEEEEEEEEEEPPPEPPKLVNDKPHKFKDHFFKKP 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KFCDVCARMIVLNNKFGLRCKNCKTNIHEHCQSYVEMQRCFGKIPPGFHR 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 KFCDVCARMIVLNNKFGLRCKNCKTNIHEHCQSYVEMQRCFGKIPPGFHR 150                                                          
						                                                            	                  .                                          
						                                                            	     151 AYSSPLYSNQQYAC                                     164                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     151 AYSSPLYSNQQYAC                                     164                                                          

						Comparison report between AA628425_P2 and Q96HU5unique head  	Sequence name: Q96HU5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA628425_P2, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 9659 x Q96HU5   ..                             
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MTEKEVLESPKPSFPAETRQSGLQRLKQLLRKGSTGTKE corresponding to     	                                                            
						amino acids 1 - 39 of AA628425_P2, a second amino acid       	                     Quality: 1305.00                      Escore:       0                                               
						MELPPEPQANGEAVGAGGGPIYYIYEEEEEEEEEEEEPPPEPPKLVNDKPHKFKDHFFKK 	             Matching length:     125                Total length:     125                                               
						PKFCDVCARMIVLNNKFGLRCKNCKTNIHEHCQSYVEMQRCFGKIPPGFHRAYSSPLYSN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QQYAC                                                        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 1 - 125 of Q96HU5, which also corresponds to     	                                                            
						amino acids 40 - 164 of AA628425_P2, and a third amino acid  	Alignment:                                                   
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	      40 MELPPEPQANGEAVGAGGGPIYYIYEEEEEEEEEEEEPPPEPPKLVNDKP 89                                                           
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence LLPIAMILCLKPCALG corresponding to amino  	       1 MELPPEPQANGEAVGAGGGPIYYIYEEEEEEEEEEEEPPPEPPKLVNDKP 50                                                           
						acids 165 - 180 of AA628425_P2, wherein said first amino acid	                  .         .         .         .         .  
						sequence, second amino acid sequence and third amino acid    	      90 HKFKDHFFKKPKFCDVCARMIVLNNKFGLRCKNCKTNIHEHCQSYVEMQR 139                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of AA628425_P2,     	      51 HKFKDHFFKKPKFCDVCARMIVLNNKFGLRCKNCKTNIHEHCQSYVEMQR 100                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .                                
						least about 80%, preferably at least about 85%, more         	     140 CFGKIPPGFHRAYSSPLYSNQQYAC                          164                                                          
						preferably at least about 90% and most preferably at least   	         |||||||||||||||||||||||||                           
						about 95% homologous to the sequence                         	     101 CFGKIPPGFHRAYSSPLYSNQQYAC                          125                                                          
						MTEKEVLESPKPSFPAETRQSGLQRLKQLLRKGSTGTKE of AA628425_P2.3.An  	                                                            
						isolated polypeptide encoding for a tail of AA628425_P2,     	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence LLPIAMILCLKPCALG in     	                                                            
						AA628425_P2.                                                 	                                                            

9661	HMR136_AA628425_9_tr0_r1_1_gPRT		Comparison report between AA628425_P9 and Q96MF2partial WT   	Sequence name: Q96MF2                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA628425_P9, comprising a first amino acid      	                                                            
						MANKERKKGQADKKNPVAAMMEEEPESARPEEGKPQDGNPEGDKKAEKKTPDDKHKQPGF 	Alignment of: 9661 x Q96MF2   ..                             
						QQSHYFVALYRFKALEKDDLDFPPGEKITVIDDSNEEWWRGKIGEKVGFFPPNFIIRVRA 	                                                            
						GERVHRVTRSFVGNREIGQITLKKDQIVVQKGDEAGGYVKVYTGRKVGLFPTDFLEEI   	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 187 - 364 of Q96MF2, which also corresponds to   	                     Quality: 1762.00                      Escore:       0                                               
						amino acids 1 - 178 of AA628425_P9.                          	             Matching length:     178                Total length:     178                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MANKERKKGQADKKNPVAAMMEEEPESARPEEGKPQDGNPEGDKKAEKKT 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     187 MANKERKKGQADKKNPVAAMMEEEPESARPEEGKPQDGNPEGDKKAEKKT 236                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PDDKHKQPGFQQSHYFVALYRFKALEKDDLDFPPGEKITVIDDSNEEWWR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     237 PDDKHKQPGFQQSHYFVALYRFKALEKDDLDFPPGEKITVIDDSNEEWWR 286                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GKIGEKVGFFPPNFIIRVRAGERVHRVTRSFVGNREIGQITLKKDQIVVQ 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     287 GKIGEKVGFFPPNFIIRVRAGERVHRVTRSFVGNREIGQITLKKDQIVVQ 336                                                          
						                                                            	                  .         .                                
						                                                            	     151 KGDEAGGYVKVYTGRKVGLFPTDFLEEI                       178                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     337 KGDEAGGYVKVYTGRKVGLFPTDFLEEI                       364                                                          

						Comparison report between AA628425_P9 and Q96HU5partial WT   	Sequence name: Q96HU5                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA628425_P9, comprising a first amino acid      	                                                            
						MANKERKKGQADKKNPVAAMMEEEPESARPEEGKPQDGNPEGDKKAEKKTPDDKHKQPGF 	Alignment of: 9661 x Q96HU5   ..                             
						QQSHYFVALYRFKALEKDDLDFPPGEKITVIDDSNEEWWRGKIGEKVGFFPPNFIIRVRA 	                                                            
						GERVHRVTRSFVGNREIGQITLKKDQIVVQKGDEAGGYVKVYTGRKVGLFPTDFLEEI   	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 148 - 325 of Q96HU5, which also corresponds to   	                     Quality: 1762.00                      Escore:       0                                               
						amino acids 1 - 178 of AA628425_P9.                          	             Matching length:     178                Total length:     178                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MANKERKKGQADKKNPVAAMMEEEPESARPEEGKPQDGNPEGDKKAEKKT 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     148 MANKERKKGQADKKNPVAAMMEEEPESARPEEGKPQDGNPEGDKKAEKKT 197                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PDDKHKQPGFQQSHYFVALYRFKALEKDDLDFPPGEKITVIDDSNEEWWR 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     198 PDDKHKQPGFQQSHYFVALYRFKALEKDDLDFPPGEKITVIDDSNEEWWR 247                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GKIGEKVGFFPPNFIIRVRAGERVHRVTRSFVGNREIGQITLKKDQIVVQ 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     248 GKIGEKVGFFPPNFIIRVRAGERVHRVTRSFVGNREIGQITLKKDQIVVQ 297                                                          
						                                                            	                  .         .                                
						                                                            	     151 KGDEAGGYVKVYTGRKVGLFPTDFLEEI                       178                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     298 KGDEAGGYVKVYTGRKVGLFPTDFLEEI                       325                                                          

10798	HMR136_AA629334_1_tr0_r1_1_gPRT		Comparison report between AA629334_P1 and Q8TCP2unique head  	Sequence name: Q8TCP2                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA629334_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 10798 x Q8TCP2   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						CKTWPAARVSRSHVTLVSWSVQLPPASELPDPNTKQSECRAECKTLKTLQSKVLIPEALQ 	Alignment segment 1/1:                                       
						NMEIKDQGAQMEPLLPTRNDEEAVVDRGGTRSILKTHFEKEDLEGHRTLFIGVHVPLGGR 	                                                            
						KSHRRHRHRGHKHRKRDRERDSGLEDGRESPSFDTPSQRVQFILGTEDDDEEHIPHDLFT 	                     Quality: 2179.00                      Escore:       0                                               
						ELDEICWREGEDAEWRETARWLKFEEDVEDGGERWSKPYVATLSLHSLFELRSCILNGTV 	             Matching length:     222                Total length:     222                                               
						LLDMHANTLEEIADMVLDQQVSSGQLNEDVRHRVHEALMKQHHHQNQKKLTNRIPIVRSF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ADIGKKQSEPNSMDKNAGQVVSPQSAPACVENKNDVSRENSTVDFSKGLGGQQKGHTSPC 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GMKQRHEKGPPHQQEREVDLHFMKKIPPGAEASNILVGELEFLDRTVVAFVRLSPAVLLQ 	                        Gaps:       0                        
						GLAEVPIPTRFLFILLGPLGKGQQYHEIGRSIATLMTDEVFHDVAYKAKDRNDLVSGIDE 	                                                            
						FLDQVTVLPPGEWDPSIRIEPPKNVPSQEKRKIPAVPNGTAAHGEAEPHGGHSGPELQRT 	Alignment:                                                   
						GRIFGGLILDIKRKAPYFWSDFRDAFSLQCLASFLFLYCACMSPVITFGGLLGEATEGRI 	                  .         .         .         .         .  
						SAIESLFGASMTGIAYSLFGGQPLTILGSTGPVLVFEKILFKFCKEYGLSYLSLRASIGL 	     958 PGEQPKFLGIREQRVTGLMIFILMGSSVFMTSILKFIPMPVLYGVFLYMG 1007                                                         
						WTATLCIILVATDASSLVCYITRFTEEAFASLICIIFIYEALEKLFELSEAYPINMHNDL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ELLTQYSCNCVEPHNPSNGTLKEWRESNISASDIIWENLTVSECKSLHGEYVGRACGHDH 	       1 PGEQPKFLGIREQRVTGLMIFILMGSSVFMTSILKFIPMPVLYGVFLYMG 50                                                           
						PYVPDVLFWSVILFFSTVTLSATLKQFKTSRYFPTKVRSIVSDFAVFLTILCMVLIDYAI 	                  .         .         .         .         .  
						GIPSPKLQVPSVFKPTRDDRGWFVTPLGPNPWWTVIAAIIPALLCTILIFMDQQITAVII 	    1008 ASSLKGIQFFDRIKLFWMPAKHQPDFIYLRHVPLRKVHLFTIIQMSCLGL 1057                                                         
						NRKEHKLKKGCGYHLDLLMVAVMLGVCSIMGLPWFVAATVLSITHVNSLKLESECSA    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 1 - 957 of  	      51 ASSLKGIQFFDRIKLFWMPAKHQPDFIYLRHVPLRKVHLFTIIQMSCLGL 100                                                          
						AA629334_P1, and a second amino acid sequence being at least 	                  .         .         .         .         .  
						PGEQPKFLGIREQRVTGLMIFILMGSSVFMTSILKFIPMPVLYGVFLYMGASSLKGIQFF 	    1058 LWIIKVSRAAIVFPMMVLALVFVRKLMDLLFTKRELSWLDDLMPESKKKK 1107                                                         
						DRIKLFWMPAKHQPDFIYLRHVPLRKVHLFTIIQMSCLGLLWIIKVSRAAIVFPMMVLAL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VFVRKLMDLLFTKRELSWLDDLMPESKKKKLEDAEKEEEQSMLAMEDEGTVQLPLEGHYR 	     101 LWIIKVSRAAIVFPMMVLALVFVRKLMDLLFTKRELSWLDDLMPESKKKK 150                                                          
						DDPSVINISDEMSKTALWRNLLITADNSKDKESSFPSKSSPS                   	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 1 - 222 of   	    1108 LEDAEKEEEQSMLAMEDEGTVQLPLEGHYRDDPSVINISDEMSKTALWRN 1157                                                         
						Q8TCP2, which also corresponds to amino acids 958 - 1179 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA629334_P1, wherein said first amino acid sequence and      	     151 LEDAEKEEEQSMLAMEDEGTVQLPLEGHYRDDPSVINISDEMSKTALWRN 200                                                          
						second amino acid sequence are contiguous and in a sequential	                  .         .                                
						order.2.An isolated polypeptide encoding for a head of       	    1158 LLITADNSKDKESSFPSKSSPS                             1179                                                         
						AA629334_P1, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||                              
						optionally at least about 80%, preferably at least about 85%,	     201 LLITADNSKDKESSFPSKSSPS                             222                                                          
						more preferably at least about 90% and most preferably at    	                                                            
						CKTWPAARVSRSHVTLVSWSVQLPPASELPDPNTKQSECRAECKTLKTLQSKVLIPEALQ 	                                                            
						NMEIKDQGAQMEPLLPTRNDEEAVVDRGGTRSILKTHFEKEDLEGHRTLFIGVHVPLGGR 	                                                            
						KSHRRHRHRGHKHRKRDRERDSGLEDGRESPSFDTPSQRVQFILGTEDDDEEHIPHDLFT 	                                                            
						ELDEICWREGEDAEWRETARWLKFEEDVEDGGERWSKPYVATLSLHSLFELRSCILNGTV 	                                                            
						LLDMHANTLEEIADMVLDQQVSSGQLNEDVRHRVHEALMKQHHHQNQKKLTNRIPIVRSF 	                                                            
						ADIGKKQSEPNSMDKNAGQVVSPQSAPACVENKNDVSRENSTVDFSKGLGGQQKGHTSPC 	                                                            
						GMKQRHEKGPPHQQEREVDLHFMKKIPPGAEASNILVGELEFLDRTVVAFVRLSPAVLLQ 	                                                            
						GLAEVPIPTRFLFILLGPLGKGQQYHEIGRSIATLMTDEVFHDVAYKAKDRNDLVSGIDE 	                                                            
						FLDQVTVLPPGEWDPSIRIEPPKNVPSQEKRKIPAVPNGTAAHGEAEPHGGHSGPELQRT 	                                                            
						GRIFGGLILDIKRKAPYFWSDFRDAFSLQCLASFLFLYCACMSPVITFGGLLGEATEGRI 	                                                            
						SAIESLFGASMTGIAYSLFGGQPLTILGSTGPVLVFEKILFKFCKEYGLSYLSLRASIGL 	                                                            
						WTATLCIILVATDASSLVCYITRFTEEAFASLICIIFIYEALEKLFELSEAYPINMHNDL 	                                                            
						ELLTQYSCNCVEPHNPSNGTLKEWRESNISASDIIWENLTVSECKSLHGEYVGRACGHDH 	                                                            
						PYVPDVLFWSVILFFSTVTLSATLKQFKTSRYFPTKVRSIVSDFAVFLTILCMVLIDYAI 	                                                            
						GIPSPKLQVPSVFKPTRDDRGWFVTPLGPNPWWTVIAAIIPALLCTILIFMDQQITAVII 	                                                            
						NRKEHKLKKGCGYHLDLLMVAVMLGVCSIMGLPWFVAATVLSITHVNSLKLESECSA    	                                                            
						least about 95% homologous to the sequence of AA629334_P1.   	                                                            

10800	HMR136_AA629334_4_tr0_r1_1_gPRT		Comparison report between AA629334_P4 and Q8TCP2unique head  	Sequence name: Q8TCP2                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA629334_P4, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 10800 x Q8TCP2   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MSPVITFGGLLGEATEGRISAIESLFGASMTGIAYSLFGGQPLTILGSTGPVLVFEKILF 	Alignment segment 1/1:                                       
						KFCKEYGLSYLSLRASIGLWTATLCIILVATDASSLVCYITRFTEEAFASLICIIFIYEA 	                                                            
						LEKLFELSEAYPINMHNDLELLTQYSCNCVEPHNPSNGTLKEWRESNISASDIIWENLTV 	                     Quality: 2179.00                      Escore:       0                                               
						SECKSLHGEYVGRACGHDHPYVPDVLFWSVILFFSTVTLSATLKQFKTSRYFPTKVRSIV 	             Matching length:     222                Total length:     222                                               
						SDFAVFLTILCMVLIDYAIGIPSPKLQVPSVFKPTRDDRGWFVTPLGPNPWWTVIAAIIP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						ALLCTILIFMDQQITAVIINRKEHKLKKGCGYHLDLLMVAVMLGVCSIMGLPWFVAATVL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SITHVNSLKLESECSA                                             	                        Gaps:       0                        
						having the sequence corresponding to amino acids 1 - 376 of  	                                                            
						AA629334_P4, and a second amino acid sequence being at least 	Alignment:                                                   
						PGEQPKFLGIREQRVTGLMIFILMGSSVFMTSILKFIPMPVLYGVFLYMGASSLKGIQFF 	                  .         .         .         .         .  
						DRIKLFWMPAKHQPDFIYLRHVPLRKVHLFTIIQMSCLGLLWIIKVSRAAIVFPMMVLAL 	     377 PGEQPKFLGIREQRVTGLMIFILMGSSVFMTSILKFIPMPVLYGVFLYMG 426                                                          
						VFVRKLMDLLFTKRELSWLDDLMPESKKKKLEDAEKEEEQSMLAMEDEGTVQLPLEGHYR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DDPSVINISDEMSKTALWRNLLITADNSKDKESSFPSKSSPS                   	       1 PGEQPKFLGIREQRVTGLMIFILMGSSVFMTSILKFIPMPVLYGVFLYMG 50                                                           
						90 % homologous to corresponding to amino acids 1 - 222 of   	                  .         .         .         .         .  
						Q8TCP2, which also corresponds to amino acids 377 - 598 of   	     427 ASSLKGIQFFDRIKLFWMPAKHQPDFIYLRHVPLRKVHLFTIIQMSCLGL 476                                                          
						AA629334_P4, wherein said first amino acid sequence and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	      51 ASSLKGIQFFDRIKLFWMPAKHQPDFIYLRHVPLRKVHLFTIIQMSCLGL 100                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AA629334_P4, comprising a polypeptide being at least 70%,    	     477 LWIIKVSRAAIVFPMMVLALVFVRKLMDLLFTKRELSWLDDLMPESKKKK 526                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     101 LWIIKVSRAAIVFPMMVLALVFVRKLMDLLFTKRELSWLDDLMPESKKKK 150                                                          
						MSPVITFGGLLGEATEGRISAIESLFGASMTGIAYSLFGGQPLTILGSTGPVLVFEKILF 	                  .         .         .         .         .  
						KFCKEYGLSYLSLRASIGLWTATLCIILVATDASSLVCYITRFTEEAFASLICIIFIYEA 	     527 LEDAEKEEEQSMLAMEDEGTVQLPLEGHYRDDPSVINISDEMSKTALWRN 576                                                          
						LEKLFELSEAYPINMHNDLELLTQYSCNCVEPHNPSNGTLKEWRESNISASDIIWENLTV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SECKSLHGEYVGRACGHDHPYVPDVLFWSVILFFSTVTLSATLKQFKTSRYFPTKVRSIV 	     151 LEDAEKEEEQSMLAMEDEGTVQLPLEGHYRDDPSVINISDEMSKTALWRN 200                                                          
						SDFAVFLTILCMVLIDYAIGIPSPKLQVPSVFKPTRDDRGWFVTPLGPNPWWTVIAAIIP 	                  .         .                                
						ALLCTILIFMDQQITAVIINRKEHKLKKGCGYHLDLLMVAVMLGVCSIMGLPWFVAATVL 	     577 LLITADNSKDKESSFPSKSSPS                             598                                                          
						SITHVNSLKLESECSA                                             	         ||||||||||||||||||||||                              
						least about 95% homologous to the sequence of AA629334_P4.   	     201 LLITADNSKDKESSFPSKSSPS                             222                                                          

14015	HMR136_AA639052_3_tr0_r1_1_gPRT		Comparison report between AA639052_P3 and Q96HJ6unique head  	Sequence name: Q96HJ6                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA639052_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 14015 x Q96HJ6   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence LAARTRTAPS corresponding to amino acids 1	Alignment segment 1/1:                                       
						- 10 of AA639052_P3, and a second amino acid sequence being  	                                                            
						MRVAALISGGKDSCYNMMQCIAAGHQIVALANLRPAENQVGSDELDSYMYQTVGHHAIDL 	                     Quality: 2150.00                      Escore:       0                                               
						YAEAMALPLYRRTIRGRSLDTRQVYTKCEGDEVEDLYELLKLVKEKEEVEGISVGAILSD 	             Matching length:     221                Total length:     221                                               
						YQRIRVENVCKRLNLQPLAYLWQRNQEDLLREMISSNIQAMIIKVAALGLDPDKHLGKTL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DQMEPYLIELSKKYGVHVCGEGGEYETFTLDCPLFKKKIIV                    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						at least 90 % homologous to corresponding to amino acids 1 - 	                        Gaps:       0                        
						221 of Q96HJ6, which also corresponds to amino acids 11 - 231	                                                            
						of AA639052_P3, wherein said first amino acid sequence and   	Alignment:                                                   
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	      11 MRVAALISGGKDSCYNMMQCIAAGHQIVALANLRPAENQVGSDELDSYMY 60                                                           
						AA639052_P3, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	       1 MRVAALISGGKDSCYNMMQCIAAGHQIVALANLRPAENQVGSDELDSYMY 50                                                           
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence LAARTRTAPS of     	      61 QTVGHHAIDLYAEAMALPLYRRTIRGRSLDTRQVYTKCEGDEVEDLYELL 110                                                          
						AA639052_P3.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 QTVGHHAIDLYAEAMALPLYRRTIRGRSLDTRQVYTKCEGDEVEDLYELL 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     111 KLVKEKEEVEGISVGAILSDYQRIRVENVCKRLNLQPLAYLWQRNQEDLL 160                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 KLVKEKEEVEGISVGAILSDYQRIRVENVCKRLNLQPLAYLWQRNQEDLL 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     161 REMISSNIQAMIIKVAALGLDPDKHLGKTLDQMEPYLIELSKKYGVHVCG 210                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 REMISSNIQAMIIKVAALGLDPDKHLGKTLDQMEPYLIELSKKYGVHVCG 200                                                          
						                                                            	                  .         .                                
						                                                            	     211 EGGEYETFTLDCPLFKKKIIV                              231                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     201 EGGEYETFTLDCPLFKKKIIV                              221                                                          

14013	HMR136_AA639052_4_tr0_r1_1_gPRT		Comparison report between AA639052_P4 and Q96HJ6unique head  	Sequence name: Q96HJ6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA639052_P4, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 14013 x Q96HJ6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence LAARTRTAPS   	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 10 of AA639052_P4, a second 	                                                            
						MRVAALISGGKDSCYNMMQCIAAGHQIVALANLRPAENQVGSDELDSYMYQTVGHHAIDL 	                     Quality: 1834.00                      Escore:       0                                               
						YAEAMALPLYRRTIRGRSLDTRQVYTKCEGDEVEDLYELLKLVKEKEEVEGISVGAILSD 	             Matching length:     189                Total length:     189                                               
						YQRIRVENVCKRLNLQPLAYLWQRNQEDLLREMISSNIQAMIIKVAALGLDPDKHLGKTL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DQMEPYLIE                                                    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 1 - 189 of Q96HJ6, which also   	                                                            
						corresponds to amino acids 11 - 199 of AA639052_P4, and a    	Alignment:                                                   
						third amino acid sequence being at least 70%, optionally at  	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	      11 MRVAALISGGKDSCYNMMQCIAAGHQIVALANLRPAENQVGSDELDSYMY 60                                                           
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence GFIRSSHTFS corresponding to  	       1 MRVAALISGGKDSCYNMMQCIAAGHQIVALANLRPAENQVGSDELDSYMY 50                                                           
						amino acids 200 - 209 of AA639052_P4, wherein said first     	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence and third    	      61 QTVGHHAIDLYAEAMALPLYRRTIRGRSLDTRQVYTKCEGDEVEDLYELL 110                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      51 QTVGHHAIDLYAEAMALPLYRRTIRGRSLDTRQVYTKCEGDEVEDLYELL 100                                                          
						AA639052_P4, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     111 KLVKEKEEVEGISVGAILSDYQRIRVENVCKRLNLQPLAYLWQRNQEDLL 160                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence LAARTRTAPS of     	     101 KLVKEKEEVEGISVGAILSDYQRIRVENVCKRLNLQPLAYLWQRNQEDLL 150                                                          
						AA639052_P4.3.An isolated polypeptide encoding for a tail of 	                  .         .         .                      
						AA639052_P4, comprising a polypeptide being at least 70%,    	     161 REMISSNIQAMIIKVAALGLDPDKHLGKTLDQMEPYLIE            199                                                          
						optionally at least about 80%, preferably at least about 85%,	         |||||||||||||||||||||||||||||||||||||||             
						more preferably at least about 90% and most preferably at    	     151 REMISSNIQAMIIKVAALGLDPDKHLGKTLDQMEPYLIE            189                                                          
						least about 95% homologous to the sequence GFIRSSHTFS in     	                                                            
						AA639052_P4.                                                 	                                                            

16688	HMR136_AA644415_0_tr0_r1_1_gPRT		Comparison report between AA644415_P0 and Q8TC68partial WT   	Sequence name: Q8TC68                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA644415_P0, comprising a first     	Sequence documentation:                                      
						RKRVPPQLRASEEMAVRQAATAGTPGPRREEEAALLFERAHYRHDPRWLLPVTPRLCLAC 	                                                            
						ALELLPDPGVSLVRKKHMLSCFQDALVRHTSLVTQLVSQDQRVCIHFISVLFGLLCSMED 	Alignment of: 16688 x Q8TC68   ..                            
						GSVTDLCIEVLIQITTQLKLEQTIRCLLDECHKELCNMPSMRGSLATLTLLGKLVDAIPA 	                                                            
						LADELVMEHGNLMEHLLRGLVYPSEGIQASVCYLYGKLYSSPVAAEMLSGHFREKLFPLF 	Alignment segment 1/1:                                       
						LSILDGAQTKELQINCLGLLRQLLKYDLFVSMIMNQDGLGESAKNIEGSSGNTSLPLVLK 	                                                            
						KLLLSRDETLQVASAHCITAVLVHSPAKHASAFIHADIPEFLFEHLSSSSEVLVWSSCNC 	                     Quality: 5536.00                      Escore:       0                                               
						LTLLVEEPLFFSKCHTVYGIEAVVRSLQGSLKMNNIELHKQGLLLFAEILTRQPEEIKLF 	             Matching length:     573                Total length:     573                                               
						TSSAMCRDAGRALQEAVSSPVLEVAAEALKATSAFLRKDHQSTPPVQYGELQALLEAMLN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						RCAEFSQTLLSRRPLGHASSRDSEKAILQRGKFLLSTLEGFRSACRLAIEFQSEPSAQEN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PFTAPSAKKEDTLEAFSEFLLSACDSLCIPMVM                            	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 573 of Q8TC68, which also   	Alignment:                                                   
						corresponds to amino acids 1 - 573 of AA644415_P0, and a     	                  .         .         .         .         .  
						second amino acid sequence being at least 70%, optionally at 	       1 RKRVPPQLRASEEMAVRQAATAGTPGPRREEEAALLFERAHYRHDPRWLL 50                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	       1 RKRVPPQLRASEEMAVRQAATAGTPGPRREEEAALLFERAHYRHDPRWLL 50                                                           
						RHLEQTTHPALMEVFLSILHNLFVIVPHMKEKFSKKLASSSFIRLTLELKARFCSGLSHS 	                  .         .         .         .         .  
						ALNQVCSNFLYYMCLNLLSAPEKTGPPSKEELSAVSELLQHGLPQISSRSPESLAFLSDR 	      51 PVTPRLCLACALELLPDPGVSLVRKKHMLSCFQDALVRHTSLVTQLVSQD 100                                                          
						QYMEGAARQRQYCILLLFYLAYIHEDRFVSEAELFEAVQSFLLSLQDQGERPPLVVFKAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IYLLAICQDKDNTLRETMVSAIRKFLEGIPDLQLVYTHHPLLLRFFLLYPELMSRYGHRV 	      51 PVTPRLCLACALELLPDPGVSLVRKKHMLSCFQDALVRHTSLVTQLVSQD 100                                                          
						LELWFFWEESSYEELDDVTSAGQPALPASLVVLFQLLRSIPSILLILLDLIYSSPVDTAH 	                  .         .         .         .         .  
						KVLISLRTFLRRNEDIQVGGLIRGHFLLILQRLLVEHGASPSGGNLPLLLSLLSLMQLRN 	     101 QRVCIHFISVLFGLLCSMEDGSVTDLCIEVLIQITTQLKLEQTIRCLLDE 150                                                          
						VSEQELDSVAMKLLHQVSKLCGKCSPTDVDILQPSFNFLYWSLHQTTPSSQKRAAAVLLS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						STGLMELLEKMLALTLAKADSPRTALLCSAWLLTASFSAQQHKGSLQVHQTLSVEMDQVL 	     101 QRVCIHFISVLFGLLCSMEDGSVTDLCIEVLIQITTQLKLEQTIRCLLDE 150                                                          
						KALSFPKKKAALLSAAILCFLRTALRQSFSSALVALVPSGAQPLPATKDTVLAPLRMSQV 	                  .         .         .         .         .  
						RSLVIGLQNLLVQKDPLLSQACVGCLEALLDYLDARSPDIALHVASQPWNRFLLFTLLDA 	     151 CHKELCNMPSMRGSLATLTLLGKLVDAIPALADELVMEHGNLMEHLLRGL 200                                                          
						GENSFLRPEILRLMTLFMRYRSSSVLSHEEVGDVLQGVALADLSTLSNTTLQALHGFFQQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LQSMGHLADHSMAQTLQASLEGLPPSTSSGQPPLQDM                        	     151 CHKELCNMPSMRGSLATLTLLGKLVDAIPALADELVMEHGNLMEHLLRGL 200                                                          
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						574 - 1270 of AA644415_P0, wherein said first amino acid     	     201 VYPSEGIQASVCYLYGKLYSSPVAAEMLSGHFREKLFPLFLSILDGAQTK 250                                                          
						sequence and second amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     201 VYPSEGIQASVCYLYGKLYSSPVAAEMLSGHFREKLFPLFLSILDGAQTK 250                                                          
						tail of AA644415_P0, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     251 ELQINCLGLLRQLLKYDLFVSMIMNQDGLGESAKNIEGSSGNTSLPLVLK 300                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RHLEQTTHPALMEVFLSILHNLFVIVPHMKEKFSKKLASSSFIRLTLELKARFCSGLSHS 	     251 ELQINCLGLLRQLLKYDLFVSMIMNQDGLGESAKNIEGSSGNTSLPLVLK 300                                                          
						ALNQVCSNFLYYMCLNLLSAPEKTGPPSKEELSAVSELLQHGLPQISSRSPESLAFLSDR 	                  .         .         .         .         .  
						QYMEGAARQRQYCILLLFYLAYIHEDRFVSEAELFEAVQSFLLSLQDQGERPPLVVFKAS 	     301 KLLLSRDETLQVASAHCITAVLVHSPAKHASAFIHADIPEFLFEHLSSSS 350                                                          
						IYLLAICQDKDNTLRETMVSAIRKFLEGIPDLQLVYTHHPLLLRFFLLYPELMSRYGHRV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LELWFFWEESSYEELDDVTSAGQPALPASLVVLFQLLRSIPSILLILLDLIYSSPVDTAH 	     301 KLLLSRDETLQVASAHCITAVLVHSPAKHASAFIHADIPEFLFEHLSSSS 350                                                          
						KVLISLRTFLRRNEDIQVGGLIRGHFLLILQRLLVEHGASPSGGNLPLLLSLLSLMQLRN 	                  .         .         .         .         .  
						VSEQELDSVAMKLLHQVSKLCGKCSPTDVDILQPSFNFLYWSLHQTTPSSQKRAAAVLLS 	     351 EVLVWSSCNCLTLLVEEPLFFSKCHTVYGIEAVVRSLQGSLKMNNIELHK 400                                                          
						STGLMELLEKMLALTLAKADSPRTALLCSAWLLTASFSAQQHKGSLQVHQTLSVEMDQVL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KALSFPKKKAALLSAAILCFLRTALRQSFSSALVALVPSGAQPLPATKDTVLAPLRMSQV 	     351 EVLVWSSCNCLTLLVEEPLFFSKCHTVYGIEAVVRSLQGSLKMNNIELHK 400                                                          
						RSLVIGLQNLLVQKDPLLSQACVGCLEALLDYLDARSPDIALHVASQPWNRFLLFTLLDA 	                  .         .         .         .         .  
						GENSFLRPEILRLMTLFMRYRSSSVLSHEEVGDVLQGVALADLSTLSNTTLQALHGFFQQ 	     401 QGLLLFAEILTRQPEEIKLFTSSAMCRDAGRALQEAVSSPVLEVAAEALK 450                                                          
						LQSMGHLADHSMAQTLQASLEGLPPSTSSGQPPLQDM                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence in AA644415_P0.	     401 QGLLLFAEILTRQPEEIKLFTSSAMCRDAGRALQEAVSSPVLEVAAEALK 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ATSAFLRKDHQSTPPVQYGELQALLEAMLNRCAEFSQTLLSRRPLGHASS 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 ATSAFLRKDHQSTPPVQYGELQALLEAMLNRCAEFSQTLLSRRPLGHASS 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 RDSEKAILQRGKFLLSTLEGFRSACRLAIEFQSEPSAQENPFTAPSAKKE 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 RDSEKAILQRGKFLLSTLEGFRSACRLAIEFQSEPSAQENPFTAPSAKKE 550                                                          
						                                                            	                  .         .                                
						                                                            	     551 DTLEAFSEFLLSACDSLCIPMVM                            573                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     551 DTLEAFSEFLLSACDSLCIPMVM                            573                                                          

						Comparison report between AA644415_P0 and Q8IYJ5unique head  	Sequence name: Q8IYJ5                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AA644415_P0, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16688 x Q8IYJ5   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence RKRVP        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 5 of AA644415_P0, a second  	                                                            
						PQLRASEEMAVRQAATAGTPGPRREEEAALLFERAHYRHDPRWLLPVTPRLCLACALELL 	                     Quality: 4344.00                      Escore:       0                                               
						PDPGVSLVRKKHMLSCFQDALVRHTSLVTQLVSQDQRVCIHFISVLFGLLCSMEDGSVTD 	             Matching length:     452                Total length:     452                                               
						LCIEVLIQITTQLKLEQTIRCLLDECHKELCNMPSMRGSLATLTLLGKLVDAIPALADEL 	 Matching Percent Similarity:   99.78   Matching Percent Identity:   99.78                                               
						VMEHGNLMEHLLRGLVYPSEGIQASVCYLYGKLYSSPVAAEMLSGHFREKLFPLFLSILD 	    Total Percent Similarity:   99.78      Total Percent Identity:   99.78                                               
						GAQTKELQINCLGLLRQLLKYDLFVSMIMNQDGLGESAKNIEGSSGNTSLPLVLKKLLLS 	                        Gaps:       0                        
						RDETLQVASAHCITAVLVHSPAKHASAFIHADIPEFLFEHLSSSSEVLVWSSCNCLTLLV 	                                                            
						EEPLFFSKCHTVYG                                               	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 1 - 374 of Q8IYJ5, which also   	       6 PQLRASEEMAVRQAATAGTPGPRREEEAALLFERAHYRHDPRWLLPVTPR 55                                                           
						corresponds to amino acids 6 - 379 of AA644415_P0, a bridging	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid I corresponding to amino acid 380 of AA644415_P0, 	       1 PQLRASEEMAVRQAATAGTPGPRREEEAALLFERAHYRHDPRWLLPVTPR 50                                                           
						EAVVRSLQGSLKMNNIELHKQGLLLFAEILTRQPEEIKLFTSSAMCRDAGRALQEAVSSP 	                  .         .         .         .         .  
						VLEVAAEALKATSAFLR                                            	      56 LCLACALELLPDPGVSLVRKKHMLSCFQDALVRHTSLVTQLVSQDQRVCI 105                                                          
						a third amino acid sequence being at least 90 % homologous to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 376 - 452 of Q8IYJ5, which also 	      51 LCLACALELLPDPGVSLVRKKHMLSCFQDALVRHTSLVTQLVSQDQRVCI 100                                                          
						corresponds to amino acids 381 - 457 of AA644415_P0, and a   	                  .         .         .         .         .  
						fourth amino acid sequence being at least 70%, optionally at 	     106 HFISVLFGLLCSMEDGSVTDLCIEVLIQITTQLKLEQTIRCLLDECHKEL 155                                                          
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	     101 HFISVLFGLLCSMEDGSVTDLCIEVLIQITTQLKLEQTIRCLLDECHKEL 150                                                          
						KDHQSTPPVQYGELQALLEAMLNRCAEFSQTLLSRRPLGHASSRDSEKAILQRGKFLLST 	                  .         .         .         .         .  
						LEGFRSACRLAIEFQSEPSAQENPFTAPSAKKEDTLEAFSEFLLSACDSLCIPMVMRHLE 	     156 CNMPSMRGSLATLTLLGKLVDAIPALADELVMEHGNLMEHLLRGLVYPSE 205                                                          
						QTTHPALMEVFLSILHNLFVIVPHMKEKFSKKLASSSFIRLTLELKARFCSGLSHSALNQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VCSNFLYYMCLNLLSAPEKTGPPSKEELSAVSELLQHGLPQISSRSPESLAFLSDRQYME 	     151 CNMPSMRGSLATLTLLGKLVDAIPALADELVMEHGNLMEHLLRGLVYPSE 200                                                          
						GAARQRQYCILLLFYLAYIHEDRFVSEAELFEAVQSFLLSLQDQGERPPLVVFKASIYLL 	                  .         .         .         .         .  
						AICQDKDNTLRETMVSAIRKFLEGIPDLQLVYTHHPLLLRFFLLYPELMSRYGHRVLELW 	     206 GIQASVCYLYGKLYSSPVAAEMLSGHFREKLFPLFLSILDGAQTKELQIN 255                                                          
						FFWEESSYEELDDVTSAGQPALPASLVVLFQLLRSIPSILLILLDLIYSSPVDTAHKVLI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLRTFLRRNEDIQVGGLIRGHFLLILQRLLVEHGASPSGGNLPLLLSLLSLMQLRNVSEQ 	     201 GIQASVCYLYGKLYSSPVAAEMLSGHFREKLFPLFLSILDGAQTKELQIN 250                                                          
						ELDSVAMKLLHQVSKLCGKCSPTDVDILQPSFNFLYWSLHQTTPSSQKRAAAVLLSSTGL 	                  .         .         .         .         .  
						MELLEKMLALTLAKADSPRTALLCSAWLLTASFSAQQHKGSLQVHQTLSVEMDQVLKALS 	     256 CLGLLRQLLKYDLFVSMIMNQDGLGESAKNIEGSSGNTSLPLVLKKLLLS 305                                                          
						FPKKKAALLSAAILCFLRTALRQSFSSALVALVPSGAQPLPATKDTVLAPLRMSQVRSLV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IGLQNLLVQKDPLLSQACVGCLEALLDYLDARSPDIALHVASQPWNRFLLFTLLDAGENS 	     251 CLGLLRQLLKYDLFVSMIMNQDGLGESAKNIEGSSGNTSLPLVLKKLLLS 300                                                          
						FLRPEILRLMTLFMRYRSSSVLSHEEVGDVLQGVALADLSTLSNTTLQALHGFFQQLQSM 	                  .         .         .         .         .  
						GHLADHSMAQTLQASLEGLPPSTSSGQPPLQDM                            	     306 RDETLQVASAHCITAVLVHSPAKHASAFIHADIPEFLFEHLSSSSEVLVW 355                                                          
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						458 - 1270 of AA644415_P0, wherein said first amino acid     	     301 RDETLQVASAHCITAVLVHSPAKHASAFIHADIPEFLFEHLSSSSEVLVW 350                                                          
						sequence, second amino acid sequence, bridging amino acid,   	                  .         .         .         .         .  
						third amino acid sequence and fourth amino acid sequence are 	     356 SSCNCLTLLVEEPLFFSKCHTVYGIEAVVRSLQGSLKMNNIELHKQGLLL 405                                                          
						contiguous and in a sequential order.2.An isolated           	         |||||||||||||||||||||||| |||||||||||||||||||||||||  
						polypeptide encoding for a head of AA644415_P0, comprising a 	     351 SSCNCLTLLVEEPLFFSKCHTVYGTEAVVRSLQGSLKMNNIELHKQGLLL 400                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     406 FAEILTRQPEEIKLFTSSAMCRDAGRALQEAVSSPVLEVAAEALKATSAF 455                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence RKRVP of AA644415_P0.3.An isolated           	     401 FAEILTRQPEEIKLFTSSAMCRDAGRALQEAVSSPVLEVAAEALKATSAF 450                                                          
						polypeptide encoding for a tail of AA644415_P0, comprising a 	                                                             
						polypeptide being at least 70%, optionally at least about    	     456 LR                                                 457                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||                                                  
						about 90% and most preferably at least about 95% homologous  	     451 LR                                                 452                                                          
						KDHQSTPPVQYGELQALLEAMLNRCAEFSQTLLSRRPLGHASSRDSEKAILQRGKFLLST 	                                                            
						LEGFRSACRLAIEFQSEPSAQENPFTAPSAKKEDTLEAFSEFLLSACDSLCIPMVMRHLE 	                                                            
						QTTHPALMEVFLSILHNLFVIVPHMKEKFSKKLASSSFIRLTLELKARFCSGLSHSALNQ 	                                                            
						VCSNFLYYMCLNLLSAPEKTGPPSKEELSAVSELLQHGLPQISSRSPESLAFLSDRQYME 	                                                            
						GAARQRQYCILLLFYLAYIHEDRFVSEAELFEAVQSFLLSLQDQGERPPLVVFKASIYLL 	                                                            
						AICQDKDNTLRETMVSAIRKFLEGIPDLQLVYTHHPLLLRFFLLYPELMSRYGHRVLELW 	                                                            
						FFWEESSYEELDDVTSAGQPALPASLVVLFQLLRSIPSILLILLDLIYSSPVDTAHKVLI 	                                                            
						SLRTFLRRNEDIQVGGLIRGHFLLILQRLLVEHGASPSGGNLPLLLSLLSLMQLRNVSEQ 	                                                            
						ELDSVAMKLLHQVSKLCGKCSPTDVDILQPSFNFLYWSLHQTTPSSQKRAAAVLLSSTGL 	                                                            
						MELLEKMLALTLAKADSPRTALLCSAWLLTASFSAQQHKGSLQVHQTLSVEMDQVLKALS 	                                                            
						FPKKKAALLSAAILCFLRTALRQSFSSALVALVPSGAQPLPATKDTVLAPLRMSQVRSLV 	                                                            
						IGLQNLLVQKDPLLSQACVGCLEALLDYLDARSPDIALHVASQPWNRFLLFTLLDAGENS 	                                                            
						FLRPEILRLMTLFMRYRSSSVLSHEEVGDVLQGVALADLSTLSNTTLQALHGFFQQLQSM 	                                                            
						GHLADHSMAQTLQASLEGLPPSTSSGQPPLQDM                            	                                                            
						to the sequence in AA644415_P0.                              	                                                            

10662	HMR136_AA651619_3_tr0_r1_1_gPRT		Comparison report between AA651619_P3 and Q9BQ54unique head  	Sequence name: Q9BQ54                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA651619_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 10662 x Q9BQ54   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MPSGCRCLHLVCLLCILGAPGQPVRADDCSSHCDLAHGCCAPDGSCRCDPGWEGLHCERC 	Alignment segment 1/1:                                       
						VRMPGCQHGTCHQPWQCICHSGWAGKFCDKDEHICTTQSPCQNGGQCMYDGGGEYHCVCL 	                                                            
						PGFHGRDCERKAGPCEQAGSPCRNGGQCQDDQGFALNFTCRCLVGFVGARCEVNVDDCL  	                     Quality: 2025.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 179 of  	             Matching length:     204                Total length:     204                                               
						AA651619_P3, and a second amino acid sequence being at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MRPCANGATCLDGINRFSCLCPEGFAGRFCTINLDDCASRPCQRGARCRDRVHDFDCLCP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SGYGGKTCELVLPVPDPPTTVDTPLGPTSAVVVPATGPAPHSAGAGLLRISVKEVVRRQE 	                        Gaps:       0                        
						AGLGEPSLVALVVFGALTAALVLATVLLTLRAWRRGVCPPGPCCYPAPHYAPACQDQECQ 	                                                            
						VSMLPAGLPLPRDLPPEPGKTTAL                                     	Alignment:                                                   
						90 % homologous to corresponding to amino acids 1 - 204 of   	                  .         .         .         .         .  
						Q9BQ54, which also corresponds to amino acids 180 - 383 of   	     180 MRPCANGATCLDGINRFSCLCPEGFAGRFCTINLDDCASRPCQRGARCRD 229                                                          
						AA651619_P3, wherein said first amino acid sequence and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	       1 MRPCANGATCLDGINRFSCLCPEGFAGRFCTINLDDCASRPCQRGARCRD 50                                                           
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AA651619_P3, comprising a polypeptide being at least 70%,    	     230 RVHDFDCLCPSGYGGKTCELVLPVPDPPTTVDTPLGPTSAVVVPATGPAP 279                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	      51 RVHDFDCLCPSGYGGKTCELVLPVPDPPTTVDTPLGPTSAVVVPATGPAP 100                                                          
						MPSGCRCLHLVCLLCILGAPGQPVRADDCSSHCDLAHGCCAPDGSCRCDPGWEGLHCERC 	                  .         .         .         .         .  
						VRMPGCQHGTCHQPWQCICHSGWAGKFCDKDEHICTTQSPCQNGGQCMYDGGGEYHCVCL 	     280 HSAGAGLLRISVKEVVRRQEAGLGEPSLVALVVFGALTAALVLATVLLTL 329                                                          
						PGFHGRDCERKAGPCEQAGSPCRNGGQCQDDQGFALNFTCRCLVGFVGARCEVNVDDCL  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of AA651619_P3.   	     101 HSAGAGLLRISVKEVVRRQEAGLGEPSLVALVVFGALTAALVLATVLLTL 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     330 RAWRRGVCPPGPCCYPAPHYAPACQDQECQVSMLPAGLPLPRDLPPEPGK 379                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 RAWRRGVCPPGPCCYPAPHYAPACQDQECQVSMLPAGLPLPRDLPPEPGK 200                                                          
						                                                            	                                                             
						                                                            	     380 TTAL                                               383                                                          
						                                                            	         ||||                                                
						                                                            	     201 TTAL                                               204                                                          

15289	HMR136_AA652566_4_tr0_r1_1_gPRT		Comparison report between AA652566_P4 and Q9H5G9unique head  	Sequence name: Q9H5G9                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA652566_P4, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 15289 x Q9H5G9   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						AGGRSLALLRSVYLHNNQLSNAGLPPDAFRGSEAIATLSLSNNQLSYLPPSLPPSLERLH 	Alignment segment 1/1:                                       
						LQ                                                           	                                                            
						having the sequence corresponding to amino acids 1 - 62 of   	                     Quality: 2794.00                      Escore:       0                                               
						AA652566_P4, and a second amino acid sequence being at least 	             Matching length:     292                Total length:     292                                               
						NNLISKVPRGALSRQTQLRELYLQHNQLTDSGLDATTFSKLHSLEYLDLSHNQLTTVPAG 	 Matching Percent Similarity:   99.66   Matching Percent Identity:   99.32                                               
						LPRTLAILHLGRNRIRQVEAARLHGARGLRYLLLQHNQLGSSGLPAGALRPLRGLHTLHL 	    Total Percent Similarity:   99.66      Total Percent Identity:   99.32                                               
						YGNGLDRVPPALPRRLRALVLPHNHVAALGARDLVATPGLTELNLAYNRLASARVHHRAF 	                        Gaps:       0                        
						RRLRALRSLDLAGNQLTRLPMGLPTGLRTLQLQRNQLRMLEPEPLAGLDQLRELSLAHNR 	                                                            
						LRVGDIGPGTWHELQALQVRHRLVSHTVPRAPPSPCLPCHVPNILVSW             	Alignment:                                                   
						90 % homologous to corresponding to amino acids 76 - 363 of  	                  .         .         .         .         .  
						Q9H5G9, which also corresponds to amino acids 63 - 350 of    	      59 LHLQNNLISKVPRGALSRQTQLRELYLQHNQLTDSGLDATTFSKLHSLEY 108                                                          
						AA652566_P4, wherein said first amino acid sequence and      	         || :||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	      72 LHNKNNLISKVPRGALSRQTQLRELYLQHNQLTDSGLDATTFSKLHSLEY 121                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AA652566_P4, comprising a polypeptide being at least 70%,    	     109 LDLSHNQLTTVPAGLPRTLAILHLGRNRIRQVEAARLHGARGLRYLLLQH 158                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     122 LDLSHNQLTTVPAGLPRTLAILHLGRNRIRQVEAARLHGARGLRYLLLQH 171                                                          
						AGGRSLALLRSVYLHNNQLSNAGLPPDAFRGSEAIATLSLSNNQLSYLPPSLPPSLERLH 	                  .         .         .         .         .  
						LQ                                                           	     159 NQLGSSGLPAGALRPLRGLHTLHLYGNGLDRVPPALPRRLRALVLPHNHV 208                                                          
						least about 95% homologous to the sequence of AA652566_P4.   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     172 NQLGSSGLPAGALRPLRGLHTLHLYGNGLDRVPPALPRRLRALVLPHNHV 221                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     209 AALGARDLVATPGLTELNLAYNRLASARVHHRAFRRLRALRSLDLAGNQL 258                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     222 AALGARDLVATPGLTELNLAYNRLASARVHHRAFRRLRALRSLDLAGNQL 271                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     259 TRLPMGLPTGLRTLQLQRNQLRMLEPEPLAGLDQLRELSLAHNRLRVGDI 308                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     272 TRLPMGLPTGLRTLQLQRNQLRMLEPEPLAGLDQLRELSLAHNRLRVGDI 321                                                          
						                                                            	                  .         .         .         .            
						                                                            	     309 GPGTWHELQALQVRHRLVSHTVPRAPPSPCLPCHVPNILVSW         350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     322 GPGTWHELQALQVRHRLVSHTVPRAPPSPCLPCHVPNILVSW         363                                                          

15291	HMR136_AA652566_6_tr0_r1_1_gPRT		Comparison report between AA652566_P6 and Q9H5G9unique head  	Sequence name: Q9H5G9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA652566_P6, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15291 x Q9H5G9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						AGGRSLALLRSVYLHNNQLSNAGLPPDAFRGSEAIATLSLSNNQLSYLPPSLPPSLERLH 	Alignment segment 1/1:                                       
						LQ                                                           	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 2481.00                      Escore:       0                                               
						to amino acids 1 - 62 of AA652566_P6, a second amino acid    	             Matching length:     262                Total length:     262                                               
						NNLISKVPRGALSRQTQLRELYLQHNQLTDSGLDATTFSKLHSLEYLDLSHNQLTTVPAG 	 Matching Percent Similarity:   99.62   Matching Percent Identity:   99.24                                               
						LPRTLAILHLGRNRIRQVEAARLHGARGLRYLLLQHNQLGSSGLPAGALRPLRGLHTLHL 	    Total Percent Similarity:   99.62      Total Percent Identity:   99.24                                               
						YGNGLDRVPPALPRRLRALVLPHNHVAALGARDLVATPGLTELNLAYNRLASARVHHRAF 	                        Gaps:       0                        
						RRLRALRSLDLAGNQLTRLPMGLPTGLRTLQLQRNQLRMLEPEPLAGLDQLRELSLAHNR 	                                                            
						LRVGDIGPGTWHELQALQ                                           	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 76 - 333 of Q9H5G9, which also corresponds to    	      59 LHLQNNLISKVPRGALSRQTQLRELYLQHNQLTDSGLDATTFSKLHSLEY 108                                                          
						amino acids 63 - 320 of AA652566_P6, and a third amino acid  	         || :||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      72 LHNKNNLISKVPRGALSRQTQLRELYLQHNQLTDSGLDATTFSKLHSLEY 121                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     109 LDLSHNQLTTVPAGLPRTLAILHLGRNRIRQVEAARLHGARGLRYLLLQH 158                                                          
						MLDLSHNELSFVPPDLPEALEELHLEGNRIGHVGPEAFLSTPRLRALFLRCPEGDRRGGG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GQGRAWEGHDRLSVQGQQASHDEHRG                                   	     122 LDLSHNQLTTVPAGLPRTLAILHLGRNRIRQVEAARLHGARGLRYLLLQH 171                                                          
						having the sequence corresponding to amino acids 321 - 406 of	                  .         .         .         .         .  
						AA652566_P6, wherein said first amino acid sequence, second  	     159 NQLGSSGLPAGALRPLRGLHTLHLYGNGLDRVPPALPRRLRALVLPHNHV 208                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     172 NQLGSSGLPAGALRPLRGLHTLHLYGNGLDRVPPALPRRLRALVLPHNHV 221                                                          
						polypeptide encoding for a head of AA652566_P6, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     209 AALGARDLVATPGLTELNLAYNRLASARVHHRAFRRLRALRSLDLAGNQL 258                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     222 AALGARDLVATPGLTELNLAYNRLASARVHHRAFRRLRALRSLDLAGNQL 271                                                          
						AGGRSLALLRSVYLHNNQLSNAGLPPDAFRGSEAIATLSLSNNQLSYLPPSLPPSLERLH 	                  .         .         .         .         .  
						LQ                                                           	     259 TRLPMGLPTGLRTLQLQRNQLRMLEPEPLAGLDQLRELSLAHNRLRVGDI 308                                                          
						to the sequence of AA652566_P6.3.An isolated polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for a tail of AA652566_P6, comprising a polypeptide 	     272 TRLPMGLPTGLRTLQLQRNQLRMLEPEPLAGLDQLRELSLAHNRLRVGDI 321                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .                                          
						at least about 85%, more preferably at least about 90% and   	     309 GPGTWHELQALQ                                       320                                                          
						MLDLSHNELSFVPPDLPEALEELHLEGNRIGHVGPEAFLSTPRLRALFLRCPEGDRRGGG 	         ||||||||||||                                        
						GQGRAWEGHDRLSVQGQQASHDEHRG                                   	     322 GPGTWHELQALQ                                       333                                                          
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA652566_P6.                                              	                                                            

15287	HMR136_AA652566_7_tr0_r1_1_gPRT		Comparison report between AA652566_P7 and Q9H5G9unique head  	Sequence name: Q9H5G9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA652566_P7, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15287 x Q9H5G9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						AGGRSLALLRSVYLHNNQLSNAGLPPDAFRGSEAIATLSLSNNQLSYLPPSLPPSLERLH 	Alignment segment 1/1:                                       
						LQ                                                           	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 2481.00                      Escore:       0                                               
						to amino acids 1 - 62 of AA652566_P7, a second amino acid    	             Matching length:     262                Total length:     262                                               
						NNLISKVPRGALSRQTQLRELYLQHNQLTDSGLDATTFSKLHSLEYLDLSHNQLTTVPAG 	 Matching Percent Similarity:   99.62   Matching Percent Identity:   99.24                                               
						LPRTLAILHLGRNRIRQVEAARLHGARGLRYLLLQHNQLGSSGLPAGALRPLRGLHTLHL 	    Total Percent Similarity:   99.62      Total Percent Identity:   99.24                                               
						YGNGLDRVPPALPRRLRALVLPHNHVAALGARDLVATPGLTELNLAYNRLASARVHHRAF 	                        Gaps:       0                        
						RRLRALRSLDLAGNQLTRLPMGLPTGLRTLQLQRNQLRMLEPEPLAGLDQLRELSLAHNR 	                                                            
						LRVGDIGPGTWHELQALQ                                           	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 76 - 333 of Q9H5G9, which also corresponds to    	      59 LHLQNNLISKVPRGALSRQTQLRELYLQHNQLTDSGLDATTFSKLHSLEY 108                                                          
						amino acids 63 - 320 of AA652566_P7, and a third amino acid  	         || :||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      72 LHNKNNLISKVPRGALSRQTQLRELYLQHNQLTDSGLDATTFSKLHSLEY 121                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     109 LDLSHNQLTTVPAGLPRTLAILHLGRNRIRQVEAARLHGARGLRYLLLQH 158                                                          
						MLDLSHNELSFVPPDLPEALEELHLEGNRIGHVGPEAFLSTPRLRALFLRANRLHMTSIA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AEAFLGLPNLRVVDTAGNPEQVLIRLPPTTPRGPRAGGP                      	     122 LDLSHNQLTTVPAGLPRTLAILHLGRNRIRQVEAARLHGARGLRYLLLQH 171                                                          
						having the sequence corresponding to amino acids 321 - 419 of	                  .         .         .         .         .  
						AA652566_P7, wherein said first amino acid sequence, second  	     159 NQLGSSGLPAGALRPLRGLHTLHLYGNGLDRVPPALPRRLRALVLPHNHV 208                                                          
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     172 NQLGSSGLPAGALRPLRGLHTLHLYGNGLDRVPPALPRRLRALVLPHNHV 221                                                          
						polypeptide encoding for a head of AA652566_P7, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     209 AALGARDLVATPGLTELNLAYNRLASARVHHRAFRRLRALRSLDLAGNQL 258                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     222 AALGARDLVATPGLTELNLAYNRLASARVHHRAFRRLRALRSLDLAGNQL 271                                                          
						AGGRSLALLRSVYLHNNQLSNAGLPPDAFRGSEAIATLSLSNNQLSYLPPSLPPSLERLH 	                  .         .         .         .         .  
						LQ                                                           	     259 TRLPMGLPTGLRTLQLQRNQLRMLEPEPLAGLDQLRELSLAHNRLRVGDI 308                                                          
						to the sequence of AA652566_P7.3.An isolated polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for a tail of AA652566_P7, comprising a polypeptide 	     272 TRLPMGLPTGLRTLQLQRNQLRMLEPEPLAGLDQLRELSLAHNRLRVGDI 321                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .                                          
						at least about 85%, more preferably at least about 90% and   	     309 GPGTWHELQALQ                                       320                                                          
						MLDLSHNELSFVPPDLPEALEELHLEGNRIGHVGPEAFLSTPRLRALFLRANRLHMTSIA 	         ||||||||||||                                        
						AEAFLGLPNLRVVDTAGNPEQVLIRLPPTTPRGPRAGGP                      	     322 GPGTWHELQALQ                                       333                                                          
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA652566_P7.                                              	                                                            

17040	HMR136_AA655034_6_tr0_r1_1_gPRT		Comparison report between AA655034_P6 and BMRB_HUMANpartial  	Sequence name: BMRB_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA655034_P6, comprising a first     	Sequence documentation:                                      
						MLLRSAGKLNVGTKKEDGESTAPTPRPKVLRCKCHHHCPEDSVNNICSTDGYCFTMIEED 	                                                            
						DSGLPVVTSGCLGLEGSDFQCRDTPIPHQRRSIECCTERNECNKDLHPTLPPLKNRDFVD 	Alignment of: 17040 x BMRB_HUMAN   ..                        
						GPIHHRALLISVTVCSLLLVLIILFCYFRYKRQETRPRYSIGLEQDETYIPPGESLRDLI 	                                                            
						EQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR                 	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 224 of BMRB_HUMAN, which    	                     Quality: 4536.00                      Escore:       0                                               
						also corresponds to amino acids 1 - 224 of AA655034_P6, and a	             Matching length:     466                Total length:     502                                               
						FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIF 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 	    Total Percent Similarity:   92.83      Total Percent Identity:   92.83                                               
						EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 	                        Gaps:       1                        
						REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 	                                                            
						KL                                                           	Alignment:                                                   
						second amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 261 - 502 of BMRB_HUMAN, which  	       1 MLLRSAGKLNVGTKKEDGESTAPTPRPKVLRCKCHHHCPEDSVNNICSTD 50                                                           
						also corresponds to amino acids 225 - 466 of AA655034_P6,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence and second amino acid 	       1 MLLRSAGKLNVGTKKEDGESTAPTPRPKVLRCKCHHHCPEDSVNNICSTD 50                                                           
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated chimeric polypeptide encoding for an edge portion of	      51 GYCFTMIEEDDSGLPVVTSGCLGLEGSDFQCRDTPIPHQRRSIECCTERN 100                                                          
						AA655034_P6, comprising a polypeptide having a length "n",   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	      51 GYCFTMIEEDDSGLPVVTSGCLGLEGSDFQCRDTPIPHQRRSIECCTERN 100                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     101 ECNKDLHPTLPPLKNRDFVDGPIHHRALLISVTVCSLLLVLIILFCYFRY 150                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     101 ECNKDLHPTLPPLKNRDFVDGPIHHRALLISVTVCSLLLVLIILFCYFRY 150                                                          
						at least two amino acids comprise RF, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     151 KRQETRPRYSIGLEQDETYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTI 200                                                          
						224-x to 225; and ending at any of amino acid numbers 225+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     151 KRQETRPRYSIGLEQDETYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTI 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 AKQIQMVKQIGKGRYGEVWMGKWR.......................... 224                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     201 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     225 ..........FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKS 264                                                          
						                                                            	                   ||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     265 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 314                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     315 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 364                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     365 YSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 414                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 YSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     415 PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 464                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 500                                                          
						                                                            	                                                             
						                                                            	     465 KL                                                 466                                                          
						                                                            	         ||                                                  
						                                                            	     501 KL                                                 502                                                          

19908	HMR136_AA669315_3_tr0_r1_1_gPRT		Comparison report between AA669315_P3 and Q96CL2unique head  	Sequence name: Q96CL2                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA669315_P3, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 19908 x Q96CL2   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MSAVGLVLLVLALRLRATTVKPEEGSFCSNSQVAFRDACYEFVPLGRTFRDAQSWCEGQG 	Alignment segment 1/1:                                       
						GHLVFIQDEGTQWFLQKHISQDREWWIGLTWNLARNGTTEGPGTWLDTSNVTYSNWHGGQ 	                                                            
						AAAAPDTCGHIGRGPSSEWVTSDCAQTFAFMCEFRVGQSLACEGLNATVHCGLGQVIQVQ 	                     Quality: 2749.00                      Escore:       0                                               
						DAIYGRQNPHFCTQDAGRPSDLEQGCSWANVKEEVAGQCQELQSCQVAADETYFGNLCPT 	             Matching length:     285                Total length:     285                                               
						QGSYLWVQYQCREALQLMVSSESFIFDNVTISLTWLLSPYIGNLSCIISTGDSHTFDPYN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PPSVSSNVTHQFTSPGEFTVFAECTTSEWHVTAQRQVTVRDKMETLSVTACSGLSQSGAG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PLCQAVFGDPLWIQVELDGGTGVTYTVLLGDITLAESTTQKGSLPYNLILDRETQKLMGP 	                        Gaps:       0                        
						GRHRLEIQATGNTTTSTISRNITVHLVELLSGLQASWASDHLELGQDLLITISLAQGTPE 	                                                            
						ELTFEVAGLNATFSHEQVSFGEPFGICRLAVPVEGTFLVTMLVRNAFSNLSLEIGNITIT 	Alignment:                                                   
						APSGLQEPSGMNAEGKSKDKGDMEVYIQPGPYVDPFTTVTLGWPDNDKELRFQWSCGSCW 	                  .         .         .         .         .  
						ALWSSCVERQLLRTDQRELVVPASCLPPPDSAVTLRLAVLRGQELENRAEQCLYVSAPWE 	     686 MGEDSPVAMFSWYLDNTPTEQAEPLPDACRLRGFWPRSLTLLQSNTSTLL 735                                                          
						LRPRVSCERNCRPVNASKDILLRVT                                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	       1 MGEDSPVAMFSWYLDNTPTEQAEPLPDACRLRGFWPRSLTLLQSNTSTLL 50                                                           
						to amino acids 1 - 685 of AA669315_P3, a second amino acid   	                  .         .         .         .         .  
						MGEDSPVAMFSWYLDNTPTEQAEPLPDACRLRGFWPRSLTLLQSNTSTLLLNSSFLQSRG 	     736 LNSSFLQSRGEVIRIRATALTRHAYGEDTYVISTVPPREVPACTIAPEEG 785                                                          
						EVIRIRATALTRHAYGEDTYVISTVPPREVPACTIAPEEGTVLTSFAIFCNASTALGPLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FCFCLESGSCLHCGPEPALPSVYLPLGEENNDFVLTVVISATNRAGDTQQTQAMAKVALG 	      51 LNSSFLQSRGEVIRIRATALTRHAYGEDTYVISTVPPREVPACTIAPEEG 100                                                          
						DTCVEDVAFQAAVSEKIPTALQGEGGPEQLLQLAKAVSSMLNQEHESQGSGQSLSIDVRQ 	                  .         .         .         .         .  
						KVREHVLGSLSAVTTGLEDVQRVQELAEVLREVTCRSKELTPSAQ                	     786 TVLTSFAIFCNASTALGPLEFCFCLESGSCLHCGPEPALPSVYLPLGEEN 835                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 285 of Q96CL2, which also corresponds to     	     101 TVLTSFAIFCNASTALGPLEFCFCLESGSCLHCGPEPALPSVYLPLGEEN 150                                                          
						amino acids 686 - 970 of AA669315_P3, and a third amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     836 NDFVLTVVISATNRAGDTQQTQAMAKVALGDTCVEDVAFQAAVSEKIPTA 885                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     151 NDFVLTVVISATNRAGDTQQTQAMAKVALGDTCVEDVAFQAAVSEKIPTA 200                                                          
						WEASLALQHASEALLTVSAKARPEDQRRQAATRDLFQAVGSVLEASLSNRPEEPAEASSS 	                  .         .         .         .         .  
						QIATVLRLLRVMEHVQTTLLLGKLPGGLPAMLATPSISVYTNRIQPWSWQGSSLRPDAAD 	     886 LQGEGGPEQLLQLAKAVSSMLNQEHESQGSGQSLSIDVRQKVREHVLGSL 935                                                          
						SATFMLPAASSLSSLEGGQEPVDIKIMSFPKSPFPARSHFDVSGTVGGLRVTSPSGQLIP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VKNLSENIEILLPRHSQRHSQPTVLNLTSPEALWVNVTSGEATLGIQLHWRPDIALTLSL 	     201 LQGEGGPEQLLQLAKAVSSMLNQEHESQGSGQSLSIDVRQKVREHVLGSL 250                                                          
						GYGYHPNKSSYDAQTHLVPMVAPDELPTWILSPQDLRFGEGVYYLTVVPESDLEPAPGRD 	                  .         .         .                      
						LTVGITTFLSHCVFWDEVQETWDDSGCQVGPRTSPYQTHCLCNHLTFFGSTFLVMPNAIN 	     936 SAVTTGLEDVQRVQELAEVLREVTCRSKELTPSAQ                970                                                          
						IHQTAELFATFEDNPVVVTTVGCLCVVYVLVVIWARRKDAQDQAKVKVTVLEDNDPFAQY 	         |||||||||||||||||||||||||||||||||||                 
						HYLVTVYTGHRRGAATSSKVTVTLYGLDGEREPHHLADPDTPVFERGAVDAFLLSTLFPL 	     251 SAVTTGLEDVQRVQELAEVLREVTCRSKELTPSAQ                285                                                          
						GELRSLRLWHDNSGDRPSWYVSRVLVYDLVMDRKWYFLCNSWLSINVGDCVLDKVFPVAT 	                                                            
						EQDRKQFSHLFFMKTSAGFQDGHIWYSIFSRCARSSFTRVQRVSCCFSLLLCTMLTSIMF 	                                                            
						WGVPKDPAEQKMDLGKIEFTWQEVMIGLESSILMFPINLLIVQIFQNTRPRVAKEQNTGK 	                                                            
						WDRGSPNLTPSPQPMEDGLLTPEAVTKDVSRIVSSLFKALKVPSPALGWDSVNLMDINSL 	                                                            
						LALVEDVIYPQNTSGQVFWEEAKKREDPVTLTLGSSEMKEKSQCPKPKAARSGPWKDSAY 	                                                            
						RQCLYLQLEHVEQELRLVGPRGFSQPHSHA                               	                                                            
						having the sequence corresponding to amino acids 971 - 1780  	                                                            
						of AA669315_P3, wherein said first amino acid sequence,      	                                                            
						second amino acid sequence and third amino acid sequence are 	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of AA669315_P3, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MSAVGLVLLVLALRLRATTVKPEEGSFCSNSQVAFRDACYEFVPLGRTFRDAQSWCEGQG 	                                                            
						GHLVFIQDEGTQWFLQKHISQDREWWIGLTWNLARNGTTEGPGTWLDTSNVTYSNWHGGQ 	                                                            
						AAAAPDTCGHIGRGPSSEWVTSDCAQTFAFMCEFRVGQSLACEGLNATVHCGLGQVIQVQ 	                                                            
						DAIYGRQNPHFCTQDAGRPSDLEQGCSWANVKEEVAGQCQELQSCQVAADETYFGNLCPT 	                                                            
						QGSYLWVQYQCREALQLMVSSESFIFDNVTISLTWLLSPYIGNLSCIISTGDSHTFDPYN 	                                                            
						PPSVSSNVTHQFTSPGEFTVFAECTTSEWHVTAQRQVTVRDKMETLSVTACSGLSQSGAG 	                                                            
						PLCQAVFGDPLWIQVELDGGTGVTYTVLLGDITLAESTTQKGSLPYNLILDRETQKLMGP 	                                                            
						GRHRLEIQATGNTTTSTISRNITVHLVELLSGLQASWASDHLELGQDLLITISLAQGTPE 	                                                            
						ELTFEVAGLNATFSHEQVSFGEPFGICRLAVPVEGTFLVTMLVRNAFSNLSLEIGNITIT 	                                                            
						APSGLQEPSGMNAEGKSKDKGDMEVYIQPGPYVDPFTTVTLGWPDNDKELRFQWSCGSCW 	                                                            
						ALWSSCVERQLLRTDQRELVVPASCLPPPDSAVTLRLAVLRGQELENRAEQCLYVSAPWE 	                                                            
						LRPRVSCERNCRPVNASKDILLRVT                                    	                                                            
						to the sequence of AA669315_P3.3.An isolated polypeptide     	                                                            
						encoding for a tail of AA669315_P3, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						WEASLALQHASEALLTVSAKARPEDQRRQAATRDLFQAVGSVLEASLSNRPEEPAEASSS 	                                                            
						QIATVLRLLRVMEHVQTTLLLGKLPGGLPAMLATPSISVYTNRIQPWSWQGSSLRPDAAD 	                                                            
						SATFMLPAASSLSSLEGGQEPVDIKIMSFPKSPFPARSHFDVSGTVGGLRVTSPSGQLIP 	                                                            
						VKNLSENIEILLPRHSQRHSQPTVLNLTSPEALWVNVTSGEATLGIQLHWRPDIALTLSL 	                                                            
						GYGYHPNKSSYDAQTHLVPMVAPDELPTWILSPQDLRFGEGVYYLTVVPESDLEPAPGRD 	                                                            
						LTVGITTFLSHCVFWDEVQETWDDSGCQVGPRTSPYQTHCLCNHLTFFGSTFLVMPNAIN 	                                                            
						IHQTAELFATFEDNPVVVTTVGCLCVVYVLVVIWARRKDAQDQAKVKVTVLEDNDPFAQY 	                                                            
						HYLVTVYTGHRRGAATSSKVTVTLYGLDGEREPHHLADPDTPVFERGAVDAFLLSTLFPL 	                                                            
						GELRSLRLWHDNSGDRPSWYVSRVLVYDLVMDRKWYFLCNSWLSINVGDCVLDKVFPVAT 	                                                            
						EQDRKQFSHLFFMKTSAGFQDGHIWYSIFSRCARSSFTRVQRVSCCFSLLLCTMLTSIMF 	                                                            
						WGVPKDPAEQKMDLGKIEFTWQEVMIGLESSILMFPINLLIVQIFQNTRPRVAKEQNTGK 	                                                            
						WDRGSPNLTPSPQPMEDGLLTPEAVTKDVSRIVSSLFKALKVPSPALGWDSVNLMDINSL 	                                                            
						LALVEDVIYPQNTSGQVFWEEAKKREDPVTLTLGSSEMKEKSQCPKPKAARSGPWKDSAY 	                                                            
						RQCLYLQLEHVEQELRLVGPRGFSQPHSHA                               	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA669315_P3.                                              	                                                            

						Comparison report between AA669315_P3 and Q8N1H9unique head  	Sequence name: Q8N1H9                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AA669315_P3, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 19908 x Q8N1H9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MSAVGLVLLVLALRLRATTVKPEEGSFCSNSQVAFRDACYEFVPLGRTFRDAQSWCEGQG 	Alignment segment 1/1:                                       
						GHLVFIQDEGTQWFLQKHISQDREWWIGLTWNLARNGTTEGPGTWLDTSNVTYSNWHGGQ 	                                                            
						AAAAPDTCGHIGRGPSSEWVTSDCAQTFAFMCEFRVGQSLACEGLNATVHCGLGQVIQVQ 	                     Quality: 4377.00                      Escore:       0                                               
						DAIYGRQNPHFCTQDAGRPSDLEQGCSWANVKEEVAGQCQELQSCQVAADETYFGNLCPT 	             Matching length:     450                Total length:     450                                               
						QGSYLWVQYQCREALQLMVSSESFIFDNVTISLTWLLSPYIGNLSCIISTGDSHTFDPYN 	 Matching Percent Similarity:   99.78   Matching Percent Identity:   99.78                                               
						PPSVSSNVTHQFTSPGEFTVFAECTTSEWHVTAQRQVTVRDKMETLSVTACSGLSQSGAG 	    Total Percent Similarity:   99.78      Total Percent Identity:   99.78                                               
						PLCQAVFGDPLWIQVELDGGTGVTYTVLLGDITLAESTTQKGSLPYNLILDRETQKLMGP 	                        Gaps:       0                        
						GRHRLEIQATGNTTTSTISRNITVHLVELLSGLQASWASDHLELGQDLLITISLAQGTPE 	                                                            
						ELTFEVAGLNATFSHEQVSFGEPFGICRLAVPVEGTFLVT                     	Alignment:                                                   
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 520 of AA669315_P3, a second amino acid   	     521 MLVRNAFSNLSLEIGNITITAPSGLQEPSGMNAEGKSKDKGDMEVYIQPG 570                                                          
						MLVRNAFSNLSLEIGNITITAPSGLQEPSGMNAEGKSKDKGDMEVYIQPGPYVDPFTTVT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LGWPDNDKELRFQWSCGSCWALWSSCVERQLLRTDQRELVVPASCLPPPDSAVTLRLAVL 	       1 MLVRNAFSNLSLEIGNITITAPSGLQEPSGMNAEGKSKDKGDMEVYIQPG 50                                                           
						RGQELENRAEQCLYVSAPWELRPRVSCERNCRPVNASKDILLRVTMGEDSPVAMFSWYLD 	                  .         .         .         .         .  
						NTPTEQAEPLPDACRLRGFWPRSLTLLQSNTSTLLLNSSFLQSRGEVIRIRATALTRHAY 	     571 PYVDPFTTVTLGWPDNDKELRFQWSCGSCWALWSSCVERQLLRTDQRELV 620                                                          
						GEDTYVISTVPPREVPACTIAP                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      51 PYVDPFTTVTLGWPDNDKELRFQWSCGSCWALWSSCVERQLLRTDQRELV 100                                                          
						amino acids 1 - 262 of Q8N1H9, which also corresponds to     	                  .         .         .         .         .  
						amino acids 521 - 782 of AA669315_P3, a bridging amino acid E	     621 VPASCLPPPDSAVTLRLAVLRGQELENRAEQCLYVSAPWELRPRVSCERN 670                                                          
						corresponding to amino acid 783 of AA669315_P3, a third amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EGTVLTSFAIFCNASTALGPLEFCFCLESGSCLHCGPEPALPSVYLPLGEENNDFVLTVV 	     101 VPASCLPPPDSAVTLRLAVLRGQELENRAEQCLYVSAPWELRPRVSCERN 150                                                          
						ISATNRAGDTQQTQAMAKVALGDTCVEDVAFQAAVSEKIPTALQGEGGPEQLLQLAKAVS 	                  .         .         .         .         .  
						SMLNQEHESQGSGQSLSIDVRQKVREHVLGSLSAVTTGLEDVQRVQELAEVLREVTCRSK 	     671 CRPVNASKDILLRVTMGEDSPVAMFSWYLDNTPTEQAEPLPDACRLRGFW 720                                                          
						ELTPSAQ                                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	     151 CRPVNASKDILLRVTMGEDSPVAMFSWYLDNTPTEQAEPLPDACRLRGFW 200                                                          
						to amino acids 264 - 450 of Q8N1H9, which also corresponds to	                  .         .         .         .         .  
						amino acids 784 - 970 of AA669315_P3, and a fourth amino acid	     721 PRSLTLLQSNTSTLLLNSSFLQSRGEVIRIRATALTRHAYGEDTYVISTV 770                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     201 PRSLTLLQSNTSTLLLNSSFLQSRGEVIRIRATALTRHAYGEDTYVISTV 250                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						WEASLALQHASEALLTVSAKARPEDQRRQAATRDLFQAVGSVLEASLSNRPEEPAEASSS 	     771 PPREVPACTIAPEEGTVLTSFAIFCNASTALGPLEFCFCLESGSCLHCGP 820                                                          
						QIATVLRLLRVMEHVQTTLLLGKLPGGLPAMLATPSISVYTNRIQPWSWQGSSLRPDAAD 	         |||||||||||| |||||||||||||||||||||||||||||||||||||  
						SATFMLPAASSLSSLEGGQEPVDIKIMSFPKSPFPARSHFDVSGTVGGLRVTSPSGQLIP 	     251 PPREVPACTIAPGEGTVLTSFAIFCNASTALGPLEFCFCLESGSCLHCGP 300                                                          
						VKNLSENIEILLPRHSQRHSQPTVLNLTSPEALWVNVTSGEATLGIQLHWRPDIALTLSL 	                  .         .         .         .         .  
						GYGYHPNKSSYDAQTHLVPMVAPDELPTWILSPQDLRFGEGVYYLTVVPESDLEPAPGRD 	     821 EPALPSVYLPLGEENNDFVLTVVISATNRAGDTQQTQAMAKVALGDTCVE 870                                                          
						LTVGITTFLSHCVFWDEVQETWDDSGCQVGPRTSPYQTHCLCNHLTFFGSTFLVMPNAIN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IHQTAELFATFEDNPVVVTTVGCLCVVYVLVVIWARRKDAQDQAKVKVTVLEDNDPFAQY 	     301 EPALPSVYLPLGEENNDFVLTVVISATNRAGDTQQTQAMAKVALGDTCVE 350                                                          
						HYLVTVYTGHRRGAATSSKVTVTLYGLDGEREPHHLADPDTPVFERGAVDAFLLSTLFPL 	                  .         .         .         .         .  
						GELRSLRLWHDNSGDRPSWYVSRVLVYDLVMDRKWYFLCNSWLSINVGDCVLDKVFPVAT 	     871 DVAFQAAVSEKIPTALQGEGGPEQLLQLAKAVSSMLNQEHESQGSGQSLS 920                                                          
						EQDRKQFSHLFFMKTSAGFQDGHIWYSIFSRCARSSFTRVQRVSCCFSLLLCTMLTSIMF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WGVPKDPAEQKMDLGKIEFTWQEVMIGLESSILMFPINLLIVQIFQNTRPRVAKEQNTGK 	     351 DVAFQAAVSEKIPTALQGEGGPEQLLQLAKAVSSMLNQEHESQGSGQSLS 400                                                          
						WDRGSPNLTPSPQPMEDGLLTPEAVTKDVSRIVSSLFKALKVPSPALGWDSVNLMDINSL 	                  .         .         .         .         .  
						LALVEDVIYPQNTSGQVFWEEAKKREDPVTLTLGSSEMKEKSQCPKPKAARSGPWKDSAY 	     921 IDVRQKVREHVLGSLSAVTTGLEDVQRVQELAEVLREVTCRSKELTPSAQ 970                                                          
						RQCLYLQLEHVEQELRLVGPRGFSQPHSHA                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 971 - 1780  	     401 IDVRQKVREHVLGSLSAVTTGLEDVQRVQELAEVLREVTCRSKELTPSAQ 450                                                          
						of AA669315_P3, wherein said first amino acid sequence,      	                                                            
						second amino acid sequence, bridging amino acid, third amino 	                                                            
						acid sequence and fourth amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	                                                            
						for a head of AA669315_P3, comprising a polypeptide being at 	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						MSAVGLVLLVLALRLRATTVKPEEGSFCSNSQVAFRDACYEFVPLGRTFRDAQSWCEGQG 	                                                            
						GHLVFIQDEGTQWFLQKHISQDREWWIGLTWNLARNGTTEGPGTWLDTSNVTYSNWHGGQ 	                                                            
						AAAAPDTCGHIGRGPSSEWVTSDCAQTFAFMCEFRVGQSLACEGLNATVHCGLGQVIQVQ 	                                                            
						DAIYGRQNPHFCTQDAGRPSDLEQGCSWANVKEEVAGQCQELQSCQVAADETYFGNLCPT 	                                                            
						QGSYLWVQYQCREALQLMVSSESFIFDNVTISLTWLLSPYIGNLSCIISTGDSHTFDPYN 	                                                            
						PPSVSSNVTHQFTSPGEFTVFAECTTSEWHVTAQRQVTVRDKMETLSVTACSGLSQSGAG 	                                                            
						PLCQAVFGDPLWIQVELDGGTGVTYTVLLGDITLAESTTQKGSLPYNLILDRETQKLMGP 	                                                            
						GRHRLEIQATGNTTTSTISRNITVHLVELLSGLQASWASDHLELGQDLLITISLAQGTPE 	                                                            
						ELTFEVAGLNATFSHEQVSFGEPFGICRLAVPVEGTFLVT                     	                                                            
						preferably at least about 95% homologous to the sequence of  	                                                            
						AA669315_P3.3.An isolated polypeptide encoding for a tail of 	                                                            
						AA669315_P3, comprising a polypeptide being at least 70%,    	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						WEASLALQHASEALLTVSAKARPEDQRRQAATRDLFQAVGSVLEASLSNRPEEPAEASSS 	                                                            
						QIATVLRLLRVMEHVQTTLLLGKLPGGLPAMLATPSISVYTNRIQPWSWQGSSLRPDAAD 	                                                            
						SATFMLPAASSLSSLEGGQEPVDIKIMSFPKSPFPARSHFDVSGTVGGLRVTSPSGQLIP 	                                                            
						VKNLSENIEILLPRHSQRHSQPTVLNLTSPEALWVNVTSGEATLGIQLHWRPDIALTLSL 	                                                            
						GYGYHPNKSSYDAQTHLVPMVAPDELPTWILSPQDLRFGEGVYYLTVVPESDLEPAPGRD 	                                                            
						LTVGITTFLSHCVFWDEVQETWDDSGCQVGPRTSPYQTHCLCNHLTFFGSTFLVMPNAIN 	                                                            
						IHQTAELFATFEDNPVVVTTVGCLCVVYVLVVIWARRKDAQDQAKVKVTVLEDNDPFAQY 	                                                            
						HYLVTVYTGHRRGAATSSKVTVTLYGLDGEREPHHLADPDTPVFERGAVDAFLLSTLFPL 	                                                            
						GELRSLRLWHDNSGDRPSWYVSRVLVYDLVMDRKWYFLCNSWLSINVGDCVLDKVFPVAT 	                                                            
						EQDRKQFSHLFFMKTSAGFQDGHIWYSIFSRCARSSFTRVQRVSCCFSLLLCTMLTSIMF 	                                                            
						WGVPKDPAEQKMDLGKIEFTWQEVMIGLESSILMFPINLLIVQIFQNTRPRVAKEQNTGK 	                                                            
						WDRGSPNLTPSPQPMEDGLLTPEAVTKDVSRIVSSLFKALKVPSPALGWDSVNLMDINSL 	                                                            
						LALVEDVIYPQNTSGQVFWEEAKKREDPVTLTLGSSEMKEKSQCPKPKAARSGPWKDSAY 	                                                            
						RQCLYLQLEHVEQELRLVGPRGFSQPHSHA                               	                                                            
						least about 95% homologous to the sequence in AA669315_P3.   	                                                            

21344	HMR136_AA677708_4_tr0_r1_1_gPRT		Comparison report between AA677708_P4 and Q8TCI3unique head  	Sequence name: Q8TCI3                                        
						followed by partial WT sequence a mismatch and a featuring a 	                                                            
						skipped exon.1.An isolated chimeric polypeptide encoding for 	Sequence documentation:                                      
						AA677708_P4, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 21344 x Q8TCI3   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MDNKISPEAQVAELELDAVIGFNGHVPTGLKCHPDQEHMIYPLGCTVLIQAINTKEQNFL 	Alignment segment 1/1:                                       
						QGHGNNVSCLAISRSGEYIASGQVTFMGFKADIILWDYKNRELLARLSLHKGKIEALAFS 	                                                            
						PNDLYLVSLGGPDDGSVVVWSIAKRDAICGSPAAGLNVGNATNVIFSRCRDEMFMTAGNG 	                     Quality: 3775.00                      Escore:       0                                               
						TIRVWELDLPNRKIWPTECQTGQLKRIV                                 	             Matching length:     399                Total length:     412                                               
						homologous to a polypeptide having the sequence corresponding	 Matching Percent Similarity:   99.75   Matching Percent Identity:   99.75                                               
						to amino acids 1 - 208 of AA677708_P4, a second amino acid   	    Total Percent Similarity:   96.60      Total Percent Identity:   96.60                                               
						sequence being at least 90 % homologous to                   	                        Gaps:       1                        
						MSIGVDDDDSFFYLGTTTGDILKMNPRTKLLTDV corresponding to amino    	                                                            
						acids 1 - 34 of Q8TCI3, which also corresponds to amino acids	Alignment:                                                   
						209 - 242 of AA677708_P4, a bridging amino acid G            	                  .         .         .         .         .  
						corresponding to amino acid 243 of AA677708_P4, a third amino	     209 MSIGVDDDDSFFYLGTTTGDILKMNPRTKLLTDVGPAKDKFSLGVSAIRC 258                                                          
						PAKDKFSLGVSAIRCLKMGGLLVGSGAGLLVFCKSPGYKPIKKIQLQGGITSITLRGEGH 	         |||||||||||||||||||||||||||||||||| |||||||||||||||  
						QFLVGTEESHIYRVSFTDFKETLIATCHFDAVKDIVFPFGTAELFATCAKKDIRVWHTSS 	       1 MSIGVDDDDSFFYLGTTTGDILKMNPRTKLLTDVEPAKDKFSLGVSAIRC 50                                                           
						NRELLRITVPNMTCHGIDFMRDGKSIISAWNDGKIRAFAPETGRLMYVINNAHRIGVTAI 	                  .         .         .         .         .  
						ATTSDCKRVISGGGEGEVRVWQIGCQTQKLEEALKEHKSSVSCIRVKRNNEECVTASTDG 	     259 LKMGGLLVGSGAGLLVFCKSPGYKPIKKIQLQGGITSITLRGEGHQFLVG 308                                                          
						TCIIWDLVRLRRNQMILANTLFQCVCYHPEEFQIITSGTDRKIAYWEVFDGTVIRELEGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LSGSIN                                                       	      51 LKMGGLLVGSGAGLLVFCKSPGYKPIKKIQLQGGITSITLRGEGHQFLVG 100                                                          
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 36 - 341 of Q8TCI3, which also corresponds to 	     309 TEESHIYRVSFTDFKETLIATCHFDAVKDIVFPFGTAELFATCAKKDIRV 358                                                          
						amino acids 244 - 549 of AA677708_P4, and a fourth amino acid	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to                   	     101 TEESHIYRVSFTDFKETLIATCHFDAVKDIVFPFGTAELFATCAKKDIRV 150                                                          
						GGNDHLVKVWDYNEGEVTHVGVGHSGNITRIRISPGNQYIVSVSADGAILRWKYPYTS   	                  .         .         .         .         .  
						corresponding to amino acids 355 - 412 of Q8TCI3, which also 	     359 WHTSSNRELLRITVPNMTCHGIDFMRDGKSIISAWNDGKIRAFAPETGRL 408                                                          
						corresponds to amino acids 550 - 607 of AA677708_P4, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     151 WHTSSNRELLRITVPNMTCHGIDFMRDGKSIISAWNDGKIRAFAPETGRL 200                                                          
						bridging amino acid, third amino acid sequence and fourth    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     409 MYVINNAHRIGVTAIATTSDCKRVISGGGEGEVRVWQIGCQTQKLEEALK 458                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA677708_P4, comprising a polypeptide being at least 70%,    	     201 MYVINNAHRIGVTAIATTSDCKRVISGGGEGEVRVWQIGCQTQKLEEALK 250                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     459 EHKSSVSCIRVKRNNEECVTASTDGTCIIWDLVRLRRNQMILANTLFQCV 508                                                          
						MDNKISPEAQVAELELDAVIGFNGHVPTGLKCHPDQEHMIYPLGCTVLIQAINTKEQNFL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QGHGNNVSCLAISRSGEYIASGQVTFMGFKADIILWDYKNRELLARLSLHKGKIEALAFS 	     251 EHKSSVSCIRVKRNNEECVTASTDGTCIIWDLVRLRRNQMILANTLFQCV 300                                                          
						PNDLYLVSLGGPDDGSVVVWSIAKRDAICGSPAAGLNVGNATNVIFSRCRDEMFMTAGNG 	                  .         .         .         .         .  
						TIRVWELDLPNRKIWPTECQTGQLKRIV                                 	     509 CYHPEEFQIITSGTDRKIAYWEVFDGTVIRELEGSLSGSIN......... 549                                                          
						least about 95% homologous to the sequence of                	         |||||||||||||||||||||||||||||||||||||||||           
						AA677708_P4.3.An isolated chimeric polypeptide encoding for  	     301 CYHPEEFQIITSGTDRKIAYWEVFDGTVIRELEGSLSGSINGMDITQEGV 350                                                          
						an edge portion of AA677708_P4, comprising a polypeptide     	                  .         .         .         .         .  
						having a length "n", wherein n is at least about 10 amino    	     550 ....GGNDHLVKVWDYNEGEVTHVGVGHSGNITRIRISPGNQYIVSVSAD 595                                                          
						acids in length, optionally at least about 20 amino acids in 	             ||||||||||||||||||||||||||||||||||||||||||||||  
						length, preferably at least about 30 amino acids in length,  	     351 HFVTGGNDHLVKVWDYNEGEVTHVGVGHSGNITRIRISPGNQYIVSVSAD 400                                                          
						more preferably at least about 40 amino acids in length and  	                  .                                          
						most preferably at least about 50 amino acids in length,     	     596 GAILRWKYPYTS                                       607                                                          
						wherein at least two amino acids comprise NG, having a       	         ||||||||||||                                        
						structure as follows: a sequence starting from any of amino  	     401 GAILRWKYPYTS                                       412                                                          
						acid numbers 549-x to 550; and ending at any of amino acid   	                                                            
						numbers 550+ ((n-2) - x), in which x varies from 0 to n-2.   	                                                            

						Comparison report between AA677708_P4 and Q8N1V2unique head  	Sequence name: Q8N1V2                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for AA677708_P4,      	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 21344 x Q8N1V2   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MDNKISPEAQVAELELDAVIGFN corresponding to amino acids 1 - 23  	                                                            
						of AA677708_P4, a second amino acid sequence being at least  	                     Quality: 5611.00                      Escore:       0                                               
						GHVPTGLKCHPDQEHMIYPLGCTVLIQAINTKEQNFLQGHGNNVSCLAISRSGEYIASGQ 	             Matching length:     584                Total length:     597                                               
						VTFMGFKADIILWDYKNRELLARLSLHKGKIEALAFSPNDLYLVSLGGPDDGSVVVWSIA 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KRDAICGSPAAGLNVGNATNVIFSRCRDEMFMTAGNGTIRVWELDLPNRKIWPTECQTGQ 	    Total Percent Similarity:   97.82      Total Percent Identity:   97.82                                               
						LKRIVMSIGVDDDDSFFYLGTTTGDILKMNPRTKLLTDVGPAKDKFSLGVSAIRCLKMGG 	                        Gaps:       1                        
						LLVGSGAGLLVFCKSPGYKPIKKIQLQGGITSITLRGEGHQFLVGTEESHIYRVSFTDFK 	                                                            
						ETLIATCHFDAVKDIVFPFGTAELFATCAKKDIRVWHTSSNRELLRITVPNMTCHGIDFM 	Alignment:                                                   
						RDGKSIISAWNDGKIRAFAPETGRLMYVINNAHRIGVTAIATTSDCKRVISGGGEGEVRV 	                  .         .         .         .         .  
						WQIGCQTQKLEEALKEHKSSVSCIRVKRNNEECVTASTDGTCIIWDLVRLRRNQMILANT 	      24 GHVPTGLKCHPDQEHMIYPLGCTVLIQAINTKEQNFLQGHGNNVSCLAIS 73                                                           
						LFQCVCYHPEEFQIITSGTDRKIAYWEVFDGTVIRELEGSLSGSIN               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 34 - 559 of  	      34 GHVPTGLKCHPDQEHMIYPLGCTVLIQAINTKEQNFLQGHGNNVSCLAIS 83                                                           
						Q8N1V2, which also corresponds to amino acids 24 - 549 of    	                  .         .         .         .         .  
						AA677708_P4, and a third amino acid sequence being at least  	      74 RSGEYIASGQVTFMGFKADIILWDYKNRELLARLSLHKGKIEALAFSPND 123                                                          
						90 % homologous to                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GGNDHLVKVWDYNEGEVTHVGVGHSGNITRIRISPGNQYIVSVSADGAILRWKYPYTS   	      84 RSGEYIASGQVTFMGFKADIILWDYKNRELLARLSLHKGKIEALAFSPND 133                                                          
						corresponding to amino acids 573 - 630 of Q8N1V2, which also 	                  .         .         .         .         .  
						corresponds to amino acids 550 - 607 of AA677708_P4, wherein 	     124 LYLVSLGGPDDGSVVVWSIAKRDAICGSPAAGLNVGNATNVIFSRCRDEM 173                                                          
						said first amino acid sequence, second amino acid sequence   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and third amino acid sequence are contiguous and in a        	     134 LYLVSLGGPDDGSVVVWSIAKRDAICGSPAAGLNVGNATNVIFSRCRDEM 183                                                          
						sequential order.2.An isolated polypeptide encoding for a    	                  .         .         .         .         .  
						head of AA677708_P4, comprising a polypeptide being at least 	     174 FMTAGNGTIRVWELDLPNRKIWPTECQTGQLKRIVMSIGVDDDDSFFYLG 223                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     184 FMTAGNGTIRVWELDLPNRKIWPTECQTGQLKRIVMSIGVDDDDSFFYLG 233                                                          
						at least about 95% homologous to the sequence                	                  .         .         .         .         .  
						MDNKISPEAQVAELELDAVIGFN of AA677708_P4.3.An isolated chimeric	     224 TTTGDILKMNPRTKLLTDVGPAKDKFSLGVSAIRCLKMGGLLVGSGAGLL 273                                                          
						polypeptide encoding for an edge portion of AA677708_P4,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	     234 TTTGDILKMNPRTKLLTDVGPAKDKFSLGVSAIRCLKMGGLLVGSGAGLL 283                                                          
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	     274 VFCKSPGYKPIKKIQLQGGITSITLRGEGHQFLVGTEESHIYRVSFTDFK 323                                                          
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length and most preferably at least about 50  	     284 VFCKSPGYKPIKKIQLQGGITSITLRGEGHQFLVGTEESHIYRVSFTDFK 333                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise NG, having a structure as follows: a sequence       	     324 ETLIATCHFDAVKDIVFPFGTAELFATCAKKDIRVWHTSSNRELLRITVP 373                                                          
						starting from any of amino acid numbers 549-x to 550; and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ending at any of amino acid numbers 550+ ((n-2) - x), in     	     334 ETLIATCHFDAVKDIVFPFGTAELFATCAKKDIRVWHTSSNRELLRITVP 383                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	     374 NMTCHGIDFMRDGKSIISAWNDGKIRAFAPETGRLMYVINNAHRIGVTAI 423                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     384 NMTCHGIDFMRDGKSIISAWNDGKIRAFAPETGRLMYVINNAHRIGVTAI 433                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     424 ATTSDCKRVISGGGEGEVRVWQIGCQTQKLEEALKEHKSSVSCIRVKRNN 473                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     434 ATTSDCKRVISGGGEGEVRVWQIGCQTQKLEEALKEHKSSVSCIRVKRNN 483                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     474 EECVTASTDGTCIIWDLVRLRRNQMILANTLFQCVCYHPEEFQIITSGTD 523                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     484 EECVTASTDGTCIIWDLVRLRRNQMILANTLFQCVCYHPEEFQIITSGTD 533                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     524 RKIAYWEVFDGTVIRELEGSLSGSIN.............GGNDHLVKVWD 560                                                          
						                                                            	         ||||||||||||||||||||||||||             |||||||||||  
						                                                            	     534 RKIAYWEVFDGTVIRELEGSLSGSINGMDITQEGVHFVTGGNDHLVKVWD 583                                                          
						                                                            	                  .         .         .         .            
						                                                            	     561 YNEGEVTHVGVGHSGNITRIRISPGNQYIVSVSADGAILRWKYPYTS    607                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     584 YNEGEVTHVGVGHSGNITRIRISPGNQYIVSVSADGAILRWKYPYTS    630                                                          

2115	HMR136_AA682572_0_tr0_r1_1_gPRT		Comparison report between AA682572_P0 and Q9P2C6partial WT   	Sequence name: Q9P2C6                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA682572_P0, comprising a first     	Sequence documentation:                                      
						QRWSQPSAAPGGSGSSLSLCLSATMVLESVVADLLNRFLGDYVENLNKSQLKLGIWGGNV 	                                                            
						ALDNLQIKENALSELDVPFKVKAGQIDKLTLKIPWKNLYGEAVVATLEGLYLLVVPGASI 	Alignment of: 2115 x Q9P2C6   ..                             
						KYDAVKEEKSLQDVKQKELSRIEEALQKAAEKGTHSGEFIYGLENFVYKDIKPGRKRKKH 	                                                            
						KKHFKKPFKGLDRSKDKPKEAKKDTFVEKLATQVIKNVQVKITDIHIKYEDDVTDPKRPL 	Alignment segment 1/1:                                       
						SFGVTLGELSLLTANEHWTPCILNEADKIIYKLIRLDSLSAYWNVNCSMSYQRSREQILD 	                                                            
						QLKNEILTSGNIPPNYQYIFQPISASAKLYMNPYAESELKTPKLDCNIEIQNIAIELTKP 	                     Quality: 7635.00                      Escore:       0                                               
						QYLSMIDLLESVDYMVRNAPYRKYKPYLPLHTNGRRWWKYAIDSVLEVHIRRYTQMWSWS 	             Matching length:     788                Total length:     788                                               
						NIKKHRQLLKSYKIAYKNKLTQSKVSEEIQKEIQDLEKTLDVFNIILARQQAQVEVIRSG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.87                                               
						QKLRKKSADTGEKRGGWFSGLWGKKESKKKDEESLIPETIDDLMTPEEKDKLFTAIGYSE 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.87                                               
						STHNLTLPKQYVAHIMTLKLVSTSVTIRENKNIPEILKIQIIGLGTQVSQRPGAQALKVE 	                        Gaps:       0                        
						AKLEHWYITGLRQQDIVPSLVASIGDTTSSLLKIKFETNPEDSPADQTLIVQSQPVEVIY 	                                                            
						DAKTVNAVVEFFQSNKGLDLEQITSATLMKLEEIKERTATGLTHIIETRKVLDLRINLKP 	Alignment:                                                   
						SYLVVPQTGFHHEKSDLLILDFGTFQLNSKDQGLQKTTNSSLEEIMDKAYDKFDVEIKNV 	                  .         .         .         .         .  
						QLLFARA                                                      	       1 QRWSQPSAAPGGSGSSLSLCLSATMVLESVVADLLNRFLGDYVENLNKSQ 50                                                           
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 1 - 787 of Q9P2C6, which also   	       1 QRWSQPSAAPGGSGSSLSLCLSATMVLESVVADLLNRFLGDYVENLNKSQ 50                                                           
						corresponds to amino acids 1 - 787 of AA682572_P0, and a     	                  .         .         .         .         .  
						second amino acid sequence being at least 70%, optionally at 	      51 LKLGIWGGNVALDNLQIKENALSELDVPFKVKAGQIDKLTLKIPWKNLYG 100                                                          
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	      51 LKLGIWGGNVALDNLQIKENALSELDVPFKVKAGQIDKLTLKIPWKNLYG 100                                                          
						polypeptide having the sequence DLKCQEDFL corresponding to   	                  .         .         .         .         .  
						amino acids 788 - 796 of AA682572_P0, wherein said first     	     101 EAVVATLEGLYLLVVPGASIKYDAVKEEKSLQDVKQKELSRIEEALQKAA 150                                                          
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     101 EAVVATLEGLYLLVVPGASIKYDAVKEEKSLQDVKQKELSRIEEALQKAA 150                                                          
						polypeptide encoding for a tail of AA682572_P0, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     151 EKGTHSGEFIYGLENFVYKDIKPGRKRKKHKKHFKKPFKGLDRSKDKPKE 200                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     151 EKGTHSGEFIYGLENFVYKDIKPGRKRKKHKKHFKKPFKGLDRSKDKPKE 200                                                          
						to the sequence DLKCQEDFL in AA682572_P0.                    	                  .         .         .         .         .  
						                                                            	     201 AKKDTFVEKLATQVIKNVQVKITDIHIKYEDDVTDPKRPLSFGVTLGELS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 AKKDTFVEKLATQVIKNVQVKITDIHIKYEDDVTDPKRPLSFGVTLGELS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LLTANEHWTPCILNEADKIIYKLIRLDSLSAYWNVNCSMSYQRSREQILD 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LLTANEHWTPCILNEADKIIYKLIRLDSLSAYWNVNCSMSYQRSREQILD 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 QLKNEILTSGNIPPNYQYIFQPISASAKLYMNPYAESELKTPKLDCNIEI 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 QLKNEILTSGNIPPNYQYIFQPISASAKLYMNPYAESELKTPKLDCNIEI 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QNIAIELTKPQYLSMIDLLESVDYMVRNAPYRKYKPYLPLHTNGRRWWKY 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 QNIAIELTKPQYLSMIDLLESVDYMVRNAPYRKYKPYLPLHTNGRRWWKY 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 AIDSVLEVHIRRYTQMWSWSNIKKHRQLLKSYKIAYKNKLTQSKVSEEIQ 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 AIDSVLEVHIRRYTQMWSWSNIKKHRQLLKSYKIAYKNKLTQSKVSEEIQ 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KEIQDLEKTLDVFNIILARQQAQVEVIRSGQKLRKKSADTGEKRGGWFSG 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KEIQDLEKTLDVFNIILARQQAQVEVIRSGQKLRKKSADTGEKRGGWFSG 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LWGKKESKKKDEESLIPETIDDLMTPEEKDKLFTAIGYSESTHNLTLPKQ 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 LWGKKESKKKDEESLIPETIDDLMTPEEKDKLFTAIGYSESTHNLTLPKQ 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 YVAHIMTLKLVSTSVTIRENKNIPEILKIQIIGLGTQVSQRPGAQALKVE 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 YVAHIMTLKLVSTSVTIRENKNIPEILKIQIIGLGTQVSQRPGAQALKVE 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 AKLEHWYITGLRQQDIVPSLVASIGDTTSSLLKIKFETNPEDSPADQTLI 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 AKLEHWYITGLRQQDIVPSLVASIGDTTSSLLKIKFETNPEDSPADQTLI 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 VQSQPVEVIYDAKTVNAVVEFFQSNKGLDLEQITSATLMKLEEIKERTAT 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 VQSQPVEVIYDAKTVNAVVEFFQSNKGLDLEQITSATLMKLEEIKERTAT 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GLTHIIETRKVLDLRINLKPSYLVVPQTGFHHEKSDLLILDFGTFQLNSK 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 GLTHIIETRKVLDLRINLKPSYLVVPQTGFHHEKSDLLILDFGTFQLNSK 750                                                          
						                                                            	                  .         .         .                      
						                                                            	     751 DQGLQKTTNSSLEEIMDKAYDKFDVEIKNVQLLFARAD             788                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||:              
						                                                            	     751 DQGLQKTTNSSLEEIMDKAYDKFDVEIKNVQLLFARAE             788                                                          

2113	HMR136_AA682572_1_tr0_r1_1_gPRT		Comparison report between AA682572_P1 and Q9P2C6partial WT   	Sequence name: Q9P2C6                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA682572_P1, comprising a first     	Sequence documentation:                                      
						QRWSQPSAAPGGSGSSLSLCLSATMVLESVVADLLNRFLGDYVENLNKSQLKLGIWGGNV 	                                                            
						ALDNLQIKENALSELDVPFKVKAGQIDKLTLKIPWKNLYGEAVVATLEGLYLLVVPGASI 	Alignment of: 2113 x Q9P2C6   ..                             
						KYDAVKEEKSLQDVKQKELSRIEEALQKAAEKGTHSGEFIYGLENFVYKDIKPGRKRKKH 	                                                            
						KKHFKKPFKGLDRSKDKPKEAKKDTFVEKLATQVIKNVQVKITDIHIKYEDDVTDPKRPL 	Alignment segment 1/1:                                       
						SFGVTLGELSLLTANEHWTPCILNEADKIIYKLIRLDSLSAYWNVNCSMSYQRSREQILD 	                                                            
						QLKNEILTSGNIPPNYQYIFQPISASAKLYMNPYAESELKTPKLDCNIEIQNIAIELTKP 	                     Quality: 7635.00                      Escore:       0                                               
						QYLSMIDLLESVDYMVRNAPYRKYKPYLPLHTNGRRWWKYAIDSVLEVHIRRYTQMWSWS 	             Matching length:     788                Total length:     788                                               
						NIKKHRQLLKSYKIAYKNKLTQSKVSEEIQKEIQDLEKTLDVFNIILARQQAQVEVIRSG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.87                                               
						QKLRKKSADTGEKRGGWFSGLWGKKESKKKDEESLIPETIDDLMTPEEKDKLFTAIGYSE 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.87                                               
						STHNLTLPKQYVAHIMTLKLVSTSVTIRENKNIPEILKIQIIGLGTQVSQRPGAQALKVE 	                        Gaps:       0                        
						AKLEHWYITGLRQQDIVPSLVASIGDTTSSLLKIKFETNPEDSPADQTLIVQSQPVEVIY 	                                                            
						DAKTVNAVVEFFQSNKGLDLEQITSATLMKLEEIKERTATGLTHIIETRKVLDLRINLKP 	Alignment:                                                   
						SYLVVPQTGFHHEKSDLLILDFGTFQLNSKDQGLQKTTNSSLEEIMDKAYDKFDVEIKNV 	                  .         .         .         .         .  
						QLLFARA                                                      	       1 QRWSQPSAAPGGSGSSLSLCLSATMVLESVVADLLNRFLGDYVENLNKSQ 50                                                           
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 1 - 787 of Q9P2C6, which also   	       1 QRWSQPSAAPGGSGSSLSLCLSATMVLESVVADLLNRFLGDYVENLNKSQ 50                                                           
						corresponds to amino acids 1 - 787 of AA682572_P1, and a     	                  .         .         .         .         .  
						second amino acid sequence being at least 70%, optionally at 	      51 LKLGIWGGNVALDNLQIKENALSELDVPFKVKAGQIDKLTLKIPWKNLYG 100                                                          
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	      51 LKLGIWGGNVALDNLQIKENALSELDVPFKVKAGQIDKLTLKIPWKNLYG 100                                                          
						polypeptide having the sequence DLKCQEDFL corresponding to   	                  .         .         .         .         .  
						amino acids 788 - 796 of AA682572_P1, wherein said first     	     101 EAVVATLEGLYLLVVPGASIKYDAVKEEKSLQDVKQKELSRIEEALQKAA 150                                                          
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     101 EAVVATLEGLYLLVVPGASIKYDAVKEEKSLQDVKQKELSRIEEALQKAA 150                                                          
						polypeptide encoding for a tail of AA682572_P1, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     151 EKGTHSGEFIYGLENFVYKDIKPGRKRKKHKKHFKKPFKGLDRSKDKPKE 200                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     151 EKGTHSGEFIYGLENFVYKDIKPGRKRKKHKKHFKKPFKGLDRSKDKPKE 200                                                          
						to the sequence DLKCQEDFL in AA682572_P1.                    	                  .         .         .         .         .  
						                                                            	     201 AKKDTFVEKLATQVIKNVQVKITDIHIKYEDDVTDPKRPLSFGVTLGELS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 AKKDTFVEKLATQVIKNVQVKITDIHIKYEDDVTDPKRPLSFGVTLGELS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LLTANEHWTPCILNEADKIIYKLIRLDSLSAYWNVNCSMSYQRSREQILD 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LLTANEHWTPCILNEADKIIYKLIRLDSLSAYWNVNCSMSYQRSREQILD 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 QLKNEILTSGNIPPNYQYIFQPISASAKLYMNPYAESELKTPKLDCNIEI 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 QLKNEILTSGNIPPNYQYIFQPISASAKLYMNPYAESELKTPKLDCNIEI 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 QNIAIELTKPQYLSMIDLLESVDYMVRNAPYRKYKPYLPLHTNGRRWWKY 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 QNIAIELTKPQYLSMIDLLESVDYMVRNAPYRKYKPYLPLHTNGRRWWKY 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 AIDSVLEVHIRRYTQMWSWSNIKKHRQLLKSYKIAYKNKLTQSKVSEEIQ 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 AIDSVLEVHIRRYTQMWSWSNIKKHRQLLKSYKIAYKNKLTQSKVSEEIQ 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 KEIQDLEKTLDVFNIILARQQAQVEVIRSGQKLRKKSADTGEKRGGWFSG 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 KEIQDLEKTLDVFNIILARQQAQVEVIRSGQKLRKKSADTGEKRGGWFSG 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 LWGKKESKKKDEESLIPETIDDLMTPEEKDKLFTAIGYSESTHNLTLPKQ 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 LWGKKESKKKDEESLIPETIDDLMTPEEKDKLFTAIGYSESTHNLTLPKQ 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 YVAHIMTLKLVSTSVTIRENKNIPEILKIQIIGLGTQVSQRPGAQALKVE 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 YVAHIMTLKLVSTSVTIRENKNIPEILKIQIIGLGTQVSQRPGAQALKVE 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 AKLEHWYITGLRQQDIVPSLVASIGDTTSSLLKIKFETNPEDSPADQTLI 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 AKLEHWYITGLRQQDIVPSLVASIGDTTSSLLKIKFETNPEDSPADQTLI 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 VQSQPVEVIYDAKTVNAVVEFFQSNKGLDLEQITSATLMKLEEIKERTAT 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 VQSQPVEVIYDAKTVNAVVEFFQSNKGLDLEQITSATLMKLEEIKERTAT 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 GLTHIIETRKVLDLRINLKPSYLVVPQTGFHHEKSDLLILDFGTFQLNSK 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 GLTHIIETRKVLDLRINLKPSYLVVPQTGFHHEKSDLLILDFGTFQLNSK 750                                                          
						                                                            	                  .         .         .                      
						                                                            	     751 DQGLQKTTNSSLEEIMDKAYDKFDVEIKNVQLLFARAD             788                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||:              
						                                                            	     751 DQGLQKTTNSSLEEIMDKAYDKFDVEIKNVQLLFARAE             788                                                          

24429	HMR136_AA689476_3_tr0_r1_1_gPRT		Comparison report between AA689476_P3 and Q96EN8unique head  	Sequence name: Q96EN8                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for AA689476_P3,      	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 24429 x Q96EN8   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						homologous to a polypeptide having the sequence LDGLAGA      	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 7 of AA689476_P3, a second  	                                                            
						MAGAAAESGRELWTFAGSRDPSAPRLAYGYGPGSLRELRAREFSRLAGTVYLDHAGATLF 	                     Quality: 6526.00                      Escore:       0                                               
						SQSQLESFTSDLMENTYGNPHSQNISSKLTHDTVEQVRY                      	             Matching length:     674                Total length:     888                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 99 of Q96EN8, which also    	    Total Percent Similarity:   75.90      Total Percent Identity:   75.90                                               
						corresponds to amino acids 8 - 106 of AA689476_P3, and a     	                        Gaps:       1                        
						RFEDGTISFLDVIALKHGFDTLERLTGGMENIKQHTFTLAQYTYMALSSLQYPNGAPVVR 	                                                            
						IYSDSEFSSPEVQGPIINFNVLDDKGNIIGYSQVDKMASLYNIHLRTGCFCNTGACQRHL 	Alignment:                                                   
						GISNEMVRKHFQAGHVCGDNMDLIDGQPTGSVRISFGYMSTLDDVQAFLRFIIDTRLHSS 	                  .         .         .         .         .  
						GDWPVPQAHADTGETGAPSADSQADVIPAVMGRRSLSPQEDALTGSRVWNNSSTVNAVPV 	       8 MAGAAAESGRELWTFAGSRDPSAPRLAYGYGPGSLRELRAREFSRLAGTV 57                                                           
						APPVCDVARTQPTPSEKAAGVLEGALGPHVVTNLYLYPIKSCAAFEVTRWPVGNQGLLYD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RSWMVVNHNGVCLSQKQEPRLCLIQPFIDLRQRIMVIKAKGMEPIEVPLEENSERTQIRQ 	       1 MAGAAAESGRELWTFAGSRDPSAPRLAYGYGPGSLRELRAREFSRLAGTV 50                                                           
						SRVCADRVSTYDCGEKISSWLSTFFGRPCHLIKQSSNSQRNAKKKHGKDQLPGTMATLSL 	                  .         .         .         .         .  
						VNEAQYLLINTSSILELHRQLNTSDENGKEELFSLKDLSLRFRANIIINGKRAFEEEKWD 	      58 YLDHAGATLFSQSQLESFTSDLMENTYGNPHSQNISSKLTHDTVEQVRY. 106                                                          
						EISIGSLRFQVLGPCHRCQMICIDQQTGQRNQHVFQKLSESRETKVNFGMYLMHASLDLS 	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						SPCFLSVGSQVLPVLKENVEGHDLPASEKHQDVTS                          	      51 YLDHAGATLFSQSQLESFTSDLMENTYGNPHSQNISSKLTHDTVEQVRYR 100                                                          
						third amino acid sequence being at least 90 % homologous to  	                  .         .         .         .         .  
						corresponding to amino acids 314 - 888 of Q96EN8, which also 	     106 .................................................. 106                                                          
						corresponds to amino acids 107 - 681 of AA689476_P3, wherein 	                                                            
						said first amino acid sequence, second amino acid sequence   	     101 ILAHFHTTAEDYTVIFTAGSTAALKLVAEAFPWVSQGPESSGSRFCYLTD 150                                                          
						and third amino acid sequence are contiguous and in a        	                  .         .         .         .         .  
						sequential order.2.An isolated polypeptide encoding for a    	     106 .................................................. 106                                                          
						head of AA689476_P3, comprising a polypeptide being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	     151 SHTSVVGMRNVTMAINVISIPVRPEDLWSAEERGASASNPDCQLPHLFCY 200                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence LDGLAGA of     	     106 .................................................. 106                                                          
						AA689476_P3.3.An isolated chimeric polypeptide encoding for  	                                                            
						an edge portion of AA689476_P3, comprising a polypeptide     	     201 PAQSNFSGVRYPLSWIEEVKSGRLRPVSTPGKWFVLLDAASYVSTSPLDL 250                                                          
						having a length "n", wherein n is at least about 10 amino    	                  .         .         .         .         .  
						acids in length, optionally at least about 20 amino acids in 	     106 .................................................. 106                                                          
						length, preferably at least about 30 amino acids in length,  	                                                            
						more preferably at least about 40 amino acids in length and  	     251 SAHQADFVPISFYKIFGFPTGLGALLVHNRAAPLLRKTYFGGGTASAYLA 300                                                          
						most preferably at least about 50 amino acids in length,     	                  .         .         .         .         .  
						wherein at least two amino acids comprise YR, having a       	     107 .............RFEDGTISFLDVIALKHGFDTLERLTGGMENIKQHTF 143                                                          
						structure as follows: a sequence starting from any of amino  	                      |||||||||||||||||||||||||||||||||||||  
						acid numbers 106-x to 107; and ending at any of amino acid   	     301 GEDFYIPRQSVAQRFEDGTISFLDVIALKHGFDTLERLTGGMENIKQHTF 350                                                          
						numbers 107+ ((n-2) - x), in which x varies from 0 to n-2.   	                  .         .         .         .         .  
						                                                            	     144 TLAQYTYMALSSLQYPNGAPVVRIYSDSEFSSPEVQGPIINFNVLDDKGN 193                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 TLAQYTYMALSSLQYPNGAPVVRIYSDSEFSSPEVQGPIINFNVLDDKGN 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     194 IIGYSQVDKMASLYNIHLRTGCFCNTGACQRHLGISNEMVRKHFQAGHVC 243                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 IIGYSQVDKMASLYNIHLRTGCFCNTGACQRHLGISNEMVRKHFQAGHVC 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     244 GDNMDLIDGQPTGSVRISFGYMSTLDDVQAFLRFIIDTRLHSSGDWPVPQ 293                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GDNMDLIDGQPTGSVRISFGYMSTLDDVQAFLRFIIDTRLHSSGDWPVPQ 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     294 AHADTGETGAPSADSQADVIPAVMGRRSLSPQEDALTGSRVWNNSSTVNA 343                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 AHADTGETGAPSADSQADVIPAVMGRRSLSPQEDALTGSRVWNNSSTVNA 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     344 VPVAPPVCDVARTQPTPSEKAAGVLEGALGPHVVTNLYLYPIKSCAAFEV 393                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 VPVAPPVCDVARTQPTPSEKAAGVLEGALGPHVVTNLYLYPIKSCAAFEV 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     394 TRWPVGNQGLLYDRSWMVVNHNGVCLSQKQEPRLCLIQPFIDLRQRIMVI 443                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 TRWPVGNQGLLYDRSWMVVNHNGVCLSQKQEPRLCLIQPFIDLRQRIMVI 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     444 KAKGMEPIEVPLEENSERTQIRQSRVCADRVSTYDCGEKISSWLSTFFGR 493                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 KAKGMEPIEVPLEENSERTQIRQSRVCADRVSTYDCGEKISSWLSTFFGR 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     494 PCHLIKQSSNSQRNAKKKHGKDQLPGTMATLSLVNEAQYLLINTSSILEL 543                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 PCHLIKQSSNSQRNAKKKHGKDQLPGTMATLSLVNEAQYLLINTSSILEL 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     544 HRQLNTSDENGKEELFSLKDLSLRFRANIIINGKRAFEEEKWDEISIGSL 593                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 HRQLNTSDENGKEELFSLKDLSLRFRANIIINGKRAFEEEKWDEISIGSL 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     594 RFQVLGPCHRCQMICIDQQTGQRNQHVFQKLSESRETKVNFGMYLMHASL 643                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 RFQVLGPCHRCQMICIDQQTGQRNQHVFQKLSESRETKVNFGMYLMHASL 850                                                          
						                                                            	                  .         .         .                      
						                                                            	     644 DLSSPCFLSVGSQVLPVLKENVEGHDLPASEKHQDVTS             681                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     851 DLSSPCFLSVGSQVLPVLKENVEGHDLPASEKHQDVTS             888                                                          

						Comparison report between AA689476_P3 and Q9NWM7unique head  	Sequence name: Q9NWM7                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a mismatch.1.An isolated chimeric polypeptide encoding for   	Sequence documentation:                                      
						AA689476_P3, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 24429 x Q9NWM7   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence LDGLAGA      	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 7 of AA689476_P3, a second  	                                                            
						MAGAAAESGRELWTFAGSRDPSAPRLAYGYGPGSLRELRAREFSRLAGTVYLDHAGATLF 	                     Quality: 6513.00                      Escore:       0                                               
						SQSQLESFTSDLMENTYGNPHSQNISSKLTHDTVEQVRY                      	             Matching length:     674                Total length:     888                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.85                                               
						corresponding to amino acids 1 - 99 of Q9NWM7, which also    	    Total Percent Similarity:   75.90      Total Percent Identity:   75.79                                               
						corresponds to amino acids 8 - 106 of AA689476_P3, a third   	                        Gaps:       1                        
						RFEDGTISFLDVIALKHGFDTLERLTGGMENIKQHTFTLAQYTYMALSSLQYPNGAPVVR 	                                                            
						IYSDSEFSSPEVQGPIINFNVLDDKGNIIGYSQVDKMASLYNIHLRTGCFCNTGACQRHL 	Alignment:                                                   
						GISNEMVRKHFQAGHVCGDNMDLIDGQPTGSVRISFGYMSTLDDVQAFLRFIIDTRLHSS 	                  .         .         .         .         .  
						GDWPVPQAHADTGETGAPSADSQADVIPAVMGRRSLSPQEDALTGSRVWNNSSTVNAVPV 	       8 MAGAAAESGRELWTFAGSRDPSAPRLAYGYGPGSLRELRAREFSRLAGTV 57                                                           
						APPVCDVARTQPTPSEKAAGVLEGALGPHVVTNLYLYPIKSCAAFEVTRWPVGNQGLLYD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RSWMVVNHNGVCLSQKQEPRLCLIQPFIDLRQRIMVIKAKGMEPIEVPLEENSERTQIRQ 	       1 MAGAAAESGRELWTFAGSRDPSAPRLAYGYGPGSLRELRAREFSRLAGTV 50                                                           
						SRVCADRVSTYDCGEKISSWLSTFFGRPC                                	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	      58 YLDHAGATLFSQSQLESFTSDLMENTYGNPHSQNISSKLTHDTVEQVRY. 106                                                          
						corresponding to amino acids 314 - 702 of Q9NWM7, which also 	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						corresponds to amino acids 107 - 495 of AA689476_P3, a       	      51 YLDHAGATLFSQSQLESFTSDLMENTYGNPHSQNISSKLTHDTVEQVRYR 100                                                          
						bridging amino acid H corresponding to amino acid 496 of     	                  .         .         .         .         .  
						AA689476_P3, and a fourth amino acid sequence being at least 	     106 .................................................. 106                                                          
						LIKQSSNSQRNAKKKHGKDQLPGTMATLSLVNEAQYLLINTSSILELHRQLNTSDENGKE 	                                                            
						ELFSLKDLSLRFRANIIINGKRAFEEEKWDEISIGSLRFQVLGPCHRCQMICIDQQTGQR 	     101 ILAHFHTTAEDYTVIFTAGSTAALKLVAEAFPWVSQGPESSGSRFCYLTD 150                                                          
						NQHVFQKLSESRETKVNFGMYLMHASLDLSSPCFLSVGSQVLPVLKENVEGHDLPASEKH 	                  .         .         .         .         .  
						QDVTS                                                        	     106 .................................................. 106                                                          
						90 % homologous to corresponding to amino acids 704 - 888 of 	                                                            
						Q9NWM7, which also corresponds to amino acids 497 - 681 of   	     151 SHTSVVGMRNVTMAINVISIPVRPEDLWSAEERGASASNPDCQLPHLFCY 200                                                          
						AA689476_P3, wherein said first amino acid sequence, second  	                  .         .         .         .         .  
						amino acid sequence, third amino acid sequence, bridging     	     106 .................................................. 106                                                          
						amino acid and fourth amino acid sequence are contiguous and 	                                                            
						in a sequential order.2.An isolated polypeptide encoding for 	     201 PAQSNFSGVRYPLSWIEEVKSGRLRPVSTPGKWFVLLDAASYVSTSPLDL 250                                                          
						a head of AA689476_P3, comprising a polypeptide being at     	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	     106 .................................................. 106                                                          
						about 85%, more preferably at least about 90% and most       	                                                            
						preferably at least about 95% homologous to the sequence     	     251 SAHQADFVPISFYKIFGFPTGLGALLVHNRAAPLLRKTYFGGGTASAYLA 300                                                          
						LDGLAGA of AA689476_P3.3.An isolated chimeric polypeptide    	                  .         .         .         .         .  
						encoding for an edge portion of AA689476_P3, comprising a    	     107 .............RFEDGTISFLDVIALKHGFDTLERLTGGMENIKQHTF 143                                                          
						polypeptide having a length "n", wherein n is at least about 	                      |||||||||||||||||||||||||||||||||||||  
						10 amino acids in length, optionally at least about 20 amino 	     301 GEDFYIPRQSVAQRFEDGTISFLDVIALKHGFDTLERLTGGMENIKQHTF 350                                                          
						acids in length, preferably at least about 30 amino acids in 	                  .         .         .         .         .  
						length, more preferably at least about 40 amino acids in     	     144 TLAQYTYMALSSLQYPNGAPVVRIYSDSEFSSPEVQGPIINFNVLDDKGN 193                                                          
						length and most preferably at least about 50 amino acids in  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, wherein at least two amino acids comprise YR, having 	     351 TLAQYTYMALSSLQYPNGAPVVRIYSDSEFSSPEVQGPIINFNVLDDKGN 400                                                          
						a structure as follows: a sequence starting from any of amino	                  .         .         .         .         .  
						acid numbers 106-x to 107; and ending at any of amino acid   	     194 IIGYSQVDKMASLYNIHLRTGCFCNTGACQRHLGISNEMVRKHFQAGHVC 243                                                          
						numbers 107+ ((n-2) - x), in which x varies from 0 to n-2.   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 IIGYSQVDKMASLYNIHLRTGCFCNTGACQRHLGISNEMVRKHFQAGHVC 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     244 GDNMDLIDGQPTGSVRISFGYMSTLDDVQAFLRFIIDTRLHSSGDWPVPQ 293                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 GDNMDLIDGQPTGSVRISFGYMSTLDDVQAFLRFIIDTRLHSSGDWPVPQ 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     294 AHADTGETGAPSADSQADVIPAVMGRRSLSPQEDALTGSRVWNNSSTVNA 343                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 AHADTGETGAPSADSQADVIPAVMGRRSLSPQEDALTGSRVWNNSSTVNA 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     344 VPVAPPVCDVARTQPTPSEKAAGVLEGALGPHVVTNLYLYPIKSCAAFEV 393                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 VPVAPPVCDVARTQPTPSEKAAGVLEGALGPHVVTNLYLYPIKSCAAFEV 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     394 TRWPVGNQGLLYDRSWMVVNHNGVCLSQKQEPRLCLIQPFIDLRQRIMVI 443                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 TRWPVGNQGLLYDRSWMVVNHNGVCLSQKQEPRLCLIQPFIDLRQRIMVI 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     444 KAKGMEPIEVPLEENSERTQIRQSRVCADRVSTYDCGEKISSWLSTFFGR 493                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 KAKGMEPIEVPLEENSERTQIRQSRVCADRVSTYDCGEKISSWLSTFFGR 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     494 PCHLIKQSSNSQRNAKKKHGKDQLPGTMATLSLVNEAQYLLINTSSILEL 543                                                          
						                                                            	         ||:|||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 PCNLIKQSSNSQRNAKKKHGKDQLPGTMATLSLVNEAQYLLINTSSILEL 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     544 HRQLNTSDENGKEELFSLKDLSLRFRANIIINGKRAFEEEKWDEISIGSL 593                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 HRQLNTSDENGKEELFSLKDLSLRFRANIIINGKRAFEEEKWDEISIGSL 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     594 RFQVLGPCHRCQMICIDQQTGQRNQHVFQKLSESRETKVNFGMYLMHASL 643                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 RFQVLGPCHRCQMICIDQQTGQRNQHVFQKLSESRETKVNFGMYLMHASL 850                                                          
						                                                            	                  .         .         .                      
						                                                            	     644 DLSSPCFLSVGSQVLPVLKENVEGHDLPASEKHQDVTS             681                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||              
						                                                            	     851 DLSSPCFLSVGSQVLPVLKENVEGHDLPASEKHQDVTS             888                                                          

						Comparison report between AA689476_P3 and Q8N3A4unique head  	Sequence name: Q8N3A4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA689476_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 24429 x Q8N3A4   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						LDGLAGAMAGAAAESGRELWTFAGSRDPSAPRLAYGYGPGSLRELRAREFSRLAGTVYLD 	Alignment segment 1/1:                                       
						HAGATLFSQSQLESFTSDLMENTYGNPHSQNISSKLTHDTVEQVRY               	                                                            
						having the sequence corresponding to amino acids 1 - 106 of  	                     Quality: 5666.00                      Escore:       0                                               
						AA689476_P3, and a second amino acid sequence being at least 	             Matching length:     578                Total length:     578                                               
						RFEDGTISFLDVIALKHGFDTLERLTGGMENIKQHTFTLAQYTYMALSSLQYPNGAPVVR 	 Matching Percent Similarity:   99.65   Matching Percent Identity:   99.65                                               
						IYSDSEFSSPEVQGPIINFNVLDDKGNIIGYSQVDKMASLYNIHLRTGCFCNTGACQRHL 	    Total Percent Similarity:   99.65      Total Percent Identity:   99.65                                               
						GISNEMVRKHFQAGHVCGDNMDLIDGQPTGSVRISFGYMSTLDDVQAFLRFIIDTRLHSS 	                        Gaps:       0                        
						GDWPVPQAHADTGETGAPSADSQADVIPAVMGRRSLSPQEDALTGSRVWNNSSTVNAVPV 	                                                            
						APPVCDVARTQPTPSEKAAGVLEGALGPHVVTNLYLYPIKSCAAFEVTRWPVGNQGLLYD 	Alignment:                                                   
						RSWMVVNHNGVCLSQKQEPRLCLIQPFIDLRQRIMVIKAKGMEPIEVPLEENSERTQIRQ 	                  .         .         .         .         .  
						SRVCADRVSTYDCGEKISSWLSTFFGRPCHLIKQSSNSQRNAKKKHGKDQLPGTMATLSL 	     104 VRYRFEDGTISFLDVIALKHGFDTLERLTGGMENIKQHTFTLAQYTYMAL 153                                                          
						VNEAQYLLINTSSILELHRQLNTSDENGKEELFSLKDLSLRFRANIIINGKRAFEEEKWD 	         |  |||||||||||||||||||||||||||||||||||||||||||||||  
						EISIGSLRFQVLGPCHRCQMICIDQQTGQRNQHVFQKLSESRETKVNFGMYLMHASLDLS 	     217 VAQRFEDGTISFLDVIALKHGFDTLERLTGGMENIKQHTFTLAQYTYMAL 266                                                          
						SPCFLSVGSQVLPVLKENVEGHDLPASEKHQDVTS                          	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 220 - 794 of 	     154 SSLQYPNGAPVVRIYSDSEFSSPEVQGPIINFNVLDDKGNIIGYSQVDKM 203                                                          
						Q8N3A4, which also corresponds to amino acids 107 - 681 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA689476_P3, wherein said first amino acid sequence and      	     267 SSLQYPNGAPVVRIYSDSEFSSPEVQGPIINFNVLDDKGNIIGYSQVDKM 316                                                          
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     204 ASLYNIHLRTGCFCNTGACQRHLGISNEMVRKHFQAGHVCGDNMDLIDGQ 253                                                          
						AA689476_P3, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     317 ASLYNIHLRTGCFCNTGACQRHLGISNEMVRKHFQAGHVCGDNMDLIDGQ 366                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						LDGLAGAMAGAAAESGRELWTFAGSRDPSAPRLAYGYGPGSLRELRAREFSRLAGTVYLD 	     254 PTGSVRISFGYMSTLDDVQAFLRFIIDTRLHSSGDWPVPQAHADTGETGA 303                                                          
						HAGATLFSQSQLESFTSDLMENTYGNPHSQNISSKLTHDTVEQVRY               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of AA689476_P3.   	     367 PTGSVRISFGYMSTLDDVQAFLRFIIDTRLHSSGDWPVPQAHADTGETGA 416                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     304 PSADSQADVIPAVMGRRSLSPQEDALTGSRVWNNSSTVNAVPVAPPVCDV 353                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     417 PSADSQADVIPAVMGRRSLSPQEDALTGSRVWNNSSTVNAVPVAPPVCDV 466                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     354 ARTQPTPSEKAAGVLEGALGPHVVTNLYLYPIKSCAAFEVTRWPVGNQGL 403                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     467 ARTQPTPSEKAAGVLEGALGPHVVTNLYLYPIKSCAAFEVTRWPVGNQGL 516                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     404 LYDRSWMVVNHNGVCLSQKQEPRLCLIQPFIDLRQRIMVIKAKGMEPIEV 453                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     517 LYDRSWMVVNHNGVCLSQKQEPRLCLIQPFIDLRQRIMVIKAKGMEPIEV 566                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     454 PLEENSERTQIRQSRVCADRVSTYDCGEKISSWLSTFFGRPCHLIKQSSN 503                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     567 PLEENSERTQIRQSRVCADRVSTYDCGEKISSWLSTFFGRPCHLIKQSSN 616                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     504 SQRNAKKKHGKDQLPGTMATLSLVNEAQYLLINTSSILELHRQLNTSDEN 553                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     617 SQRNAKKKHGKDQLPGTMATLSLVNEAQYLLINTSSILELHRQLNTSDEN 666                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     554 GKEELFSLKDLSLRFRANIIINGKRAFEEEKWDEISIGSLRFQVLGPCHR 603                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     667 GKEELFSLKDLSLRFRANIIINGKRAFEEEKWDEISIGSLRFQVLGPCHR 716                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     604 CQMICIDQQTGQRNQHVFQKLSESRETKVNFGMYLMHASLDLSSPCFLSV 653                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     717 CQMICIDQQTGQRNQHVFQKLSESRETKVNFGMYLMHASLDLSSPCFLSV 766                                                          
						                                                            	                  .         .                                
						                                                            	     654 GSQVLPVLKENVEGHDLPASEKHQDVTS                       681                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     767 GSQVLPVLKENVEGHDLPASEKHQDVTS                       794                                                          

28482	HMR136_AA705893_11_tr0_r1_1_gPRT		Comparison report between AA705893_P11 and Q9Y4Q0unique head 	Sequence name: Q9Y4Q0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA705893_P11, comprising a first amino acid sequence being at	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 28482 x Q9Y4Q0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						HLWLEGCRLAPCSPLCPLLP corresponding to amino acids 1 - 20 of  	                                                            
						AA705893_P11, a second amino acid sequence being at least 90 	                     Quality: 4919.00                      Escore:       0                                               
						STILVEPGCQAEVTKTGDICISVGAEVPGTVGPQLDPIQLSIFSHRFMSIAEQMGRILQR 	             Matching length:     510                Total length:     510                                               
						TAISTNIKERLDFSCALFGPDGGLVSNAPHIPVHLGAMQETVQFQIQHLGADLHPGDVLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SNHPSAGGSHLPDLTVITPVFWPGQTRPVFYVASRGHHADIGGITPGSMPPHSTMLQQEG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						AVFLSFKLVQGGVFQEEAVTEALRAPGKVPNCSGTRNLHDNLSDLRAQVAANQKGIQLVG 	                        Gaps:       0                        
						ELIGQYGLDVVQAYMGHIQANAELAVRDMLRAFGTSRQARGLPLEVSSEDHMDDGSPIRL 	                                                            
						RVQISLSQGSAVFDFSGTGPEVFGNLNAPRAVTLSALIYCLRCLVGRDIPLNQGCLAPVR 	Alignment:                                                   
						VVIPRGSILDPSPEAAVVGGNVLTSQRVVDVILGAFGACAASQGCMNNVTLGNAHMGYYE 	                  .         .         .         .         .  
						TVAGGAGAGPSWHGRSGVHSHMTNTRITDPEILESRYPVILRRFELRRGSGGRGRFRGGD 	      21 STILVEPGCQAEVTKTGDICISVGAEVPGTVGPQLDPIQLSIFSHRFMSI 70                                                           
						GVTRELLFREEALLSVLTERRAFRPYGLHG                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 299 - 808 of    	     299 STILVEPGCQAEVTKTGDICISVGAEVPGTVGPQLDPIQLSIFSHRFMSI 348                                                          
						Q9Y4Q0, which also corresponds to amino acids 21 - 530 of    	                  .         .         .         .         .  
						AA705893_P11, and a third amino acid sequence being at least 	      71 AEQMGRILQRTAISTNIKERLDFSCALFGPDGGLVSNAPHIPVHLGAMQE 120                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	     349 AEQMGRILQRTAISTNIKERLDFSCALFGPDGGLVSNAPHIPVHLGAMQE 398                                                          
						GEPGARGLNLLIRKNGRTVNLGGKTSVTVYPGDVFCLHTPGGGGYGDPEDPAPPPGSPPQ 	                  .         .         .         .         .  
						ALAFPEHGSVYEYRRAQEAV                                         	     121 TVQFQIQHLGADLHPGDVLLSNHPSAGGSHLPDLTVITPVFWPGQTRPVF 170                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 531 - 610 of AA705893_P11, wherein said first 	     399 TVQFQIQHLGADLHPGDVLLSNHPSAGGSHLPDLTVITPVFWPGQTRPVF 448                                                          
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     171 YVASRGHHADIGGITPGSMPPHSTMLQQEGAVFLSFKLVQGGVFQEEAVT 220                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA705893_P11, comprising a polypeptide being at least 70%,   	     449 YVASRGHHADIGGITPGSMPPHSTMLQQEGAVFLSFKLVQGGVFQEEAVT 498                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     221 EALRAPGKVPNCSGTRNLHDNLSDLRAQVAANQKGIQLVGELIGQYGLDV 270                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HLWLEGCRLAPCSPLCPLLP of AA705893_P11.3.An isolated           	     499 EALRAPGKVPNCSGTRNLHDNLSDLRAQVAANQKGIQLVGELIGQYGLDV 548                                                          
						polypeptide encoding for a tail of AA705893_P11, comprising a	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     271 VQAYMGHIQANAELAVRDMLRAFGTSRQARGLPLEVSSEDHMDDGSPIRL 320                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     549 VQAYMGHIQANAELAVRDMLRAFGTSRQARGLPLEVSSEDHMDDGSPIRL 598                                                          
						GEPGARGLNLLIRKNGRTVNLGGKTSVTVYPGDVFCLHTPGGGGYGDPEDPAPPPGSPPQ 	                  .         .         .         .         .  
						ALAFPEHGSVYEYRRAQEAV                                         	     321 RVQISLSQGSAVFDFSGTGPEVFGNLNAPRAVTLSALIYCLRCLVGRDIP 370                                                          
						to the sequence in AA705893_P11.                             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     599 RVQISLSQGSAVFDFSGTGPEVFGNLNAPRAVTLSALIYCLRCLVGRDIP 648                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     371 LNQGCLAPVRVVIPRGSILDPSPEAAVVGGNVLTSQRVVDVILGAFGACA 420                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     649 LNQGCLAPVRVVIPRGSILDPSPEAAVVGGNVLTSQRVVDVILGAFGACA 698                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     421 ASQGCMNNVTLGNAHMGYYETVAGGAGAGPSWHGRSGVHSHMTNTRITDP 470                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     699 ASQGCMNNVTLGNAHMGYYETVAGGAGAGPSWHGRSGVHSHMTNTRITDP 748                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     471 EILESRYPVILRRFELRRGSGGRGRFRGGDGVTRELLFREEALLSVLTER 520                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     749 EILESRYPVILRRFELRRGSGGRGRFRGGDGVTRELLFREEALLSVLTER 798                                                          
						                                                            	                  .                                          
						                                                            	     521 RAFRPYGLHG                                         530                                                          
						                                                            	         ||||||||||                                          
						                                                            	     799 RAFRPYGLHG                                         808                                                          

28470	HMR136_AA705893_12_tr0_r1_1_gPRT		Comparison report between AA705893_P12 and Q9Y4Q0partial WT  	Sequence name: Q9Y4Q0                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA705893_P12, comprising a first    	Sequence documentation:                                      
						MPPHSTMLQQEGAVFLSFKLVQGGVFQEEAVTEALRAPGKVPNCSGTRNLHDNLSDLRAQ 	                                                            
						VAANQKGIQLVGELIGQYGLDVVQAYMGHIQANAELAVRDMLRAFGTSRQARGLPLEVSS 	Alignment of: 28470 x Q9Y4Q0   ..                            
						EDHMDDGSPIRLRVQISLSQGSAVFDFSGTGPEVFGNLNAPRAVTLSALIYCLRCLVGRD 	                                                            
						IPLNQGCLAPVRVVIPRGSILDPSPEAAVVGGNVLTSQRVVDVILGAFGACAASQGCMNN 	Alignment segment 1/1:                                       
						VTLGNAHMGYYETVAGGAGAGPSWHGRSGVHSHMTNTRITDPEILESRYPVILRRFELRR 	                                                            
						GSGGRGRFRGGDGVTRELLFREEALLSVLTERRAFRPYGLHG                   	                     Quality: 3284.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     342                Total length:     342                                               
						corresponding to amino acids 467 - 808 of Q9Y4Q0, which also 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 342 of AA705893_P12, and a    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						GEPGARGLNLLIRKNGRTVNLGGKTSVTVYPGDVFCLHTPGGGGYGDPEDPAPPPGSPPQ 	                  .         .         .         .         .  
						ALAFPEHGSVYEYRRAQEAV                                         	       1 MPPHSTMLQQEGAVFLSFKLVQGGVFQEEAVTEALRAPGKVPNCSGTRNL 50                                                           
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						343 - 422 of AA705893_P12, wherein said first amino acid     	     467 MPPHSTMLQQEGAVFLSFKLVQGGVFQEEAVTEALRAPGKVPNCSGTRNL 516                                                          
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	      51 HDNLSDLRAQVAANQKGIQLVGELIGQYGLDVVQAYMGHIQANAELAVRD 100                                                          
						tail of AA705893_P12, comprising a polypeptide being at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     517 HDNLSDLRAQVAANQKGIQLVGELIGQYGLDVVQAYMGHIQANAELAVRD 566                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						GEPGARGLNLLIRKNGRTVNLGGKTSVTVYPGDVFCLHTPGGGGYGDPEDPAPPPGSPPQ 	     101 MLRAFGTSRQARGLPLEVSSEDHMDDGSPIRLRVQISLSQGSAVFDFSGT 150                                                          
						ALAFPEHGSVYEYRRAQEAV                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence in             	     567 MLRAFGTSRQARGLPLEVSSEDHMDDGSPIRLRVQISLSQGSAVFDFSGT 616                                                          
						AA705893_P12.                                                	                  .         .         .         .         .  
						                                                            	     151 GPEVFGNLNAPRAVTLSALIYCLRCLVGRDIPLNQGCLAPVRVVIPRGSI 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     617 GPEVFGNLNAPRAVTLSALIYCLRCLVGRDIPLNQGCLAPVRVVIPRGSI 666                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LDPSPEAAVVGGNVLTSQRVVDVILGAFGACAASQGCMNNVTLGNAHMGY 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     667 LDPSPEAAVVGGNVLTSQRVVDVILGAFGACAASQGCMNNVTLGNAHMGY 716                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 YETVAGGAGAGPSWHGRSGVHSHMTNTRITDPEILESRYPVILRRFELRR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     717 YETVAGGAGAGPSWHGRSGVHSHMTNTRITDPEILESRYPVILRRFELRR 766                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 GSGGRGRFRGGDGVTRELLFREEALLSVLTERRAFRPYGLHG         342                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     767 GSGGRGRFRGGDGVTRELLFREEALLSVLTERRAFRPYGLHG         808                                                          

28480	HMR136_AA705893_9_tr0_r1_1_gPRT		Comparison report between AA705893_P9 and Q9Y4Q0partial WT   	Sequence name: Q9Y4Q0                                        
						sequence featuring skipped exon plus extra amino acids.1.An  	                                                            
						isolated chimeric polypeptide encoding for AA705893_P9,      	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MLGNSSTSSRPAQLASPSRPRSWTSTPWQREGVPASSSGLASLWLGPSQQEPTQDPPATA 	Alignment of: 28480 x Q9Y4Q0   ..                            
						KVRVRIWPAWPCPPLAAAGPAPPVSPIPAAYSCSPASSPQAPHPVHLPGGPVTVTDANLV 	                                                            
						LGRLLPASFPCIFGPGENQPLSPEASRKALEAVATEVNSFLTNGPCPASPLSLEEVAMGF 	Alignment segment 1/1:                                       
						VRVANEAMCRPIRALTQVRPPLLSRLSCPQP                              	                                                            
						homologous to corresponding to amino acids 1 - 211 of Q9Y4Q0,	                     Quality: 8115.00                      Escore:       0                                               
						which also corresponds to amino acids 1 - 211 of AA705893_P9,	             Matching length:     841                Total length:     845                                               
						a second amino acid sequence bridging amino acid sequence    	 Matching Percent Similarity:   99.88   Matching Percent Identity:   99.88                                               
						comprising of Y, and a third amino acid sequence being at    	    Total Percent Similarity:   99.41      Total Percent Identity:   99.41                                               
						MREFGFVIPERPVVVDDVRVRGTGRSGLRLEDAPKAQTGPPRVDKMTQCYFEGGYQETPV 	                        Gaps:       1                        
						YLLAELGYGHKLHGPCLIIDSNSTILVEPGCQAEVTKTGDICISVGAEVPGTVGPQLDPI 	                                                            
						QLSIFSHRFMSIAEQMGRILQRTAISTNIKERLDFSCALFGPDGGLVSNAPHIPVHLGAM 	Alignment:                                                   
						QETVQFQIQHLGADLHPGDVLLSNHPSAGGSHLPDLTVITPVFWPGQTRPVFYVASRGHH 	                  .         .         .         .         .  
						ADIGGITPGSMPPHSTMLQQEGAVFLSFKLVQGGVFQEEAVTEALRAPGKVPNCSGTRNL 	       1 MLGNSSTSSRPAQLASPSRPRSWTSTPWQREGVPASSSGLASLWLGPSQQ 50                                                           
						HDNLSDLRAQVAANQKGIQLVGELIGQYGLDVVQAYMGHIQANAELAVRDMLRAFGTSRQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ARGLPLEVSSEDHMDDGSPIRLRVQISLSQGSAVFDFSGTGPEVFGNLNAPRAVTLSALI 	       1 MLGNSSTSSRPAQLASPSRPRSWTSTPWQREGVPASSSGLASLWLGPSQQ 50                                                           
						YCLRCLVGRDIPLNQGCLAPVRVVIPRGSILDPSPEAAVVGGNVLTSQRVVDVILGAFGA 	                  .         .         .         .         .  
						CAASQGCMNNVTLGNAHMGYYETVAGGAGAGPSWHGRSGVHSHMTNTRITDPEILESRYP 	      51 EPTQDPPATAKVRVRIWPAWPCPPLAAAGPAPPVSPIPAAYSCSPASSPQ 100                                                          
						VILRRFELRRGSGGRGRFRGGDGVTRELLFREEALLSVLTERRAFRPYGLHGARFPSPRG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPRPRPHPRPWSLWTPRLPPQGASLAPAA                                	      51 EPTQDPPATAKVRVRIWPAWPCPPLAAAGPAPPVSPIPAAYSCSPASSPQ 100                                                          
						least 90 % homologous to corresponding to amino acids 217 -  	                  .         .         .         .         .  
						845 of Q9Y4Q0, which also corresponds to amino acids 213 -   	     101 APHPVHLPGGPVTVTDANLVLGRLLPASFPCIFGPGENQPLSPEASRKAL 150                                                          
						841 of AA705893_P9, wherein said first amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence and third amino acid sequence are 	     101 APHPVHLPGGPVTVTDANLVLGRLLPASFPCIFGPGENQPLSPEASRKAL 150                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of AA705893_P9,     	     151 EAVATEVNSFLTNGPCPASPLSLEEVAMGFVRVANEAMCRPIRALTQVRP 200                                                          
						comprising a polypeptide having a length "n", wherein n is at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 10 amino acids in length, optionally at least    	     151 EAVATEVNSFLTNGPCPASPLSLEEVAMGFVRVANEAMCRPIRALTQVRP 200                                                          
						about 20 amino acids in length, preferably at least about 30 	                  .         .         .         .         .  
						amino acids in length, more preferably at least about 40     	     201 PLLSRLSCPQPY....MREFGFVIPERPVVVDDVRVRGTGRSGLRLEDAP 246                                                          
						amino acids in length and most preferably at least about 50  	         |||||||||||     ||||||||||||||||||||||||||||||||||  
						amino acids in length, wherein at least two amino acids      	     201 PLLSRLSCPQPLWSGTMREFGFVIPERPVVVDDVRVRGTGRSGLRLEDAP 250                                                          
						comprise PYM having a structure as follows (numbering        	                  .         .         .         .         .  
						according to AA705893_P9): a sequence starting from any of   	     247 KAQTGPPRVDKMTQCYFEGGYQETPVYLLAELGYGHKLHGPCLIIDSNST 296                                                          
						amino acid numbers 211-x to 211; and ending at any of amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid numbers 213 + ((n-2) - x), in which x varies from 0 to  	     251 KAQTGPPRVDKMTQCYFEGGYQETPVYLLAELGYGHKLHGPCLIIDSNST 300                                                          
						n-2.                                                         	                  .         .         .         .         .  
						                                                            	     297 ILVEPGCQAEVTKTGDICISVGAEVPGTVGPQLDPIQLSIFSHRFMSIAE 346                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 ILVEPGCQAEVTKTGDICISVGAEVPGTVGPQLDPIQLSIFSHRFMSIAE 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     347 QMGRILQRTAISTNIKERLDFSCALFGPDGGLVSNAPHIPVHLGAMQETV 396                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 QMGRILQRTAISTNIKERLDFSCALFGPDGGLVSNAPHIPVHLGAMQETV 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     397 QFQIQHLGADLHPGDVLLSNHPSAGGSHLPDLTVITPVFWPGQTRPVFYV 446                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 QFQIQHLGADLHPGDVLLSNHPSAGGSHLPDLTVITPVFWPGQTRPVFYV 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     447 ASRGHHADIGGITPGSMPPHSTMLQQEGAVFLSFKLVQGGVFQEEAVTEA 496                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 ASRGHHADIGGITPGSMPPHSTMLQQEGAVFLSFKLVQGGVFQEEAVTEA 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     497 LRAPGKVPNCSGTRNLHDNLSDLRAQVAANQKGIQLVGELIGQYGLDVVQ 546                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 LRAPGKVPNCSGTRNLHDNLSDLRAQVAANQKGIQLVGELIGQYGLDVVQ 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     547 AYMGHIQANAELAVRDMLRAFGTSRQARGLPLEVSSEDHMDDGSPIRLRV 596                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 AYMGHIQANAELAVRDMLRAFGTSRQARGLPLEVSSEDHMDDGSPIRLRV 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     597 QISLSQGSAVFDFSGTGPEVFGNLNAPRAVTLSALIYCLRCLVGRDIPLN 646                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 QISLSQGSAVFDFSGTGPEVFGNLNAPRAVTLSALIYCLRCLVGRDIPLN 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     647 QGCLAPVRVVIPRGSILDPSPEAAVVGGNVLTSQRVVDVILGAFGACAAS 696                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 QGCLAPVRVVIPRGSILDPSPEAAVVGGNVLTSQRVVDVILGAFGACAAS 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     697 QGCMNNVTLGNAHMGYYETVAGGAGAGPSWHGRSGVHSHMTNTRITDPEI 746                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 QGCMNNVTLGNAHMGYYETVAGGAGAGPSWHGRSGVHSHMTNTRITDPEI 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     747 LESRYPVILRRFELRRGSGGRGRFRGGDGVTRELLFREEALLSVLTERRA 796                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 LESRYPVILRRFELRRGSGGRGRFRGGDGVTRELLFREEALLSVLTERRA 800                                                          
						                                                            	                  .         .         .         .            
						                                                            	     797 FRPYGLHGARFPSPRGPPRPRPHPRPWSLWTPRLPPQGASLAPAA      841                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     801 FRPYGLHGARFPSPRGPPRPRPHPRPWSLWTPRLPPQGASLAPAA      845                                                          

14017	HMR136_AA731827_2_tr0_r1_1_gPRT		Comparison report between AA731827_P2 and Q8N158partial WT   	Sequence name: Q8N158                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA731827_P2, comprising a first amino acid      	                                                            
						MRLIGCPLCRGVPSLMPCQGFCLNVVRGCLSSRGLEPDWGNYLDGLLILADKLQGPFSFE 	Alignment of: 14017 x Q8N158   ..                            
						LTAESIGVKISEGLMYLQENSAKVSAQVFQECGPPDPVPARNRRAPPPREEAGRLWSMVT 	                                                            
						EEERPTTAAGTNLHRLVWELRERLARMRGFWARLSLTVCGDSRMAADASLEAAPCWTGAG 	Alignment segment 1/1:                                       
						RGRYLPPVVGGSPAEQVNNPELKVDASGPDVPTRRRRLQLRAATARMKTAALGHDLDGQD 	                                                            
						ADEDASGSGGGQQYADDWMAGAVAPPARPPRPPYPPRRDGSGGKGGGGSARYNQGRSRSG 	                     Quality: 3186.00                      Escore:       0                                               
						GASIGFHTQTILILSLSALALLGPR                                    	             Matching length:     325                Total length:     325                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acids 255 - 579 of Q8N158, which also corresponds to   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 1 - 325 of AA731827_P2.                          	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MRLIGCPLCRGVPSLMPCQGFCLNVVRGCLSSRGLEPDWGNYLDGLLILA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     255 MRLIGCPLCRGVPSLMPCQGFCLNVVRGCLSSRGLEPDWGNYLDGLLILA 304                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 DKLQGPFSFELTAESIGVKISEGLMYLQENSAKVSAQVFQECGPPDPVPA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     305 DKLQGPFSFELTAESIGVKISEGLMYLQENSAKVSAQVFQECGPPDPVPA 354                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RNRRAPPPREEAGRLWSMVTEEERPTTAAGTNLHRLVWELRERLARMRGF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     355 RNRRAPPPREEAGRLWSMVTEEERPTTAAGTNLHRLVWELRERLARMRGF 404                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 WARLSLTVCGDSRMAADASLEAAPCWTGAGRGRYLPPVVGGSPAEQVNNP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     405 WARLSLTVCGDSRMAADASLEAAPCWTGAGRGRYLPPVVGGSPAEQVNNP 454                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 ELKVDASGPDVPTRRRRLQLRAATARMKTAALGHDLDGQDADEDASGSGG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     455 ELKVDASGPDVPTRRRRLQLRAATARMKTAALGHDLDGQDADEDASGSGG 504                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 GQQYADDWMAGAVAPPARPPRPPYPPRRDGSGGKGGGGSARYNQGRSRSG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     505 GQQYADDWMAGAVAPPARPPRPPYPPRRDGSGGKGGGGSARYNQGRSRSG 554                                                          
						                                                            	                  .         .                                
						                                                            	     301 GASIGFHTQTILILSLSALALLGPR                          325                                                          
						                                                            	         |||||||||||||||||||||||||                           
						                                                            	     555 GASIGFHTQTILILSLSALALLGPR                          579                                                          

15897	HMR136_AA737811_5_tr0_r1_1_gPRT		Comparison report between AA737811_P5 and Q8N5R6unique head  	Sequence name: Q8N5R6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA737811_P5, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15897 x Q8N5R6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MWRSKLRMQGKK 	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 12 of AA737811_P5, a second 	                                                            
						IFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITPLSFPIPSMMNFD 	                     Quality: 5517.00                      Escore:       0                                               
						VPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFSEDTALVLEYYSSTSMKGSQP 	             Matching length:     565                Total length:     565                                               
						WTLNQPLGISVLPLKSRLYQKMLTGKGLDGLHVERLPIMDTSLKTINDEAPTVALSFQLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SSERPENFLTPNNSKALPTLDPKILDKKLRTIQESWSKDTVSSTMDLSTSTPREAEEEPL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VPEMSHDTEMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKASEA 	                        Gaps:       0                        
						QNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQAQQPQAALLKQYQG 	                                                            
						KLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPPPLNRQQGKPYTGFPMLSASGLPL 	Alignment:                                                   
						GSMGENLPVELYSVLLAENAKLRTELDKNRHQQAPIILQQQALPVDPGELGAGGDLTERL 	                  .         .         .         .         .  
						QETHGPGHSECTETLPAQDLLSGTSDKFNLLAKLEHAQSRILSLESQLEDSARRWGREKQ 	      13 IFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITPLS 62                                                           
						DLATRLQEQEKGFRHPSNSIIIEQP                                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	      63 IFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITPLS 112                                                          
						corresponding to amino acids 63 - 627 of Q8N5R6, which also  	                  .         .         .         .         .  
						corresponds to amino acids 13 - 577 of AA737811_P5, and a    	      63 FPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFS 112                                                          
						third amino acid sequence being at least 70%, optionally at  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	     113 FPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFS 162                                                          
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence VSDPPGVAPRGSGGGAGSHRTPKVTGP  	     113 EDTALVLEYYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDG 162                                                          
						corresponding to amino acids 578 - 604 of AA737811_P5,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	     163 EDTALVLEYYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDG 212                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     163 LHVERLPIMDTSLKTINDEAPTVALSFQLLSSERPENFLTPNNSKALPTL 212                                                          
						head of AA737811_P5, comprising a polypeptide being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     213 LHVERLPIMDTSLKTINDEAPTVALSFQLLSSERPENFLTPNNSKALPTL 262                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence MWRSKLRMQGKK of	     213 DPKILDKKLRTIQESWSKDTVSSTMDLSTSTPREAEEEPLVPEMSHDTEM 262                                                          
						AA737811_P5.3.An isolated polypeptide encoding for a tail of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA737811_P5, comprising a polypeptide being at least 70%,    	     263 DPKILDKKLRTIQESWSKDTVSSTMDLSTSTPREAEEEPLVPEMSHDTEM 312                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     263 NNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKASEA 312                                                          
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VSDPPGVAPRGSGGGAGSHRTPKVTGP in AA737811_P5.                  	     313 NNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKASEA 362                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     313 QNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQAQQP 362                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     363 QNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQAQQP 412                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     363 QAALLKQYQGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPPPLN 412                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     413 QAALLKQYQGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPPPLN 462                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     413 RQQGKPYTGFPMLSASGLPLGSMGENLPVELYSVLLAENAKLRTELDKNR 462                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     463 RQQGKPYTGFPMLSASGLPLGSMGENLPVELYSVLLAENAKLRTELDKNR 512                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     463 HQQAPIILQQQALPVDPGELGAGGDLTERLQETHGPGHSECTETLPAQDL 512                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     513 HQQAPIILQQQALPVDPGELGAGGDLTERLQETHGPGHSECTETLPAQDL 562                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     513 LSGTSDKFNLLAKLEHAQSRILSLESQLEDSARRWGREKQDLATRLQEQE 562                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     563 LSGTSDKFNLLAKLEHAQSRILSLESQLEDSARRWGREKQDLATRLQEQE 612                                                          
						                                                            	                  .                                          
						                                                            	     563 KGFRHPSNSIIIEQP                                    577                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     613 KGFRHPSNSIIIEQP                                    627                                                          

						Comparison report between AA737811_P5 and Q9H5Q6unique head  	Sequence name: Q9H5Q6                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique insertion.1.An isolated chimeric polypeptide        	Sequence documentation:                                      
						encoding for AA737811_P5, comprising a first amino acid      	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 15897 x Q9H5Q6   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						MWRSKLRMQGKKIFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITP 	                                                            
						LSFPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFSEDTALVLE 	                     Quality: 2905.00                      Escore:       0                                               
						YYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDGLHVERLPIMDTSLKTIND 	             Matching length:     311                Total length:     345                                               
						EAPTVALSFQLLSSERPENFLTPNNSKALPTLDPKILDKKLRTIQESWSKDTVSSTMDLS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.36                                               
						TSTPREAEEEPLVPEMSHDT                                         	    Total Percent Similarity:   90.14      Total Percent Identity:   89.57                                               
						having the sequence corresponding to amino acids 1 - 260 of  	                        Gaps:       1                        
						AA737811_P5, a second amino acid sequence being at least 90 %	                                                            
						homologous to                                                	Alignment:                                                   
						EMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKA            	                  .         .         .         .         .  
						corresponding to amino acids 24 - 72 of Q9H5Q6, which also   	     260 TEMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKA 309                                                          
						corresponds to amino acids 261 - 309 of AA737811_P5, a       	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						bridging amino acid S corresponding to amino acid 310 of     	      23 SEMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKA 72                                                           
						AA737811_P5, a third amino acid sequence being at least 90 % 	                  .         .         .         .         .  
						EAQNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQAQQPQAALLKQY 	     310 SEAQNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQA 359                                                          
						QGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPPPLNRQQGKPYTGFPMLSASGL 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						PLGSMGENLPVELYSVLLAENAKLRTELDKNRHQQAPIILQQQALP               	      73 NEAQNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQA 122                                                          
						homologous to corresponding to amino acids 74 - 239 of       	                  .         .         .         .         .  
						Q9H5Q6, which also corresponds to amino acids 311 - 476 of   	     360 QQPQAALLKQYQGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPP 409                                                          
						AA737811_P5, a fourth amino acid sequence being at least 70%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least 80%, preferably at least 85%, more       	     123 QQPQAALLKQYQGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPP 172                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     410 PLNRQQGKPYTGFPMLSASGLPLGSMGENLPVELYSVLLAENAKLRTELD 459                                                          
						VDPGELGAGGDLTERLQETHGPGHSECTETLPAQ corresponding to amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 477 - 510 of AA737811_P5, and a fifth amino acid       	     173 PLNRQQGKPYTGFPMLSASGLPLGSMGENLPVELYSVLLAENAKLRTELD 222                                                          
						DLLSGTSDKFNLLAKLEHAQSRILSLESQLEDSARRWGREKQDLATRLQEQEKGFRHPSN 	                  .         .         .         .         .  
						SIIIEQPVSDPPGVAPRGSGGGAGSHRTPKVTGP                           	     460 KNRHQQAPIILQQQALPVDPGELGAGGDLTERLQETHGPGHSECTETLPA 509                                                          
						sequence being at least 90 % homologous to corresponding to  	         |||||||||||||||||                                   
						amino acids 240 - 333 of Q9H5Q6, which also corresponds to   	     223 KNRHQQAPIILQQQALP................................. 239                                                          
						amino acids 511 - 604 of AA737811_P5, wherein said first     	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence, bridging    	     510 QDLLSGTSDKFNLLAKLEHAQSRILSLESQLEDSARRWGREKQDLATRLQ 559                                                          
						amino acid, third amino acid sequence, fourth amino acid     	          |||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and fifth amino acid sequence are contiguous and in 	     240 .DLLSGTSDKFNLLAKLEHAQSRILSLESQLEDSARRWGREKQDLATRLQ 288                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .            
						head of AA737811_P5, comprising a polypeptide being at least 	     560 EQEKGFRHPSNSIIIEQPVSDPPGVAPRGSGGGAGSHRTPKVTGP      604                                                          
						70%, optionally at least about 80%, preferably at least about	         |||||||||||||||||||||||||||||||||||||||||||||       
						85%, more preferably at least about 90% and most preferably  	     289 EQEKGFRHPSNSIIIEQPVSDPPGVAPRGSGGGAGSHRTPKVTGP      333                                                          
						MWRSKLRMQGKKIFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITP 	                                                            
						LSFPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFSEDTALVLE 	                                                            
						YYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDGLHVERLPIMDTSLKTIND 	                                                            
						EAPTVALSFQLLSSERPENFLTPNNSKALPTLDPKILDKKLRTIQESWSKDTVSSTMDLS 	                                                            
						TSTPREAEEEPLVPEMSHDT                                         	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						AA737811_P5.3.An isolated polypeptide encoding for an edge   	                                                            
						portion of AA737811_P5, comprising an amino acid sequence    	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for VDPGELGAGGDLTERLQETHGPGHSECTETLPAQ,             	                                                            
						corresponding to AA737811_P5.                                	                                                            

						Comparison report between AA737811_P5 and Q8TAX6unique head  	Sequence name: Q8TAX6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA737811_P5, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15897 x Q8TAX6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MWRSKLRMQGKKIFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITP 	Alignment segment 1/1:                                       
						LSFPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFSEDTALVLE 	                                                            
						YYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDGLHVERLPIMDTSLKTIND 	                     Quality: 2008.00                      Escore:       0                                               
						EAPTVALSFQLLSSERPENFLTPNNSKALPTLDPKILDKKLRTIQESWSKDTVSSTMDLS 	             Matching length:     207                Total length:     207                                               
						TSTPREAEEEPLVPEMSHDT                                         	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.52                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:   99.52                                               
						to amino acids 1 - 260 of AA737811_P5, a second amino acid   	                        Gaps:       0                        
						EMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKASEAQNTVSMKQ 	                                                            
						KLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQAQQPQAALLKQYQGKLQKMKAL 	Alignment:                                                   
						EETVRHQEKVIEKMERVLEDRLQDRSKPPPLNRQQGKPYTGFPMLSASGLPLGSMGENLP 	                  .         .         .         .         .  
						VELYSVLLAENAKLRTELDKNRHQQA                                   	     260 TEMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKA 309                                                          
						sequence being at least 90 % homologous to corresponding to  	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 24 - 229 of Q8TAX6, which also corresponds to    	      23 SEMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKA 72                                                           
						amino acids 261 - 466 of AA737811_P5, and a third amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     310 SEAQNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQA 359                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      73 SEAQNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQA 122                                                          
						PIILQQQALPVDPGELGAGGDLTERLQETHGPGHSECTETLPAQDLLSGTSDKFNLLAKL 	                  .         .         .         .         .  
						EHAQSRILSLESQLEDSARRWGREKQDLATRLQEQEKGFRHPSNSIIIEQPVSDPPGVAP 	     360 QQPQAALLKQYQGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPP 409                                                          
						RGSGGGAGSHRTPKVTGP                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 467 - 604 of	     123 QQPQAALLKQYQGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPP 172                                                          
						AA737811_P5, wherein said first amino acid sequence, second  	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     410 PLNRQQGKPYTGFPMLSASGLPLGSMGENLPVELYSVLLAENAKLRTELD 459                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of AA737811_P5, comprising a 	     173 PLNRQQGKPYTGFPMLSASGLPLGSMGENLPVELYSVLLAENAKLRTELD 222                                                          
						polypeptide being at least 70%, optionally at least about    	                                                             
						80%, preferably at least about 85%, more preferably at least 	     460 KNRHQQA                                            466                                                          
						about 90% and most preferably at least about 95% homologous  	         |||||||                                             
						MWRSKLRMQGKKIFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITP 	     223 KNRHQQA                                            229                                                          
						LSFPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFSEDTALVLE 	                                                            
						YYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDGLHVERLPIMDTSLKTIND 	                                                            
						EAPTVALSFQLLSSERPENFLTPNNSKALPTLDPKILDKKLRTIQESWSKDTVSSTMDLS 	                                                            
						TSTPREAEEEPLVPEMSHDT                                         	                                                            
						to the sequence of AA737811_P5.3.An isolated polypeptide     	                                                            
						encoding for a tail of AA737811_P5, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						PIILQQQALPVDPGELGAGGDLTERLQETHGPGHSECTETLPAQDLLSGTSDKFNLLAKL 	                                                            
						EHAQSRILSLESQLEDSARRWGREKQDLATRLQEQEKGFRHPSNSIIIEQPVSDPPGVAP 	                                                            
						RGSGGGAGSHRTPKVTGP                                           	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA737811_P5.                                              	                                                            

15891	HMR136_AA737811_6_tr0_r1_1_gPRT		Comparison report between AA737811_P6 and Q8N5R6unique head  	Sequence name: Q8N5R6                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a followed by a unique tail.1.An isolated chimeric           	Sequence documentation:                                      
						polypeptide encoding for AA737811_P6, comprising a first     	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment of: 15891 x Q8N5R6   ..                            
						80%, preferably at least 85%, more preferably at least 90%   	                                                            
						and most preferably at least 95% homologous to a polypeptide 	Alignment segment 1/1:                                       
						having the sequence MWRSKLRMQGKK corresponding to amino acids	                                                            
						1 - 12 of AA737811_P6, a second amino acid sequence being at 	                     Quality: 5084.00                      Escore:       0                                               
						IFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITPLSFPIPSMMNFD 	             Matching length:     531                Total length:     565                                               
						VPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFSEDTALVLEYYSSTSMKGSQP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						WTLNQPLGISVLPLKSRLYQKMLTGKGLDGLHVERLPIMDTSLKTINDEAPTVALSFQLL 	    Total Percent Similarity:   93.98      Total Percent Identity:   93.98                                               
						SSERPENFLTPNNSKALPTLDPKILDKKLRTIQESWSKDTVSSTMDLSTSTPREAEEEPL 	                        Gaps:       1                        
						VPEMSHDTEMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKASEA 	                                                            
						QNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQAQQPQAALLKQYQG 	Alignment:                                                   
						KLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPPPLNRQQGKPYTGFPMLSASGLPL 	                  .         .         .         .         .  
						GSMGENLPVELYSVLLAENAKLRTELDKNRHQQAPIILQQQALP                 	      13 IFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITPLS 62                                                           
						least 90 % homologous to corresponding to amino acids 63 -   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						526 of Q8N5R6, which also corresponds to amino acids 13 - 476	      63 IFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITPLS 112                                                          
						of AA737811_P6, a third amino acid sequence being at least 90	                  .         .         .         .         .  
						DLLSGTSDKFNLLAKLEHAQSRILSLESQLEDSARRWGREKQDLATRLQEQEKGFRHPSN 	      63 FPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFS 112                                                          
						SIIIEQP                                                      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						% homologous to corresponding to amino acids 561 - 627 of    	     113 FPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFS 162                                                          
						Q8N5R6, which also corresponds to amino acids 477 - 543 of   	                  .         .         .         .         .  
						AA737811_P6, and a fourth amino acid sequence being at least 	     113 EDTALVLEYYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDG 162                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	     163 EDTALVLEYYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDG 212                                                          
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						SALTHSMDLKQPSELEPLLPSSDSKLNKPLSPQKETANSQQT corresponding to  	     163 LHVERLPIMDTSLKTINDEAPTVALSFQLLSSERPENFLTPNNSKALPTL 212                                                          
						amino acids 544 - 585 of AA737811_P6, wherein said first     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence, third amino 	     213 LHVERLPIMDTSLKTINDEAPTVALSFQLLSSERPENFLTPNNSKALPTL 262                                                          
						acid sequence and fourth amino acid sequence are contiguous  	                  .         .         .         .         .  
						and in a sequential order.2.An isolated polypeptide encoding 	     213 DPKILDKKLRTIQESWSKDTVSSTMDLSTSTPREAEEEPLVPEMSHDTEM 262                                                          
						for a head of AA737811_P6, comprising a polypeptide being at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     263 DPKILDKKLRTIQESWSKDTVSSTMDLSTSTPREAEEEPLVPEMSHDTEM 312                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     263 NNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKASEA 312                                                          
						MWRSKLRMQGKK of AA737811_P6.3.An isolated chimeric           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for an edge portion of AA737811_P6,     	     313 NNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKASEA 362                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     313 QNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQAQQP 362                                                          
						about 20 amino acids in length, preferably at least about 30 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, more preferably at least about 40     	     363 QNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQAQQP 412                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     363 QAALLKQYQGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPPPLN 412                                                          
						comprise PD, having a structure as follows: a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 476-x to 477; and    	     413 QAALLKQYQGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPPPLN 462                                                          
						ending at any of amino acid numbers 477+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.4.An isolated polypeptide       	     413 RQQGKPYTGFPMLSASGLPLGSMGENLPVELYSVLLAENAKLRTELDKNR 462                                                          
						encoding for a tail of AA737811_P6, comprising a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     463 RQQGKPYTGFPMLSASGLPLGSMGENLPVELYSVLLAENAKLRTELDKNR 512                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	     463 HQQAPIILQQQALP..................................DL 478                                                          
						SALTHSMDLKQPSELEPLLPSSDSKLNKPLSPQKETANSQQT in AA737811_P6.   	         ||||||||||||||                                  ||  
						                                                            	     513 HQQAPIILQQQALPVDPGELGAGGDLTERLQETHGPGHSECTETLPAQDL 562                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     479 LSGTSDKFNLLAKLEHAQSRILSLESQLEDSARRWGREKQDLATRLQEQE 528                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     563 LSGTSDKFNLLAKLEHAQSRILSLESQLEDSARRWGREKQDLATRLQEQE 612                                                          
						                                                            	                  .                                          
						                                                            	     529 KGFRHPSNSIIIEQP                                    543                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     613 KGFRHPSNSIIIEQP                                    627                                                          

						Comparison report between AA737811_P6 and Q9H5Q6unique head  	Sequence name: Q9H5Q6                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AA737811_P6, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15891 x Q9H5Q6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MWRSKLRMQGKKIFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITP 	Alignment segment 1/1:                                       
						LSFPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFSEDTALVLE 	                                                            
						YYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDGLHVERLPIMDTSLKTIND 	                     Quality: 2744.00                      Escore:       0                                               
						EAPTVALSFQLLSSERPENFLTPNNSKALPTLDPKILDKKLRTIQESWSKDTVSSTMDLS 	             Matching length:     284                Total length:     284                                               
						TSTPREAEEEPLVPEMSHDT                                         	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.30                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:   99.30                                               
						to amino acids 1 - 260 of AA737811_P6, a second amino acid   	                        Gaps:       0                        
						sequence being at least 90 % homologous to                   	                                                            
						EMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKA            	Alignment:                                                   
						corresponding to amino acids 24 - 72 of Q9H5Q6, which also   	                  .         .         .         .         .  
						corresponds to amino acids 261 - 309 of AA737811_P6, a       	     260 TEMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKA 309                                                          
						bridging amino acid S corresponding to amino acid 310 of     	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						AA737811_P6, a third amino acid sequence being at least 90 % 	      23 SEMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKA 72                                                           
						EAQNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQAQQPQAALLKQY 	                  .         .         .         .         .  
						QGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPPPLNRQQGKPYTGFPMLSASGL 	     310 SEAQNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQA 359                                                          
						PLGSMGENLPVELYSVLLAENAKLRTELDKNRHQQAPIILQQQALPDLLSGTSDKFNLLA 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						KLEHAQSRILSLESQLEDSARRWGREKQDLATRLQEQEKGFRHPSNSIIIEQP        	      73 NEAQNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQA 122                                                          
						homologous to corresponding to amino acids 74 - 306 of       	                  .         .         .         .         .  
						Q9H5Q6, which also corresponds to amino acids 311 - 543 of   	     360 QQPQAALLKQYQGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPP 409                                                          
						AA737811_P6, and a fourth amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	     123 QQPQAALLKQYQGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPP 172                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     410 PLNRQQGKPYTGFPMLSASGLPLGSMGENLPVELYSVLLAENAKLRTELD 459                                                          
						SALTHSMDLKQPSELEPLLPSSDSKLNKPLSPQKETANSQQT corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 544 - 585 of AA737811_P6, wherein said first     	     173 PLNRQQGKPYTGFPMLSASGLPLGSMGENLPVELYSVLLAENAKLRTELD 222                                                          
						amino acid sequence, second amino acid sequence, bridging    	                  .         .         .         .         .  
						amino acid, third amino acid sequence and fourth amino acid  	     460 KNRHQQAPIILQQQALPDLLSGTSDKFNLLAKLEHAQSRILSLESQLEDS 509                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of AA737811_P6,     	     223 KNRHQQAPIILQQQALPDLLSGTSDKFNLLAKLEHAQSRILSLESQLEDS 272                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .                      
						least about 80%, preferably at least about 85%, more         	     510 ARRWGREKQDLATRLQEQEKGFRHPSNSIIIEQP                 543                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||                  
						MWRSKLRMQGKKIFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITP 	     273 ARRWGREKQDLATRLQEQEKGFRHPSNSIIIEQP                 306                                                          
						LSFPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFSEDTALVLE 	                                                            
						YYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDGLHVERLPIMDTSLKTIND 	                                                            
						EAPTVALSFQLLSSERPENFLTPNNSKALPTLDPKILDKKLRTIQESWSKDTVSSTMDLS 	                                                            
						TSTPREAEEEPLVPEMSHDT                                         	                                                            
						about 95% homologous to the sequence of AA737811_P6.3.An     	                                                            
						isolated polypeptide encoding for a tail of AA737811_P6,     	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence                         	                                                            
						SALTHSMDLKQPSELEPLLPSSDSKLNKPLSPQKETANSQQT in AA737811_P6.   	                                                            

						Comparison report between AA737811_P6 and Q8TAX6unique head  	Sequence name: Q8TAX6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA737811_P6, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15891 x Q8TAX6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MWRSKLRMQGKKIFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITP 	Alignment segment 1/1:                                       
						LSFPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFSEDTALVLE 	                                                            
						YYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDGLHVERLPIMDTSLKTIND 	                     Quality: 2008.00                      Escore:       0                                               
						EAPTVALSFQLLSSERPENFLTPNNSKALPTLDPKILDKKLRTIQESWSKDTVSSTMDLS 	             Matching length:     207                Total length:     207                                               
						TSTPREAEEEPLVPEMSHDT                                         	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.52                                               
						homologous to a polypeptide having the sequence corresponding	    Total Percent Similarity:  100.00      Total Percent Identity:   99.52                                               
						to amino acids 1 - 260 of AA737811_P6, a second amino acid   	                        Gaps:       0                        
						EMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKASEAQNTVSMKQ 	                                                            
						KLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQAQQPQAALLKQYQGKLQKMKAL 	Alignment:                                                   
						EETVRHQEKVIEKMERVLEDRLQDRSKPPPLNRQQGKPYTGFPMLSASGLPLGSMGENLP 	                  .         .         .         .         .  
						VELYSVLLAENAKLRTELDKNRHQQA                                   	     260 TEMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKA 309                                                          
						sequence being at least 90 % homologous to corresponding to  	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 24 - 229 of Q8TAX6, which also corresponds to    	      23 SEMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKA 72                                                           
						amino acids 261 - 466 of AA737811_P6, and a third amino acid 	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     310 SEAQNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQA 359                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      73 SEAQNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQA 122                                                          
						PIILQQQALPDLLSGTSDKFNLLAKLEHAQSRILSLESQLEDSARRWGREKQDLATRLQE 	                  .         .         .         .         .  
						QEKGFRHPSNSIIIEQPSALTHSMDLKQPSELEPLLPSSDSKLNKPLSPQKETANSQQT  	     360 QQPQAALLKQYQGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPP 409                                                          
						having the sequence corresponding to amino acids 467 - 585 of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA737811_P6, wherein said first amino acid sequence, second  	     123 QQPQAALLKQYQGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPP 172                                                          
						amino acid sequence and third amino acid sequence are        	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	     410 PLNRQQGKPYTGFPMLSASGLPLGSMGENLPVELYSVLLAENAKLRTELD 459                                                          
						polypeptide encoding for a head of AA737811_P6, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     173 PLNRQQGKPYTGFPMLSASGLPLGSMGENLPVELYSVLLAENAKLRTELD 222                                                          
						80%, preferably at least about 85%, more preferably at least 	                                                             
						about 90% and most preferably at least about 95% homologous  	     460 KNRHQQA                                            466                                                          
						MWRSKLRMQGKKIFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITP 	         |||||||                                             
						LSFPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFSEDTALVLE 	     223 KNRHQQA                                            229                                                          
						YYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDGLHVERLPIMDTSLKTIND 	                                                            
						EAPTVALSFQLLSSERPENFLTPNNSKALPTLDPKILDKKLRTIQESWSKDTVSSTMDLS 	                                                            
						TSTPREAEEEPLVPEMSHDT                                         	                                                            
						to the sequence of AA737811_P6.3.An isolated polypeptide     	                                                            
						encoding for a tail of AA737811_P6, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						PIILQQQALPDLLSGTSDKFNLLAKLEHAQSRILSLESQLEDSARRWGREKQDLATRLQE 	                                                            
						QEKGFRHPSNSIIIEQPSALTHSMDLKQPSELEPLLPSSDSKLNKPLSPQKETANSQQT  	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA737811_P6.                                              	                                                            

15889	HMR136_AA737811_8_tr0_r1_1_gPRT		Comparison report between AA737811_P8 and Q8N5R6unique head  	Sequence name: Q8N5R6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA737811_P8, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15889 x Q8N5R6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MWRSKLRMQGKK 	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 12 of AA737811_P8, a second 	                                                            
						IFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITPLSFPIPSMMNFD 	                     Quality: 1875.00                      Escore:       0                                               
						VPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFSEDTALVLEYYSSTSMKGSQP 	             Matching length:     191                Total length:     191                                               
						WTLNQPLGISVLPLKSRLYQKMLTGKGLDGLHVERLPIMDTSLKTINDEAPTVALSFQLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SSERPENFLTP                                                  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 63 - 253 of Q8N5R6, which also  	                                                            
						corresponds to amino acids 13 - 203 of AA737811_P8, and a    	Alignment:                                                   
						third amino acid sequence being at least 70%, optionally at  	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	      13 IFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITPLS 62                                                           
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SGPPETHRVSRAVGMPLSLTHPTLFQARHPSLFLTLDYVLVYPLTSGSVSSSIHHLRLKR 	      63 IFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITPLS 112                                                          
						LINETHNSAAGMQQIFT                                            	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	      63 FPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFS 112                                                          
						204 - 280 of AA737811_P8, wherein said first amino acid      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence and third amino acid    	     113 FPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFS 162                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of AA737811_P8,     	     113 EDTALVLEYYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDG 162                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     163 EDTALVLEYYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDG 212                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .            
						about 95% homologous to the sequence MWRSKLRMQGKK of         	     163 LHVERLPIMDTSLKTINDEAPTVALSFQLLSSERPENFLTP          203                                                          
						AA737811_P8.3.An isolated polypeptide encoding for a tail of 	         |||||||||||||||||||||||||||||||||||||||||           
						AA737811_P8, comprising a polypeptide being at least 70%,    	     213 LHVERLPIMDTSLKTINDEAPTVALSFQLLSSERPENFLTP          253                                                          
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						SGPPETHRVSRAVGMPLSLTHPTLFQARHPSLFLTLDYVLVYPLTSGSVSSSIHHLRLKR 	                                                            
						LINETHNSAAGMQQIFT                                            	                                                            
						least about 95% homologous to the sequence in AA737811_P8.   	                                                            

15895	HMR136_AA737811_9_tr0_r1_1_gPRT		Comparison report between AA737811_P9 and Q8N5R6unique head  	Sequence name: Q8N5R6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA737811_P9, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15895 x Q8N5R6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MWRSKLRMQGKK 	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 12 of AA737811_P9, a second 	                                                            
						IFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITPLSFPIPSMMNFD 	                     Quality: 2433.00                      Escore:       0                                               
						VPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFSEDTALVLEYYSSTSMKGSQP 	             Matching length:     248                Total length:     248                                               
						WTLNQPLGISVLPLKSRLYQKMLTGKGLDGLHVERLPIMDTSLKTINDEAPTVALSFQLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SSERPENFLTPNNSKALPTLDPKILDKKLRTIQESWSKDTVSSTMDLSTSTPREAEEEPL 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VPEMSHDT                                                     	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 63 - 310 of Q8N5R6, which also  	Alignment:                                                   
						corresponds to amino acids 13 - 260 of AA737811_P9, and a    	                  .         .         .         .         .  
						third amino acid sequence being at least 70%, optionally at  	      13 IFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITPLS 62                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	      63 IFLRGVNEPLANNPNPIVVIARVVPNYKEFKVSQANRDLASVGLPITPLS 112                                                          
						polypeptide having the sequence IRLQLNRKLNIFWREKRSGNR        	                  .         .         .         .         .  
						corresponding to amino acids 261 - 281 of AA737811_P9,       	      63 FPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFS 112                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     113 FPIPSMMNFDVPRVSQNGCPQLSKPGGPPEQPLWNQSFLFQGRDGATSFS 162                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of AA737811_P9, comprising a polypeptide being at least 	     113 EDTALVLEYYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDG 162                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     163 EDTALVLEYYSSTSMKGSQPWTLNQPLGISVLPLKSRLYQKMLTGKGLDG 212                                                          
						at least about 95% homologous to the sequence MWRSKLRMQGKK of	                  .         .         .         .         .  
						AA737811_P9.3.An isolated polypeptide encoding for a tail of 	     163 LHVERLPIMDTSLKTINDEAPTVALSFQLLSSERPENFLTPNNSKALPTL 212                                                          
						AA737811_P9, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     213 LHVERLPIMDTSLKTINDEAPTVALSFQLLSSERPENFLTPNNSKALPTL 262                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .            
						least about 95% homologous to the sequence                   	     213 DPKILDKKLRTIQESWSKDTVSSTMDLSTSTPREAEEEPLVPEMSHDT   260                                                          
						IRLQLNRKLNIFWREKRSGNR in AA737811_P9.                        	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     263 DPKILDKKLRTIQESWSKDTVSSTMDLSTSTPREAEEEPLVPEMSHDT   310                                                          

16328	HMR136_AA741219_2_tr0_r1_1_gPRT		Comparison report between AA741219_P2 and FXI1_HUMANunique   	Sequence name: FXI1_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA741219_P2, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16328 x FXI1_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MSSFDLPAPSPPRCSPQFPSIGQEPPE corresponding to amino acids 1 - 	                                                            
						27 of AA741219_P2, a second amino acid sequence being at     	                     Quality: 1703.00                      Escore:       0                                               
						MNLYYENFFHPQGVPSPQRPSFEGGGEYGATPNPYLWFNGPTMTPPPYLPGPNASPFLPQ 	             Matching length:     167                Total length:     167                                               
						AYGVQRPLLPSVSGLGGSDLGWLPIPSQEELMKLVRPPYSYSALIAMAIHGAPDKRLTLS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QIYQYVADNFPFYNKSKAGWQNSIRHNLSLNDCFKKVPRDEDDPGKG              	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 90 % homologous to corresponding to amino acids 1 - 167	                        Gaps:       0                        
						of FXI1_HUMAN, which also corresponds to amino acids 28 - 194	                                                            
						of AA741219_P2, and a third amino acid sequence being at     	Alignment:                                                   
						least 70%, optionally at least 80%, preferably at least 85%, 	                  .         .         .         .         .  
						more preferably at least 90% and most preferably at least 95%	      28 MNLYYENFFHPQGVPSPQRPSFEGGGEYGATPNPYLWFNGPTMTPPPYLP 77                                                           
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RENQMFPLAQPPWP corresponding to amino acids 195 - 208 of     	       1 MNLYYENFFHPQGVPSPQRPSFEGGGEYGATPNPYLWFNGPTMTPPPYLP 50                                                           
						AA741219_P2, wherein said first amino acid sequence, second  	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	      78 GPNASPFLPQAYGVQRPLLPSVSGLGGSDLGWLPIPSQEELMKLVRPPYS 127                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of AA741219_P2, comprising a 	      51 GPNASPFLPQAYGVQRPLLPSVSGLGGSDLGWLPIPSQEELMKLVRPPYS 100                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     128 YSALIAMAIHGAPDKRLTLSQIYQYVADNFPFYNKSKAGWQNSIRHNLSL 177                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence MSSFDLPAPSPPRCSPQFPSIGQEPPE of               	     101 YSALIAMAIHGAPDKRLTLSQIYQYVADNFPFYNKSKAGWQNSIRHNLSL 150                                                          
						AA741219_P2.3.An isolated polypeptide encoding for a tail of 	                  .                                          
						AA741219_P2, comprising a polypeptide being at least 70%,    	     178 NDCFKKVPRDEDDPGKG                                  194                                                          
						optionally at least about 80%, preferably at least about 85%,	         |||||||||||||||||                                   
						more preferably at least about 90% and most preferably at    	     151 NDCFKKVPRDEDDPGKG                                  167                                                          
						least about 95% homologous to the sequence RENQMFPLAQPPWP in 	                                                            
						AA741219_P2.                                                 	                                                            

17749	HMR136_AA757440_1_tr0_r1_1_gPRT		Comparison report between AA757440_P1 and Q9Y2K9unique head  	Sequence name: Q9Y2K9                                        
						followed by partial WT sequence featuring a skipped exon plus	                                                            
						extra amino acids and a followed by a unique tail.1.An       	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for AA757440_P1,      	                                                            
						comprising a first amino acid sequence being at least 70%,   	Alignment of: 17749 x Q9Y2K9   ..                            
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence              	                                                            
						GSPNVVFLKIKYSEPNVSKKESPPLRERQSL corresponding to amino acids 	                     Quality: 9609.00                      Escore:       0                                               
						1 - 31 of AA757440_P1, a second amino acid sequence being at 	             Matching length:     985                Total length:    1009                                               
						VFKMKKFNFRKVLDGLTASSPGSGSSSGSNSGGGAGSGSVHPAGTAGVLREEIQETLTSE 	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.90                                               
						YFQICKTVRHGFPHQPTALAFDPVQKILAIGTRTGAIRILGRPGVDCYCQHESGAAVLQL 	    Total Percent Similarity:   97.52      Total Percent Identity:   97.52                                               
						QFLINEGALVSASSDDTLHLWNLRQKRPAILHSLKFNRERITYCHLPFQSKWLYVGTERG 	                        Gaps:       1                        
						NTHIVNIESFILSGYVIMWNKAIELSTKTHPGPVVHLSDSPRDEGKLLIGYENGTVVFWD 	                                                            
						LKSKRAELRVYYDEAIHSIDWHHEGKQFMCSHSDGSLTLWNLKSPSRPFQTTIPHGKSQR 	Alignment:                                                   
						EGRKSESCKPILKVEYKTCKNSEPFIIFSGGLSYDKACRRPSLTIMHGKAITVLEMDHPI 	                  .         .         .         .         .  
						VEFLTLCETPYPNEFQEPYAVVVLLEKDLIVVDLTQSNFPIFENPYPMDIHESPVTCTAY 	      32 VFKMKKFNFRKVLDGLTASSPGSGSSSGSNSGGGAGSGSVHPAGTAGVLR 81                                                           
						FADCPPDLILVLYSIGVKHKKQGYSNKEWPISGGAWNLGAQTYPEIIITGHADGSIKFWD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ASAITLQMLYKLKTSKVFEKQKVGEGKQTCEIVEEDPFAIQMIYWCPESRIFCVSGVSAY 	      33 VFKMKKFNFRKVLDGLTASSPGSGSSSGSNSGGGAGSGSVHPAGTAGVLR 82                                                           
						VIIYKFSRHEITTEIVSLEVRLQYDVEDIITPEPETSPPFPDLSAQLPSSRSLSGSTNTV 	                  .         .         .         .         .  
						ASEGVTKDSIPCLNVKTRPVRMPPGYQAELVIQLVWVDGEPPQQITSLAVSSAYGIVAFG 	      82 EEIQETLTSEYFQICKTVRHGFPHQPTALAFDPVQKILAIGTRTGAIRIL 131                                                          
						NCNGLAVVDFIQKTVLLSMGTIDLYRSSDLYQRQPRSPRKNKQFIA               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 90 % homologous to corresponding to amino acids 33 -   	      83 EEIQETLTSEYFQICKTVRHGFPHQPTALAFDPVQKILAIGTRTGAIRIL 132                                                          
						738 of Q9Y2K9, which also corresponds to amino acids 32 - 737	                  .         .         .         .         .  
						of AA757440_P1, a third amino acid sequence bridging amino   	     132 GRPGVDCYCQHESGAAVLQLQFLINEGALVSASSDDTLHLWNLRQKRPAI 181                                                          
						acid sequence comprising of G, a fourth amino acid sequence  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LTELNDSPVPLELERCKSPTSDHVNGHCTSPTSQSCSSGKRLSSADVSKVNRWGPGRPPF 	     133 GRPGVDCYCQHESGAAVLQLQFLINEGALVSASSDDTLHLWNLRQKRPAI 182                                                          
						RKAQSAACMEISLPVTTEENRENSYNRSRSSSISSIDKDSKEAITALYFMDSFARKNDST 	                  .         .         .         .         .  
						ISPCLFVGTSLGMVLIISLNLPLADEQRFTEPVMVLPSGTFLSLKGAVLTFSCMDRMGGL 	     182 LHSLKFNRERITYCHLPFQSKWLYVGTERGNTHIVNIESFILSGYVIMWN 231                                                          
						MQPPYEVWRDPNNIDENEKSWRRKVVMNSSSASQEIGDHQYTIICSEKQAKVFSLPSQTC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LYVHNITETSFILQANVVVMCSSACLACFCANGHIMIM                       	     183 LHSLKFNRERITYCHLPFQSKWLYVGTERGNTHIVNIESFILSGYVIMWN 232                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 764 - 1041 of Q9Y2K9, which also corresponds to amino  	     232 KAIELSTKTHPGPVVHLSDSPRDEGKLLIGYENGTVVFWDLKSKRAELRV 281                                                          
						acids 739 - 1016 of AA757440_P1, and a fifth amino acid      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     233 KAIELSTKTHPGPVVHLSDSPRDEGKLLIGYENGTVVFWDLKSKRAELRV 282                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     282 YYDEAIHSIDWHHEGKQFMCSHSDGSLTLWNLKSPSRPFQTTIPHGKSQR 331                                                          
						having the sequence RYLPSYKLSGNHNNTSKVQS corresponding to    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1017 - 1036 of AA757440_P1, wherein said first   	     283 YYDEAIHSIDWHHEGKQFMCSHSDGSLTLWNLKSPSRPFQTTIPHGKSQR 332                                                          
						amino acid sequence, second amino acid sequence, third amino 	                  .         .         .         .         .  
						acid sequence, fourth amino acid sequence and fifth amino    	     332 EGRKSESCKPILKVEYKTCKNSEPFIIFSGGLSYDKACRRPSLTIMHGKA 381                                                          
						acid sequence are contiguous and in a sequential order.2.An  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of AA757440_P1,     	     333 EGRKSESCKPILKVEYKTCKNSEPFIIFSGGLSYDKACRRPSLTIMHGKA 382                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     382 ITVLEMDHPIVEFLTLCETPYPNEFQEPYAVVVLLEKDLIVVDLTQSNFP 431                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence                         	     383 ITVLEMDHPIVEFLTLCETPYPNEFQEPYAVVVLLEKDLIVVDLTQSNFP 432                                                          
						GSPNVVFLKIKYSEPNVSKKESPPLRERQSL of AA757440_P1.3.An isolated 	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of AA757440_P1,     	     432 IFENPYPMDIHESPVTCTAYFADCPPDLILVLYSIGVKHKKQGYSNKEWP 481                                                          
						comprising a polypeptide having a length "n", wherein n is at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 10 amino acids in length, optionally at least    	     433 IFENPYPMDIHESPVTCTAYFADCPPDLILVLYSIGVKHKKQGYSNKEWP 482                                                          
						about 20 amino acids in length, preferably at least about 30 	                  .         .         .         .         .  
						amino acids in length, more preferably at least about 40     	     482 ISGGAWNLGAQTYPEIIITGHADGSIKFWDASAITLQMLYKLKTSKVFEK 531                                                          
						amino acids in length and most preferably at least about 50  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, wherein at least two amino acids      	     483 ISGGAWNLGAQTYPEIIITGHADGSIKFWDASAITLQMLYKLKTSKVFEK 532                                                          
						comprise AGL having a structure as follows (numbering        	                  .         .         .         .         .  
						according to AA757440_P1): a sequence starting from any of   	     532 QKVGEGKQTCEIVEEDPFAIQMIYWCPESRIFCVSGVSAYVIIYKFSRHE 581                                                          
						amino acid numbers 737-x to 737; and ending at any of amino  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid numbers 739 + ((n-2) - x), in which x varies from 0 to  	     533 QKVGEGKQTCEIVEEDPFAIQMIYWCPESRIFCVSGVSAYVIIYKFSRHE 582                                                          
						n-2.4.An isolated polypeptide encoding for a tail of         	                  .         .         .         .         .  
						AA757440_P1, comprising a polypeptide being at least 70%,    	     582 ITTEIVSLEVRLQYDVEDIITPEPETSPPFPDLSAQLPSSRSLSGSTNTV 631                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     583 ITTEIVSLEVRLQYDVEDIITPEPETSPPFPDLSAQLPSSRSLSGSTNTV 632                                                          
						least about 95% homologous to the sequence                   	                  .         .         .         .         .  
						RYLPSYKLSGNHNNTSKVQS in AA757440_P1.                         	     632 ASEGVTKDSIPCLNVKTRPVRMPPGYQAELVIQLVWVDGEPPQQITSLAV 681                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     633 ASEGVTKDSIPCLNVKTRPVRMPPGYQAELVIQLVWVDGEPPQQITSLAV 682                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     682 SSAYGIVAFGNCNGLAVVDFIQKTVLLSMGTIDLYRSSDLYQRQPRSPRK 731                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     683 SSAYGIVAFGNCNGLAVVDFIQKTVLLSMGTIDLYRSSDLYQRQPRSPRK 732                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     732 NKQFIA........................GLTELNDSPVPLELERCKSP 757                                                          
						                                                            	         ||||||                         |||||||||||||||||||  
						                                                            	     733 NKQFIADNFCMRGLSNFYPDLTKRIRTSYQSLTELNDSPVPLELERCKSP 782                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     758 TSDHVNGHCTSPTSQSCSSGKRLSSADVSKVNRWGPGRPPFRKAQSAACM 807                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     783 TSDHVNGHCTSPTSQSCSSGKRLSSADVSKVNRWGPGRPPFRKAQSAACM 832                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     808 EISLPVTTEENRENSYNRSRSSSISSIDKDSKEAITALYFMDSFARKNDS 857                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     833 EISLPVTTEENRENSYNRSRSSSISSIDKDSKEAITALYFMDSFARKNDS 882                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     858 TISPCLFVGTSLGMVLIISLNLPLADEQRFTEPVMVLPSGTFLSLKGAVL 907                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     883 TISPCLFVGTSLGMVLIISLNLPLADEQRFTEPVMVLPSGTFLSLKGAVL 932                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     908 TFSCMDRMGGLMQPPYEVWRDPNNIDENEKSWRRKVVMNSSSASQEIGDH 957                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     933 TFSCMDRMGGLMQPPYEVWRDPNNIDENEKSWRRKVVMNSSSASQEIGDH 982                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     958 QYTIICSEKQAKVFSLPSQTCLYVHNITETSFILQANVVVMCSSACLACF 1007                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     983 QYTIICSEKQAKVFSLPSQTCLYVHNITETSFILQANVVVMCSSACLACF 1032                                                         
						                                                            	                                                             
						                                                            	    1008 CANGHIMIM                                          1016                                                         
						                                                            	         |||||||||                                           
						                                                            	    1033 CANGHIMIM                                          1041                                                         

18059	HMR136_AA757499_2_tr0_r1_1_gPRT		Comparison report between AA757499_P2 and WN16_HUMANpartial  	Sequence name: WN16_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for AA757499_P2, comprising a first     	Sequence documentation:                                      
						MDRAALLGLARLCALWAALLVLFPYGAQGNWMWLGIASFGVPEKLGCANLPLNSRQKELC 	                                                            
						KRKPYLLPSIREGARLGIQECGSQFRHERWNCMITAAATTAPMGASPLFGYELSSGTKET 	Alignment of: 18059 x WN16_HUMAN   ..                        
						AFIYAVMAAGLVHSVTRSCSAGNMTECSCDTTLQNGGSASEGWHWGGCSDDVQYGMWFSR 	                                                            
						KFLDFPIGNTTGKENKVLLAMNLHNNEAGRQ                              	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 211 of WN16_HUMAN, which    	                     Quality: 2106.00                      Escore:       0                                               
						also corresponds to amino acids 1 - 211 of AA757499_P2, and a	             Matching length:     211                Total length:     211                                               
						second amino acid sequence being at least 70%, optionally at 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 80%, preferably at least 85%, more preferably at least 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	                        Gaps:       0                        
						polypeptide having the sequence VCIRKWNNQNPV corresponding to	                                                            
						amino acids 212 - 223 of AA757499_P2, wherein said first     	Alignment:                                                   
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	       1 MDRAALLGLARLCALWAALLVLFPYGAQGNWMWLGIASFGVPEKLGCANL 50                                                           
						polypeptide encoding for a tail of AA757499_P2, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	       1 MDRAALLGLARLCALWAALLVLFPYGAQGNWMWLGIASFGVPEKLGCANL 50                                                           
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	      51 PLNSRQKELCKRKPYLLPSIREGARLGIQECGSQFRHERWNCMITAAATT 100                                                          
						to the sequence VCIRKWNNQNPV in AA757499_P2.                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 PLNSRQKELCKRKPYLLPSIREGARLGIQECGSQFRHERWNCMITAAATT 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 APMGASPLFGYELSSGTKETAFIYAVMAAGLVHSVTRSCSAGNMTECSCD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 APMGASPLFGYELSSGTKETAFIYAVMAAGLVHSVTRSCSAGNMTECSCD 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 TTLQNGGSASEGWHWGGCSDDVQYGMWFSRKFLDFPIGNTTGKENKVLLA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 TTLQNGGSASEGWHWGGCSDDVQYGMWFSRKFLDFPIGNTTGKENKVLLA 200                                                          
						                                                            	                  .                                          
						                                                            	     201 MNLHNNEAGRQ                                        211                                                          
						                                                            	         |||||||||||                                         
						                                                            	     201 MNLHNNEAGRQ                                        211                                                          

19401	HMR136_AA758818_1_tr0_r1_1_gPRT		Comparison report between AA758818_P1 and Q8NA31partial WT   	Sequence name: Q8NA31                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA758818_P1, comprising a first     	Sequence documentation:                                      
						MESEDTKKTQEMKTDLNLLLECLKYQMDNAFSQKEALVTIHSICQQNSNASVYFREIGGL 	                                                            
						MFVKNLAKSSEHSMVKEAALYTLGAIAEKNVYCQQTLCTSELFEDLTWFLSNDSNINLKR 	Alignment of: 19401 x Q8NA31   ..                            
						MSVYVILVLVSNNRTGQTLVRETGCITVLSRLFRTVISKHELDLSDKNVFQSYQLWSSVC 	                                                            
						STLCVCVNNPQNDENQMFCCSLFPHANEWLKNCTTPEIIRPICSFIGLTLANNTYVQKYF 	Alignment segment 1/1:                                       
						VSVGGLDVLSQVLMQLESDSHETLSSAKLAVVVTKTVDACIADN                 	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2786.00                      Escore:       0                                               
						corresponding to amino acids 1 - 284 of Q8NA31, which also   	             Matching length:     284                Total length:     284                                               
						corresponds to amino acids 1 - 284 of AA758818_P1, and a     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 80%, preferably at least 85%, more preferably at least 	                        Gaps:       0                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence QLLLG corresponding to amino 	Alignment:                                                   
						acids 285 - 289 of AA758818_P1, wherein said first amino acid	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	       1 MESEDTKKTQEMKTDLNLLLECLKYQMDNAFSQKEALVTIHSICQQNSNA 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of AA758818_P1, comprising a polypeptide being at least 	       1 MESEDTKKTQEMKTDLNLLLECLKYQMDNAFSQKEALVTIHSICQQNSNA 50                                                           
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      51 SVYFREIGGLMFVKNLAKSSEHSMVKEAALYTLGAIAEKNVYCQQTLCTS 100                                                          
						at least about 95% homologous to the sequence QLLLG in       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA758818_P1.                                                 	      51 SVYFREIGGLMFVKNLAKSSEHSMVKEAALYTLGAIAEKNVYCQQTLCTS 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 ELFEDLTWFLSNDSNINLKRMSVYVILVLVSNNRTGQTLVRETGCITVLS 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 ELFEDLTWFLSNDSNINLKRMSVYVILVLVSNNRTGQTLVRETGCITVLS 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 RLFRTVISKHELDLSDKNVFQSYQLWSSVCSTLCVCVNNPQNDENQMFCC 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 RLFRTVISKHELDLSDKNVFQSYQLWSSVCSTLCVCVNNPQNDENQMFCC 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SLFPHANEWLKNCTTPEIIRPICSFIGLTLANNTYVQKYFVSVGGLDVLS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 SLFPHANEWLKNCTTPEIIRPICSFIGLTLANNTYVQKYFVSVGGLDVLS 250                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 QVLMQLESDSHETLSSAKLAVVVTKTVDACIADN                 284                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||                  
						                                                            	     251 QVLMQLESDSHETLSSAKLAVVVTKTVDACIADN                 284                                                          

19403	HMR136_AA758818_2_tr0_r1_1_gPRT		Comparison report between AA758818_P2 and Q8NA31partial WT   	Sequence name: Q8NA31                                        
						sequence followed by unique insertion with extra amino       	                                                            
						acids.1.An isolated chimeric polypeptide encoding for        	Sequence documentation:                                      
						AA758818_P2, comprising a first amino acid sequence being at 	                                                            
						least 90 % homologous to MLTLGHCTEDC corresponding to amino  	Alignment of: 19403 x Q8NA31   ..                            
						acids 318 - 328 of Q8NA31, which also corresponds to amino   	                                                            
						acids 1 - 11 of AA758818_P2, a second amino acid sequence    	Alignment segment 1/1:                                       
						being at least 70%, optionally at least 80%, preferably at   	                                                            
						least 85%, more preferably at least 90% and most preferably  	                     Quality: 1817.00                      Escore:       0                                               
						at least 95% homologous to a polypeptide having the sequence 	             Matching length:     191                Total length:     233                                               
						EENQYDLFKNNGLPLMIQALTESQNEELNKAATFVLHNCKKIT corresponding to 	 Matching Percent Similarity:   99.48   Matching Percent Identity:   99.48                                               
						amino acids 12 - 54 of AA758818_P2, and a third amino acid   	    Total Percent Similarity:   81.55      Total Percent Identity:   81.55                                               
						EKLSLSLGEYPFDENETQQLKDISVKENNLEEHWRKAKEILHRIEQLEREGNEEEIQREN 	                        Gaps:       1                        
						YQDNISSMNISIQNTWKHLHADRIGRGSKAEDEDKSHSRQLQSYKSHGVMSKACTNDDQM 	                                                            
						KTPLKSANPVHACYRESEQNKTLYKAKSSCNQNLHEETTFEKNFVSQSRSIYIMFRYNK  	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 330 - 508 of Q8NA31, which also corresponds to   	       1 MLTLGHCTEDCEENQYDLFKNNGLPLMIQALTESQNEELNKAATFVLHNC 50                                                           
						amino acids 55 - 233 of AA758818_P2, wherein said first amino	         |||||||||||                                         
						acid sequence, second amino acid sequence and third amino    	     318 MLTLGHCTEDC....................................... 328                                                          
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .         .         .         .  
						isolated polypeptide encoding for an edge portion of         	      51 KKITEKLSLSLGEYPFDENETQQLKDISVKENNLEEHWRKAKEILHRIEQ 100                                                          
						AA758818_P2, comprising an amino acid sequence being at least	             ||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     329 ...AEKLSLSLGEYPFDENETQQLKDISVKENNLEEHWRKAKEILHRIEQ 375                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence encoding for   	     101 LEREGNEEEIQRENYQDNISSMNISIQNTWKHLHADRIGRGSKAEDEDKS 150                                                          
						EENQYDLFKNNGLPLMIQALTESQNEELNKAATFVLHNCKKIT, corresponding to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA758818_P2.3.A bridge portion of AA758818_P2, comprising a  	     376 LEREGNEEEIQRENYQDNISSMNISIQNTWKHLHADRIGRGSKAEDEDKS 425                                                          
						polypeptide having a length "n", wherein n is at least about 	                  .         .         .         .         .  
						10 amino acids in length, optionally at least about 20 amino 	     151 HSRQLQSYKSHGVMSKACTNDDQMKTPLKSANPVHACYRESEQNKTLYKA 200                                                          
						acids in length, preferably at least about 30 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, more preferably at least about 40 amino acids in     	     426 HSRQLQSYKSHGVMSKACTNDDQMKTPLKSANPVHACYRESEQNKTLYKA 475                                                          
						length and most preferably at least about 50 amino acids in  	                  .         .         .                      
						length, wherein at least two amino acids comprise C, having a	     201 KSSCNQNLHEETTFEKNFVSQSRSIYIMFRYNK                  233                                                          
						structure as follows (numbering according to AA758818_P2): a 	         |||||||||||||||||||||||||||||||||                   
						sequence starting from any of amino acid numbers 328-x to    	     476 KSSCNQNLHEETTFEKNFVSQSRSIYIMFRYNK                  508                                                          
						328; and ending at any of amino acid numbers 12 + ((n-2) -   	                                                            
						x), in which x varies from 0 to n-2.                         	                                                            

26434	HMR136_AA778646_1_tr0_r1_1_gPRT		Comparison report between AA778646_P1 and Q8N136partial WT   	Sequence name: Q8N136                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for AA778646_P1, comprising a first     	Sequence documentation:                                      
						MKLKSLLLRYYPPGIMLEYEKHGELKTKSIDLLDLGPSTDVSALVEEIQKAEPLLTASRT 	                                                            
						EQVKLLIQRLQEKLGQNSNHTFYLFKVLKAHILPLTNVALNKSGSCFITGSYDRTCKLWD 	Alignment of: 26434 x Q8N136   ..                            
						TASGEELNTLEGHRNVVYAIAFNNPYG                                  	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 147 of Q8N136, which also   	                                                            
						corresponds to amino acids 1 - 147 of AA778646_P1, and a     	                     Quality: 2925.00                      Escore:       0                                               
						KVNILIGHCAEISSASFNWDCSLILTGSMDKTCKLWDATNGKCVATLTGHDDEILDSCFD 	             Matching length:     310                Total length:     415                                               
						YTGKLIATASADGTARIFSAATRKCIAKLEGHEGEISKISFNPQGNHLLTGSSDKTARIW 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DAQTGQCLQVLEGHTDEIFSCAFNYKGNIVITGSKDNTCRIWR                  	    Total Percent Similarity:   74.70      Total Percent Identity:   74.70                                               
						second amino acid sequence being at least 90 % homologous to 	                        Gaps:       1                        
						corresponding to amino acids 253 - 415 of Q8N136, which also 	                                                            
						corresponds to amino acids 148 - 310 of AA778646_P1, wherein 	Alignment:                                                   
						said first amino acid sequence and second amino acid sequence	                  .         .         .         .         .  
						are contiguous and in a sequential order.2.An isolated       	       1 MKLKSLLLRYYPPGIMLEYEKHGELKTKSIDLLDLGPSTDVSALVEEIQK 50                                                           
						chimeric polypeptide encoding for an edge portion of         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA778646_P1, comprising a polypeptide having a length "n",   	       1 MKLKSLLLRYYPPGIMLEYEKHGELKTKSIDLLDLGPSTDVSALVEEIQK 50                                                           
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	      51 AEPLLTASRTEQVKLLIQRLQEKLGQNSNHTFYLFKVLKAHILPLTNVAL 100                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	      51 AEPLLTASRTEQVKLLIQRLQEKLGQNSNHTFYLFKVLKAHILPLTNVAL 100                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise GK, having a structure as  	     101 NKSGSCFITGSYDRTCKLWDTASGEELNTLEGHRNVVYAIAFNNPYG... 147                                                          
						follows: a sequence starting from any of amino acid numbers  	         |||||||||||||||||||||||||||||||||||||||||||||||     
						147-x to 148; and ending at any of amino acid numbers 148+   	     101 NKSGSCFITGSYDRTCKLWDTASGEELNTLEGHRNVVYAIAFNNPYGDKI 150                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     147 .................................................. 147                                                          
						                                                            	                                                            
						                                                            	     151 ATGSFDKTCKLWSVETGKCYHTFRGHTAEIVCLSFNPQSTLVATGSMDTT 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     147 .................................................. 147                                                          
						                                                            	                                                            
						                                                            	     201 AKLWDIQNGEEVYTLRGHSAEIISLSFNTSGDRIITGSFDHTVVVWDADT 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     148 ..KVNILIGHCAEISSASFNWDCSLILTGSMDKTCKLWDATNGKCVATLT 195                                                          
						                                                            	           ||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 GRKVNILIGHCAEISSASFNWDCSLILTGSMDKTCKLWDATNGKCVATLT 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     196 GHDDEILDSCFDYTGKLIATASADGTARIFSAATRKCIAKLEGHEGEISK 245                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 GHDDEILDSCFDYTGKLIATASADGTARIFSAATRKCIAKLEGHEGEISK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     246 ISFNPQGNHLLTGSSDKTARIWDAQTGQCLQVLEGHTDEIFSCAFNYKGN 295                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 ISFNPQGNHLLTGSSDKTARIWDAQTGQCLQVLEGHTDEIFSCAFNYKGN 400                                                          
						                                                            	                  .                                          
						                                                            	     296 IVITGSKDNTCRIWR                                    310                                                          
						                                                            	         |||||||||||||||                                     
						                                                            	     401 IVITGSKDNTCRIWR                                    415                                                          

27031	HMR136_AA779697_2_tr0_r1_1_gPRT		Comparison report between AA779697_P2 and AAH43568unique     	Sequence name: AAH43568                                      
						head followed by partial WT sequence a mismatch.1.An isolated	                                                            
						chimeric polypeptide encoding for AA779697_P2, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 27031 x AAH43568   ..                          
						90% and most preferably at least 95% homologous to a         	                                                            
						MTEAALVEGQWKSRWLVLRKPSPVADCLLMLVYKDKSERIKGLRERSSLTLEDICGLEPG 	Alignment segment 1/1:                                       
						LPYEGLVHTLAIVCLSQAIMLGFDSHEAMCAWDARIRYALGEVHRFHVTVAPGTKLESGP 	                                                            
						ATLHLCNDVLVLARDIPPAVTGQWKLSDLRRYGAVPSGFIFEGGTRCGYWAGVFFLSSAE 	                     Quality: 2977.00                      Escore:       0                                               
						GEQISFLFDC                                                   	             Matching length:     306                Total length:     306                                               
						polypeptide having the sequence corresponding to amino acids 	 Matching Percent Similarity:   99.67   Matching Percent Identity:   99.67                                               
						1 - 190 of AA779697_P2, a second amino acid sequence being at	    Total Percent Similarity:   99.67      Total Percent Identity:   99.67                                               
						IVRGISPTKGPFGLRPVLPDPSPPGPSTVEERVAQEALETLQLEKRLSLLSHAGRPGSGG 	                        Gaps:       0                        
						DDRSLSSSSSEASHLDVSASSRLTAWPEQSSSSASTSQEGPRPAAAQAAGEAMVGASRPP 	                                                            
						PKPLRPRQLQEVGRQSSSDSGIATGSHSSYSSSLSSYAGSSLDVWRATDELGSLLSLPAA 	Alignment:                                                   
						GAPEPSLCTCLPGTVEYQVPTSLRAHYDTPRSLCLAPRDHSPPSQGSPGNSAARDSGGQT 	                  .         .         .         .         .  
						SAGCPSGWLGTRRRGLVMEAPQ                                       	     191 IVRGISPTKGPFGLRPVLPDPSPPGPSTVEERVAQEALETLQLEKRLSLL 240                                                          
						least 90 % homologous to corresponding to amino acids 1 - 262	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of AAH43568, which also corresponds to amino acids 191 - 452 	       1 IVRGISPTKGPFGLRPVLPDPSPPGPSTVEERVAQEALETLQLEKRLSLL 50                                                           
						of AA779697_P2, a bridging amino acid G corresponding to     	                  .         .         .         .         .  
						amino acid 453 of AA779697_P2, and a third amino acid        	     241 SHAGRPGSGGDDRSLSSSSSEASHLDVSASSRLTAWPEQSSSSASTSQEG 290                                                          
						sequence being at least 90 % homologous to                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SEATLPGPAPGEPWEAGGPHAGPPPAFFSACPVCGGLKVNPPP corresponding to 	      51 SHAGRPGSGGDDRSLSSSSSEASHLDVSASSRLTAWPEQSSSSASTSQEG 100                                                          
						amino acids 264 - 306 of AAH43568, which also corresponds to 	                  .         .         .         .         .  
						amino acids 454 - 496 of AA779697_P2, wherein said first     	     291 PRPAAAQAAGEAMVGASRPPPKPLRPRQLQEVGRQSSSDSGIATGSHSSY 340                                                          
						amino acid sequence, second amino acid sequence, bridging    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid and third amino acid sequence are contiguous and  	     101 PRPAAAQAAGEAMVGASRPPPKPLRPRQLQEVGRQSSSDSGIATGSHSSY 150                                                          
						in a sequential order.2.An isolated polypeptide encoding for 	                  .         .         .         .         .  
						a head of AA779697_P2, comprising a polypeptide being at     	     341 SSSLSSYAGSSLDVWRATDELGSLLSLPAAGAPEPSLCTCLPGTVEYQVP 390                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     151 SSSLSSYAGSSLDVWRATDELGSLLSLPAAGAPEPSLCTCLPGTVEYQVP 200                                                          
						MTEAALVEGQWKSRWLVLRKPSPVADCLLMLVYKDKSERIKGLRERSSLTLEDICGLEPG 	                  .         .         .         .         .  
						LPYEGLVHTLAIVCLSQAIMLGFDSHEAMCAWDARIRYALGEVHRFHVTVAPGTKLESGP 	     391 TSLRAHYDTPRSLCLAPRDHSPPSQGSPGNSAARDSGGQTSAGCPSGWLG 440                                                          
						ATLHLCNDVLVLARDIPPAVTGQWKLSDLRRYGAVPSGFIFEGGTRCGYWAGVFFLSSAE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GEQISFLFDC                                                   	     201 TSLRAHYDTPRSLCLAPRDHSPPSQGSPGNSAARDSGGQTSAGCPSGWLG 250                                                          
						preferably at least about 95% homologous to the sequence of  	                  .         .         .         .         .  
						AA779697_P2.                                                 	     441 TRRRGLVMEAPQGSEATLPGPAPGEPWEAGGPHAGPPPAFFSACPVCGGL 490                                                          
						                                                            	         |||||||||||| |||||||||||||||||||||||||||||||||||||  
						                                                            	     251 TRRRGLVMEAPQDSEATLPGPAPGEPWEAGGPHAGPPPAFFSACPVCGGL 300                                                          
						                                                            	                                                             
						                                                            	     491 KVNPPP                                             496                                                          
						                                                            	         ||||||                                              
						                                                            	     301 KVNPPP                                             306                                                          

						Comparison report between AA779697_P2 and Q8NBC1unique head  	Sequence name: Q8NBC1                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA779697_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 27031 x Q8NBC1   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MTEAALVEGQWKSRWLVLRKPSPVADCLLMLVYKDKSERIKGLRERSSLTLEDICGLEPG 	Alignment segment 1/1:                                       
						LPYEGLVHTLAIVCLSQAIMLGFDSHEAMCAWDARIRYALGEVHRFHVTVAPGTKLESGP 	                                                            
						ATLHLCNDVLVLARDIPPAVTGQWKLSDLRRYGAVPSGFIFEGGTRCGYW           	                     Quality: 3182.00                      Escore:       0                                               
						having the sequence corresponding to amino acids 1 - 170 of  	             Matching length:     326                Total length:     326                                               
						AA779697_P2, and a second amino acid sequence being at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AGVFFLSSAEGEQISFLFDCIVRGISPTKGPFGLRPVLPDPSPPGPSTVEERVAQEALET 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LQLEKRLSLLSHAGRPGSGGDDRSLSSSSSEASHLDVSASSRLTAWPEQSSSSASTSQEG 	                        Gaps:       0                        
						PRPAAAQAAGEAMVGASRPPPKPLRPRQLQEVGRQSSSDSGIATGSHSSYSSSLSSYAGS 	                                                            
						SLDVWRATDELGSLLSLPAAGAPEPSLCTCLPGTVEYQVPTSLRAHYDTPRSLCLAPRDH 	Alignment:                                                   
						SPPSQGSPGNSAARDSGGQTSAGCPSGWLGTRRRGLVMEAPQGSEATLPGPAPGEPWEAG 	                  .         .         .         .         .  
						GPHAGPPPAFFSACPVCGGLKVNPPP                                   	     171 AGVFFLSSAEGEQISFLFDCIVRGISPTKGPFGLRPVLPDPSPPGPSTVE 220                                                          
						90 % homologous to corresponding to amino acids 41 - 366 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q8NBC1, which also corresponds to amino acids 171 - 496 of   	      41 AGVFFLSSAEGEQISFLFDCIVRGISPTKGPFGLRPVLPDPSPPGPSTVE 90                                                           
						AA779697_P2, wherein said first amino acid sequence and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	     221 ERVAQEALETLQLEKRLSLLSHAGRPGSGGDDRSLSSSSSEASHLDVSAS 270                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA779697_P2, comprising a polypeptide being at least 70%,    	      91 ERVAQEALETLQLEKRLSLLSHAGRPGSGGDDRSLSSSSSEASHLDVSAS 140                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     271 SRLTAWPEQSSSSASTSQEGPRPAAAQAAGEAMVGASRPPPKPLRPRQLQ 320                                                          
						MTEAALVEGQWKSRWLVLRKPSPVADCLLMLVYKDKSERIKGLRERSSLTLEDICGLEPG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPYEGLVHTLAIVCLSQAIMLGFDSHEAMCAWDARIRYALGEVHRFHVTVAPGTKLESGP 	     141 SRLTAWPEQSSSSASTSQEGPRPAAAQAAGEAMVGASRPPPKPLRPRQLQ 190                                                          
						ATLHLCNDVLVLARDIPPAVTGQWKLSDLRRYGAVPSGFIFEGGTRCGYW           	                  .         .         .         .         .  
						least about 95% homologous to the sequence of AA779697_P2.   	     321 EVGRQSSSDSGIATGSHSSYSSSLSSYAGSSLDVWRATDELGSLLSLPAA 370                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     191 EVGRQSSSDSGIATGSHSSYSSSLSSYAGSSLDVWRATDELGSLLSLPAA 240                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     371 GAPEPSLCTCLPGTVEYQVPTSLRAHYDTPRSLCLAPRDHSPPSQGSPGN 420                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     241 GAPEPSLCTCLPGTVEYQVPTSLRAHYDTPRSLCLAPRDHSPPSQGSPGN 290                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     421 SAARDSGGQTSAGCPSGWLGTRRRGLVMEAPQGSEATLPGPAPGEPWEAG 470                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     291 SAARDSGGQTSAGCPSGWLGTRRRGLVMEAPQGSEATLPGPAPGEPWEAG 340                                                          
						                                                            	                  .         .                                
						                                                            	     471 GPHAGPPPAFFSACPVCGGLKVNPPP                         496                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     341 GPHAGPPPAFFSACPVCGGLKVNPPP                         366                                                          

						Comparison report between AA779697_P2 and Q8N2J3unique head  	Sequence name: Q8N2J3                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AA779697_P2, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 27031 x Q8N2J3   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MTEAALVEGQWKSRWLVLRKPSPVADCLLMLVYKDKSERIKGLRERSSLTLEDICGLEPG 	Alignment segment 1/1:                                       
						LPYEGLVHTLAIVCLSQAIMLGFDSHEAMCAWDARIRYALGEVHRFHVTVAPGTKLESGP 	                                                            
						ATLHLCNDVLVLARDIPPAVTGQWKLSDLRRYGAVPSGFIFEGGTRCGYWAGVFFLSSAE 	                     Quality: 1858.00                      Escore:       0                                               
						GEQISFLFDCIVRGISPTKGPFGLRPVLPDPSPPGPSTVEERVAQEALETLQLEKRLSLL 	             Matching length:     189                Total length:     189                                               
						SHAGRPGSGGDDRSLSSSSSEASHLDVSASSRLTAWPEQSSSSASTSQEGPRPAAAQAAG 	 Matching Percent Similarity:   99.47   Matching Percent Identity:   99.47                                               
						EA                                                           	    Total Percent Similarity:   99.47      Total Percent Identity:   99.47                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       0                        
						to amino acids 1 - 302 of AA779697_P2, a second amino acid   	                                                            
						MVGASRPPPKPLRPRQLQEVGRQSSSDSGIATGSHSSYSSSLSSYAGSSLDVWRATDELG 	Alignment:                                                   
						SLLSLPAAGAPEPSLCTCLPGTVEYQVPTSLRAHYDTPRSLCLAPRDHSPPSQGSPGNSA 	                  .         .         .         .         .  
						ARDSGGQTSAGCPSGWLGTRRRGLVMEAPQ                               	     303 MVGASRPPPKPLRPRQLQEVGRQSSSDSGIATGSHSSYSSSLSSYAGSSL 352                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 150 of Q8N2J3, which also corresponds to     	       1 MVGASRPPPKPLRPRQLQEVGRQSSSDSGIATGSHSSYSSSLSSYAGSSL 50                                                           
						amino acids 303 - 452 of AA779697_P2, a bridging amino acid G	                  .         .         .         .         .  
						corresponding to amino acid 453 of AA779697_P2, a third amino	     353 DVWRATDELGSLLSLPAAGAPEPSLCTCLPGTVEYQVPTSLRAHYDTPRS 402                                                          
						acid sequence being at least 90 % homologous to              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SEATLPGPAPGEPWEAGGPHAGPPPAFFSACPVCGGLK corresponding to amino	      51 DVWRATDELGSLLSLPAAGAPEPSLCTCLPGTVEYQVPTSLRAHYDTPRS 100                                                          
						acids 152 - 189 of Q8N2J3, which also corresponds to amino   	                  .         .         .         .         .  
						acids 454 - 491 of AA779697_P2, and a fourth amino acid      	     403 LCLAPRDHSPPSQGSPGNSAARDSGGQTSAGCPSGWLGTRRRGLVMEAPQ 452                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 LCLAPRDHSPPSQGSPGNSAARDSGGQTSAGCPSGWLGTRRRGLVMEAPQ 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .                      
						having the sequence VNPPP corresponding to amino acids 492 - 	     453 GSEATLPGPAPGEPWEAGGPHAGPPPAFFSACPVCGGLK            491                                                          
						496 of AA779697_P2, wherein said first amino acid sequence,  	          ||||||||||||||||||||||||||||||||||||||             
						second amino acid sequence, bridging amino acid, third amino 	     151 DSEATLPGPAPGEPWEAGGPHAGPPPAFFSACPVCGGLK            189                                                          
						acid sequence and fourth amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	                                                            
						for a head of AA779697_P2, comprising a polypeptide being at 	                                                            
						least 70%, optionally at least about 80%, preferably at least	                                                            
						about 85%, more preferably at least about 90% and most       	                                                            
						MTEAALVEGQWKSRWLVLRKPSPVADCLLMLVYKDKSERIKGLRERSSLTLEDICGLEPG 	                                                            
						LPYEGLVHTLAIVCLSQAIMLGFDSHEAMCAWDARIRYALGEVHRFHVTVAPGTKLESGP 	                                                            
						ATLHLCNDVLVLARDIPPAVTGQWKLSDLRRYGAVPSGFIFEGGTRCGYWAGVFFLSSAE 	                                                            
						GEQISFLFDCIVRGISPTKGPFGLRPVLPDPSPPGPSTVEERVAQEALETLQLEKRLSLL 	                                                            
						SHAGRPGSGGDDRSLSSSSSEASHLDVSASSRLTAWPEQSSSSASTSQEGPRPAAAQAAG 	                                                            
						EA                                                           	                                                            
						preferably at least about 95% homologous to the sequence of  	                                                            
						AA779697_P2.3.An isolated polypeptide encoding for a tail of 	                                                            
						AA779697_P2, comprising a polypeptide being at least 70%,    	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence VNPPP in          	                                                            
						AA779697_P2.                                                 	                                                            

28006	HMR136_AA781495_1_tr0_r1_1_gPRT		Comparison report between AA781495_P1 and Q8WUP9unique head  	Sequence name: Q8WUP9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA781495_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 28006 x Q8WUP9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	Alignment segment 1/1:                                       
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                                                            
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	                     Quality: 3040.00                      Escore:       0                                               
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	             Matching length:     309                Total length:     309                                               
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	                        Gaps:       0                        
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	                                                            
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	Alignment:                                                   
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                  .         .         .         .         .  
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	    1005 DSRSLAQKIVATYRLCSEQLSSQHHYDYGMRAVKSVLTAAGNLKLKYPEE 1054                                                         
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	       1 DSRSLAQKIVATYRLCSEQLSSQHHYDYGMRAVKSVLTAAGNLKLKYPEE 50                                                           
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGYEYLGNSPRLVITPLTD 	                  .         .         .         .         .  
						RCYRTLMGALKLNLGGAPEGPAGTGKTETTKDLAKALAKQCVVFNCSDGLDYKAMGKFFK 	    1055 NESVLLLRALLDVNLAKFLAQDVPLFQGIISDLFPGVVLPKPDYEVFLKV 1104                                                         
						GLAQAGAWACFDEFNRIEVEVLSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVFI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TMNPGYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFL                 	      51 NESVLLLRALLDVNLAKFLAQDVPLFQGIISDLFPGVVLPKPDYEVFLKV 100                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 1004 of AA781495_P1, a second amino acid  	    1105 LNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIVGDPMGGKTSAYKVL 1154                                                         
						DSRSLAQKIVATYRLCSEQLSSQHHYDYGMRAVKSVLTAAGNLKLKYPEENESVLLLRAL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDVNLAKFLAQDVPLFQGIISDLFPGVVLPKPDYEVFLKVLNDNIKKMKLQPVPWFIGKI 	     101 LNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIVGDPMGGKTSAYKVL 150                                                          
						IQIYEMMLVRHGYMIVGDPMGGKTSAYKVLAAALGDLHAANQMEEFAVEYKIINPKAITM 	                  .         .         .         .         .  
						GQLYGCFDQVSHEWMDGVLANAFREQASSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKK 	    1155 AAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMDGVLA 1204                                                         
						LCLMSGEIIQMNSKMSLIFEPADLEQASPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLTKEHKEL                                                    	     151 AAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMDGVLA 200                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 309 of Q8WUP9, which also corresponds to     	    1205 NAFREQASSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQ 1254                                                         
						amino acids 1005 - 1313 of AA781495_P1, and a third amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 70%, optionally at least 80%,   	     201 NAFREQASSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQ 250                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	    1255 MNSKMSLIFEPADLEQASPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPS 1304                                                         
						VNDMFMWLVQPCLEFGRLHCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSQQIFLWLQGLFLFSLVWTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNN 	     251 MNSKMSLIFEPADLEQASPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPS 300                                                          
						IFPERGSIYDFYFIKQASGHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKT 	                                                             
						YLDHEIPMLFVGPTGTGKSAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDR 	    1305 SLTKEHKEL                                          1313                                                         
						RRKGLFGPPIGKKAVVFVDDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVD 	         |||||||||                                           
						MLLVTAMGPPGGGRNDITGRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLR 	     301 SLTKEHKEL                                          309                                                          
						YGKMLVQATKTIYRDAVENFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRL 	                                                            
						WIHEVYRVFYDRLIDKEDRQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLF 	                                                            
						FGDYFKPESDQKIYDEITDLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRV 	                                                            
						LKQDKGHLLLVGIGGSGRQSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGV 	                                                            
						ATKSTVFLFADNQIKDESFVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVE 	                                                            
						VTPLSMYNFFIERVRKNLHIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALEL 	                                                            
						VANKFLEDVELDDNIRVEVVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFK 	                                                            
						TLLNSKRQEVAMMRNRYLTGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIE 	                                                            
						AETREADGKKLLVQADEKEANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADI 	                                                            
						SLVKSMQNPPGPVKLVMESICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLES 	                                                            
						LKTYDKDNIPPLTMKRIRERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVA 	                                                            
						PKRERLREAEGKLAAQMQKLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQ 	                                                            
						KLVRAEKLISGLGGEKDRWTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQN 	                                                            
						QWLAECKDKVIPGFSDFSLSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMI 	                                                            
						DPHGQANKWIKNMEKANKLAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPIL 	                                                            
						LKATFKQQGVEYMRLGENIIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGLQ 	                                                            
						DQLLGIVAAKEKPELEEKKNQLIVESAKNKKHLKEIEDKILEVLSMSKGNILEDETAIKV 	                                                            
						LSSSKVLSEEISEKQKVASMTETQIDETRMGYKPVAVHSATIFFCISDLANIEPMYQYSL 	                                                            
						TWFINLYMHSLTHSTKSEELNLRIKYIIDHFTLSIYNNVCRSLFEKDKLLFSLLLTIGIM 	                                                            
						KQKKEITEEVWYFLLTGGIALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQN 	                                                            
						LGEWKLIYDSAWPHEEQLPGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYIE 	                                                            
						APTFDLQGSYNDSSCCAPLIFVLSPSADPMAGLLKFADDLGMGGTRTQTISLGQGQGPIA 	                                                            
						AKMINNAIKDGTWVVLQNCHLAASWMPTLEKICEEVIVPESTNARFRLWLTSYPSEKFPV 	                                                            
						SILQNGIKMTNEPPKGLRANLLRSYLNDPISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQ 	                                                            
						ERRNFGPLGWNIPYEFNESDLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDK 	                                                            
						DRRLLLSLLSMFYCKEIEEDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGLH 	                                                            
						ENADITKDNQETNQLFEGVLLTLPRQSGGSGKSPQEVVEELAQDILSKLPRDFDLEEVMK 	                                                            
						LYPVVYEESMNTVLRQELIRFNRLTKVVRRSLINLGRAIKGQVLMSSELEEVFNSMLVGK 	                                                            
						VPAMWAAKSYPSLKPLGGYVADLLARLTFFQEWIDKGPPVVFWISGFYFTQSFLTGVSQN 	                                                            
						YARKYTIPIDHIGFEFEVTPQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLPKIL 	                                                            
						YDPLPIIWLKPGESAMFLHQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMPQKH 	                                                            
						WINRGVASLCQLDN                                               	                                                            
						having the sequence corresponding to amino acids 1314 - 3547 	                                                            
						of AA781495_P1, wherein said first amino acid sequence,      	                                                            
						second amino acid sequence and third amino acid sequence are 	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of AA781495_P1, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	                                                            
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                                                            
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	                                                            
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	                                                            
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	                                                            
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	                                                            
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	                                                            
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	                                                            
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	                                                            
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                                                            
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	                                                            
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	                                                            
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	                                                            
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGYEYLGNSPRLVITPLTD 	                                                            
						RCYRTLMGALKLNLGGAPEGPAGTGKTETTKDLAKALAKQCVVFNCSDGLDYKAMGKFFK 	                                                            
						GLAQAGAWACFDEFNRIEVEVLSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVFI 	                                                            
						TMNPGYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFL                 	                                                            
						to the sequence of AA781495_P1.3.An isolated polypeptide     	                                                            
						encoding for a tail of AA781495_P1, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						VNDMFMWLVQPCLEFGRLHCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGL 	                                                            
						SSQQIFLWLQGLFLFSLVWTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNN 	                                                            
						IFPERGSIYDFYFIKQASGHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKT 	                                                            
						YLDHEIPMLFVGPTGTGKSAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDR 	                                                            
						RRKGLFGPPIGKKAVVFVDDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVD 	                                                            
						MLLVTAMGPPGGGRNDITGRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLR 	                                                            
						YGKMLVQATKTIYRDAVENFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRL 	                                                            
						WIHEVYRVFYDRLIDKEDRQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLF 	                                                            
						FGDYFKPESDQKIYDEITDLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRV 	                                                            
						LKQDKGHLLLVGIGGSGRQSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGV 	                                                            
						ATKSTVFLFADNQIKDESFVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVE 	                                                            
						VTPLSMYNFFIERVRKNLHIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALEL 	                                                            
						VANKFLEDVELDDNIRVEVVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFK 	                                                            
						TLLNSKRQEVAMMRNRYLTGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIE 	                                                            
						AETREADGKKLLVQADEKEANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADI 	                                                            
						SLVKSMQNPPGPVKLVMESICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLES 	                                                            
						LKTYDKDNIPPLTMKRIRERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVA 	                                                            
						PKRERLREAEGKLAAQMQKLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQ 	                                                            
						KLVRAEKLISGLGGEKDRWTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQN 	                                                            
						QWLAECKDKVIPGFSDFSLSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMI 	                                                            
						DPHGQANKWIKNMEKANKLAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPIL 	                                                            
						LKATFKQQGVEYMRLGENIIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGLQ 	                                                            
						DQLLGIVAAKEKPELEEKKNQLIVESAKNKKHLKEIEDKILEVLSMSKGNILEDETAIKV 	                                                            
						LSSSKVLSEEISEKQKVASMTETQIDETRMGYKPVAVHSATIFFCISDLANIEPMYQYSL 	                                                            
						TWFINLYMHSLTHSTKSEELNLRIKYIIDHFTLSIYNNVCRSLFEKDKLLFSLLLTIGIM 	                                                            
						KQKKEITEEVWYFLLTGGIALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQN 	                                                            
						LGEWKLIYDSAWPHEEQLPGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYIE 	                                                            
						APTFDLQGSYNDSSCCAPLIFVLSPSADPMAGLLKFADDLGMGGTRTQTISLGQGQGPIA 	                                                            
						AKMINNAIKDGTWVVLQNCHLAASWMPTLEKICEEVIVPESTNARFRLWLTSYPSEKFPV 	                                                            
						SILQNGIKMTNEPPKGLRANLLRSYLNDPISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQ 	                                                            
						ERRNFGPLGWNIPYEFNESDLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDK 	                                                            
						DRRLLLSLLSMFYCKEIEEDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGLH 	                                                            
						ENADITKDNQETNQLFEGVLLTLPRQSGGSGKSPQEVVEELAQDILSKLPRDFDLEEVMK 	                                                            
						LYPVVYEESMNTVLRQELIRFNRLTKVVRRSLINLGRAIKGQVLMSSELEEVFNSMLVGK 	                                                            
						VPAMWAAKSYPSLKPLGGYVADLLARLTFFQEWIDKGPPVVFWISGFYFTQSFLTGVSQN 	                                                            
						YARKYTIPIDHIGFEFEVTPQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLPKIL 	                                                            
						YDPLPIIWLKPGESAMFLHQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMPQKH 	                                                            
						WINRGVASLCQLDN                                               	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA781495_P1.                                              	                                                            

						Comparison report between AA781495_P1 and Q9UG35unique head  	Sequence name: Q9UG35                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for AA781495_P1, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 28006 x Q9UG35   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	Alignment segment 1/1:                                       
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                                                            
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	                     Quality: 9527.00                      Escore:       0                                               
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	             Matching length:     965                Total length:     965                                               
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	 Matching Percent Similarity:   99.90   Matching Percent Identity:   99.90                                               
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	    Total Percent Similarity:   99.90      Total Percent Identity:   99.90                                               
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	                        Gaps:       0                        
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	                                                            
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	Alignment:                                                   
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                  .         .         .         .         .  
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	    2583 VEYMRLGENIIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGL 2632                                                         
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	       1 VEYMRLGENIIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGL 50                                                           
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGYEYLGNSPRLVITPLTD 	                  .         .         .         .         .  
						RCYRTLMGALKLNLGGAPEGPAGTGKTETTKDLAKALAKQCVVFNCSDGLDYKAMGKFFK 	    2633 QDQLLGIVAAKEKPELEEKKNQLIVESAKNKKHLKEIEDKILEVLSMSKG 2682                                                         
						GLAQAGAWACFDEFNRIEVEVLSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVFI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TMNPGYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFLDSRSLAQKIVATYRLC 	      51 QDQLLGIVAAKEKPELEEKKNQLIVESAKNKKHLKEIEDKILEVLSMSKG 100                                                          
						SEQLSSQHHYDYGMRAVKSVLTAAGNLKLKYPEENESVLLLRALLDVNLAKFLAQDVPLF 	                  .         .         .         .         .  
						QGIISDLFPGVVLPKPDYEVFLKVLNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIV 	    2683 NILEDETAIKVLSSSKVLSEEISEKQKVASMTETQIDETRMGYKPVAVHS 2732                                                         
						GDPMGGKTSAYKVLAAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVLANAFREQASSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQMNSKMS 	     101 NILEDETAIKVLSSSKVLSEEISEKQKVASMTETQIDETRMGYKPVAVHS 150                                                          
						LIFEPADLEQASPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPSSLTKEHKELVNDMFMW 	                  .         .         .         .         .  
						LVQPCLEFGRLHCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGLSSQQIFL 	    2733 ATIFFCISDLANIEPMYQYSLTWFINLYMHSLTHSTKSEELNLRIKYIID 2782                                                         
						WLQGLFLFSLVWTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNNIFPERGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IYDFYFIKQASGHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKTYLDHEIP 	     151 ATIFFCISDLANIEPMYQYSLTWFINLYMHSLTHSTKSEELNLRIKYIID 200                                                          
						MLFVGPTGTGKSAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDRRRKGLFG 	                  .         .         .         .         .  
						PPIGKKAVVFVDDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVDMLLVTAM 	    2783 HFTLSIYNNVCRSLFEKDKLLFSLLLTIGIMKQKKEITEEVWYFLLTGGI 2832                                                         
						GPPGGGRNDITGRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLRYGKMLVQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ATKTIYRDAVENFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRLWIHEVYR 	     201 HFTLSIYNNVCRSLFEKDKLLFSLLLTIGIMKQKKEITEEVWYFLLTGGI 250                                                          
						VFYDRLIDKEDRQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLFFGDYFKP 	                  .         .         .         .         .  
						ESDQKIYDEITDLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRVLKQDKGH 	    2833 ALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQNLGEWKLIYD 2882                                                         
						LLLVGIGGSGRQSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGVATKSTVF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LFADNQIKDESFVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVEVTPLSMY 	     251 ALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQNLGEWKLIYD 300                                                          
						NFFIERVRKNLHIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALELVANKFLE 	                  .         .         .         .         .  
						DVELDDNIRVEVVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFKTLLNSKR 	    2883 SAWPHEEQLPGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYI 2932                                                         
						QEVAMMRNRYLTGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIEAETREAD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GKKLLVQADEKEANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADISLVKSMQ 	     301 SAWPHEEQLPGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYI 350                                                          
						NPPGPVKLVMESICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLESLKTYDKD 	                  .         .         .         .         .  
						NIPPLTMKRIRERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVAPKRERLR 	    2933 EAPTFDLQGSYNDSSCCAPLIFVLSPSADPMAGLLKFADDLGMGGTRTQT 2982                                                         
						EAEGKLAAQMQKLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQKLVRAEK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LISGLGGEKDRWTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQNQWLAECK 	     351 EAPTFDLQGSYNDSSCCAPLIFVLSPSADPMAGLLKFADDLGMGGTRTQT 400                                                          
						DKVIPGFSDFSLSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMIDPHGQAN 	                  .         .         .         .         .  
						KWIKNMEKANKLAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPILLKATFKQ 	    2983 ISLGQGQGPIAAKMINNAIKDGTWVVLQNCHLAASWMPTLEKICEEVIVP 3032                                                         
						QG                                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence corresponding to amino acids 	     401 ISLGQGQGPIAAKMINNAIKDGTWVVLQNCHLAASWMPTLEKICEEVIVP 450                                                          
						1 - 2582 of AA781495_P1, a second amino acid sequence being  	                  .         .         .         .         .  
						VEYMRLGENIIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGLQDQLLGIVAA 	    3033 ESTNARFRLWLTSYPSEKFPVSILQNGIKMTNEPPKGLRANLLRSYLNDP 3082                                                         
						KEKPELEEKKNQLIVESAKNKKHLKEIEDKILEVLSMSKGNILEDETAIKVLSSSKVLSE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EISEKQKVASMTETQIDETRMGYKPVAVHSATIFFCISDLANIEPMYQYSLTWFINLYMH 	     451 ESTNARFRLWLTSYPSEKFPVSILQNGIKMTNEPPKGLRANLLRSYLNDP 500                                                          
						SLTHSTKSEELNLRIKYIIDHFTLSIYNNVCRSLFEKDKLLFSLLLTIGIMKQKKEITEE 	                  .         .         .         .         .  
						VWYFLLTGGIALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQNLGEWKLIYD 	    3083 ISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQERRNFGPLGWNIPYEFNES 3132                                                         
						SAWPHEEQLPGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYIEAPTFDLQGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YNDSSCCAPLIFVLSPSADPMAGLLKFADDLGMGGTRTQTISLGQGQGPIAAKMINNAIK 	     501 ISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQERRNFGPLGWNIPYEFNES 550                                                          
						DGTWVVLQNCHLAASWMPTLEKICEEVIVPESTNARFRLWLTSYPSEKFPVSILQNGIKM 	                  .         .         .         .         .  
						TNEPPKGLRANLLRSYLNDPISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQERRNFGPLG 	    3133 DLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDKDRRLLLSLL 3182                                                         
						WNIPYEFNESDLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDKDRRLLLSLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SMFYCKEIEEDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGLHENADITKDN 	     551 DLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDKDRRLLLSLL 600                                                          
						QETNQLFEGVLLTLPR                                             	                  .         .         .         .         .  
						at least 90 % homologous to corresponding to amino acids 1 - 	    3183 SMFYCKEIEEDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGL 3232                                                         
						676 of Q9UG35, which also corresponds to amino acids 2583 -  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						3258 of AA781495_P1, a bridging amino acid Q corresponding to	     601 SMFYCKEIEEDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGL 650                                                          
						amino acid 3259 of AA781495_P1, and a third amino acid       	                  .         .         .         .         .  
						SGGSGKSPQEVVEELAQDILSKLPRDFDLEEVMKLYPVVYEESMNTVLRQELIRFNRLTK 	    3233 HENADITKDNQETNQLFEGVLLTLPRQSGGSGKSPQEVVEELAQDILSKL 3282                                                         
						VVRRSLINLGRAIKGQVLMSSELEEVFNSMLVGKVPAMWAAKSYPSLKPLGGYVADLLAR 	         |||||||||||||||||||||||||| |||||||||||||||||||||||  
						LTFFQEWIDKGPPVVFWISGFYFTQSFLTGVSQNYARKYTIPIDHIGFEFEVTPQETVME 	     651 HENADITKDNQETNQLFEGVLLTLPRMSGGSGKSPQEVVEELAQDILSKL 700                                                          
						NNPEDGAYIKGLFLEGARWDRKTMQIGESLPKILYDPLPIIWLKPGESAMFLHQDIYVCP 	                  .         .         .         .         .  
						VYKTSARRGTLSTTGHSTNYVLSIELPTDMPQKHWINRGVASLCQLDN             	    3283 PRDFDLEEVMKLYPVVYEESMNTVLRQELIRFNRLTKVVRRSLINLGRAI 3332                                                         
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 678 - 965 of Q9UG35, which also corresponds to   	     701 PRDFDLEEVMKLYPVVYEESMNTVLRQELIRFNRLTKVVRRSLINLGRAI 750                                                          
						amino acids 3260 - 3547 of AA781495_P1, wherein said first   	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence, bridging    	    3333 KGQVLMSSELEEVFNSMLVGKVPAMWAAKSYPSLKPLGGYVADLLARLTF 3382                                                         
						amino acid and third amino acid sequence are contiguous and  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						in a sequential order.2.An isolated polypeptide encoding for 	     751 KGQVLMSSELEEVFNSMLVGKVPAMWAAKSYPSLKPLGGYVADLLARLTF 800                                                          
						a head of AA781495_P1, comprising a polypeptide being at     	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	    3383 FQEWIDKGPPVVFWISGFYFTQSFLTGVSQNYARKYTIPIDHIGFEFEVT 3432                                                         
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	     801 FQEWIDKGPPVVFWISGFYFTQSFLTGVSQNYARKYTIPIDHIGFEFEVT 850                                                          
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                  .         .         .         .         .  
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	    3433 PQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLPKILYDPLPIIWL 3482                                                         
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	     851 PQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLPKILYDPLPIIWL 900                                                          
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	                  .         .         .         .         .  
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	    3483 KPGESAMFLHQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMPQK 3532                                                         
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	     901 KPGESAMFLHQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMPQK 950                                                          
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                  .                                          
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	    3533 HWINRGVASLCQLDN                                    3547                                                         
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	         |||||||||||||||                                     
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	     951 HWINRGVASLCQLDN                                    965                                                          
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGYEYLGNSPRLVITPLTD 	                                                            
						RCYRTLMGALKLNLGGAPEGPAGTGKTETTKDLAKALAKQCVVFNCSDGLDYKAMGKFFK 	                                                            
						GLAQAGAWACFDEFNRIEVEVLSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVFI 	                                                            
						TMNPGYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFLDSRSLAQKIVATYRLC 	                                                            
						SEQLSSQHHYDYGMRAVKSVLTAAGNLKLKYPEENESVLLLRALLDVNLAKFLAQDVPLF 	                                                            
						QGIISDLFPGVVLPKPDYEVFLKVLNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIV 	                                                            
						GDPMGGKTSAYKVLAAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMD 	                                                            
						GVLANAFREQASSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQMNSKMS 	                                                            
						LIFEPADLEQASPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPSSLTKEHKELVNDMFMW 	                                                            
						LVQPCLEFGRLHCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGLSSQQIFL 	                                                            
						WLQGLFLFSLVWTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNNIFPERGS 	                                                            
						IYDFYFIKQASGHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKTYLDHEIP 	                                                            
						MLFVGPTGTGKSAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDRRRKGLFG 	                                                            
						PPIGKKAVVFVDDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVDMLLVTAM 	                                                            
						GPPGGGRNDITGRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLRYGKMLVQ 	                                                            
						ATKTIYRDAVENFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRLWIHEVYR 	                                                            
						VFYDRLIDKEDRQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLFFGDYFKP 	                                                            
						ESDQKIYDEITDLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRVLKQDKGH 	                                                            
						LLLVGIGGSGRQSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGVATKSTVF 	                                                            
						LFADNQIKDESFVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVEVTPLSMY 	                                                            
						NFFIERVRKNLHIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALELVANKFLE 	                                                            
						DVELDDNIRVEVVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFKTLLNSKR 	                                                            
						QEVAMMRNRYLTGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIEAETREAD 	                                                            
						GKKLLVQADEKEANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADISLVKSMQ 	                                                            
						NPPGPVKLVMESICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLESLKTYDKD 	                                                            
						NIPPLTMKRIRERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVAPKRERLR 	                                                            
						EAEGKLAAQMQKLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQKLVRAEK 	                                                            
						LISGLGGEKDRWTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQNQWLAECK 	                                                            
						DKVIPGFSDFSLSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMIDPHGQAN 	                                                            
						KWIKNMEKANKLAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPILLKATFKQ 	                                                            
						QG                                                           	                                                            
						preferably at least about 95% homologous to the sequence of  	                                                            
						AA781495_P1.                                                 	                                                            

						Comparison report between AA781495_P1 and Q9UEM5unique head  	Sequence name: Q9UEM5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA781495_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 28006 x Q9UEM5   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	Alignment segment 1/1:                                       
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                                                            
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	                     Quality: 1376.00                      Escore:       0                                               
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	             Matching length:     143                Total length:     143                                               
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.30                                               
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.30                                               
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	                        Gaps:       0                        
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	                                                            
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	Alignment:                                                   
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                  .         .         .         .         .  
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	     822 YGYEYLGNSPRLVITPLTDRCYRTLMGALKLNLGGAPEGPAGTGKTETTK 871                                                          
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	         ||:|||||||||||||||||||||||||||||||||||||||||||||||  
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	       1 YGFEYLGNSPRLVITPLTDRCYRTLMGALKLNLGGAPEGPAGTGKTETTK 50                                                           
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGY                 	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     872 DLAKALAKQCVVFNCSDGLDYKAMGKFFKGLAQAGAWACFDEFNRIEVEV 921                                                          
						to amino acids 1 - 824 of AA781495_P1, a second amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EYLGNSPRLVITPLTDRCYRTLMGALKLNLGGAPEGPAGTGKTETTKDLAKALAKQCVVF 	      51 DLAKALAKQCVVFNCSDGLDYKAMGKFFKGLAQAGAWACFDEFNRIEVEV 100                                                          
						NCSDGLDYKAMGKFFKGLAQAGAWACFDEFNRIEVEVLSVVAQQILSIQQAIIRKLKTFI 	                  .         .         .         .            
						FEGTELSLNPTCAVFITMNP                                         	     922 LSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVFITMNP        964                                                          
						sequence being at least 90 % homologous to corresponding to  	         |||||||||||||||||||||||||||||||||||||||||||         
						amino acids 4 - 143 of Q9UEM5, which also corresponds to     	     101 LSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVFITMNP        143                                                          
						amino acids 825 - 964 of AA781495_P1, and a third amino acid 	                                                            
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						GYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFLDSRSLAQKIVATYRLCSEQL 	                                                            
						SSQHHYDYGMRAVKSVLTAAGNLKLKYPEENESVLLLRALLDVNLAKFLAQDVPLFQGII 	                                                            
						SDLFPGVVLPKPDYEVFLKVLNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIVGDPM 	                                                            
						GGKTSAYKVLAAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMDGVLA 	                                                            
						NAFREQASSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQMNSKMSLIFE 	                                                            
						PADLEQASPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPSSLTKEHKELVNDMFMWLVQP 	                                                            
						CLEFGRLHCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGLSSQQIFLWLQG 	                                                            
						LFLFSLVWTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNNIFPERGSIYDF 	                                                            
						YFIKQASGHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKTYLDHEIPMLFV 	                                                            
						GPTGTGKSAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDRRRKGLFGPPIG 	                                                            
						KKAVVFVDDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVDMLLVTAMGPPG 	                                                            
						GGRNDITGRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLRYGKMLVQATKT 	                                                            
						IYRDAVENFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRLWIHEVYRVFYD 	                                                            
						RLIDKEDRQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLFFGDYFKPESDQ 	                                                            
						KIYDEITDLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRVLKQDKGHLLLV 	                                                            
						GIGGSGRQSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGVATKSTVFLFAD 	                                                            
						NQIKDESFVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVEVTPLSMYNFFI 	                                                            
						ERVRKNLHIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALELVANKFLEDVEL 	                                                            
						DDNIRVEVVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFKTLLNSKRQEVA 	                                                            
						MMRNRYLTGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIEAETREADGKKL 	                                                            
						LVQADEKEANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADISLVKSMQNPPG 	                                                            
						PVKLVMESICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLESLKTYDKDNIPP 	                                                            
						LTMKRIRERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVAPKRERLREAEG 	                                                            
						KLAAQMQKLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQKLVRAEKLISG 	                                                            
						LGGEKDRWTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQNQWLAECKDKVI 	                                                            
						PGFSDFSLSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMIDPHGQANKWIK 	                                                            
						NMEKANKLAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPILLKATFKQQGVE 	                                                            
						YMRLGENIIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGLQDQLLGIVAAKE 	                                                            
						KPELEEKKNQLIVESAKNKKHLKEIEDKILEVLSMSKGNILEDETAIKVLSSSKVLSEEI 	                                                            
						SEKQKVASMTETQIDETRMGYKPVAVHSATIFFCISDLANIEPMYQYSLTWFINLYMHSL 	                                                            
						THSTKSEELNLRIKYIIDHFTLSIYNNVCRSLFEKDKLLFSLLLTIGIMKQKKEITEEVW 	                                                            
						YFLLTGGIALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQNLGEWKLIYDSA 	                                                            
						WPHEEQLPGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYIEAPTFDLQGSYN 	                                                            
						DSSCCAPLIFVLSPSADPMAGLLKFADDLGMGGTRTQTISLGQGQGPIAAKMINNAIKDG 	                                                            
						TWVVLQNCHLAASWMPTLEKICEEVIVPESTNARFRLWLTSYPSEKFPVSILQNGIKMTN 	                                                            
						EPPKGLRANLLRSYLNDPISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQERRNFGPLGWN 	                                                            
						IPYEFNESDLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDKDRRLLLSLLSM 	                                                            
						FYCKEIEEDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGLHENADITKDNQE 	                                                            
						TNQLFEGVLLTLPRQSGGSGKSPQEVVEELAQDILSKLPRDFDLEEVMKLYPVVYEESMN 	                                                            
						TVLRQELIRFNRLTKVVRRSLINLGRAIKGQVLMSSELEEVFNSMLVGKVPAMWAAKSYP 	                                                            
						SLKPLGGYVADLLARLTFFQEWIDKGPPVVFWISGFYFTQSFLTGVSQNYARKYTIPIDH 	                                                            
						IGFEFEVTPQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLPKILYDPLPIIWLKP 	                                                            
						GESAMFLHQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMPQKHWINRGVASLCQ 	                                                            
						LDN                                                          	                                                            
						having the sequence corresponding to amino acids 965 - 3547  	                                                            
						of AA781495_P1, wherein said first amino acid sequence,      	                                                            
						second amino acid sequence and third amino acid sequence are 	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of AA781495_P1, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	                                                            
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                                                            
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	                                                            
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	                                                            
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	                                                            
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	                                                            
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	                                                            
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	                                                            
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	                                                            
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                                                            
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	                                                            
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	                                                            
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	                                                            
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGY                 	                                                            
						to the sequence of AA781495_P1.3.An isolated polypeptide     	                                                            
						encoding for a tail of AA781495_P1, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						GYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFLDSRSLAQKIVATYRLCSEQL 	                                                            
						SSQHHYDYGMRAVKSVLTAAGNLKLKYPEENESVLLLRALLDVNLAKFLAQDVPLFQGII 	                                                            
						SDLFPGVVLPKPDYEVFLKVLNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIVGDPM 	                                                            
						GGKTSAYKVLAAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMDGVLA 	                                                            
						NAFREQASSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQMNSKMSLIFE 	                                                            
						PADLEQASPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPSSLTKEHKELVNDMFMWLVQP 	                                                            
						CLEFGRLHCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGLSSQQIFLWLQG 	                                                            
						LFLFSLVWTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNNIFPERGSIYDF 	                                                            
						YFIKQASGHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKTYLDHEIPMLFV 	                                                            
						GPTGTGKSAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDRRRKGLFGPPIG 	                                                            
						KKAVVFVDDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVDMLLVTAMGPPG 	                                                            
						GGRNDITGRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLRYGKMLVQATKT 	                                                            
						IYRDAVENFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRLWIHEVYRVFYD 	                                                            
						RLIDKEDRQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLFFGDYFKPESDQ 	                                                            
						KIYDEITDLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRVLKQDKGHLLLV 	                                                            
						GIGGSGRQSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGVATKSTVFLFAD 	                                                            
						NQIKDESFVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVEVTPLSMYNFFI 	                                                            
						ERVRKNLHIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALELVANKFLEDVEL 	                                                            
						DDNIRVEVVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFKTLLNSKRQEVA 	                                                            
						MMRNRYLTGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIEAETREADGKKL 	                                                            
						LVQADEKEANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADISLVKSMQNPPG 	                                                            
						PVKLVMESICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLESLKTYDKDNIPP 	                                                            
						LTMKRIRERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVAPKRERLREAEG 	                                                            
						KLAAQMQKLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQKLVRAEKLISG 	                                                            
						LGGEKDRWTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQNQWLAECKDKVI 	                                                            
						PGFSDFSLSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMIDPHGQANKWIK 	                                                            
						NMEKANKLAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPILLKATFKQQGVE 	                                                            
						YMRLGENIIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGLQDQLLGIVAAKE 	                                                            
						KPELEEKKNQLIVESAKNKKHLKEIEDKILEVLSMSKGNILEDETAIKVLSSSKVLSEEI 	                                                            
						SEKQKVASMTETQIDETRMGYKPVAVHSATIFFCISDLANIEPMYQYSLTWFINLYMHSL 	                                                            
						THSTKSEELNLRIKYIIDHFTLSIYNNVCRSLFEKDKLLFSLLLTIGIMKQKKEITEEVW 	                                                            
						YFLLTGGIALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQNLGEWKLIYDSA 	                                                            
						WPHEEQLPGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYIEAPTFDLQGSYN 	                                                            
						DSSCCAPLIFVLSPSADPMAGLLKFADDLGMGGTRTQTISLGQGQGPIAAKMINNAIKDG 	                                                            
						TWVVLQNCHLAASWMPTLEKICEEVIVPESTNARFRLWLTSYPSEKFPVSILQNGIKMTN 	                                                            
						EPPKGLRANLLRSYLNDPISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQERRNFGPLGWN 	                                                            
						IPYEFNESDLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDKDRRLLLSLLSM 	                                                            
						FYCKEIEEDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGLHENADITKDNQE 	                                                            
						TNQLFEGVLLTLPRQSGGSGKSPQEVVEELAQDILSKLPRDFDLEEVMKLYPVVYEESMN 	                                                            
						TVLRQELIRFNRLTKVVRRSLINLGRAIKGQVLMSSELEEVFNSMLVGKVPAMWAAKSYP 	                                                            
						SLKPLGGYVADLLARLTFFQEWIDKGPPVVFWISGFYFTQSFLTGVSQNYARKYTIPIDH 	                                                            
						IGFEFEVTPQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLPKILYDPLPIIWLKP 	                                                            
						GESAMFLHQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMPQKHWINRGVASLCQ 	                                                            
						LDN                                                          	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA781495_P1.                                              	                                                            

						Comparison report between AA781495_P1 and O00437unique head  	Sequence name: O00437                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AA781495_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 28006 x O00437   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	Alignment segment 1/1:                                       
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                                                            
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	                     Quality: 1667.00                      Escore:       0                                               
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	             Matching length:     177                Total length:     177                                               
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	 Matching Percent Similarity:   98.87   Matching Percent Identity:   97.74                                               
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	    Total Percent Similarity:   98.87      Total Percent Identity:   97.74                                               
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	                        Gaps:       0                        
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	                                                            
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	Alignment:                                                   
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                  .         .         .         .         .  
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	     860 GPAGTGKTETTKDLAKALAKQCVVFNCSDGLDYKAMGKFFKGLAQAGAWA 909                                                          
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	         |||||||||||| |||||||||||||||||||||||||||||||||||||  
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	       1 GPAGTGKTETTKVLAKALAKQCVVFNCSDGLDYKAMGKFFKGLAQAGAWA 50                                                           
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGYEYLGNSPRLVITPLTD 	                  .         .         .         .         .  
						RCYRTLMGALKLNLGGAPE                                          	     910 CFDEFNRIEVEVLSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVF 959                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 859 of AA781495_P1, a second amino acid   	      51 CFDEFNRIEVEVLSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVF 100                                                          
						sequence being at least 90 % homologous to GPAGTGKTETTK      	                  .         .         .         .         .  
						corresponding to amino acids 1 - 12 of O00437, which also    	     960 ITMNPGYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFLDSRSL 1009                                                         
						corresponds to amino acids 860 - 871 of AA781495_P1, a       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						bridging amino acid D corresponding to amino acid 872 of     	     101 ITMNPGYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFLDSRSL 150                                                          
						AA781495_P1, a third amino acid sequence being at least 90 % 	                  .         .                                
						LAKALAKQCVVFNCSDGLDYKAMGKFFKGLAQAGAWACFDEFNRIEVEVLSVVAQQILSI 	    1010 AQKIVATYRLCSEQLSSQHHYDYGMRA                        1036                                                         
						QQAIIRKLKTFIFEGTELSLNPTCAVFITMNPGYAGRAELPDNLKALFRTVAMMVPDYAL 	         ||||||||||||||||||||||:|: |                         
						IGEISLYSMGFLDSRSLAQKIVATYRLCSEQLSSQHHYD                      	     151 AQKIVATYRLCSEQLSSQHHYDFGLHA                        177                                                          
						homologous to corresponding to amino acids 14 - 172 of       	                                                            
						O00437, which also corresponds to amino acids 873 - 1031 of  	                                                            
						AA781495_P1, and a fourth amino acid sequence being at least 	                                                            
						70%, optionally at least 80%, preferably at least 85%, more  	                                                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						YGMRAVKSVLTAAGNLKLKYPEENESVLLLRALLDVNLAKFLAQDVPLFQGIISDLFPGV 	                                                            
						VLPKPDYEVFLKVLNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIVGDPMGGKTSAY 	                                                            
						KVLAAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMDGVLANAFREQA 	                                                            
						SSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQMNSKMSLIFEPADLEQA 	                                                            
						SPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPSSLTKEHKELVNDMFMWLVQPCLEFGRL 	                                                            
						HCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGLSSQQIFLWLQGLFLFSLV 	                                                            
						WTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNNIFPERGSIYDFYFIKQAS 	                                                            
						GHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKTYLDHEIPMLFVGPTGTGK 	                                                            
						SAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDRRRKGLFGPPIGKKAVVFV 	                                                            
						DDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVDMLLVTAMGPPGGGRNDIT 	                                                            
						GRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLRYGKMLVQATKTIYRDAVE 	                                                            
						NFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRLWIHEVYRVFYDRLIDKED 	                                                            
						RQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLFFGDYFKPESDQKIYDEIT 	                                                            
						DLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRVLKQDKGHLLLVGIGGSGR 	                                                            
						QSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGVATKSTVFLFADNQIKDES 	                                                            
						FVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVEVTPLSMYNFFIERVRKNL 	                                                            
						HIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALELVANKFLEDVELDDNIRVE 	                                                            
						VVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFKTLLNSKRQEVAMMRNRYL 	                                                            
						TGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIEAETREADGKKLLVQADEK 	                                                            
						EANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADISLVKSMQNPPGPVKLVME 	                                                            
						SICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLESLKTYDKDNIPPLTMKRIR 	                                                            
						ERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVAPKRERLREAEGKLAAQMQ 	                                                            
						KLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQKLVRAEKLISGLGGEKDR 	                                                            
						WTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQNQWLAECKDKVIPGFSDFS 	                                                            
						LSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMIDPHGQANKWIKNMEKANK 	                                                            
						LAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPILLKATFKQQGVEYMRLGEN 	                                                            
						IIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGLQDQLLGIVAAKEKPELEEK 	                                                            
						KNQLIVESAKNKKHLKEIEDKILEVLSMSKGNILEDETAIKVLSSSKVLSEEISEKQKVA 	                                                            
						SMTETQIDETRMGYKPVAVHSATIFFCISDLANIEPMYQYSLTWFINLYMHSLTHSTKSE 	                                                            
						ELNLRIKYIIDHFTLSIYNNVCRSLFEKDKLLFSLLLTIGIMKQKKEITEEVWYFLLTGG 	                                                            
						IALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQNLGEWKLIYDSAWPHEEQL 	                                                            
						PGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYIEAPTFDLQGSYNDSSCCAP 	                                                            
						LIFVLSPSADPMAGLLKFADDLGMGGTRTQTISLGQGQGPIAAKMINNAIKDGTWVVLQN 	                                                            
						CHLAASWMPTLEKICEEVIVPESTNARFRLWLTSYPSEKFPVSILQNGIKMTNEPPKGLR 	                                                            
						ANLLRSYLNDPISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQERRNFGPLGWNIPYEFNE 	                                                            
						SDLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDKDRRLLLSLLSMFYCKEIE 	                                                            
						EDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGLHENADITKDNQETNQLFEG 	                                                            
						VLLTLPRQSGGSGKSPQEVVEELAQDILSKLPRDFDLEEVMKLYPVVYEESMNTVLRQEL 	                                                            
						IRFNRLTKVVRRSLINLGRAIKGQVLMSSELEEVFNSMLVGKVPAMWAAKSYPSLKPLGG 	                                                            
						YVADLLARLTFFQEWIDKGPPVVFWISGFYFTQSFLTGVSQNYARKYTIPIDHIGFEFEV 	                                                            
						TPQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLPKILYDPLPIIWLKPGESAMFL 	                                                            
						HQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMPQKHWINRGVASLCQLDN     	                                                            
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1032 - 3547 of AA781495_P1, wherein said first	                                                            
						amino acid sequence, second amino acid sequence, bridging    	                                                            
						amino acid, third amino acid sequence and fourth amino acid  	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of AA781495_P1,     	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	                                                            
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                                                            
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	                                                            
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	                                                            
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	                                                            
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	                                                            
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	                                                            
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	                                                            
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	                                                            
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                                                            
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	                                                            
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	                                                            
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	                                                            
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGYEYLGNSPRLVITPLTD 	                                                            
						RCYRTLMGALKLNLGGAPE                                          	                                                            
						about 95% homologous to the sequence of AA781495_P1.3.An     	                                                            
						isolated polypeptide encoding for a tail of AA781495_P1,     	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						YGMRAVKSVLTAAGNLKLKYPEENESVLLLRALLDVNLAKFLAQDVPLFQGIISDLFPGV 	                                                            
						VLPKPDYEVFLKVLNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIVGDPMGGKTSAY 	                                                            
						KVLAAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMDGVLANAFREQA 	                                                            
						SSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQMNSKMSLIFEPADLEQA 	                                                            
						SPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPSSLTKEHKELVNDMFMWLVQPCLEFGRL 	                                                            
						HCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGLSSQQIFLWLQGLFLFSLV 	                                                            
						WTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNNIFPERGSIYDFYFIKQAS 	                                                            
						GHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKTYLDHEIPMLFVGPTGTGK 	                                                            
						SAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDRRRKGLFGPPIGKKAVVFV 	                                                            
						DDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVDMLLVTAMGPPGGGRNDIT 	                                                            
						GRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLRYGKMLVQATKTIYRDAVE 	                                                            
						NFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRLWIHEVYRVFYDRLIDKED 	                                                            
						RQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLFFGDYFKPESDQKIYDEIT 	                                                            
						DLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRVLKQDKGHLLLVGIGGSGR 	                                                            
						QSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGVATKSTVFLFADNQIKDES 	                                                            
						FVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVEVTPLSMYNFFIERVRKNL 	                                                            
						HIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALELVANKFLEDVELDDNIRVE 	                                                            
						VVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFKTLLNSKRQEVAMMRNRYL 	                                                            
						TGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIEAETREADGKKLLVQADEK 	                                                            
						EANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADISLVKSMQNPPGPVKLVME 	                                                            
						SICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLESLKTYDKDNIPPLTMKRIR 	                                                            
						ERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVAPKRERLREAEGKLAAQMQ 	                                                            
						KLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQKLVRAEKLISGLGGEKDR 	                                                            
						WTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQNQWLAECKDKVIPGFSDFS 	                                                            
						LSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMIDPHGQANKWIKNMEKANK 	                                                            
						LAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPILLKATFKQQGVEYMRLGEN 	                                                            
						IIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGLQDQLLGIVAAKEKPELEEK 	                                                            
						KNQLIVESAKNKKHLKEIEDKILEVLSMSKGNILEDETAIKVLSSSKVLSEEISEKQKVA 	                                                            
						SMTETQIDETRMGYKPVAVHSATIFFCISDLANIEPMYQYSLTWFINLYMHSLTHSTKSE 	                                                            
						ELNLRIKYIIDHFTLSIYNNVCRSLFEKDKLLFSLLLTIGIMKQKKEITEEVWYFLLTGG 	                                                            
						IALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQNLGEWKLIYDSAWPHEEQL 	                                                            
						PGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYIEAPTFDLQGSYNDSSCCAP 	                                                            
						LIFVLSPSADPMAGLLKFADDLGMGGTRTQTISLGQGQGPIAAKMINNAIKDGTWVVLQN 	                                                            
						CHLAASWMPTLEKICEEVIVPESTNARFRLWLTSYPSEKFPVSILQNGIKMTNEPPKGLR 	                                                            
						ANLLRSYLNDPISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQERRNFGPLGWNIPYEFNE 	                                                            
						SDLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDKDRRLLLSLLSMFYCKEIE 	                                                            
						EDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGLHENADITKDNQETNQLFEG 	                                                            
						VLLTLPRQSGGSGKSPQEVVEELAQDILSKLPRDFDLEEVMKLYPVVYEESMNTVLRQEL 	                                                            
						IRFNRLTKVVRRSLINLGRAIKGQVLMSSELEEVFNSMLVGKVPAMWAAKSYPSLKPLGG 	                                                            
						YVADLLARLTFFQEWIDKGPPVVFWISGFYFTQSFLTGVSQNYARKYTIPIDHIGFEFEV 	                                                            
						TPQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLPKILYDPLPIIWLKPGESAMFL 	                                                            
						HQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMPQKHWINRGVASLCQLDN     	                                                            
						about 95% homologous to the sequence in AA781495_P1.         	                                                            

28004	HMR136_AA781495_4_tr0_r1_1_gPRT		Comparison report between AA781495_P4 and Q8WUP9unique head  	Sequence name: Q8WUP9                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA781495_P4, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 28004 x Q8WUP9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	Alignment segment 1/1:                                       
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                                                            
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	                     Quality: 3040.00                      Escore:       0                                               
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	             Matching length:     309                Total length:     309                                               
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	                        Gaps:       0                        
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	                                                            
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	Alignment:                                                   
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                  .         .         .         .         .  
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	    1005 DSRSLAQKIVATYRLCSEQLSSQHHYDYGMRAVKSVLTAAGNLKLKYPEE 1054                                                         
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	       1 DSRSLAQKIVATYRLCSEQLSSQHHYDYGMRAVKSVLTAAGNLKLKYPEE 50                                                           
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGYEYLGNSPRLVITPLTD 	                  .         .         .         .         .  
						RCYRTLMGALKLNLGGAPEGPAGTGKTETTKDLAKALAKQCVVFNCSDGLDYKAMGKFFK 	    1055 NESVLLLRALLDVNLAKFLAQDVPLFQGIISDLFPGVVLPKPDYEVFLKV 1104                                                         
						GLAQAGAWACFDEFNRIEVEVLSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVFI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TMNPGYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFL                 	      51 NESVLLLRALLDVNLAKFLAQDVPLFQGIISDLFPGVVLPKPDYEVFLKV 100                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 1004 of AA781495_P4, a second amino acid  	    1105 LNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIVGDPMGGKTSAYKVL 1154                                                         
						DSRSLAQKIVATYRLCSEQLSSQHHYDYGMRAVKSVLTAAGNLKLKYPEENESVLLLRAL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LDVNLAKFLAQDVPLFQGIISDLFPGVVLPKPDYEVFLKVLNDNIKKMKLQPVPWFIGKI 	     101 LNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIVGDPMGGKTSAYKVL 150                                                          
						IQIYEMMLVRHGYMIVGDPMGGKTSAYKVLAAALGDLHAANQMEEFAVEYKIINPKAITM 	                  .         .         .         .         .  
						GQLYGCFDQVSHEWMDGVLANAFREQASSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKK 	    1155 AAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMDGVLA 1204                                                         
						LCLMSGEIIQMNSKMSLIFEPADLEQASPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SLTKEHKEL                                                    	     151 AAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMDGVLA 200                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 309 of Q8WUP9, which also corresponds to     	    1205 NAFREQASSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQ 1254                                                         
						amino acids 1005 - 1313 of AA781495_P4, and a third amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 70%, optionally at least 80%,   	     201 NAFREQASSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQ 250                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	    1255 MNSKMSLIFEPADLEQASPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPS 1304                                                         
						VNDMFMWLVQPCLEFGRLHCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSQQIFLWLQGLFLFSLVWTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNN 	     251 MNSKMSLIFEPADLEQASPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPS 300                                                          
						IFPERGSIYDFYFIKQASGHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKT 	                                                             
						YLDHEIPMLFVGPTGTGKSAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDR 	    1305 SLTKEHKEL                                          1313                                                         
						RRKGLFGPPIGKKAVVFVDDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVD 	         |||||||||                                           
						MLLVTAMGPPGGGRNDITGRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLR 	     301 SLTKEHKEL                                          309                                                          
						YGKMLVQATKTIYRDAVENFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRL 	                                                            
						WIHEVYRVFYDRLIDKEDRQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLF 	                                                            
						FGDYFKPESDQKIYDEITDLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRV 	                                                            
						LKQDKGHLLLVGIGGSGRQSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGV 	                                                            
						ATKSTVFLFADNQIKDESFVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVE 	                                                            
						VTPLSMYNFFIERVRKNLHIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALEL 	                                                            
						VANKFLEDVELDDNIRVEVVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFK 	                                                            
						TLLNSKRQEVAMMRNRYLTGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIE 	                                                            
						AETREADGKKLLVQADEKEANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADI 	                                                            
						SLVKSMQNPPGPVKLVMESICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLES 	                                                            
						LKTYDKDNIPPLTMKRIRERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVA 	                                                            
						PKRERLREAEGKLAAQMQKLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQ 	                                                            
						KLVRAEKLISGLGGEKDRWTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQN 	                                                            
						QWLAECKDKVIPGFSDFSLSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMI 	                                                            
						DPHGQANKWIKNMEKANKLAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPIL 	                                                            
						LKATFKQQGVEYMRLGENIIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGLQ 	                                                            
						DQLLGIVAAKEKPELEEKKNQLIVESAKNKKHLKEIEDKILEVLSMSKGNILEDETAIKV 	                                                            
						LSSSKVLSEEISEKQKVASMTETQIDETRMGYKPVAVHSATIFFCISDLANIEPMYQYSL 	                                                            
						TWFINLYMHSLTHSTKSEELNLRIKYIIDHFTLSIYNNVCRSLFEKDKLLFSLLLTIGIM 	                                                            
						KQKKEITEEVWYFLLTGGIALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQN 	                                                            
						LGEWKLIYDSAWPHEEQLPGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYIE 	                                                            
						APTFDLQGSYNDSSCCAPLIFVLSPSADPMAGLLKFADDLGMGGTRTQTISLGQGQGPIA 	                                                            
						AKMINNAIKDGTWVVLQNCHLAASWMPTLEKICEEVIVPESTNARFRLWLTSYPSEKFPV 	                                                            
						SILQNGIKMTNEPPKGLRANLLRSYLNDPISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQ 	                                                            
						ERRNFGPLGWNIPYEFNESDLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDK 	                                                            
						DRRLLLSLLSMFYCKEIEEDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGLH 	                                                            
						ENADITKDNQETNQLFEGVLLTLPRQSGGSGKSPQEVVEELAQDILSKLPRDFDLEEVMK 	                                                            
						LYPVVYEESMNTVLRQELIRFNRLTKVVRRSLINLGRAIKGQVLMSSELEEVFNSMLVGK 	                                                            
						VPAMWAAKSYPSLKPLGGYVADLLARLTFFQVTPQETVMENNPEDGAYIKGLFLEGARWD 	                                                            
						RKTMQIGESLPKILYDPLPIIWLKPGESAMFLHQDIYVCPVYKTSARRGTLSTTGHSTNY 	                                                            
						VLSIELPTDMPQKHWINRGVASLCQLDN                                 	                                                            
						having the sequence corresponding to amino acids 1314 - 3501 	                                                            
						of AA781495_P4, wherein said first amino acid sequence,      	                                                            
						second amino acid sequence and third amino acid sequence are 	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of AA781495_P4, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	                                                            
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                                                            
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	                                                            
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	                                                            
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	                                                            
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	                                                            
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	                                                            
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	                                                            
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	                                                            
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                                                            
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	                                                            
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	                                                            
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	                                                            
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGYEYLGNSPRLVITPLTD 	                                                            
						RCYRTLMGALKLNLGGAPEGPAGTGKTETTKDLAKALAKQCVVFNCSDGLDYKAMGKFFK 	                                                            
						GLAQAGAWACFDEFNRIEVEVLSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVFI 	                                                            
						TMNPGYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFL                 	                                                            
						to the sequence of AA781495_P4.3.An isolated polypeptide     	                                                            
						encoding for a tail of AA781495_P4, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						VNDMFMWLVQPCLEFGRLHCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGL 	                                                            
						SSQQIFLWLQGLFLFSLVWTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNN 	                                                            
						IFPERGSIYDFYFIKQASGHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKT 	                                                            
						YLDHEIPMLFVGPTGTGKSAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDR 	                                                            
						RRKGLFGPPIGKKAVVFVDDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVD 	                                                            
						MLLVTAMGPPGGGRNDITGRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLR 	                                                            
						YGKMLVQATKTIYRDAVENFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRL 	                                                            
						WIHEVYRVFYDRLIDKEDRQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLF 	                                                            
						FGDYFKPESDQKIYDEITDLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRV 	                                                            
						LKQDKGHLLLVGIGGSGRQSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGV 	                                                            
						ATKSTVFLFADNQIKDESFVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVE 	                                                            
						VTPLSMYNFFIERVRKNLHIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALEL 	                                                            
						VANKFLEDVELDDNIRVEVVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFK 	                                                            
						TLLNSKRQEVAMMRNRYLTGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIE 	                                                            
						AETREADGKKLLVQADEKEANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADI 	                                                            
						SLVKSMQNPPGPVKLVMESICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLES 	                                                            
						LKTYDKDNIPPLTMKRIRERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVA 	                                                            
						PKRERLREAEGKLAAQMQKLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQ 	                                                            
						KLVRAEKLISGLGGEKDRWTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQN 	                                                            
						QWLAECKDKVIPGFSDFSLSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMI 	                                                            
						DPHGQANKWIKNMEKANKLAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPIL 	                                                            
						LKATFKQQGVEYMRLGENIIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGLQ 	                                                            
						DQLLGIVAAKEKPELEEKKNQLIVESAKNKKHLKEIEDKILEVLSMSKGNILEDETAIKV 	                                                            
						LSSSKVLSEEISEKQKVASMTETQIDETRMGYKPVAVHSATIFFCISDLANIEPMYQYSL 	                                                            
						TWFINLYMHSLTHSTKSEELNLRIKYIIDHFTLSIYNNVCRSLFEKDKLLFSLLLTIGIM 	                                                            
						KQKKEITEEVWYFLLTGGIALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQN 	                                                            
						LGEWKLIYDSAWPHEEQLPGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYIE 	                                                            
						APTFDLQGSYNDSSCCAPLIFVLSPSADPMAGLLKFADDLGMGGTRTQTISLGQGQGPIA 	                                                            
						AKMINNAIKDGTWVVLQNCHLAASWMPTLEKICEEVIVPESTNARFRLWLTSYPSEKFPV 	                                                            
						SILQNGIKMTNEPPKGLRANLLRSYLNDPISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQ 	                                                            
						ERRNFGPLGWNIPYEFNESDLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDK 	                                                            
						DRRLLLSLLSMFYCKEIEEDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGLH 	                                                            
						ENADITKDNQETNQLFEGVLLTLPRQSGGSGKSPQEVVEELAQDILSKLPRDFDLEEVMK 	                                                            
						LYPVVYEESMNTVLRQELIRFNRLTKVVRRSLINLGRAIKGQVLMSSELEEVFNSMLVGK 	                                                            
						VPAMWAAKSYPSLKPLGGYVADLLARLTFFQVTPQETVMENNPEDGAYIKGLFLEGARWD 	                                                            
						RKTMQIGESLPKILYDPLPIIWLKPGESAMFLHQDIYVCPVYKTSARRGTLSTTGHSTNY 	                                                            
						VLSIELPTDMPQKHWINRGVASLCQLDN                                 	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA781495_P4.                                              	                                                            

						Comparison report between AA781495_P4 and Q9UG35unique head  	Sequence name: Q9UG35                                        
						followed by partial WT sequence a mismatch and a featuring a 	                                                            
						skipped exon.1.An isolated chimeric polypeptide encoding for 	Sequence documentation:                                      
						AA781495_P4, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 28004 x Q9UG35   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	Alignment segment 1/1:                                       
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                                                            
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	                     Quality: 8959.00                      Escore:       0                                               
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	             Matching length:     919                Total length:     965                                               
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	 Matching Percent Similarity:   99.89   Matching Percent Identity:   99.89                                               
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	    Total Percent Similarity:   95.13      Total Percent Identity:   95.13                                               
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	                        Gaps:       1                        
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	                                                            
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	Alignment:                                                   
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                  .         .         .         .         .  
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	    2583 VEYMRLGENIIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGL 2632                                                         
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	       1 VEYMRLGENIIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGL 50                                                           
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGYEYLGNSPRLVITPLTD 	                  .         .         .         .         .  
						RCYRTLMGALKLNLGGAPEGPAGTGKTETTKDLAKALAKQCVVFNCSDGLDYKAMGKFFK 	    2633 QDQLLGIVAAKEKPELEEKKNQLIVESAKNKKHLKEIEDKILEVLSMSKG 2682                                                         
						GLAQAGAWACFDEFNRIEVEVLSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVFI 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TMNPGYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFLDSRSLAQKIVATYRLC 	      51 QDQLLGIVAAKEKPELEEKKNQLIVESAKNKKHLKEIEDKILEVLSMSKG 100                                                          
						SEQLSSQHHYDYGMRAVKSVLTAAGNLKLKYPEENESVLLLRALLDVNLAKFLAQDVPLF 	                  .         .         .         .         .  
						QGIISDLFPGVVLPKPDYEVFLKVLNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIV 	    2683 NILEDETAIKVLSSSKVLSEEISEKQKVASMTETQIDETRMGYKPVAVHS 2732                                                         
						GDPMGGKTSAYKVLAAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GVLANAFREQASSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQMNSKMS 	     101 NILEDETAIKVLSSSKVLSEEISEKQKVASMTETQIDETRMGYKPVAVHS 150                                                          
						LIFEPADLEQASPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPSSLTKEHKELVNDMFMW 	                  .         .         .         .         .  
						LVQPCLEFGRLHCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGLSSQQIFL 	    2733 ATIFFCISDLANIEPMYQYSLTWFINLYMHSLTHSTKSEELNLRIKYIID 2782                                                         
						WLQGLFLFSLVWTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNNIFPERGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IYDFYFIKQASGHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKTYLDHEIP 	     151 ATIFFCISDLANIEPMYQYSLTWFINLYMHSLTHSTKSEELNLRIKYIID 200                                                          
						MLFVGPTGTGKSAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDRRRKGLFG 	                  .         .         .         .         .  
						PPIGKKAVVFVDDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVDMLLVTAM 	    2783 HFTLSIYNNVCRSLFEKDKLLFSLLLTIGIMKQKKEITEEVWYFLLTGGI 2832                                                         
						GPPGGGRNDITGRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLRYGKMLVQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ATKTIYRDAVENFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRLWIHEVYR 	     201 HFTLSIYNNVCRSLFEKDKLLFSLLLTIGIMKQKKEITEEVWYFLLTGGI 250                                                          
						VFYDRLIDKEDRQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLFFGDYFKP 	                  .         .         .         .         .  
						ESDQKIYDEITDLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRVLKQDKGH 	    2833 ALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQNLGEWKLIYD 2882                                                         
						LLLVGIGGSGRQSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGVATKSTVF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LFADNQIKDESFVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVEVTPLSMY 	     251 ALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQNLGEWKLIYD 300                                                          
						NFFIERVRKNLHIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALELVANKFLE 	                  .         .         .         .         .  
						DVELDDNIRVEVVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFKTLLNSKR 	    2883 SAWPHEEQLPGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYI 2932                                                         
						QEVAMMRNRYLTGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIEAETREAD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GKKLLVQADEKEANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADISLVKSMQ 	     301 SAWPHEEQLPGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYI 350                                                          
						NPPGPVKLVMESICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLESLKTYDKD 	                  .         .         .         .         .  
						NIPPLTMKRIRERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVAPKRERLR 	    2933 EAPTFDLQGSYNDSSCCAPLIFVLSPSADPMAGLLKFADDLGMGGTRTQT 2982                                                         
						EAEGKLAAQMQKLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQKLVRAEK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LISGLGGEKDRWTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQNQWLAECK 	     351 EAPTFDLQGSYNDSSCCAPLIFVLSPSADPMAGLLKFADDLGMGGTRTQT 400                                                          
						DKVIPGFSDFSLSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMIDPHGQAN 	                  .         .         .         .         .  
						KWIKNMEKANKLAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPILLKATFKQ 	    2983 ISLGQGQGPIAAKMINNAIKDGTWVVLQNCHLAASWMPTLEKICEEVIVP 3032                                                         
						QG                                                           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	     401 ISLGQGQGPIAAKMINNAIKDGTWVVLQNCHLAASWMPTLEKICEEVIVP 450                                                          
						to amino acids 1 - 2582 of AA781495_P4, a second amino acid  	                  .         .         .         .         .  
						VEYMRLGENIIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGLQDQLLGIVAA 	    3033 ESTNARFRLWLTSYPSEKFPVSILQNGIKMTNEPPKGLRANLLRSYLNDP 3082                                                         
						KEKPELEEKKNQLIVESAKNKKHLKEIEDKILEVLSMSKGNILEDETAIKVLSSSKVLSE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EISEKQKVASMTETQIDETRMGYKPVAVHSATIFFCISDLANIEPMYQYSLTWFINLYMH 	     451 ESTNARFRLWLTSYPSEKFPVSILQNGIKMTNEPPKGLRANLLRSYLNDP 500                                                          
						SLTHSTKSEELNLRIKYIIDHFTLSIYNNVCRSLFEKDKLLFSLLLTIGIMKQKKEITEE 	                  .         .         .         .         .  
						VWYFLLTGGIALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQNLGEWKLIYD 	    3083 ISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQERRNFGPLGWNIPYEFNES 3132                                                         
						SAWPHEEQLPGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYIEAPTFDLQGS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						YNDSSCCAPLIFVLSPSADPMAGLLKFADDLGMGGTRTQTISLGQGQGPIAAKMINNAIK 	     501 ISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQERRNFGPLGWNIPYEFNES 550                                                          
						DGTWVVLQNCHLAASWMPTLEKICEEVIVPESTNARFRLWLTSYPSEKFPVSILQNGIKM 	                  .         .         .         .         .  
						TNEPPKGLRANLLRSYLNDPISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQERRNFGPLG 	    3133 DLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDKDRRLLLSLL 3182                                                         
						WNIPYEFNESDLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDKDRRLLLSLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SMFYCKEIEEDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGLHENADITKDN 	     551 DLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDKDRRLLLSLL 600                                                          
						QETNQLFEGVLLTLPR                                             	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	    3183 SMFYCKEIEEDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGL 3232                                                         
						amino acids 1 - 676 of Q9UG35, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 2583 - 3258 of AA781495_P4, a bridging amino acid	     601 SMFYCKEIEEDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGL 650                                                          
						Q corresponding to amino acid 3259 of AA781495_P4, a third   	                  .         .         .         .         .  
						SGGSGKSPQEVVEELAQDILSKLPRDFDLEEVMKLYPVVYEESMNTVLRQELIRFNRLTK 	    3233 HENADITKDNQETNQLFEGVLLTLPRQSGGSGKSPQEVVEELAQDILSKL 3282                                                         
						VVRRSLINLGRAIKGQVLMSSELEEVFNSMLVGKVPAMWAAKSYPSLKPLGGYVADLLAR 	         |||||||||||||||||||||||||| |||||||||||||||||||||||  
						LTFFQ                                                        	     651 HENADITKDNQETNQLFEGVLLTLPRMSGGSGKSPQEVVEELAQDILSKL 700                                                          
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 678 - 802 of Q9UG35, which also 	    3283 PRDFDLEEVMKLYPVVYEESMNTVLRQELIRFNRLTKVVRRSLINLGRAI 3332                                                         
						corresponds to amino acids 3260 - 3384 of AA781495_P4, and a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VTPQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLPKILYDPLPIIWLKPGESAMF 	     701 PRDFDLEEVMKLYPVVYEESMNTVLRQELIRFNRLTKVVRRSLINLGRAI 750                                                          
						LHQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMPQKHWINRGVASLCQLDN    	                  .         .         .         .         .  
						fourth amino acid sequence being at least 90 % homologous to 	    3333 KGQVLMSSELEEVFNSMLVGKVPAMWAAKSYPSLKPLGGYVADLLARLTF 3382                                                         
						corresponding to amino acids 849 - 965 of Q9UG35, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 3385 - 3501 of AA781495_P4,       	     751 KGQVLMSSELEEVFNSMLVGKVPAMWAAKSYPSLKPLGGYVADLLARLTF 800                                                          
						wherein said first amino acid sequence, second amino acid    	                  .         .         .         .         .  
						sequence, bridging amino acid, third amino acid sequence and 	    3383 FQ..............................................VT 3386                                                         
						fourth amino acid sequence are contiguous and in a sequential	         ||                                              ||  
						order.2.An isolated polypeptide encoding for a head of       	     801 FQEWIDKGPPVVFWISGFYFTQSFLTGVSQNYARKYTIPIDHIGFEFEVT 850                                                          
						AA781495_P4, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	    3387 PQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLPKILYDPLPIIWL 3436                                                         
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	     851 PQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLPKILYDPLPIIWL 900                                                          
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                  .         .         .         .         .  
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	    3437 KPGESAMFLHQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMPQK 3486                                                         
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	     901 KPGESAMFLHQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMPQK 950                                                          
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	                  .                                          
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	    3487 HWINRGVASLCQLDN                                    3501                                                         
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	         |||||||||||||||                                     
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	     951 HWINRGVASLCQLDN                                    965                                                          
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                                                            
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	                                                            
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	                                                            
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	                                                            
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGYEYLGNSPRLVITPLTD 	                                                            
						RCYRTLMGALKLNLGGAPEGPAGTGKTETTKDLAKALAKQCVVFNCSDGLDYKAMGKFFK 	                                                            
						GLAQAGAWACFDEFNRIEVEVLSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVFI 	                                                            
						TMNPGYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFLDSRSLAQKIVATYRLC 	                                                            
						SEQLSSQHHYDYGMRAVKSVLTAAGNLKLKYPEENESVLLLRALLDVNLAKFLAQDVPLF 	                                                            
						QGIISDLFPGVVLPKPDYEVFLKVLNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIV 	                                                            
						GDPMGGKTSAYKVLAAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMD 	                                                            
						GVLANAFREQASSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQMNSKMS 	                                                            
						LIFEPADLEQASPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPSSLTKEHKELVNDMFMW 	                                                            
						LVQPCLEFGRLHCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGLSSQQIFL 	                                                            
						WLQGLFLFSLVWTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNNIFPERGS 	                                                            
						IYDFYFIKQASGHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKTYLDHEIP 	                                                            
						MLFVGPTGTGKSAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDRRRKGLFG 	                                                            
						PPIGKKAVVFVDDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVDMLLVTAM 	                                                            
						GPPGGGRNDITGRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLRYGKMLVQ 	                                                            
						ATKTIYRDAVENFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRLWIHEVYR 	                                                            
						VFYDRLIDKEDRQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLFFGDYFKP 	                                                            
						ESDQKIYDEITDLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRVLKQDKGH 	                                                            
						LLLVGIGGSGRQSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGVATKSTVF 	                                                            
						LFADNQIKDESFVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVEVTPLSMY 	                                                            
						NFFIERVRKNLHIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALELVANKFLE 	                                                            
						DVELDDNIRVEVVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFKTLLNSKR 	                                                            
						QEVAMMRNRYLTGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIEAETREAD 	                                                            
						GKKLLVQADEKEANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADISLVKSMQ 	                                                            
						NPPGPVKLVMESICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLESLKTYDKD 	                                                            
						NIPPLTMKRIRERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVAPKRERLR 	                                                            
						EAEGKLAAQMQKLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQKLVRAEK 	                                                            
						LISGLGGEKDRWTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQNQWLAECK 	                                                            
						DKVIPGFSDFSLSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMIDPHGQAN 	                                                            
						KWIKNMEKANKLAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPILLKATFKQ 	                                                            
						QG                                                           	                                                            
						least about 95% homologous to the sequence of                	                                                            
						AA781495_P4.3.An isolated chimeric polypeptide encoding for  	                                                            
						an edge portion of AA781495_P4, comprising a polypeptide     	                                                            
						having a length "n", wherein n is at least about 10 amino    	                                                            
						acids in length, optionally at least about 20 amino acids in 	                                                            
						length, preferably at least about 30 amino acids in length,  	                                                            
						more preferably at least about 40 amino acids in length and  	                                                            
						most preferably at least about 50 amino acids in length,     	                                                            
						wherein at least two amino acids comprise QV, having a       	                                                            
						structure as follows: a sequence starting from any of amino  	                                                            
						acid numbers 3384-x to 3385; and ending at any of amino acid 	                                                            
						numbers 3385+ ((n-2) - x), in which x varies from 0 to n-2.  	                                                            

						Comparison report between AA781495_P4 and Q9UEM5unique head  	Sequence name: Q9UEM5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA781495_P4, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 28004 x Q9UEM5   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	Alignment segment 1/1:                                       
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                                                            
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	                     Quality: 1376.00                      Escore:       0                                               
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	             Matching length:     143                Total length:     143                                               
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.30                                               
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.30                                               
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	                        Gaps:       0                        
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	                                                            
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	Alignment:                                                   
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                  .         .         .         .         .  
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	     822 YGYEYLGNSPRLVITPLTDRCYRTLMGALKLNLGGAPEGPAGTGKTETTK 871                                                          
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	         ||:|||||||||||||||||||||||||||||||||||||||||||||||  
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	       1 YGFEYLGNSPRLVITPLTDRCYRTLMGALKLNLGGAPEGPAGTGKTETTK 50                                                           
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGY                 	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     872 DLAKALAKQCVVFNCSDGLDYKAMGKFFKGLAQAGAWACFDEFNRIEVEV 921                                                          
						to amino acids 1 - 824 of AA781495_P4, a second amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EYLGNSPRLVITPLTDRCYRTLMGALKLNLGGAPEGPAGTGKTETTKDLAKALAKQCVVF 	      51 DLAKALAKQCVVFNCSDGLDYKAMGKFFKGLAQAGAWACFDEFNRIEVEV 100                                                          
						NCSDGLDYKAMGKFFKGLAQAGAWACFDEFNRIEVEVLSVVAQQILSIQQAIIRKLKTFI 	                  .         .         .         .            
						FEGTELSLNPTCAVFITMNP                                         	     922 LSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVFITMNP        964                                                          
						sequence being at least 90 % homologous to corresponding to  	         |||||||||||||||||||||||||||||||||||||||||||         
						amino acids 4 - 143 of Q9UEM5, which also corresponds to     	     101 LSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVFITMNP        143                                                          
						amino acids 825 - 964 of AA781495_P4, and a third amino acid 	                                                            
						sequence being at least 70%, optionally at least 80%,        	                                                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	                                                            
						GYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFLDSRSLAQKIVATYRLCSEQL 	                                                            
						SSQHHYDYGMRAVKSVLTAAGNLKLKYPEENESVLLLRALLDVNLAKFLAQDVPLFQGII 	                                                            
						SDLFPGVVLPKPDYEVFLKVLNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIVGDPM 	                                                            
						GGKTSAYKVLAAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMDGVLA 	                                                            
						NAFREQASSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQMNSKMSLIFE 	                                                            
						PADLEQASPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPSSLTKEHKELVNDMFMWLVQP 	                                                            
						CLEFGRLHCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGLSSQQIFLWLQG 	                                                            
						LFLFSLVWTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNNIFPERGSIYDF 	                                                            
						YFIKQASGHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKTYLDHEIPMLFV 	                                                            
						GPTGTGKSAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDRRRKGLFGPPIG 	                                                            
						KKAVVFVDDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVDMLLVTAMGPPG 	                                                            
						GGRNDITGRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLRYGKMLVQATKT 	                                                            
						IYRDAVENFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRLWIHEVYRVFYD 	                                                            
						RLIDKEDRQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLFFGDYFKPESDQ 	                                                            
						KIYDEITDLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRVLKQDKGHLLLV 	                                                            
						GIGGSGRQSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGVATKSTVFLFAD 	                                                            
						NQIKDESFVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVEVTPLSMYNFFI 	                                                            
						ERVRKNLHIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALELVANKFLEDVEL 	                                                            
						DDNIRVEVVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFKTLLNSKRQEVA 	                                                            
						MMRNRYLTGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIEAETREADGKKL 	                                                            
						LVQADEKEANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADISLVKSMQNPPG 	                                                            
						PVKLVMESICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLESLKTYDKDNIPP 	                                                            
						LTMKRIRERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVAPKRERLREAEG 	                                                            
						KLAAQMQKLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQKLVRAEKLISG 	                                                            
						LGGEKDRWTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQNQWLAECKDKVI 	                                                            
						PGFSDFSLSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMIDPHGQANKWIK 	                                                            
						NMEKANKLAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPILLKATFKQQGVE 	                                                            
						YMRLGENIIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGLQDQLLGIVAAKE 	                                                            
						KPELEEKKNQLIVESAKNKKHLKEIEDKILEVLSMSKGNILEDETAIKVLSSSKVLSEEI 	                                                            
						SEKQKVASMTETQIDETRMGYKPVAVHSATIFFCISDLANIEPMYQYSLTWFINLYMHSL 	                                                            
						THSTKSEELNLRIKYIIDHFTLSIYNNVCRSLFEKDKLLFSLLLTIGIMKQKKEITEEVW 	                                                            
						YFLLTGGIALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQNLGEWKLIYDSA 	                                                            
						WPHEEQLPGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYIEAPTFDLQGSYN 	                                                            
						DSSCCAPLIFVLSPSADPMAGLLKFADDLGMGGTRTQTISLGQGQGPIAAKMINNAIKDG 	                                                            
						TWVVLQNCHLAASWMPTLEKICEEVIVPESTNARFRLWLTSYPSEKFPVSILQNGIKMTN 	                                                            
						EPPKGLRANLLRSYLNDPISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQERRNFGPLGWN 	                                                            
						IPYEFNESDLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDKDRRLLLSLLSM 	                                                            
						FYCKEIEEDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGLHENADITKDNQE 	                                                            
						TNQLFEGVLLTLPRQSGGSGKSPQEVVEELAQDILSKLPRDFDLEEVMKLYPVVYEESMN 	                                                            
						TVLRQELIRFNRLTKVVRRSLINLGRAIKGQVLMSSELEEVFNSMLVGKVPAMWAAKSYP 	                                                            
						SLKPLGGYVADLLARLTFFQVTPQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLP 	                                                            
						KILYDPLPIIWLKPGESAMFLHQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMP 	                                                            
						QKHWINRGVASLCQLDN                                            	                                                            
						having the sequence corresponding to amino acids 965 - 3501  	                                                            
						of AA781495_P4, wherein said first amino acid sequence,      	                                                            
						second amino acid sequence and third amino acid sequence are 	                                                            
						contiguous and in a sequential order.2.An isolated           	                                                            
						polypeptide encoding for a head of AA781495_P4, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	                                                            
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                                                            
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	                                                            
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	                                                            
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	                                                            
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	                                                            
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	                                                            
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	                                                            
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	                                                            
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                                                            
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	                                                            
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	                                                            
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	                                                            
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGY                 	                                                            
						to the sequence of AA781495_P4.3.An isolated polypeptide     	                                                            
						encoding for a tail of AA781495_P4, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						GYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFLDSRSLAQKIVATYRLCSEQL 	                                                            
						SSQHHYDYGMRAVKSVLTAAGNLKLKYPEENESVLLLRALLDVNLAKFLAQDVPLFQGII 	                                                            
						SDLFPGVVLPKPDYEVFLKVLNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIVGDPM 	                                                            
						GGKTSAYKVLAAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMDGVLA 	                                                            
						NAFREQASSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQMNSKMSLIFE 	                                                            
						PADLEQASPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPSSLTKEHKELVNDMFMWLVQP 	                                                            
						CLEFGRLHCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGLSSQQIFLWLQG 	                                                            
						LFLFSLVWTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNNIFPERGSIYDF 	                                                            
						YFIKQASGHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKTYLDHEIPMLFV 	                                                            
						GPTGTGKSAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDRRRKGLFGPPIG 	                                                            
						KKAVVFVDDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVDMLLVTAMGPPG 	                                                            
						GGRNDITGRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLRYGKMLVQATKT 	                                                            
						IYRDAVENFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRLWIHEVYRVFYD 	                                                            
						RLIDKEDRQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLFFGDYFKPESDQ 	                                                            
						KIYDEITDLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRVLKQDKGHLLLV 	                                                            
						GIGGSGRQSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGVATKSTVFLFAD 	                                                            
						NQIKDESFVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVEVTPLSMYNFFI 	                                                            
						ERVRKNLHIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALELVANKFLEDVEL 	                                                            
						DDNIRVEVVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFKTLLNSKRQEVA 	                                                            
						MMRNRYLTGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIEAETREADGKKL 	                                                            
						LVQADEKEANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADISLVKSMQNPPG 	                                                            
						PVKLVMESICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLESLKTYDKDNIPP 	                                                            
						LTMKRIRERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVAPKRERLREAEG 	                                                            
						KLAAQMQKLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQKLVRAEKLISG 	                                                            
						LGGEKDRWTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQNQWLAECKDKVI 	                                                            
						PGFSDFSLSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMIDPHGQANKWIK 	                                                            
						NMEKANKLAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPILLKATFKQQGVE 	                                                            
						YMRLGENIIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGLQDQLLGIVAAKE 	                                                            
						KPELEEKKNQLIVESAKNKKHLKEIEDKILEVLSMSKGNILEDETAIKVLSSSKVLSEEI 	                                                            
						SEKQKVASMTETQIDETRMGYKPVAVHSATIFFCISDLANIEPMYQYSLTWFINLYMHSL 	                                                            
						THSTKSEELNLRIKYIIDHFTLSIYNNVCRSLFEKDKLLFSLLLTIGIMKQKKEITEEVW 	                                                            
						YFLLTGGIALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQNLGEWKLIYDSA 	                                                            
						WPHEEQLPGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYIEAPTFDLQGSYN 	                                                            
						DSSCCAPLIFVLSPSADPMAGLLKFADDLGMGGTRTQTISLGQGQGPIAAKMINNAIKDG 	                                                            
						TWVVLQNCHLAASWMPTLEKICEEVIVPESTNARFRLWLTSYPSEKFPVSILQNGIKMTN 	                                                            
						EPPKGLRANLLRSYLNDPISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQERRNFGPLGWN 	                                                            
						IPYEFNESDLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDKDRRLLLSLLSM 	                                                            
						FYCKEIEEDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGLHENADITKDNQE 	                                                            
						TNQLFEGVLLTLPRQSGGSGKSPQEVVEELAQDILSKLPRDFDLEEVMKLYPVVYEESMN 	                                                            
						TVLRQELIRFNRLTKVVRRSLINLGRAIKGQVLMSSELEEVFNSMLVGKVPAMWAAKSYP 	                                                            
						SLKPLGGYVADLLARLTFFQVTPQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLP 	                                                            
						KILYDPLPIIWLKPGESAMFLHQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMP 	                                                            
						QKHWINRGVASLCQLDN                                            	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA781495_P4.                                              	                                                            

						Comparison report between AA781495_P4 and O00437unique head  	Sequence name: O00437                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AA781495_P4, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 28004 x O00437   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	Alignment segment 1/1:                                       
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                                                            
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	                     Quality: 1667.00                      Escore:       0                                               
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	             Matching length:     177                Total length:     177                                               
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	 Matching Percent Similarity:   98.87   Matching Percent Identity:   97.74                                               
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	    Total Percent Similarity:   98.87      Total Percent Identity:   97.74                                               
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	                        Gaps:       0                        
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	                                                            
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	Alignment:                                                   
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                  .         .         .         .         .  
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	     860 GPAGTGKTETTKDLAKALAKQCVVFNCSDGLDYKAMGKFFKGLAQAGAWA 909                                                          
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	         |||||||||||| |||||||||||||||||||||||||||||||||||||  
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	       1 GPAGTGKTETTKVLAKALAKQCVVFNCSDGLDYKAMGKFFKGLAQAGAWA 50                                                           
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGYEYLGNSPRLVITPLTD 	                  .         .         .         .         .  
						RCYRTLMGALKLNLGGAPE                                          	     910 CFDEFNRIEVEVLSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVF 959                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 1 - 859 of AA781495_P4, a second amino acid   	      51 CFDEFNRIEVEVLSVVAQQILSIQQAIIRKLKTFIFEGTELSLNPTCAVF 100                                                          
						sequence being at least 90 % homologous to GPAGTGKTETTK      	                  .         .         .         .         .  
						corresponding to amino acids 1 - 12 of O00437, which also    	     960 ITMNPGYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFLDSRSL 1009                                                         
						corresponds to amino acids 860 - 871 of AA781495_P4, a       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						bridging amino acid D corresponding to amino acid 872 of     	     101 ITMNPGYAGRAELPDNLKALFRTVAMMVPDYALIGEISLYSMGFLDSRSL 150                                                          
						AA781495_P4, a third amino acid sequence being at least 90 % 	                  .         .                                
						LAKALAKQCVVFNCSDGLDYKAMGKFFKGLAQAGAWACFDEFNRIEVEVLSVVAQQILSI 	    1010 AQKIVATYRLCSEQLSSQHHYDYGMRA                        1036                                                         
						QQAIIRKLKTFIFEGTELSLNPTCAVFITMNPGYAGRAELPDNLKALFRTVAMMVPDYAL 	         ||||||||||||||||||||||:|: |                         
						IGEISLYSMGFLDSRSLAQKIVATYRLCSEQLSSQHHYD                      	     151 AQKIVATYRLCSEQLSSQHHYDFGLHA                        177                                                          
						homologous to corresponding to amino acids 14 - 172 of       	                                                            
						O00437, which also corresponds to amino acids 873 - 1031 of  	                                                            
						AA781495_P4, and a fourth amino acid sequence being at least 	                                                            
						70%, optionally at least 80%, preferably at least 85%, more  	                                                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						YGMRAVKSVLTAAGNLKLKYPEENESVLLLRALLDVNLAKFLAQDVPLFQGIISDLFPGV 	                                                            
						VLPKPDYEVFLKVLNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIVGDPMGGKTSAY 	                                                            
						KVLAAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMDGVLANAFREQA 	                                                            
						SSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQMNSKMSLIFEPADLEQA 	                                                            
						SPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPSSLTKEHKELVNDMFMWLVQPCLEFGRL 	                                                            
						HCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGLSSQQIFLWLQGLFLFSLV 	                                                            
						WTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNNIFPERGSIYDFYFIKQAS 	                                                            
						GHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKTYLDHEIPMLFVGPTGTGK 	                                                            
						SAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDRRRKGLFGPPIGKKAVVFV 	                                                            
						DDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVDMLLVTAMGPPGGGRNDIT 	                                                            
						GRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLRYGKMLVQATKTIYRDAVE 	                                                            
						NFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRLWIHEVYRVFYDRLIDKED 	                                                            
						RQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLFFGDYFKPESDQKIYDEIT 	                                                            
						DLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRVLKQDKGHLLLVGIGGSGR 	                                                            
						QSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGVATKSTVFLFADNQIKDES 	                                                            
						FVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVEVTPLSMYNFFIERVRKNL 	                                                            
						HIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALELVANKFLEDVELDDNIRVE 	                                                            
						VVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFKTLLNSKRQEVAMMRNRYL 	                                                            
						TGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIEAETREADGKKLLVQADEK 	                                                            
						EANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADISLVKSMQNPPGPVKLVME 	                                                            
						SICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLESLKTYDKDNIPPLTMKRIR 	                                                            
						ERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVAPKRERLREAEGKLAAQMQ 	                                                            
						KLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQKLVRAEKLISGLGGEKDR 	                                                            
						WTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQNQWLAECKDKVIPGFSDFS 	                                                            
						LSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMIDPHGQANKWIKNMEKANK 	                                                            
						LAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPILLKATFKQQGVEYMRLGEN 	                                                            
						IIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGLQDQLLGIVAAKEKPELEEK 	                                                            
						KNQLIVESAKNKKHLKEIEDKILEVLSMSKGNILEDETAIKVLSSSKVLSEEISEKQKVA 	                                                            
						SMTETQIDETRMGYKPVAVHSATIFFCISDLANIEPMYQYSLTWFINLYMHSLTHSTKSE 	                                                            
						ELNLRIKYIIDHFTLSIYNNVCRSLFEKDKLLFSLLLTIGIMKQKKEITEEVWYFLLTGG 	                                                            
						IALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQNLGEWKLIYDSAWPHEEQL 	                                                            
						PGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYIEAPTFDLQGSYNDSSCCAP 	                                                            
						LIFVLSPSADPMAGLLKFADDLGMGGTRTQTISLGQGQGPIAAKMINNAIKDGTWVVLQN 	                                                            
						CHLAASWMPTLEKICEEVIVPESTNARFRLWLTSYPSEKFPVSILQNGIKMTNEPPKGLR 	                                                            
						ANLLRSYLNDPISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQERRNFGPLGWNIPYEFNE 	                                                            
						SDLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDKDRRLLLSLLSMFYCKEIE 	                                                            
						EDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGLHENADITKDNQETNQLFEG 	                                                            
						VLLTLPRQSGGSGKSPQEVVEELAQDILSKLPRDFDLEEVMKLYPVVYEESMNTVLRQEL 	                                                            
						IRFNRLTKVVRRSLINLGRAIKGQVLMSSELEEVFNSMLVGKVPAMWAAKSYPSLKPLGG 	                                                            
						YVADLLARLTFFQVTPQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLPKILYDPL 	                                                            
						PIIWLKPGESAMFLHQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMPQKHWINR 	                                                            
						GVASLCQLDN                                                   	                                                            
						homologous to a polypeptide having the sequence corresponding	                                                            
						to amino acids 1032 - 3501 of AA781495_P4, wherein said first	                                                            
						amino acid sequence, second amino acid sequence, bridging    	                                                            
						amino acid, third amino acid sequence and fourth amino acid  	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of AA781495_P4,     	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						MTNLLLGTVNAEEKLVSDFLIQTFKVFQKNQVGPCKYLNVYKKYVDLLDNTAEQNIAAFL 	                                                            
						KENHDIDDFVTKINAIKKRRNEIASMNITVPLAMFCLDATALNHDLCERAQNLKDHLIQF 	                                                            
						QVDVNRDTNTSICNQYSHIADKVSEVPANTKELVSLIEFLKKSSAVTVFKLRRQLRDASE 	                                                            
						RLEFLMDYADLPYQIEDIFDNSRNLLLHKRDQAEMDLIKRCSEFELRLEGYHRELESFRK 	                                                            
						REVMTTEEMKHNVEKLNELSKNLNRAFAEFELINKEEELLEKEKSTYPLLQAMLKNKVPY 	                                                            
						EQLWSTAYEFSIKSEEWMNGPLFLLNAEQIAEEIGNMWRTTYKLIKTLSDVPAPRRLAEN 	                                                            
						VKIKIDKFKQYIPILSISCNPGMKDRHWQQISEIVGYEIKPTETTCLSNMLEFGFGKFVE 	                                                            
						KLEPIGAAASKEYSLEKNLDRMKLDWVNVTFSFVKYRDTDTNILCAIDDIQMLLDDHVIK 	                                                            
						TQTMCGSPFIKPIEAECRKWEEKLIRIQDNLDAWLKCQATWLYLEPIFSSEDIIAQMPEE 	                                                            
						GRKFGIVDSYWKSLMSQAVKDNRILVAADQPRMAEKLQEANFLLEDIQKGLNDYLEKKRL 	                                                            
						FFPRFFFLSNDELLEILSETKDPLRVQPHLKKCFEGIAKLEFTDNLEIVGMISSEKETVP 	                                                            
						FIQKIYPANAKGMVEKWLQQVEQMMLASMREVIGLGIEAYVKVPRNHWVLQWPGQVVICV 	                                                            
						SSIFWTQEVSQALAENTLLDFLKKSNDQIAQIVQLVRGKLSSGARLTLGALTVIDVHARD 	                                                            
						VVAKLSEDRVSDLNDFQWISQLRYYWVAKDVQVQIITTEALYGYEYLGNSPRLVITPLTD 	                                                            
						RCYRTLMGALKLNLGGAPE                                          	                                                            
						about 95% homologous to the sequence of AA781495_P4.3.An     	                                                            
						isolated polypeptide encoding for a tail of AA781495_P4,     	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						YGMRAVKSVLTAAGNLKLKYPEENESVLLLRALLDVNLAKFLAQDVPLFQGIISDLFPGV 	                                                            
						VLPKPDYEVFLKVLNDNIKKMKLQPVPWFIGKIIQIYEMMLVRHGYMIVGDPMGGKTSAY 	                                                            
						KVLAAALGDLHAANQMEEFAVEYKIINPKAITMGQLYGCFDQVSHEWMDGVLANAFREQA 	                                                            
						SSLSDDRKWIIFDGPVDAIWIENMNTVLDDNKKLCLMSGEIIQMNSKMSLIFEPADLEQA 	                                                            
						SPATVSRCGMIYMEPHQLGWKPLKDSYMDTLPSSLTKEHKELVNDMFMWLVQPCLEFGRL 	                                                            
						HCKFVVQTSPIHLAFSMMRLYSSLLDEIRAVEEEEMELGEGLSSQQIFLWLQGLFLFSLV 	                                                            
						WTVAGTINADSRKKFDVFFRNLIMGMDDNHPRPKSVKLTKNNIFPERGSIYDFYFIKQAS 	                                                            
						GHWETWTQYITKEEEKVPAGAKVSELIIPTMETARQSFFLKTYLDHEIPMLFVGPTGTGK 	                                                            
						SAITNNFLLHLPKNTYLPNCINFSARTSANQTQDIIMSKLDRRRKGLFGPPIGKKAVVFV 	                                                            
						DDLNMPAKEVYGAQPPIELLRQWIDHGYWFDKKDTTRLDIVDMLLVTAMGPPGGGRNDIT 	                                                            
						GRFTRHLNIISINAFEDDILTKIFSSIVDWHFGKGFDVMFLRYGKMLVQATKTIYRDAVE 	                                                            
						NFLPTPSKSHYVFNLRDFSRVIQGVLLCPHTHLQDVEKCIRLWIHEVYRVFYDRLIDKED 	                                                            
						RQVFFNMVKETTSNCFKQTIEKVLIHLSPTGKIVDDNIRSLFFGDYFKPESDQKIYDEIT 	                                                            
						DLKQLTVVMEHYLEEFNNISKAPMSLVMFRFAIEHISRICRVLKQDKGHLLLVGIGGSGR 	                                                            
						QSAAKLSTFMNAYELYQIEITKNYAGNDWREDLKKIILQVGVATKSTVFLFADNQIKDES 	                                                            
						FVEDINMLLNTGDVPNIFPADEKADIVEKMQTAARTQGEKVEVTPLSMYNFFIERVRKNL 	                                                            
						HIVLAMSPIGDAFRNRLRMFPSLINCCTIDWFQSWPTDALELVANKFLEDVELDDNIRVE 	                                                            
						VVSMCKYFQESVKKLSLDYYNKLRRHNYVTPTSYLELILTFKTLLNSKRQEVAMMRNRYL 	                                                            
						TGLQKLDFAASQVAVMQRELTALQPQLILTSEETAKMMVKIEAETREADGKKLLVQADEK 	                                                            
						EANVAAAIAQGIKNECEGDLAEAMPALEAALAALDTLNPADISLVKSMQNPPGPVKLVME 	                                                            
						SICIMKGMKPERKPDPSGSGKMIEDYWGVSKKILGDLKFLESLKTYDKDNIPPLTMKRIR 	                                                            
						ERFINHPEFQPAVIKNVSSACEGLCKWVRAMEVYDRVAKVVAPKRERLREAEGKLAAQMQ 	                                                            
						KLNQKRAELKLVVDRLQALNDDFEEMNTKKKDLEENIEICSQKLVRAEKLISGLGGEKDR 	                                                            
						WTEAARQLGIRYTNLTGDVLLSSGTVAYLGAFTVDYRVQCQNQWLAECKDKVIPGFSDFS 	                                                            
						LSHTLGDPIKIRAWQIAGLPVDSFSIDNGIIVSNSRRWALMIDPHGQANKWIKNMEKANK 	                                                            
						LAVIKFSDSNYMRMLENALQLGTPVLIENIGEELDASIEPILLKATFKQQGVEYMRLGEN 	                                                            
						IIEYSRDFKLYITTRLRNPHYLPEVAVKVCLLNFMITPLGLQDQLLGIVAAKEKPELEEK 	                                                            
						KNQLIVESAKNKKHLKEIEDKILEVLSMSKGNILEDETAIKVLSSSKVLSEEISEKQKVA 	                                                            
						SMTETQIDETRMGYKPVAVHSATIFFCISDLANIEPMYQYSLTWFINLYMHSLTHSTKSE 	                                                            
						ELNLRIKYIIDHFTLSIYNNVCRSLFEKDKLLFSLLLTIGIMKQKKEITEEVWYFLLTGG 	                                                            
						IALDNPYPNPAPQWLSEKAWAEIVRASALPKLHGLMEHLEQNLGEWKLIYDSAWPHEEQL 	                                                            
						PGSWKFSQGLEKMVILRCLRPDKMVPAVREFIAEHMGKLYIEAPTFDLQGSYNDSSCCAP 	                                                            
						LIFVLSPSADPMAGLLKFADDLGMGGTRTQTISLGQGQGPIAAKMINNAIKDGTWVVLQN 	                                                            
						CHLAASWMPTLEKICEEVIVPESTNARFRLWLTSYPSEKFPVSILQNGIKMTNEPPKGLR 	                                                            
						ANLLRSYLNDPISDPVFFQSCAKAVMWQKMLFGLCFFHAVVQERRNFGPLGWNIPYEFNE 	                                                            
						SDLRISMWQIQMFLNDYKEVPFDALTYLTGECNYGGRVTDDKDRRLLLSLLSMFYCKEIE 	                                                            
						EDYYSLAPGDTYYIPPHGSYQSYIDYLRNLPITAHPEVFGLHENADITKDNQETNQLFEG 	                                                            
						VLLTLPRQSGGSGKSPQEVVEELAQDILSKLPRDFDLEEVMKLYPVVYEESMNTVLRQEL 	                                                            
						IRFNRLTKVVRRSLINLGRAIKGQVLMSSELEEVFNSMLVGKVPAMWAAKSYPSLKPLGG 	                                                            
						YVADLLARLTFFQVTPQETVMENNPEDGAYIKGLFLEGARWDRKTMQIGESLPKILYDPL 	                                                            
						PIIWLKPGESAMFLHQDIYVCPVYKTSARRGTLSTTGHSTNYVLSIELPTDMPQKHWINR 	                                                            
						GVASLCQLDN                                                   	                                                            
						about 95% homologous to the sequence in AA781495_P4.         	                                                            

28924	HMR136_AA788877_8_tr0_r1_1_gPRT		Comparison report between AA788877_P8 and Q9H5C0unique head  	Sequence name: Q9H5C0                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AA788877_P8, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 28924 x Q9H5C0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MKPLLYSQLDANTRNIGWRREGNEIKYYKNNTDDGQQPFYCLTWTIQFPYDQDTCFFAHF 	Alignment segment 1/1:                                       
						YPYTYTDLQCYLLSVANNPIQSQFCKLQTLCRSLAGNTVYLLTITNPSQTPQEAAAKKAV 	                                                            
						VLSARVHPGESNGSWV                                             	                     Quality: 3241.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     325                Total length:     325                                               
						to amino acids 1 - 136 of AA788877_P8, a second amino acid   	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.69                                               
						MKGFLDFILSNSPDAQLLRDIFVFKVLPMLNPDGVIVGNYRCSLAGRDLNRHYKTILKES 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.69                                               
						FPCIWYTRNMIKRLLEEREVLLYCDFHGHSRKNNIFLYGCNNNNRKYWLHERVFPLMLCK 	                        Gaps:       0                        
						NAPDKFSFHSCNFKVQKCKEGTGRVVMWRMGILNSYTMESTFGGSTLGNKRDTHFTIEDL 	                                                            
						KSLGYHVCDTLLDFCDPDQ                                          	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 1 - 199 of Q9H5C0, which also corresponds to     	     137 MKGFLDFILSNSPDAQLLRDIFVFKVLPMLNPDGVIVGNYRCSLAGRDLN 186                                                          
						amino acids 137 - 335 of AA788877_P8, a bridging amino acid M	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acid 336 of AA788877_P8, a third amino	       1 MKGFLDFILSNSPDAQLLRDIFVFKVLPMLNPDGVIVGNYRCSLAGRDLN 50                                                           
						KFTQCLAELKELLRQEIHKKFHELGQDVDLEGSWSDISLSDIESSTSGSDSSLSDGLPVH 	                  .         .         .         .         .  
						LANIADELTQKKKMFKKKKKKSLQTRKQRNEQYQKKNLMQKLKLTEDTSEKAGFASTLQK 	     187 RHYKTILKESFPCIWYTRNMIKRLLEEREVLLYCDFHGHSRKNNIFLYGC 236                                                          
						QPTFF                                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	      51 RHYKTILKESFPCIWYTRNMIKRLLEEREVLLYCDFHGHSRKNNIFLYGC 100                                                          
						to amino acids 201 - 325 of Q9H5C0, which also corresponds to	                  .         .         .         .         .  
						amino acids 337 - 461 of AA788877_P8, and a fourth amino acid	     237 NNNNRKYWLHERVFPLMLCKNAPDKFSFHSCNFKVQKCKEGTGRVVMWRM 286                                                          
						sequence being at least 70%, optionally at least 80%,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 85%, more preferably at least 90% and    	     101 NNNNRKYWLHERVFPLMLCKNAPDKFSFHSCNFKVQKCKEGTGRVVMWRM 150                                                          
						most preferably at least 95% homologous to a polypeptide     	                  .         .         .         .         .  
						KNSENSSFLPMKNENPRLNETNLNRRDKDTPLDPSMATLILPKNKGRMQNKKPGFTVSCS 	     287 GILNSYTMESTFGGSTLGNKRDTHFTIEDLKSLGYHVCDTLLDFCDPDQM 336                                                          
						PKRTINSSQEPAPGMKPNWPRSRYPATKRGCAAMAAYPSLHIYTYP               	         |||||||||||||||||||||||||||||||||||||||||||||||||:  
						having the sequence corresponding to amino acids 462 - 567 of	     151 GILNSYTMESTFGGSTLGNKRDTHFTIEDLKSLGYHVCDTLLDFCDPDQI 200                                                          
						AA788877_P8, wherein said first amino acid sequence, second  	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid, third amino acid   	     337 KFTQCLAELKELLRQEIHKKFHELGQDVDLEGSWSDISLSDIESSTSGSD 386                                                          
						sequence and fourth amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     201 KFTQCLAELKELLRQEIHKKFHELGQDVDLEGSWSDISLSDIESSTSGSD 250                                                          
						head of AA788877_P8, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     387 SSLSDGLPVHLANIADELTQKKKMFKKKKKKSLQTRKQRNEQYQKKNLMQ 436                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MKPLLYSQLDANTRNIGWRREGNEIKYYKNNTDDGQQPFYCLTWTIQFPYDQDTCFFAHF 	     251 SSLSDGLPVHLANIADELTQKKKMFKKKKKKSLQTRKQRNEQYQKKNLMQ 300                                                          
						YPYTYTDLQCYLLSVANNPIQSQFCKLQTLCRSLAGNTVYLLTITNPSQTPQEAAAKKAV 	                  .         .                                
						VLSARVHPGESNGSWV                                             	     437 KLKLTEDTSEKAGFASTLQKQPTFF                          461                                                          
						at least about 95% homologous to the sequence of             	         |||||||||||||||||||||||||                           
						AA788877_P8.3.An isolated polypeptide encoding for a tail of 	     301 KLKLTEDTSEKAGFASTLQKQPTFF                          325                                                          
						AA788877_P8, comprising a polypeptide being at least 70%,    	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						KNSENSSFLPMKNENPRLNETNLNRRDKDTPLDPSMATLILPKNKGRMQNKKPGFTVSCS 	                                                            
						PKRTINSSQEPAPGMKPNWPRSRYPATKRGCAAMAAYPSLHIYTYP               	                                                            
						least about 95% homologous to the sequence in AA788877_P8.   	                                                            

						Comparison report between AA788877_P8 and Q8IV57unique head  	Sequence name: Q8IV57                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for AA788877_P8, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 28924 x Q8IV57   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MKPLLYSQLDANTRNIGWRREGNEIKYYKNNTDDGQQPFYCLTWTIQFPYDQDTCFFAHF 	Alignment segment 1/1:                                       
						YPYTYTDLQCYLLSVANNPIQSQFCKLQTLCRSLAGNTVYLLTITNPSQTPQEAAAKKAV 	                                                            
						VLSARVHPGESNGSWVMKGFLDFILSNSPDAQLLRDIFVFKVLPMLNPDGVIVGNYRCSL 	                     Quality: 2838.00                      Escore:       0                                               
						AGRDLNRHYKTILKESFPCIWYTRNMIKRLLEEREVLLYCDFHGHSRKNNIFLYGCNNNN 	             Matching length:     285                Total length:     285                                               
						RKYWLHERVFPLMLCKNAPDKFSFHSCNFKVQKCKEGTGRVV                   	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.65                                               
						polypeptide having the sequence corresponding to amino acids 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.65                                               
						1 - 282 of AA788877_P8, a second amino acid sequence being at	                        Gaps:       0                        
						least 90 % homologous to                                     	                                                            
						MWRMGILNSYTMESTFGGSTLGNKRDTHFTIEDLKSLGYHVCDTLLDFCDPDQ        	Alignment:                                                   
						corresponding to amino acids 1 - 53 of Q8IV57, which also    	                  .         .         .         .         .  
						corresponds to amino acids 283 - 335 of AA788877_P8, a       	     283 MWRMGILNSYTMESTFGGSTLGNKRDTHFTIEDLKSLGYHVCDTLLDFCD 332                                                          
						bridging amino acid M corresponding to amino acid 336 of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA788877_P8, and a third amino acid sequence being at least  	       1 MWRMGILNSYTMESTFGGSTLGNKRDTHFTIEDLKSLGYHVCDTLLDFCD 50                                                           
						KFTQCLAELKELLRQEIHKKFHELGQDVDLEGSWSDISLSDIESSTSGSDSSLSDGLPVH 	                  .         .         .         .         .  
						LANIADELTQKKKMFKKKKKKSLQTRKQRNEQYQKKNLMQKLKLTEDTSEKAGFASTLQK 	     333 PDQMKFTQCLAELKELLRQEIHKKFHELGQDVDLEGSWSDISLSDIESST 382                                                          
						QPTFFKNSENSSFLPMKNENPRLNETNLNRRDKDTPLDPSMATLILPKNKGRMQNKKPGF 	         |||:||||||||||||||||||||||||||||||||||||||||||||||  
						TVSCSPKRTINSSQEPAPGMKPNWPRSRYPATKRGCAAMAAYPSLHIYTYP          	      51 PDQIKFTQCLAELKELLRQEIHKKFHELGQDVDLEGSWSDISLSDIESST 100                                                          
						90 % homologous to corresponding to amino acids 55 - 285 of  	                  .         .         .         .         .  
						Q8IV57, which also corresponds to amino acids 337 - 567 of   	     383 SGSDSSLSDGLPVHLANIADELTQKKKMFKKKKKKSLQTRKQRNEQYQKK 432                                                          
						AA788877_P8, wherein said first amino acid sequence, second  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, bridging amino acid and third amino acid	     101 SGSDSSLSDGLPVHLANIADELTQKKKMFKKKKKKSLQTRKQRNEQYQKK 150                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of AA788877_P8,     	     433 NLMQKLKLTEDTSEKAGFASTLQKQPTFFKNSENSSFLPMKNENPRLNET 482                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     151 NLMQKLKLTEDTSEKAGFASTLQKQPTFFKNSENSSFLPMKNENPRLNET 200                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						MKPLLYSQLDANTRNIGWRREGNEIKYYKNNTDDGQQPFYCLTWTIQFPYDQDTCFFAHF 	     483 NLNRRDKDTPLDPSMATLILPKNKGRMQNKKPGFTVSCSPKRTINSSQEP 532                                                          
						YPYTYTDLQCYLLSVANNPIQSQFCKLQTLCRSLAGNTVYLLTITNPSQTPQEAAAKKAV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VLSARVHPGESNGSWVMKGFLDFILSNSPDAQLLRDIFVFKVLPMLNPDGVIVGNYRCSL 	     201 NLNRRDKDTPLDPSMATLILPKNKGRMQNKKPGFTVSCSPKRTINSSQEP 250                                                          
						AGRDLNRHYKTILKESFPCIWYTRNMIKRLLEEREVLLYCDFHGHSRKNNIFLYGCNNNN 	                  .         .         .                      
						RKYWLHERVFPLMLCKNAPDKFSFHSCNFKVQKCKEGTGRVV                   	     533 APGMKPNWPRSRYPATKRGCAAMAAYPSLHIYTYP                567                                                          
						about 95% homologous to the sequence of AA788877_P8.         	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     251 APGMKPNWPRSRYPATKRGCAAMAAYPSLHIYTYP                285                                                          

5248	HMR136_AA812168_10_tr0_r1_1_gPRT		Comparison report between AA812168_P10 and Q9H666unique head 	Sequence name: Q9H666                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for AA812168_P10, comprising a 	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 5248 x Q9H666   ..                             
						90% and most preferably at least 95% homologous to a         	                                                            
						MASSTSSMSSLARSAGGRCGLCCMQEAHQAWHGWRAGRSGMVAWEQRVTGRQGLAGEGSD 	Alignment segment 1/1:                                       
						GSSAWLTVCPCCRLTARAAPGTPVPSCSPPPSEAIYWLLSTARPGWAPSASWPSRGQGRP 	                                                            
						PQDPQMPSLPRGAWSPWRKTPSTPPGRK                                 	                     Quality: 2718.00                      Escore:       0                                               
						polypeptide having the sequence corresponding to amino acids 	             Matching length:     289                Total length:     289                                               
						1 - 148 of AA812168_P10, a second amino acid sequence being  	 Matching Percent Similarity:   97.23   Matching Percent Identity:   95.50                                               
						at least 90 % homologous to                                  	    Total Percent Similarity:   97.23      Total Percent Identity:   95.50                                               
						RTEAATRCQLKGPALLVLGPDAIQLREAKGTQALYSWPYHFLRK corresponding to	                        Gaps:       0                        
						amino acids 223 - 266 of Q9H666, which also corresponds to   	                                                            
						amino acids 149 - 192 of AA812168_P10, a bridging amino acid 	Alignment:                                                   
						F corresponding to amino acid 193 of AA812168_P10, and a     	                  .         .         .         .         .  
						GSDKGVFSFEAGRRCHSGEGLFAFSTPCAPDLCRAVAGAIARQRERLPELTRPQPCPLPR 	     134 WSPWRKTPSTPPGRKRTEAATRCQLKGPALLVLGPDAIQLREAKGTQALY 183                                                          
						ATSLPSLDTPGELREMPPGPEPPTSRKMHLAEPGPQSLPLLLGPEPNDLASGLYASVCKR 	         :| |::    |   :|||||||||||||||||||||||||||||||||||  
						ASGPPGNEHLYENLCVLEASPTLHGGEPEPHEGPGSRSPTTSPIYHNGQDLSWPGPANDS 	     208 YSSWQEVGEFPVVVQRTEAATRCQLKGPALLVLGPDAIQLREAKGTQALY 257                                                          
						TLEAQYRRLLELDQVEGTGRPDPQAGFKAKLVTLLSRERRKGPAPCDRP            	                  .         .         .         .         .  
						third amino acid sequence being at least 90 % homologous to  	     184 SWPYHFLRKFGSDKGVFSFEAGRRCHSGEGLFAFSTPCAPDLCRAVAGAI 233                                                          
						corresponding to amino acids 268 - 496 of Q9H666, which also 	         |||||||||:||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 194 - 422 of AA812168_P10, wherein	     258 SWPYHFLRKLGSDKGVFSFEAGRRCHSGEGLFAFSTPCAPDLCRAVAGAI 307                                                          
						said first amino acid sequence, second amino acid sequence,  	                  .         .         .         .         .  
						bridging amino acid and third amino acid sequence are        	     234 ARQRERLPELTRPQPCPLPRATSLPSLDTPGELREMPPGPEPPTSRKMHL 283                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of AA812168_P10, comprising a	     308 ARQRERLPELTRPQPCPLPRATSLPSLDTPGELREMPPGPEPPTSRKMHL 357                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     284 AEPGPQSLPLLLGPEPNDLASGLYASVCKRASGPPGNEHLYENLCVLEAS 333                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MASSTSSMSSLARSAGGRCGLCCMQEAHQAWHGWRAGRSGMVAWEQRVTGRQGLAGEGSD 	     358 AEPGPQSLPLLLGPEPNDLASGLYASVCKRASGPPGNEHLYENLCVLEAS 407                                                          
						GSSAWLTVCPCCRLTARAAPGTPVPSCSPPPSEAIYWLLSTARPGWAPSASWPSRGQGRP 	                  .         .         .         .         .  
						PQDPQMPSLPRGAWSPWRKTPSTPPGRK                                 	     334 PTLHGGEPEPHEGPGSRSPTTSPIYHNGQDLSWPGPANDSTLEAQYRRLL 383                                                          
						to the sequence of AA812168_P10.                             	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     408 PTLHGGEPEPHEGPGSRSPTTSPIYHNGQDLSWPGPANDSTLEAQYRRLL 457                                                          
						                                                            	                  .         .         .                      
						                                                            	     384 ELDQVEGTGRPDPQAGFKAKLVTLLSRERRKGPAPCDRP            422                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     458 ELDQVEGTGRPDPQAGFKAKLVTLLSRERRKGPAPCDRP            496                                                          

5250	HMR136_AA812168_12_tr0_r1_1_gPRT		Comparison report between AA812168_P12 and Q9H666partial WT  	Sequence name: Q9H666                                        
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for AA812168_P12, comprising a 	Sequence documentation:                                      
						first amino acid sequence being at least 90 % homologous to  	                                                            
						MDPLETPIKDGILYQQH corresponding to amino acids 57 - 73 of    	Alignment of: 5250 x Q9H666   ..                             
						Q9H666, which also corresponds to amino acids 1 - 17 of      	                                                            
						AA812168_P12, a second amino acid sequence being at least 90 	Alignment segment 1/1:                                       
						KCWRKVWALLYAGGPSGVARLESWEVRDGGLGAAGDRSAGPGRRGERRVIRLADCVSVLP 	                                                            
						ADGESCPRDTGAFLLTTTERSHLLAAQHRQAWMGPICQLAF                    	                     Quality: 3903.00                      Escore:       0                                               
						% homologous to corresponding to amino acids 79 - 179 of     	             Matching length:     414                Total length:     440                                               
						Q9H666, which also corresponds to amino acids 18 - 118 of    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.76                                               
						AA812168_P12, a third amino acid sequence being at least 90 %	    Total Percent Similarity:   94.09      Total Percent Identity:   93.86                                               
						PMEENSIYSSWQEVGEFPVVVQRTEAATRCQLKGPALLVLGPDAIQLREAKGTQALYSWP 	                        Gaps:       2                        
						YHFLRK                                                       	                                                            
						homologous to corresponding to amino acids 201 - 266 of      	Alignment:                                                   
						Q9H666, which also corresponds to amino acids 119 - 184 of   	                  .         .         .         .         .  
						AA812168_P12, a bridging amino acid F corresponding to amino 	       1 MDPLETPIKDGILYQQH.....KCWRKVWALLYAGGPSGVARLESWEVRD 45                                                           
						acid 185 of AA812168_P12, and a fourth amino acid sequence   	         |||||||||||||||||     ||||||||||||||||||||||||||||  
						GSDKGVFSFEAGRRCHSGEGLFAFSTPCAPDLCRAVAGAIARQRERLPELTRPQPCPLPR 	      57 MDPLETPIKDGILYQQHVKFGKKCWRKVWALLYAGGPSGVARLESWEVRD 106                                                          
						ATSLPSLDTPGELREMPPGPEPPTSRKMHLAEPGPQSLPLLLGPEPNDLASGLYASVCKR 	                  .         .         .         .         .  
						ASGPPGNEHLYENLCVLEASPTLHGGEPEPHEGPGSRSPTTSPIYHNGQDLSWPGPANDS 	      46 GGLGAAGDRSAGPGRRGERRVIRLADCVSVLPADGESCPRDTGAFLLTTT 95                                                           
						TLEAQYRRLLELDQVEGTGRPDPQAGFKAKLVTLLSRERRKGPAPCDRP            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 90 % homologous to corresponding to amino     	     107 GGLGAAGDRSAGPGRRGERRVIRLADCVSVLPADGESCPRDTGAFLLTTT 156                                                          
						acids 268 - 496 of Q9H666, which also corresponds to amino   	                  .         .         .         .         .  
						acids 186 - 414 of AA812168_P12, wherein said first amino    	      96 ERSHLLAAQHRQAWMGPICQLAF.....................PMEENS 124                                                          
						acid sequence, second amino acid sequence, third amino acid  	         |||||||||||||||||||||||                     ||||||  
						sequence, bridging amino acid and fourth amino acid sequence 	     157 ERSHLLAAQHRQAWMGPICQLAFPGTGEASSGSTDAQSPKRGLVPMEENS 206                                                          
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						chimeric polypeptide encoding for an edge portion of         	     125 IYSSWQEVGEFPVVVQRTEAATRCQLKGPALLVLGPDAIQLREAKGTQAL 174                                                          
						AA812168_P12, comprising a polypeptide having a length "n",  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     207 IYSSWQEVGEFPVVVQRTEAATRCQLKGPALLVLGPDAIQLREAKGTQAL 256                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     175 YSWPYHFLRKFGSDKGVFSFEAGRRCHSGEGLFAFSTPCAPDLCRAVAGA 224                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||:|||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     257 YSWPYHFLRKLGSDKGVFSFEAGRRCHSGEGLFAFSTPCAPDLCRAVAGA 306                                                          
						at least two amino acids comprise HK, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     225 IARQRERLPELTRPQPCPLPRATSLPSLDTPGELREMPPGPEPPTSRKMH 274                                                          
						17-x to 18; and ending at any of amino acid numbers 18+      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	     307 IARQRERLPELTRPQPCPLPRATSLPSLDTPGELREMPPGPEPPTSRKMH 356                                                          
						chimeric polypeptide encoding for an edge portion of         	                  .         .         .         .         .  
						AA812168_P12, comprising a polypeptide having a length "n",  	     275 LAEPGPQSLPLLLGPEPNDLASGLYASVCKRASGPPGNEHLYENLCVLEA 324                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 20 amino acids in length,          	     357 LAEPGPQSLPLLLGPEPNDLASGLYASVCKRASGPPGNEHLYENLCVLEA 406                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	     325 SPTLHGGEPEPHEGPGSRSPTTSPIYHNGQDLSWPGPANDSTLEAQYRRL 374                                                          
						preferably at least about 50 amino acids in length, wherein  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise FP, having a structure as  	     407 SPTLHGGEPEPHEGPGSRSPTTSPIYHNGQDLSWPGPANDSTLEAQYRRL 456                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .            
						118-x to 119; and ending at any of amino acid numbers 119+   	     375 LELDQVEGTGRPDPQAGFKAKLVTLLSRERRKGPAPCDRP           414                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     457 LELDQVEGTGRPDPQAGFKAKLVTLLSRERRKGPAPCDRP           496                                                          

10935	HMR136_AA812932_4_tr0_r1_1_gPRT		Comparison report between AA812932_P4 and Q96BT4unique head  	Sequence name: Q96BT4                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA812932_P4, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 10935 x Q96BT4   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						QSREANLSKHSSPSVPKAKMLRTSTPNLCGGLHCRAPWLSSGILCLCLIFLLGQVGLLQG 	Alignment segment 1/1:                                       
						HPQCLDYGPPFQPPLHLD                                           	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 2385.00                      Escore:       0                                               
						to amino acids 1 - 78 of AA812932_P4, a second amino acid    	             Matching length:     243                Total length:     243                                               
						EVANGLRNPVSMVHAGDGTHRFFVAEQVGVVWVYLPDGSRLEQPFLDLKNIVLTTPWIGD 	 Matching Percent Similarity:   99.59   Matching Percent Identity:   99.59                                               
						ERGFLGLAFHPKFRHNRKFYIYYSCLDKKKVEKIRISEMKVSRADPNKADLKSERVILEI 	    Total Percent Similarity:   99.59      Total Percent Identity:   99.59                                               
						EEPASNHNGGQLLFGLDGYMYIFTGDGGQAGDPFGLFGNAQNKSSLLGKVLRIDVNRAGS 	                        Gaps:       0                        
						HGKRYRVPSDNPFVSEPGAHPAIYAYGIRNMWRCAVDRGDPITRQGRGRIFCGDVGQNRF 	                                                            
						E                                                            	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 16 - 256 of Q96BT4, which also corresponds to    	      77 LDEVANGLRNPVSMVHAGDGTHRFFVAEQVGVVWVYLPDGSRLEQPFLDL 126                                                          
						amino acids 79 - 319 of AA812932_P4, and a third amino acid  	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	      14 LSEVANGLRNPVSMVHAGDGTHRFFVAEQVGVVWVYLPDGSRLEQPFLDL 63                                                           
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     127 KNIVLTTPWIGDERGFLGLAFHPKFRHNRKFYIYYSCLDKKKVEKIRISE 176                                                          
						EVDLILKGGNYGWRAKEGFACYDKKLCHNASLDDVLPIYAYGHAVGKSVTGGYVYRGCES 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PNLNGLYIFGDFMSGRLMALQEDRKNKKWKKQDLCLGSTTSCAFPGLISTHSKFIISFAE 	      64 KNIVLTTPWIGDERGFLGLAFHPKFRHNRKFYIYYSCLDKKKVEKIRISE 113                                                          
						DEAGELYFLATSYPSAYAPRGSIYKFVDPSRRAPPGKCKYKPVPVRTKSKRIPFRPLAKT 	                  .         .         .         .         .  
						VLDLLKEQSEKAARKSSSATLASGPAQGLSEKGSSKKLASPTSSKNTLRGPGTKKKARVG 	     177 MKVSRADPNKADLKSERVILEIEEPASNHNGGQLLFGLDGYMYIFTGDGG 226                                                          
						PHVRQGKRRKSLKSHSGRMRPSAEQKRAGRSLP                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 320 - 592 of	     114 MKVSRADPNKADLKSERVILEIEEPASNHNGGQLLFGLDGYMYIFTGDGG 163                                                          
						AA812932_P4, wherein said first amino acid sequence, second  	                  .         .         .         .         .  
						amino acid sequence and third amino acid sequence are        	     227 QAGDPFGLFGNAQNKSSLLGKVLRIDVNRAGSHGKRYRVPSDNPFVSEPG 276                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of AA812932_P4, comprising a 	     164 QAGDPFGLFGNAQNKSSLLGKVLRIDVNRAGSHGKRYRVPSDNPFVSEPG 213                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .            
						80%, preferably at least about 85%, more preferably at least 	     277 AHPAIYAYGIRNMWRCAVDRGDPITRQGRGRIFCGDVGQNRFE        319                                                          
						about 90% and most preferably at least about 95% homologous  	         |||||||||||||||||||||||||||||||||||||||||||         
						QSREANLSKHSSPSVPKAKMLRTSTPNLCGGLHCRAPWLSSGILCLCLIFLLGQVGLLQG 	     214 AHPAIYAYGIRNMWRCAVDRGDPITRQGRGRIFCGDVGQNRFE        256                                                          
						HPQCLDYGPPFQPPLHLD                                           	                                                            
						to the sequence of AA812932_P4.3.An isolated polypeptide     	                                                            
						encoding for a tail of AA812932_P4, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						EVDLILKGGNYGWRAKEGFACYDKKLCHNASLDDVLPIYAYGHAVGKSVTGGYVYRGCES 	                                                            
						PNLNGLYIFGDFMSGRLMALQEDRKNKKWKKQDLCLGSTTSCAFPGLISTHSKFIISFAE 	                                                            
						DEAGELYFLATSYPSAYAPRGSIYKFVDPSRRAPPGKCKYKPVPVRTKSKRIPFRPLAKT 	                                                            
						VLDLLKEQSEKAARKSSSATLASGPAQGLSEKGSSKKLASPTSSKNTLRGPGTKKKARVG 	                                                            
						PHVRQGKRRKSLKSHSGRMRPSAEQKRAGRSLP                            	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA812932_P4.                                              	                                                            

						Comparison report between AA812932_P4 and Q9H8A0unique head  	Sequence name: Q9H8A0                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA812932_P4, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 10935 x Q9H8A0   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						QSREANLSKHSSPSVPKAKMLRTSTPNLCGGLHCRAPWLSSGILCLCLIFLLGQVGLLQG 	Alignment segment 1/1:                                       
						HPQCLDYGPPFQPPLHLD                                           	                                                            
						having the sequence corresponding to amino acids 1 - 78 of   	                     Quality: 5056.00                      Escore:       0                                               
						AA812932_P4, and a second amino acid sequence being at least 	             Matching length:     516                Total length:     516                                               
						EVANGLRNPVSMVHAGDGTHRFFVAEQVGVVWVYLPDGSRLEQPFLDLKNIVLTTPWIGD 	 Matching Percent Similarity:   99.81   Matching Percent Identity:   99.81                                               
						ERGFLGLAFHPKFRHNRKFYIYYSCLDKKKVEKIRISEMKVSRADPNKADLKSERVILEI 	    Total Percent Similarity:   99.81      Total Percent Identity:   99.81                                               
						EEPASNHNGGQLLFGLDGYMYIFTGDGGQAGDPFGLFGNAQNKSSLLGKVLRIDVNRAGS 	                        Gaps:       0                        
						HGKRYRVPSDNPFVSEPGAHPAIYAYGIRNMWRCAVDRGDPITRQGRGRIFCGDVGQNRF 	                                                            
						EEVDLILKGGNYGWRAKEGFACYDKKLCHNASLDDVLPIYAYGHAVGKSVTGGYVYRGCE 	Alignment:                                                   
						SPNLNGLYIFGDFMSGRLMALQEDRKNKKWKKQDLCLGSTTSCAFPGLISTHSKFIISFA 	                  .         .         .         .         .  
						EDEAGELYFLATSYPSAYAPRGSIYKFVDPSRRAPPGKCKYKPVPVRTKSKRIPFRPLAK 	      77 LDEVANGLRNPVSMVHAGDGTHRFFVAEQVGVVWVYLPDGSRLEQPFLDL 126                                                          
						TVLDLLKEQSEKAARKSSSATLASGPAQGLSEKGSSKKLASPTSSKNTLRGPGTKKKARV 	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						GPHVRQGKRRKSLKSHSGRMRPSAEQKRAGRSLP                           	      14 LSEVANGLRNPVSMVHAGDGTHRFFVAEQVGVVWVYLPDGSRLEQPFLDL 63                                                           
						90 % homologous to corresponding to amino acids 16 - 529 of  	                  .         .         .         .         .  
						Q9H8A0, which also corresponds to amino acids 79 - 592 of    	     127 KNIVLTTPWIGDERGFLGLAFHPKFRHNRKFYIYYSCLDKKKVEKIRISE 176                                                          
						AA812932_P4, wherein said first amino acid sequence and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	      64 KNIVLTTPWIGDERGFLGLAFHPKFRHNRKFYIYYSCLDKKKVEKIRISE 113                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AA812932_P4, comprising a polypeptide being at least 70%,    	     177 MKVSRADPNKADLKSERVILEIEEPASNHNGGQLLFGLDGYMYIFTGDGG 226                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     114 MKVSRADPNKADLKSERVILEIEEPASNHNGGQLLFGLDGYMYIFTGDGG 163                                                          
						QSREANLSKHSSPSVPKAKMLRTSTPNLCGGLHCRAPWLSSGILCLCLIFLLGQVGLLQG 	                  .         .         .         .         .  
						HPQCLDYGPPFQPPLHLD                                           	     227 QAGDPFGLFGNAQNKSSLLGKVLRIDVNRAGSHGKRYRVPSDNPFVSEPG 276                                                          
						least about 95% homologous to the sequence of AA812932_P4.   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     164 QAGDPFGLFGNAQNKSSLLGKVLRIDVNRAGSHGKRYRVPSDNPFVSEPG 213                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     277 AHPAIYAYGIRNMWRCAVDRGDPITRQGRGRIFCGDVGQNRFEEVDLILK 326                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     214 AHPAIYAYGIRNMWRCAVDRGDPITRQGRGRIFCGDVGQNRFEEVDLILK 263                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     327 GGNYGWRAKEGFACYDKKLCHNASLDDVLPIYAYGHAVGKSVTGGYVYRG 376                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     264 GGNYGWRAKEGFACYDKKLCHNASLDDVLPIYAYGHAVGKSVTGGYVYRG 313                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     377 CESPNLNGLYIFGDFMSGRLMALQEDRKNKKWKKQDLCLGSTTSCAFPGL 426                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     314 CESPNLNGLYIFGDFMSGRLMALQEDRKNKKWKKQDLCLGSTTSCAFPGL 363                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     427 ISTHSKFIISFAEDEAGELYFLATSYPSAYAPRGSIYKFVDPSRRAPPGK 476                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     364 ISTHSKFIISFAEDEAGELYFLATSYPSAYAPRGSIYKFVDPSRRAPPGK 413                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     477 CKYKPVPVRTKSKRIPFRPLAKTVLDLLKEQSEKAARKSSSATLASGPAQ 526                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     414 CKYKPVPVRTKSKRIPFRPLAKTVLDLLKEQSEKAARKSSSATLASGPAQ 463                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     527 GLSEKGSSKKLASPTSSKNTLRGPGTKKKARVGPHVRQGKRRKSLKSHSG 576                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     464 GLSEKGSSKKLASPTSSKNTLRGPGTKKKARVGPHVRQGKRRKSLKSHSG 513                                                          
						                                                            	                  .                                          
						                                                            	     577 RMRPSAEQKRAGRSLP                                   592                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     514 RMRPSAEQKRAGRSLP                                   529                                                          

						Comparison report between AA812932_P4 and Q96BU5unique head  	Sequence name: Q96BU5                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA812932_P4, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 10935 x Q96BU5   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						QSREANLSKHSSPSVPKAKMLRTSTPNLCGGLHCRAPWLSSGILCLCLIFLLGQVGLLQG 	Alignment segment 1/1:                                       
						HPQCLDYGPPFQPPLHLDEVANGLRNPVSMVHAGDGTHRFFVAEQVGVVWVYLPDGSRLE 	                                                            
						QPFLDLKNIVLTTPWIGDERGFLGLAFHPKFRHNRKFYIYYSCLDKKKVEKIRISEMKVS 	                     Quality: 2329.00                      Escore:       0                                               
						RADPNKADLKSERVILEIEEPASNHNGGQLLFGLDGYMYIFTGDGGQAGDPFGLFGNAQN 	             Matching length:     239                Total length:     239                                               
						KSSLLGKVLRIDVNRAGSHGKRYRVPSDNPFVSEPGAHPAIYAYGIRNMWRCAVDRGDPI 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TRQGRGRIFCGDVGQNRFEEVDLILKGGNYGWRAKEGFACYDKKLCHNASLDD        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 353 of  	                        Gaps:       0                        
						AA812932_P4, and a second amino acid sequence being at least 	                                                            
						VLPIYAYGHAVGKSVTGGYVYRGCESPNLNGLYIFGDFMSGRLMALQEDRKNKKWKKQDL 	Alignment:                                                   
						CLGSTTSCAFPGLISTHSKFIISFAEDEAGELYFLATSYPSAYAPRGSIYKFVDPSRRAP 	                  .         .         .         .         .  
						PGKCKYKPVPVRTKSKRIPFRPLAKTVLDLLKEQSEKAARKSSSATLASGPAQGLSEKGS 	     354 VLPIYAYGHAVGKSVTGGYVYRGCESPNLNGLYIFGDFMSGRLMALQEDR 403                                                          
						SKKLASPTSSKNTLRGPGTKKKARVGPHVRQGKRRKSLKSHSGRMRPSAEQKRAGRSLP  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 1 - 239 of   	       1 VLPIYAYGHAVGKSVTGGYVYRGCESPNLNGLYIFGDFMSGRLMALQEDR 50                                                           
						Q96BU5, which also corresponds to amino acids 354 - 592 of   	                  .         .         .         .         .  
						AA812932_P4, wherein said first amino acid sequence and      	     404 KNKKWKKQDLCLGSTTSCAFPGLISTHSKFIISFAEDEAGELYFLATSYP 453                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	      51 KNKKWKKQDLCLGSTTSCAFPGLISTHSKFIISFAEDEAGELYFLATSYP 100                                                          
						AA812932_P4, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     454 SAYAPRGSIYKFVDPSRRAPPGKCKYKPVPVRTKSKRIPFRPLAKTVLDL 503                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QSREANLSKHSSPSVPKAKMLRTSTPNLCGGLHCRAPWLSSGILCLCLIFLLGQVGLLQG 	     101 SAYAPRGSIYKFVDPSRRAPPGKCKYKPVPVRTKSKRIPFRPLAKTVLDL 150                                                          
						HPQCLDYGPPFQPPLHLDEVANGLRNPVSMVHAGDGTHRFFVAEQVGVVWVYLPDGSRLE 	                  .         .         .         .         .  
						QPFLDLKNIVLTTPWIGDERGFLGLAFHPKFRHNRKFYIYYSCLDKKKVEKIRISEMKVS 	     504 LKEQSEKAARKSSSATLASGPAQGLSEKGSSKKLASPTSSKNTLRGPGTK 553                                                          
						RADPNKADLKSERVILEIEEPASNHNGGQLLFGLDGYMYIFTGDGGQAGDPFGLFGNAQN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KSSLLGKVLRIDVNRAGSHGKRYRVPSDNPFVSEPGAHPAIYAYGIRNMWRCAVDRGDPI 	     151 LKEQSEKAARKSSSATLASGPAQGLSEKGSSKKLASPTSSKNTLRGPGTK 200                                                          
						TRQGRGRIFCGDVGQNRFEEVDLILKGGNYGWRAKEGFACYDKKLCHNASLDD        	                  .         .         .                      
						least about 95% homologous to the sequence of AA812932_P4.   	     554 KKARVGPHVRQGKRRKSLKSHSGRMRPSAEQKRAGRSLP            592                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||             
						                                                            	     201 KKARVGPHVRQGKRRKSLKSHSGRMRPSAEQKRAGRSLP            239                                                          

11190	HMR136_AA813184_2_tr0_r1_1_gPRT		Comparison report between AA813184_P2 and AAH44661partial WT 	Sequence name: AAH44661                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA813184_P2, comprising a first     	Sequence documentation:                                      
						MRQPEVSEDCIQMYFKVKAPITQFLGRAHLCRAQMCAPKSAENLEEFENCVTEYMKAINF 	                                                            
						AKGEPRYYFLVYNASVLYWQMVRPFLKPGYRHHLIPSLSQIINVLSQTEEEDKEWRAELM 	Alignment of: 11190 x AAH44661   ..                          
						LELLECYLQAGRKEEAARFCSTAAPFIKSHVPQKYRQIFSVMV                  	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 59 - 221 of AAH44661, which also	                                                            
						corresponds to amino acids 1 - 163 of AA813184_P2, and a     	                     Quality: 1645.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     163                Total length:     163                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RHELMDELQLKEEKKNSISLSVTFYINMLKAKAEQNDLPGDINVILRKAYRHLGHYNHQR 	                        Gaps:       0                        
						FPSISEEKMLLLFELARFSLTLKCMEISSACLSDLKKMESKVSGFMTLLPGDEALLTVQL 	                                                            
						DKRQRKEEQFTRPRPPGLRSVVGTLPSFLPVFCTVAVRWCLQFYTCPFLFTFLVATGPQH 	Alignment:                                                   
						HSCF                                                         	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	       1 MRQPEVSEDCIQMYFKVKAPITQFLGRAHLCRAQMCAPKSAENLEEFENC 50                                                           
						164 - 347 of AA813184_P2, wherein said first amino acid      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and second amino acid sequence are contiguous and in	      59 MRQPEVSEDCIQMYFKVKAPITQFLGRAHLCRAQMCAPKSAENLEEFENC 108                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of AA813184_P2, comprising a polypeptide being at least 	      51 VTEYMKAINFAKGEPRYYFLVYNASVLYWQMVRPFLKPGYRHHLIPSLSQ 100                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     109 VTEYMKAINFAKGEPRYYFLVYNASVLYWQMVRPFLKPGYRHHLIPSLSQ 158                                                          
						RHELMDELQLKEEKKNSISLSVTFYINMLKAKAEQNDLPGDINVILRKAYRHLGHYNHQR 	                  .         .         .         .         .  
						FPSISEEKMLLLFELARFSLTLKCMEISSACLSDLKKMESKVSGFMTLLPGDEALLTVQL 	     101 IINVLSQTEEEDKEWRAELMLELLECYLQAGRKEEAARFCSTAAPFIKSH 150                                                          
						DKRQRKEEQFTRPRPPGLRSVVGTLPSFLPVFCTVAVRWCLQFYTCPFLFTFLVATGPQH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						HSCF                                                         	     159 IINVLSQTEEEDKEWRAELMLELLECYLQAGRKEEAARFCSTAAPFIKSH 208                                                          
						at least about 95% homologous to the sequence in AA813184_P2.	                  .                                          
						                                                            	     151 VPQKYRQIFSVMV                                      163                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     209 VPQKYRQIFSVMV                                      221                                                          

11688	HMR136_AA813635_1_tr0_r1_1_gPRT		Comparison report between AA813635_P1 and Q96GG3unique head  	Sequence name: Q96GG3                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA813635_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 11688 x Q96GG3   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MNPPGSLEALDPNVDEHLSTQILAPSVHSDNSQERIQARRLRIAARLEARRREALGEYLD 	Alignment segment 1/1:                                       
						GKKESEEDQSKSYKQKEESRLKLAKLLLCGTELVTNIQVAIDIREIHRRVEEEEIKRQRI 	                                                            
						EKLENEVKTSQDKFDEITSKWEEGKQKRIPQELWEMLNTQQLHCAGLLEDKNKLISELQQ 	                     Quality: 1652.00                      Escore:       0                                               
						ELKTKDDQYVKDLKKQSDDICLLLERMEEQVKNVMKTFREELYNIELEYLNNRMKKVEDY 	             Matching length:     169                Total length:     169                                               
						EKQLNRQRIWDCEEYNMIKIKLEQDVQILEQQLQQRKAIYQLNQEKLEYNLQVLKKRDEE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						STVIKSQQKRKINRLHDILNNLRSKYAKQIKQFQEENQSLTSDYKRLVMQFKELQKAMRH 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						FALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDFWFLNNVGPISQQ 	                        Gaps:       0                        
						PQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQISEKTTKRILMLLCDESGFLIES 	                                                            
						KLLSLLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFFLKYRAHRLSSSLQIKPCSQ 	Alignment:                                                   
						AS                                                           	                  .         .         .         .         .  
						having the sequence corresponding to amino acids 1 - 542 of  	     543 MEKASMEETSTRSELELAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIH 592                                                          
						AA813635_P1, and a second amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MEKASMEETSTRSELELAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIHPNDVLKILEA 	       1 MEKASMEETSTRSELELAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIH 50                                                           
						FVMGLKKPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPSSKQNLWDALYTALEKYHLVL 	                  .         .         .         .         .  
						TQRAKLLLENSSLEQQNTELQALLQQYLNSKINSELQVPPTQVLRVPTK            	     593 PNDVLKILEAFVMGLKKPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPS 642                                                          
						90 % homologous to corresponding to amino acids 1 - 169 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						Q96GG3, which also corresponds to amino acids 543 - 711 of   	      51 PNDVLKILEAFVMGLKKPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPS 100                                                          
						AA813635_P1, wherein said first amino acid sequence and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	     643 SKQNLWDALYTALEKYHLVLTQRAKLLLENSSLEQQNTELQALLQQYLNS 692                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA813635_P1, comprising a polypeptide being at least 70%,    	     101 SKQNLWDALYTALEKYHLVLTQRAKLLLENSSLEQQNTELQALLQQYLNS 150                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .                                          
						more preferably at least about 90% and most preferably at    	     693 KINSELQVPPTQVLRVPTK                                711                                                          
						MNPPGSLEALDPNVDEHLSTQILAPSVHSDNSQERIQARRLRIAARLEARRREALGEYLD 	         |||||||||||||||||||                                 
						GKKESEEDQSKSYKQKEESRLKLAKLLLCGTELVTNIQVAIDIREIHRRVEEEEIKRQRI 	     151 KINSELQVPPTQVLRVPTK                                169                                                          
						EKLENEVKTSQDKFDEITSKWEEGKQKRIPQELWEMLNTQQLHCAGLLEDKNKLISELQQ 	                                                            
						ELKTKDDQYVKDLKKQSDDICLLLERMEEQVKNVMKTFREELYNIELEYLNNRMKKVEDY 	                                                            
						EKQLNRQRIWDCEEYNMIKIKLEQDVQILEQQLQQRKAIYQLNQEKLEYNLQVLKKRDEE 	                                                            
						STVIKSQQKRKINRLHDILNNLRSKYAKQIKQFQEENQSLTSDYKRLVMQFKELQKAMRH 	                                                            
						FALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDFWFLNNVGPISQQ 	                                                            
						PQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQISEKTTKRILMLLCDESGFLIES 	                                                            
						KLLSLLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFFLKYRAHRLSSSLQIKPCSQ 	                                                            
						AS                                                           	                                                            
						least about 95% homologous to the sequence of AA813635_P1.   	                                                            

						Comparison report between AA813635_P1 and Q96MC2partial WT   	Sequence name: Q96MC2                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for AA813635_P1, comprising a first     	Sequence documentation:                                      
						MNPPGSLEALDPNVDEHLSTQILAPSVHSDNSQERIQARRLRIAARLEARRREALGEYLD 	                                                            
						GKKESEEDQSKSYKQKEESRLKLAKLLLCGTELVTNIQVAIDIREIHRRVEEEEIKRQRI 	Alignment of: 11688 x Q96MC2   ..                            
						EKLENEVKTSQDKFDEITSKWEEGKQKRIPQELWEMLNTQQLHCAGLLEDKNKLISELQQ 	                                                            
						ELKTKDDQYVKDLKKQSDDICLLLERMEEQVKNVMKTFREELYNI                	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 225 of Q96MC2, which also   	                     Quality: 6868.00                      Escore:       0                                               
						corresponds to amino acids 1 - 225 of AA813635_P1, and a     	             Matching length:     711                Total length:     740                                               
						ELEYLNNRMKKVEDYEKQLNRQRIWDCEEYNMIKIKLEQDVQILEQQLQQRKAIYQLNQE 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KLEYNLQVLKKRDEESTVIKSQQKRKINRLHDILNNLRSKYAKQIKQFQEENQSLTSDYK 	    Total Percent Similarity:   96.08      Total Percent Identity:   96.08                                               
						RLVMQFKELQKAMRHFALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAA 	                        Gaps:       1                        
						PDFWFLNNVGPISQQPQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQISEKTTKR 	                                                            
						ILMLLCDESGFLIESKLLSLLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFFLKYR 	Alignment:                                                   
						AHRLSSSLQIKPCSQASMEKASMEETSTRSELELAEQTEMEGEKEESLVEGEKEEEEETP 	                  .         .         .         .         .  
						PSPWVIHPNDVLKILEAFVMGLKKPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPSSKQ 	       1 MNPPGSLEALDPNVDEHLSTQILAPSVHSDNSQERIQARRLRIAARLEAR 50                                                           
						NLWDALYTALEKYHLVLTQRAKLLLENSSLEQQNTELQALLQQYLNSKINSELQVPPTQV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LRVPTK                                                       	       1 MNPPGSLEALDPNVDEHLSTQILAPSVHSDNSQERIQARRLRIAARLEAR 50                                                           
						second amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 255 - 740 of Q96MC2, which also 	      51 RREALGEYLDGKKESEEDQSKSYKQKEESRLKLAKLLLCGTELVTNIQVA 100                                                          
						corresponds to amino acids 226 - 711 of AA813635_P1, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence and second amino acid sequence	      51 RREALGEYLDGKKESEEDQSKSYKQKEESRLKLAKLLLCGTELVTNIQVA 100                                                          
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						chimeric polypeptide encoding for an edge portion of         	     101 IDIREIHRRVEEEEIKRQRIEKLENEVKTSQDKFDEITSKWEEGKQKRIP 150                                                          
						AA813635_P1, comprising a polypeptide having a length "n",   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     101 IDIREIHRRVEEEEIKRQRIEKLENEVKTSQDKFDEITSKWEEGKQKRIP 150                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     151 QELWEMLNTQQLHCAGLLEDKNKLISELQQELKTKDDQYVKDLKKQSDDI 200                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     151 QELWEMLNTQQLHCAGLLEDKNKLISELQQELKTKDDQYVKDLKKQSDDI 200                                                          
						at least two amino acids comprise IE, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     201 CLLLERMEEQVKNVMKTFREELYNI......................... 225                                                          
						225-x to 226; and ending at any of amino acid numbers 226+   	         |||||||||||||||||||||||||                           
						((n-2) - x), in which x varies from 0 to n-2.                	     201 CLLLERMEEQVKNVMKTFREELYNIEKAFEVERQELLASNKKKWEQALQA 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     226 ....ELEYLNNRMKKVEDYEKQLNRQRIWDCEEYNMIKIKLEQDVQILEQ 271                                                          
						                                                            	             ||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 HNAKELEYLNNRMKKVEDYEKQLNRQRIWDCEEYNMIKIKLEQDVQILEQ 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     272 QLQQRKAIYQLNQEKLEYNLQVLKKRDEESTVIKSQQKRKINRLHDILNN 321                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 QLQQRKAIYQLNQEKLEYNLQVLKKRDEESTVIKSQQKRKINRLHDILNN 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     322 LRSKYAKQIKQFQEENQSLTSDYKRLVMQFKELQKAMRHFALIDDEKFRE 371                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LRSKYAKQIKQFQEENQSLTSDYKRLVMQFKELQKAMRHFALIDDEKFRE 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     372 IWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDFWFLNNVGPISQQP 421                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 IWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDFWFLNNVGPISQQP 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     422 QKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQISEKTTKRILMLLC 471                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 QKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQISEKTTKRILMLLC 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     472 DESGFLIESKLLSLLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFF 521                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 DESGFLIESKLLSLLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFF 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     522 LKYRAHRLSSSLQIKPCSQASMEKASMEETSTRSELELAEQTEMEGEKEE 571                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 LKYRAHRLSSSLQIKPCSQASMEKASMEETSTRSELELAEQTEMEGEKEE 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     572 SLVEGEKEEEEETPPSPWVIHPNDVLKILEAFVMGLKKPRDSRAPLRVQK 621                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 SLVEGEKEEEEETPPSPWVIHPNDVLKILEAFVMGLKKPRDSRAPLRVQK 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     622 NVRDNSKDSEYWQALTTVIPSSKQNLWDALYTALEKYHLVLTQRAKLLLE 671                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 NVRDNSKDSEYWQALTTVIPSSKQNLWDALYTALEKYHLVLTQRAKLLLE 700                                                          
						                                                            	                  .         .         .         .            
						                                                            	     672 NSSLEQQNTELQALLQQYLNSKINSELQVPPTQVLRVPTK           711                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     701 NSSLEQQNTELQALLQQYLNSKINSELQVPPTQVLRVPTK           740                                                          

						Comparison report between AA813635_P1 and Q8NDI5unique head  	Sequence name: Q8NDI5                                        
						followed by partial WT sequence featuring a skipped exon and 	                                                            
						a mismatch.1.An isolated chimeric polypeptide encoding for   	Sequence documentation:                                      
						AA813635_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 11688 x Q8NDI5   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MNPPGSLEALDPNVDEHLSTQILAPSVHSDNSQERIQARRLRIAARLEARRREALGEYLD 	Alignment segment 1/1:                                       
						GKK                                                          	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 6253.00                      Escore:       0                                               
						to amino acids 1 - 63 of AA813635_P1, a second amino acid    	             Matching length:     648                Total length:     677                                               
						ESEEDQSKSYKQKEESRLKLAKLLLCGTELVTNIQVAIDIREIHRRVEEEEIKRQRIEKL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.85                                               
						ENEVKTSQDKFDEITSKWEEGKQKRIPQELWEMLNTQQLHCAGLLEDKNKLISELQQELK 	    Total Percent Similarity:   95.72      Total Percent Identity:   95.57                                               
						TKDDQYVKDLKKQSDDICLLLERMEEQVKNVMKTFREELYNI                   	                        Gaps:       1                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 162 of Q8NDI5, which also corresponds to     	Alignment:                                                   
						amino acids 64 - 225 of AA813635_P1, a third amino acid      	                  .         .         .         .         .  
						ELEYLNNRMKKVEDYEKQLNRQRIWDCEEYNMIKIKLEQDVQILEQQLQQRKAIYQLNQE 	      64 ESEEDQSKSYKQKEESRLKLAKLLLCGTELVTNIQVAIDIREIHRRVEEE 113                                                          
						KLEYNLQVLKKRDEESTVIKSQQKRKINRLHDILNNLRSKYA                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 ESEEDQSKSYKQKEESRLKLAKLLLCGTELVTNIQVAIDIREIHRRVEEE 50                                                           
						amino acids 192 - 293 of Q8NDI5, which also corresponds to   	                  .         .         .         .         .  
						amino acids 226 - 327 of AA813635_P1, a bridging amino acid K	     114 EIKRQRIEKLENEVKTSQDKFDEITSKWEEGKQKRIPQELWEMLNTQQLH 163                                                          
						corresponding to amino acid 328 of AA813635_P1, and a fourth 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QIKQFQEENQSLTSDYKRLVMQFKELQKAMRHFALIDDEKFREIWLMNEEEAKDLIARAF 	      51 EIKRQRIEKLENEVKTSQDKFDEITSKWEEGKQKRIPQELWEMLNTQQLH 100                                                          
						DVDRIIHTHHLGLPWAAPDFWFLNNVGPISQQPQKSATQIVEEMLMRSEEEEAEEAAAEP 	                  .         .         .         .         .  
						ESYLDLPKQISEKTTKRILMLLCDESGFLIESKLLSLLLPLEQNECYLLRLDAIFSALGI 	     164 CAGLLEDKNKLISELQQELKTKDDQYVKDLKKQSDDICLLLERMEEQVKN 213                                                          
						ESEDDLYKLVNFFLKYRAHRLSSSLQIKPCSQASMEKASMEETSTRSELELAEQTEMEGE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KEESLVEGEKEEEEETPPSPWVIHPNDVLKILEAFVMGLKKPRDSRAPLRVQKNVRDNSK 	     101 CAGLLEDKNKLISELQQELKTKDDQYVKDLKKQSDDICLLLERMEEQVKN 150                                                          
						DSEYWQALTTVIPSSKQNLWDALYTALEKYHLVLTQRAKLLLENSSLEQQNTELQALLQQ 	                  .         .         .         .         .  
						YLNSKINSELQVPPTQVLRVPTK                                      	     214 VMKTFREELYNI.............................ELEYLNNRM 234                                                          
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||                             |||||||||  
						corresponding to amino acids 295 - 677 of Q8NDI5, which also 	     151 VMKTFREELYNIEKAFEVERQELLASNKKKWEQALQAHNAKELEYLNNRM 200                                                          
						corresponds to amino acids 329 - 711 of AA813635_P1, wherein 	                  .         .         .         .         .  
						said first amino acid sequence, second amino acid sequence,  	     235 KKVEDYEKQLNRQRIWDCEEYNMIKIKLEQDVQILEQQLQQRKAIYQLNQ 284                                                          
						third amino acid sequence, bridging amino acid and fourth    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence are contiguous and in a sequential       	     201 KKVEDYEKQLNRQRIWDCEEYNMIKIKLEQDVQILEQQLQQRKAIYQLNQ 250                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AA813635_P1, comprising a polypeptide being at least 70%,    	     285 EKLEYNLQVLKKRDEESTVIKSQQKRKINRLHDILNNLRSKYAKQIKQFQ 334                                                          
						optionally at least about 80%, preferably at least about 85%,	         |||||||||||||||||||||||||||||||||||||||||||:||||||  
						more preferably at least about 90% and most preferably at    	     251 EKLEYNLQVLKKRDEESTVIKSQQKRKINRLHDILNNLRSKYAEQIKQFQ 300                                                          
						MNPPGSLEALDPNVDEHLSTQILAPSVHSDNSQERIQARRLRIAARLEARRREALGEYLD 	                  .         .         .         .         .  
						GKK                                                          	     335 EENQSLTSDYKRLVMQFKELQKAMRHFALIDDEKFREIWLMNEEEAKDLI 384                                                          
						least about 95% homologous to the sequence of                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA813635_P1.3.An isolated chimeric polypeptide encoding for  	     301 EENQSLTSDYKRLVMQFKELQKAMRHFALIDDEKFREIWLMNEEEAKDLI 350                                                          
						an edge portion of AA813635_P1, comprising a polypeptide     	                  .         .         .         .         .  
						having a length "n", wherein n is at least about 10 amino    	     385 ARAFDVDRIIHTHHLGLPWAAPDFWFLNNVGPISQQPQKSATQIVEEMLM 434                                                          
						acids in length, optionally at least about 20 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, preferably at least about 30 amino acids in length,  	     351 ARAFDVDRIIHTHHLGLPWAAPDFWFLNNVGPISQQPQKSATQIVEEMLM 400                                                          
						more preferably at least about 40 amino acids in length and  	                  .         .         .         .         .  
						most preferably at least about 50 amino acids in length,     	     435 RSEEEEAEEAAAEPESYLDLPKQISEKTTKRILMLLCDESGFLIESKLLS 484                                                          
						wherein at least two amino acids comprise IE, having a       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						structure as follows: a sequence starting from any of amino  	     401 RSEEEEAEEAAAEPESYLDLPKQISEKTTKRILMLLCDESGFLIESKLLS 450                                                          
						acid numbers 225-x to 226; and ending at any of amino acid   	                  .         .         .         .         .  
						numbers 226+ ((n-2) - x), in which x varies from 0 to n-2.   	     485 LLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFFLKYRAHRLSSSLQ 534                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 LLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFFLKYRAHRLSSSLQ 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     535 IKPCSQASMEKASMEETSTRSELELAEQTEMEGEKEESLVEGEKEEEEET 584                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 IKPCSQASMEKASMEETSTRSELELAEQTEMEGEKEESLVEGEKEEEEET 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     585 PPSPWVIHPNDVLKILEAFVMGLKKPRDSRAPLRVQKNVRDNSKDSEYWQ 634                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 PPSPWVIHPNDVLKILEAFVMGLKKPRDSRAPLRVQKNVRDNSKDSEYWQ 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     635 ALTTVIPSSKQNLWDALYTALEKYHLVLTQRAKLLLENSSLEQQNTELQA 684                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 ALTTVIPSSKQNLWDALYTALEKYHLVLTQRAKLLLENSSLEQQNTELQA 650                                                          
						                                                            	                  .         .                                
						                                                            	     685 LLQQYLNSKINSELQVPPTQVLRVPTK                        711                                                          
						                                                            	         |||||||||||||||||||||||||||                         
						                                                            	     651 LLQQYLNSKINSELQVPPTQVLRVPTK                        677                                                          

						Comparison report between AA813635_P1 and AAH09488unique     	Sequence name: AAH09488                                      
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA813635_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 11688 x AAH09488   ..                          
						more preferably at least 90% and most preferably at least 95%	                                                            
						MNPPGSLEALDPNVDEHLSTQILAPSVHSDNSQERIQARRLRIAARLEARRREALGEYLD 	Alignment segment 1/1:                                       
						GKKESEEDQSKSYKQKEESRLKLAKLLLCGTELVTNIQVAIDIREIHRRVEEEEIKRQRI 	                                                            
						EKLENEVKTSQDKFDEITSKWEEGKQKRIPQELWE                          	                     Quality: 5364.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     556                Total length:     585                                               
						to amino acids 1 - 155 of AA813635_P1, a second amino acid   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MLNTQQLHCAGLLEDKNKLISELQQELKTKDDQYVKDLKKQSDDICLLLERMEEQVKNVM 	    Total Percent Similarity:   95.04      Total Percent Identity:   95.04                                               
						KTFREELYNI                                                   	                        Gaps:       1                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 70 of AAH09488, which also corresponds to    	Alignment:                                                   
						amino acids 156 - 225 of AA813635_P1, and a third amino acid 	                  .         .         .         .         .  
						ELEYLNNRMKKVEDYEKQLNRQRIWDCEEYNMIKIKLEQDVQILEQQLQQRKAIYQLNQE 	     156 MLNTQQLHCAGLLEDKNKLISELQQELKTKDDQYVKDLKKQSDDICLLLE 205                                                          
						KLEYNLQVLKKRDEESTVIKSQQKRKINRLHDILNNLRSKYAKQIKQFQEENQSLTSDYK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RLVMQFKELQKAMRHFALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAA 	       1 MLNTQQLHCAGLLEDKNKLISELQQELKTKDDQYVKDLKKQSDDICLLLE 50                                                           
						PDFWFLNNVGPISQQPQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQISEKTTKR 	                  .         .         .         .         .  
						ILMLLCDESGFLIESKLLSLLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFFLKYR 	     206 RMEEQVKNVMKTFREELYNI.............................E 226                                                          
						AHRLSSSLQIKPCSQASMEKASMEETSTRSELELAEQTEMEGEKEESLVEGEKEEEEETP 	         ||||||||||||||||||||                             |  
						PSPWVIHPNDVLKILEAFVMGLKKPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPSSKQ 	      51 RMEEQVKNVMKTFREELYNIEKAFEVERQELLASNKKKWEQALQAHNAKE 100                                                          
						NLWDALYTALEKYHLVLTQRAKLLLENSSLEQQNTELQALLQQYLNSKINSELQVPPTQV 	                  .         .         .         .         .  
						LRVPTK                                                       	     227 LEYLNNRMKKVEDYEKQLNRQRIWDCEEYNMIKIKLEQDVQILEQQLQQR 276                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 100 - 585 of AAH09488, which also corresponds to 	     101 LEYLNNRMKKVEDYEKQLNRQRIWDCEEYNMIKIKLEQDVQILEQQLQQR 150                                                          
						amino acids 226 - 711 of AA813635_P1, wherein said first     	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence and third    	     277 KAIYQLNQEKLEYNLQVLKKRDEESTVIKSQQKRKINRLHDILNNLRSKY 326                                                          
						amino acid sequence are contiguous and in a sequential       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     151 KAIYQLNQEKLEYNLQVLKKRDEESTVIKSQQKRKINRLHDILNNLRSKY 200                                                          
						AA813635_P1, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     327 AKQIKQFQEENQSLTSDYKRLVMQFKELQKAMRHFALIDDEKFREIWLMN 376                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MNPPGSLEALDPNVDEHLSTQILAPSVHSDNSQERIQARRLRIAARLEARRREALGEYLD 	     201 AKQIKQFQEENQSLTSDYKRLVMQFKELQKAMRHFALIDDEKFREIWLMN 250                                                          
						GKKESEEDQSKSYKQKEESRLKLAKLLLCGTELVTNIQVAIDIREIHRRVEEEEIKRQRI 	                  .         .         .         .         .  
						EKLENEVKTSQDKFDEITSKWEEGKQKRIPQELWE                          	     377 EEEAKDLIARAFDVDRIIHTHHLGLPWAAPDFWFLNNVGPISQQPQKSAT 426                                                          
						least about 95% homologous to the sequence of                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA813635_P1.3.An isolated chimeric polypeptide encoding for  	     251 EEEAKDLIARAFDVDRIIHTHHLGLPWAAPDFWFLNNVGPISQQPQKSAT 300                                                          
						an edge portion of AA813635_P1, comprising a polypeptide     	                  .         .         .         .         .  
						having a length "n", wherein n is at least about 10 amino    	     427 QIVEEMLMRSEEEEAEEAAAEPESYLDLPKQISEKTTKRILMLLCDESGF 476                                                          
						acids in length, optionally at least about 20 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, preferably at least about 30 amino acids in length,  	     301 QIVEEMLMRSEEEEAEEAAAEPESYLDLPKQISEKTTKRILMLLCDESGF 350                                                          
						more preferably at least about 40 amino acids in length and  	                  .         .         .         .         .  
						most preferably at least about 50 amino acids in length,     	     477 LIESKLLSLLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFFLKYRA 526                                                          
						wherein at least two amino acids comprise IE, having a       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						structure as follows: a sequence starting from any of amino  	     351 LIESKLLSLLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFFLKYRA 400                                                          
						acid numbers 225-x to 226; and ending at any of amino acid   	                  .         .         .         .         .  
						numbers 226+ ((n-2) - x), in which x varies from 0 to n-2.   	     527 HRLSSSLQIKPCSQASMEKASMEETSTRSELELAEQTEMEGEKEESLVEG 576                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 HRLSSSLQIKPCSQASMEKASMEETSTRSELELAEQTEMEGEKEESLVEG 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     577 EKEEEEETPPSPWVIHPNDVLKILEAFVMGLKKPRDSRAPLRVQKNVRDN 626                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 EKEEEEETPPSPWVIHPNDVLKILEAFVMGLKKPRDSRAPLRVQKNVRDN 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     627 SKDSEYWQALTTVIPSSKQNLWDALYTALEKYHLVLTQRAKLLLENSSLE 676                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 SKDSEYWQALTTVIPSSKQNLWDALYTALEKYHLVLTQRAKLLLENSSLE 550                                                          
						                                                            	                  .         .         .                      
						                                                            	     677 QQNTELQALLQQYLNSKINSELQVPPTQVLRVPTK                711                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	     551 QQNTELQALLQQYLNSKINSELQVPPTQVLRVPTK                585                                                          

11690	HMR136_AA813635_3_tr0_r1_1_gPRT		Comparison report between AA813635_P3 and Q96GG3unique head  	Sequence name: Q96GG3                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA813635_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 11690 x Q96GG3   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						WPCSVTLLHRHFALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDFW 	Alignment segment 1/1:                                       
						FLNNVGPISQQPQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQISEKTTKRILML 	                                                            
						LCDESGFLIESKLLSLLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFFLKYRAHRL 	                     Quality: 1652.00                      Escore:       0                                               
						SSSLQIKPCSQAS                                                	             Matching length:     169                Total length:     169                                               
						having the sequence corresponding to amino acids 1 - 193 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AA813635_P3, and a second amino acid sequence being at least 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MEKASMEETSTRSELELAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIHPNDVLKILEA 	                        Gaps:       0                        
						FVMGLKKPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPSSKQNLWDALYTALEKYHLVL 	                                                            
						TQRAKLLLENSSLEQQNTELQALLQQYLNSKINSELQVPPTQVLRVPTK            	Alignment:                                                   
						90 % homologous to corresponding to amino acids 1 - 169 of   	                  .         .         .         .         .  
						Q96GG3, which also corresponds to amino acids 194 - 362 of   	     194 MEKASMEETSTRSELELAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIH 243                                                          
						AA813635_P3, wherein said first amino acid sequence and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	       1 MEKASMEETSTRSELELAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIH 50                                                           
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AA813635_P3, comprising a polypeptide being at least 70%,    	     244 PNDVLKILEAFVMGLKKPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPS 293                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	      51 PNDVLKILEAFVMGLKKPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPS 100                                                          
						WPCSVTLLHRHFALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDFW 	                  .         .         .         .         .  
						FLNNVGPISQQPQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQISEKTTKRILML 	     294 SKQNLWDALYTALEKYHLVLTQRAKLLLENSSLEQQNTELQALLQQYLNS 343                                                          
						LCDESGFLIESKLLSLLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFFLKYRAHRL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SSSLQIKPCSQAS                                                	     101 SKQNLWDALYTALEKYHLVLTQRAKLLLENSSLEQQNTELQALLQQYLNS 150                                                          
						least about 95% homologous to the sequence of AA813635_P3.   	                  .                                          
						                                                            	     344 KINSELQVPPTQVLRVPTK                                362                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     151 KINSELQVPPTQVLRVPTK                                169                                                          

						Comparison report between AA813635_P3 and Q96MC2unique head  	Sequence name: Q96MC2                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA813635_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 11690 x Q96MC2   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence WPCSVTLLH corresponding to amino acids 1 	Alignment segment 1/1:                                       
						- 9 of AA813635_P3, and a second amino acid sequence being at	                                                            
						RHFALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDFWFLNNVGPIS 	                     Quality: 3451.00                      Escore:       0                                               
						QQPQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQISEKTTKRILMLLCDESGFLI 	             Matching length:     353                Total length:     353                                               
						ESKLLSLLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFFLKYRAHRLSSSLQIKPC 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SQASMEKASMEETSTRSELELAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIHPNDVLK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ILEAFVMGLKKPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPSSKQNLWDALYTALEKY 	                        Gaps:       0                        
						HLVLTQRAKLLLENSSLEQQNTELQALLQQYLNSKINSELQVPPTQVLRVPTK        	                                                            
						least 90 % homologous to corresponding to amino acids 388 -  	Alignment:                                                   
						740 of Q96MC2, which also corresponds to amino acids 10 - 362	                  .         .         .         .         .  
						of AA813635_P3, wherein said first amino acid sequence and   	      10 RHFALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDF 59                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     388 RHFALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDF 437                                                          
						AA813635_P3, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      60 WFLNNVGPISQQPQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQI 109                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence WPCSVTLLH of      	     438 WFLNNVGPISQQPQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQI 487                                                          
						AA813635_P3.                                                 	                  .         .         .         .         .  
						                                                            	     110 SEKTTKRILMLLCDESGFLIESKLLSLLLPLEQNECYLLRLDAIFSALGI 159                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     488 SEKTTKRILMLLCDESGFLIESKLLSLLLPLEQNECYLLRLDAIFSALGI 537                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     160 ESEDDLYKLVNFFLKYRAHRLSSSLQIKPCSQASMEKASMEETSTRSELE 209                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     538 ESEDDLYKLVNFFLKYRAHRLSSSLQIKPCSQASMEKASMEETSTRSELE 587                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     210 LAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIHPNDVLKILEAFVMGLK 259                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     588 LAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIHPNDVLKILEAFVMGLK 637                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     260 KPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPSSKQNLWDALYTALEKY 309                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     638 KPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPSSKQNLWDALYTALEKY 687                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     310 HLVLTQRAKLLLENSSLEQQNTELQALLQQYLNSKINSELQVPPTQVLRV 359                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     688 HLVLTQRAKLLLENSSLEQQNTELQALLQQYLNSKINSELQVPPTQVLRV 737                                                          
						                                                            	                                                             
						                                                            	     360 PTK                                                362                                                          
						                                                            	         |||                                                 
						                                                            	     738 PTK                                                740                                                          

						Comparison report between AA813635_P3 and Q8NDI5unique head  	Sequence name: Q8NDI5                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA813635_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 11690 x Q8NDI5   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence WPCSVTLLH corresponding to amino acids 1 	Alignment segment 1/1:                                       
						- 9 of AA813635_P3, and a second amino acid sequence being at	                                                            
						RHFALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDFWFLNNVGPIS 	                     Quality: 3451.00                      Escore:       0                                               
						QQPQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQISEKTTKRILMLLCDESGFLI 	             Matching length:     353                Total length:     353                                               
						ESKLLSLLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFFLKYRAHRLSSSLQIKPC 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SQASMEKASMEETSTRSELELAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIHPNDVLK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ILEAFVMGLKKPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPSSKQNLWDALYTALEKY 	                        Gaps:       0                        
						HLVLTQRAKLLLENSSLEQQNTELQALLQQYLNSKINSELQVPPTQVLRVPTK        	                                                            
						least 90 % homologous to corresponding to amino acids 325 -  	Alignment:                                                   
						677 of Q8NDI5, which also corresponds to amino acids 10 - 362	                  .         .         .         .         .  
						of AA813635_P3, wherein said first amino acid sequence and   	      10 RHFALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDF 59                                                           
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     325 RHFALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDF 374                                                          
						AA813635_P3, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	      60 WFLNNVGPISQQPQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQI 109                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence WPCSVTLLH of      	     375 WFLNNVGPISQQPQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQI 424                                                          
						AA813635_P3.                                                 	                  .         .         .         .         .  
						                                                            	     110 SEKTTKRILMLLCDESGFLIESKLLSLLLPLEQNECYLLRLDAIFSALGI 159                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     425 SEKTTKRILMLLCDESGFLIESKLLSLLLPLEQNECYLLRLDAIFSALGI 474                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     160 ESEDDLYKLVNFFLKYRAHRLSSSLQIKPCSQASMEKASMEETSTRSELE 209                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     475 ESEDDLYKLVNFFLKYRAHRLSSSLQIKPCSQASMEKASMEETSTRSELE 524                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     210 LAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIHPNDVLKILEAFVMGLK 259                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     525 LAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIHPNDVLKILEAFVMGLK 574                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     260 KPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPSSKQNLWDALYTALEKY 309                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     575 KPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPSSKQNLWDALYTALEKY 624                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     310 HLVLTQRAKLLLENSSLEQQNTELQALLQQYLNSKINSELQVPPTQVLRV 359                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     625 HLVLTQRAKLLLENSSLEQQNTELQALLQQYLNSKINSELQVPPTQVLRV 674                                                          
						                                                            	                                                             
						                                                            	     360 PTK                                                362                                                          
						                                                            	         |||                                                 
						                                                            	     675 PTK                                                677                                                          

						Comparison report between AA813635_P3 and AAH09488unique     	Sequence name: AAH09488                                      
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA813635_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 11690 x AAH09488   ..                          
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence WPCSVTLLH corresponding to amino acids 1 	Alignment segment 1/1:                                       
						- 9 of AA813635_P3, and a second amino acid sequence being at	                                                            
						RHFALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDFWFLNNVGPIS 	                     Quality: 3451.00                      Escore:       0                                               
						QQPQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQISEKTTKRILMLLCDESGFLI 	             Matching length:     353                Total length:     353                                               
						ESKLLSLLLPLEQNECYLLRLDAIFSALGIESEDDLYKLVNFFLKYRAHRLSSSLQIKPC 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SQASMEKASMEETSTRSELELAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIHPNDVLK 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						ILEAFVMGLKKPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPSSKQNLWDALYTALEKY 	                        Gaps:       0                        
						HLVLTQRAKLLLENSSLEQQNTELQALLQQYLNSKINSELQVPPTQVLRVPTK        	                                                            
						least 90 % homologous to corresponding to amino acids 233 -  	Alignment:                                                   
						585 of AAH09488, which also corresponds to amino acids 10 -  	                  .         .         .         .         .  
						362 of AA813635_P3, wherein said first amino acid sequence   	      10 RHFALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDF 59                                                           
						and second amino acid sequence are contiguous and in a       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequential order.2.An isolated polypeptide encoding for a    	     233 RHFALIDDEKFREIWLMNEEEAKDLIARAFDVDRIIHTHHLGLPWAAPDF 282                                                          
						head of AA813635_P3, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	      60 WFLNNVGPISQQPQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQI 109                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence WPCSVTLLH of   	     283 WFLNNVGPISQQPQKSATQIVEEMLMRSEEEEAEEAAAEPESYLDLPKQI 332                                                          
						AA813635_P3.                                                 	                  .         .         .         .         .  
						                                                            	     110 SEKTTKRILMLLCDESGFLIESKLLSLLLPLEQNECYLLRLDAIFSALGI 159                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     333 SEKTTKRILMLLCDESGFLIESKLLSLLLPLEQNECYLLRLDAIFSALGI 382                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     160 ESEDDLYKLVNFFLKYRAHRLSSSLQIKPCSQASMEKASMEETSTRSELE 209                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     383 ESEDDLYKLVNFFLKYRAHRLSSSLQIKPCSQASMEKASMEETSTRSELE 432                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     210 LAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIHPNDVLKILEAFVMGLK 259                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     433 LAEQTEMEGEKEESLVEGEKEEEEETPPSPWVIHPNDVLKILEAFVMGLK 482                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     260 KPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPSSKQNLWDALYTALEKY 309                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     483 KPRDSRAPLRVQKNVRDNSKDSEYWQALTTVIPSSKQNLWDALYTALEKY 532                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     310 HLVLTQRAKLLLENSSLEQQNTELQALLQQYLNSKINSELQVPPTQVLRV 359                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     533 HLVLTQRAKLLLENSSLEQQNTELQALLQQYLNSKINSELQVPPTQVLRV 582                                                          
						                                                            	                                                             
						                                                            	     360 PTK                                                362                                                          
						                                                            	         |||                                                 
						                                                            	     583 PTK                                                585                                                          

11846	HMR136_AA814374_4_tr0_r1_1_gPRT		Comparison report between AA814374_P4 and Q9H5N9partial WT   	Sequence name: Q9H5N9                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA814374_P4, comprising a first amino acid      	                                                            
						MRIFLNPSNFRNFTRTCQDITGEFKMCSSCLVCESKGNMDFISQEQTSKVLIRRGSMEVK 	Alignment of: 11846 x Q9H5N9   ..                            
						ANDFHSPCQHFNFSVAPLVDHLEEYNTTCHLKNHTGRSTIMEDEPSKEKSINYTCRIMEY 	                                                            
						PNDCIHISLHLEMDIKNITCSMKITWYILVLLVFIFLIILTIRKILEGQRRVQKWQSHRD 	Alignment segment 1/1:                                       
						KPTSVLLRGSDSEKLRALNVQVLSAETTQRLPLDQVQEVLPPIPEL               	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 2253.00                      Escore:       0                                               
						amino acids 71 - 296 of Q9H5N9, which also corresponds to    	             Matching length:     226                Total length:     226                                               
						amino acids 1 - 226 of AA814374_P4.                          	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MRIFLNPSNFRNFTRTCQDITGEFKMCSSCLVCESKGNMDFISQEQTSKV 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      71 MRIFLNPSNFRNFTRTCQDITGEFKMCSSCLVCESKGNMDFISQEQTSKV 120                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LIRRGSMEVKANDFHSPCQHFNFSVAPLVDHLEEYNTTCHLKNHTGRSTI 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     121 LIRRGSMEVKANDFHSPCQHFNFSVAPLVDHLEEYNTTCHLKNHTGRSTI 170                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 MEDEPSKEKSINYTCRIMEYPNDCIHISLHLEMDIKNITCSMKITWYILV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     171 MEDEPSKEKSINYTCRIMEYPNDCIHISLHLEMDIKNITCSMKITWYILV 220                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LLVFIFLIILTIRKILEGQRRVQKWQSHRDKPTSVLLRGSDSEKLRALNV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     221 LLVFIFLIILTIRKILEGQRRVQKWQSHRDKPTSVLLRGSDSEKLRALNV 270                                                          
						                                                            	                  .         .                                
						                                                            	     201 QVLSAETTQRLPLDQVQEVLPPIPEL                         226                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     271 QVLSAETTQRLPLDQVQEVLPPIPEL                         296                                                          

						Comparison report between AA814374_P4 and Q8N614partial WT   	Sequence name: Q8N614                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for AA814374_P4, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MRIFLNPSNFRNFTRTCQDITGEFKMCSSCLVCE corresponding to amino    	Alignment of: 11846 x Q8N614   ..                            
						acids 71 - 104 of Q8N614, which also corresponds to amino    	                                                            
						acids 1 - 34 of AA814374_P4, a bridging amino acid S         	Alignment segment 1/1:                                       
						corresponding to amino acid 35 of AA814374_P4, and a second  	                                                            
						KGNMDFISQEQTSKVLIRRGSMEVKANDFHSPCQHFNFSVAPLVDHLEEYNTTCHLKNHT 	                     Quality: 2241.00                      Escore:       0                                               
						GRSTIMEDEPSKEKSINYTCRIMEYPNDCIHISLHLEMDIKNITCSMKITWYILVLLVFI 	             Matching length:     226                Total length:     226                                               
						FLIILTIRKILEGQRRVQKWQSHRDKPTSVLLRGSDSEKLRALNVQVLSAETTQRLPLDQ 	 Matching Percent Similarity:   99.56   Matching Percent Identity:   99.56                                               
						VQEVLPPIPEL                                                  	    Total Percent Similarity:   99.56      Total Percent Identity:   99.56                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       0                        
						corresponding to amino acids 106 - 296 of Q8N614, which also 	                                                            
						corresponds to amino acids 36 - 226 of AA814374_P4, wherein  	Alignment:                                                   
						said first amino acid sequence, bridging amino acid and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	       1 MRIFLNPSNFRNFTRTCQDITGEFKMCSSCLVCESKGNMDFISQEQTSKV 50                                                           
						order.                                                       	         |||||||||||||||||||||||||||||||||| |||||||||||||||  
						                                                            	      71 MRIFLNPSNFRNFTRTCQDITGEFKMCSSCLVCEPKGNMDFISQEQTSKV 120                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LIRRGSMEVKANDFHSPCQHFNFSVAPLVDHLEEYNTTCHLKNHTGRSTI 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     121 LIRRGSMEVKANDFHSPCQHFNFSVAPLVDHLEEYNTTCHLKNHTGRSTI 170                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 MEDEPSKEKSINYTCRIMEYPNDCIHISLHLEMDIKNITCSMKITWYILV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     171 MEDEPSKEKSINYTCRIMEYPNDCIHISLHLEMDIKNITCSMKITWYILV 220                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LLVFIFLIILTIRKILEGQRRVQKWQSHRDKPTSVLLRGSDSEKLRALNV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     221 LLVFIFLIILTIRKILEGQRRVQKWQSHRDKPTSVLLRGSDSEKLRALNV 270                                                          
						                                                            	                  .         .                                
						                                                            	     201 QVLSAETTQRLPLDQVQEVLPPIPEL                         226                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     271 QVLSAETTQRLPLDQVQEVLPPIPEL                         296                                                          

13570	HMR136_AA826386_1_tr0_r1_1_gPRT		Comparison report between AA826386_P1 and Q8N1M6unique head  	Sequence name: Q8N1M6                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for AA826386_P1, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 13570 x Q8N1M6   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence MCLSPAAH corresponding to    	Alignment segment 1/1:                                       
						amino acids 1 - 8 of AA826386_P1, a second amino acid        	                                                            
						LQGSINHKEAVTIPKGCVLAFRVRQLMVKGKDEWDIPHICNDNMQTFPPGEKSGEEKVIL 	                     Quality: 2475.00                      Escore:       0                                               
						IQASDVGDVHEGFRTLKEEVQRETQQVEKLSRVGQSSLLSSLSKLLGKKKELQDLELALE 	             Matching length:     261                Total length:     261                                               
						GALDKGHEVTLEALPKDVLLSKEAVGAILYFVGALTELSEAQQKLLVKSMEKKILPVQLK 	 Matching Percent Similarity:   99.62   Matching Percent Identity:   99.62                                               
						LVESTMEQNFLLDKEGVFPLQPELLSSLGDEELTLTEALVGLSGLEVQRSGPQYMWDPDT 	    Total Percent Similarity:   99.62      Total Percent Identity:   99.62                                               
						LPRLCALYAGLS                                                 	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 185 - 436 of Q8N1M6, which also corresponds to   	Alignment:                                                   
						amino acids 9 - 260 of AA826386_P1, a bridging amino acid L  	                  .         .         .         .         .  
						corresponding to amino acid 261 of AA826386_P1, and a third  	       9 LQGSINHKEAVTIPKGCVLAFRVRQLMVKGKDEWDIPHICNDNMQTFPPG 58                                                           
						amino acid sequence being at least 90 % homologous to        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LQQLTKAS corresponding to amino acids 438 - 445 of Q8N1M6,   	     185 LQGSINHKEAVTIPKGCVLAFRVRQLMVKGKDEWDIPHICNDNMQTFPPG 234                                                          
						which also corresponds to amino acids 262 - 269 of           	                  .         .         .         .         .  
						AA826386_P1, wherein said first amino acid sequence, second  	      59 EKSGEEKVILIQASDVGDVHEGFRTLKEEVQRETQQVEKLSRVGQSSLLS 108                                                          
						amino acid sequence, bridging amino acid and third amino acid	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     235 EKSGEEKVILIQASDVGDVHEGFRTLKEEVQRETQQVEKLSRVGQSSLLS 284                                                          
						isolated polypeptide encoding for a head of AA826386_P1,     	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     109 SLSKLLGKKKELQDLELALEGALDKGHEVTLEALPKDVLLSKEAVGAILY 158                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     285 SLSKLLGKKKELQDLELALEGALDKGHEVTLEALPKDVLLSKEAVGAILY 334                                                          
						about 95% homologous to the sequence MCLSPAAH of AA826386_P1.	                  .         .         .         .         .  
						                                                            	     159 FVGALTELSEAQQKLLVKSMEKKILPVQLKLVESTMEQNFLLDKEGVFPL 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     335 FVGALTELSEAQQKLLVKSMEKKILPVQLKLVESTMEQNFLLDKEGVFPL 384                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     209 QPELLSSLGDEELTLTEALVGLSGLEVQRSGPQYMWDPDTLPRLCALYAG 258                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     385 QPELLSSLGDEELTLTEALVGLSGLEVQRSGPQYMWDPDTLPRLCALYAG 434                                                          
						                                                            	                  .                                          
						                                                            	     259 LSLLQQLTKAS                                        269                                                          
						                                                            	         || ||||||||                                         
						                                                            	     435 LSHLQQLTKAS                                        445                                                          

						Comparison report between AA826386_P1 and BAC75636unique     	Sequence name: BAC75636                                      
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA826386_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 13570 x BAC75636   ..                          
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence MCLSPAAH corresponding to amino acids 1 -	Alignment segment 1/1:                                       
						8 of AA826386_P1, and a second amino acid sequence being at  	                                                            
						LQGSINHKEAVTIPKGCVLAFRVRQLMVKGKDEWDIPHICNDNMQTFPPGEKSGEEKVIL 	                     Quality: 2489.00                      Escore:       0                                               
						IQASDVGDVHEGFRTLKEEVQRETQQVEKLSRVGQSSLLSSLSKLLGKKKELQDLELALE 	             Matching length:     261                Total length:     261                                               
						GALDKGHEVTLEALPKDVLLSKEAVGAILYFVGALTELSEAQQKLLVKSMEKKILPVQLK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LVESTMEQNFLLDKEGVFPLQPELLSSLGDEELTLTEALVGLSGLEVQRSGPQYMWDPDT 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LPRLCALYAGLSLLQQLTKAS                                        	                        Gaps:       0                        
						least 90 % homologous to corresponding to amino acids 185 -  	                                                            
						445 of BAC75636, which also corresponds to amino acids 9 -   	Alignment:                                                   
						269 of AA826386_P1, wherein said first amino acid sequence   	                  .         .         .         .         .  
						and second amino acid sequence are contiguous and in a       	       9 LQGSINHKEAVTIPKGCVLAFRVRQLMVKGKDEWDIPHICNDNMQTFPPG 58                                                           
						sequential order.2.An isolated polypeptide encoding for a    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of AA826386_P1, comprising a polypeptide being at least 	     185 LQGSINHKEAVTIPKGCVLAFRVRQLMVKGKDEWDIPHICNDNMQTFPPG 234                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      59 EKSGEEKVILIQASDVGDVHEGFRTLKEEVQRETQQVEKLSRVGQSSLLS 108                                                          
						at least about 95% homologous to the sequence MCLSPAAH of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA826386_P1.                                                 	     235 EKSGEEKVILIQASDVGDVHEGFRTLKEEVQRETQQVEKLSRVGQSSLLS 284                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     109 SLSKLLGKKKELQDLELALEGALDKGHEVTLEALPKDVLLSKEAVGAILY 158                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     285 SLSKLLGKKKELQDLELALEGALDKGHEVTLEALPKDVLLSKEAVGAILY 334                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     159 FVGALTELSEAQQKLLVKSMEKKILPVQLKLVESTMEQNFLLDKEGVFPL 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     335 FVGALTELSEAQQKLLVKSMEKKILPVQLKLVESTMEQNFLLDKEGVFPL 384                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     209 QPELLSSLGDEELTLTEALVGLSGLEVQRSGPQYMWDPDTLPRLCALYAG 258                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     385 QPELLSSLGDEELTLTEALVGLSGLEVQRSGPQYMWDPDTLPRLCALYAG 434                                                          
						                                                            	                  .                                          
						                                                            	     259 LSLLQQLTKAS                                        269                                                          
						                                                            	         |||||||||||                                         
						                                                            	     435 LSLLQQLTKAS                                        445                                                          

13568	HMR136_AA826386_2_tr0_r1_1_gPRT		Comparison report between AA826386_P2 and Q8N1M6partial WT   	Sequence name: Q8N1M6                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for AA826386_P2, comprising a first     	Sequence documentation:                                      
						MFENVTRALARQLNPRGDLTPLDSLIDFKRFHPFCLVLRKRKSTLFWGARYVRTDYTLLD 	                                                            
						VLEPGSSPSDPTDTGNFGFKNMLDTRVEGDVDVPKTVKVKGTAGLSQNSTLEVQTLSVAP 	Alignment of: 13568 x Q8N1M6   ..                            
						KALET                                                        	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 3 - 127 of Q8N1M6, which also   	                                                            
						corresponds to amino acids 1 - 125 of AA826386_P2, a bridging	                     Quality: 1237.00                      Escore:       0                                               
						amino acid V corresponding to amino acid 126 of AA826386_P2, 	             Matching length:     129                Total length:     129                                               
						and a second amino acid sequence being at least 90 %         	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.22                                               
						homologous to QER corresponding to amino acids 129 - 131 of  	    Total Percent Similarity:  100.00      Total Percent Identity:   99.22                                               
						Q8N1M6, which also corresponds to amino acids 127 - 129 of   	                        Gaps:       0                        
						AA826386_P2, wherein said first amino acid sequence, bridging	                                                            
						amino acid and second amino acid sequence are contiguous and 	Alignment:                                                   
						in a sequential order.                                       	                  .         .         .         .         .  
						                                                            	       1 MFENVTRALARQLNPRGDLTPLDSLIDFKRFHPFCLVLRKRKSTLFWGAR 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       3 MFENVTRALARQLNPRGDLTPLDSLIDFKRFHPFCLVLRKRKSTLFWGAR 52                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 YVRTDYTLLDVLEPGSSPSDPTDTGNFGFKNMLDTRVEGDVDVPKTVKVK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      53 YVRTDYTLLDVLEPGSSPSDPTDTGNFGFKNMLDTRVEGDVDVPKTVKVK 102                                                          
						                                                            	                  .         .                                
						                                                            	     101 GTAGLSQNSTLEVQTLSVAPKALETVQER                      129                                                          
						                                                            	         |||||||||||||||||||||||||:|||                       
						                                                            	     103 GTAGLSQNSTLEVQTLSVAPKALETLQER                      131                                                          

						Comparison report between AA826386_P2 and BAC75636partial WT 	Sequence name: BAC75636                                      
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA826386_P2, comprising a first     	Sequence documentation:                                      
						MFENVTRALARQLNPRGDLTPLDSLIDFKRFHPFCLVLRKRKSTLFWGARYVRTDYTLLD 	                                                            
						VLEPGSSPSDPTDTGNFGFKNMLDTRVEGDVDVPKTVKVKGTAGLSQNSTLEVQTLSVAP 	Alignment of: 13568 x BAC75636   ..                          
						KALET                                                        	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 3 - 127 of BAC75636, which also 	                                                            
						corresponds to amino acids 1 - 125 of AA826386_P2, and a     	                     Quality: 1227.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     129                Total length:     129                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   98.45                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:  100.00      Total Percent Identity:   98.45                                               
						polypeptide having the sequence VQER corresponding to amino  	                        Gaps:       0                        
						acids 126 - 129 of AA826386_P2, wherein said first amino acid	                                                            
						sequence and second amino acid sequence are contiguous and in	Alignment:                                                   
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of AA826386_P2, comprising a polypeptide being at least 	       1 MFENVTRALARQLNPRGDLTPLDSLIDFKRFHPFCLVLRKRKSTLFWGAR 50                                                           
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	       3 MFENVTRALARQLNPRGDLTPLDSLIDFKRFHPFCLVLRKRKSTLFWGAR 52                                                           
						at least about 95% homologous to the sequence VQER in        	                  .         .         .         .         .  
						AA826386_P2.                                                 	      51 YVRTDYTLLDVLEPGSSPSDPTDTGNFGFKNMLDTRVEGDVDVPKTVKVK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      53 YVRTDYTLLDVLEPGSSPSDPTDTGNFGFKNMLDTRVEGDVDVPKTVKVK 102                                                          
						                                                            	                  .         .                                
						                                                            	     101 GTAGLSQNSTLEVQTLSVAPKALETVQER                      129                                                          
						                                                            	         |||||||||||||||||||||||||:|:|                       
						                                                            	     103 GTAGLSQNSTLEVQTLSVAPKALETLQKR                      131                                                          

15901	HMR136_AA833546_1_tr0_r1_1_gPRT		Comparison report between AA833546_P1 and Q96M87partial WT   	Sequence name: Q96M87                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA833546_P1, comprising a first amino acid sequence being at 	                                                            
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	Alignment of: 15901 x Q96M87   ..                            
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	                                                            
						ILEGIHFKINVAEVEAELSQTRTKHQERPPES                             	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 152	                                                            
						of Q96M87, which also corresponds to amino acids 1 - 152 of  	                     Quality: 2977.00                      Escore:       0                                               
						AA833546_P1, a bridging amino acid H corresponding to amino  	             Matching length:     308                Total length:     308                                               
						acid 153 of AA833546_P1, a second amino acid sequence being  	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.68                                               
						RVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIEPSSDVESREPILR 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.68                                               
						INRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENLEEWLGPENQPSGEDGSSAEEVTA 	                        Gaps:       0                        
						MVIDTTGHGSVGQENYTLGSSGAKVARPTSSEVDR                          	                                                            
						at least 90 % homologous to corresponding to amino acids 154 	Alignment:                                                   
						- 308 of Q96M87, which also corresponds to amino acids 154 - 	                  .         .         .         .         .  
						308 of AA833546_P1, and a third amino acid sequence being at 	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						FSPSGSVVPLTERHRARSESPGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFR 	                  .         .         .         .         .  
						YNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNKP 	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						FHCHVCGKSFPFQAILNQHFRKNHPGCIPLEGPHSISPETTVTSRGQAEEESPSQEETVA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGEAVQGSVSTTGPD                                              	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 309 - 503 of AA833546_P1, wherein said first  	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						amino acid sequence, bridging amino acid, second amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of AA833546_P1, comprising a polypeptide being at least 	     151 ESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						70%, optionally at least about 80%, preferably at least about	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     151 ESRRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						FSPSGSVVPLTERHRARSESPGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFR 	                  .         .         .         .         .  
						YNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNKP 	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						FHCHVCGKSFPFQAILNQHFRKNHPGCIPLEGPHSISPETTVTSRGQAEEESPSQEETVA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGEAVQGSVSTTGPD                                              	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						at least about 95% homologous to the sequence in AA833546_P1.	                  .         .         .         .         .  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	                                                             
						                                                            	     301 PTSSEVDR                                           308                                                          
						                                                            	         ||||||||                                            
						                                                            	     301 PTSSEVDR                                           308                                                          

						Comparison report between AA833546_P1 and Q9BQ88partial WT   	Sequence name: Q9BQ88                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA833546_P1, comprising a first     	Sequence documentation:                                      
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	                                                            
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	Alignment of: 15901 x Q9BQ88   ..                            
						ILEGIHFKINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQVSA 	                                                            
						VLDIRELSPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVL 	Alignment segment 1/1:                                       
						GAVHIKTENLEEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 	                                                            
						PTSSEVDRFSPSGSVVPLTERHRARSESPGRMDEPKQPSSQV                   	                     Quality: 3329.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     342                Total length:     342                                               
						corresponding to amino acids 1 - 342 of Q9BQ88, which also   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 342 of AA833546_P1, and a     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						EESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFV 	                  .         .         .         .         .  
						CRMCGKKYTRKDQLEYHIRKHTGNKPFHCHVCGKSFPFQAILNQHFRKNHPGCIPLEGPH 	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						SISPETTVTSRGQAEEESPSQEETVAPGEAVQGSVSTTGPD                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence corresponding to amino acids 	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						343 - 503 of AA833546_P1, wherein said first amino acid      	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of AA833546_P1, comprising a polypeptide being at least 	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						EESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CRMCGKKYTRKDQLEYHIRKHTGNKPFHCHVCGKSFPFQAILNQHFRKNHPGCIPLEGPH 	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						SISPETTVTSRGQAEEESPSQEETVAPGEAVQGSVSTTGPD                    	                  .         .         .         .         .  
						at least about 95% homologous to the sequence in AA833546_P1.	     151 ESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 PTSSEVDRFSPSGSVVPLTERHRARSESPGRMDEPKQPSSQV         342                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     301 PTSSEVDRFSPSGSVVPLTERHRARSESPGRMDEPKQPSSQV         342                                                          

						Comparison report between AA833546_P1 and Q8WYT0unique head  	Sequence name: Q8WYT0                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for AA833546_P1, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 15901 x Q8WYT0   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	Alignment segment 1/1:                                       
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	                                                            
						ILEGIHF                                                      	                     Quality: 3718.00                      Escore:       0                                               
						polypeptide having the sequence corresponding to amino acids 	             Matching length:     376                Total length:     376                                               
						1 - 127 of AA833546_P1, a second amino acid sequence being at	 Matching Percent Similarity:   99.73   Matching Percent Identity:   99.73                                               
						KINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIREL 	    Total Percent Similarity:   99.73      Total Percent Identity:   99.73                                               
						SPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKT 	                        Gaps:       0                        
						ENLEEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVARPTSSEVD 	                                                            
						RFSPSGSVVPLTERHRARSES                                        	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 37 -   	                  .         .         .         .         .  
						237 of Q8WYT0, which also corresponds to amino acids 128 -   	     128 KINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQ 177                                                          
						328 of AA833546_P1, a bridging amino acid P corresponding to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid 329 of AA833546_P1, and a third amino acid        	      37 KINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQ 86                                                           
						GRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIYCAKSFNQKGSLD 	                  .         .         .         .         .  
						RHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNKPFHCHVCGKSFPFQAILNQHFR 	     178 VSAVLDIRELSPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVA 227                                                          
						KNHPGCIPLEGPHSISPETTVTSRGQAEEESPSQEETVAPGEAVQGSVSTTGPD       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      87 VSAVLDIRELSPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVA 136                                                          
						amino acids 239 - 412 of Q8WYT0, which also corresponds to   	                  .         .         .         .         .  
						amino acids 330 - 503 of AA833546_P1, wherein said first     	     228 DRGGRSDDEVRVLGAVHIKTENLEEWLGPENQPSGEDGSSAEEVTAMVID 277                                                          
						amino acid sequence, second amino acid sequence, bridging    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid and third amino acid sequence are contiguous and  	     137 DRGGRSDDEVRVLGAVHIKTENLEEWLGPENQPSGEDGSSAEEVTAMVID 186                                                          
						in a sequential order.2.An isolated polypeptide encoding for 	                  .         .         .         .         .  
						a head of AA833546_P1, comprising a polypeptide being at     	     278 TTGHGSVGQENYTLGSSGAKVARPTSSEVDRFSPSGSVVPLTERHRARSE 327                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     187 TTGHGSVGQENYTLGSSGAKVARPTSSEVDRFSPSGSVVPLTERHRARSE 236                                                          
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	                  .         .         .         .         .  
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	     328 SPGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIY 377                                                          
						ILEGIHF                                                      	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence of  	     237 SXGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIY 286                                                          
						AA833546_P1.                                                 	                  .         .         .         .         .  
						                                                            	     378 CAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNK 427                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     287 CAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNK 336                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     428 PFHCHVCGKSFPFQAILNQHFRKNHPGCIPLEGPHSISPETTVTSRGQAE 477                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     337 PFHCHVCGKSFPFQAILNQHFRKNHPGCIPLEGPHSISPETTVTSRGQAE 386                                                          
						                                                            	                  .         .                                
						                                                            	     478 EESPSQEETVAPGEAVQGSVSTTGPD                         503                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     387 EESPSQEETVAPGEAVQGSVSTTGPD                         412                                                          

15903	HMR136_AA833546_3_tr0_r1_1_gPRT		Comparison report between AA833546_P3 and Q96M87partial WT   	Sequence name: Q96M87                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA833546_P3, comprising a first amino acid sequence being at 	                                                            
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	Alignment of: 15903 x Q96M87   ..                            
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	                                                            
						ILEGIHFKINVAEVEAELSQTRTKHQERPPES                             	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 152	                                                            
						of Q96M87, which also corresponds to amino acids 1 - 152 of  	                     Quality: 2977.00                      Escore:       0                                               
						AA833546_P3, a bridging amino acid H corresponding to amino  	             Matching length:     308                Total length:     308                                               
						acid 153 of AA833546_P3, a second amino acid sequence being  	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.68                                               
						RVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIEPSSDVESREPILR 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.68                                               
						INRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENLEEWLGPENQPSGEDGSSAEEVTA 	                        Gaps:       0                        
						MVIDTTGHGSVGQENYTLGSSGAKVARPTSSEVDR                          	                                                            
						at least 90 % homologous to corresponding to amino acids 154 	Alignment:                                                   
						- 308 of Q96M87, which also corresponds to amino acids 154 - 	                  .         .         .         .         .  
						308 of AA833546_P3, and a third amino acid sequence being at 	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						FSPSGSVVPLTERHRARSESPGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFR 	                  .         .         .         .         .  
						YNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNKP 	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						FHCHVCGKSFPFQAILNQHFRKNHPGCIPLEGPHSISPETTVTSRGQAEEESPSQEETVA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGEAVQGSVSTTGPD                                              	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 309 - 503 of AA833546_P3, wherein said first  	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						amino acid sequence, bridging amino acid, second amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of AA833546_P3, comprising a polypeptide being at least 	     151 ESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						70%, optionally at least about 80%, preferably at least about	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     151 ESRRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						FSPSGSVVPLTERHRARSESPGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFR 	                  .         .         .         .         .  
						YNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNKP 	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						FHCHVCGKSFPFQAILNQHFRKNHPGCIPLEGPHSISPETTVTSRGQAEEESPSQEETVA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PGEAVQGSVSTTGPD                                              	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						at least about 95% homologous to the sequence in AA833546_P3.	                  .         .         .         .         .  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	                                                             
						                                                            	     301 PTSSEVDR                                           308                                                          
						                                                            	         ||||||||                                            
						                                                            	     301 PTSSEVDR                                           308                                                          

						Comparison report between AA833546_P3 and Q9BQ88partial WT   	Sequence name: Q9BQ88                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA833546_P3, comprising a first     	Sequence documentation:                                      
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	                                                            
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	Alignment of: 15903 x Q9BQ88   ..                            
						ILEGIHFKINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQVSA 	                                                            
						VLDIRELSPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVL 	Alignment segment 1/1:                                       
						GAVHIKTENLEEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 	                                                            
						PTSSEVDRFSPSGSVVPLTERHRARSESPGRMDEPKQPSSQV                   	                     Quality: 3329.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     342                Total length:     342                                               
						corresponding to amino acids 1 - 342 of Q9BQ88, which also   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 342 of AA833546_P3, and a     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						EESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFV 	                  .         .         .         .         .  
						CRMCGKKYTRKDQLEYHIRKHTGNKPFHCHVCGKSFPFQAILNQHFRKNHPGCIPLEGPH 	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						SISPETTVTSRGQAEEESPSQEETVAPGEAVQGSVSTTGPD                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence corresponding to amino acids 	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						343 - 503 of AA833546_P3, wherein said first amino acid      	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of AA833546_P3, comprising a polypeptide being at least 	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						EESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CRMCGKKYTRKDQLEYHIRKHTGNKPFHCHVCGKSFPFQAILNQHFRKNHPGCIPLEGPH 	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						SISPETTVTSRGQAEEESPSQEETVAPGEAVQGSVSTTGPD                    	                  .         .         .         .         .  
						at least about 95% homologous to the sequence in AA833546_P3.	     151 ESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 PTSSEVDRFSPSGSVVPLTERHRARSESPGRMDEPKQPSSQV         342                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     301 PTSSEVDRFSPSGSVVPLTERHRARSESPGRMDEPKQPSSQV         342                                                          

						Comparison report between AA833546_P3 and Q8WYT0unique head  	Sequence name: Q8WYT0                                        
						followed by partial WT sequence a mismatch.1.An isolated     	                                                            
						chimeric polypeptide encoding for AA833546_P3, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 15903 x Q8WYT0   ..                            
						90% and most preferably at least 95% homologous to a         	                                                            
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	Alignment segment 1/1:                                       
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	                                                            
						ILEGIHF                                                      	                     Quality: 3718.00                      Escore:       0                                               
						polypeptide having the sequence corresponding to amino acids 	             Matching length:     376                Total length:     376                                               
						1 - 127 of AA833546_P3, a second amino acid sequence being at	 Matching Percent Similarity:   99.73   Matching Percent Identity:   99.73                                               
						KINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIREL 	    Total Percent Similarity:   99.73      Total Percent Identity:   99.73                                               
						SPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKT 	                        Gaps:       0                        
						ENLEEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVARPTSSEVD 	                                                            
						RFSPSGSVVPLTERHRARSES                                        	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 37 -   	                  .         .         .         .         .  
						237 of Q8WYT0, which also corresponds to amino acids 128 -   	     128 KINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQ 177                                                          
						328 of AA833546_P3, a bridging amino acid P corresponding to 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid 329 of AA833546_P3, and a third amino acid        	      37 KINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQ 86                                                           
						GRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIYCAKSFNQKGSLD 	                  .         .         .         .         .  
						RHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNKPFHCHVCGKSFPFQAILNQHFR 	     178 VSAVLDIRELSPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVA 227                                                          
						KNHPGCIPLEGPHSISPETTVTSRGQAEEESPSQEETVAPGEAVQGSVSTTGPD       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	      87 VSAVLDIRELSPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVA 136                                                          
						amino acids 239 - 412 of Q8WYT0, which also corresponds to   	                  .         .         .         .         .  
						amino acids 330 - 503 of AA833546_P3, wherein said first     	     228 DRGGRSDDEVRVLGAVHIKTENLEEWLGPENQPSGEDGSSAEEVTAMVID 277                                                          
						amino acid sequence, second amino acid sequence, bridging    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid and third amino acid sequence are contiguous and  	     137 DRGGRSDDEVRVLGAVHIKTENLEEWLGPENQPSGEDGSSAEEVTAMVID 186                                                          
						in a sequential order.2.An isolated polypeptide encoding for 	                  .         .         .         .         .  
						a head of AA833546_P3, comprising a polypeptide being at     	     278 TTGHGSVGQENYTLGSSGAKVARPTSSEVDRFSPSGSVVPLTERHRARSE 327                                                          
						least 70%, optionally at least about 80%, preferably at least	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 85%, more preferably at least about 90% and most       	     187 TTGHGSVGQENYTLGSSGAKVARPTSSEVDRFSPSGSVVPLTERHRARSE 236                                                          
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	                  .         .         .         .         .  
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	     328 SPGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIY 377                                                          
						ILEGIHF                                                      	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence of  	     237 SXGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIY 286                                                          
						AA833546_P3.                                                 	                  .         .         .         .         .  
						                                                            	     378 CAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNK 427                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     287 CAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNK 336                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     428 PFHCHVCGKSFPFQAILNQHFRKNHPGCIPLEGPHSISPETTVTSRGQAE 477                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     337 PFHCHVCGKSFPFQAILNQHFRKNHPGCIPLEGPHSISPETTVTSRGQAE 386                                                          
						                                                            	                  .         .                                
						                                                            	     478 EESPSQEETVAPGEAVQGSVSTTGPD                         503                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     387 EESPSQEETVAPGEAVQGSVSTTGPD                         412                                                          

15905	HMR136_AA833546_4_tr0_r1_1_gPRT		Comparison report between AA833546_P4 and Q96M87partial WT   	Sequence name: Q96M87                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA833546_P4, comprising a first amino acid sequence being at 	                                                            
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	Alignment of: 15905 x Q96M87   ..                            
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	                                                            
						ILEGIHFKINVAEVEAELSQTRTKHQERPPES                             	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 152	                                                            
						of Q96M87, which also corresponds to amino acids 1 - 152 of  	                     Quality: 2977.00                      Escore:       0                                               
						AA833546_P4, a bridging amino acid H corresponding to amino  	             Matching length:     308                Total length:     308                                               
						acid 153 of AA833546_P4, a second amino acid sequence being  	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.68                                               
						RVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIEPSSDVESREPILR 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.68                                               
						INRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENLEEWLGPENQPSGEDGSSAEEVTA 	                        Gaps:       0                        
						MVIDTTGHGSVGQENYTLGSSGAKVARPTSSEVDR                          	                                                            
						at least 90 % homologous to corresponding to amino acids 154 	Alignment:                                                   
						- 308 of Q96M87, which also corresponds to amino acids 154 - 	                  .         .         .         .         .  
						308 of AA833546_P4, and a third amino acid sequence being at 	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						FSPSGSVVPLTERHRARSESPGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFR 	                  .         .         .         .         .  
						YNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNKP 	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						FHCHVCGKSFPFQTETSRGRGLTLFPYEP                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						to amino acids 309 - 457 of AA833546_P4, wherein said first  	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid, second amino acid  	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						tail of AA833546_P4, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     151 ESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						85%, more preferably at least about 90% and most preferably  	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						FSPSGSVVPLTERHRARSESPGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFR 	     151 ESRRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						YNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNKP 	                  .         .         .         .         .  
						FHCHVCGKSFPFQTETSRGRGLTLFPYEP                                	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						at least about 95% homologous to the sequence in AA833546_P4.	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	                                                             
						                                                            	     301 PTSSEVDR                                           308                                                          
						                                                            	         ||||||||                                            
						                                                            	     301 PTSSEVDR                                           308                                                          

						Comparison report between AA833546_P4 and Q9BQ88partial WT   	Sequence name: Q9BQ88                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA833546_P4, comprising a first     	Sequence documentation:                                      
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	                                                            
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	Alignment of: 15905 x Q9BQ88   ..                            
						ILEGIHFKINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQVSA 	                                                            
						VLDIRELSPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVL 	Alignment segment 1/1:                                       
						GAVHIKTENLEEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 	                                                            
						PTSSEVDRFSPSGSVVPLTERHRARSESPGRMDEPKQPSSQV                   	                     Quality: 3329.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     342                Total length:     342                                               
						corresponding to amino acids 1 - 342 of Q9BQ88, which also   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 342 of AA833546_P4, and a     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						EESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFV 	                  .         .         .         .         .  
						CRMCGKKYTRKDQLEYHIRKHTGNKPFHCHVCGKSFPFQTETSRGRGLTLFPYEP      	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						343 - 457 of AA833546_P4, wherein said first amino acid      	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						tail of AA833546_P4, comprising a polypeptide being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						EESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFV 	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						CRMCGKKYTRKDQLEYHIRKHTGNKPFHCHVCGKSFPFQTETSRGRGLTLFPYEP      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence in AA833546_P4.	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 PTSSEVDRFSPSGSVVPLTERHRARSESPGRMDEPKQPSSQV         342                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     301 PTSSEVDRFSPSGSVVPLTERHRARSESPGRMDEPKQPSSQV         342                                                          

						Comparison report between AA833546_P4 and Q8WYT0unique head  	Sequence name: Q8WYT0                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AA833546_P4, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15905 x Q8WYT0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	Alignment segment 1/1:                                       
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	                                                            
						ILEGIHF                                                      	                     Quality: 3109.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     314                Total length:     314                                               
						to amino acids 1 - 127 of AA833546_P4, a second amino acid   	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.68                                               
						KINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIREL 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.68                                               
						SPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKT 	                        Gaps:       0                        
						ENLEEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVARPTSSEVD 	                                                            
						RFSPSGSVVPLTERHRARSES                                        	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 37 - 237 of Q8WYT0, which also corresponds to    	     128 KINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQ 177                                                          
						amino acids 128 - 328 of AA833546_P4, a bridging amino acid P	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acid 329 of AA833546_P4, a third amino	      37 KINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQ 86                                                           
						GRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIYCAKSFNQKGSLD 	                  .         .         .         .         .  
						RHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNKPFHCHVCGKSFPFQ         	     178 VSAVLDIRELSPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVA 227                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 239 - 350 of Q8WYT0, which also corresponds to	      87 VSAVLDIRELSPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVA 136                                                          
						amino acids 330 - 441 of AA833546_P4, and a fourth amino acid	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     228 DRGGRSDDEVRVLGAVHIKTENLEEWLGPENQPSGEDGSSAEEVTAMVID 277                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     137 DRGGRSDDEVRVLGAVHIKTENLEEWLGPENQPSGEDGSSAEEVTAMVID 186                                                          
						having the sequence TETSRGRGLTLFPYEP corresponding to amino  	                  .         .         .         .         .  
						acids 442 - 457 of AA833546_P4, wherein said first amino acid	     278 TTGHGSVGQENYTLGSSGAKVARPTSSEVDRFSPSGSVVPLTERHRARSE 327                                                          
						sequence, second amino acid sequence, bridging amino acid,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence and fourth amino acid sequence are 	     187 TTGHGSVGQENYTLGSSGAKVARPTSSEVDRFSPSGSVVPLTERHRARSE 236                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of AA833546_P4, comprising a 	     328 SPGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIY 377                                                          
						polypeptide being at least 70%, optionally at least about    	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     237 SXGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIY 286                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	     378 CAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNK 427                                                          
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ILEGIHF                                                      	     287 CAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNK 336                                                          
						to the sequence of AA833546_P4.3.An isolated polypeptide     	                  .                                          
						encoding for a tail of AA833546_P4, comprising a polypeptide 	     428 PFHCHVCGKSFPFQ                                     441                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||                                      
						at least about 85%, more preferably at least about 90% and   	     337 PFHCHVCGKSFPFQ                                     350                                                          
						most preferably at least about 95% homologous to the sequence	                                                            
						TETSRGRGLTLFPYEP in AA833546_P4.                             	                                                            

15899	HMR136_AA833546_5_tr0_r1_1_gPRT		Comparison report between AA833546_P5 and Q96M87partial WT   	Sequence name: Q96M87                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA833546_P5, comprising a first amino acid sequence being at 	                                                            
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	Alignment of: 15899 x Q96M87   ..                            
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	                                                            
						ILEGIHFKINVAEVEAELSQTRTKHQERPPES                             	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 152	                                                            
						of Q96M87, which also corresponds to amino acids 1 - 152 of  	                     Quality: 2977.00                      Escore:       0                                               
						AA833546_P5, a bridging amino acid H corresponding to amino  	             Matching length:     308                Total length:     308                                               
						acid 153 of AA833546_P5, a second amino acid sequence being  	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.68                                               
						RVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIEPSSDVESREPILR 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.68                                               
						INRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENLEEWLGPENQPSGEDGSSAEEVTA 	                        Gaps:       0                        
						MVIDTTGHGSVGQENYTLGSSGAKVARPTSSEVDR                          	                                                            
						at least 90 % homologous to corresponding to amino acids 154 	Alignment:                                                   
						- 308 of Q96M87, which also corresponds to amino acids 154 - 	                  .         .         .         .         .  
						308 of AA833546_P5, and a third amino acid sequence being at 	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						FSPSGSVVPLTERHRARSESPGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFR 	                  .         .         .         .         .  
						YNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNKP 	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						FHCHVCGKSFPFQTETSRGRGLTLFPYEP                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence corresponding	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						to amino acids 309 - 457 of AA833546_P5, wherein said first  	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid, second amino acid  	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						tail of AA833546_P5, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     151 ESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						85%, more preferably at least about 90% and most preferably  	         || |||||||||||||||||||||||||||||||||||||||||||||||  
						FSPSGSVVPLTERHRARSESPGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFR 	     151 ESRRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						YNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNKP 	                  .         .         .         .         .  
						FHCHVCGKSFPFQTETSRGRGLTLFPYEP                                	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						at least about 95% homologous to the sequence in AA833546_P5.	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	                                                             
						                                                            	     301 PTSSEVDR                                           308                                                          
						                                                            	         ||||||||                                            
						                                                            	     301 PTSSEVDR                                           308                                                          

						Comparison report between AA833546_P5 and Q9BQ88partial WT   	Sequence name: Q9BQ88                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA833546_P5, comprising a first     	Sequence documentation:                                      
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	                                                            
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	Alignment of: 15899 x Q9BQ88   ..                            
						ILEGIHFKINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQVSA 	                                                            
						VLDIRELSPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVL 	Alignment segment 1/1:                                       
						GAVHIKTENLEEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 	                                                            
						PTSSEVDRFSPSGSVVPLTERHRARSESPGRMDEPKQPSSQV                   	                     Quality: 3329.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     342                Total length:     342                                               
						corresponding to amino acids 1 - 342 of Q9BQ88, which also   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 342 of AA833546_P5, and a     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						EESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFV 	                  .         .         .         .         .  
						CRMCGKKYTRKDQLEYHIRKHTGNKPFHCHVCGKSFPFQTETSRGRGLTLFPYEP      	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						343 - 457 of AA833546_P5, wherein said first amino acid      	       1 MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVL 50                                                           
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						tail of AA833546_P5, comprising a polypeptide being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	      51 AASSPYFRDHMSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADII 100                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						EESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIYCAKSFNQKGSLDRHMRLHMGITPFV 	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						CRMCGKKYTRKDQLEYHIRKHTGNKPFHCHVCGKSFPFQTETSRGRGLTLFPYEP      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence in AA833546_P5.	     101 SYLTAASFLQMQHIIDKCTQILEGIHFKINVAEVEAELSQTRTKHQERPP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 ESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 ESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIRELSPPEESTSPQIIE 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 PSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKTENL 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 EEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVAR 300                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 PTSSEVDRFSPSGSVVPLTERHRARSESPGRMDEPKQPSSQV         342                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||          
						                                                            	     301 PTSSEVDRFSPSGSVVPLTERHRARSESPGRMDEPKQPSSQV         342                                                          

						Comparison report between AA833546_P5 and Q8WYT0unique head  	Sequence name: Q8WYT0                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AA833546_P5, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 15899 x Q8WYT0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	Alignment segment 1/1:                                       
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	                                                            
						ILEGIHF                                                      	                     Quality: 3109.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     314                Total length:     314                                               
						to amino acids 1 - 127 of AA833546_P5, a second amino acid   	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.68                                               
						KINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQVSAVLDIREL 	    Total Percent Similarity:   99.68      Total Percent Identity:   99.68                                               
						SPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVADRGGRSDDEVRVLGAVHIKT 	                        Gaps:       0                        
						ENLEEWLGPENQPSGEDGSSAEEVTAMVIDTTGHGSVGQENYTLGSSGAKVARPTSSEVD 	                                                            
						RFSPSGSVVPLTERHRARSES                                        	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 37 - 237 of Q8WYT0, which also corresponds to    	     128 KINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQ 177                                                          
						amino acids 128 - 328 of AA833546_P5, a bridging amino acid P	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acid 329 of AA833546_P5, a third amino	      37 KINVAEVEAELSQTRTKHQERPPESHRVTPNLNRSLSPRHNTPKGNRRGQ 86                                                           
						GRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIYCAKSFNQKGSLD 	                  .         .         .         .         .  
						RHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNKPFHCHVCGKSFPFQ         	     178 VSAVLDIRELSPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVA 227                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 239 - 350 of Q8WYT0, which also corresponds to	      87 VSAVLDIRELSPPEESTSPQIIEPSSDVESREPILRINRAGQWYVETGVA 136                                                          
						amino acids 330 - 441 of AA833546_P5, and a fourth amino acid	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	     228 DRGGRSDDEVRVLGAVHIKTENLEEWLGPENQPSGEDGSSAEEVTAMVID 277                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	     137 DRGGRSDDEVRVLGAVHIKTENLEEWLGPENQPSGEDGSSAEEVTAMVID 186                                                          
						having the sequence TETSRGRGLTLFPYEP corresponding to amino  	                  .         .         .         .         .  
						acids 442 - 457 of AA833546_P5, wherein said first amino acid	     278 TTGHGSVGQENYTLGSSGAKVARPTSSEVDRFSPSGSVVPLTERHRARSE 327                                                          
						sequence, second amino acid sequence, bridging amino acid,   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						third amino acid sequence and fourth amino acid sequence are 	     187 TTGHGSVGQENYTLGSSGAKVARPTSSEVDRFSPSGSVVPLTERHRARSE 236                                                          
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a head of AA833546_P5, comprising a 	     328 SPGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIY 377                                                          
						polypeptide being at least 70%, optionally at least about    	         | ||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	     237 SXGRMDEPKQPSSQVEESAMMGVSGYVEYLREQEVSERWFRYNPRLTCIY 286                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						MEKGGNIQLEIPDFSNSVLSHLNQLRMQGRLCDIVVNVQGQAFRAHKVVLAASSPYFRDH 	     378 CAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNK 427                                                          
						MSLNEMSTVSISVIKNPTVFEQLLSFCYTGRICLQLADIISYLTAASFLQMQHIIDKCTQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ILEGIHF                                                      	     287 CAKSFNQKGSLDRHMRLHMGITPFVCRMCGKKYTRKDQLEYHIRKHTGNK 336                                                          
						to the sequence of AA833546_P5.3.An isolated polypeptide     	                  .                                          
						encoding for a tail of AA833546_P5, comprising a polypeptide 	     428 PFHCHVCGKSFPFQ                                     441                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||                                      
						at least about 85%, more preferably at least about 90% and   	     337 PFHCHVCGKSFPFQ                                     350                                                          
						most preferably at least about 95% homologous to the sequence	                                                            
						TETSRGRGLTLFPYEP in AA833546_P5.                             	                                                            

27680	HMR136_AA846073_1_tr0_r1_1_gPRT		Comparison report between AA846073_P1 and Q8N6W7partial WT   	Sequence name: Q8N6W7                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA846073_P1, comprising a first amino acid      	                                                            
						MQSFRRPSAASIDLRRTRSAAGLHFQDRQPEDIPQVPDEIYELYDDVEPRDDSSPSPKGR 	Alignment of: 27680 x Q8N6W7   ..                            
						DEAPSVQQAARRPPQDPALRKEKDPQPQQLPPMDPKLLKQLRKAEKAEREFRKKFKFEGE 	                                                            
						IVVHTKMMIDPNAKTRRGGGKHLGIRRGEILEVIEFTSNEEMLCRDPKGKYGYVPRTALL 	Alignment segment 1/1:                                       
						PLETEVYDDVDFCDPLENQPLPLGR                                    	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 2037.00                      Escore:       0                                               
						amino acids 466 - 670 of Q8N6W7, which also corresponds to   	             Matching length:     205                Total length:     205                                               
						amino acids 1 - 205 of AA846073_P1.                          	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MQSFRRPSAASIDLRRTRSAAGLHFQDRQPEDIPQVPDEIYELYDDVEPR 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     466 MQSFRRPSAASIDLRRTRSAAGLHFQDRQPEDIPQVPDEIYELYDDVEPR 515                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 DDSSPSPKGRDEAPSVQQAARRPPQDPALRKEKDPQPQQLPPMDPKLLKQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     516 DDSSPSPKGRDEAPSVQQAARRPPQDPALRKEKDPQPQQLPPMDPKLLKQ 565                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LRKAEKAEREFRKKFKFEGEIVVHTKMMIDPNAKTRRGGGKHLGIRRGEI 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     566 LRKAEKAEREFRKKFKFEGEIVVHTKMMIDPNAKTRRGGGKHLGIRRGEI 615                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LEVIEFTSNEEMLCRDPKGKYGYVPRTALLPLETEVYDDVDFCDPLENQP 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     616 LEVIEFTSNEEMLCRDPKGKYGYVPRTALLPLETEVYDDVDFCDPLENQP 665                                                          
						                                                            	                                                             
						                                                            	     201 LPLGR                                              205                                                          
						                                                            	         |||||                                               
						                                                            	     666 LPLGR                                              670                                                          

27684	HMR136_AA846073_3_tr0_r1_1_gPRT		Comparison report between AA846073_P3 and Q8N6W7partial WT   	Sequence name: Q8N6W7                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AA846073_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to MQSFRRPSAASIDLRRTRSAAGLHFQDRQPEDIPQVPDEIYELYDDVEPRDDSSPSPKGR       	                                                            
						corresponding to amino acids 466 - 525 of Q8N6W7, which also 	Alignment of: 27684 x Q8N6W7   ..                            
						corresponds to amino acids 1 - 60 of AA846073_P3, and a      	                                                            
						second amino acid sequence being at least 70%, optionally at 	Alignment segment 1/1:                                       
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	                     Quality:  595.00                      Escore:       0                                               
						polypeptide having the sequence GLLVACPSPCKTFGARPFSAMLLV     	             Matching length:      60                Total length:      60                                               
						corresponding to amino acids 61 - 84 of AA846073_P3, wherein 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						said first amino acid sequence and second amino acid sequence	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						are contiguous and in a sequential order.2.An isolated       	                        Gaps:       0                        
						polypeptide encoding for a tail of AA846073_P3, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	Alignment:                                                   
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	       1 MQSFRRPSAASIDLRRTRSAAGLHFQDRQPEDIPQVPDEIYELYDDVEPR 50                                                           
						to the sequence GLLVACPSPCKTFGARPFSAMLLV in AA846073_P3.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     466 MQSFRRPSAASIDLRRTRSAAGLHFQDRQPEDIPQVPDEIYELYDDVEPR 515                                                          
						                                                            	                  .                                          
						                                                            	      51 DDSSPSPKGR                                         60                                                           
						                                                            	         ||||||||||                                          
						                                                            	     516 DDSSPSPKGR                                         525                                                          

16571	HMR136_AA847856_2_tr0_r1_1_gPRT		Comparison report between AA847856_P2 and Q96NA6partial WT   	Sequence name: Q96NA6                                        
						sequence followed by unique insertion and a followed by a    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						AA847856_P2, comprising a first amino acid sequence being at 	                                                            
						least 90 % homologous to                                     	Alignment of: 16571 x Q96NA6   ..                            
						MSRSPLNPSQLRSVGSQDALAPLPPPAPQNPSTHSWDPLCGSLPWGLSCLLAL        	                                                            
						corresponding to amino acids 1 - 53 of Q96NA6, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 53 of AA847856_P2, a second   	                                                            
						amino acid sequence being at least 70%, optionally at least  	                     Quality: 1820.00                      Escore:       0                                               
						80%, preferably at least 85%, more preferably at least 90%   	             Matching length:     194                Total length:     225                                               
						and most preferably at least 95% homologous to a polypeptide 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence QHVLVMASLLCVSHLLLLCSLSPGGLSYSPS          	    Total Percent Similarity:   86.22      Total Percent Identity:   86.22                                               
						corresponding to amino acids 54 - 84 of AA847856_P2, a third 	                        Gaps:       1                        
						QLLASSFFSCGMSTILQTWMGSRLPLVQAPSLEFLIPALVLTSQKLPRAIQTPGNSSLML 	                                                            
						HLCRGPSCHGLGHWNTSLQEVSGAVVVSGLLQGMMGLLGSPGHVFPHCGPLVLAPSLVVA 	Alignment:                                                   
						GLSAHREVAQFCFTHWGLALL                                        	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MSRSPLNPSQLRSVGSQDALAPLPPPAPQNPSTHSWDPLCGSLPWGLSCL 50                                                           
						corresponding to amino acids 54 - 194 of Q96NA6, which also  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 85 - 225 of AA847856_P2, and a    	       1 MSRSPLNPSQLRSVGSQDALAPLPPPAPQNPSTHSWDPLCGSLPWGLSCL 50                                                           
						fourth amino acid sequence being at least 70%, optionally at 	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	      51 LALQHVLVMASLLCVSHLLLLCSLSPGGLSYSPSQLLASSFFSCGMSTIL 100                                                          
						90% and most preferably at least 95% homologous to a         	         |||                               ||||||||||||||||  
						VILLMVVCSQHLGSCQFHVCPWRRASTSSTHTPLPVFRLLSVLIPVACVWIVSAFVGFSV 	      51 LAL...............................QLLASSFFSCGMSTIL 69                                                           
						IPQELSAPTKAPWIWLPHPGEWNWPLLTPRALAAGISMALAASTSSLGCYALCGRLLHLP 	                  .         .         .         .         .  
						PPPPHACSRGLSLEGLGSVLAGLLGSPMGTASSFPNVGKVGLIQAGSQQVAHLVGLLCVG 	     101 QTWMGSRLPLVQAPSLEFLIPALVLTSQKLPRAIQTPGNSSLMLHLCRGP 150                                                          
						LGLSPRLAQLLTTIPLPVVGGVLGVTQAVVLSAGFSSFYLADIDSGRNIFIVGFSIFMAL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLPRWFREAPVLFSTGWSPLDVLLHSLLTQPIFLAGLSGFLLENTIPGTQLERGLGQGLP 	      70 QTWMGSRLPLVQAPSLEFLIPALVLTSQKLPRAIQTPGNSSLMLHLCRGP 119                                                          
						SPFTAQEARMPQKPREKAAQVYRLPFPIQNLCPCIPQPLHCLCPLPEDPGDEEGGSSEPE 	                  .         .         .         .         .  
						EMADLLPGSGEPCPESSREGFRSQK                                    	     151 SCHGLGHWNTSLQEVSGAVVVSGLLQGMMGLLGSPGHVFPHCGPLVLAPS 200                                                          
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						226 - 610 of AA847856_P2, wherein said first amino acid      	     120 SCHGLGHWNTSLQEVSGAVVVSGLLQGMMGLLGSPGHVFPHCGPLVLAPS 169                                                          
						sequence, second amino acid sequence, third amino acid       	                  .         .                                
						sequence and fourth amino acid sequence are contiguous and in	     201 LVVAGLSAHREVAQFCFTHWGLALL                          225                                                          
						a sequential order.2.An isolated polypeptide encoding for an 	         |||||||||||||||||||||||||                           
						edge portion of AA847856_P2, comprising an amino acid        	     170 LVVAGLSAHREVAQFCFTHWGLALL                          194                                                          
						sequence being at least 70%, optionally at least about 80%,  	                                                            
						preferably at least about 85%, more preferably at least about	                                                            
						90% and most preferably at least about 95% homologous to the 	                                                            
						sequence encoding for QHVLVMASLLCVSHLLLLCSLSPGGLSYSPS,       	                                                            
						corresponding to AA847856_P2.3.An isolated polypeptide       	                                                            
						encoding for a tail of AA847856_P2, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						VILLMVVCSQHLGSCQFHVCPWRRASTSSTHTPLPVFRLLSVLIPVACVWIVSAFVGFSV 	                                                            
						IPQELSAPTKAPWIWLPHPGEWNWPLLTPRALAAGISMALAASTSSLGCYALCGRLLHLP 	                                                            
						PPPPHACSRGLSLEGLGSVLAGLLGSPMGTASSFPNVGKVGLIQAGSQQVAHLVGLLCVG 	                                                            
						LGLSPRLAQLLTTIPLPVVGGVLGVTQAVVLSAGFSSFYLADIDSGRNIFIVGFSIFMAL 	                                                            
						LLPRWFREAPVLFSTGWSPLDVLLHSLLTQPIFLAGLSGFLLENTIPGTQLERGLGQGLP 	                                                            
						SPFTAQEARMPQKPREKAAQVYRLPFPIQNLCPCIPQPLHCLCPLPEDPGDEEGGSSEPE 	                                                            
						EMADLLPGSGEPCPESSREGFRSQK                                    	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA847856_P2.                                              	                                                            

16573	HMR136_AA847856_3_tr0_r1_1_gPRT		Comparison report between AA847856_P3 and Q96NA6partial WT   	Sequence name: Q96NA6                                        
						sequence followed by unique insertion and a followed by a    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						AA847856_P3, comprising a first amino acid sequence being at 	                                                            
						least 90 % homologous to                                     	Alignment of: 16573 x Q96NA6   ..                            
						MSRSPLNPSQLRSVGSQDALAPLPPPAPQNPSTHSWDPLCGSLPWGLSCLLAL        	                                                            
						corresponding to amino acids 1 - 53 of Q96NA6, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 53 of AA847856_P3, a second   	                                                            
						amino acid sequence being at least 70%, optionally at least  	                     Quality: 1820.00                      Escore:       0                                               
						80%, preferably at least 85%, more preferably at least 90%   	             Matching length:     194                Total length:     225                                               
						and most preferably at least 95% homologous to a polypeptide 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						having the sequence QHVLVMASLLCVSHLLLLCSLSPGGLSYSPS          	    Total Percent Similarity:   86.22      Total Percent Identity:   86.22                                               
						corresponding to amino acids 54 - 84 of AA847856_P3, a third 	                        Gaps:       1                        
						QLLASSFFSCGMSTILQTWMGSRLPLVQAPSLEFLIPALVLTSQKLPRAIQTPGNSSLML 	                                                            
						HLCRGPSCHGLGHWNTSLQEVSGAVVVSGLLQGMMGLLGSPGHVFPHCGPLVLAPSLVVA 	Alignment:                                                   
						GLSAHREVAQFCFTHWGLALL                                        	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       1 MSRSPLNPSQLRSVGSQDALAPLPPPAPQNPSTHSWDPLCGSLPWGLSCL 50                                                           
						corresponding to amino acids 54 - 194 of Q96NA6, which also  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 85 - 225 of AA847856_P3, and a    	       1 MSRSPLNPSQLRSVGSQDALAPLPPPAPQNPSTHSWDPLCGSLPWGLSCL 50                                                           
						fourth amino acid sequence being at least 70%, optionally at 	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	      51 LALQHVLVMASLLCVSHLLLLCSLSPGGLSYSPSQLLASSFFSCGMSTIL 100                                                          
						90% and most preferably at least 95% homologous to a         	         |||                               ||||||||||||||||  
						VILLMVVCSQHLGSCQFHVCPWRRASTSSTHTPLPVFRLLSVLIPVACVWIVSAFVGFSV 	      51 LAL...............................QLLASSFFSCGMSTIL 69                                                           
						IPQELSAPTKAPWIWLPHPGEWNWPLLTPRALAAGISMALAASTSSLGCYALCGRLLHLP 	                  .         .         .         .         .  
						PPPPHACSRGLSLEGLGSVLAGLLGSPMGTASSFPNVGKVGLIQAGSQQVAHLVGLLCVG 	     101 QTWMGSRLPLVQAPSLEFLIPALVLTSQKLPRAIQTPGNSSLMLHLCRGP 150                                                          
						LGLSPRLAQLLTTIPLPVVGGVLGVTQAVVLSAGFSSFYLADIDSGRNIFIVGFSIFMAL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLPRWFREAPVLFSTGWSPLDVLLHSLLTQPIFLAGLSGFLLENTIPGTQLERGLGQGLP 	      70 QTWMGSRLPLVQAPSLEFLIPALVLTSQKLPRAIQTPGNSSLMLHLCRGP 119                                                          
						SPFTAQEARMPQKPREKAAQVYRLPFPIQNLCPCIPQPLHCLCPLPEDPGDEEGGSSEPE 	                  .         .         .         .         .  
						EMADLLPGSGEPCPESSREGFRSQK                                    	     151 SCHGLGHWNTSLQEVSGAVVVSGLLQGMMGLLGSPGHVFPHCGPLVLAPS 200                                                          
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						226 - 610 of AA847856_P3, wherein said first amino acid      	     120 SCHGLGHWNTSLQEVSGAVVVSGLLQGMMGLLGSPGHVFPHCGPLVLAPS 169                                                          
						sequence, second amino acid sequence, third amino acid       	                  .         .                                
						sequence and fourth amino acid sequence are contiguous and in	     201 LVVAGLSAHREVAQFCFTHWGLALL                          225                                                          
						a sequential order.2.An isolated polypeptide encoding for an 	         |||||||||||||||||||||||||                           
						edge portion of AA847856_P3, comprising an amino acid        	     170 LVVAGLSAHREVAQFCFTHWGLALL                          194                                                          
						sequence being at least 70%, optionally at least about 80%,  	                                                            
						preferably at least about 85%, more preferably at least about	                                                            
						90% and most preferably at least about 95% homologous to the 	                                                            
						sequence encoding for QHVLVMASLLCVSHLLLLCSLSPGGLSYSPS,       	                                                            
						corresponding to AA847856_P3.3.An isolated polypeptide       	                                                            
						encoding for a tail of AA847856_P3, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						VILLMVVCSQHLGSCQFHVCPWRRASTSSTHTPLPVFRLLSVLIPVACVWIVSAFVGFSV 	                                                            
						IPQELSAPTKAPWIWLPHPGEWNWPLLTPRALAAGISMALAASTSSLGCYALCGRLLHLP 	                                                            
						PPPPHACSRGLSLEGLGSVLAGLLGSPMGTASSFPNVGKVGLIQAGSQQVAHLVGLLCVG 	                                                            
						LGLSPRLAQLLTTIPLPVVGGVLGVTQAVVLSAGFSSFYLADIDSGRNIFIVGFSIFMAL 	                                                            
						LLPRWFREAPVLFSTGWSPLDVLLHSLLTQPIFLAGLSGFLLENTIPGTQLERGLGQGLP 	                                                            
						SPFTAQEARMPQKPREKAAQVYRLPFPIQNLCPCIPQPLHCLCPLPEDPGDEEGGSSEPE 	                                                            
						EMADLLPGSGEPCPESSREGFRSQK                                    	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AA847856_P3.                                              	                                                            

17317	HMR136_AA858019_4_tr0_r1_1_gPRT		Comparison report between AA858019_P4 and S131_HUMANpartial  	Sequence name: S131_HUMAN                                    
						WT sequence featuring skipped exon plus extra amino          	                                                            
						acids.1.An isolated chimeric polypeptide encoding for        	Sequence documentation:                                      
						AA858019_P4, comprising a first amino acid sequence being at 	                                                            
						MKFFSYILVYRRFLFVVFTVLVLLPLPIVLHTKEAECAYTLFVVATFWLTEALPLSVTAL 	Alignment of: 17317 x S131_HUMAN   ..                        
						LPSL                                                         	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 64 	Alignment segment 1/1:                                       
						of S131_HUMAN, which also corresponds to amino acids 1 - 64  	                                                            
						of AA858019_P4, a second amino acid sequence bridging amino  	                     Quality: 3271.00                      Escore:       0                                               
						acid sequence comprising of I, and a third amino acid        	             Matching length:     349                Total length:     595                                               
						FKEMFKCGKTKTVQQKACAEVIKQEYQKLGPIRYQEIVTLVLFIIMALLWFSRDPGFVPG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.71                                               
						WSALFSEYPGFATDSTVALLIGLLFFLIPAKTLTKTTPTGEIVAFDYSPLITWKEFQSFM 	    Total Percent Similarity:   58.66      Total Percent Identity:   58.49                                               
						PWDIAILVGGGFALADGCEESGLSKWIGNKLSPLGSLPAWLIILISSLMVTSLTEVASNP 	                        Gaps:       1                        
						ATITLFLPILSPLAEAIHVNPLYILIPSTLCTSFAFLLPVANPPNAIVFSYGHLKVIDMV 	                                                            
						KAGLGVNIVGVAVVMLGICTWIVPMFDLYTYPSWAPAMSNETMP                 	Alignment:                                                   
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 312 - 595 of S131_HUMAN, which also corresponds  	       1 MKFFSYILVYRRFLFVVFTVLVLLPLPIVLHTKEAECAYTLFVVATFWLT 50                                                           
						to amino acids 66 - 349 of AA858019_P4, wherein said first   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	       1 MKFFSYILVYRRFLFVVFTVLVLLPLPIVLHTKEAECAYTLFVVATFWLT 50                                                           
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for an edge portion 	      51 EALPLSVTALLPSLI................................... 65                                                           
						of AA858019_P4, comprising a polypeptide having a length "n",	         ||||||||||||||:                                     
						wherein n is at least about 10 amino acids in length,        	      51 EALPLSVTALLPSLMLPMFGIMPSKKVASAYFKDFHLLLIGVICLATSIE 100                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	      65 .................................................. 65                                                           
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	     101 KWNLHKRIALKMVMMVGVNPAWLTLGFMSSTAFLSMWLSNTSTAAMVMPI 150                                                          
						at least two amino acids comprise LIF having a structure as  	                  .         .         .         .         .  
						follows (numbering according to AA858019_P4): a sequence     	      65 .................................................. 65                                                           
						starting from any of amino acid numbers 64-x to 64; and      	                                                            
						ending at any of amino acid numbers 66 + ((n-2) - x), in     	     151 AEAVVQQIINAEAEVEATQMTYFNGSTNHGLEIDESVNGHEINERKEKTK 200                                                          
						which x varies from 0 to n-2.                                	                  .         .         .         .         .  
						                                                            	      65 .................................................. 65                                                           
						                                                            	                                                            
						                                                            	     201 PVPGYNNDTGKISSKVELEKNSGMRTKYRTKKGHVTRKLTCLCIAYSSTI 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      65 .................................................. 65                                                           
						                                                            	                                                            
						                                                            	     251 GGLTTITGTSTNLIFAEYFNTRYPDCRCLNFGSWFTFSFPAALIILLLSW 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      66 ...........FKEMFKCGKTKTVQQKACAEVIKQEYQKLGPIRYQEIVT 104                                                          
						                                                            	                    |||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 IWLQWLFLGFNFKEMFKCGKTKTVQQKACAEVIKQEYQKLGPIRYQEIVT 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     105 LVLFIIMALLWFSRDPGFVPGWSALFSEYPGFATDSTVALLIGLLFFLIP 154                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LVLFIIMALLWFSRDPGFVPGWSALFSEYPGFATDSTVALLIGLLFFLIP 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     155 AKTLTKTTPTGEIVAFDYSPLITWKEFQSFMPWDIAILVGGGFALADGCE 204                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 AKTLTKTTPTGEIVAFDYSPLITWKEFQSFMPWDIAILVGGGFALADGCE 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     205 ESGLSKWIGNKLSPLGSLPAWLIILISSLMVTSLTEVASNPATITLFLPI 254                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 ESGLSKWIGNKLSPLGSLPAWLIILISSLMVTSLTEVASNPATITLFLPI 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     255 LSPLAEAIHVNPLYILIPSTLCTSFAFLLPVANPPNAIVFSYGHLKVIDM 304                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 LSPLAEAIHVNPLYILIPSTLCTSFAFLLPVANPPNAIVFSYGHLKVIDM 550                                                          
						                                                            	                  .         .         .         .            
						                                                            	     305 VKAGLGVNIVGVAVVMLGICTWIVPMFDLYTYPSWAPAMSNETMP      349                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||       
						                                                            	     551 VKAGLGVNIVGVAVVMLGICTWIVPMFDLYTYPSWAPAMSNETMP      595                                                          

18970	HMR136_AA862421_2_tr0_r1_1_gPRT		Comparison report between AA862421_P2 and Q96PK9partial WT   	Sequence name: Q96PK9                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA862421_P2, comprising a first amino acid      	                                                            
						MSQPRPRYVVDRAAYSLTLFDDEFEKKDRTYPVGEKLRNAFRCSSAKIKAVVFGLLPVLS 	Alignment of: 18970 x Q96PK9   ..                            
						WLPKYKIKDYIIPDLLGGLSGGSIQVPQGMAFALLANLPAVNGLYSSFFPLLTYFFLGGV 	                                                            
						HQMVPGTFAVISILVGNICLQLAPESKFQVFNNATNESYVDTAAMEAERLHVSATLACLT 	Alignment segment 1/1:                                       
						AIIQMGLGFMQFGFVAIYLSESFIRGFMTAAGLQILISVLKYIFGLTIPSYTGPGSIVFT 	                                                            
						FIDICKNLPHTNIASLIFALISGAFLVLVKELNARYMHKIRFPIPTEMIVVVVATAISGG 	                     Quality: 7664.00                      Escore:       0                                               
						CKMPKKYHMQIVGEIQRGFPTPVSPVVSQWKDMIGTAFSLAIVSYVINLAMGRTLANKHG 	             Matching length:     791                Total length:     791                                               
						YDVDSNQEMIALGCSNFFGSFFKIHVICCALSVTLAVDGAGGKSQVASLCVSLVVMITML 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VLGIYLYPLPKSVLGALIAVNLKNSLKQLTDPYYLWRKSKLDCCIWVVSFLSSFFLSLPY 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GVAVGVAFSVLVVVFQTQFRNGYALAQVMDTDIYVNPKTYNRAQDIQGIKIITYCSPLYF 	                        Gaps:       0                        
						ANSEIFRQKVIAKTGMDPQKVLLAKQKYLKKQEKRRMRPTQQRRSLFMKTKTVSLQELQQ 	                                                            
						DFENAPPTDPNNNQTPANGTSVSYITFSPDSSSPAQSEPPASAEAPGEPSDMLASVPPFV 	Alignment:                                                   
						TFHTLILDMSGVSFVDLMGIKALAKLSSTYGKIGVKVFLVNIHAQVYNDISHGGVFEDGS 	                  .         .         .         .         .  
						LECKHVFPSIHDAVLFAQANARDVTPGHNFQGAPGDAELSLYDSEEDIRSYWDLEQEMFG 	       1 MSQPRPRYVVDRAAYSLTLFDDEFEKKDRTYPVGEKLRNAFRCSSAKIKA 50                                                           
						SMFHAETLTAL                                                  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 MSQPRPRYVVDRAAYSLTLFDDEFEKKDRTYPVGEKLRNAFRCSSAKIKA 50                                                           
						amino acids 1 - 791 of Q96PK9, which also corresponds to     	                  .         .         .         .         .  
						amino acids 1 - 791 of AA862421_P2.                          	      51 VVFGLLPVLSWLPKYKIKDYIIPDLLGGLSGGSIQVPQGMAFALLANLPA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 VVFGLLPVLSWLPKYKIKDYIIPDLLGGLSGGSIQVPQGMAFALLANLPA 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 VNGLYSSFFPLLTYFFLGGVHQMVPGTFAVISILVGNICLQLAPESKFQV 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 VNGLYSSFFPLLTYFFLGGVHQMVPGTFAVISILVGNICLQLAPESKFQV 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 FNNATNESYVDTAAMEAERLHVSATLACLTAIIQMGLGFMQFGFVAIYLS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 FNNATNESYVDTAAMEAERLHVSATLACLTAIIQMGLGFMQFGFVAIYLS 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 ESFIRGFMTAAGLQILISVLKYIFGLTIPSYTGPGSIVFTFIDICKNLPH 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 ESFIRGFMTAAGLQILISVLKYIFGLTIPSYTGPGSIVFTFIDICKNLPH 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 TNIASLIFALISGAFLVLVKELNARYMHKIRFPIPTEMIVVVVATAISGG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 TNIASLIFALISGAFLVLVKELNARYMHKIRFPIPTEMIVVVVATAISGG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 CKMPKKYHMQIVGEIQRGFPTPVSPVVSQWKDMIGTAFSLAIVSYVINLA 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 CKMPKKYHMQIVGEIQRGFPTPVSPVVSQWKDMIGTAFSLAIVSYVINLA 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 MGRTLANKHGYDVDSNQEMIALGCSNFFGSFFKIHVICCALSVTLAVDGA 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 MGRTLANKHGYDVDSNQEMIALGCSNFFGSFFKIHVICCALSVTLAVDGA 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 GGKSQVASLCVSLVVMITMLVLGIYLYPLPKSVLGALIAVNLKNSLKQLT 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GGKSQVASLCVSLVVMITMLVLGIYLYPLPKSVLGALIAVNLKNSLKQLT 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 DPYYLWRKSKLDCCIWVVSFLSSFFLSLPYGVAVGVAFSVLVVVFQTQFR 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 DPYYLWRKSKLDCCIWVVSFLSSFFLSLPYGVAVGVAFSVLVVVFQTQFR 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 NGYALAQVMDTDIYVNPKTYNRAQDIQGIKIITYCSPLYFANSEIFRQKV 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 NGYALAQVMDTDIYVNPKTYNRAQDIQGIKIITYCSPLYFANSEIFRQKV 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 IAKTGMDPQKVLLAKQKYLKKQEKRRMRPTQQRRSLFMKTKTVSLQELQQ 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 IAKTGMDPQKVLLAKQKYLKKQEKRRMRPTQQRRSLFMKTKTVSLQELQQ 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 DFENAPPTDPNNNQTPANGTSVSYITFSPDSSSPAQSEPPASAEAPGEPS 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 DFENAPPTDPNNNQTPANGTSVSYITFSPDSSSPAQSEPPASAEAPGEPS 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 DMLASVPPFVTFHTLILDMSGVSFVDLMGIKALAKLSSTYGKIGVKVFLV 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 DMLASVPPFVTFHTLILDMSGVSFVDLMGIKALAKLSSTYGKIGVKVFLV 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 NIHAQVYNDISHGGVFEDGSLECKHVFPSIHDAVLFAQANARDVTPGHNF 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 NIHAQVYNDISHGGVFEDGSLECKHVFPSIHDAVLFAQANARDVTPGHNF 750                                                          
						                                                            	                  .         .         .         .            
						                                                            	     751 QGAPGDAELSLYDSEEDIRSYWDLEQEMFGSMFHAETLTAL          791                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||           
						                                                            	     751 QGAPGDAELSLYDSEEDIRSYWDLEQEMFGSMFHAETLTAL          791                                                          

15704	HMR136_AA910446_1_tr0_r1_1_gPRT		Comparison report between AA910446_P1 and Q8NA85unique head  	Sequence name: Q8NA85                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA910446_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 15704 x Q8NA85   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						GTSGVAPGTTVAPGSFSTAATTSPGASGVTGTGPTAETTTFLGGSSTTGAEIKSGATTGA 	Alignment segment 1/1:                                       
						PGSKTGTAKVLSGTTVASGSSNSEATTFSGITEAVTVPSKNGS                  	                                                            
						having the sequence corresponding to amino acids 1 - 103 of  	                     Quality: 2601.00                      Escore:       0                                               
						AA910446_P1, and a second amino acid sequence being at least 	             Matching length:     280                Total length:     280                                               
						MTTALGSQLSSSQTVIPGSSGTISHTTVAPGSSVTGTTTGASDDQVTGSKTGTTGVALST 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						TVAPGSSSTEATTSTGVHRTTVVGQKTGATTRGSAKQGTRSTIEATTSFRGTGTTGSGMN 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						TGTTGVVSGNTISPSSFNTEATSGTSERPNPGSEIGTTGIVSGTTVAPGSSNTEATTSLG 	                        Gaps:       0                        
						NGGTTEAGSKIVTTGITTGTTIVPGSFNTKATTSTDVGVATGVGMATGITNIISGRSQPT 	                                                            
						GSKTGYTVTGSGTTALPGGFRTDSPSFPLFLICSYRGHNF                     	Alignment:                                                   
						90 % homologous to corresponding to amino acids 1 - 280 of   	                  .         .         .         .         .  
						Q8NA85, which also corresponds to amino acids 104 - 383 of   	     104 MTTALGSQLSSSQTVIPGSSGTISHTTVAPGSSVTGTTTGASDDQVTGSK 153                                                          
						AA910446_P1, wherein said first amino acid sequence and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	       1 MTTALGSQLSSSQTVIPGSSGTISHTTVAPGSSVTGTTTGASDDQVTGSK 50                                                           
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AA910446_P1, comprising a polypeptide being at least 70%,    	     154 TGTTGVALSTTVAPGSSSTEATTSTGVHRTTVVGQKTGATTRGSAKQGTR 203                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	      51 TGTTGVALSTTVAPGSSSTEATTSTGVHRTTVVGQKTGATTRGSAKQGTR 100                                                          
						GTSGVAPGTTVAPGSFSTAATTSPGASGVTGTGPTAETTTFLGGSSTTGAEIKSGATTGA 	                  .         .         .         .         .  
						PGSKTGTAKVLSGTTVASGSSNSEATTFSGITEAVTVPSKNGS                  	     204 STIEATTSFRGTGTTGSGMNTGTTGVVSGNTISPSSFNTEATSGTSERPN 253                                                          
						least about 95% homologous to the sequence of AA910446_P1.   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 STIEATTSFRGTGTTGSGMNTGTTGVVSGNTISPSSFNTEATSGTSERPN 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     254 PGSEIGTTGIVSGTTVAPGSSNTEATTSLGNGGTTEAGSKIVTTGITTGT 303                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 PGSEIGTTGIVSGTTVAPGSSNTEATTSLGNGGTTEAGSKIVTTGITTGT 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     304 TIVPGSFNTKATTSTDVGVATGVGMATGITNIISGRSQPTGSKTGYTVTG 353                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 TIVPGSFNTKATTSTDVGVATGVGMATGITNIISGRSQPTGSKTGYTVTG 250                                                          
						                                                            	                  .         .         .                      
						                                                            	     354 SGTTALPGGFRTDSPSFPLFLICSYRGHNF                     383                                                          
						                                                            	         ||||||||||||||||||||||||||||||                      
						                                                            	     251 SGTTALPGGFRTDSPSFPLFLICSYRGHNF                     280                                                          

16692	HMR136_AA912226_1_tr0_r1_1_gPRT		Comparison report between AA912226_P1 and ABG4_HUMANpartial  	Sequence name: ABG4_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for AA912226_P1, comprising a first     	Sequence documentation:                                      
						MAEKALEAVGCGLGPGAVAMAVTLEDGAEPPVLTTHLKKVENHITEAQRFSHLPKRSAVD 	                                                            
						IEFVELSYSVREGPCWRKRGYKTLLKCLSGKFCRRELIGIMGPSGAGKSTFMNILAGYRE 	Alignment of: 16692 x ABG4_HUMAN   ..                        
						SGMKGQILVNGRPRELRTFRKMSCYIMQDDMLLPHLTVLEAMMVSANLKLSEKQEVKKEL 	                                                            
						VTEILTALGLMSCSHTRTALLSGGQRKRLAIALELVNNPPVMFFDEPTSGLDSASCFQVV 	Alignment segment 1/1:                                       
						SLMKSLAQGGRTIICTIHQPSAKLFEMFDKLYILSQGQCIFKGVVTNLIPYLKGLGLHCP 	                                                            
						TYHNPADF                                                     	                     Quality: 3001.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     308                Total length:     308                                               
						corresponding to amino acids 1 - 308 of ABG4_HUMAN, which    	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						also corresponds to amino acids 1 - 308 of AA912226_P1, and a	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						polypeptide having the sequence RSGSH corresponding to amino 	                  .         .         .         .         .  
						acids 309 - 313 of AA912226_P1, wherein said first amino acid	       1 MAEKALEAVGCGLGPGAVAMAVTLEDGAEPPVLTTHLKKVENHITEAQRF 50                                                           
						sequence and second amino acid sequence are contiguous and in	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	       1 MAEKALEAVGCGLGPGAVAMAVTLEDGAEPPVLTTHLKKVENHITEAQRF 50                                                           
						tail of AA912226_P1, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	      51 SHLPKRSAVDIEFVELSYSVREGPCWRKRGYKTLLKCLSGKFCRRELIGI 100                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence RSGSH in       	      51 SHLPKRSAVDIEFVELSYSVREGPCWRKRGYKTLLKCLSGKFCRRELIGI 100                                                          
						AA912226_P1.                                                 	                  .         .         .         .         .  
						                                                            	     101 MGPSGAGKSTFMNILAGYRESGMKGQILVNGRPRELRTFRKMSCYIMQDD 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 MGPSGAGKSTFMNILAGYRESGMKGQILVNGRPRELRTFRKMSCYIMQDD 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 MLLPHLTVLEAMMVSANLKLSEKQEVKKELVTEILTALGLMSCSHTRTAL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 MLLPHLTVLEAMMVSANLKLSEKQEVKKELVTEILTALGLMSCSHTRTAL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LSGGQRKRLAIALELVNNPPVMFFDEPTSGLDSASCFQVVSLMKSLAQGG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LSGGQRKRLAIALELVNNPPVMFFDEPTSGLDSASCFQVVSLMKSLAQGG 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RTIICTIHQPSAKLFEMFDKLYILSQGQCIFKGVVTNLIPYLKGLGLHCP 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 RTIICTIHQPSAKLFEMFDKLYILSQGQCIFKGVVTNLIPYLKGLGLHCP 300                                                          
						                                                            	                                                             
						                                                            	     301 TYHNPADF                                           308                                                          
						                                                            	         ||||||||                                            
						                                                            	     301 TYHNPADF                                           308                                                          

16694	HMR136_AA912226_2_tr0_r1_1_gPRT		Comparison report between AA912226_P2 and ABG4_HUMANunique   	Sequence name: ABG4_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA912226_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 16694 x ABG4_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence IPFTAAAPPQTLPSFGLTHLTWPPGGLSLD           	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 30 of AA912226_P2, and a    	                                                            
						SGLDSASCFQVVSLMKSLAQGGRTIICTIHQPSAKLFEMFDKLYILSQGQCIFKGVVTNL 	                     Quality: 4075.00                      Escore:       0                                               
						IPYLKGLGLHCPTYHNPADFIIEVASGEYGDLNPMLFRAVQNGLCAMAEKKSSPEKNEVP 	             Matching length:     418                Total length:     418                                               
						APCPPCPPEVDPIESHTFATSTLTQFCILFKRTFLSILRDTVLTHLRFMSHVVIGVLIGL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LYLHIGDDASKVFNNTGCLFFSMLFLMFAALMPTVLTFPLEMAVFMREHLNYWYSLKAYY 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LAKTMADVPFQVVCPVVYCSIVYWMTGQPAETSRFLLFSALATATALVAQSLGLLIGAAS 	                        Gaps:       0                        
						NSLQVATFVGPVTAIPVLLFSGFFVSFKTIPTYLQWSSYLSYVRYGFEGVILTIYGMERG 	                                                            
						DLTCLEERCPFREPQSILRALDVEDAKLYMDFLVLGIFFLALRLLAYLVLRYRVKSER   	Alignment:                                                   
						second amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 229 - 646 of ABG4_HUMAN, which  	      31 SGLDSASCFQVVSLMKSLAQGGRTIICTIHQPSAKLFEMFDKLYILSQGQ 80                                                           
						also corresponds to amino acids 31 - 448 of AA912226_P2,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence and second amino acid 	     229 SGLDSASCFQVVSLMKSLAQGGRTIICTIHQPSAKLFEMFDKLYILSQGQ 278                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of AA912226_P2,     	      81 CIFKGVVTNLIPYLKGLGLHCPTYHNPADFIIEVASGEYGDLNPMLFRAV 130                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     279 CIFKGVVTNLIPYLKGLGLHCPTYHNPADFIIEVASGEYGDLNPMLFRAV 328                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence                         	     131 QNGLCAMAEKKSSPEKNEVPAPCPPCPPEVDPIESHTFATSTLTQFCILF 180                                                          
						IPFTAAAPPQTLPSFGLTHLTWPPGGLSLD of AA912226_P2.               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     329 QNGLCAMAEKKSSPEKNEVPAPCPPCPPEVDPIESHTFATSTLTQFCILF 378                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     181 KRTFLSILRDTVLTHLRFMSHVVIGVLIGLLYLHIGDDASKVFNNTGCLF 230                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     379 KRTFLSILRDTVLTHLRFMSHVVIGVLIGLLYLHIGDDASKVFNNTGCLF 428                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     231 FSMLFLMFAALMPTVLTFPLEMAVFMREHLNYWYSLKAYYLAKTMADVPF 280                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     429 FSMLFLMFAALMPTVLTFPLEMAVFMREHLNYWYSLKAYYLAKTMADVPF 478                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     281 QVVCPVVYCSIVYWMTGQPAETSRFLLFSALATATALVAQSLGLLIGAAS 330                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     479 QVVCPVVYCSIVYWMTGQPAETSRFLLFSALATATALVAQSLGLLIGAAS 528                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     331 NSLQVATFVGPVTAIPVLLFSGFFVSFKTIPTYLQWSSYLSYVRYGFEGV 380                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     529 NSLQVATFVGPVTAIPVLLFSGFFVSFKTIPTYLQWSSYLSYVRYGFEGV 578                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     381 ILTIYGMERGDLTCLEERCPFREPQSILRALDVEDAKLYMDFLVLGIFFL 430                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     579 ILTIYGMERGDLTCLEERCPFREPQSILRALDVEDAKLYMDFLVLGIFFL 628                                                          
						                                                            	                  .                                          
						                                                            	     431 ALRLLAYLVLRYRVKSER                                 448                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     629 ALRLLAYLVLRYRVKSER                                 646                                                          

16690	HMR136_AA912226_3_tr0_r1_1_gPRT		Comparison report between AA912226_P3 and ABG4_HUMANpartial  	Sequence name: ABG4_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for AA912226_P3, comprising a first     	                                                            
						MSHVVIGVLIGLLYLHIGDDASKVFNNTGCLFFSMLFLMFAALMPTVLTFPLEMAVFMRE 	Alignment of: 16690 x ABG4_HUMAN   ..                        
						HLNYWYSLKAYYLAKTMADVPFQVVCPVVYCSIVYWMTGQPAETSRFLLFSALATATALV 	                                                            
						AQSLGLLIGAASNSLQVATFVGPVTAIPVLLFSGFFVSFKTIPTYLQWSSYLSYVRYGFE 	Alignment segment 1/1:                                       
						GVILTIYGMERGDLTCLEERCPFREPQSILRALDVEDAKLYMDFLVLGIFFLALRLLAYL 	                                                            
						VLRYRVKSER                                                   	                     Quality: 2415.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     250                Total length:     250                                               
						corresponding to amino acids 397 - 646 of ABG4_HUMAN, which  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						also corresponds to amino acids 1 - 250 of AA912226_P3.      	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MSHVVIGVLIGLLYLHIGDDASKVFNNTGCLFFSMLFLMFAALMPTVLTF 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     397 MSHVVIGVLIGLLYLHIGDDASKVFNNTGCLFFSMLFLMFAALMPTVLTF 446                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PLEMAVFMREHLNYWYSLKAYYLAKTMADVPFQVVCPVVYCSIVYWMTGQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     447 PLEMAVFMREHLNYWYSLKAYYLAKTMADVPFQVVCPVVYCSIVYWMTGQ 496                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 PAETSRFLLFSALATATALVAQSLGLLIGAASNSLQVATFVGPVTAIPVL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     497 PAETSRFLLFSALATATALVAQSLGLLIGAASNSLQVATFVGPVTAIPVL 546                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LFSGFFVSFKTIPTYLQWSSYLSYVRYGFEGVILTIYGMERGDLTCLEER 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     547 LFSGFFVSFKTIPTYLQWSSYLSYVRYGFEGVILTIYGMERGDLTCLEER 596                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 CPFREPQSILRALDVEDAKLYMDFLVLGIFFLALRLLAYLVLRYRVKSER 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     597 CPFREPQSILRALDVEDAKLYMDFLVLGIFFLALRLLAYLVLRYRVKSER 646                                                          

7599	HMR136_AA912308_4_tr0_r1_1_gPRT		Comparison report between AA912308_P4 and NTR2_HUMANpartial  	Sequence name: NTR2_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for AA912308_P4, comprising a first     	                                                            
						MYVICWLPYHARRLMYCYVPDDAWTDPLYNFYHYFYMVTNTLFYVSSAVTPLLYNAVSSS 	Alignment of: 7599 x NTR2_HUMAN   ..                         
						FRKLFLEAVSSLCGEHHPMKRLPPKPQSPTLMDTASGFGDPPETRT               	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 305 - 410 of NTR2_HUMAN, which  	                                                            
						also corresponds to amino acids 1 - 106 of AA912308_P4.      	                     Quality: 1090.00                      Escore:       0                                               
						                                                            	             Matching length:     106                Total length:     106                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MYVICWLPYHARRLMYCYVPDDAWTDPLYNFYHYFYMVTNTLFYVSSAVT 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     305 MYVICWLPYHARRLMYCYVPDDAWTDPLYNFYHYFYMVTNTLFYVSSAVT 354                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PLLYNAVSSSFRKLFLEAVSSLCGEHHPMKRLPPKPQSPTLMDTASGFGD 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     355 PLLYNAVSSSFRKLFLEAVSSLCGEHHPMKRLPPKPQSPTLMDTASGFGD 404                                                          
						                                                            	                                                             
						                                                            	     101 PPETRT                                             106                                                          
						                                                            	         ||||||                                              
						                                                            	     405 PPETRT                                             410                                                          

17596	HMR136_AA917682_5_tr0_r1_1_gPRT		Comparison report between AA917682_P5 and B3A4_HUMANunique   	Sequence name: B3A4_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA917682_P5, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 17596 x B3A4_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MGHTHTARSCSGPAGCLGALSRTCAGRSRGTPAISWTPCISSASRPYSTFTWPLSLMPSL 	Alignment segment 1/1:                                       
						LGVCWEMPLMVP                                                 	                                                            
						having the sequence corresponding to amino acids 1 - 72 of   	                     Quality: 4843.00                      Escore:       0                                               
						AA917682_P5, and a second amino acid sequence being at least 	             Matching length:     497                Total length:     497                                               
						RDYSLDYLPFRLWVGIWVATFCLVLVATEASVLVRYFTRFTEEGFCALISLIFIYDAVGK 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						MLNLTHTYPIQKPGSSAYGCLCQYPGPGGNESQWIRTRPKDRDDIVSMDLGLINASLLPP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PECTRQGGHPRGPGCHTVPDIAFFSLLLFLTSFFFAMALKCVKTSRFFPSVVRKGLSDFS 	                        Gaps:       0                        
						SVLAILLGCGLDAFLGLATPKLMVPREFKPTLPGRGWLVSPFGANPWWWSVAAALPALLL 	                                                            
						SILIFMDQQITAVILNRMEYRLQKGAGFHLDLFCVAVLMLLTSALGLPWYVSATVISLAH 	Alignment:                                                   
						MDSLRRESRACAPGERPNFLGIREQRLTGLVVFILTGASIFLAPVLKFIPMPVLYGIFLY 	                  .         .         .         .         .  
						MGVAALSSIQFTNRVKLLLMPAKHQPDLLLLRHVPLTRVHLFTAIQLACLGLLWIIKSTP 	      73 RDYSLDYLPFRLWVGIWVATFCLVLVATEASVLVRYFTRFTEEGFCALIS 122                                                          
						AAIIFPLMLLGLVGVRKALERVFSPQELLWLDELMPEEERSIPEKGLEPEHSFSGSDSED 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SELMYQPKAPEINISVN                                            	     487 RDYSLDYLPFRLWVGIWVATFCLVLVATEASVLVRYFTRFTEEGFCALIS 536                                                          
						90 % homologous to corresponding to amino acids 487 - 983 of 	                  .         .         .         .         .  
						B3A4_HUMAN, which also corresponds to amino acids 73 - 569 of	     123 LIFIYDAVGKMLNLTHTYPIQKPGSSAYGCLCQYPGPGGNESQWIRTRPK 172                                                          
						AA917682_P5, wherein said first amino acid sequence and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	     537 LIFIYDAVGKMLNLTHTYPIQKPGSSAYGCLCQYPGPGGNESQWIRTRPK 586                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AA917682_P5, comprising a polypeptide being at least 70%,    	     173 DRDDIVSMDLGLINASLLPPPECTRQGGHPRGPGCHTVPDIAFFSLLLFL 222                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     587 DRDDIVSMDLGLINASLLPPPECTRQGGHPRGPGCHTVPDIAFFSLLLFL 636                                                          
						MGHTHTARSCSGPAGCLGALSRTCAGRSRGTPAISWTPCISSASRPYSTFTWPLSLMPSL 	                  .         .         .         .         .  
						LGVCWEMPLMVP                                                 	     223 TSFFFAMALKCVKTSRFFPSVVRKGLSDFSSVLAILLGCGLDAFLGLATP 272                                                          
						least about 95% homologous to the sequence of AA917682_P5.   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     637 TSFFFAMALKCVKTSRFFPSVVRKGLSDFSSVLAILLGCGLDAFLGLATP 686                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     273 KLMVPREFKPTLPGRGWLVSPFGANPWWWSVAAALPALLLSILIFMDQQI 322                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     687 KLMVPREFKPTLPGRGWLVSPFGANPWWWSVAAALPALLLSILIFMDQQI 736                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     323 TAVILNRMEYRLQKGAGFHLDLFCVAVLMLLTSALGLPWYVSATVISLAH 372                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     737 TAVILNRMEYRLQKGAGFHLDLFCVAVLMLLTSALGLPWYVSATVISLAH 786                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     373 MDSLRRESRACAPGERPNFLGIREQRLTGLVVFILTGASIFLAPVLKFIP 422                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     787 MDSLRRESRACAPGERPNFLGIREQRLTGLVVFILTGASIFLAPVLKFIP 836                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     423 MPVLYGIFLYMGVAALSSIQFTNRVKLLLMPAKHQPDLLLLRHVPLTRVH 472                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     837 MPVLYGIFLYMGVAALSSIQFTNRVKLLLMPAKHQPDLLLLRHVPLTRVH 886                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     473 LFTAIQLACLGLLWIIKSTPAAIIFPLMLLGLVGVRKALERVFSPQELLW 522                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     887 LFTAIQLACLGLLWIIKSTPAAIIFPLMLLGLVGVRKALERVFSPQELLW 936                                                          
						                                                            	                  .         .         .         .            
						                                                            	     523 LDELMPEEERSIPEKGLEPEHSFSGSDSEDSELMYQPKAPEINISVN    569                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     937 LDELMPEEERSIPEKGLEPEHSFSGSDSEDSELMYQPKAPEINISVN    983                                                          

17598	HMR136_AA917682_8_tr0_r1_1_gPRT		Comparison report between AA917682_P8 and B3A4_HUMANunique   	Sequence name: B3A4_HUMAN                                    
						head followed by partial WT sequence featuring a skipped exon	                                                            
						and a followed by a short unique deletion.1.An isolated      	Sequence documentation:                                      
						chimeric polypeptide encoding for AA917682_P8, comprising a  	                                                            
						first amino acid sequence being at least 70%, optionally at  	Alignment of: 17598 x B3A4_HUMAN   ..                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment segment 1/1:                                       
						polypeptide having the sequence TVLVLRFCASL corresponding to 	                                                            
						amino acids 1 - 11 of AA917682_P8, a second amino acid       	                     Quality: 8253.00                      Escore:       0                                               
						MEMKLPGQEGFEASSAPRNIPSGELDSNPDPGTGPSPDGPSDTESKELGVPKDPLLFIQL 	             Matching length:     876                Total length:     983                                               
						NELLGWPQALEWRETG                                             	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						sequence being at least 90 % homologous to corresponding to  	    Total Percent Similarity:   89.11      Total Percent Identity:   89.11                                               
						amino acids 1 - 76 of B3A4_HUMAN, which also corresponds to  	                        Gaps:       3                        
						amino acids 12 - 87 of AA917682_P8, a third amino acid       	                                                            
						RWVLFEEKLEVAAGRWSAPHVPTLALPSLQKLRSLLAEGLVLLDCPAQSLLELVEQVTRV 	Alignment:                                                   
						ESLSPELRGQLQALLLQRPQHYNQTTGTRPCWGSTHPRKASDNEEAPLRE           	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	      12 MEMKLPGQEGFEASSAPRNIPSGELDSNPDPGTGPSPDGPSDTESKELGV 61                                                           
						amino acids 101 - 210 of B3A4_HUMAN, which also corresponds  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 88 - 197 of AA917682_P8, a fourth amino acid  	       1 MEMKLPGQEGFEASSAPRNIPSGELDSNPDPGTGPSPDGPSDTESKELGV 50                                                           
						QNPLRQKLPPGAEAGTVLAGELGFLAQPLGAFVRLRNPVVLGSLTEVSLPSRFFCLLLGP 	                  .         .         .         .         .  
						CMLGKGYHEMGRAAAVLLSDPQFQWSVRRASNLHDLLAALDAFLEEVTVLPPGRWDPTAR 	      62 PKDPLLFIQLNELLGWPQALEWRETG........................ 87                                                           
						IPPPKCLPSQHKRLPSQQREIRGPAVPRLTSAEDRHRHGPHAHSPELQRTGRLFGGLIQD 	         ||||||||||||||||||||||||||                          
						VRRKVPWYPSDFLDALHLQCFSAVLYIYLATVTNAITFGGLLGDATDGAQGVLESFLGTA 	      51 PKDPLLFIQLNELLGWPQALEWRETGSSSASLLLDMGEMPSITLSTHLHH 100                                                          
						VAGAAFCLMAGQPLTILSSTGPVLVFERLLFSFSRDYSLDYLPFRLWVGIWVATFCLVLV 	                  .         .         .         .         .  
						ATEASVLVRYFTRFTEEGFCALISLIFIYDAVGKMLNLTHTYPIQKPGSSAYGCLCQYPG 	      88 RWVLFEEKLEVAAGRWSAPHVPTLALPSLQKLRSLLAEGLVLLDCPAQSL 137                                                          
						PGGNESQWIRTRPKDRDDIVSMDLGLINASLLPPPECTRQGGHPRGPGCHTVPDIAFFSL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLFLTSFFFAMALKCVKTSRFFPSVVRKGLSDFSSVLAILLGCGLDAFLGLATPKLMVPR 	     101 RWVLFEEKLEVAAGRWSAPHVPTLALPSLQKLRSLLAEGLVLLDCPAQSL 150                                                          
						EFKPTLPGRGWLVSPFGANPWWWSVAAALPALLLSILIFMDQQITAVILNRMEYRLQKGA 	                  .         .         .         .         .  
						GFHLDLFCVAVLMLLTSALGLPWYVSATVISLAHMDSLRRESRACAPGERPNFLGIREQR 	     138 LELVEQVTRVESLSPELRGQLQALLLQRPQHYNQTTGTRPCWGSTHPRKA 187                                                          
						LTGLVVFILTGASIFLAPVLK                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	     151 LELVEQVTRVESLSPELRGQLQALLLQRPQHYNQTTGTRPCWGSTHPRKA 200                                                          
						amino acids 213 - 833 of B3A4_HUMAN, which also corresponds  	                  .         .         .         .         .  
						to amino acids 198 - 818 of AA917682_P8, and a fifth amino   	     188 SDNEEAPLRE..QNPLRQKLPPGAEAGTVLAGELGFLAQPLGAFVRLRNP 235                                                          
						LLGLVGVRKALERVFSPQELLWLDELMPEEERSIPEKGLEPEHSFSGSDSEDSELMYQPK 	         ||||||||||  ||||||||||||||||||||||||||||||||||||||  
						APEINISVN                                                    	     201 SDNEEAPLREQCQNPLRQKLPPGAEAGTVLAGELGFLAQPLGAFVRLRNP 250                                                          
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 915 - 983 of B3A4_HUMAN, which also           	     236 VVLGSLTEVSLPSRFFCLLLGPCMLGKGYHEMGRAAAVLLSDPQFQWSVR 285                                                          
						corresponds to amino acids 819 - 887 of AA917682_P8, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence,  	     251 VVLGSLTEVSLPSRFFCLLLGPCMLGKGYHEMGRAAAVLLSDPQFQWSVR 300                                                          
						third amino acid sequence, fourth amino acid sequence and    	                  .         .         .         .         .  
						fifth amino acid sequence are contiguous and in a sequential 	     286 RASNLHDLLAALDAFLEEVTVLPPGRWDPTARIPPPKCLPSQHKRLPSQQ 335                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA917682_P8, comprising a polypeptide being at least 70%,    	     301 RASNLHDLLAALDAFLEEVTVLPPGRWDPTARIPPPKCLPSQHKRLPSQQ 350                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     336 REIRGPAVPRLTSAEDRHRHGPHAHSPELQRTGRLFGGLIQDVRRKVPWY 385                                                          
						least about 95% homologous to the sequence TVLVLRFCASL of    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA917682_P8.3.An isolated chimeric polypeptide encoding for  	     351 REIRGPAVPRLTSAEDRHRHGPHAHSPELQRTGRLFGGLIQDVRRKVPWY 400                                                          
						an edge portion of AA917682_P8, comprising a polypeptide     	                  .         .         .         .         .  
						having a length "n", wherein n is at least about 10 amino    	     386 PSDFLDALHLQCFSAVLYIYLATVTNAITFGGLLGDATDGAQGVLESFLG 435                                                          
						acids in length, optionally at least about 20 amino acids in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, preferably at least about 30 amino acids in length,  	     401 PSDFLDALHLQCFSAVLYIYLATVTNAITFGGLLGDATDGAQGVLESFLG 450                                                          
						more preferably at least about 40 amino acids in length and  	                  .         .         .         .         .  
						most preferably at least about 50 amino acids in length,     	     436 TAVAGAAFCLMAGQPLTILSSTGPVLVFERLLFSFSRDYSLDYLPFRLWV 485                                                          
						wherein at least two amino acids comprise GR, having a       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						structure as follows: a sequence starting from any of amino  	     451 TAVAGAAFCLMAGQPLTILSSTGPVLVFERLLFSFSRDYSLDYLPFRLWV 500                                                          
						acid numbers 87-x to 88; and ending at any of amino acid     	                  .         .         .         .         .  
						numbers 88+ ((n-2) - x), in which x varies from 0 to n-2.4.An	     486 GIWVATFCLVLVATEASVLVRYFTRFTEEGFCALISLIFIYDAVGKMLNL 535                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA917682_P8, comprising a polypeptide having a length "n",   	     501 GIWVATFCLVLVATEASVLVRYFTRFTEEGFCALISLIFIYDAVGKMLNL 550                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     536 THTYPIQKPGSSAYGCLCQYPGPGGNESQWIRTRPKDRDDIVSMDLGLIN 585                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     551 THTYPIQKPGSSAYGCLCQYPGPGGNESQWIRTRPKDRDDIVSMDLGLIN 600                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise EQ, having a structure as  	     586 ASLLPPPECTRQGGHPRGPGCHTVPDIAFFSLLLFLTSFFFAMALKCVKT 635                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						197-x to 198; and ending at any of amino acid numbers 198+   	     601 ASLLPPPECTRQGGHPRGPGCHTVPDIAFFSLLLFLTSFFFAMALKCVKT 650                                                          
						((n-2) - x), in which x varies from 0 to n-2.5.An isolated   	                  .         .         .         .         .  
						chimeric polypeptide encoding for an edge portion of         	     636 SRFFPSVVRKGLSDFSSVLAILLGCGLDAFLGLATPKLMVPREFKPTLPG 685                                                          
						AA917682_P8, comprising a polypeptide having a length "n",   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	     651 SRFFPSVVRKGLSDFSSVLAILLGCGLDAFLGLATPKLMVPREFKPTLPG 700                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     686 RGWLVSPFGANPWWWSVAAALPALLLSILIFMDQQITAVILNRMEYRLQK 735                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 50 amino acids in length, wherein  	     701 RGWLVSPFGANPWWWSVAAALPALLLSILIFMDQQITAVILNRMEYRLQK 750                                                          
						at least two amino acids comprise KL, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     736 GAGFHLDLFCVAVLMLLTSALGLPWYVSATVISLAHMDSLRRESRACAPG 785                                                          
						818-x to 819; and ending at any of amino acid numbers 819+   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     751 GAGFHLDLFCVAVLMLLTSALGLPWYVSATVISLAHMDSLRRESRACAPG 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     786 ERPNFLGIREQRLTGLVVFILTGASIFLAPVLK................. 818                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     801 ERPNFLGIREQRLTGLVVFILTGASIFLAPVLKFIPMPVLYGIFLYMGVA 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     818 .................................................. 818                                                          
						                                                            	                                                            
						                                                            	     851 ALSSIQFTNRVKLLLMPAKHQPDLLLLRHVPLTRVHLFTAIQLACLGLLW 900                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     819 ..............LLGLVGVRKALERVFSPQELLWLDELMPEEERSIPE 854                                                          
						                                                            	                       ||||||||||||||||||||||||||||||||||||  
						                                                            	     901 IIKSTPAAIIFPLMLLGLVGVRKALERVFSPQELLWLDELMPEEERSIPE 950                                                          
						                                                            	                  .         .         .                      
						                                                            	     855 KGLEPEHSFSGSDSEDSELMYQPKAPEINISVN                  887                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     951 KGLEPEHSFSGSDSEDSELMYQPKAPEINISVN                  983                                                          

21671	HMR136_AA928170_1_tr0_r1_1_gPRT		Comparison report between AA928170_P1 and Q8N8C6partial WT   	Sequence name: Q8N8C6                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA928170_P1, comprising a first amino acid sequence being at 	                                                            
						MDCKVHMETTVSRPVLSPTHINATASETFTVLQQRMRIVEEQTSSLRDDLIMLDFGEKRG 	Alignment of: 21671 x Q8N8C6   ..                            
						YLEAPDCLEDLDSQKVISPIQNEAICAGKTDILWKNCEFLVNRMCRLESLMQSLKMNIFR 	                                                            
						LQTEKDLNPQKTAFLKDRLNAIQEEHSKDLKLLHLEVMNLRQQLRAVKEEEDKAQDEVQR 	Alignment segment 1/1:                                       
						LTATLKIASQTKKNAAIIEEELKTTKRKMNLKIQELR                        	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 217	                     Quality: 2728.00                      Escore:       0                                               
						of Q8N8C6, which also corresponds to amino acids 1 - 217 of  	             Matching length:     283                Total length:     283                                               
						AA928170_P1, a bridging amino acid R corresponding to amino  	 Matching Percent Similarity:   99.65   Matching Percent Identity:   99.65                                               
						acid 218 of AA928170_P1, a second amino acid sequence being  	    Total Percent Similarity:   99.65      Total Percent Identity:   99.65                                               
						QLAQEKYLRESLEKSASAMLLKIQEMGSTVEVERKQVHILQQNCIALRDSIQSAQELLAQ 	                        Gaps:       0                        
						EQKKK                                                        	                                                            
						at least 90 % homologous to corresponding to amino acids 219 	Alignment:                                                   
						- 283 of Q8N8C6, which also corresponds to amino acids 219 - 	                  .         .         .         .         .  
						283 of AA928170_P1, and a third amino acid sequence being at 	       1 MDCKVHMETTVSRPVLSPTHINATASETFTVLQQRMRIVEEQTSSLRDDL 50                                                           
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	       1 MDCKVHMETTVSRPVLSPTHINATASETFTVLQQRMRIVEEQTSSLRDDL 50                                                           
						EELEIATSQLKSDLTSRDDLISKLVEENKNLQISFNKEHEENAYLRSEIMSLHEASEKAQ 	                  .         .         .         .         .  
						VLNDQLTKKCSELSCMLQTVTMEKARIIADHQAILQVEQKMMTQTFQEQNLLLDAAHASI 	      51 IMLDFGEKRGYLEAPDCLEDLDSQKVISPIQNEAICAGKTDILWKNCEFL 100                                                          
						TNELQTVQNEKTQLQAHLDHLILEHNQCIQKAQDAEKRTAVQKELLESTIARLRGELEAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MQEKKSLLEEKERFQREVNKTEKEIVQERCNLEKELAKNKVDINTLTHNLQTLEEENKHL 	      51 IMLDFGEKRGYLEAPDCLEDLDSQKVISPIQNEAICAGKTDILWKNCEFL 100                                                          
						ADQMASLELQQVTSDYHGLAQQKVEKITESKNKLAYENGKLQIKVKQLEEQVQSFTDTSL 	                  .         .         .         .         .  
						QNDHLRKMNKYLQTKYAQANSELSAKRVHLQQADAHLKEVKSILERSKEELSRTVKCRNA 	     101 VNRMCRLESLMQSLKMNIFRLQTEKDLNPQKTAFLKDRLNAIQEEHSKDL 150                                                          
						ALKESQKLKEDLEAVEDRENKKVGNFQRQLAEAKEDNCKVTIMLENVLASHSKMQGALEK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VQIELGRRDSEIAGLKKERDLNQQRVQKLEAEVDQWQARMLVMEDQHNSEIESLQKALGV 	     101 VNRMCRLESLMQSLKMNIFRLQTEKDLNPQKTAFLKDRLNAIQEEHSKDL 150                                                          
						AREDNRKLAMSLEQALQTNNHLQTKLDHIQEQLESKELERQNLETFKDRMTEESKVEAEL 	                  .         .         .         .         .  
						HAERIEALRKQFQTERETTKKVAQREVAELKKALDEANFRSVEVSRTNRELRQKLAELEK 	     151 KLLHLEVMNLRQQLRAVKEEEDKAQDEVQRLTATLKIASQTKKNAAIIEE 200                                                          
						ILESNKEKIKNQKTQIKLHLSAKANNAQNIERMKQIEKELKQMELIKDQYQKKNYEQSLS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IQRFVCEMTNLQKEMQMLAKSQYDASVRNKQQELHLEAERKIRQELENRCQELEETVRHL 	     151 KLLHLEVMNLRQQLRAVKEEEDKAQDEVQRLTATLKIASQTKKNAAIIEE 200                                                          
						KKCKEATENTLKEASVESEQITANLEEAHRWFKHRFDGLQLELTKNRLQRPSGEDRWQE  	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	     201 ELKTTKRKMNLKIQELRRQLAQEKYLRESLEKSASAMLLKIQEMGSTVEV 250                                                          
						to amino acids 284 - 1062 of AA928170_P1, wherein said first 	         ||||||||||||||||| ||||||||||||||||||||||||||||||||  
						amino acid sequence, bridging amino acid, second amino acid  	     201 ELKTTKRKMNLKIQELRGQLAQEKYLRESLEKSASAMLLKIQEMGSTVEV 250                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .                      
						a sequential order.2.An isolated polypeptide encoding for a  	     251 ERKQVHILQQNCIALRDSIQSAQELLAQEQKKK                  283                                                          
						tail of AA928170_P1, comprising a polypeptide being at least 	         |||||||||||||||||||||||||||||||||                   
						70%, optionally at least about 80%, preferably at least about	     251 ERKQVHILQQNCIALRDSIQSAQELLAQEQKKK                  283                                                          
						85%, more preferably at least about 90% and most preferably  	                                                            
						EELEIATSQLKSDLTSRDDLISKLVEENKNLQISFNKEHEENAYLRSEIMSLHEASEKAQ 	                                                            
						VLNDQLTKKCSELSCMLQTVTMEKARIIADHQAILQVEQKMMTQTFQEQNLLLDAAHASI 	                                                            
						TNELQTVQNEKTQLQAHLDHLILEHNQCIQKAQDAEKRTAVQKELLESTIARLRGELEAS 	                                                            
						MQEKKSLLEEKERFQREVNKTEKEIVQERCNLEKELAKNKVDINTLTHNLQTLEEENKHL 	                                                            
						ADQMASLELQQVTSDYHGLAQQKVEKITESKNKLAYENGKLQIKVKQLEEQVQSFTDTSL 	                                                            
						QNDHLRKMNKYLQTKYAQANSELSAKRVHLQQADAHLKEVKSILERSKEELSRTVKCRNA 	                                                            
						ALKESQKLKEDLEAVEDRENKKVGNFQRQLAEAKEDNCKVTIMLENVLASHSKMQGALEK 	                                                            
						VQIELGRRDSEIAGLKKERDLNQQRVQKLEAEVDQWQARMLVMEDQHNSEIESLQKALGV 	                                                            
						AREDNRKLAMSLEQALQTNNHLQTKLDHIQEQLESKELERQNLETFKDRMTEESKVEAEL 	                                                            
						HAERIEALRKQFQTERETTKKVAQREVAELKKALDEANFRSVEVSRTNRELRQKLAELEK 	                                                            
						ILESNKEKIKNQKTQIKLHLSAKANNAQNIERMKQIEKELKQMELIKDQYQKKNYEQSLS 	                                                            
						IQRFVCEMTNLQKEMQMLAKSQYDASVRNKQQELHLEAERKIRQELENRCQELEETVRHL 	                                                            
						KKCKEATENTLKEASVESEQITANLEEAHRWFKHRFDGLQLELTKNRLQRPSGEDRWQE  	                                                            
						at least about 95% homologous to the sequence in AA928170_P1.	                                                            

21667	HMR136_AA928170_2_tr0_r1_1_gPRT		Comparison report between AA928170_P2 and Q8N8C6partial WT   	Sequence name: Q8N8C6                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA928170_P2, comprising a first amino acid sequence being at 	                                                            
						MDCKVHMETTVSRPVLSPTHINATASETFTVLQQRMRIVEEQTSSLRDDLIMLDFGEKRG 	Alignment of: 21667 x Q8N8C6   ..                            
						YLEAPDCLEDLDSQKVISPIQNEAICAGKTDILWKNCEFLVNRMCRLESLMQSLKMNIFR 	                                                            
						LQTEKDLNPQKTAFLKDRLNAIQEEHSKDLKLLHLEVMNLRQQLRAVKEEEDKAQDEVQR 	Alignment segment 1/1:                                       
						LTATLKIASQTKKNAAIIEEELKTTKRKMNLKIQELR                        	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 217	                     Quality: 2728.00                      Escore:       0                                               
						of Q8N8C6, which also corresponds to amino acids 1 - 217 of  	             Matching length:     283                Total length:     283                                               
						AA928170_P2, a bridging amino acid R corresponding to amino  	 Matching Percent Similarity:   99.65   Matching Percent Identity:   99.65                                               
						acid 218 of AA928170_P2, a second amino acid sequence being  	    Total Percent Similarity:   99.65      Total Percent Identity:   99.65                                               
						QLAQEKYLRESLEKSASAMLLKIQEMGSTVEVERKQVHILQQNCIALRDSIQSAQELLAQ 	                        Gaps:       0                        
						EQKKK                                                        	                                                            
						at least 90 % homologous to corresponding to amino acids 219 	Alignment:                                                   
						- 283 of Q8N8C6, which also corresponds to amino acids 219 - 	                  .         .         .         .         .  
						283 of AA928170_P2, and a third amino acid sequence being at 	       1 MDCKVHMETTVSRPVLSPTHINATASETFTVLQQRMRIVEEQTSSLRDDL 50                                                           
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	       1 MDCKVHMETTVSRPVLSPTHINATASETFTVLQQRMRIVEEQTSSLRDDL 50                                                           
						EELEIATSQLKSDLTSRDDLISKLVEENKNLQISFNKEHEENAYLRSEIMSLHEASEKAQ 	                  .         .         .         .         .  
						VLNDQLTKKCSELSCMLQTVTMEKARIIADHQAILQVEQKMMTQTFQEQNLLLDAAHASI 	      51 IMLDFGEKRGYLEAPDCLEDLDSQKVISPIQNEAICAGKTDILWKNCEFL 100                                                          
						TNELQTVQNEKTQLQAHLDHLILEHNQCIQKAQDAEKRTAVQKELLESTIARLRGELEAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MQEKKSLLEEKERFQREVNKTEKEIVQERCNLEKELAKNKVDINTLTHNLQTLEEENKHL 	      51 IMLDFGEKRGYLEAPDCLEDLDSQKVISPIQNEAICAGKTDILWKNCEFL 100                                                          
						ADQMASLELQQVTSDYHGLAQQKVEKITESKNKLAYENGKLQIKVKQLEEQVQSFTDTSL 	                  .         .         .         .         .  
						QNDHLRKMNKYLQTKYAQV                                          	     101 VNRMCRLESLMQSLKMNIFRLQTEKDLNPQKTAFLKDRLNAIQEEHSKDL 150                                                          
						homologous to a polypeptide having the sequence corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 284 - 602 of AA928170_P2, wherein said first  	     101 VNRMCRLESLMQSLKMNIFRLQTEKDLNPQKTAFLKDRLNAIQEEHSKDL 150                                                          
						amino acid sequence, bridging amino acid, second amino acid  	                  .         .         .         .         .  
						sequence and third amino acid sequence are contiguous and in 	     151 KLLHLEVMNLRQQLRAVKEEEDKAQDEVQRLTATLKIASQTKKNAAIIEE 200                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of AA928170_P2, comprising a polypeptide being at least 	     151 KLLHLEVMNLRQQLRAVKEEEDKAQDEVQRLTATLKIASQTKKNAAIIEE 200                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     201 ELKTTKRKMNLKIQELRRQLAQEKYLRESLEKSASAMLLKIQEMGSTVEV 250                                                          
						EELEIATSQLKSDLTSRDDLISKLVEENKNLQISFNKEHEENAYLRSEIMSLHEASEKAQ 	         ||||||||||||||||| ||||||||||||||||||||||||||||||||  
						VLNDQLTKKCSELSCMLQTVTMEKARIIADHQAILQVEQKMMTQTFQEQNLLLDAAHASI 	     201 ELKTTKRKMNLKIQELRGQLAQEKYLRESLEKSASAMLLKIQEMGSTVEV 250                                                          
						TNELQTVQNEKTQLQAHLDHLILEHNQCIQKAQDAEKRTAVQKELLESTIARLRGELEAS 	                  .         .         .                      
						MQEKKSLLEEKERFQREVNKTEKEIVQERCNLEKELAKNKVDINTLTHNLQTLEEENKHL 	     251 ERKQVHILQQNCIALRDSIQSAQELLAQEQKKK                  283                                                          
						ADQMASLELQQVTSDYHGLAQQKVEKITESKNKLAYENGKLQIKVKQLEEQVQSFTDTSL 	         |||||||||||||||||||||||||||||||||                   
						QNDHLRKMNKYLQTKYAQV                                          	     251 ERKQVHILQQNCIALRDSIQSAQELLAQEQKKK                  283                                                          
						at least about 95% homologous to the sequence in AA928170_P2.	                                                            

21665	HMR136_AA928170_5_tr0_r1_1_gPRT		Comparison report between AA928170_P5 and Q8N8C6partial WT   	Sequence name: Q8N8C6                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA928170_P5, comprising a first amino acid sequence being at 	                                                            
						MDCKVHMETTVSRPVLSPTHINATASETFTVLQQRMRIVEEQTSSLRDDLIMLDFGEKRG 	Alignment of: 21665 x Q8N8C6   ..                            
						YLEAPDCLEDLDSQKVISPIQNEAICAGKTDILWKNCEFLVNRMCRLESLMQSLKMNIFR 	                                                            
						LQTEKDLNPQKTAFLKDRLNAIQEEHSKDLKLLHLEVMNLRQQLRAVKEEEDKAQDEVQR 	Alignment segment 1/1:                                       
						LTATLKIASQTKKNAAIIEEELKTTKRKMNLKIQELR                        	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 217	                     Quality: 2728.00                      Escore:       0                                               
						of Q8N8C6, which also corresponds to amino acids 1 - 217 of  	             Matching length:     283                Total length:     283                                               
						AA928170_P5, a bridging amino acid R corresponding to amino  	 Matching Percent Similarity:   99.65   Matching Percent Identity:   99.65                                               
						acid 218 of AA928170_P5, a second amino acid sequence being  	    Total Percent Similarity:   99.65      Total Percent Identity:   99.65                                               
						QLAQEKYLRESLEKSASAMLLKIQEMGSTVEVERKQVHILQQNCIALRDSIQSAQELLAQ 	                        Gaps:       0                        
						EQKKK                                                        	                                                            
						at least 90 % homologous to corresponding to amino acids 219 	Alignment:                                                   
						- 283 of Q8N8C6, which also corresponds to amino acids 219 - 	                  .         .         .         .         .  
						283 of AA928170_P5, and a third amino acid sequence being at 	       1 MDCKVHMETTVSRPVLSPTHINATASETFTVLQQRMRIVEEQTSSLRDDL 50                                                           
						least 70%, optionally at least 80%, preferably at least 85%, 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least 90% and most preferably at least 95%	       1 MDCKVHMETTVSRPVLSPTHINATASETFTVLQQRMRIVEEQTSSLRDDL 50                                                           
						EELEIATSQLKSDLTSRDDLISKLVEENKNLQISFNKEHEENAYLRSEIMSLHEASEKAQ 	                  .         .         .         .         .  
						VLNDQLTKKCSELSCMLQTVTMEKARIIADHQAILQVEQKMMTQTFQEQNLLLDAAHASI 	      51 IMLDFGEKRGYLEAPDCLEDLDSQKVISPIQNEAICAGKTDILWKNCEFL 100                                                          
						TNELQTVQNEKTQLQAHLDHLILEHNQCIQKAQDAEKRTAVQKELLESTIARLRGELEAS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MQEKKSLLEEKERFQREGYL                                         	      51 IMLDFGEKRGYLEAPDCLEDLDSQKVISPIQNEAICAGKTDILWKNCEFL 100                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 284 - 483 of AA928170_P5, wherein said first  	     101 VNRMCRLESLMQSLKMNIFRLQTEKDLNPQKTAFLKDRLNAIQEEHSKDL 150                                                          
						amino acid sequence, bridging amino acid, second amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     101 VNRMCRLESLMQSLKMNIFRLQTEKDLNPQKTAFLKDRLNAIQEEHSKDL 150                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of AA928170_P5, comprising a polypeptide being at least 	     151 KLLHLEVMNLRQQLRAVKEEEDKAQDEVQRLTATLKIASQTKKNAAIIEE 200                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     151 KLLHLEVMNLRQQLRAVKEEEDKAQDEVQRLTATLKIASQTKKNAAIIEE 200                                                          
						EELEIATSQLKSDLTSRDDLISKLVEENKNLQISFNKEHEENAYLRSEIMSLHEASEKAQ 	                  .         .         .         .         .  
						VLNDQLTKKCSELSCMLQTVTMEKARIIADHQAILQVEQKMMTQTFQEQNLLLDAAHASI 	     201 ELKTTKRKMNLKIQELRRQLAQEKYLRESLEKSASAMLLKIQEMGSTVEV 250                                                          
						TNELQTVQNEKTQLQAHLDHLILEHNQCIQKAQDAEKRTAVQKELLESTIARLRGELEAS 	         ||||||||||||||||| ||||||||||||||||||||||||||||||||  
						MQEKKSLLEEKERFQREGYL                                         	     201 ELKTTKRKMNLKIQELRGQLAQEKYLRESLEKSASAMLLKIQEMGSTVEV 250                                                          
						at least about 95% homologous to the sequence in AA928170_P5.	                  .         .         .                      
						                                                            	     251 ERKQVHILQQNCIALRDSIQSAQELLAQEQKKK                  283                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     251 ERKQVHILQQNCIALRDSIQSAQELLAQEQKKK                  283                                                          

22055	HMR136_AA928325_1_tr0_r1_1_gPRT		Comparison report between AA928325_P1 and Q96LS3unique head  	Sequence name: Q96LS3                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA928325_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 22055 x Q96LS3   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MKRIFSCSSTQVAVERWNRHDQKLLEAVHRGDVGRVAALASRKSARPTKLDSNGQSPFHL 	Alignment segment 1/1:                                       
						AASKGLTECLTILLANGADINSKNEDGSTALHLATISCQPQCVKVLLQHGANEDAVDAEN 	                                                            
						RSPLHWAASSGCASSVLLLCDHEAFLDVLDNDGRTPLMIASLGGHAAICSQLLQRGARVN 	                     Quality: 3059.00                      Escore:       0                                               
						VTDKNDKSALILACEKGSAEVAELLLSHGADAGAVDSTGHDALHYALHTQDKALWRHLQQ 	             Matching length:     320                Total length:     320                                               
						ALSRRRRGGQRLVQHPDLASQASPSEPQAGSPPKSSWRAEPEEEQEEKEDEDPCSEEWRW 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						KYEEERRKVVRLEQELVQKTEECKTQAAAYLDLENQIREQAQELGVLLSWEPRASGKQGS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SLRPGGDGMEQGCPKDLLAESTQELKKQQQAAATVNPVLAPKKAEDSAPGKIQYEVHGRS 	                        Gaps:       0                        
						QPEEQGPPQSPASETIRKATGQQLTTNGAQTFGPDHADQLPAGQKESSQVLGVEPGGTVA 	                                                            
						EPVGPAAMNQLLLQLREELAAVWREKDAARGALSRPVMEGALGTPRAEAAAAAWEKMEAR 	Alignment:                                                   
						LERVLARLEWAKAGLQVKPEVPSQESREGALKAAPGSIKQDEEKEKRVPGARGEPLGALG 	                  .         .         .         .         .  
						GEKALGGLAKGQLEKEMSVLRLSNSNLLEELGELGRERQRLQRELQSLSQRLQREFVPKP 	     682 MEKEATEKLRKLLASQSSGLRGLWDCLPADLVGERSAQSKAAESLEELRA 731                                                          
						EAQVQLQQLRQSVGLLTNELA                                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence corresponding to amino acids 1 - 681 of  	       1 MEKEATEKLRKLLASQSSGLRGLWDCLPADLVGERSAQSKAAESLEELRA 50                                                           
						AA928325_P1, and a second amino acid sequence being at least 	                  .         .         .         .         .  
						MEKEATEKLRKLLASQSSGLRGLWDCLPADLVGERSAQSKAAESLEELRACISTLVDRHR 	     732 CISTLVDRHREAQQVLARLQEENQQLRGSLSPCREPGTSLKAPASPQVAA 781                                                          
						EAQQVLARLQEENQQLRGSLSPCREPGTSLKAPASPQVAALEQDLGKLEEELRAVQATMS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GKSQEIGKLKQLLYQATEEVAELRAREAASLRQHEKTRGSLVAQAQAWGQELKALLEKYN 	      51 CISTLVDRHREAQQVLARLQEENQQLRGSLSPCREPGTSLKAPASPQVAA 100                                                          
						TACREVGRLREAVAEERRRSGDLAAQAAEQERQASEMRGRSEQFEKTAELLKEKMEHLIG 	                  .         .         .         .         .  
						ACRDKEAKIKELLKKLEQLSEEVLAIRGENARLALQLQDSQKNHEEIISTYRNHLLNAAR 	     782 LEQDLGKLEEELRAVQATMSGKSQEIGKLKQLLYQATEEVAELRAREAAS 831                                                          
						GYMEHEVYNILLQILSMEEE                                         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90 % homologous to corresponding to amino acids 1 - 320 of   	     101 LEQDLGKLEEELRAVQATMSGKSQEIGKLKQLLYQATEEVAELRAREAAS 150                                                          
						Q96LS3, which also corresponds to amino acids 682 - 1001 of  	                  .         .         .         .         .  
						AA928325_P1, wherein said first amino acid sequence and      	     832 LRQHEKTRGSLVAQAQAWGQELKALLEKYNTACREVGRLREAVAEERRRS 881                                                          
						second amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for a head of       	     151 LRQHEKTRGSLVAQAQAWGQELKALLEKYNTACREVGRLREAVAEERRRS 200                                                          
						AA928325_P1, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     882 GDLAAQAAEQERQASEMRGRSEQFEKTAELLKEKMEHLIGACRDKEAKIK 931                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MKRIFSCSSTQVAVERWNRHDQKLLEAVHRGDVGRVAALASRKSARPTKLDSNGQSPFHL 	     201 GDLAAQAAEQERQASEMRGRSEQFEKTAELLKEKMEHLIGACRDKEAKIK 250                                                          
						AASKGLTECLTILLANGADINSKNEDGSTALHLATISCQPQCVKVLLQHGANEDAVDAEN 	                  .         .         .         .         .  
						RSPLHWAASSGCASSVLLLCDHEAFLDVLDNDGRTPLMIASLGGHAAICSQLLQRGARVN 	     932 ELLKKLEQLSEEVLAIRGENARLALQLQDSQKNHEEIISTYRNHLLNAAR 981                                                          
						VTDKNDKSALILACEKGSAEVAELLLSHGADAGAVDSTGHDALHYALHTQDKALWRHLQQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ALSRRRRGGQRLVQHPDLASQASPSEPQAGSPPKSSWRAEPEEEQEEKEDEDPCSEEWRW 	     251 ELLKKLEQLSEEVLAIRGENARLALQLQDSQKNHEEIISTYRNHLLNAAR 300                                                          
						KYEEERRKVVRLEQELVQKTEECKTQAAAYLDLENQIREQAQELGVLLSWEPRASGKQGS 	                  .         .                                
						SLRPGGDGMEQGCPKDLLAESTQELKKQQQAAATVNPVLAPKKAEDSAPGKIQYEVHGRS 	     982 GYMEHEVYNILLQILSMEEE                               1001                                                         
						QPEEQGPPQSPASETIRKATGQQLTTNGAQTFGPDHADQLPAGQKESSQVLGVEPGGTVA 	         ||||||||||||||||||||                                
						EPVGPAAMNQLLLQLREELAAVWREKDAARGALSRPVMEGALGTPRAEAAAAAWEKMEAR 	     301 GYMEHEVYNILLQILSMEEE                               320                                                          
						LERVLARLEWAKAGLQVKPEVPSQESREGALKAAPGSIKQDEEKEKRVPGARGEPLGALG 	                                                            
						GEKALGGLAKGQLEKEMSVLRLSNSNLLEELGELGRERQRLQRELQSLSQRLQREFVPKP 	                                                            
						EAQVQLQQLRQSVGLLTNELA                                        	                                                            
						least about 95% homologous to the sequence of AA928325_P1.   	                                                            

22053	HMR136_AA928325_3_tr0_r1_1_gPRT		Comparison report between AA928325_P3 and Q96LS3unique head  	Sequence name: Q96LS3                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA928325_P3, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 22053 x Q96LS3   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MEQGCPKDLLAESTQELKKQQQAAATVNPVLAPKKAEDSAPGKIQYEVHGRSQPEEQGPP 	Alignment segment 1/1:                                       
						QSPASETIRKATGQQLTTNGAQTFGPDHADQLPAGQKESSQVLGVEPGGTVAEPVGPAAM 	                                                            
						NQLLLQLREELAAVWREKDAARGALSRPVMEGALGTPRAEAAAAAWEKMEARLERVLARL 	                     Quality: 3059.00                      Escore:       0                                               
						EWAKAGLQVKPEVPSQESREGALKAAPGSIKQDEEKEKRVPGARGEPLGALGGEKALGGL 	             Matching length:     320                Total length:     320                                               
						AKGQLEKEMSVLRLSNSNLLEELGELGRERQRLQRELQSLSQRLQREFVPKPEAQVQLQQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LRQSVGLLTNELA                                                	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						having the sequence corresponding to amino acids 1 - 313 of  	                        Gaps:       0                        
						AA928325_P3, and a second amino acid sequence being at least 	                                                            
						MEKEATEKLRKLLASQSSGLRGLWDCLPADLVGERSAQSKAAESLEELRACISTLVDRHR 	Alignment:                                                   
						EAQQVLARLQEENQQLRGSLSPCREPGTSLKAPASPQVAALEQDLGKLEEELRAVQATMS 	                  .         .         .         .         .  
						GKSQEIGKLKQLLYQATEEVAELRAREAASLRQHEKTRGSLVAQAQAWGQELKALLEKYN 	     314 MEKEATEKLRKLLASQSSGLRGLWDCLPADLVGERSAQSKAAESLEELRA 363                                                          
						TACREVGRLREAVAEERRRSGDLAAQAAEQERQASEMRGRSEQFEKTAELLKEKMEHLIG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ACRDKEAKIKELLKKLEQLSEEVLAIRGENARLALQLQDSQKNHEEIISTYRNHLLNAAR 	       1 MEKEATEKLRKLLASQSSGLRGLWDCLPADLVGERSAQSKAAESLEELRA 50                                                           
						GYMEHEVYNILLQILSMEEE                                         	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 1 - 320 of   	     364 CISTLVDRHREAQQVLARLQEENQQLRGSLSPCREPGTSLKAPASPQVAA 413                                                          
						Q96LS3, which also corresponds to amino acids 314 - 633 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA928325_P3, wherein said first amino acid sequence and      	      51 CISTLVDRHREAQQVLARLQEENQQLRGSLSPCREPGTSLKAPASPQVAA 100                                                          
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     414 LEQDLGKLEEELRAVQATMSGKSQEIGKLKQLLYQATEEVAELRAREAAS 463                                                          
						AA928325_P3, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     101 LEQDLGKLEEELRAVQATMSGKSQEIGKLKQLLYQATEEVAELRAREAAS 150                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MEQGCPKDLLAESTQELKKQQQAAATVNPVLAPKKAEDSAPGKIQYEVHGRSQPEEQGPP 	     464 LRQHEKTRGSLVAQAQAWGQELKALLEKYNTACREVGRLREAVAEERRRS 513                                                          
						QSPASETIRKATGQQLTTNGAQTFGPDHADQLPAGQKESSQVLGVEPGGTVAEPVGPAAM 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NQLLLQLREELAAVWREKDAARGALSRPVMEGALGTPRAEAAAAAWEKMEARLERVLARL 	     151 LRQHEKTRGSLVAQAQAWGQELKALLEKYNTACREVGRLREAVAEERRRS 200                                                          
						EWAKAGLQVKPEVPSQESREGALKAAPGSIKQDEEKEKRVPGARGEPLGALGGEKALGGL 	                  .         .         .         .         .  
						AKGQLEKEMSVLRLSNSNLLEELGELGRERQRLQRELQSLSQRLQREFVPKPEAQVQLQQ 	     514 GDLAAQAAEQERQASEMRGRSEQFEKTAELLKEKMEHLIGACRDKEAKIK 563                                                          
						LRQSVGLLTNELA                                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of AA928325_P3.   	     201 GDLAAQAAEQERQASEMRGRSEQFEKTAELLKEKMEHLIGACRDKEAKIK 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     564 ELLKKLEQLSEEVLAIRGENARLALQLQDSQKNHEEIISTYRNHLLNAAR 613                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 ELLKKLEQLSEEVLAIRGENARLALQLQDSQKNHEEIISTYRNHLLNAAR 300                                                          
						                                                            	                  .         .                                
						                                                            	     614 GYMEHEVYNILLQILSMEEE                               633                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	     301 GYMEHEVYNILLQILSMEEE                               320                                                          

22178	HMR136_AA928510_1_tr0_r1_1_gPRT		Comparison report between AA928510_P1 and Q8NEE4unique head  	Sequence name: Q8NEE4                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA928510_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 22178 x Q8NEE4   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						MLPCLYYPHSLTSPTPSPVLPNFPRNLCKACGGENICTKSEGARQGAS             	                                                            
						corresponding to amino acids 1 - 48 of AA928510_P1, and a    	                     Quality: 1172.00                      Escore:       0                                               
						MTKRRPDEFSKQSSNTQDTPHPLPRAFCNVAVHVHLPINICHNNPSLTTIIPPSTTNSAP 	             Matching length:     116                Total length:     116                                               
						SLKCPLMGSGFGLCLANYVQRVNINFSFSYSSLMLDSVHHSASCQENHSKSYFLLK     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						second amino acid sequence being at least 90 % homologous to 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 116 of Q8NEE4, which also   	                        Gaps:       0                        
						corresponds to amino acids 49 - 164 of AA928510_P1, wherein  	                                                            
						said first amino acid sequence and second amino acid sequence	Alignment:                                                   
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a head of AA928510_P1, comprising a 	      49 MTKRRPDEFSKQSSNTQDTPHPLPRAFCNVAVHVHLPINICHNNPSLTTI 98                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MTKRRPDEFSKQSSNTQDTPHPLPRAFCNVAVHVHLPINICHNNPSLTTI 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence                                              	      99 IPPSTTNSAPSLKCPLMGSGFGLCLANYVQRVNINFSFSYSSLMLDSVHH 148                                                          
						MLPCLYYPHSLTSPTPSPVLPNFPRNLCKACGGENICTKSEGARQGAS of          	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA928510_P1.                                                 	      51 IPPSTTNSAPSLKCPLMGSGFGLCLANYVQRVNINFSFSYSSLMLDSVHH 100                                                          
						                                                            	                  .                                          
						                                                            	     149 SASCQENHSKSYFLLK                                   164                                                          
						                                                            	         ||||||||||||||||                                    
						                                                            	     101 SASCQENHSKSYFLLK                                   116                                                          

22711	HMR136_AA931684_4_tr0_r1_1_gPRT		Comparison report between AA931684_P4 and CTE7_HUMANunique   	Sequence name: CTE7_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA931684_P4, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22711 x CTE7_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence VARLRFAPAAGA 	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 12 of AA931684_P4, a second 	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality:  280.00                      Escore:       0                                               
						MGLSRVRAVFFDLDNTLIDTAGASRRGMLE corresponding to amino acids 1	             Matching length:      30                Total length:      30                                               
						- 30 of CTE7_HUMAN, which also corresponds to amino acids 13 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						- 42 of AA931684_P4, and a third amino acid sequence being at	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 70%, optionally at least 80%, preferably at least 85%, 	                        Gaps:       0                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment:                                                   
						LQGEREGFIRCGKLTFK corresponding to amino acids 43 - 59 of    	                  .         .         .                      
						AA931684_P4, wherein said first amino acid sequence, second  	      13 MGLSRVRAVFFDLDNTLIDTAGASRRGMLE                     42                                                           
						amino acid sequence and third amino acid sequence are        	         ||||||||||||||||||||||||||||||                      
						contiguous and in a sequential order.2.An isolated           	       1 MGLSRVRAVFFDLDNTLIDTAGASRRGMLE                     30                                                           
						polypeptide encoding for a head of AA931684_P4, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence VARLRFAPAAGA of AA931684_P4.3.An isolated    	                                                            
						polypeptide encoding for a tail of AA931684_P4, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						to the sequence LQGEREGFIRCGKLTFK in AA931684_P4.            	                                                            

25853	HMR136_AA939053_1_tr0_r1_1_gPRT		Comparison report between AA939053_P1 and Q9H5E5unique head  	Sequence name: Q9H5E5                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion and a mismatch.1.An isolated chimeric polypeptide  	Sequence documentation:                                      
						encoding for AA939053_P1, comprising a first amino acid      	                                                            
						sequence being at least 70%, optionally at least 80%,        	Alignment of: 25853 x Q9H5E5   ..                            
						preferably at least 85%, more preferably at least 90% and    	                                                            
						most preferably at least 95% homologous to a polypeptide     	Alignment segment 1/1:                                       
						GVQIPAFGTFTFIRQKLEVGNNKFILIQRPVFIMVEKLVQIHGLKQNKVYTPGEIPIVPL 	                                                            
						NFVMISLEGPFNRDVVEGCVKETLLFLSRSISMKQNVEFTFKGIGVLMIRDSKVKMRFYK 	                     Quality: 3745.00                      Escore:       0                                               
						DFLCTMDGSGALAKALANRPGTVDSVLSSREALRKWPSSVLAFPRIELKE           	             Matching length:     387                Total length:     435                                               
						having the sequence corresponding to amino acids 1 - 170 of  	 Matching Percent Similarity:   99.74   Matching Percent Identity:   99.74                                               
						AA939053_P1, a second amino acid sequence being at least 90 %	    Total Percent Similarity:   88.74      Total Percent Identity:   88.74                                               
						MENKLPMETLVEECGENRERKCKLKDQSDKEEGTRDISSPKRLRDRQALFPAKVTNVSLL 	                        Gaps:       1                        
						EKFERSESGGKIMTPESLSYPSCLKHDSEMKPQTSPACQDHNKAG                	                                                            
						homologous to corresponding to amino acids 1 - 105 of Q9H5E5,	Alignment:                                                   
						which also corresponds to amino acids 171 - 275 of           	                  .         .         .         .         .  
						AA939053_P1, a third amino acid sequence being at least 70%, 	     171 MENKLPMETLVEECGENRERKCKLKDQSDKEEGTRDISSPKRLRDRQALF 220                                                          
						optionally at least 80%, preferably at least 85%, more       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	       1 MENKLPMETLVEECGENRERKCKLKDQSDKEEGTRDISSPKRLRDRQALF 50                                                           
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						QEMCYVCLQRAQRNSLLYYSEERRREIEDERLIQQYQMLKDQEALFRH             	     221 PAKVTNVSLLEKFERSESGGKIMTPESLSYPSCLKHDSEMKPQTSPACQD 270                                                          
						corresponding to amino acids 276 - 323 of AA939053_P1, a     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence being at least 90 % homologous to 	      51 PAKVTNVSLLEKFERSESGGKIMTPESLSYPSCLKHDSEMKPQTSPACQD 100                                                          
						QMKSLATREQNQKNAAYNLGVAEAIRNHKNEKPEFY corresponding to amino  	                  .         .         .         .         .  
						acids 106 - 141 of Q9H5E5, which also corresponds to amino   	     271 HNKAGQEMCYVCLQRAQRNSLLYYSEERRREIEDERLIQQYQMLKDQEAL 320                                                          
						acids 324 - 359 of AA939053_P1, a bridging amino acid K      	         |||||                                               
						corresponding to amino acid 360 of AA939053_P1, and a fifth  	     101 HNKAG............................................. 105                                                          
						SFLFDKRPLSPALNALKQEEYSRSLLKQMDNRQENEIKQRQYRELMDRLEQVQLTEELAA 	                  .         .         .         .         .  
						QRAKFLKDKMEETQCYKRALDAQIKNKPSRLPPFEPDSSEPIFGKNEGELMVEKQKREQN 	     321 FRHQMKSLATREQNQKNAAYNLGVAEAIRNHKNEKPEFYKSFLFDKRPLS 370                                                          
						YMKHQLEAAANHKRKAILHQLVDQRRDLQMLQRTQREHLADRTAELERVNRVNQCLQEDW 	            |||||||||||||||||||||||||||||||||||| ||||||||||  
						ERSAAMKKQRDLEDKAFERASDKLFLLDQCEKYRRCKQCQRRTSNVGESNLWPLNKFLPG 	     106 ...QMKSLATREQNQKNAAYNLGVAEAIRNHKNEKPEFYISFLFDKRPLS 152                                                          
						SRLLV                                                        	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	     371 PALNALKQEEYSRSLLKQMDNRQENEIKQRQYRELMDRLEQVQLTEELAA 420                                                          
						corresponding to amino acids 143 - 387 of Q9H5E5, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 361 - 605 of AA939053_P1, wherein 	     153 PALNALKQEEYSRSLLKQMDNRQENEIKQRQYRELMDRLEQVQLTEELAA 202                                                          
						said first amino acid sequence, second amino acid sequence,  	                  .         .         .         .         .  
						third amino acid sequence, fourth amino acid sequence,       	     421 QRAKFLKDKMEETQCYKRALDAQIKNKPSRLPPFEPDSSEPIFGKNEGEL 470                                                          
						bridging amino acid and fifth amino acid sequence are        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	     203 QRAKFLKDKMEETQCYKRALDAQIKNKPSRLPPFEPDSSEPIFGKNEGEL 252                                                          
						polypeptide encoding for a head of AA939053_P1, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	     471 MVEKQKREQNYMKHQLEAAANHKRKAILHQLVDQRRDLQMLQRTQREHLA 520                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	     253 MVEKQKREQNYMKHQLEAAANHKRKAILHQLVDQRRDLQMLQRTQREHLA 302                                                          
						GVQIPAFGTFTFIRQKLEVGNNKFILIQRPVFIMVEKLVQIHGLKQNKVYTPGEIPIVPL 	                  .         .         .         .         .  
						NFVMISLEGPFNRDVVEGCVKETLLFLSRSISMKQNVEFTFKGIGVLMIRDSKVKMRFYK 	     521 DRTAELERVNRVNQCLQEDWERSAAMKKQRDLEDKAFERASDKLFLLDQC 570                                                          
						DFLCTMDGSGALAKALANRPGTVDSVLSSREALRKWPSSVLAFPRIELKE           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence of AA939053_P1.3.An isolated polypeptide     	     303 DRTAELERVNRVNQCLQEDWERSAAMKKQRDLEDKAFERASDKLFLLDQC 352                                                          
						encoding for an edge portion of AA939053_P1, comprising an   	                  .         .         .                      
						amino acid sequence being at least 70%, optionally at least  	     571 EKYRRCKQCQRRTSNVGESNLWPLNKFLPGSRLLV                605                                                          
						about 80%, preferably at least about 85%, more preferably at 	         |||||||||||||||||||||||||||||||||||                 
						least about 90% and most preferably at least about 95%       	     353 EKYRRCKQCQRRTSNVGESNLWPLNKFLPGSRLLV                387                                                          
						homologous to the sequence encoding for                      	                                                            
						QEMCYVCLQRAQRNSLLYYSEERRREIEDERLIQQYQMLKDQEALFRH,            	                                                            
						corresponding to AA939053_P1.                                	                                                            

27268	HMR136_AA952933_4_tr0_r1_1_gPRT		Comparison report between AA952933_P4 and TX22_HUMANpartial  	Sequence name: TX22_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for AA952933_P4, comprising a first     	                                                            
						MFPSVRVKVKGLDPGKQYHVAIDVVPVDSKRYRYVYHSSQWMVAGNTDHLCIIPRFYVHP 	Alignment of: 27268 x TX22_HUMAN   ..                        
						DSPCSGETWMRQIISFDRMKLTNNEMDDKGHIILQSMHKYKPRVHVIEQGSSVDLSQIQS 	                                                            
						LPTEGVKTFSFKETEFTTVTAYQNQQITKLKIERNPFAKGFRDTGRNRGVLDGLLETYPW 	Alignment segment 1/1:                                       
						RPSFTLDFKTFGADTQSGSSGSSPVTSSGGAPSPLNSLLSPLCFSPMFHLPTSSLGMPCP 	                                                            
						EAYLPNVNLPLCYKICPTNFWQQQPLVLPAPERLASSNSSQSLAPLMMEVPMLSSLGVTN 	                     Quality: 4021.00                      Escore:       0                                               
						SKSGSSEDSSDQYLQAPNSTNQMLYGLQSPGNIFLPNSITPEALSCSFHPSYDFYRYNFS 	             Matching length:     400                Total length:     400                                               
						MPSRLISGSNHLKVNDDSQVSFGEGKCNHVHWYPAINHYL                     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 121 - 520 of TX22_HUMAN, which  	                        Gaps:       0                        
						also corresponds to amino acids 1 - 400 of AA952933_P4.      	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MFPSVRVKVKGLDPGKQYHVAIDVVPVDSKRYRYVYHSSQWMVAGNTDHL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     121 MFPSVRVKVKGLDPGKQYHVAIDVVPVDSKRYRYVYHSSQWMVAGNTDHL 170                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 CIIPRFYVHPDSPCSGETWMRQIISFDRMKLTNNEMDDKGHIILQSMHKY 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     171 CIIPRFYVHPDSPCSGETWMRQIISFDRMKLTNNEMDDKGHIILQSMHKY 220                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 KPRVHVIEQGSSVDLSQIQSLPTEGVKTFSFKETEFTTVTAYQNQQITKL 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     221 KPRVHVIEQGSSVDLSQIQSLPTEGVKTFSFKETEFTTVTAYQNQQITKL 270                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 KIERNPFAKGFRDTGRNRGVLDGLLETYPWRPSFTLDFKTFGADTQSGSS 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     271 KIERNPFAKGFRDTGRNRGVLDGLLETYPWRPSFTLDFKTFGADTQSGSS 320                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GSSPVTSSGGAPSPLNSLLSPLCFSPMFHLPTSSLGMPCPEAYLPNVNLP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     321 GSSPVTSSGGAPSPLNSLLSPLCFSPMFHLPTSSLGMPCPEAYLPNVNLP 370                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LCYKICPTNFWQQQPLVLPAPERLASSNSSQSLAPLMMEVPMLSSLGVTN 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     371 LCYKICPTNFWQQQPLVLPAPERLASSNSSQSLAPLMMEVPMLSSLGVTN 420                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SKSGSSEDSSDQYLQAPNSTNQMLYGLQSPGNIFLPNSITPEALSCSFHP 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     421 SKSGSSEDSSDQYLQAPNSTNQMLYGLQSPGNIFLPNSITPEALSCSFHP 470                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 SYDFYRYNFSMPSRLISGSNHLKVNDDSQVSFGEGKCNHVHWYPAINHYL 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     471 SYDFYRYNFSMPSRLISGSNHLKVNDDSQVSFGEGKCNHVHWYPAINHYL 520                                                          

8129	HMR136_AA961509_6_tr0_r1_1_gPRT		Comparison report between AA961509_P6 and P2X2_HUMANunique   	Sequence name: P2X2_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						AA961509_P6, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 8129 x P2X2_HUMAN   ..                         
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence CSAFLEVGAARA 	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 12 of AA961509_P6, a second 	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 4572.00                      Escore:       0                                               
						MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVW   	             Matching length:     471                Total length:     483                                               
						corresponding to amino acids 1 - 58 of P2X2_HUMAN, which also	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 13 - 70 of AA961509_P6, a third   	    Total Percent Similarity:   97.52      Total Percent Identity:   97.52                                               
						amino acid sequence being at least 70%, optionally at least  	                        Gaps:       1                        
						80%, preferably at least 85%, more preferably at least 90%   	                                                            
						and most preferably at least 95% homologous to a polypeptide 	Alignment:                                                   
						having the sequence VASGAGAAPARR corresponding to amino acids	                  .         .         .         .         .  
						71 - 82 of AA961509_P6, and a fourth amino acid sequence     	      13 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQL 62                                                           
						YVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPV 	       1 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQL 50                                                           
						EDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPI 	                  .         .         .         .         .  
						FKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSG 	      63 LILLYFVWVASGAGAAPARRYVFIVQKSYQESETGPESSIITKVKGITTS 112                                                          
						YNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFL 	         ||||||||            ||||||||||||||||||||||||||||||  
						CDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPP 	      51 LILLYFVW............YVFIVQKSYQESETGPESSIITKVKGITTS 88                                                           
						SGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL        	                  .         .         .         .         .  
						being at least 90 % homologous to corresponding to amino     	     113 EHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLS 162                                                          
						acids 59 - 471 of P2X2_HUMAN, which also corresponds to amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 83 - 495 of AA961509_P6, wherein said first amino acid 	      89 EHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLS 138                                                          
						sequence, second amino acid sequence, third amino acid       	                  .         .         .         .         .  
						sequence and fourth amino acid sequence are contiguous and in	     163 DADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFL 212                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of AA961509_P6, comprising a polypeptide being at least 	     139 DADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFL 188                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     213 GTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPI 262                                                          
						at least about 95% homologous to the sequence CSAFLEVGAARA of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA961509_P6.3.An isolated polypeptide encoding for an edge   	     189 GTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPI 238                                                          
						portion of AA961509_P6, comprising an amino acid sequence    	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     263 FKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRL 312                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 95% homologous to the sequence	     239 FKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRL 288                                                          
						encoding for VASGAGAAPARR, corresponding to AA961509_P6.     	                  .         .         .         .         .  
						                                                            	     313 DPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSL 362                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     289 DPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSL 338                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     363 IPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPS 412                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     339 IPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPS 388                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     413 GSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRP 462                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     389 GSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRP 438                                                          
						                                                            	                  .         .         .                      
						                                                            	     463 CPISAPSEQMVDTPASEPAQASTPTDPKGLAQL                  495                                                          
						                                                            	         |||||||||||||||||||||||||||||||||                   
						                                                            	     439 CPISAPSEQMVDTPASEPAQASTPTDPKGLAQL                  471                                                          

8133	HMR136_AA961509_7_tr0_r1_1_gPRT		Comparison report between AA961509_P7 and P2X2_HUMANunique   	Sequence name: P2X2_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA961509_P7, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 8133 x P2X2_HUMAN   ..                         
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						LQRLPGGGGRPRHGRRPAQVPRRGDRPAPGPGLLVRPLGLRDAQGDRGEEPAPGGPVPRR 	Alignment segment 1/1:                                       
						AAAHPALLRV                                                   	                                                            
						having the sequence corresponding to amino acids 1 - 70 of   	                     Quality: 4045.00                      Escore:       0                                               
						AA961509_P7, and a second amino acid sequence being at least 	             Matching length:     407                Total length:     407                                               
						KSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						CPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASV 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						SQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFI 	                        Gaps:       0                        
						VEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFA 	                                                            
						KYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILL 	Alignment:                                                   
						TFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQ 	                  .         .         .         .         .  
						QGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL              	      71 KSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRV 120                                                          
						90 % homologous to corresponding to amino acids 65 - 471 of  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						P2X2_HUMAN, which also corresponds to amino acids 71 - 477 of	      65 KSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRV 114                                                          
						AA961509_P7, wherein said first amino acid sequence and      	                  .         .         .         .         .  
						second amino acid sequence are contiguous and in a sequential	     121 EATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQ 170                                                          
						order.2.An isolated polypeptide encoding for a head of       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AA961509_P7, comprising a polypeptide being at least 70%,    	     115 EATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQ 164                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     171 GPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGN 220                                                          
						LQRLPGGGGRPRHGRRPAQVPRRGDRPAPGPGLLVRPLGLRDAQGDRGEEPAPGGPVPRR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AAAHPALLRV                                                   	     165 GPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGN 214                                                          
						least about 95% homologous to the sequence of AA961509_P7.   	                  .         .         .         .         .  
						                                                            	     221 IADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGV 270                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     215 IADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGV 264                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     271 IINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTT 320                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     265 IINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTT 314                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     321 RTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILL 370                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     315 RTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILL 364                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     371 TFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQH 420                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     365 TFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQH 414                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     421 PSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTD 470                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     415 PSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTD 464                                                          
						                                                            	                                                             
						                                                            	     471 PKGLAQL                                            477                                                          
						                                                            	         |||||||                                             
						                                                            	     465 PKGLAQL                                            471                                                          

8131	HMR136_AA961509_8_tr0_r1_1_gPRT		Comparison report between AA961509_P8 and P2X2_HUMANpartial  	Sequence name: P2X2_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for AA961509_P8, comprising a first     	                                                            
						MLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKF 	Alignment of: 8131 x P2X2_HUMAN   ..                         
						HFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINW 	                                                            
						DCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVI 	Alignment segment 1/1:                                       
						VHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPS 	                                                            
						GSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQM 	                     Quality: 3225.00                      Escore:       0                                               
						VDTPASEPAQASTPTDPKGLAQL                                      	             Matching length:     323                Total length:     323                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 149 - 471 of P2X2_HUMAN, which  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						also corresponds to amino acids 1 - 323 of AA961509_P8.      	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTIL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     149 MLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTIL 198                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 IKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     199 IKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKA 248                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 GESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSG 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     249 GESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSG 298                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 YNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     299 YNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATA 348                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 LTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARV 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     349 LTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARV 398                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 LGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQM 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     399 LGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQM 448                                                          
						                                                            	                  .         .                                
						                                                            	     301 VDTPASEPAQASTPTDPKGLAQL                            323                                                          
						                                                            	         |||||||||||||||||||||||                             
						                                                            	     449 VDTPASEPAQASTPTDPKGLAQL                            471                                                          

12017	HMR136_AA972667_0_tr0_r1_1_gPRT		Comparison report between AA972667_P0 and Q96NW7partial WT   	Sequence name: Q96NW7                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for AA972667_P0, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MHKLAQLERLDLGNNEF corresponding to amino acids 180 - 196 of  	Alignment of: 12017 x Q96NW7   ..                            
						Q96NW7, which also corresponds to amino acids 1 - 17 of      	                                                            
						AA972667_P0, a bridging amino acid S corresponding to amino  	Alignment segment 1/1:                                       
						acid 18 of AA972667_P0, and a second amino acid sequence     	                                                            
						ELPEVLDQIQNLRELWMDNNALQVLPGSIGKLKMLVYLDMSKNRIETVDMDISGCEALED 	                     Quality: 13486.00                      Escore:       0                                              
						LLLSSNMLQQLPDSIGLLKKLTTLKVDDNQLTMLPNTIGNLSLLEEFDCSCNELESLPST 	             Matching length:    1358                Total length:    1358                                               
						IGYLHSLRTLAVDENFLPELPREIGSCKNVTVMSLRSNKLEFLPEEIGQMQKLRVLNLSD 	 Matching Percent Similarity:   99.93   Matching Percent Identity:   99.93                                               
						NRLKNLPFSFTKLKELAALWLSDNQSKALIPLQTEAHPETKQRVLTNYMFPQQPRGDEDF 	    Total Percent Similarity:   99.93      Total Percent Identity:   99.93                                               
						QSDSDSFNPTLWEEQRQQRMTVAFEFEDKKEDDENAGKVKDLSCQAPWERGQRGITLQPA 	                        Gaps:       0                        
						RLSGDCCTPWARCDQQIQDMPVPQNDPQLAWGCISGLQQERSMCTPLPVAAQSTTLPSLS 	                                                            
						GRQVEINLKRYPTPYPEDLKNMVKSVQNLVGKPSHGVRVENSNPTANTEQTVKEKYEHKW 	Alignment:                                                   
						PVAPKEITVEDSFVHPANEMRIGELHPSLAETPLYPPKLVLLGKDKKESTDESEVDKTHC 	                  .         .         .         .         .  
						LNNSVSSGTYSDYSPSQASSGSSNTRVKVGSLQTTAKDAVHNSLWGNRIAPSFPQPLDSK 	       1 MHKLAQLERLDLGNNEFSELPEVLDQIQNLRELWMDNNALQVLPGSIGKL 50                                                           
						PLLSQREAVPPGNIPQRPDRLPMSDTFTDNWTDGSHYDNTGFVAEETTAENANSNPLLSS 	         ||||||||||||||||| ||||||||||||||||||||||||||||||||  
						KSRSTSSHGRRPLIRQDRIVGVPLELEQSTHRHTPETEVPPSNPWQNWTRTPSPFEDRTA 	     180 MHKLAQLERLDLGNNEFGELPEVLDQIQNLRELWMDNNALQVLPGSIGKL 229                                                          
						FPSKLETTPTTSPLPERKEHIKESTEIPSPFSPGVPWEYHDSNPNRSLSNVFSQIHCRPE 	                  .         .         .         .         .  
						SSKGVISISKSTERLSPLMKDIKSNKFKKSQSIDEIDIGTYKVYNIPLENYASGSDHLGS 	      51 KMLVYLDMSKNRIETVDMDISGCEALEDLLLSSNMLQQLPDSIGLLKKLT 100                                                          
						HERPDKMLGPEHGMSSMSRSQSVPMLDDEMLTYGSSKGPQQQKASMTKKVYQFDQSFNPQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GSVEVKAEKRIPPPFQHNPEYVQQASKNIAKDLISPRAYRGYPPMEQMFSFSQPSVNEDA 	     230 KMLVYLDMSKNRIETVDMDISGCEALEDLLLSSNMLQQLPDSIGLLKKLT 279                                                          
						VVNAQFASQGARAGFLRRADSLVSATEMAMFRRVNEPHELPPTDRYGRPPYRGGLDRQSS 	                  .         .         .         .         .  
						VTVTESQFLKRNGRYEDEHPSYQEVKAQAGSFPVKNLTQRRPLSARSYSTESYGASQTRP 	     101 TLKVDDNQLTMLPNTIGNLSLLEEFDCSCNELESLPSTIGYLHSLRTLAV 150                                                          
						VSARPTMAALLEKIPSDYNLGNYGDKPSDNSDLKTRPTPVKGEESCGKMPADWRQQLLRH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IEARRLDRNAAYKHNTVNLGMLPYGGISAMHAGRSMTLNLQTKSKFDHQELPLQKTPSQQ 	     280 TLKVDDNQLTMLPNTIGNLSLLEEFDCSCNELESLPSTIGYLHSLRTLAV 329                                                          
						SNILDNGQEDVSPSGQWNPYPLGRRDVPPDTITKKAGSHIQTLMGSQSLQHRSREQQPYE 	                  .         .         .         .         .  
						GNINKVTIQQFQSPLPIQIPSSQATRGPQPGRCLIQTKGQRSMDGYPEQFCVRIEKNPGL 	     151 DENFLPELPREIGSCKNVTVMSLRSNKLEFLPEEIGQMQKLRVLNLSDNR 200                                                          
						GFSISGGISGQGNPFKPSDKGIFVTRVQPDGPASNLLQPGDKILQANGHSFVHMEHEKAV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LLLKSFQNTVDLVIQRELTV                                         	     330 DENFLPELPREIGSCKNVTVMSLRSNKLEFLPEEIGQMQKLRVLNLSDNR 379                                                          
						being at least 90 % homologous to corresponding to amino     	                  .         .         .         .         .  
						acids 198 - 1537 of Q96NW7, which also corresponds to amino  	     201 LKNLPFSFTKLKELAALWLSDNQSKALIPLQTEAHPETKQRVLTNYMFPQ 250                                                          
						acids 19 - 1358 of AA972667_P0, wherein said first amino acid	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, bridging amino acid and second amino acid sequence 	     380 LKNLPFSFTKLKELAALWLSDNQSKALIPLQTEAHPETKQRVLTNYMFPQ 429                                                          
						are contiguous and in a sequential order.                    	                  .         .         .         .         .  
						                                                            	     251 QPRGDEDFQSDSDSFNPTLWEEQRQQRMTVAFEFEDKKEDDENAGKVKDL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     430 QPRGDEDFQSDSDSFNPTLWEEQRQQRMTVAFEFEDKKEDDENAGKVKDL 479                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SCQAPWERGQRGITLQPARLSGDCCTPWARCDQQIQDMPVPQNDPQLAWG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     480 SCQAPWERGQRGITLQPARLSGDCCTPWARCDQQIQDMPVPQNDPQLAWG 529                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 CISGLQQERSMCTPLPVAAQSTTLPSLSGRQVEINLKRYPTPYPEDLKNM 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     530 CISGLQQERSMCTPLPVAAQSTTLPSLSGRQVEINLKRYPTPYPEDLKNM 579                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VKSVQNLVGKPSHGVRVENSNPTANTEQTVKEKYEHKWPVAPKEITVEDS 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     580 VKSVQNLVGKPSHGVRVENSNPTANTEQTVKEKYEHKWPVAPKEITVEDS 629                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 FVHPANEMRIGELHPSLAETPLYPPKLVLLGKDKKESTDESEVDKTHCLN 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     630 FVHPANEMRIGELHPSLAETPLYPPKLVLLGKDKKESTDESEVDKTHCLN 679                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 NSVSSGTYSDYSPSQASSGSSNTRVKVGSLQTTAKDAVHNSLWGNRIAPS 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     680 NSVSSGTYSDYSPSQASSGSSNTRVKVGSLQTTAKDAVHNSLWGNRIAPS 729                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 FPQPLDSKPLLSQREAVPPGNIPQRPDRLPMSDTFTDNWTDGSHYDNTGF 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     730 FPQPLDSKPLLSQREAVPPGNIPQRPDRLPMSDTFTDNWTDGSHYDNTGF 779                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 VAEETTAENANSNPLLSSKSRSTSSHGRRPLIRQDRIVGVPLELEQSTHR 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     780 VAEETTAENANSNPLLSSKSRSTSSHGRRPLIRQDRIVGVPLELEQSTHR 829                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 HTPETEVPPSNPWQNWTRTPSPFEDRTAFPSKLETTPTTSPLPERKEHIK 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     830 HTPETEVPPSNPWQNWTRTPSPFEDRTAFPSKLETTPTTSPLPERKEHIK 879                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 ESTEIPSPFSPGVPWEYHDSNPNRSLSNVFSQIHCRPESSKGVISISKST 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     880 ESTEIPSPFSPGVPWEYHDSNPNRSLSNVFSQIHCRPESSKGVISISKST 929                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 ERLSPLMKDIKSNKFKKSQSIDEIDIGTYKVYNIPLENYASGSDHLGSHE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     930 ERLSPLMKDIKSNKFKKSQSIDEIDIGTYKVYNIPLENYASGSDHLGSHE 979                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 RPDKMLGPEHGMSSMSRSQSVPMLDDEMLTYGSSKGPQQQKASMTKKVYQ 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     980 RPDKMLGPEHGMSSMSRSQSVPMLDDEMLTYGSSKGPQQQKASMTKKVYQ 1029                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     851 FDQSFNPQGSVEVKAEKRIPPPFQHNPEYVQQASKNIAKDLISPRAYRGY 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1030 FDQSFNPQGSVEVKAEKRIPPPFQHNPEYVQQASKNIAKDLISPRAYRGY 1079                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     901 PPMEQMFSFSQPSVNEDAVVNAQFASQGARAGFLRRADSLVSATEMAMFR 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1080 PPMEQMFSFSQPSVNEDAVVNAQFASQGARAGFLRRADSLVSATEMAMFR 1129                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     951 RVNEPHELPPTDRYGRPPYRGGLDRQSSVTVTESQFLKRNGRYEDEHPSY 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1130 RVNEPHELPPTDRYGRPPYRGGLDRQSSVTVTESQFLKRNGRYEDEHPSY 1179                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 QEVKAQAGSFPVKNLTQRRPLSARSYSTESYGASQTRPVSARPTMAALLE 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1180 QEVKAQAGSFPVKNLTQRRPLSARSYSTESYGASQTRPVSARPTMAALLE 1229                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 KIPSDYNLGNYGDKPSDNSDLKTRPTPVKGEESCGKMPADWRQQLLRHIE 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1230 KIPSDYNLGNYGDKPSDNSDLKTRPTPVKGEESCGKMPADWRQQLLRHIE 1279                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 ARRLDRNAAYKHNTVNLGMLPYGGISAMHAGRSMTLNLQTKSKFDHQELP 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1280 ARRLDRNAAYKHNTVNLGMLPYGGISAMHAGRSMTLNLQTKSKFDHQELP 1329                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 LQKTPSQQSNILDNGQEDVSPSGQWNPYPLGRRDVPPDTITKKAGSHIQT 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1330 LQKTPSQQSNILDNGQEDVSPSGQWNPYPLGRRDVPPDTITKKAGSHIQT 1379                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 LMGSQSLQHRSREQQPYEGNINKVTIQQFQSPLPIQIPSSQATRGPQPGR 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1380 LMGSQSLQHRSREQQPYEGNINKVTIQQFQSPLPIQIPSSQATRGPQPGR 1429                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 CLIQTKGQRSMDGYPEQFCVRIEKNPGLGFSISGGISGQGNPFKPSDKGI 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1430 CLIQTKGQRSMDGYPEQFCVRIEKNPGLGFSISGGISGQGNPFKPSDKGI 1479                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1301 FVTRVQPDGPASNLLQPGDKILQANGHSFVHMEHEKAVLLLKSFQNTVDL 1350                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1480 FVTRVQPDGPASNLLQPGDKILQANGHSFVHMEHEKAVLLLKSFQNTVDL 1529                                                         
						                                                            	                                                             
						                                                            	    1351 VIQRELTV                                           1358                                                         
						                                                            	         ||||||||                                            
						                                                            	    1530 VIQRELTV                                           1537                                                         

						Comparison report between AA972667_P0 and Q9P2I2unique head  	Sequence name: Q9P2I2                                        
						followed by partial WT sequence followed by a unique         	                                                            
						insertion.1.An isolated chimeric polypeptide encoding for    	Sequence documentation:                                      
						AA972667_P0, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 12017 x Q9P2I2   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						MHKLAQLERLDLGNNEFSELPEVLDQIQNLRELWMDNNALQVLPGSIGKLKMLVYLDMSK 	Alignment segment 1/1:                                       
						NRIETVDMDISGCEALEDLLLSSNMLQQLPDSIGLLKKLTTLKVDDNQLTMLPNTIGNLS 	                                                            
						LLEEFDCSCNELESLPSTIGYLHSLRTLAVDENFLPELPREIGSCKNVTVMSLRSNKLEF 	                     Quality: 8149.00                      Escore:       0                                               
						LPEEIGQMQKLRVLNLSDNRLKNLPFSFTKLKELAALWLSDNQSKALIPLQTEAHPETKQ 	             Matching length:     831                Total length:     878                                               
						RVLTNYMFPQQPRGDEDFQSDSDSFNPTLWEEQRQQRMTVAFEFEDKKEDDENAGKVKDL 	 Matching Percent Similarity:   99.88   Matching Percent Identity:   99.76                                               
						SCQAPWERGQRGITLQPARLSGDCCTPWARCDQQIQDMPVPQNDPQLAWGCISGLQQERS 	    Total Percent Similarity:   94.53      Total Percent Identity:   94.42                                               
						MCTPLPVAAQSTTLPSLSGRQVEINLKRYPTPYPEDLKNMVKSVQNLVGKPSHGVRVENS 	                        Gaps:       1                        
						NPTANTEQTVKEKYEHKWPVAPKEITVEDSFVHPANEMRIGELHPSLAETPLYPPKLVLL 	                                                            
						GKD                                                          	Alignment:                                                   
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 1 - 483 of AA972667_P0, a second amino acid   	     481 GKDKKESTDESEVDKTHCLNNSVSSGTYSDYSPSQASSGSSNTRVKVGSL 530                                                          
						KKESTDESEVDKTHCLNNSVSSGTYSDYSPSQASSGSSNTRVKVGSLQTTAKDAVHNSLW 	         |: |||||||||||||||||||||||||||||||||||||||||||||||  
						GNRIAPSFPQPLDSKPLLSQREAVPPGNIPQRPDRLPMSDTFTDNWTDGSHYDNTGFVAE 	       1 GRTKKESTDESEVDKTHCLNNSVSSGTYSDYSPSQASSGSSNTRVKVGSL 50                                                           
						ETTAENANSNPLLSSKSRSTSSHGRRPLIRQDRIVGVPLELEQSTHRHTPETEVPPSNPW 	                  .         .         .         .         .  
						QNWTRTPSPFEDRTAFPSKLETTPTTSPLPERKEHIKESTEIPSPFSPGVPWEYHDSNPN 	     531 QTTAKDAVHNSLWGNRIAPSFPQPLDSKPLLSQREAVPPGNIPQRPDRLP 580                                                          
						RSLSNVFSQIHCRPESSKGVISISKSTERLSPLMKDIKSNKFKKSQSIDEIDIGTYKVYN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IPLENYASGSDHLGSHERPDKMLGPEHGMSSMSRSQSVPMLDDEMLTYGSSKGPQQQKAS 	      51 QTTAKDAVHNSLWGNRIAPSFPQPLDSKPLLSQREAVPPGNIPQRPDRLP 100                                                          
						MTKKVYQFDQSFNPQGSVEVKAEKRIPPPFQHNPEYVQQASKNIAKDLISPRAYRGYPPM 	                  .         .         .         .         .  
						EQMFSFSQPSVNEDAVVNAQFASQGARAGFLRRADSLVSATEMAMFRRVNEPHELPPTDR 	     581 MSDTFTDNWTDGSHYDNTGFVAEETTAENANSNPLLSSKSRSTSSHGRRP 630                                                          
						YGRPPYRGGLDRQSSVTVTESQFLKRNGRYEDEHPSYQEVKAQAGSFPVKNLTQRRPLSA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RSYSTESYGASQTRPVSARPTMAALLEKIPSDYNLGNYGDKPSDNSDLKTRPTPVKGEES 	     101 MSDTFTDNWTDGSHYDNTGFVAEETTAENANSNPLLSSKSRSTSSHGRRP 150                                                          
						CGKMPADWRQQLLRHIEARRLDR                                      	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     631 LIRQDRIVGVPLELEQSTHRHTPETEVPPSNPWQNWTRTPSPFEDRTAFP 680                                                          
						amino acids 4 - 626 of Q9P2I2, which also corresponds to     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 484 - 1106 of AA972667_P0, a third amino acid    	     151 LIRQDRIVGVPLELEQSTHRHTPETEVPPSNPWQNWTRTPSPFEDRTAFP 200                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     681 SKLETTPTTSPLPERKEHIKESTEIPSPFSPGVPWEYHDSNPNRSLSNVF 730                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence                                          	     201 SKLETTPTTSPLPERKEHIKESTEIPSPFSPGVPWEYHDSNPNRSLSNVF 250                                                          
						NAAYKHNTVNLGMLPYGGISAMHAGRSMTLNLQTKSKFDHQELPLQK corresponding	                  .         .         .         .         .  
						to amino acids 1107 - 1153 of AA972667_P0, and a fourth amino	     731 SQIHCRPESSKGVISISKSTERLSPLMKDIKSNKFKKSQSIDEIDIGTYK 780                                                          
						TPSQQSNILDNGQEDVSPSGQWNPYPLGRRDVPPDTITKKAGSHIQTLMGSQSLQHRSRE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QQPYEGNINKVTIQQFQSPLPIQIPSSQATRGPQPGRCLIQTKGQRSMDGYPEQFCVRIE 	     251 SQIHCRPESSKGVISISKSTERLSPLMKDIKSNKFKKSQSIDEIDIGTYK 300                                                          
						KNPGLGFSISGGISGQGNPFKPSDKGIFVTRVQPDGPASNLLQPGDKILQANGHSFVHME 	                  .         .         .         .         .  
						HEKAVLLLKSFQNTVDLVIQRELTV                                    	     781 VYNIPLENYASGSDHLGSHERPDKMLGPEHGMSSMSRSQSVPMLDDEMLT 830                                                          
						acid sequence being at least 90 % homologous to corresponding	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 627 - 831 of Q9P2I2, which also corresponds to	     301 VYNIPLENYASGSDHLGSHERPDKMLGPEHGMSSMSRSQSVPMLDDEMLT 350                                                          
						amino acids 1154 - 1358 of AA972667_P0, wherein said first   	                  .         .         .         .         .  
						amino acid sequence, second amino acid sequence, third amino 	     831 YGSSKGPQQQKASMTKKVYQFDQSFNPQGSVEVKAEKRIPPPFQHNPEYV 880                                                          
						acid sequence and fourth amino acid sequence are contiguous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						and in a sequential order.2.An isolated polypeptide encoding 	     351 YGSSKGPQQQKASMTKKVYQFDQSFNPQGSVEVKAEKRIPPPFQHNPEYV 400                                                          
						for a head of AA972667_P0, comprising a polypeptide being at 	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	     881 QQASKNIAKDLISPRAYRGYPPMEQMFSFSQPSVNEDAVVNAQFASQGAR 930                                                          
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MHKLAQLERLDLGNNEFSELPEVLDQIQNLRELWMDNNALQVLPGSIGKLKMLVYLDMSK 	     401 QQASKNIAKDLISPRAYRGYPPMEQMFSFSQPSVNEDAVVNAQFASQGAR 450                                                          
						NRIETVDMDISGCEALEDLLLSSNMLQQLPDSIGLLKKLTTLKVDDNQLTMLPNTIGNLS 	                  .         .         .         .         .  
						LLEEFDCSCNELESLPSTIGYLHSLRTLAVDENFLPELPREIGSCKNVTVMSLRSNKLEF 	     931 AGFLRRADSLVSATEMAMFRRVNEPHELPPTDRYGRPPYRGGLDRQSSVT 980                                                          
						LPEEIGQMQKLRVLNLSDNRLKNLPFSFTKLKELAALWLSDNQSKALIPLQTEAHPETKQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RVLTNYMFPQQPRGDEDFQSDSDSFNPTLWEEQRQQRMTVAFEFEDKKEDDENAGKVKDL 	     451 AGFLRRADSLVSATEMAMFRRVNEPHELPPTDRYGRPPYRGGLDRQSSVT 500                                                          
						SCQAPWERGQRGITLQPARLSGDCCTPWARCDQQIQDMPVPQNDPQLAWGCISGLQQERS 	                  .         .         .         .         .  
						MCTPLPVAAQSTTLPSLSGRQVEINLKRYPTPYPEDLKNMVKSVQNLVGKPSHGVRVENS 	     981 VTESQFLKRNGRYEDEHPSYQEVKAQAGSFPVKNLTQRRPLSARSYSTES 1030                                                         
						NPTANTEQTVKEKYEHKWPVAPKEITVEDSFVHPANEMRIGELHPSLAETPLYPPKLVLL 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GKD                                                          	     501 VTESQFLKRNGRYEDEHPSYQEVKAQAGSFPVKNLTQRRPLSARSYSTES 550                                                          
						preferably at least about 95% homologous to the sequence of  	                  .         .         .         .         .  
						AA972667_P0.3.An isolated polypeptide encoding for an edge   	    1031 YGASQTRPVSARPTMAALLEKIPSDYNLGNYGDKPSDNSDLKTRPTPVKG 1080                                                         
						portion of AA972667_P0, comprising an amino acid sequence    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     551 YGASQTRPVSARPTMAALLEKIPSDYNLGNYGDKPSDNSDLKTRPTPVKG 600                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .         .         .  
						most preferably at least about 95% homologous to the sequence	    1081 EESCGKMPADWRQQLLRHIEARRLDRNAAYKHNTVNLGMLPYGGISAMHA 1130                                                         
						encoding for NAAYKHNTVNLGMLPYGGISAMHAGRSMTLNLQTKSKFDHQELPLQK,	         ||||||||||||||||||||||||||                          
						corresponding to AA972667_P0.                                	     601 EESCGKMPADWRQQLLRHIEARRLDR........................ 626                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1131 GRSMTLNLQTKSKFDHQELPLQKTPSQQSNILDNGQEDVSPSGQWNPYPL 1180                                                         
						                                                            	                                |||||||||||||||||||||||||||  
						                                                            	     627 .......................TPSQQSNILDNGQEDVSPSGQWNPYPL 653                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1181 GRRDVPPDTITKKAGSHIQTLMGSQSLQHRSREQQPYEGNINKVTIQQFQ 1230                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     654 GRRDVPPDTITKKAGSHIQTLMGSQSLQHRSREQQPYEGNINKVTIQQFQ 703                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1231 SPLPIQIPSSQATRGPQPGRCLIQTKGQRSMDGYPEQFCVRIEKNPGLGF 1280                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     704 SPLPIQIPSSQATRGPQPGRCLIQTKGQRSMDGYPEQFCVRIEKNPGLGF 753                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1281 SISGGISGQGNPFKPSDKGIFVTRVQPDGPASNLLQPGDKILQANGHSFV 1330                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     754 SISGGISGQGNPFKPSDKGIFVTRVQPDGPASNLLQPGDKILQANGHSFV 803                                                          
						                                                            	                  .         .                                
						                                                            	    1331 HMEHEKAVLLLKSFQNTVDLVIQRELTV                       1358                                                         
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     804 HMEHEKAVLLLKSFQNTVDLVIQRELTV                       831                                                          

12019	HMR136_AA972667_1_tr0_r1_1_gPRT		Comparison report between AA972667_P1 and Q96NW7partial WT   	Sequence name: Q96NW7                                        
						sequence followed by mismatch and a featuring a skipped      	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AA972667_P1, comprising a first amino acid sequence being at 	                                                            
						least 90 % homologous to MHKLAQLERLDLGNNEF corresponding to  	Alignment of: 12019 x Q96NW7   ..                            
						amino acids 180 - 196 of Q96NW7, which also corresponds to   	                                                            
						amino acids 1 - 17 of AA972667_P1, a bridging amino acid S   	Alignment segment 1/1:                                       
						corresponding to amino acid 18 of AA972667_P1, a second amino	                                                            
						ELPEVLDQIQNLRELWMDNNALQVLPGSIGKLKMLVYLDMSKNRIETVDMDISGCEALED 	                     Quality: 12919.00                      Escore:       0                                              
						LLLSSNMLQQLPDSIGLLKKLTTLKVDDNQLTMLPNTIGNLSLLEEFDCSCNELESLPST 	             Matching length:    1311                Total length:    1358                                               
						IGYLHSLRTLAVDENFLPELPREIGSCKNVTVMSLRSNKLEFLPEEIGQMQKLRVLNLSD 	 Matching Percent Similarity:   99.92   Matching Percent Identity:   99.92                                               
						NRLKNLPFSFTKLKELAALWLSDNQSKALIPLQTEAHPETKQRVLTNYMFPQQPRGDEDF 	    Total Percent Similarity:   96.47      Total Percent Identity:   96.47                                               
						QSDSDSFNPTLWEEQRQQRMTVAFEFEDKKEDDENAGKVKDLSCQAPWERGQRGITLQPA 	                        Gaps:       1                        
						RLSGDCCTPWARCDQQIQDMPVPQNDPQLAWGCISGLQQERSMCTPLPVAAQSTTLPSLS 	                                                            
						GRQVEINLKRYPTPYPEDLKNMVKSVQNLVGKPSHGVRVENSNPTANTEQTVKEKYEHKW 	Alignment:                                                   
						PVAPKEITVEDSFVHPANEMRIGELHPSLAETPLYPPKLVLLGKDKKESTDESEVDKTHC 	                  .         .         .         .         .  
						LNNSVSSGTYSDYSPSQASSGSSNTRVKVGSLQTTAKDAVHNSLWGNRIAPSFPQPLDSK 	       1 MHKLAQLERLDLGNNEFSELPEVLDQIQNLRELWMDNNALQVLPGSIGKL 50                                                           
						PLLSQREAVPPGNIPQRPDRLPMSDTFTDNWTDGSHYDNTGFVAEETTAENANSNPLLSS 	         ||||||||||||||||| ||||||||||||||||||||||||||||||||  
						KSRSTSSHGRRPLIRQDRIVGVPLELEQSTHRHTPETEVPPSNPWQNWTRTPSPFEDRTA 	     180 MHKLAQLERLDLGNNEFGELPEVLDQIQNLRELWMDNNALQVLPGSIGKL 229                                                          
						FPSKLETTPTTSPLPERKEHIKESTEIPSPFSPGVPWEYHDSNPNRSLSNVFSQIHCRPE 	                  .         .         .         .         .  
						SSKGVISISKSTERLSPLMKDIKSNKFKKSQSIDEIDIGTYKVYNIPLENYASGSDHLGS 	      51 KMLVYLDMSKNRIETVDMDISGCEALEDLLLSSNMLQQLPDSIGLLKKLT 100                                                          
						HERPDKMLGPEHGMSSMSRSQSVPMLDDEMLTYGSSKGPQQQKASMTKKVYQFDQSFNPQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GSVEVKAEKRIPPPFQHNPEYVQQASKNIAKDLISPRAYRGYPPMEQMFSFSQPSVNEDA 	     230 KMLVYLDMSKNRIETVDMDISGCEALEDLLLSSNMLQQLPDSIGLLKKLT 279                                                          
						VVNAQFASQGARAGFLRRADSLVSATEMAMFRRVNEPHELPPTDRYGRPPYRGGLDRQSS 	                  .         .         .         .         .  
						VTVTESQFLKRNGRYEDEHPSYQEVKAQAGSFPVKNLTQRRPLSARSYSTESYGASQTRP 	     101 TLKVDDNQLTMLPNTIGNLSLLEEFDCSCNELESLPSTIGYLHSLRTLAV 150                                                          
						VSARPTMAALLEKIPSDYNLGNYGDKPSDNSDLKTRPTPVKGEESCGKMPADWRQQLLRH 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IEARRLDR                                                     	     280 TLKVDDNQLTMLPNTIGNLSLLEEFDCSCNELESLPSTIGYLHSLRTLAV 329                                                          
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 198 - 1285 of Q96NW7, which also corresponds  	     151 DENFLPELPREIGSCKNVTVMSLRSNKLEFLPEEIGQMQKLRVLNLSDNR 200                                                          
						to amino acids 19 - 1106 of AA972667_P1, and a third amino   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TPSQQSNILDNGQEDVSPSGQWNPYPLGRRDVPPDTITKKAGSHIQTLMGSQSLQHRSRE 	     330 DENFLPELPREIGSCKNVTVMSLRSNKLEFLPEEIGQMQKLRVLNLSDNR 379                                                          
						QQPYEGNINKVTIQQFQSPLPIQIPSSQATRGPQPGRCLIQTKGQRSMDGYPEQFCVRIE 	                  .         .         .         .         .  
						KNPGLGFSISGGISGQGNPFKPSDKGIFVTRVQPDGPASNLLQPGDKILQANGHSFVHME 	     201 LKNLPFSFTKLKELAALWLSDNQSKALIPLQTEAHPETKQRVLTNYMFPQ 250                                                          
						HEKAVLLLKSFQNTVDLVIQRELTV                                    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence being at least 90 % homologous to corresponding	     380 LKNLPFSFTKLKELAALWLSDNQSKALIPLQTEAHPETKQRVLTNYMFPQ 429                                                          
						to amino acids 1333 - 1537 of Q96NW7, which also corresponds 	                  .         .         .         .         .  
						to amino acids 1107 - 1311 of AA972667_P1, wherein said first	     251 QPRGDEDFQSDSDSFNPTLWEEQRQQRMTVAFEFEDKKEDDENAGKVKDL 300                                                          
						amino acid sequence, bridging amino acid, second amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     430 QPRGDEDFQSDSDSFNPTLWEEQRQQRMTVAFEFEDKKEDDENAGKVKDL 479                                                          
						a sequential order.2.An isolated chimeric polypeptide        	                  .         .         .         .         .  
						encoding for an edge portion of AA972667_P1, comprising a    	     301 SCQAPWERGQRGITLQPARLSGDCCTPWARCDQQIQDMPVPQNDPQLAWG 350                                                          
						polypeptide having a length "n", wherein n is at least about 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						10 amino acids in length, optionally at least about 20 amino 	     480 SCQAPWERGQRGITLQPARLSGDCCTPWARCDQQIQDMPVPQNDPQLAWG 529                                                          
						acids in length, preferably at least about 30 amino acids in 	                  .         .         .         .         .  
						length, more preferably at least about 40 amino acids in     	     351 CISGLQQERSMCTPLPVAAQSTTLPSLSGRQVEINLKRYPTPYPEDLKNM 400                                                          
						length and most preferably at least about 50 amino acids in  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						length, wherein at least two amino acids comprise RT, having 	     530 CISGLQQERSMCTPLPVAAQSTTLPSLSGRQVEINLKRYPTPYPEDLKNM 579                                                          
						a structure as follows: a sequence starting from any of amino	                  .         .         .         .         .  
						acid numbers 1106-x to 1107; and ending at any of amino acid 	     401 VKSVQNLVGKPSHGVRVENSNPTANTEQTVKEKYEHKWPVAPKEITVEDS 450                                                          
						numbers 1107+ ((n-2) - x), in which x varies from 0 to n-2.  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     580 VKSVQNLVGKPSHGVRVENSNPTANTEQTVKEKYEHKWPVAPKEITVEDS 629                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 FVHPANEMRIGELHPSLAETPLYPPKLVLLGKDKKESTDESEVDKTHCLN 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     630 FVHPANEMRIGELHPSLAETPLYPPKLVLLGKDKKESTDESEVDKTHCLN 679                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 NSVSSGTYSDYSPSQASSGSSNTRVKVGSLQTTAKDAVHNSLWGNRIAPS 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     680 NSVSSGTYSDYSPSQASSGSSNTRVKVGSLQTTAKDAVHNSLWGNRIAPS 729                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 FPQPLDSKPLLSQREAVPPGNIPQRPDRLPMSDTFTDNWTDGSHYDNTGF 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     730 FPQPLDSKPLLSQREAVPPGNIPQRPDRLPMSDTFTDNWTDGSHYDNTGF 779                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 VAEETTAENANSNPLLSSKSRSTSSHGRRPLIRQDRIVGVPLELEQSTHR 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     780 VAEETTAENANSNPLLSSKSRSTSSHGRRPLIRQDRIVGVPLELEQSTHR 829                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 HTPETEVPPSNPWQNWTRTPSPFEDRTAFPSKLETTPTTSPLPERKEHIK 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     830 HTPETEVPPSNPWQNWTRTPSPFEDRTAFPSKLETTPTTSPLPERKEHIK 879                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 ESTEIPSPFSPGVPWEYHDSNPNRSLSNVFSQIHCRPESSKGVISISKST 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     880 ESTEIPSPFSPGVPWEYHDSNPNRSLSNVFSQIHCRPESSKGVISISKST 929                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 ERLSPLMKDIKSNKFKKSQSIDEIDIGTYKVYNIPLENYASGSDHLGSHE 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     930 ERLSPLMKDIKSNKFKKSQSIDEIDIGTYKVYNIPLENYASGSDHLGSHE 979                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 RPDKMLGPEHGMSSMSRSQSVPMLDDEMLTYGSSKGPQQQKASMTKKVYQ 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     980 RPDKMLGPEHGMSSMSRSQSVPMLDDEMLTYGSSKGPQQQKASMTKKVYQ 1029                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     851 FDQSFNPQGSVEVKAEKRIPPPFQHNPEYVQQASKNIAKDLISPRAYRGY 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1030 FDQSFNPQGSVEVKAEKRIPPPFQHNPEYVQQASKNIAKDLISPRAYRGY 1079                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     901 PPMEQMFSFSQPSVNEDAVVNAQFASQGARAGFLRRADSLVSATEMAMFR 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1080 PPMEQMFSFSQPSVNEDAVVNAQFASQGARAGFLRRADSLVSATEMAMFR 1129                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     951 RVNEPHELPPTDRYGRPPYRGGLDRQSSVTVTESQFLKRNGRYEDEHPSY 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1130 RVNEPHELPPTDRYGRPPYRGGLDRQSSVTVTESQFLKRNGRYEDEHPSY 1179                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 QEVKAQAGSFPVKNLTQRRPLSARSYSTESYGASQTRPVSARPTMAALLE 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1180 QEVKAQAGSFPVKNLTQRRPLSARSYSTESYGASQTRPVSARPTMAALLE 1229                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 KIPSDYNLGNYGDKPSDNSDLKTRPTPVKGEESCGKMPADWRQQLLRHIE 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1230 KIPSDYNLGNYGDKPSDNSDLKTRPTPVKGEESCGKMPADWRQQLLRHIE 1279                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 ARRLDR............................................ 1106                                                         
						                                                            	         ||||||                                              
						                                                            	    1280 ARRLDRNAAYKHNTVNLGMLPYGGISAMHAGRSMTLNLQTKSKFDHQELP 1329                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1107 ...TPSQQSNILDNGQEDVSPSGQWNPYPLGRRDVPPDTITKKAGSHIQT 1153                                                         
						                                                            	            |||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1330 LQKTPSQQSNILDNGQEDVSPSGQWNPYPLGRRDVPPDTITKKAGSHIQT 1379                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1154 LMGSQSLQHRSREQQPYEGNINKVTIQQFQSPLPIQIPSSQATRGPQPGR 1203                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1380 LMGSQSLQHRSREQQPYEGNINKVTIQQFQSPLPIQIPSSQATRGPQPGR 1429                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1204 CLIQTKGQRSMDGYPEQFCVRIEKNPGLGFSISGGISGQGNPFKPSDKGI 1253                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1430 CLIQTKGQRSMDGYPEQFCVRIEKNPGLGFSISGGISGQGNPFKPSDKGI 1479                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1254 FVTRVQPDGPASNLLQPGDKILQANGHSFVHMEHEKAVLLLKSFQNTVDL 1303                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1480 FVTRVQPDGPASNLLQPGDKILQANGHSFVHMEHEKAVLLLKSFQNTVDL 1529                                                         
						                                                            	                                                             
						                                                            	    1304 VIQRELTV                                           1311                                                         
						                                                            	         ||||||||                                            
						                                                            	    1530 VIQRELTV                                           1537                                                         

						Comparison report between AA972667_P1 and Q9P2I2unique head  	Sequence name: Q9P2I2                                        
						followed by partial WT sequence1.An isolated chimeric        	                                                            
						polypeptide encoding for AA972667_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 12019 x Q9P2I2   ..                            
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MHKLAQLERLDLGNNEFSELPEVLDQIQNLRELWMDNNALQVLPGSIGKLKMLVYLDMSK 	Alignment segment 1/1:                                       
						NRIETVDMDISGCEALEDLLLSSNMLQQLPDSIGLLKKLTTLKVDDNQLTMLPNTIGNLS 	                                                            
						LLEEFDCSCNELESLPSTIGYLHSLRTLAVDENFLPELPREIGSCKNVTVMSLRSNKLEF 	                     Quality: 8249.00                      Escore:       0                                               
						LPEEIGQMQKLRVLNLSDNRLKNLPFSFTKLKELAALWLSDNQSKALIPLQTEAHPETKQ 	             Matching length:     831                Total length:     831                                               
						RVLTNYMFPQQPRGDEDFQSDSDSFNPTLWEEQRQQRMTVAFEFEDKKEDDENAGKVKDL 	 Matching Percent Similarity:   99.88   Matching Percent Identity:   99.76                                               
						SCQAPWERGQRGITLQPARLSGDCCTPWARCDQQIQDMPVPQNDPQLAWGCISGLQQERS 	    Total Percent Similarity:   99.88      Total Percent Identity:   99.76                                               
						MCTPLPVAAQSTTLPSLSGRQVEINLKRYPTPYPEDLKNMVKSVQNLVGKPSHGVRVENS 	                        Gaps:       0                        
						NPTANTEQTVKEKYEHKWPVAPKEITVEDSFVHPANEMRIGELHPSLAETPLYPPKLVLL 	                                                            
						GKD                                                          	Alignment:                                                   
						having the sequence corresponding to amino acids 1 - 483 of  	                  .         .         .         .         .  
						AA972667_P1, and a second amino acid sequence being at least 	     481 GKDKKESTDESEVDKTHCLNNSVSSGTYSDYSPSQASSGSSNTRVKVGSL 530                                                          
						KKESTDESEVDKTHCLNNSVSSGTYSDYSPSQASSGSSNTRVKVGSLQTTAKDAVHNSLW 	         |: |||||||||||||||||||||||||||||||||||||||||||||||  
						GNRIAPSFPQPLDSKPLLSQREAVPPGNIPQRPDRLPMSDTFTDNWTDGSHYDNTGFVAE 	       1 GRTKKESTDESEVDKTHCLNNSVSSGTYSDYSPSQASSGSSNTRVKVGSL 50                                                           
						ETTAENANSNPLLSSKSRSTSSHGRRPLIRQDRIVGVPLELEQSTHRHTPETEVPPSNPW 	                  .         .         .         .         .  
						QNWTRTPSPFEDRTAFPSKLETTPTTSPLPERKEHIKESTEIPSPFSPGVPWEYHDSNPN 	     531 QTTAKDAVHNSLWGNRIAPSFPQPLDSKPLLSQREAVPPGNIPQRPDRLP 580                                                          
						RSLSNVFSQIHCRPESSKGVISISKSTERLSPLMKDIKSNKFKKSQSIDEIDIGTYKVYN 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IPLENYASGSDHLGSHERPDKMLGPEHGMSSMSRSQSVPMLDDEMLTYGSSKGPQQQKAS 	      51 QTTAKDAVHNSLWGNRIAPSFPQPLDSKPLLSQREAVPPGNIPQRPDRLP 100                                                          
						MTKKVYQFDQSFNPQGSVEVKAEKRIPPPFQHNPEYVQQASKNIAKDLISPRAYRGYPPM 	                  .         .         .         .         .  
						EQMFSFSQPSVNEDAVVNAQFASQGARAGFLRRADSLVSATEMAMFRRVNEPHELPPTDR 	     581 MSDTFTDNWTDGSHYDNTGFVAEETTAENANSNPLLSSKSRSTSSHGRRP 630                                                          
						YGRPPYRGGLDRQSSVTVTESQFLKRNGRYEDEHPSYQEVKAQAGSFPVKNLTQRRPLSA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RSYSTESYGASQTRPVSARPTMAALLEKIPSDYNLGNYGDKPSDNSDLKTRPTPVKGEES 	     101 MSDTFTDNWTDGSHYDNTGFVAEETTAENANSNPLLSSKSRSTSSHGRRP 150                                                          
						CGKMPADWRQQLLRHIEARRLDRTPSQQSNILDNGQEDVSPSGQWNPYPLGRRDVPPDTI 	                  .         .         .         .         .  
						TKKAGSHIQTLMGSQSLQHRSREQQPYEGNINKVTIQQFQSPLPIQIPSSQATRGPQPGR 	     631 LIRQDRIVGVPLELEQSTHRHTPETEVPPSNPWQNWTRTPSPFEDRTAFP 680                                                          
						CLIQTKGQRSMDGYPEQFCVRIEKNPGLGFSISGGISGQGNPFKPSDKGIFVTRVQPDGP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ASNLLQPGDKILQANGHSFVHMEHEKAVLLLKSFQNTVDLVIQRELTV             	     151 LIRQDRIVGVPLELEQSTHRHTPETEVPPSNPWQNWTRTPSPFEDRTAFP 200                                                          
						90 % homologous to corresponding to amino acids 4 - 831 of   	                  .         .         .         .         .  
						Q9P2I2, which also corresponds to amino acids 484 - 1311 of  	     681 SKLETTPTTSPLPERKEHIKESTEIPSPFSPGVPWEYHDSNPNRSLSNVF 730                                                          
						AA972667_P1, wherein said first amino acid sequence and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	     201 SKLETTPTTSPLPERKEHIKESTEIPSPFSPGVPWEYHDSNPNRSLSNVF 250                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AA972667_P1, comprising a polypeptide being at least 70%,    	     731 SQIHCRPESSKGVISISKSTERLSPLMKDIKSNKFKKSQSIDEIDIGTYK 780                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     251 SQIHCRPESSKGVISISKSTERLSPLMKDIKSNKFKKSQSIDEIDIGTYK 300                                                          
						MHKLAQLERLDLGNNEFSELPEVLDQIQNLRELWMDNNALQVLPGSIGKLKMLVYLDMSK 	                  .         .         .         .         .  
						NRIETVDMDISGCEALEDLLLSSNMLQQLPDSIGLLKKLTTLKVDDNQLTMLPNTIGNLS 	     781 VYNIPLENYASGSDHLGSHERPDKMLGPEHGMSSMSRSQSVPMLDDEMLT 830                                                          
						LLEEFDCSCNELESLPSTIGYLHSLRTLAVDENFLPELPREIGSCKNVTVMSLRSNKLEF 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPEEIGQMQKLRVLNLSDNRLKNLPFSFTKLKELAALWLSDNQSKALIPLQTEAHPETKQ 	     301 VYNIPLENYASGSDHLGSHERPDKMLGPEHGMSSMSRSQSVPMLDDEMLT 350                                                          
						RVLTNYMFPQQPRGDEDFQSDSDSFNPTLWEEQRQQRMTVAFEFEDKKEDDENAGKVKDL 	                  .         .         .         .         .  
						SCQAPWERGQRGITLQPARLSGDCCTPWARCDQQIQDMPVPQNDPQLAWGCISGLQQERS 	     831 YGSSKGPQQQKASMTKKVYQFDQSFNPQGSVEVKAEKRIPPPFQHNPEYV 880                                                          
						MCTPLPVAAQSTTLPSLSGRQVEINLKRYPTPYPEDLKNMVKSVQNLVGKPSHGVRVENS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NPTANTEQTVKEKYEHKWPVAPKEITVEDSFVHPANEMRIGELHPSLAETPLYPPKLVLL 	     351 YGSSKGPQQQKASMTKKVYQFDQSFNPQGSVEVKAEKRIPPPFQHNPEYV 400                                                          
						GKD                                                          	                  .         .         .         .         .  
						least about 95% homologous to the sequence of AA972667_P1.   	     881 QQASKNIAKDLISPRAYRGYPPMEQMFSFSQPSVNEDAVVNAQFASQGAR 930                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 QQASKNIAKDLISPRAYRGYPPMEQMFSFSQPSVNEDAVVNAQFASQGAR 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     931 AGFLRRADSLVSATEMAMFRRVNEPHELPPTDRYGRPPYRGGLDRQSSVT 980                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 AGFLRRADSLVSATEMAMFRRVNEPHELPPTDRYGRPPYRGGLDRQSSVT 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     981 VTESQFLKRNGRYEDEHPSYQEVKAQAGSFPVKNLTQRRPLSARSYSTES 1030                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 VTESQFLKRNGRYEDEHPSYQEVKAQAGSFPVKNLTQRRPLSARSYSTES 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1031 YGASQTRPVSARPTMAALLEKIPSDYNLGNYGDKPSDNSDLKTRPTPVKG 1080                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 YGASQTRPVSARPTMAALLEKIPSDYNLGNYGDKPSDNSDLKTRPTPVKG 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1081 EESCGKMPADWRQQLLRHIEARRLDRTPSQQSNILDNGQEDVSPSGQWNP 1130                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 EESCGKMPADWRQQLLRHIEARRLDRTPSQQSNILDNGQEDVSPSGQWNP 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1131 YPLGRRDVPPDTITKKAGSHIQTLMGSQSLQHRSREQQPYEGNINKVTIQ 1180                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 YPLGRRDVPPDTITKKAGSHIQTLMGSQSLQHRSREQQPYEGNINKVTIQ 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1181 QFQSPLPIQIPSSQATRGPQPGRCLIQTKGQRSMDGYPEQFCVRIEKNPG 1230                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 QFQSPLPIQIPSSQATRGPQPGRCLIQTKGQRSMDGYPEQFCVRIEKNPG 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	    1231 LGFSISGGISGQGNPFKPSDKGIFVTRVQPDGPASNLLQPGDKILQANGH 1280                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 LGFSISGGISGQGNPFKPSDKGIFVTRVQPDGPASNLLQPGDKILQANGH 800                                                          
						                                                            	                  .         .         .                      
						                                                            	    1281 SFVHMEHEKAVLLLKSFQNTVDLVIQRELTV                    1311                                                         
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     801 SFVHMEHEKAVLLLKSFQNTVDLVIQRELTV                    831                                                          

14627	HMR136_AA975424_3_tr0_r1_1_gPRT		Comparison report between AA975424_P3 and                    	Sequence name: PGD2_HUMAN_V1                                 
						PGD2_HUMAN_V1unique head followed by partial WT sequence     	                                                            
						followed by a short unique tail.1.An isolated chimeric       	Sequence documentation:                                      
						polypeptide encoding for AA975424_P3, comprising a first     	                                                            
						amino acid sequence being at least 70%, optionally at least  	Alignment of: 14627 x PGD2_HUMAN_V1   ..                     
						80%, preferably at least 85%, more preferably at least 90%   	                                                            
						and most preferably at least 95% homologous to a polypeptide 	Alignment segment 1/1:                                       
						having the sequence TRHINPRHSHIPRDTRHCRLPRDITQNCT            	                                                            
						corresponding to amino acids 1 - 29 of AA975424_P3, a second 	                     Quality: 1117.00                      Escore:       0                                               
						MPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLT 	             Matching length:     112                Total length:     112                                               
						LHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVK         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 112 of PGD2_HUMAN_V1, which 	                        Gaps:       0                        
						also corresponds to amino acids 30 - 141 of AA975424_P3, and 	                                                            
						a third amino acid sequence being at least 70%, optionally at	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	      30 MPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGK 79                                                           
						polypeptide having the sequence VM corresponding to amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 142 - 143 of AA975424_P3, wherein said first amino acid	       1 MPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGK 50                                                           
						sequence, second amino acid sequence and third amino acid    	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	      80 IPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMS 129                                                          
						isolated polypeptide encoding for a head of AA975424_P3,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide being at least 70%, optionally at   	      51 IPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMS 100                                                          
						least about 80%, preferably at least about 85%, more         	                  .                                          
						preferably at least about 90% and most preferably at least   	     130 CFPWAEKKQDVK                                       141                                                          
						about 95% homologous to the sequence                         	         ||||||||||||                                        
						TRHINPRHSHIPRDTRHCRLPRDITQNCT of AA975424_P3.                	     101 CFPWAEKKQDVK                                       112                                                          

6994	HMR136_AA976830_1_tr0_r1_1_gPRT		Comparison report between AA976830_P1 and AAH47336unique     	Sequence name: AAH47336                                      
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AA976830_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 6994 x AAH47336   ..                           
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						MTKLILLTGLVLILNLQLGSAYQLTCYFTNWAQYRPGLGRFMPDNIDPCLCTHLIYAFAG 	Alignment segment 1/1:                                       
						RQNNEITTIEWNDVTLYQAFNGLKNK                                   	                                                            
						having the sequence corresponding to amino acids 1 - 86 of   	                     Quality: 1143.00                      Escore:       0                                               
						AA976830_P1, and a second amino acid sequence being at least 	             Matching length:     117                Total length:     117                                               
						NSQLKTLLAIGGWNFGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPGSRG 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.15                                               
						SPPQDKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVAAGISNIQSGYEIPQLSQ     	    Total Percent Similarity:  100.00      Total Percent Identity:   99.15                                               
						90 % homologous to corresponding to amino acids 16 - 131 of  	                        Gaps:       0                        
						AAH47336, which also corresponds to amino acids 87 - 202 of  	                                                            
						AA976830_P1, wherein said first amino acid sequence and      	Alignment:                                                   
						second amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	      86 KNSQLKTLLAIGGWNFGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGL 135                                                          
						AA976830_P1, comprising a polypeptide being at least 70%,    	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	      15 RNSQLKTLLAIGGWNFGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGL 64                                                           
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MTKLILLTGLVLILNLQLGSAYQLTCYFTNWAQYRPGLGRFMPDNIDPCLCTHLIYAFAG 	     136 DFDWEYPGSRGSPPQDKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVA 185                                                          
						RQNNEITTIEWNDVTLYQAFNGLKNK                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of AA976830_P1.   	      65 DFDWEYPGSRGSPPQDKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVA 114                                                          
						                                                            	                  .                                          
						                                                            	     186 AGISNIQSGYEIPQLSQ                                  202                                                          
						                                                            	         |||||||||||||||||                                   
						                                                            	     115 AGISNIQSGYEIPQLSQ                                  131                                                          

						Comparison report between AA976830_P1 and Q9BZP6partial WT   	Sequence name: Q9BZP6                                        
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AA976830_P1, comprising a first amino acid      	                                                            
						MTKLILLTGLVLILNLQLGSAYQLTCYFTNWAQYRPGLGRFMPDNIDPCLCTHLIYAFAG 	Alignment of: 6994 x Q9BZP6   ..                             
						RQNNEITTIEWNDVTLYQAFNGLKNKNSQLKTLLAIGGWNFGTAPFTAMVSTPENRQTFI 	                                                            
						TSVIKFLRQYEFDGLDFDWEYPGSRGSPPQDKHLFTVLVQEMREAFEQEAKQINKPRLMV 	Alignment segment 1/1:                                       
						TAAVAAGISNIQSGYEIPQLSQ                                       	                                                            
						sequence being at least 90 % homologous to corresponding to  	                     Quality: 1997.00                      Escore:       0                                               
						amino acids 1 - 202 of Q9BZP6, which also corresponds to     	             Matching length:     202                Total length:     202                                               
						amino acids 1 - 202 of AA976830_P1.                          	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MTKLILLTGLVLILNLQLGSAYQLTCYFTNWAQYRPGLGRFMPDNIDPCL 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MTKLILLTGLVLILNLQLGSAYQLTCYFTNWAQYRPGLGRFMPDNIDPCL 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 CTHLIYAFAGRQNNEITTIEWNDVTLYQAFNGLKNKNSQLKTLLAIGGWN 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 CTHLIYAFAGRQNNEITTIEWNDVTLYQAFNGLKNKNSQLKTLLAIGGWN 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 FGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPGSRGSPPQ 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 FGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPGSRGSPPQ 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 DKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVAAGISNIQSGYEIPQL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 DKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVAAGISNIQSGYEIPQL 200                                                          
						                                                            	                                                             
						                                                            	     201 SQ                                                 202                                                          
						                                                            	         ||                                                  
						                                                            	     201 SQ                                                 202                                                          

7601	HMR136_AA984421_3_tr0_r1_1_gPRT		Comparison report between AA984421_P3 and PRAX_HUMANpartial  	Sequence name: PRAX_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for AA984421_P3, comprising a first     	                                                            
						MVPGALGVPADLAPVDVEFSFPKFSRLRRGLKAEAVKGPVPAAPARRRLQLPRLRVREVA 	Alignment of: 7601 x PRAX_HUMAN   ..                         
						EEAQAARLAAAAPPPRKAKVEAEVAAGARFTAPQVELVGPRLPGAEVGVPQVSAPKAAPS 	                                                            
						AEAAGGFALHLPTLGLGAPAPPAVEAPAVGIQVPQVELPALPSLPTLPTLPCLETREGAV 	Alignment segment 1/1:                                       
						SVVVPTLDVAAPTVGVDLALPGAEVEARGEAPEVALKMPRLSFPRFGARAKEVAEAKVAK 	                                                            
						VSPEARVKGPRLRMPTFGLSLLEPRPAAPEVVESKLKLPTIKMPSLGIGVSGPEVKVPKG 	                     Quality: 12663.00                      Escore:       0                                              
						PEVKLPKAPEVKLPKVPEAALPEVRLPEVELPKVSEMKLPKVPEMAVPEVRLPEVELPKV 	             Matching length:    1322                Total length:    1322                                               
						SEMKLPKVPEMAVPEVRLPEVQLLKVSEMKLPKVPEMAVPEVRLPEVQLPKVSEMKLPEV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SEVAVPEVRLPEVQLPKVPEMKVPEMKLPKVPEMKLPEMKLPEVQLPKVPEMAVPDVHLP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						EVQLPKVPEMKLPEMKLPEVKLPKVPEMAVPDVHLPEVQLPKVPEMKLPKMPEMAVPEVR 	                        Gaps:       0                        
						LPEVQLPKVSEMKLPKVPEMAVPDVHLPEVQLPKVCEMKVPDMKLPEIKLPKVPEMAVPD 	                                                            
						VHLPEVQLPKVSEIRLPEMQVPKVPDVHLPKAPEVKLPRAPEVQLKATKAEQAEGMEFGF 	Alignment:                                                   
						KMPKMTMPKLGRAESPSRGKPGEAGAEVSGKLVTLPCLQPEVDGEAHVGVPSLTLPSVEL 	                  .         .         .         .         .  
						DLPGALGLQGQVPAAKMGKGERVEGPEVAAGVREVGFRVPSVEIVTPQLPAVEIEEGRLE 	       1 MVPGALGVPADLAPVDVEFSFPKFSRLRRGLKAEAVKGPVPAAPARRRLQ 50                                                           
						MIETKVKPSSKFSLPKFGLSGPKVAKAEAEGAGRATKLKVSKFAISLPKARVGAEAEAKG 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AGEAGLLPALDLSIPQLSLDAHLPSGKVEVAGADLKFKGPRFALPKFGVRGRDTEAAELV 	     140 MVPGALGVPADLAPVDVEFSFPKFSRLRRGLKAEAVKGPVPAAPARRRLQ 189                                                          
						PGVAELEGKGWGWDGRVKMPKLKMPSFGLARGKEAEVQGDRASPGEKAESTAVQLKIPEV 	                  .         .         .         .         .  
						ELVTLGAQEEGRAEGAVAVSGMQLSGLKVSTARQVVTEGHDAGLRMPPLGISLPQVELTG 	      51 LPRLRVREVAEEAQAARLAAAAPPPRKAKVEAEVAAGARFTAPQVELVGP 100                                                          
						FGEAGTPGQQAQSTVPSAEGTAGYRVQVPQVTLSLPGAQVAGGELLVGEGVFKMPTVTVP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						QLELDVGLSREAQAGEAATGEGGLRLKLPTLGARARVGGEGAEEQPPGAERTFCLSLPDV 	     190 LPRLRVREVAEEAQAARLAAAAPPPRKAKVEAEVAAGARFTAPQVELVGP 239                                                          
						ELSPSGGNHAEYQVAEGEGEAGHKLKVRLPRFGLVRAKEGAEEGEKAKSPKLRLPRVGFS 	                  .         .         .         .         .  
						QSEMVTGEGSPSPEEEEEEEEEGSGEGASGRRGRVRVRLPRVGLAAPSKASRGQEGDAAP 	     101 RLPGAEVGVPQVSAPKAAPSAEAAGGFALHLPTLGLGAPAPPAVEAPAVG 150                                                          
						KSPVREKSPKFRFPRVSLSPKARSGSGDQEEGGLRVRLPSVGFSETGAPGPARMEGAQAA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AV                                                           	     240 RLPGAEVGVPQVSAPKAAPSAEAAGGFALHLPTLGLGAPAPPAVEAPAVG 289                                                          
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 140 - 1461 of PRAX_HUMAN, which 	     151 IQVPQVELPALPSLPTLPTLPCLETREGAVSVVVPTLDVAAPTVGVDLAL 200                                                          
						also corresponds to amino acids 1 - 1322 of AA984421_P3.     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     290 IQVPQVELPALPSLPTLPTLPCLETREGAVSVVVPTLDVAAPTVGVDLAL 339                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 PGAEVEARGEAPEVALKMPRLSFPRFGARAKEVAEAKVAKVSPEARVKGP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     340 PGAEVEARGEAPEVALKMPRLSFPRFGARAKEVAEAKVAKVSPEARVKGP 389                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RLRMPTFGLSLLEPRPAAPEVVESKLKLPTIKMPSLGIGVSGPEVKVPKG 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     390 RLRMPTFGLSLLEPRPAAPEVVESKLKLPTIKMPSLGIGVSGPEVKVPKG 439                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 PEVKLPKAPEVKLPKVPEAALPEVRLPEVELPKVSEMKLPKVPEMAVPEV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     440 PEVKLPKAPEVKLPKVPEAALPEVRLPEVELPKVSEMKLPKVPEMAVPEV 489                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 RLPEVELPKVSEMKLPKVPEMAVPEVRLPEVQLLKVSEMKLPKVPEMAVP 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     490 RLPEVELPKVSEMKLPKVPEMAVPEVRLPEVQLLKVSEMKLPKVPEMAVP 539                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 EVRLPEVQLPKVSEMKLPEVSEVAVPEVRLPEVQLPKVPEMKVPEMKLPK 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     540 EVRLPEVQLPKVSEMKLPEVSEVAVPEVRLPEVQLPKVPEMKVPEMKLPK 589                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 VPEMKLPEMKLPEVQLPKVPEMAVPDVHLPEVQLPKVPEMKLPEMKLPEV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     590 VPEMKLPEMKLPEVQLPKVPEMAVPDVHLPEVQLPKVPEMKLPEMKLPEV 639                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 KLPKVPEMAVPDVHLPEVQLPKVPEMKLPKMPEMAVPEVRLPEVQLPKVS 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     640 KLPKVPEMAVPDVHLPEVQLPKVPEMKLPKMPEMAVPEVRLPEVQLPKVS 689                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 EMKLPKVPEMAVPDVHLPEVQLPKVCEMKVPDMKLPEIKLPKVPEMAVPD 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     690 EMKLPKVPEMAVPDVHLPEVQLPKVCEMKVPDMKLPEIKLPKVPEMAVPD 739                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 VHLPEVQLPKVSEIRLPEMQVPKVPDVHLPKAPEVKLPRAPEVQLKATKA 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     740 VHLPEVQLPKVSEIRLPEMQVPKVPDVHLPKAPEVKLPRAPEVQLKATKA 789                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 EQAEGMEFGFKMPKMTMPKLGRAESPSRGKPGEAGAEVSGKLVTLPCLQP 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     790 EQAEGMEFGFKMPKMTMPKLGRAESPSRGKPGEAGAEVSGKLVTLPCLQP 839                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 EVDGEAHVGVPSLTLPSVELDLPGALGLQGQVPAAKMGKGERVEGPEVAA 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     840 EVDGEAHVGVPSLTLPSVELDLPGALGLQGQVPAAKMGKGERVEGPEVAA 889                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     751 GVREVGFRVPSVEIVTPQLPAVEIEEGRLEMIETKVKPSSKFSLPKFGLS 800                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     890 GVREVGFRVPSVEIVTPQLPAVEIEEGRLEMIETKVKPSSKFSLPKFGLS 939                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     801 GPKVAKAEAEGAGRATKLKVSKFAISLPKARVGAEAEAKGAGEAGLLPAL 850                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     940 GPKVAKAEAEGAGRATKLKVSKFAISLPKARVGAEAEAKGAGEAGLLPAL 989                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     851 DLSIPQLSLDAHLPSGKVEVAGADLKFKGPRFALPKFGVRGRDTEAAELV 900                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     990 DLSIPQLSLDAHLPSGKVEVAGADLKFKGPRFALPKFGVRGRDTEAAELV 1039                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     901 PGVAELEGKGWGWDGRVKMPKLKMPSFGLARGKEAEVQGDRASPGEKAES 950                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1040 PGVAELEGKGWGWDGRVKMPKLKMPSFGLARGKEAEVQGDRASPGEKAES 1089                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     951 TAVQLKIPEVELVTLGAQEEGRAEGAVAVSGMQLSGLKVSTARQVVTEGH 1000                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1090 TAVQLKIPEVELVTLGAQEEGRAEGAVAVSGMQLSGLKVSTARQVVTEGH 1139                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1001 DAGLRMPPLGISLPQVELTGFGEAGTPGQQAQSTVPSAEGTAGYRVQVPQ 1050                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1140 DAGLRMPPLGISLPQVELTGFGEAGTPGQQAQSTVPSAEGTAGYRVQVPQ 1189                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1051 VTLSLPGAQVAGGELLVGEGVFKMPTVTVPQLELDVGLSREAQAGEAATG 1100                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1190 VTLSLPGAQVAGGELLVGEGVFKMPTVTVPQLELDVGLSREAQAGEAATG 1239                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1101 EGGLRLKLPTLGARARVGGEGAEEQPPGAERTFCLSLPDVELSPSGGNHA 1150                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1240 EGGLRLKLPTLGARARVGGEGAEEQPPGAERTFCLSLPDVELSPSGGNHA 1289                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1151 EYQVAEGEGEAGHKLKVRLPRFGLVRAKEGAEEGEKAKSPKLRLPRVGFS 1200                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1290 EYQVAEGEGEAGHKLKVRLPRFGLVRAKEGAEEGEKAKSPKLRLPRVGFS 1339                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1201 QSEMVTGEGSPSPEEEEEEEEEGSGEGASGRRGRVRVRLPRVGLAAPSKA 1250                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1340 QSEMVTGEGSPSPEEEEEEEEEGSGEGASGRRGRVRVRLPRVGLAAPSKA 1389                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	    1251 SRGQEGDAAPKSPVREKSPKFRFPRVSLSPKARSGSGDQEEGGLRVRLPS 1300                                                         
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1390 SRGQEGDAAPKSPVREKSPKFRFPRVSLSPKARSGSGDQEEGGLRVRLPS 1439                                                         
						                                                            	                  .         .                                
						                                                            	    1301 VGFSETGAPGPARMEGAQAAAV                             1322                                                         
						                                                            	         ||||||||||||||||||||||                              
						                                                            	    1440 VGFSETGAPGPARMEGAQAAAV                             1461                                                         

19764	HMR136_AB010438_2_tr0_r1_1_gPRT		Comparison report between AB010438_P2 and Q9Y226partial WT   	Sequence name: Q9Y226                                        
						sequence followed by mismatch and a featuring a skipped      	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AB010438_P2, comprising a first amino acid sequence being at 	                                                            
						MAQFVQVLAEIGDFGRFQIQLLILLCVLNFLSPFYFFAHVFMVLDEPHHCAVAWVKNHTF 	Alignment of: 19764 x Q9Y226   ..                            
						NLSAAEQLVLSVPLDTAGHPEPCLMFRPPPANASLQDILSHRFNETQPCDMGWEYPENRL 	                                                            
						PSLKNEFNLVCDRKHLKDTTQSVFM                                    	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 145	                                                            
						of Q9Y226, which also corresponds to amino acids 1 - 145 of  	                     Quality: 3505.00                      Escore:       0                                               
						AB010438_P2, a bridging amino acid A corresponding to amino  	             Matching length:     371                Total length:     551                                               
						acid 146 of AB010438_P2, a second amino acid sequence being  	 Matching Percent Similarity:   99.73   Matching Percent Identity:   99.73                                               
						at least 90 % homologous to GLLVGTLMFGPLCDR corresponding to 	    Total Percent Similarity:   67.15      Total Percent Identity:   67.15                                               
						amino acids 147 - 161 of Q9Y226, which also corresponds to   	                        Gaps:       1                        
						amino acids 147 - 161 of AB010438_P2, and a third amino acid 	                                                            
						FVDSLGYYGLSLQVGDFGLDVYLTQLIFGAVEVPARCSSIFMMQRFGRKWSQLGTLVLGG 	Alignment:                                                   
						LMCIIIIFIPADLPVVVTMLAVVGKMATAAAFTISYVYSAELFPTILRQTGMGLVGIFSR 	                  .         .         .         .         .  
						IGGILTPLVILLGEYHAALPMLIYGSLPIVAGLLCTLLPETHGQGLKDTLQDLELGPHPR 	       1 MAQFVQVLAEIGDFGRFQIQLLILLCVLNFLSPFYFFAHVFMVLDEPHHC 50                                                           
						SPKSVPSEKETEAKGRTSSPGVAFVSSTYF                               	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 MAQFVQVLAEIGDFGRFQIQLLILLCVLNFLSPFYFFAHVFMVLDEPHHC 50                                                           
						amino acids 342 - 551 of Q9Y226, which also corresponds to   	                  .         .         .         .         .  
						amino acids 162 - 371 of AB010438_P2, wherein said first     	      51 AVAWVKNHTFNLSAAEQLVLSVPLDTAGHPEPCLMFRPPPANASLQDILS 100                                                          
						amino acid sequence, bridging amino acid, second amino acid  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	      51 AVAWVKNHTFNLSAAEQLVLSVPLDTAGHPEPCLMFRPPPANASLQDILS 100                                                          
						a sequential order.2.An isolated chimeric polypeptide        	                  .         .         .         .         .  
						encoding for an edge portion of AB010438_P2, comprising a    	     101 HRFNETQPCDMGWEYPENRLPSLKNEFNLVCDRKHLKDTTQSVFMAGLLV 150                                                          
						polypeptide having a length "n", wherein n is at least about 	         ||||||||||||||||||||||||||||||||||||||||||||| ||||  
						10 amino acids in length, optionally at least about 20 amino 	     101 HRFNETQPCDMGWEYPENRLPSLKNEFNLVCDRKHLKDTTQSVFMGGLLV 150                                                          
						acids in length, preferably at least about 30 amino acids in 	                  .         .         .         .         .  
						length, more preferably at least about 40 amino acids in     	     151 GTLMFGPLCDR....................................... 161                                                          
						length and most preferably at least about 50 amino acids in  	         |||||||||||                                         
						length, wherein at least two amino acids comprise RF, having 	     151 GTLMFGPLCDRIGRKATILAQLLLFTLIGLATAFVPSFELYMALRFAVAT 200                                                          
						a structure as follows: a sequence starting from any of amino	                  .         .         .         .         .  
						acid numbers 161-x to 162; and ending at any of amino acid   	     161 .................................................. 161                                                          
						numbers 162+ ((n-2) - x), in which x varies from 0 to n-2.   	                                                            
						                                                            	     201 AVAGLSFSNVTLLTEWVGPSWRTQAVVLAQCNFSLGQMVLAGLAYGFRNW 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     161 .................................................. 161                                                          
						                                                            	                                                            
						                                                            	     251 RLLQITGTAPGLLLFFYFWALPESARWLLTRGRMDEAIQLIQKAASVNRR 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     162 .........................................FVDSLGYYG 170                                                          
						                                                            	                                                  |||||||||  
						                                                            	     301 KLSPELMNQLVPEKTGPSGNALDLFRHPQLRKVTLIIFCVWFVDSLGYYG 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     171 LSLQVGDFGLDVYLTQLIFGAVEVPARCSSIFMMQRFGRKWSQLGTLVLG 220                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 LSLQVGDFGLDVYLTQLIFGAVEVPARCSSIFMMQRFGRKWSQLGTLVLG 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     221 GLMCIIIIFIPADLPVVVTMLAVVGKMATAAAFTISYVYSAELFPTILRQ 270                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 GLMCIIIIFIPADLPVVVTMLAVVGKMATAAAFTISYVYSAELFPTILRQ 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     271 TGMGLVGIFSRIGGILTPLVILLGEYHAALPMLIYGSLPIVAGLLCTLLP 320                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 TGMGLVGIFSRIGGILTPLVILLGEYHAALPMLIYGSLPIVAGLLCTLLP 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     321 ETHGQGLKDTLQDLELGPHPRSPKSVPSEKETEAKGRTSSPGVAFVSSTY 370                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 ETHGQGLKDTLQDLELGPHPRSPKSVPSEKETEAKGRTSSPGVAFVSSTY 550                                                          
						                                                            	                                                             
						                                                            	     371 F                                                  371                                                          
						                                                            	         |                                                   
						                                                            	     551 F                                                  551                                                          

20845	HMR136_AB023021_3_tr0_r1_1_gPRT		Comparison report between AB023021_P3 and Q9Y231partial WT   	Sequence name: Q9Y231                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for AB023021_P3, comprising a first     	Sequence documentation:                                      
						MTSTSKGILRPFLIVCIILGCFMACLLIYIKPTNSWIFSPMESASSVLKMKNFFSTKTDY 	                                                            
						FNETTILVWVWPFGQTFDLTSCQAMFNIQGCHLTTDRSLYNKSHAVLIHHRDISWDLTNL 	Alignment of: 20845 x Q9Y231   ..                            
						PQQARPPFQKWIWMNLESPTHTPQKSGIEHLFNLTLTYRRDSDIQVPYGFLTVSTNPFVF 	                                                            
						EVPSKEKLVCWVVSNWNPEHARVKYYNELSKSIEIHTYGQAFGEYVNDKNLIPTIS     	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 236 of Q9Y231, which also   	                     Quality: 3642.00                      Escore:       0                                               
						corresponds to amino acids 1 - 236 of AB023021_P3, a bridging	             Matching length:     359                Total length:     359                                               
						amino acid T corresponding to amino acid 237 of AB023021_P3, 	 Matching Percent Similarity:   99.72   Matching Percent Identity:   99.72                                               
						and a second amino acid sequence being at least 90 %         	    Total Percent Similarity:   99.72      Total Percent Identity:   99.72                                               
						CKFYLSFENSIHKDYITEKLYNAFLAGSVPVVLGPSRENYENYIPADSFIHVEDYNSPSE 	                        Gaps:       0                        
						LAKYLKEVDKNNKLYLSYFNWRKDFTVNLPRFWESHACLACDHVKRHQEYKSVGNLEKWF 	                                                            
						WN                                                           	Alignment:                                                   
						homologous to corresponding to amino acids 238 - 359 of      	                  .         .         .         .         .  
						Q9Y231, which also corresponds to amino acids 238 - 359 of   	       1 MTSTSKGILRPFLIVCIILGCFMACLLIYIKPTNSWIFSPMESASSVLKM 50                                                           
						AB023021_P3, wherein said first amino acid sequence, bridging	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid and second amino acid sequence are contiguous and 	       1 MTSTSKGILRPFLIVCIILGCFMACLLIYIKPTNSWIFSPMESASSVLKM 50                                                           
						in a sequential order.                                       	                  .         .         .         .         .  
						                                                            	      51 KNFFSTKTDYFNETTILVWVWPFGQTFDLTSCQAMFNIQGCHLTTDRSLY 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 KNFFSTKTDYFNETTILVWVWPFGQTFDLTSCQAMFNIQGCHLTTDRSLY 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 NKSHAVLIHHRDISWDLTNLPQQARPPFQKWIWMNLESPTHTPQKSGIEH 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 NKSHAVLIHHRDISWDLTNLPQQARPPFQKWIWMNLESPTHTPQKSGIEH 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 LFNLTLTYRRDSDIQVPYGFLTVSTNPFVFEVPSKEKLVCWVVSNWNPEH 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 LFNLTLTYRRDSDIQVPYGFLTVSTNPFVFEVPSKEKLVCWVVSNWNPEH 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 ARVKYYNELSKSIEIHTYGQAFGEYVNDKNLIPTISTCKFYLSFENSIHK 250                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||| |||||||||||||  
						                                                            	     201 ARVKYYNELSKSIEIHTYGQAFGEYVNDKNLIPTISACKFYLSFENSIHK 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 DYITEKLYNAFLAGSVPVVLGPSRENYENYIPADSFIHVEDYNSPSELAK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 DYITEKLYNAFLAGSVPVVLGPSRENYENYIPADSFIHVEDYNSPSELAK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 YLKEVDKNNKLYLSYFNWRKDFTVNLPRFWESHACLACDHVKRHQEYKSV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 YLKEVDKNNKLYLSYFNWRKDFTVNLPRFWESHACLACDHVKRHQEYKSV 350                                                          
						                                                            	                                                             
						                                                            	     351 GNLEKWFWN                                          359                                                          
						                                                            	         |||||||||                                           
						                                                            	     351 GNLEKWFWN                                          359                                                          

23003	HMR136_AB080222_0_tr0_r1_1_gPRT		Comparison report between AB080222_P0 and Q8TDW5partial WT   	Sequence name: Q8TDW5                                        
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for AB080222_P0, comprising a first     	Sequence documentation:                                      
						MSKNSEFINLSFLLDHEKEMILGVLKRDEYLKKVEDKRIRKLKNELLEAKRRSGKTQQEA 	                                                            
						SRVCVHCHRNLGLIFDRGDPCQACSLRVCRECRVAGPNGSWKCTVCDKIAQLRIITGEWF 	Alignment of: 23003 x Q8TDW5   ..                            
						FEEKAKRFKQVNVLGTDVVRQSILRRSPGAEEVQSQEQTRQDAEKSDTSPVAGKKASHDG 	                                                            
						PKRKGFLLSKFRSATRGEIITPKTDTGRSYSLDLDGQHFRSLKSPPGSDRGSTGSSDLND 	Alignment segment 1/1:                                       
						QEPGPRTPKSSRSNGVTPGTQSSPAPSTRTVTSVISREYGFENSMDLAAIEGTSQELTKS 	                                                            
						HRRNTSGTPSIAVSGTSLSSDQSRSELDLSESFTEDSEDTVSIRSKSVPGALDKDSLEET 	                     Quality: 7041.00                      Escore:       0                                               
						EESIDALVSSQLSTNTHRLASGLS                                     	             Matching length:     730                Total length:     752                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 384 of Q8TDW5, which also   	    Total Percent Similarity:   97.07      Total Percent Identity:   97.07                                               
						corresponds to amino acids 1 - 384 of AB080222_P0, a second  	                        Gaps:       1                        
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment:                                                   
						and most preferably at least 95% homologous to a polypeptide 	                  .         .         .         .         .  
						having the sequence TSSQAGSDRKWTYLNVPDADSD corresponding to  	       1 MSKNSEFINLSFLLDHEKEMILGVLKRDEYLKKVEDKRIRKLKNELLEAK 50                                                           
						amino acids 385 - 406 of AB080222_P0, and a third amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						TTSLNSMMSVYSETGDYGNVKVSGEILLHISYCYKTGGLYIFVKNCRNLAIGDEKKQRTD 	       1 MSKNSEFINLSFLLDHEKEMILGVLKRDEYLKKVEDKRIRKLKNELLEAK 50                                                           
						AYVKSYLLPDKSRNNKRKTKIRTGTNPEFNETLKYTISHTQLETRTLQLSVWHYDRFGRN 	                  .         .         .         .         .  
						SFLGEVEIPFDSWNFENPTDEWFVLQPKVEFAPDIGLQYKGELTVVLRYIPPEENLMLPP 	      51 RRSGKTQQEASRVCVHCHRNLGLIFDRGDPCQACSLRVCRECRVAGPNGS 100                                                          
						EQLQGNKTFKKGKKKESPVISGGILEVFIKEAKNLTAVKSGGTSDSFVKGYLLPDDSKAT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KHKTLVIKKSVNPQWNHTFMFSGIHPQDIKNVCLELTIWDKEAFSSNIFLGGVRLNSGSG 	      51 RRSGKTQQEASRVCVHCHRNLGLIFDRGDPCQACSLRVCRECRVAGPNGS 100                                                          
						VSHGKNVDWMDSQGEEQRLWQKMANNPGTPFEGVLMLRSSMGKCRL               	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     101 WKCTVCDKIAQLRIITGEWFFEEKAKRFKQVNVLGTDVVRQSILRRSPGA 150                                                          
						amino acids 385 - 730 of Q8TDW5, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 407 - 752 of AB080222_P0, wherein said first     	     101 WKCTVCDKIAQLRIITGEWFFEEKAKRFKQVNVLGTDVVRQSILRRSPGA 150                                                          
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     151 EEVQSQEQTRQDAEKSDTSPVAGKKASHDGPKRKGFLLSKFRSATRGEII 200                                                          
						order.2.An isolated polypeptide encoding for an edge portion 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of AB080222_P0, comprising an amino acid sequence being at   	     151 EEVQSQEQTRQDAEKSDTSPVAGKKASHDGPKRKGFLLSKFRSATRGEII 200                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	     201 TPKTDTGRSYSLDLDGQHFRSLKSPPGSDRGSTGSSDLNDQEPGPRTPKS 250                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for TSSQAGSDRKWTYLNVPDADSD, corresponding to        	     201 TPKTDTGRSYSLDLDGQHFRSLKSPPGSDRGSTGSSDLNDQEPGPRTPKS 250                                                          
						AB080222_P0.                                                 	                  .         .         .         .         .  
						                                                            	     251 SRSNGVTPGTQSSPAPSTRTVTSVISREYGFENSMDLAAIEGTSQELTKS 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SRSNGVTPGTQSSPAPSTRTVTSVISREYGFENSMDLAAIEGTSQELTKS 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 HRRNTSGTPSIAVSGTSLSSDQSRSELDLSESFTEDSEDTVSIRSKSVPG 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 HRRNTSGTPSIAVSGTSLSSDQSRSELDLSESFTEDSEDTVSIRSKSVPG 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 ALDKDSLEETEESIDALVSSQLSTNTHRLASGLSTSSQAGSDRKWTYLNV 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||                  
						                                                            	     351 ALDKDSLEETEESIDALVSSQLSTNTHRLASGLS................ 384                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 PDADSDTTSLNSMMSVYSETGDYGNVKVSGEILLHISYCYKTGGLYIFVK 450                                                          
						                                                            	               ||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     385 ......TTSLNSMMSVYSETGDYGNVKVSGEILLHISYCYKTGGLYIFVK 428                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 NCRNLAIGDEKKQRTDAYVKSYLLPDKSRNNKRKTKIRTGTNPEFNETLK 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     429 NCRNLAIGDEKKQRTDAYVKSYLLPDKSRNNKRKTKIRTGTNPEFNETLK 478                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 YTISHTQLETRTLQLSVWHYDRFGRNSFLGEVEIPFDSWNFENPTDEWFV 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     479 YTISHTQLETRTLQLSVWHYDRFGRNSFLGEVEIPFDSWNFENPTDEWFV 528                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 LQPKVEFAPDIGLQYKGELTVVLRYIPPEENLMLPPEQLQGNKTFKKGKK 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     529 LQPKVEFAPDIGLQYKGELTVVLRYIPPEENLMLPPEQLQGNKTFKKGKK 578                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 KESPVISGGILEVFIKEAKNLTAVKSGGTSDSFVKGYLLPDDSKATKHKT 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     579 KESPVISGGILEVFIKEAKNLTAVKSGGTSDSFVKGYLLPDDSKATKHKT 628                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     651 LVIKKSVNPQWNHTFMFSGIHPQDIKNVCLELTIWDKEAFSSNIFLGGVR 700                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     629 LVIKKSVNPQWNHTFMFSGIHPQDIKNVCLELTIWDKEAFSSNIFLGGVR 678                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     701 LNSGSGVSHGKNVDWMDSQGEEQRLWQKMANNPGTPFEGVLMLRSSMGKC 750                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     679 LNSGSGVSHGKNVDWMDSQGEEQRLWQKMANNPGTPFEGVLMLRSSMGKC 728                                                          
						                                                            	                                                             
						                                                            	     751 RL                                                 752                                                          
						                                                            	         ||                                                  
						                                                            	     729 RL                                                 730                                                          

24696	HMR136_AF012130_1_tr0_r1_1_gPRT		Comparison report between AF012130_P1 and TBX1_HUMANunique   	Sequence name: TBX1_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AF012130_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 24696 x TBX1_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						GRGSEEEGNRGRASGGGGAHRPPGLRVLRPGEASLAARIPGRDALQHRHQGHG        	                                                            
						corresponding to amino acids 1 - 53 of AF012130_P1, a second 	                     Quality: 3176.00                      Escore:       0                                               
						SLGAAGGFPGAASPGADPYGPREPPPPPPRYDPCAAAAPGAPGPPPPPHAYPFAPAAGAA 	             Matching length:     317                Total length:     317                                               
						TSAAAEPEGPGASCAAAAKAPVKKNAKVAGVSVQLEMKALWDEFNQLGTEMIVTKAGRRM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FPTFQVKLFGMDPMADYMLLMDFVPVDDKRYRYAFHSSSWLVAGKADPATPGRVHYHPDS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PAKGAQWMKQIVSFDKLKLTNNLLDDNGHIILNSMHRYQPRFHVVYVDPRKDSEKYAEEN 	                        Gaps:       0                        
						FKTFVFEETRFTAVTAYQNHRITQLKIASNPFAKGFRDCDPEDWPRNHRPGALPLMSAFA 	                                                            
						RSRNPVASPTQPSGTEK                                            	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 20 - 336 of TBX1_HUMAN, which   	      54 SLGAAGGFPGAASPGADPYGPREPPPPPPRYDPCAAAAPGAPGPPPPPHA 103                                                          
						also corresponds to amino acids 54 - 370 of AF012130_P1, and 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a third amino acid sequence being at least 70%, optionally at	      20 SLGAAGGFPGAASPGADPYGPREPPPPPPRYDPCAAAAPGAPGPPPPPHA 69                                                           
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     104 YPFAPAAGAATSAAAEPEGPGASCAAAAKAPVKKNAKVAGVSVQLEMKAL 153                                                          
						DAAEARREFQRDAGGPAVLGDPAHPPQLLARVLSPSLPGAGGAGGLVPLPGAPGGRPSPP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						NPELRLEAPGASEPLHHHPYKYPAAAYDHYLGAKSRPAPYPLPGLRGHGYHPHAHPHHHH 	      70 YPFAPAAGAATSAAAEPEGPGASCAAAAKAPVKKNAKVAGVSVQLEMKAL 119                                                          
						HPVSPAAAAAAAAAAAAAAANMYSSAGAAPPGSYDYCPR                      	                  .         .         .         .         .  
						polypeptide having the sequence corresponding to amino acids 	     154 WDEFNQLGTEMIVTKAGRRMFPTFQVKLFGMDPMADYMLLMDFVPVDDKR 203                                                          
						371 - 529 of AF012130_P1, wherein said first amino acid      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence and third amino acid    	     120 WDEFNQLGTEMIVTKAGRRMFPTFQVKLFGMDPMADYMLLMDFVPVDDKR 169                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a head of AF012130_P1,     	     204 YRYAFHSSSWLVAGKADPATPGRVHYHPDSPAKGAQWMKQIVSFDKLKLT 253                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     170 YRYAFHSSSWLVAGKADPATPGRVHYHPDSPAKGAQWMKQIVSFDKLKLT 219                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence                         	     254 NNLLDDNGHIILNSMHRYQPRFHVVYVDPRKDSEKYAEENFKTFVFEETR 303                                                          
						GRGSEEEGNRGRASGGGGAHRPPGLRVLRPGEASLAARIPGRDALQHRHQGHG of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AF012130_P1.3.An isolated polypeptide encoding for a tail of 	     220 NNLLDDNGHIILNSMHRYQPRFHVVYVDPRKDSEKYAEENFKTFVFEETR 269                                                          
						AF012130_P1, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     304 FTAVTAYQNHRITQLKIASNPFAKGFRDCDPEDWPRNHRPGALPLMSAFA 353                                                          
						more preferably at least about 90% and most preferably at    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DAAEARREFQRDAGGPAVLGDPAHPPQLLARVLSPSLPGAGGAGGLVPLPGAPGGRPSPP 	     270 FTAVTAYQNHRITQLKIASNPFAKGFRDCDPEDWPRNHRPGALPLMSAFA 319                                                          
						NPELRLEAPGASEPLHHHPYKYPAAAYDHYLGAKSRPAPYPLPGLRGHGYHPHAHPHHHH 	                  .                                          
						HPVSPAAAAAAAAAAAAAAANMYSSAGAAPPGSYDYCPR                      	     354 RSRNPVASPTQPSGTEK                                  370                                                          
						least about 95% homologous to the sequence in AF012130_P1.   	         |||||||||||||||||                                   
						                                                            	     320 RSRNPVASPTQPSGTEK                                  336                                                          

24690	HMR136_AF012130_6_tr0_r1_1_gPRT		Comparison report between AF012130_P6 and TBX1_HUMANunique   	Sequence name: TBX1_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AF012130_P6, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 24690 x TBX1_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						GRGSEEEGNRGRASGGGGAHRPPGLRVLRPGEASLAARIPGRDALQHRHQGHG        	                                                            
						corresponding to amino acids 1 - 53 of AF012130_P6, a second 	                     Quality: 2724.00                      Escore:       0                                               
						SLGAAGGFPGAASPGADPYGPREPPPPPPRYDPCAAAAPGAPGPPPPPHAYPFAPAAGAA 	             Matching length:     273                Total length:     273                                               
						TSAAAEPEGPGASCAAAAKAPVKKNAKVAGVSVQLEMKALWDEFNQLGTEMIVTKAGRRM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FPTFQVKLFGMDPMADYMLLMDFVPVDDKRYRYAFHSSSWLVAGKADPATPGRVHYHPDS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PAKGAQWMKQIVSFDKLKLTNNLLDDNGHIILNSMHRYQPRFHVVYVDPRKDSEKYAEEN 	                        Gaps:       0                        
						FKTFVFEETRFTAVTAYQNHRITQLKIASNPFA                            	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 20 - 292 of TBX1_HUMAN, which   	                  .         .         .         .         .  
						also corresponds to amino acids 54 - 326 of AF012130_P6, and 	      54 SLGAAGGFPGAASPGADPYGPREPPPPPPRYDPCAAAAPGAPGPPPPPHA 103                                                          
						a third amino acid sequence being at least 70%, optionally at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	      20 SLGAAGGFPGAASPGADPYGPREPPPPPPRYDPCAAAAPGAPGPPPPPHA 69                                                           
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						YDHYLGAKSRPAPYPLPGLRGHGYHPHAHPHHHHHPVSPAAAAAAAAAAAAAAANMYSSA 	     104 YPFAPAAGAATSAAAEPEGPGASCAAAAKAPVKKNAKVAGVSVQLEMKAL 153                                                          
						GAAPPGSYDYCPR                                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence corresponding to amino acids 	      70 YPFAPAAGAATSAAAEPEGPGASCAAAAKAPVKKNAKVAGVSVQLEMKAL 119                                                          
						327 - 399 of AF012130_P6, wherein said first amino acid      	                  .         .         .         .         .  
						sequence, second amino acid sequence and third amino acid    	     154 WDEFNQLGTEMIVTKAGRRMFPTFQVKLFGMDPMADYMLLMDFVPVDDKR 203                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of AF012130_P6,     	     120 WDEFNQLGTEMIVTKAGRRMFPTFQVKLFGMDPMADYMLLMDFVPVDDKR 169                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     204 YRYAFHSSSWLVAGKADPATPGRVHYHPDSPAKGAQWMKQIVSFDKLKLT 253                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence                         	     170 YRYAFHSSSWLVAGKADPATPGRVHYHPDSPAKGAQWMKQIVSFDKLKLT 219                                                          
						GRGSEEEGNRGRASGGGGAHRPPGLRVLRPGEASLAARIPGRDALQHRHQGHG of     	                  .         .         .         .         .  
						AF012130_P6.3.An isolated polypeptide encoding for a tail of 	     254 NNLLDDNGHIILNSMHRYQPRFHVVYVDPRKDSEKYAEENFKTFVFEETR 303                                                          
						AF012130_P6, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     220 NNLLDDNGHIILNSMHRYQPRFHVVYVDPRKDSEKYAEENFKTFVFEETR 269                                                          
						more preferably at least about 90% and most preferably at    	                  .         .                                
						YDHYLGAKSRPAPYPLPGLRGHGYHPHAHPHHHHHPVSPAAAAAAAAAAAAAAANMYSSA 	     304 FTAVTAYQNHRITQLKIASNPFA                            326                                                          
						GAAPPGSYDYCPR                                                	         |||||||||||||||||||||||                             
						least about 95% homologous to the sequence in AF012130_P6.   	     270 FTAVTAYQNHRITQLKIASNPFA                            292                                                          

24694	HMR136_AF012130_7_tr0_r1_1_gPRT		Comparison report between AF012130_P7 and TBX1_HUMANunique   	Sequence name: TBX1_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AF012130_P7, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 24694 x TBX1_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						GRGSEEEGNRGRASGGGGAHRPPGLRVLRPGEASLAARIPGRDALQHRHQGHG        	                                                            
						corresponding to amino acids 1 - 53 of AF012130_P7, a second 	                     Quality: 3185.00                      Escore:       0                                               
						SLGAAGGFPGAASPGADPYGPREPPPPPPRYDPCAAAAPGAPGPPPPPHAYPFAPAAGAA 	             Matching length:     318                Total length:     318                                               
						TSAAAEPEGPGASCAAAAKAPVKKNAKVAGVSVQLEMKALWDEFNQLGTEMIVTKAGRRM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						FPTFQVKLFGMDPMADYMLLMDFVPVDDKRYRYAFHSSSWLVAGKADPATPGRVHYHPDS 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						PAKGAQWMKQIVSFDKLKLTNNLLDDNGHIILNSMHRYQPRFHVVYVDPRKDSEKYAEEN 	                        Gaps:       0                        
						FKTFVFEETRFTAVTAYQNHRITQLKIASNPFAKGFRDCDPEDWPRNHRPGALPLMSAFA 	                                                            
						RSRNPVASPTQPSGTEKG                                           	Alignment:                                                   
						amino acid sequence being at least 90 % homologous to        	                  .         .         .         .         .  
						corresponding to amino acids 20 - 337 of TBX1_HUMAN, which   	      54 SLGAAGGFPGAASPGADPYGPREPPPPPPRYDPCAAAAPGAPGPPPPPHA 103                                                          
						also corresponds to amino acids 54 - 371 of AF012130_P7, and 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a third amino acid sequence being at least 70%, optionally at	      20 SLGAAGGFPGAASPGADPYGPREPPPPPPRYDPCAAAAPGAPGPPPPPHA 69                                                           
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     104 YPFAPAAGAATSAAAEPEGPGASCAAAAKAPVKKNAKVAGVSVQLEMKAL 153                                                          
						RAGVVGSGFRPCARSTPGRRPRPTSPAPPGRSRLSRRLHNGRGGGQARTRPPGPTAAPRP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPPPPAEGRGPRGGLG                                             	      70 YPFAPAAGAATSAAAEPEGPGASCAAAAKAPVKKNAKVAGVSVQLEMKAL 119                                                          
						polypeptide having the sequence corresponding to amino acids 	                  .         .         .         .         .  
						372 - 447 of AF012130_P7, wherein said first amino acid      	     154 WDEFNQLGTEMIVTKAGRRMFPTFQVKLFGMDPMADYMLLMDFVPVDDKR 203                                                          
						sequence, second amino acid sequence and third amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     120 WDEFNQLGTEMIVTKAGRRMFPTFQVKLFGMDPMADYMLLMDFVPVDDKR 169                                                          
						isolated polypeptide encoding for a head of AF012130_P7,     	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     204 YRYAFHSSSWLVAGKADPATPGRVHYHPDSPAKGAQWMKQIVSFDKLKLT 253                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     170 YRYAFHSSSWLVAGKADPATPGRVHYHPDSPAKGAQWMKQIVSFDKLKLT 219                                                          
						about 95% homologous to the sequence                         	                  .         .         .         .         .  
						GRGSEEEGNRGRASGGGGAHRPPGLRVLRPGEASLAARIPGRDALQHRHQGHG of     	     254 NNLLDDNGHIILNSMHRYQPRFHVVYVDPRKDSEKYAEENFKTFVFEETR 303                                                          
						AF012130_P7.3.An isolated polypeptide encoding for a tail of 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AF012130_P7, comprising a polypeptide being at least 70%,    	     220 NNLLDDNGHIILNSMHRYQPRFHVVYVDPRKDSEKYAEENFKTFVFEETR 269                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     304 FTAVTAYQNHRITQLKIASNPFAKGFRDCDPEDWPRNHRPGALPLMSAFA 353                                                          
						RAGVVGSGFRPCARSTPGRRPRPTSPAPPGRSRLSRRLHNGRGGGQARTRPPGPTAAPRP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						PPPPPAEGRGPRGGLG                                             	     270 FTAVTAYQNHRITQLKIASNPFAKGFRDCDPEDWPRNHRPGALPLMSAFA 319                                                          
						least about 95% homologous to the sequence in AF012130_P7.   	                  .                                          
						                                                            	     354 RSRNPVASPTQPSGTEKG                                 371                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     320 RSRNPVASPTQPSGTEKG                                 337                                                          

24692	HMR136_AF012130_8_tr0_r1_1_gPRT		Comparison report between AF012130_P8 and TBX1_HUMANunique   	Sequence name: TBX1_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AF012130_P8, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 24692 x TBX1_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						GRGSEEEGNRGRASGGGGAHRPPGLRVLRPGEASLAARIPGRDALQHRHQGHG        	                                                            
						corresponding to amino acids 1 - 53 of AF012130_P8, a second 	                     Quality: 2615.00                      Escore:       0                                               
						SLGAAGGFPGAASPGADPYGPREPPPPPPRYDPCAAAAPGAPGPPPPPHAYPFAPAAGAA 	             Matching length:     262                Total length:     262                                               
						TSAAAEPEGPGASCAAAAKAPVKKNAKVAGVSVQLEMKALWDEFNQLGTEMIVTKAGRRM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.62                                               
						FPTFQVKLFGMDPMADYMLLMDFVPVDDKRYRYAFHSSSWLVAGKADPATPGRVHYHPDS 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.62                                               
						PAKGAQWMKQIVSFDKLKLTNNLLDDNGHIILNSMHRYQPRFHVVYVDPRKDSEKYAEEN 	                        Gaps:       0                        
						FKTFVFEETRFTAVTAYQNHR                                        	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 20 - 280 of TBX1_HUMAN, which   	                  .         .         .         .         .  
						also corresponds to amino acids 54 - 314 of AF012130_P8, and 	      54 SLGAAGGFPGAASPGADPYGPREPPPPPPRYDPCAAAAPGAPGPPPPPHA 103                                                          
						a third amino acid sequence being at least 70%, optionally at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	      20 SLGAAGGFPGAASPGADPYGPREPPPPPPRYDPCAAAAPGAPGPPPPPHA 69                                                           
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence                              	     104 YPFAPAAGAATSAAAEPEGPGASCAAAAKAPVKKNAKVAGVSVQLEMKAL 153                                                          
						VRACGESQGPQAAPSLSRLAGPASYQLDLSSGNCHFVLKVCFPNHSGNSPSGA        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 315 - 367 of AF012130_P8,       	      70 YPFAPAAGAATSAAAEPEGPGASCAAAAKAPVKKNAKVAGVSVQLEMKAL 119                                                          
						wherein said first amino acid sequence, second amino acid    	                  .         .         .         .         .  
						sequence and third amino acid sequence are contiguous and in 	     154 WDEFNQLGTEMIVTKAGRRMFPTFQVKLFGMDPMADYMLLMDFVPVDDKR 203                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						head of AF012130_P8, comprising a polypeptide being at least 	     120 WDEFNQLGTEMIVTKAGRRMFPTFQVKLFGMDPMADYMLLMDFVPVDDKR 169                                                          
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	     204 YRYAFHSSSWLVAGKADPATPGRVHYHPDSPAKGAQWMKQIVSFDKLKLT 253                                                          
						at least about 95% homologous to the sequence                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GRGSEEEGNRGRASGGGGAHRPPGLRVLRPGEASLAARIPGRDALQHRHQGHG of     	     170 YRYAFHSSSWLVAGKADPATPGRVHYHPDSPAKGAQWMKQIVSFDKLKLT 219                                                          
						AF012130_P8.3.An isolated polypeptide encoding for a tail of 	                  .         .         .         .         .  
						AF012130_P8, comprising a polypeptide being at least 70%,    	     254 NNLLDDNGHIILNSMHRYQPRFHVVYVDPRKDSEKYAEENFKTFVFEETR 303                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     220 NNLLDDNGHIILNSMHRYQPRFHVVYVDPRKDSEKYAEENFKTFVFEETR 269                                                          
						least about 95% homologous to the sequence                   	                  .                                          
						VRACGESQGPQAAPSLSRLAGPASYQLDLSSGNCHFVLKVCFPNHSGNSPSGA in     	     304 FTAVTAYQNHRV                                       315                                                          
						AF012130_P8.                                                 	         |||||||||||:                                        
						                                                            	     270 FTAVTAYQNHRI                                       281                                                          

25769	HMR136_AF019352_1_tr0_r1_1_gPRT		Comparison report between AF019352_P1 and KDGB_HUMANpartial  	Sequence name: KDGB_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for AF019352_P1, comprising a first     	                                                            
						MQRANSVTVDGQGLQVTPVPGTHPLLVFVNPKSGGKQGERIYRKFQYLLNPRQVYSLSGN 	Alignment of: 25769 x KDGB_HUMAN   ..                        
						GPMPGLNFFRDVPDFRVLACGGDGTVGWVLDCIEKANVGKHPPVAILPLGTGNDLARCLR 	                                                            
						WGGGYEGENLMKILKDIENSTEIMLDRWKFEVIPNDKDEKGDPVPYSIINNYFSIGVDAS 	Alignment segment 1/1:                                       
						IAHRFHIMREKHPEKFNSRMKNKFWYFEFGTSETFSATCKKLHESVEIECDGVQIDLINI 	                                                            
						SLEGIAILNIPSMHGGSNLWGESKKRRSHRRIEKKGSDKRTTVTDAKELKFASQDLSDQL 	                     Quality: 3867.00                      Escore:       0                                               
						LEVVGLEGAMEMGQIYTGLKSAGRRLAQCSCVVIRTSKSLPMQIDGEPWMQTPCTIKITH 	             Matching length:     390                Total length:     390                                               
						KNQAPMLMGPPPKTGLFCSLVKRTRNRSKE                               	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						amino acid sequence being at least 90 % homologous to        	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 415 - 804 of KDGB_HUMAN, which  	                        Gaps:       0                        
						also corresponds to amino acids 1 - 390 of AF019352_P1.      	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MQRANSVTVDGQGLQVTPVPGTHPLLVFVNPKSGGKQGERIYRKFQYLLN 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     415 MQRANSVTVDGQGLQVTPVPGTHPLLVFVNPKSGGKQGERIYRKFQYLLN 464                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 PRQVYSLSGNGPMPGLNFFRDVPDFRVLACGGDGTVGWVLDCIEKANVGK 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     465 PRQVYSLSGNGPMPGLNFFRDVPDFRVLACGGDGTVGWVLDCIEKANVGK 514                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 HPPVAILPLGTGNDLARCLRWGGGYEGENLMKILKDIENSTEIMLDRWKF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     515 HPPVAILPLGTGNDLARCLRWGGGYEGENLMKILKDIENSTEIMLDRWKF 564                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EVIPNDKDEKGDPVPYSIINNYFSIGVDASIAHRFHIMREKHPEKFNSRM 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     565 EVIPNDKDEKGDPVPYSIINNYFSIGVDASIAHRFHIMREKHPEKFNSRM 614                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 KNKFWYFEFGTSETFSATCKKLHESVEIECDGVQIDLINISLEGIAILNI 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     615 KNKFWYFEFGTSETFSATCKKLHESVEIECDGVQIDLINISLEGIAILNI 664                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 PSMHGGSNLWGESKKRRSHRRIEKKGSDKRTTVTDAKELKFASQDLSDQL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     665 PSMHGGSNLWGESKKRRSHRRIEKKGSDKRTTVTDAKELKFASQDLSDQL 714                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 LEVVGLEGAMEMGQIYTGLKSAGRRLAQCSCVVIRTSKSLPMQIDGEPWM 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     715 LEVVGLEGAMEMGQIYTGLKSAGRRLAQCSCVVIRTSKSLPMQIDGEPWM 764                                                          
						                                                            	                  .         .         .         .            
						                                                            	     351 QTPCTIKITHKNQAPMLMGPPPKTGLFCSLVKRTRNRSKE           390                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||            
						                                                            	     765 QTPCTIKITHKNQAPMLMGPPPKTGLFCSLVKRTRNRSKE           804                                                          

25765	HMR136_AF019352_4_tr0_r1_1_gPRT		Comparison report between AF019352_P4 and KDGB_HUMANpartial  	Sequence name: KDGB_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for AF019352_P4, comprising a first     	Sequence documentation:                                      
						MTNQEKWAHLSPSEFSQLQKYAEYSTKKLKDVLEEFHGNGVLAKYNPEGKQDILNQTIDF 	                                                            
						EGFKLFMKTFLEAELPDDFTAHLFMSFSNKFPHSSPMVKSKPALLSGGLRMNKGAITPPR 	Alignment of: 25765 x KDGB_HUMAN   ..                        
						TTSPANTCSPEVIHLKDIVCYLSLLERGRPEDKLEFMFRLYDTDGNGFLDSSELENIISQ 	                                                            
						MMHVAEYLEWDVTELNPILHEMMEEIDYDHDGTVSLEEWIQGGMTTIPLLVLLGLENNVK 	Alignment segment 1/1:                                       
						DDGQHVWRLKHFNKPAYCNLCLNMLIGVGKQGLCCSFCKYTVHERCVARAPPSCIKTYVK 	                                                            
						SKRNTDVMHHYWVEGNCPTKCDKCHKTVKCYQGLTGLHCVWCQITLHNKCASHLKPECDC 	                     Quality: 3840.00                      Escore:       0                                               
						GPLKDHILPPTTICPVVL                                           	             Matching length:     378                Total length:     378                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 378 of KDGB_HUMAN, which    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						also corresponds to amino acids 1 - 378 of AF019352_P4, and a	                        Gaps:       0                        
						second amino acid sequence being at least 70%, optionally at 	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence DSAHFRSFSS corresponding to  	       1 MTNQEKWAHLSPSEFSQLQKYAEYSTKKLKDVLEEFHGNGVLAKYNPEGK 50                                                           
						amino acids 379 - 388 of AF019352_P4, wherein said first     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and second amino acid sequence are       	       1 MTNQEKWAHLSPSEFSQLQKYAEYSTKKLKDVLEEFHGNGVLAKYNPEGK 50                                                           
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of AF019352_P4, comprising a 	      51 QDILNQTIDFEGFKLFMKTFLEAELPDDFTAHLFMSFSNKFPHSSPMVKS 100                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	      51 QDILNQTIDFEGFKLFMKTFLEAELPDDFTAHLFMSFSNKFPHSSPMVKS 100                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence DSAHFRSFSS in AF019352_P4.                   	     101 KPALLSGGLRMNKGAITPPRTTSPANTCSPEVIHLKDIVCYLSLLERGRP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 KPALLSGGLRMNKGAITPPRTTSPANTCSPEVIHLKDIVCYLSLLERGRP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EDKLEFMFRLYDTDGNGFLDSSELENIISQMMHVAEYLEWDVTELNPILH 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 EDKLEFMFRLYDTDGNGFLDSSELENIISQMMHVAEYLEWDVTELNPILH 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 EMMEEIDYDHDGTVSLEEWIQGGMTTIPLLVLLGLENNVKDDGQHVWRLK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 EMMEEIDYDHDGTVSLEEWIQGGMTTIPLLVLLGLENNVKDDGQHVWRLK 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 HFNKPAYCNLCLNMLIGVGKQGLCCSFCKYTVHERCVARAPPSCIKTYVK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 HFNKPAYCNLCLNMLIGVGKQGLCCSFCKYTVHERCVARAPPSCIKTYVK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SKRNTDVMHHYWVEGNCPTKCDKCHKTVKCYQGLTGLHCVWCQITLHNKC 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SKRNTDVMHHYWVEGNCPTKCDKCHKTVKCYQGLTGLHCVWCQITLHNKC 350                                                          
						                                                            	                  .         .                                
						                                                            	     351 ASHLKPECDCGPLKDHILPPTTICPVVL                       378                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     351 ASHLKPECDCGPLKDHILPPTTICPVVL                       378                                                          

25767	HMR136_AF019352_5_tr0_r1_1_gPRT		Comparison report between AF019352_P5 and KDGB_HUMANpartial  	Sequence name: KDGB_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for AF019352_P5, comprising a first     	Sequence documentation:                                      
						MTNQEKWAHLSPSEFSQLQKYAEYSTKKLKDVLEEFHGNGVLAKYNPEGKQDILNQTIDF 	                                                            
						EGFKLFMKTFLEAELPDDFTAHLFMSFSNKFPHSSPMVKSKPALLSGGLRMNKGAITPPR 	Alignment of: 25767 x KDGB_HUMAN   ..                        
						TTSPANTCSPEVIHLKDIVCYLSLLERGRPEDKLEFMFRLYDTDGNGFLDSSELENIISQ 	                                                            
						MMHVAEYLEWDVTELNPILHEMMEEIDYDHDGTVSLEEWIQGGMTTIPLLVLLGLENNVK 	Alignment segment 1/1:                                       
						DDGQHVWRLKHFNKPAYCNLCLNMLIGVGKQGLCCSFCKYTVHERCVARAPPSCIKTYVK 	                                                            
						SKRNTDVMHHYWVEGNCPTKCDKCHKTVKCYQGLTGLHCVWCQITLHNKCASHLKPECDC 	                     Quality: 3840.00                      Escore:       0                                               
						GPLKDHILPPTTICPVVL                                           	             Matching length:     378                Total length:     378                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 378 of KDGB_HUMAN, which    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						also corresponds to amino acids 1 - 378 of AF019352_P5, and a	                        Gaps:       0                        
						second amino acid sequence being at least 70%, optionally at 	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence DSAHFRSFSS corresponding to  	       1 MTNQEKWAHLSPSEFSQLQKYAEYSTKKLKDVLEEFHGNGVLAKYNPEGK 50                                                           
						amino acids 379 - 388 of AF019352_P5, wherein said first     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and second amino acid sequence are       	       1 MTNQEKWAHLSPSEFSQLQKYAEYSTKKLKDVLEEFHGNGVLAKYNPEGK 50                                                           
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of AF019352_P5, comprising a 	      51 QDILNQTIDFEGFKLFMKTFLEAELPDDFTAHLFMSFSNKFPHSSPMVKS 100                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	      51 QDILNQTIDFEGFKLFMKTFLEAELPDDFTAHLFMSFSNKFPHSSPMVKS 100                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence DSAHFRSFSS in AF019352_P5.                   	     101 KPALLSGGLRMNKGAITPPRTTSPANTCSPEVIHLKDIVCYLSLLERGRP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 KPALLSGGLRMNKGAITPPRTTSPANTCSPEVIHLKDIVCYLSLLERGRP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EDKLEFMFRLYDTDGNGFLDSSELENIISQMMHVAEYLEWDVTELNPILH 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 EDKLEFMFRLYDTDGNGFLDSSELENIISQMMHVAEYLEWDVTELNPILH 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 EMMEEIDYDHDGTVSLEEWIQGGMTTIPLLVLLGLENNVKDDGQHVWRLK 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 EMMEEIDYDHDGTVSLEEWIQGGMTTIPLLVLLGLENNVKDDGQHVWRLK 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 HFNKPAYCNLCLNMLIGVGKQGLCCSFCKYTVHERCVARAPPSCIKTYVK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 HFNKPAYCNLCLNMLIGVGKQGLCCSFCKYTVHERCVARAPPSCIKTYVK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SKRNTDVMHHYWVEGNCPTKCDKCHKTVKCYQGLTGLHCVWCQITLHNKC 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SKRNTDVMHHYWVEGNCPTKCDKCHKTVKCYQGLTGLHCVWCQITLHNKC 350                                                          
						                                                            	                  .         .                                
						                                                            	     351 ASHLKPECDCGPLKDHILPPTTICPVVL                       378                                                          
						                                                            	         ||||||||||||||||||||||||||||                        
						                                                            	     351 ASHLKPECDCGPLKDHILPPTTICPVVL                       378                                                          

26298	HMR136_AF030626_5_tr0_r1_1_gPRT		Comparison report between AF030626_P5 and V2R_HUMANpartial   	Sequence name: V2R_HUMAN                                     
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for AF030626_P5, comprising a first     	Sequence documentation:                                      
						MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLA 	                                                            
						ALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQM 	Alignment of: 26298 x V2R_HUMAN   ..                         
						VGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQ 	                                                            
						RNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGP 	Alignment segment 1/1:                                       
						SERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTL                           	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2675.00                      Escore:       0                                               
						corresponding to amino acids 1 - 274 of V2R_HUMAN, which also	             Matching length:     284                Total length:     284                                               
						corresponds to amino acids 1 - 274 of AF030626_P5, and a     	 Matching Percent Similarity:   97.89   Matching Percent Identity:   97.54                                               
						second amino acid sequence being at least 70%, optionally at 	    Total Percent Similarity:   97.89      Total Percent Identity:   97.54                                               
						least 80%, preferably at least 85%, more preferably at least 	                        Gaps:       0                        
						90% and most preferably at least 95% homologous to a         	                                                            
						GRPLCYSCCWPASTAAPTPGSMHLSAAACPQSCEACSAVPGDAPHPAWVPKMSPAPPPAP 	Alignment:                                                   
						PWPRTLHREELLGVLPLEALRSSAAFLGLVLGATGRGTRGELARACGPEAGTLCGPGQAT 	                  .         .         .         .         .  
						APAWVSTSPAV                                                  	       1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVA 50                                                           
						polypeptide having the sequence corresponding to amino acids 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						275 - 405 of AF030626_P5, wherein said first amino acid      	       1 MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVA 50                                                           
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	      51 VALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWK 100                                                          
						tail of AF030626_P5, comprising a polypeptide being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	      51 VALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWK 100                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						GRPLCYSCCWPASTAAPTPGSMHLSAAACPQSCEACSAVPGDAPHPAWVPKMSPAPPPAP 	     101 ATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRH 150                                                          
						PWPRTLHREELLGVLPLEALRSSAAFLGLVLGATGRGTRGELARACGPEAGTLCGPGQAT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						APAWVSTSPAV                                                  	     101 ATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRH 150                                                          
						at least about 95% homologous to the sequence in AF030626_P5.	                  .         .         .         .         .  
						                                                            	     151 GSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPW 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 GSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPW 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 GRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 GRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRG 250                                                          
						                                                            	                  .         .         .                      
						                                                            	     251 RRTGSPGEGAHVSAAVAKTVRMTLGRPLCYSCCW                 284                                                          
						                                                            	         ||||||||||||||||||||||||   : |  ||                  
						                                                            	     251 RRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCW                 284                                                          

27814	HMR136_AF048712_2_tr0_r1_1_gPRT		Comparison report between AF048712_P2 and Q9UH86partial WT   	Sequence name: Q9UH86                                        
						sequence followed by unique insertion.1.An isolated chimeric 	                                                            
						polypeptide encoding for AF048712_P2, comprising a first     	Sequence documentation:                                      
						MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLER 	                                                            
						YPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISAYDDELAF 	Alignment of: 27814 x Q9UH86   ..                            
						YGILPEIIGDCCYEEYKDRKRENAERLMDDNDSENNQESMPSLSFRQTMWRAFENPHTST 	                                                            
						LALVFYYVTGFFIAVSVITNVVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVE 	Alignment segment 1/1:                                       
						YLLRLFAAPSRYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 	                                                            
						SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASKFTSIPASFWY 	                     Quality: 6150.00                      Escore:       0                                               
						TIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVPVIVSNFSRIYHQNQRADKRR 	             Matching length:     636                Total length:     655                                               
						AQKKARLARIRVAKTGSSNAYLHSKRNGLLNEALELTGTPEEEHMGKTTSLIESQHHHLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						HCLEKTT                                                      	    Total Percent Similarity:   97.10      Total Percent Identity:   97.10                                               
						amino acid sequence being at least 90 % homologous to        	                        Gaps:       1                        
						corresponding to amino acids 1 - 487 of Q9UH86, which also   	                                                            
						corresponds to amino acids 1 - 487 of AF048712_P2, a second  	Alignment:                                                   
						amino acid sequence being at least 70%, optionally at least  	                  .         .         .         .         .  
						80%, preferably at least 85%, more preferably at least 90%   	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						and most preferably at least 95% homologous to a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence GLSYLVDDPLLSVRTSTIK corresponding to     	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						amino acids 488 - 506 of AF048712_P2, and a third amino acid 	                  .         .         .         .         .  
						NHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRRSKKTTHLPNSNLPATR 	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						LRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDGLRPNCKTSQITTAIISIPTPPALTPE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						GESRPPPASPGPNTNIPSIASNVVKVSAL                                	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 488 - 636 of Q9UH86, which also corresponds to   	     101 GKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDD 150                                                          
						amino acids 507 - 655 of AF048712_P2, wherein said first     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	     101 GKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDD 150                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for an edge portion 	     151 NDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITN 200                                                          
						of AF048712_P2, comprising an amino acid sequence being at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least about 80%, preferably at least	     151 NDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITN 200                                                          
						about 85%, more preferably at least about 90% and most       	                  .         .         .         .         .  
						preferably at least about 95% homologous to the sequence     	     201 VVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPS 250                                                          
						encoding for GLSYLVDDPLLSVRTSTIK, corresponding to           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AF048712_P2.                                                 	     201 VVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 RYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 FTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVP 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 FTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVP 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 NEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTTGLSYLVDDPLLSV 500                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     451 NEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTT............. 487                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 RTSTIKNHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRR 550                                                          
						                                                            	               ||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     488 ......NHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRR 531                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 SKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDG 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     532 SKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDG 581                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     601 LRPNCKTSQITTAIISIPTPPALTPEGESRPPPASPGPNTNIPSIASNVV 650                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     582 LRPNCKTSQITTAIISIPTPPALTPEGESRPPPASPGPNTNIPSIASNVV 631                                                          
						                                                            	                                                             
						                                                            	     651 KVSAL                                              655                                                          
						                                                            	         |||||                                               
						                                                            	     632 KVSAL                                              636                                                          

27818	HMR136_AF048712_3_tr0_r1_1_gPRT		Comparison report between AF048712_P3 and Q9UH86partial WT   	Sequence name: Q9UH86                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF048712_P3, comprising a first     	Sequence documentation:                                      
						MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLER 	                                                            
						YPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISAYDDELAF 	Alignment of: 27818 x Q9UH86   ..                            
						YGILPEIIGDCCYEEYKDRKRENAERLMDDNDSENNQESMPSLSFRQTMWRAFENPHTST 	                                                            
						LALVFYYVTGFFIAVSVITNVVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVE 	Alignment segment 1/1:                                       
						YLLRLFAAPSRYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 	                                                            
						SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASKFTSIPASFWY 	                     Quality: 5803.00                      Escore:       0                                               
						TIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVPVIVSNFSRIYHQNQRADKRR 	             Matching length:     590                Total length:     590                                               
						AQKKARLARIRVAKTGSSNAYLHSKRNGLLNEALELTGTPEEEHMGKTTSLIESQHHHLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.83                                               
						HCLEKTTNHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRRSKKTTHLPN 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.83                                               
						SNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDGLRPNCKTS            	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 589 of Q9UH86, which also   	Alignment:                                                   
						corresponds to amino acids 1 - 589 of AF048712_P3, and a     	                  .         .         .         .         .  
						second amino acid sequence being at least 70%, optionally at 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						polypeptide having the sequence KTKSSKEAKLSQAKQEENITLCI      	                  .         .         .         .         .  
						corresponding to amino acids 590 - 612 of AF048712_P3,       	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						wherein said first amino acid sequence and second amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						isolated polypeptide encoding for a tail of AF048712_P3,     	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     101 GKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDD 150                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     101 GKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDD 150                                                          
						about 95% homologous to the sequence KTKSSKEAKLSQAKQEENITLCI 	                  .         .         .         .         .  
						in AF048712_P3.                                              	     151 NDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITN 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 NDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITN 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 RYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 FTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVP 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 FTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVP 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 NEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTTNHEFIDEQMFEQN 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 NEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTTNHEFIDEQMFEQN 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 CMESSMQNYPSTRSPSLSSHPGLTTTCCSRRSKKTTHLPNSNLPATRLRS 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 CMESSMQNYPSTRSPSLSSHPGLTTTCCSRRSKKTTHLPNSNLPATRLRS 550                                                          
						                                                            	                  .         .         .         .            
						                                                            	     551 MQELSTIHIQGSEQPSLTTSRSSLNLKADDGLRPNCKTSK           590                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||:            
						                                                            	     551 MQELSTIHIQGSEQPSLTTSRSSLNLKADDGLRPNCKTSQ           590                                                          

						Comparison report between AF048712_P3 and Q9UH85partial WT   	Sequence name: Q9UH85                                        
						sequence featuring skipped exon and a followed by a unique   	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AF048712_P3, comprising a first amino acid sequence being at 	                                                            
						MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLER 	Alignment of: 27818 x Q9UH85   ..                            
						YPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISAYDDELAF 	                                                            
						YGILPEIIGDCCYEEYKDRKRENAERLMDDNDSENNQESMPSLSFRQTMWRAFENPHTST 	Alignment segment 1/1:                                       
						LALVFYYVTGFFIAVSVITNVVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVE 	                                                            
						YLLRLFAAPSRYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 	                     Quality: 5703.00                      Escore:       0                                               
						SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASKFTSIPASFWY 	             Matching length:     590                Total length:     609                                               
						TIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVPVIVSNFSRIYHQNQRADKRR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.83                                               
						AQKKARLARIRVAKTGSSNAYLHSKRNGLLNEALELTGTPEEEHMGKTTSLIESQHHHLL 	    Total Percent Similarity:   96.88      Total Percent Identity:   96.72                                               
						HCLEKTT                                                      	                        Gaps:       1                        
						least 90 % homologous to corresponding to amino acids 1 - 487	                                                            
						of Q9UH85, which also corresponds to amino acids 1 - 487 of  	Alignment:                                                   
						AF048712_P3, a second amino acid sequence being at least 90 %	                  .         .         .         .         .  
						NHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRRSKKTTHLPNSNLPATR 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						LRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDGLRPNCKTS                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 507 - 608 of      	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						Q9UH85, which also corresponds to amino acids 488 - 589 of   	                  .         .         .         .         .  
						AF048712_P3, and a third amino acid sequence being at least  	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						homologous to a polypeptide having the sequence              	                  .         .         .         .         .  
						KTKSSKEAKLSQAKQEENITLCI corresponding to amino acids 590 -   	     101 GKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDD 150                                                          
						612 of AF048712_P3, wherein said first amino acid sequence,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence and third amino acid sequence are 	     101 GKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDD 150                                                          
						contiguous and in a sequential order.2.An isolated chimeric  	                  .         .         .         .         .  
						polypeptide encoding for an edge portion of AF048712_P3,     	     151 NDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITN 200                                                          
						comprising a polypeptide having a length "n", wherein n is at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 10 amino acids in length, optionally at least    	     151 NDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITN 200                                                          
						about 20 amino acids in length, preferably at least about 30 	                  .         .         .         .         .  
						amino acids in length, more preferably at least about 40     	     201 VVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPS 250                                                          
						amino acids in length and most preferably at least about 50  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids in length, wherein at least two amino acids      	     201 VVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPS 250                                                          
						comprise TN, having a structure as follows: a sequence       	                  .         .         .         .         .  
						starting from any of amino acid numbers 487-x to 488; and    	     251 RYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 300                                                          
						ending at any of amino acid numbers 488+ ((n-2) - x), in     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						which x varies from 0 to n-2.3.An isolated polypeptide       	     251 RYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 300                                                          
						encoding for a tail of AF048712_P3, comprising a polypeptide 	                  .         .         .         .         .  
						being at least 70%, optionally at least about 80%, preferably	     301 SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASK 350                                                          
						at least about 85%, more preferably at least about 90% and   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 95% homologous to the sequence	     301 SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASK 350                                                          
						KTKSSKEAKLSQAKQEENITLCI in AF048712_P3.                      	                  .         .         .         .         .  
						                                                            	     351 FTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVP 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 FTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVP 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 NEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTT............. 487                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     451 NEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTTGLSYLVDDPLLSV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     488 ......NHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRR 531                                                          
						                                                            	               ||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 RTSTIKNHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRR 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     532 SKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDG 581                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 SKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDG 600                                                          
						                                                            	                                                             
						                                                            	     582 LRPNCKTSK                                          590                                                          
						                                                            	         ||||||||:                                           
						                                                            	     601 LRPNCKTSQ                                          609                                                          

27820	HMR136_AF048712_4_tr0_r1_1_gPRT		Comparison report between AF048712_P4 and Q9UH86partial WT   	Sequence name: Q9UH86                                        
						sequence followed by unique insertion and a followed by a    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						AF048712_P4, comprising a first amino acid sequence being at 	                                                            
						MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLER 	Alignment of: 27820 x Q9UH86   ..                            
						YPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISAYDDELAF 	                                                            
						YGILPEIIGDCCYEEYKDRKRENAERLMDDNDSENNQESMPSLSFRQTMWRAFENPHTST 	Alignment segment 1/1:                                       
						LALVFYYVTGFFIAVSVITNVVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVE 	                                                            
						YLLRLFAAPSRYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 	                     Quality: 5974.00                      Escore:       0                                               
						SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASKFTSIPASFWY 	             Matching length:     617                Total length:     636                                               
						TIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVPVIVSNFSRIYHQNQRADKRR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AQKKARLARIRVAKTGSSNAYLHSKRNGLLNEALELTGTPEEEHMGKTTSLIESQHHHLL 	    Total Percent Similarity:   97.01      Total Percent Identity:   97.01                                               
						HCLEKTT                                                      	                        Gaps:       1                        
						least 90 % homologous to corresponding to amino acids 1 - 487	                                                            
						of Q9UH86, which also corresponds to amino acids 1 - 487 of  	Alignment:                                                   
						AF048712_P4, a second amino acid sequence being at least 70%,	                  .         .         .         .         .  
						optionally at least 80%, preferably at least 85%, more       	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						GLSYLVDDPLLSVRTSTIK corresponding to amino acids 488 - 506 of	                  .         .         .         .         .  
						AF048712_P4, a third amino acid sequence being at least 90 % 	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						NHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRRSKKTTHLPNSNLPATR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDGLRPNCKTSQITTAIISIPTPPALTPE 	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						GESRPPPASP                                                   	                  .         .         .         .         .  
						homologous to corresponding to amino acids 488 - 617 of      	     101 GKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDD 150                                                          
						Q9UH86, which also corresponds to amino acids 507 - 636 of   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AF048712_P4, and a fourth amino acid sequence being at least 	     101 GKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDD 150                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	                  .         .         .         .         .  
						preferably at least 90% and most preferably at least 95%     	     151 NDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITN 200                                                          
						homologous to a polypeptide having the sequence              	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AKAFRLRSQLLLSSLSIPPGG corresponding to amino acids 637 - 657 	     151 NDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITN 200                                                          
						of AF048712_P4, wherein said first amino acid sequence,      	                  .         .         .         .         .  
						second amino acid sequence, third amino acid sequence and    	     201 VVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPS 250                                                          
						fourth amino acid sequence are contiguous and in a sequential	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						order.2.An isolated polypeptide encoding for an edge portion 	     201 VVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPS 250                                                          
						of AF048712_P4, comprising an amino acid sequence being at   	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	     251 RYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 300                                                          
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	     251 RYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 300                                                          
						encoding for GLSYLVDDPLLSVRTSTIK, corresponding to           	                  .         .         .         .         .  
						AF048712_P4.3.An isolated polypeptide encoding for a tail of 	     301 SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASK 350                                                          
						AF048712_P4, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     301 SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASK 350                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence                   	     351 FTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVP 400                                                          
						AKAFRLRSQLLLSSLSIPPGG in AF048712_P4.                        	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 FTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVP 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 NEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTTGLSYLVDDPLLSV 500                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     451 NEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTT............. 487                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 RTSTIKNHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRR 550                                                          
						                                                            	               ||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     488 ......NHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRR 531                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 SKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDG 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     532 SKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDG 581                                                          
						                                                            	                  .         .         .                      
						                                                            	     601 LRPNCKTSQITTAIISIPTPPALTPEGESRPPPASP               636                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     582 LRPNCKTSQITTAIISIPTPPALTPEGESRPPPASP               617                                                          

						Comparison report between AF048712_P4 and Q9UH85partial WT   	Sequence name: Q9UH85                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF048712_P4, comprising a first     	Sequence documentation:                                      
						MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLER 	                                                            
						YPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISAYDDELAF 	Alignment of: 27820 x Q9UH85   ..                            
						YGILPEIIGDCCYEEYKDRKRENAERLMDDNDSENNQESMPSLSFRQTMWRAFENPHTST 	                                                            
						LALVFYYVTGFFIAVSVITNVVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVE 	Alignment segment 1/1:                                       
						YLLRLFAAPSRYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 	                                                            
						SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASKFTSIPASFWY 	                     Quality: 6248.00                      Escore:       0                                               
						TIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVPVIVSNFSRIYHQNQRADKRR 	             Matching length:     636                Total length:     636                                               
						AQKKARLARIRVAKTGSSNAYLHSKRNGLLNEALELTGTPEEEHMGKTTSLIESQHHHLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						HCLEKTTGLSYLVDDPLLSVRTSTIKNHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GLTTTCCSRRSKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDG 	                        Gaps:       0                        
						LRPNCKTSQITTAIISIPTPPALTPEGESRPPPASP                         	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 1 - 636 of Q9UH85, which also   	                  .         .         .         .         .  
						corresponds to amino acids 1 - 636 of AF048712_P4, and a     	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						second amino acid sequence being at least 70%, optionally at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence AKAFRLRSQLLLSSLSIPPGG        	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						corresponding to amino acids 637 - 657 of AF048712_P4,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence and second amino acid 	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of AF048712_P4,     	     101 GKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDD 150                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     101 GKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDD 150                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence AKAFRLRSQLLLSSLSIPPGG in	     151 NDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITN 200                                                          
						AF048712_P4.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 NDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITN 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 RYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 FTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVP 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 FTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVP 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 NEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTTGLSYLVDDPLLSV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 NEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTTGLSYLVDDPLLSV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 RTSTIKNHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRR 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 RTSTIKNHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRR 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 SKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDG 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 SKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDG 600                                                          
						                                                            	                  .         .         .                      
						                                                            	     601 LRPNCKTSQITTAIISIPTPPALTPEGESRPPPASP               636                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     601 LRPNCKTSQITTAIISIPTPPALTPEGESRPPPASP               636                                                          

27812	HMR136_AF048712_5_tr0_r1_1_gPRT		Comparison report between AF048712_P5 and Q9UH86partial WT   	Sequence name: Q9UH86                                        
						sequence followed by unique insertion and a followed by a    	                                                            
						unique tail.1.An isolated chimeric polypeptide encoding for  	Sequence documentation:                                      
						AF048712_P5, comprising a first amino acid sequence being at 	                                                            
						MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLER 	Alignment of: 27812 x Q9UH86   ..                            
						YPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISAYDDELAF 	                                                            
						YGILPEIIGDCCYEEYKDRKRENAERLMDDNDSENNQESMPSLSFRQTMWRAFENPHTST 	Alignment segment 1/1:                                       
						LALVFYYVTGFFIAVSVITNVVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVE 	                                                            
						YLLRLFAAPSRYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 	                     Quality: 5729.00                      Escore:       0                                               
						SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASKFTSIPASFWY 	             Matching length:     592                Total length:     611                                               
						TIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVPVIVSNFSRIYHQNQRADKRR 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AQKKARLARIRVAKTGSSNAYLHSKRNGLLNEALELTGTPEEEHMGKTTSLIESQHHHLL 	    Total Percent Similarity:   96.89      Total Percent Identity:   96.89                                               
						HCLEKTT                                                      	                        Gaps:       1                        
						least 90 % homologous to corresponding to amino acids 1 - 487	                                                            
						of Q9UH86, which also corresponds to amino acids 1 - 487 of  	Alignment:                                                   
						AF048712_P5, a second amino acid sequence being at least 70%,	                  .         .         .         .         .  
						optionally at least 80%, preferably at least 85%, more       	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence              	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						GLSYLVDDPLLSVRTSTIK corresponding to amino acids 488 - 506 of	                  .         .         .         .         .  
						AF048712_P5, a third amino acid sequence being at least 90 % 	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						NHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRRSKKTTHLPNSNLPATR 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDGLRPNCKTSQIT                	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						homologous to corresponding to amino acids 488 - 592 of      	                  .         .         .         .         .  
						Q9UH86, which also corresponds to amino acids 507 - 611 of   	     101 GKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDD 150                                                          
						AF048712_P5, and a fourth amino acid sequence being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	     101 GKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDD 150                                                          
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence              	     151 NDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITN 200                                                          
						VVSGDPSEENTRPRAAKRPSCHKQNRKKI corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						612 - 640 of AF048712_P5, wherein said first amino acid      	     151 NDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITN 200                                                          
						sequence, second amino acid sequence, third amino acid       	                  .         .         .         .         .  
						sequence and fourth amino acid sequence are contiguous and in	     201 VVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPS 250                                                          
						a sequential order.2.An isolated polypeptide encoding for an 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						edge portion of AF048712_P5, comprising an amino acid        	     201 VVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPS 250                                                          
						sequence being at least 70%, optionally at least about 80%,  	                  .         .         .         .         .  
						preferably at least about 85%, more preferably at least about	     251 RYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 300                                                          
						90% and most preferably at least about 95% homologous to the 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence encoding for GLSYLVDDPLLSVRTSTIK, corresponding to  	     251 RYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 300                                                          
						AF048712_P5.3.An isolated polypeptide encoding for a tail of 	                  .         .         .         .         .  
						AF048712_P5, comprising a polypeptide being at least 70%,    	     301 SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASK 350                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     301 SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASK 350                                                          
						least about 95% homologous to the sequence                   	                  .         .         .         .         .  
						VVSGDPSEENTRPRAAKRPSCHKQNRKKI in AF048712_P5.                	     351 FTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVP 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 FTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVP 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 NEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTTGLSYLVDDPLLSV 500                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||               
						                                                            	     451 NEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTT............. 487                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 RTSTIKNHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRR 550                                                          
						                                                            	               ||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     488 ......NHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRR 531                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 SKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDG 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     532 SKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDG 581                                                          
						                                                            	                  .                                          
						                                                            	     601 LRPNCKTSQIT                                        611                                                          
						                                                            	         |||||||||||                                         
						                                                            	     582 LRPNCKTSQIT                                        592                                                          

						Comparison report between AF048712_P5 and Q9UH85partial WT   	Sequence name: Q9UH85                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF048712_P5, comprising a first     	Sequence documentation:                                      
						MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLER 	                                                            
						YPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISAYDDELAF 	Alignment of: 27812 x Q9UH85   ..                            
						YGILPEIIGDCCYEEYKDRKRENAERLMDDNDSENNQESMPSLSFRQTMWRAFENPHTST 	                                                            
						LALVFYYVTGFFIAVSVITNVVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVE 	Alignment segment 1/1:                                       
						YLLRLFAAPSRYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 	                                                            
						SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASKFTSIPASFWY 	                     Quality: 6003.00                      Escore:       0                                               
						TIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVPVIVSNFSRIYHQNQRADKRR 	             Matching length:     611                Total length:     611                                               
						AQKKARLARIRVAKTGSSNAYLHSKRNGLLNEALELTGTPEEEHMGKTTSLIESQHHHLL 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						HCLEKTTGLSYLVDDPLLSVRTSTIKNHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHP 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GLTTTCCSRRSKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDG 	                        Gaps:       0                        
						LRPNCKTSQIT                                                  	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 1 - 611 of Q9UH85, which also   	                  .         .         .         .         .  
						corresponds to amino acids 1 - 611 of AF048712_P5, and a     	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						second amino acid sequence being at least 70%, optionally at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 80%, preferably at least 85%, more preferably at least 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence VVSGDPSEENTRPRAAKRPSCHKQNRKKI	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						corresponding to amino acids 612 - 640 of AF048712_P5,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence and second amino acid 	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						sequence are contiguous and in a sequential order.2.An       	                  .         .         .         .         .  
						isolated polypeptide encoding for a tail of AF048712_P5,     	     101 GKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDD 150                                                          
						comprising a polypeptide being at least 70%, optionally at   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 80%, preferably at least about 85%, more         	     101 GKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDD 150                                                          
						preferably at least about 90% and most preferably at least   	                  .         .         .         .         .  
						about 95% homologous to the sequence                         	     151 NDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITN 200                                                          
						VVSGDPSEENTRPRAAKRPSCHKQNRKKI in AF048712_P5.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 NDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITN 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPS 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 RYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 RYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKF 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASK 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 SRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASK 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 FTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVP 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 FTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVP 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 VIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 VIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLL 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 NEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTTGLSYLVDDPLLSV 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 NEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTTGLSYLVDDPLLSV 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 RTSTIKNHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRR 550                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 RTSTIKNHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRR 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     551 SKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDG 600                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     551 SKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDG 600                                                          
						                                                            	                  .                                          
						                                                            	     601 LRPNCKTSQIT                                        611                                                          
						                                                            	         |||||||||||                                         
						                                                            	     601 LRPNCKTSQIT                                        611                                                          

27816	HMR136_AF048712_6_tr0_r1_1_gPRT		Comparison report between AF048712_P6 and Q9UK16partial WT   	Sequence name: Q9UK16                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF048712_P6, comprising a first     	Sequence documentation:                                      
						MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLER 	                                                            
						YPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISAY       	Alignment of: 27816 x Q9UK16   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 114 of Q9UK16, which also   	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 114 of AF048712_P6, and a     	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality: 1151.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:     114                Total length:     114                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence                              	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VTDLGNMPVCYQGLITGMQLPGDEKMKNMTKLSSHTGCH corresponding to     	                        Gaps:       0                        
						amino acids 115 - 153 of AF048712_P6, wherein said first     	                                                            
						amino acid sequence and second amino acid sequence are       	Alignment:                                                   
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of AF048712_P6, comprising a 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VTDLGNMPVCYQGLITGMQLPGDEKMKNMTKLSSHTGCH in   	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						AF048712_P6.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						                                                            	                  .                                          
						                                                            	     101 GKLHYPRYECISAY                                     114                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     101 GKLHYPRYECISAY                                     114                                                          

						Comparison report between AF048712_P6 and Q9UK17partial WT   	Sequence name: Q9UK17                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF048712_P6, comprising a first     	Sequence documentation:                                      
						MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLER 	                                                            
						YPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISAY       	Alignment of: 27816 x Q9UK17   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 114 of Q9UK17, which also   	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 114 of AF048712_P6, and a     	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality: 1151.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:     114                Total length:     114                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence                              	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VTDLGNMPVCYQGLITGMQLPGDEKMKNMTKLSSHTGCH corresponding to     	                        Gaps:       0                        
						amino acids 115 - 153 of AF048712_P6, wherein said first     	                                                            
						amino acid sequence and second amino acid sequence are       	Alignment:                                                   
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of AF048712_P6, comprising a 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VTDLGNMPVCYQGLITGMQLPGDEKMKNMTKLSSHTGCH in   	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						AF048712_P6.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						                                                            	                  .                                          
						                                                            	     101 GKLHYPRYECISAY                                     114                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     101 GKLHYPRYECISAY                                     114                                                          

						Comparison report between AF048712_P6 and O60576partial WT   	Sequence name: O60576                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF048712_P6, comprising a first     	Sequence documentation:                                      
						MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLER 	                                                            
						YPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISAY       	Alignment of: 27816 x O60576   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 114 of O60576, which also   	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 114 of AF048712_P6, and a     	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality: 1151.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:     114                Total length:     114                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence                              	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VTDLGNMPVCYQGLITGMQLPGDEKMKNMTKLSSHTGCH corresponding to     	                        Gaps:       0                        
						amino acids 115 - 153 of AF048712_P6, wherein said first     	                                                            
						amino acid sequence and second amino acid sequence are       	Alignment:                                                   
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of AF048712_P6, comprising a 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VTDLGNMPVCYQGLITGMQLPGDEKMKNMTKLSSHTGCH in   	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						AF048712_P6.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						                                                            	                  .                                          
						                                                            	     101 GKLHYPRYECISAY                                     114                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     101 GKLHYPRYECISAY                                     114                                                          

						Comparison report between AF048712_P6 and O60577partial WT   	Sequence name: O60577                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF048712_P6, comprising a first     	Sequence documentation:                                      
						MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLER 	                                                            
						YPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISAY       	Alignment of: 27816 x O60577   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 114 of O60577, which also   	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 114 of AF048712_P6, and a     	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality: 1151.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:     114                Total length:     114                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence                              	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VTDLGNMPVCYQGLITGMQLPGDEKMKNMTKLSSHTGCH corresponding to     	                        Gaps:       0                        
						amino acids 115 - 153 of AF048712_P6, wherein said first     	                                                            
						amino acid sequence and second amino acid sequence are       	Alignment:                                                   
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of AF048712_P6, comprising a 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VTDLGNMPVCYQGLITGMQLPGDEKMKNMTKLSSHTGCH in   	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						AF048712_P6.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						                                                            	                  .                                          
						                                                            	     101 GKLHYPRYECISAY                                     114                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     101 GKLHYPRYECISAY                                     114                                                          

						Comparison report between AF048712_P6 and Q9UH86partial WT   	Sequence name: Q9UH86                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF048712_P6, comprising a first     	Sequence documentation:                                      
						MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLER 	                                                            
						YPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISAY       	Alignment of: 27816 x Q9UH86   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 114 of Q9UH86, which also   	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 114 of AF048712_P6, and a     	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality: 1151.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:     114                Total length:     114                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence                              	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VTDLGNMPVCYQGLITGMQLPGDEKMKNMTKLSSHTGCH corresponding to     	                        Gaps:       0                        
						amino acids 115 - 153 of AF048712_P6, wherein said first     	                                                            
						amino acid sequence and second amino acid sequence are       	Alignment:                                                   
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of AF048712_P6, comprising a 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VTDLGNMPVCYQGLITGMQLPGDEKMKNMTKLSSHTGCH in   	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						AF048712_P6.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						                                                            	                  .                                          
						                                                            	     101 GKLHYPRYECISAY                                     114                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     101 GKLHYPRYECISAY                                     114                                                          

						Comparison report between AF048712_P6 and Q9UH85partial WT   	Sequence name: Q9UH85                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF048712_P6, comprising a first     	Sequence documentation:                                      
						MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLER 	                                                            
						YPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISAY       	Alignment of: 27816 x Q9UH85   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 114 of Q9UH85, which also   	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 114 of AF048712_P6, and a     	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality: 1151.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:     114                Total length:     114                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence                              	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						VTDLGNMPVCYQGLITGMQLPGDEKMKNMTKLSSHTGCH corresponding to     	                        Gaps:       0                        
						amino acids 115 - 153 of AF048712_P6, wherein said first     	                                                            
						amino acid sequence and second amino acid sequence are       	Alignment:                                                   
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of AF048712_P6, comprising a 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	       1 MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRR 50                                                           
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence VTDLGNMPVCYQGLITGMQLPGDEKMKNMTKLSSHTGCH in   	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						AF048712_P6.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 FQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRT 100                                                          
						                                                            	                  .                                          
						                                                            	     101 GKLHYPRYECISAY                                     114                                                          
						                                                            	         ||||||||||||||                                      
						                                                            	     101 GKLHYPRYECISAY                                     114                                                          

9529	HMR136_AF097366_3_tr0_r1_1_gPRT		Comparison report between AF097366_P3 and NKX2_HUMANpartial  	Sequence name: NKX2_HUMAN                                    
						WT sequence followed by short unique tail.1.An isolated      	                                                            
						chimeric polypeptide encoding for AF097366_P3, comprising a  	Sequence documentation:                                      
						MDLQQSTTITSLEKWCLDESLSGCRRHYSVKKKLKLIRVLGLFMGLVAISTVSFSISAFS 	                                                            
						ETDTQSTGEASVVSGPRVAQGYHQRTLLDLNDKILDYTPQPPLSKEGESENSTDHAQGDY 	Alignment of: 9529 x NKX2_HUMAN   ..                         
						PKDIFSLEERRKGAIILHVIGMIYMFIALAIVCDEFFVPSLTVITEKLGISDDVAGATFM 	                                                            
						AAGGSAPELFTSLIGVFIAHSNVGIGTIVGSAVFNILFVIGMCALFSREILNLTWWPLFR 	Alignment segment 1/1:                                       
						DVSFYIVDLIMLIIFFLDNVIMWWESLLLLTAYFCYVVFMKFNVQVEKWVKQMINRNKVV 	                                                            
						KVTAPEAQAKPSAARDKDEPTLPAKPRLQRGGSSASLHNSLMRNSIFQLMIHTLDPLAEE 	                     Quality: 4352.00                      Escore:       0                                               
						LGSYGKLKYYDTMTEEGRFREKASILHKIAKKKCHVDENERQNGAANHVEKIELPNSTST 	             Matching length:     449                Total length:     449                                               
						DVEMTPSSDASEPVQNGNLSHNIEGAEAQ                                	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						first amino acid sequence being at least 90 % homologous to  	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 449 of NKX2_HUMAN, which    	                        Gaps:       0                        
						also corresponds to amino acids 1 - 449 of AF097366_P3, and a	                                                            
						second amino acid sequence being at least 70%, optionally at 	Alignment:                                                   
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	       1 MDLQQSTTITSLEKWCLDESLSGCRRHYSVKKKLKLIRVLGLFMGLVAIS 50                                                           
						polypeptide having the sequence PDR corresponding to amino   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 450 - 452 of AF097366_P3, wherein said first amino acid	       1 MDLQQSTTITSLEKWCLDESLSGCRRHYSVKKKLKLIRVLGLFMGLVAIS 50                                                           
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.                                          	      51 TVSFSISAFSETDTQSTGEASVVSGPRVAQGYHQRTLLDLNDKILDYTPQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 TVSFSISAFSETDTQSTGEASVVSGPRVAQGYHQRTLLDLNDKILDYTPQ 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 PPLSKEGESENSTDHAQGDYPKDIFSLEERRKGAIILHVIGMIYMFIALA 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 PPLSKEGESENSTDHAQGDYPKDIFSLEERRKGAIILHVIGMIYMFIALA 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 IVCDEFFVPSLTVITEKLGISDDVAGATFMAAGGSAPELFTSLIGVFIAH 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 IVCDEFFVPSLTVITEKLGISDDVAGATFMAAGGSAPELFTSLIGVFIAH 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 SNVGIGTIVGSAVFNILFVIGMCALFSREILNLTWWPLFRDVSFYIVDLI 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 SNVGIGTIVGSAVFNILFVIGMCALFSREILNLTWWPLFRDVSFYIVDLI 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 MLIIFFLDNVIMWWESLLLLTAYFCYVVFMKFNVQVEKWVKQMINRNKVV 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 MLIIFFLDNVIMWWESLLLLTAYFCYVVFMKFNVQVEKWVKQMINRNKVV 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 KVTAPEAQAKPSAARDKDEPTLPAKPRLQRGGSSASLHNSLMRNSIFQLM 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 KVTAPEAQAKPSAARDKDEPTLPAKPRLQRGGSSASLHNSLMRNSIFQLM 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 IHTLDPLAEELGSYGKLKYYDTMTEEGRFREKASILHKIAKKKCHVDENE 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 IHTLDPLAEELGSYGKLKYYDTMTEEGRFREKASILHKIAKKKCHVDENE 400                                                          
						                                                            	                  .         .         .         .            
						                                                            	     401 RQNGAANHVEKIELPNSTSTDVEMTPSSDASEPVQNGNLSHNIEGAEAQ  449                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     401 RQNGAANHVEKIELPNSTSTDVEMTPSSDASEPVQNGNLSHNIEGAEAQ  449                                                          

10267	HMR136_AF111782_3_tr0_r1_1_gPRT		Comparison report between AF111782_P3 and MYHD_HUMANunique   	Sequence name: MYHD_HUMAN                                    
						head followed by partial WT sequence a mismatch.1.An isolated	                                                            
						chimeric polypeptide encoding for AF111782_P3, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 10267 x MYHD_HUMAN   ..                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence LWPHSGSPLQ corresponding to  	Alignment segment 1/1:                                       
						amino acids 1 - 10 of AF111782_P3, a second amino acid       	                                                            
						DSQLHLDDALRSNEDLKEQLAIVERRNGLLLEELEEMKVALEQTERTRRLSEQELLDASD 	                     Quality: 2711.00                      Escore:       0                                               
						RVQLLHSQNTSLINTKKKLEADIAQCQAEVENSIQESRNAEEKAKKAITDAAMMAEELKK 	             Matching length:     285                Total length:     285                                               
						EQDTSAHLERMKKNLEQTVKDLQHRLDEAEQLALKGGKKQIQKLENRVRELENELDVEQK 	 Matching Percent Similarity:   99.65   Matching Percent Identity:   99.30                                               
						RGAEALKGAHKYERKVKEMTYQAEED                                   	    Total Percent Similarity:   99.65      Total Percent Identity:   99.30                                               
						sequence being at least 90 % homologous to corresponding to  	                        Gaps:       0                        
						amino acids 1656 - 1861 of MYHD_HUMAN, which also corresponds	                                                            
						to amino acids 11 - 216 of AF111782_P3, a bridging amino acid	Alignment:                                                   
						H corresponding to amino acid 217 of AF111782_P3, and a third	                  .         .         .         .         .  
						KNILRLQDLVDKLQAKVKSYKRQAEEAEEQANTQLSRCRRVQHELEEAAERADIAESQVN 	       9 LQDSQLHLDDALRSNEDLKEQLAIVERRNGLLLEELEEMKVALEQTERTR 58                                                           
						KLRAKSRDVGSQKMEE                                             	         |:||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence being at least 90 % homologous to        	    1654 LKDSQLHLDDALRSNEDLKEQLAIVERRNGLLLEELEEMKVALEQTERTR 1703                                                         
						corresponding to amino acids 1863 - 1938 of MYHD_HUMAN, which	                  .         .         .         .         .  
						also corresponds to amino acids 218 - 293 of AF111782_P3,    	      59 RLSEQELLDASDRVQLLHSQNTSLINTKKKLEADIAQCQAEVENSIQESR 108                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, bridging amino acid and third amino acid sequence  	    1704 RLSEQELLDASDRVQLLHSQNTSLINTKKKLEADIAQCQAEVENSIQESR 1753                                                         
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						polypeptide encoding for a head of AF111782_P3, comprising a 	     109 NAEEKAKKAITDAAMMAEELKKEQDTSAHLERMKKNLEQTVKDLQHRLDE 158                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	    1754 NAEEKAKKAITDAAMMAEELKKEQDTSAHLERMKKNLEQTVKDLQHRLDE 1803                                                         
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence LWPHSGSPLQ of AF111782_P3.                   	     159 AEQLALKGGKKQIQKLENRVRELENELDVEQKRGAEALKGAHKYERKVKE 208                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1804 AEQLALKGGKKQIQKLENRVRELENELDVEQKRGAEALKGAHKYERKVKE 1853                                                         
						                                                            	                  .         .         .         .         .  
						                                                            	     209 MTYQAEEDHKNILRLQDLVDKLQAKVKSYKRQAEEAEEQANTQLSRCRRV 258                                                          
						                                                            	         |||||||| |||||||||||||||||||||||||||||||||||||||||  
						                                                            	    1854 MTYQAEEDRKNILRLQDLVDKLQAKVKSYKRQAEEAEEQANTQLSRCRRV 1903                                                         
						                                                            	                  .         .         .                      
						                                                            	     259 QHELEEAAERADIAESQVNKLRAKSRDVGSQKMEE                293                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||                 
						                                                            	    1904 QHELEEAAERADIAESQVNKLRAKSRDVGSQKMEE                1938                                                         

10461	HMR136_AF111783_4_tr0_r1_1_gPRT		Comparison report between AF111783_P4 and MYH4_HUMANpartial  	Sequence name: MYH4_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for AF111783_P4, comprising a first     	                                                            
						MSSDSEMAIFGEAAPFLRKSEKERIEAQNKPFDAKTSVFVVDPKESYVKAIVQSREGGKV 	Alignment of: 10461 x MYH4_HUMAN   ..                        
						TAKTEAGATVTVKEDQVFSMNPPKYDKIEDMAMMTHLHEPAVLYNLKERYAAWMIYTYSG 	                                                            
						LFCVTVNPYKWLPVYNPEVVTAYRGKKRQEAPPHIFSISDNAYQFMLTDRENQSILITGE 	Alignment segment 1/1:                                       
						SGAGKTVNTKRVIQYFATIAVTGEKKKEEPASGKMQGTLEDQIISANPLLEAFGNAKTVR 	                                                            
						NDNSSRFGKFIRIHFGATGKLASADIETYLLEKSRVTFQLKAERSYHIFYQILSNKKPEL 	                     Quality: 4858.00                      Escore:       0                                               
						IEMLLITTNPYDFAFVSQGEITVPSIDDQEELMATDSAVDILGFTADEKVAIYKLTGAVM 	             Matching length:     498                Total length:     498                                               
						HYGNMKFKQKQREEQAEPDGTEVADKAAYLTSLNSADLLKSLCYPRVKVGNEFVTKGQTV 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QQVYNAVGALAKAIYEKMFLWMVTRINQQLDTKQPRQYFIGVLDIAGFEIFDFNSLEQLC 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						INFTNEKLQQFFNHHMFV                                           	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 498 of MYH4_HUMAN, which    	Alignment:                                                   
						also corresponds to amino acids 1 - 498 of AF111783_P4.      	                  .         .         .         .         .  
						                                                            	       1 MSSDSEMAIFGEAAPFLRKSEKERIEAQNKPFDAKTSVFVVDPKESYVKA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 MSSDSEMAIFGEAAPFLRKSEKERIEAQNKPFDAKTSVFVVDPKESYVKA 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 IVQSREGGKVTAKTEAGATVTVKEDQVFSMNPPKYDKIEDMAMMTHLHEP 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 IVQSREGGKVTAKTEAGATVTVKEDQVFSMNPPKYDKIEDMAMMTHLHEP 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 AVLYNLKERYAAWMIYTYSGLFCVTVNPYKWLPVYNPEVVTAYRGKKRQE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 AVLYNLKERYAAWMIYTYSGLFCVTVNPYKWLPVYNPEVVTAYRGKKRQE 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 APPHIFSISDNAYQFMLTDRENQSILITGESGAGKTVNTKRVIQYFATIA 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 APPHIFSISDNAYQFMLTDRENQSILITGESGAGKTVNTKRVIQYFATIA 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VTGEKKKEEPASGKMQGTLEDQIISANPLLEAFGNAKTVRNDNSSRFGKF 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VTGEKKKEEPASGKMQGTLEDQIISANPLLEAFGNAKTVRNDNSSRFGKF 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 IRIHFGATGKLASADIETYLLEKSRVTFQLKAERSYHIFYQILSNKKPEL 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 IRIHFGATGKLASADIETYLLEKSRVTFQLKAERSYHIFYQILSNKKPEL 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 IEMLLITTNPYDFAFVSQGEITVPSIDDQEELMATDSAVDILGFTADEKV 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 IEMLLITTNPYDFAFVSQGEITVPSIDDQEELMATDSAVDILGFTADEKV 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     351 AIYKLTGAVMHYGNMKFKQKQREEQAEPDGTEVADKAAYLTSLNSADLLK 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 AIYKLTGAVMHYGNMKFKQKQREEQAEPDGTEVADKAAYLTSLNSADLLK 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 SLCYPRVKVGNEFVTKGQTVQQVYNAVGALAKAIYEKMFLWMVTRINQQL 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 SLCYPRVKVGNEFVTKGQTVQQVYNAVGALAKAIYEKMFLWMVTRINQQL 450                                                          
						                                                            	                  .         .         .         .            
						                                                            	     451 DTKQPRQYFIGVLDIAGFEIFDFNSLEQLCINFTNEKLQQFFNHHMFV   498                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     451 DTKQPRQYFIGVLDIAGFEIFDFNSLEQLCINFTNEKLQQFFNHHMFV   498                                                          

11025	HMR136_AF120493_1_tr0_r1_1_gPRT		Comparison report between AF120493_P1 and EL1_HUMANunique    	Sequence name: EL1_HUMAN                                     
						head followed by partial WT sequence a mismatch.1.An isolated	                                                            
						chimeric polypeptide encoding for AF120493_P1, comprising a  	Sequence documentation:                                      
						first amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment of: 11025 x EL1_HUMAN   ..                         
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence DCQCRVSCSA corresponding to  	Alignment segment 1/1:                                       
						amino acids 1 - 10 of AF120493_P1, a second amino acid       	                                                            
						NGQLAQTLQQAYLPSVDYAICSSSSYWGSTVKNTMVCAGGDGVRSGCQGDSGGPLHCLVN 	                     Quality: 1007.00                      Escore:       0                                               
						GKYS                                                         	             Matching length:     103                Total length:     103                                               
						sequence being at least 90 % homologous to corresponding to  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.03                                               
						amino acids 156 - 219 of EL1_HUMAN, which also corresponds to	    Total Percent Similarity:  100.00      Total Percent Identity:   99.03                                               
						amino acids 11 - 74 of AF120493_P1, a bridging amino acid V  	                        Gaps:       0                        
						corresponding to amino acid 75 of AF120493_P1, and a third   	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						HGVTSFVSSRGCNVSRKPTVFTQVSAYISWINNVIASN corresponding to amino	                  .         .         .         .         .  
						acids 221 - 258 of EL1_HUMAN, which also corresponds to amino	      11 NGQLAQTLQQAYLPSVDYAICSSSSYWGSTVKNTMVCAGGDGVRSGCQGD 60                                                           
						acids 76 - 113 of AF120493_P1, wherein said first amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, second amino acid sequence, bridging amino acid and	     156 NGQLAQTLQQAYLPSVDYAICSSSSYWGSTVKNTMVCAGGDGVRSGCQGD 205                                                          
						third amino acid sequence are contiguous and in a sequential 	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	      61 SGGPLHCLVNGKYSVHGVTSFVSSRGCNVSRKPTVFTQVSAYISWINNVI 110                                                          
						AF120493_P1, comprising a polypeptide being at least 70%,    	         ||||||||||||||:|||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     206 SGGPLHCLVNGKYSLHGVTSFVSSRGCNVSRKPTVFTQVSAYISWINNVI 255                                                          
						more preferably at least about 90% and most preferably at    	                                                             
						least about 95% homologous to the sequence DCQCRVSCSA of     	     111 ASN                                                113                                                          
						AF120493_P1.                                                 	         |||                                                 
						                                                            	     256 ASN                                                258                                                          

11578	HMR136_AF129512_6_tr0_r1_1_gPRT		Comparison report between AF129512_P6 and AIOL_HUMANpartial  	Sequence name: AIOL_HUMAN                                    
						WT sequence (truncation of last part or first part of        	                                                            
						sequence, no other amino acids)1.An isolated chimeric        	Sequence documentation:                                      
						polypeptide encoding for AF129512_P6, comprising a first     	                                                            
						MGSERALVLDRLASNVAKRKSSMPQKFIGEKRHCFDVNYNSSYMYEKESELIQTRMMDQA 	Alignment of: 11578 x AIOL_HUMAN   ..                        
						INNAISYLGAEALCPLVQTPPAPTSEMVPVISSMYPIALTRAEMSNGAPQELERKSILLP 	                                                            
						EKSVPSERGLSPNNSGHDSTDTDSNHEERQNHIYQQNHMVLSRARNGMPLLKEVPRSYEL 	Alignment segment 1/1:                                       
						LKPPPICPRDSVKVIDKEGEVMDVYRCDHCRVLFLDYVMFTIHMGCHGFRDPFECNMCGD 	                                                            
						RSHDRYEFSSHIARGEHRSLLK                                       	                     Quality: 2630.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     262                Total length:     262                                               
						corresponding to amino acids 248 - 509 of AIOL_HUMAN, which  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						also corresponds to amino acids 1 - 262 of AF129512_P6.      	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MGSERALVLDRLASNVAKRKSSMPQKFIGEKRHCFDVNYNSSYMYEKESE 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     248 MGSERALVLDRLASNVAKRKSSMPQKFIGEKRHCFDVNYNSSYMYEKESE 297                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 LIQTRMMDQAINNAISYLGAEALCPLVQTPPAPTSEMVPVISSMYPIALT 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     298 LIQTRMMDQAINNAISYLGAEALCPLVQTPPAPTSEMVPVISSMYPIALT 347                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RAEMSNGAPQELERKSILLPEKSVPSERGLSPNNSGHDSTDTDSNHEERQ 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     348 RAEMSNGAPQELERKSILLPEKSVPSERGLSPNNSGHDSTDTDSNHEERQ 397                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 NHIYQQNHMVLSRARNGMPLLKEVPRSYELLKPPPICPRDSVKVIDKEGE 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     398 NHIYQQNHMVLSRARNGMPLLKEVPRSYELLKPPPICPRDSVKVIDKEGE 447                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VMDVYRCDHCRVLFLDYVMFTIHMGCHGFRDPFECNMCGDRSHDRYEFSS 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     448 VMDVYRCDHCRVLFLDYVMFTIHMGCHGFRDPFECNMCGDRSHDRYEFSS 497                                                          
						                                                            	                  .                                          
						                                                            	     251 HIARGEHRSLLK                                       262                                                          
						                                                            	         ||||||||||||                                        
						                                                            	     498 HIARGEHRSLLK                                       509                                                          

13862	HMR136_AF150351_2_tr0_r1_1_gPRT		Comparison report between AF150351_P2 and Q96SQ3unique head  	Sequence name: Q96SQ3                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AF150351_P2, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 13862 x Q96SQ3   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						ALDSVSRSEIALGCKDLNHVSLSSLIPELDVTSEYINSDTLVREINKHTSPEEYNLNLFL 	Alignment segment 1/1:                                       
						QEKKHINLTKLGLNVQKHPGNEKEDSLQYLANKKYTQGRGSHSQE                	                                                            
						homologous to a polypeptide having the sequence corresponding	                     Quality: 5105.00                      Escore:       0                                               
						to amino acids 1 - 105 of AF150351_P2, a second amino acid   	             Matching length:     507                Total length:     507                                               
						MRYNRQNRWKRQNFHEFPPLFAFPSLSQTDLEELTYFFPEDHAEDVQQEFFPSWPTPSGL 	 Matching Percent Similarity:   99.80   Matching Percent Identity:   99.80                                               
						TEYSTLTLCQETLANSSIGRLCLAFLGKRLDSVIEMCVKDVLLKDDLSWAEAGVALLENE 	    Total Percent Similarity:   99.80      Total Percent Identity:   99.80                                               
						CEKRIVEEGKYNTEEYGTSIEDILSVLKCPNLCSGNGQCMEWGCACSPSFSSYDCSDSYD 	                        Gaps:       0                        
						KAPEITELGNAGFCDVQKYNCMMVRVFGKGFKELPSIKCEVTKLQYNSSEWMPGEPIYTQ 	                                                            
						TVFHNSRAVDCQLPTDVQQFDTMDLVGGKPTGKWQLKVSNDGYKFSNPKITVIYDGACQV 	Alignment:                                                   
						CGLYKNDSCTIKENVCIIDGLCYVEGDKNPTSPCLICRPKISRFTWSFLENNQPPVIQAL 	                  .         .         .         .         .  
						QDKL                                                         	     106 MRYNRQNRWKRQNFHEFPPLFAFPSLSQTDLEELTYFFPEDHAEDVQQEF 155                                                          
						sequence being at least 90 % homologous to corresponding to  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 1 - 364 of Q96SQ3, which also corresponds to     	       1 MRYNRQNRWKRQNFHEFPPLFAFPSLSQTDLEELTYFFPEDHAEDVQQEF 50                                                           
						amino acids 106 - 469 of AF150351_P2, a bridging amino acid Q	                  .         .         .         .         .  
						corresponding to amino acid 470 of AF150351_P2, a third amino	     156 FPSWPTPSGLTEYSTLTLCQETLANSSIGRLCLAFLGKRLDSVIEMCVKD 205                                                          
						TFYGENFEYQFVAFDPEGSDIHFTLDSGPEGASVSSAGLFMWKTDLLTTQQITVRLNDDC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DAETRVTIEVTVKSCDCLNGGSCVSDRNFSPGSGVYLCVCLPGFHGSLCEVDISGCQSNP 	      51 FPSWPTPSGLTEYSTLTLCQETLANSSIGRLCLAFLGKRLDSVIEMCVKD 100                                                          
						CGLGSYISGFHSYSCDCPPELK                                       	                  .         .         .         .         .  
						acid sequence being at least 90 % homologous to corresponding	     206 VLLKDDLSWAEAGVALLENECEKRIVEEGKYNTEEYGTSIEDILSVLKCP 255                                                          
						to amino acids 366 - 507 of Q96SQ3, which also corresponds to	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 471 - 612 of AF150351_P2, and a fourth amino acid	     101 VLLKDDLSWAEAGVALLENECEKRIVEEGKYNTEEYGTSIEDILSVLKCP 150                                                          
						sequence being at least 70%, optionally at least 80%,        	                  .         .         .         .         .  
						preferably at least 85%, more preferably at least 90% and    	     256 NLCSGNGQCMEWGCACSPSFSSYDCSDSYDKAPEITELGNAGFCDVQKYN 305                                                          
						most preferably at least 95% homologous to a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having the sequence GKNCQEDVDECDSKPCFEGVACLNTFGSYHCGSCPEGFYGD	     151 NLCSGNGQCMEWGCACSPSFSSYDCSDSYDKAPEITELGNAGFCDVQKYN 200                                                          
						corresponding to amino acids 613 - 653 of AF150351_P2,       	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     306 CMMVRVFGKGFKELPSIKCEVTKLQYNSSEWMPGEPIYTQTVFHNSRAVD 355                                                          
						sequence, bridging amino acid, third amino acid sequence and 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						fourth amino acid sequence are contiguous and in a sequential	     201 CMMVRVFGKGFKELPSIKCEVTKLQYNSSEWMPGEPIYTQTVFHNSRAVD 250                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AF150351_P2, comprising a polypeptide being at least 70%,    	     356 CQLPTDVQQFDTMDLVGGKPTGKWQLKVSNDGYKFSNPKITVIYDGACQV 405                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     251 CQLPTDVQQFDTMDLVGGKPTGKWQLKVSNDGYKFSNPKITVIYDGACQV 300                                                          
						ALDSVSRSEIALGCKDLNHVSLSSLIPELDVTSEYINSDTLVREINKHTSPEEYNLNLFL 	                  .         .         .         .         .  
						QEKKHINLTKLGLNVQKHPGNEKEDSLQYLANKKYTQGRGSHSQE                	     406 CGLYKNDSCTIKENVCIIDGLCYVEGDKNPTSPCLICRPKISRFTWSFLE 455                                                          
						least about 95% homologous to the sequence of                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AF150351_P2.3.An isolated polypeptide encoding for a tail of 	     301 CGLYKNDSCTIKENVCIIDGLCYVEGDKNPTSPCLICRPKISRFTWSFLE 350                                                          
						AF150351_P2, comprising a polypeptide being at least 70%,    	                  .         .         .         .         .  
						optionally at least about 80%, preferably at least about 85%,	     456 NNQPPVIQALQDKLQTFYGENFEYQFVAFDPEGSDIHFTLDSGPEGASVS 505                                                          
						more preferably at least about 90% and most preferably at    	         |||||||||||||| |||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence                   	     351 NNQPPVIQALQDKLLTFYGENFEYQFVAFDPEGSDIHFTLDSGPEGASVS 400                                                          
						GKNCQEDVDECDSKPCFEGVACLNTFGSYHCGSCPEGFYGD in AF150351_P2.    	                  .         .         .         .         .  
						                                                            	     506 SAGLFMWKTDLLTTQQITVRLNDDCDAETRVTIEVTVKSCDCLNGGSCVS 555                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 SAGLFMWKTDLLTTQQITVRLNDDCDAETRVTIEVTVKSCDCLNGGSCVS 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     556 DRNFSPGSGVYLCVCLPGFHGSLCEVDISGCQSNPCGLGSYISGFHSYSC 605                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 DRNFSPGSGVYLCVCLPGFHGSLCEVDISGCQSNPCGLGSYISGFHSYSC 500                                                          
						                                                            	                                                             
						                                                            	     606 DCPPELK                                            612                                                          
						                                                            	         |||||||                                             
						                                                            	     501 DCPPELK                                            507                                                          

16330	HMR136_AF181285_1_tr0_r1_1_gPRT		Comparison report between AF181285_P1 and Q9NZN0unique head  	Sequence name: Q9NZN0                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AF181285_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 16330 x Q9NZN0   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MKPPFLLALVVCSVVSTNLKMVSKRNSV corresponding to amino acids 1 -	                                                            
						28 of AF181285_P1, a second amino acid sequence being at     	                     Quality: 3192.00                      Escore:       0                                               
						DGCIDWSVDLKTYMALAGEPVRVKCALFYSYIRTNYSTAQSTGLRLMWYKNKGDLEEPII 	             Matching length:     321                Total length:     321                                               
						FSEVRMSKEEDSIWFHSAEAQDSGFYTCVLRNSTYCMKVSMSLTVAENESGLCYNSRIRY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LEKSEVTKRKEISCPDMDDFKKSDQEPDVVWYKECKPKMWRSIIIQKGNALLIQEVQEED 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						GGNYTCELKYEGKLVRRTTELKVTALLTDKPPKPLFPMENQPSVIDVQLGKPLNIPCKAF 	                        Gaps:       0                        
						FGFSGESGPMIYWMKGEKFIEELAGHIREGEIRLLKEHLGEKEVELALIFDSVVEADLAN 	                                                            
						YTCHVENRNGRKHASVLLRKK                                        	Alignment:                                                   
						least 90 % homologous to corresponding to amino acids 1 - 321	                  .         .         .         .         .  
						of Q9NZN0, which also corresponds to amino acids 29 - 349 of 	      29 DGCIDWSVDLKTYMALAGEPVRVKCALFYSYIRTNYSTAQSTGLRLMWYK 78                                                           
						AF181285_P1, and a third amino acid sequence being at least  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least 80%, preferably at least 85%, more  	       1 DGCIDWSVDLKTYMALAGEPVRVKCALFYSYIRTNYSTAQSTGLRLMWYK 50                                                           
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence GIYFYNYN     	      79 NKGDLEEPIIFSEVRMSKEEDSIWFHSAEAQDSGFYTCVLRNSTYCMKVS 128                                                          
						corresponding to amino acids 350 - 357 of AF181285_P1,       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein said first amino acid sequence, second amino acid    	      51 NKGDLEEPIIFSEVRMSKEEDSIWFHSAEAQDSGFYTCVLRNSTYCMKVS 100                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     129 MSLTVAENESGLCYNSRIRYLEKSEVTKRKEISCPDMDDFKKSDQEPDVV 178                                                          
						head of AF181285_P1, comprising a polypeptide being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     101 MSLTVAENESGLCYNSRIRYLEKSEVTKRKEISCPDMDDFKKSDQEPDVV 150                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence                	     179 WYKECKPKMWRSIIIQKGNALLIQEVQEEDGGNYTCELKYEGKLVRRTTE 228                                                          
						MKPPFLLALVVCSVVSTNLKMVSKRNSV of AF181285_P1.3.An isolated    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a tail of AF181285_P1, comprising a 	     151 WYKECKPKMWRSIIIQKGNALLIQEVQEEDGGNYTCELKYEGKLVRRTTE 200                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     229 LKVTALLTDKPPKPLFPMENQPSVIDVQLGKPLNIPCKAFFGFSGESGPM 278                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to the sequence GIYFYNYN in AF181285_P1.                     	     201 LKVTALLTDKPPKPLFPMENQPSVIDVQLGKPLNIPCKAFFGFSGESGPM 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     279 IYWMKGEKFIEELAGHIREGEIRLLKEHLGEKEVELALIFDSVVEADLAN 328                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 IYWMKGEKFIEELAGHIREGEIRLLKEHLGEKEVELALIFDSVVEADLAN 300                                                          
						                                                            	                  .         .                                
						                                                            	     329 YTCHVENRNGRKHASVLLRKK                              349                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     301 YTCHVENRNGRKHASVLLRKK                              321                                                          

						Comparison report between AF181285_P1 and Q9NP60partial WT   	Sequence name: Q9NP60                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF181285_P1, comprising a first     	Sequence documentation:                                      
						MKPPFLLALVVCSVVSTNLKMVSKRNSVDGCIDWSVDLKTYMALAGEPVRVKCALFYSYI 	                                                            
						RTNYSTAQSTGLRLMWYKNKGDLEEPIIFSEVRMSKEEDSIWFHSAEAQDSGFYTCVLRN 	Alignment of: 16330 x Q9NP60   ..                            
						STYCMKVSMSLTVAENESGLCYNSRIRYLEKSEVTKRKEISCPDMDDFKKSDQEPDVVWY 	                                                            
						KECKPKMWRSIIIQKGNALLIQEVQEEDGGNYTCELKYEGKLVRRTTELKVTALLTDKPP 	Alignment segment 1/1:                                       
						KPLFPMENQPSVIDVQLGKPLNIPCKAFFGFSGESGPMIYWMKGEKFIEELAGHIREGEI 	                                                            
						RLLKEHLGEKEVELALIFDSVVEADLANYTCHVENRNGRKHASVLLRKK            	                     Quality: 3460.00                      Escore:       0                                               
						amino acid sequence being at least 90 % homologous to        	             Matching length:     349                Total length:     349                                               
						corresponding to amino acids 1 - 349 of Q9NP60, which also   	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 349 of AF181285_P1, and a     	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	                        Gaps:       0                        
						least 80%, preferably at least 85%, more preferably at least 	                                                            
						90% and most preferably at least 95% homologous to a         	Alignment:                                                   
						polypeptide having the sequence GIYFYNYN corresponding to    	                  .         .         .         .         .  
						amino acids 350 - 357 of AF181285_P1, wherein said first     	       1 MKPPFLLALVVCSVVSTNLKMVSKRNSVDGCIDWSVDLKTYMALAGEPVR 50                                                           
						amino acid sequence and second amino acid sequence are       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						contiguous and in a sequential order.2.An isolated           	       1 MKPPFLLALVVCSVVSTNLKMVSKRNSVDGCIDWSVDLKTYMALAGEPVR 50                                                           
						polypeptide encoding for a tail of AF181285_P1, comprising a 	                  .         .         .         .         .  
						polypeptide being at least 70%, optionally at least about    	      51 VKCALFYSYIRTNYSTAQSTGLRLMWYKNKGDLEEPIIFSEVRMSKEEDS 100                                                          
						80%, preferably at least about 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 90% and most preferably at least about 95% homologous  	      51 VKCALFYSYIRTNYSTAQSTGLRLMWYKNKGDLEEPIIFSEVRMSKEEDS 100                                                          
						to the sequence GIYFYNYN in AF181285_P1.                     	                  .         .         .         .         .  
						                                                            	     101 IWFHSAEAQDSGFYTCVLRNSTYCMKVSMSLTVAENESGLCYNSRIRYLE 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 IWFHSAEAQDSGFYTCVLRNSTYCMKVSMSLTVAENESGLCYNSRIRYLE 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 KSEVTKRKEISCPDMDDFKKSDQEPDVVWYKECKPKMWRSIIIQKGNALL 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 KSEVTKRKEISCPDMDDFKKSDQEPDVVWYKECKPKMWRSIIIQKGNALL 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 IQEVQEEDGGNYTCELKYEGKLVRRTTELKVTALLTDKPPKPLFPMENQP 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 IQEVQEEDGGNYTCELKYEGKLVRRTTELKVTALLTDKPPKPLFPMENQP 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 SVIDVQLGKPLNIPCKAFFGFSGESGPMIYWMKGEKFIEELAGHIREGEI 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SVIDVQLGKPLNIPCKAFFGFSGESGPMIYWMKGEKFIEELAGHIREGEI 300                                                          
						                                                            	                  .         .         .         .            
						                                                            	     301 RLLKEHLGEKEVELALIFDSVVEADLANYTCHVENRNGRKHASVLLRKK  349                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||||   
						                                                            	     301 RLLKEHLGEKEVELALIFDSVVEADLANYTCHVENRNGRKHASVLLRKK  349                                                          

12191	HMR136_AF248482_1_tr0_r1_1_gPRT		Comparison report between AF248482_P1 and Q9NR89partial WT   	Sequence name: Q9NR89                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF248482_P1, comprising a first     	Sequence documentation:                                      
						MSAANPETPNSTISREASTQSSSAAASQGWVLPEGKIVPNTVFVGGIDARMDETEIGSCF 	                                                            
						GRYGSVKEVKIITNRTGVSKGYGFVSFVNDVDVQKIVGSQIHFHGKKLKLGPAIRKQKLC 	Alignment of: 12191 x Q9NR89   ..                            
						ARHVQPRPLVVNPPPPPQFQNVWRNPNTETYLQPQITPNPVTQHVQ               	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 166 of Q9NR89, which also   	                                                            
						corresponds to amino acids 1 - 166 of AF248482_P1, and a     	                     Quality: 1642.00                      Escore:       0                                               
						second amino acid sequence being at least 70%, optionally at 	             Matching length:     167                Total length:     167                                               
						least 80%, preferably at least 85%, more preferably at least 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.40                                               
						90% and most preferably at least 95% homologous to a         	    Total Percent Similarity:  100.00      Total Percent Identity:   99.40                                               
						polypeptide having the sequence                              	                        Gaps:       0                        
						AFPAYPSSPFQVTTGYQLPVYNYQMPPQCPVGEQRR corresponding to amino  	                                                            
						acids 167 - 202 of AF248482_P1, wherein said first amino acid	Alignment:                                                   
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	       1 MSAANPETPNSTISREASTQSSSAAASQGWVLPEGKIVPNTVFVGGIDAR 50                                                           
						tail of AF248482_P1, comprising a polypeptide being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	       1 MSAANPETPNSTISREASTQSSSAAASQGWVLPEGKIVPNTVFVGGIDAR 50                                                           
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						at least about 95% homologous to the sequence                	      51 MDETEIGSCFGRYGSVKEVKIITNRTGVSKGYGFVSFVNDVDVQKIVGSQ 100                                                          
						AFPAYPSSPFQVTTGYQLPVYNYQMPPQCPVGEQRR in AF248482_P1.         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 MDETEIGSCFGRYGSVKEVKIITNRTGVSKGYGFVSFVNDVDVQKIVGSQ 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 IHFHGKKLKLGPAIRKQKLCARHVQPRPLVVNPPPPPQFQNVWRNPNTET 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 IHFHGKKLKLGPAIRKQKLCARHVQPRPLVVNPPPPPQFQNVWRNPNTET 150                                                          
						                                                            	                  .                                          
						                                                            	     151 YLQPQITPNPVTQHVQA                                  167                                                          
						                                                            	         ||||||||||||||||:                                   
						                                                            	     151 YLQPQITPNPVTQHVQS                                  167                                                          

15294	HMR136_AF263464_2_tr0_r1_1_gPRT		Comparison report between AF263464_P2 and AMBN_HUMANpartial  	Sequence name: AMBN_HUMAN                                    
						WT sequence featuring skipped exon.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF263464_P2, comprising a first     	Sequence documentation:                                      
						MSASKIPLFKMKDLILILCLLEMSFAVPFFPQQSGTPGMASLSLETMRQLGSLQRLNTLS 	                                                            
						QYSRYGFGKSFNSLWMHGLLPPHSSLPWMRPREHETQ                        	Alignment of: 15294 x AMBN_HUMAN   ..                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 97 of AMBN_HUMAN, which also	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 97 of AF263464_P2, and a      	                                                            
						QPSLKPQQPGLKPFLQSAAATTNQATALKEALQPPIHLGHLPLQEGELPLVQQQVAPSDK 	                     Quality: 4225.00                      Escore:       0                                               
						PPKPELPGVDFADPQGPSLPGMDFPDPQGPSLPGLDFADPQGSTIFQIARLISHGPMPQN 	             Matching length:     432                Total length:     447                                               
						KQSPLYPGMLYVPFGANQLNAPARLGIMSSEEVAGGREDPMAYGAMFPGFGGMRPGFEGM 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						PHNPAMGGDFTLEFDSPVAATKGPENEEGGAQGSPMPEANPDNLENPAFLTELEPAPHAG 	    Total Percent Similarity:   96.64      Total Percent Identity:   96.64                                               
						LLALPKDDIPGLPRSPSGKMKGLPSVTPAAADPLMTPELADVYRTYDADMTTSVDFQEEA 	                        Gaps:       1                        
						TMDTTMAPNSLQTSMPGNKAQEPEMMHDAWHFQEP                          	                                                            
						second amino acid sequence being at least 90 % homologous to 	Alignment:                                                   
						corresponding to amino acids 113 - 447 of AMBN_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 98 - 432 of AF263464_P2,     	       1 MSASKIPLFKMKDLILILCLLEMSFAVPFFPQQSGTPGMASLSLETMRQL 50                                                           
						wherein said first amino acid sequence and second amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	       1 MSASKIPLFKMKDLILILCLLEMSFAVPFFPQQSGTPGMASLSLETMRQL 50                                                           
						isolated chimeric polypeptide encoding for an edge portion of	                  .         .         .         .         .  
						AF263464_P2, comprising a polypeptide having a length "n",   	      51 GSLQRLNTLSQYSRYGFGKSFNSLWMHGLLPPHSSLPWMRPREHETQ... 97                                                           
						wherein n is at least about 10 amino acids in length,        	         |||||||||||||||||||||||||||||||||||||||||||||||     
						optionally at least about 20 amino acids in length,          	      51 GSLQRLNTLSQYSRYGFGKSFNSLWMHGLLPPHSSLPWMRPREHETQQYE 100                                                          
						preferably at least about 30 amino acids in length, more     	                  .         .         .         .         .  
						preferably at least about 40 amino acids in length and most  	      98 ............QPSLKPQQPGLKPFLQSAAATTNQATALKEALQPPIHL 135                                                          
						preferably at least about 50 amino acids in length, wherein  	                     ||||||||||||||||||||||||||||||||||||||  
						at least two amino acids comprise QQ, having a structure as  	     101 YSLPVHPPPLPSQPSLKPQQPGLKPFLQSAAATTNQATALKEALQPPIHL 150                                                          
						follows: a sequence starting from any of amino acid numbers  	                  .         .         .         .         .  
						97-x to 98; and ending at any of amino acid numbers 98+      	     136 GHLPLQEGELPLVQQQVAPSDKPPKPELPGVDFADPQGPSLPGMDFPDPQ 185                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 GHLPLQEGELPLVQQQVAPSDKPPKPELPGVDFADPQGPSLPGMDFPDPQ 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     186 GPSLPGLDFADPQGSTIFQIARLISHGPMPQNKQSPLYPGMLYVPFGANQ 235                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 GPSLPGLDFADPQGSTIFQIARLISHGPMPQNKQSPLYPGMLYVPFGANQ 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     236 LNAPARLGIMSSEEVAGGREDPMAYGAMFPGFGGMRPGFEGMPHNPAMGG 285                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 LNAPARLGIMSSEEVAGGREDPMAYGAMFPGFGGMRPGFEGMPHNPAMGG 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     286 DFTLEFDSPVAATKGPENEEGGAQGSPMPEANPDNLENPAFLTELEPAPH 335                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 DFTLEFDSPVAATKGPENEEGGAQGSPMPEANPDNLENPAFLTELEPAPH 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     336 AGLLALPKDDIPGLPRSPSGKMKGLPSVTPAAADPLMTPELADVYRTYDA 385                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 AGLLALPKDDIPGLPRSPSGKMKGLPSVTPAAADPLMTPELADVYRTYDA 400                                                          
						                                                            	                  .         .         .         .            
						                                                            	     386 DMTTSVDFQEEATMDTTMAPNSLQTSMPGNKAQEPEMMHDAWHFQEP    432                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     401 DMTTSVDFQEEATMDTTMAPNSLQTSMPGNKAQEPEMMHDAWHFQEP    447                                                          

17485	HMR136_AF275816_1_tr0_r1_1_gPRT		Comparison report between AF275816_P1 and PRD9_HUMANunique   	Sequence name: PRD9_HUMAN                                    
						head followed by partial WT sequence featuring a skipped exon	                                                            
						plus extra amino acids and a followed by a unique tail.1.An  	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for AF275816_P1,      	                                                            
						comprising a first amino acid sequence being at least 70%,   	Alignment of: 17485 x PRD9_HUMAN   ..                        
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment segment 1/1:                                       
						FSNESSLKELSRTANLLNASGSEQAQKPVSPSGEASTSGQHSRLKLELRKKETERKMYSL 	                                                            
						RERKGHAYKEVSEPQDDDYLYCE                                      	                     Quality: 1635.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     170                Total length:     176                                               
						to amino acids 1 - 83 of AF275816_P1, a second amino acid    	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.41                                               
						MCQNFFIDSCAAHGPPTFVKDSAVDKGHPNRSALSLPPGLRIGPSGIPQAGLGVWNEASD 	    Total Percent Similarity:   96.59      Total Percent Identity:   96.02                                               
						LPLGLHFGPYEGRITEDEEAANNGYSWL                                 	                        Gaps:       1                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 1 - 88 of PRD9_HUMAN, which also corresponds to  	Alignment:                                                   
						amino acids 84 - 171 of AF275816_P1, a third amino acid      	                  .         .         .         .         .  
						sequence bridging amino acid sequence comprising of I, a     	      84 MCQNFFIDSCAAHGPPTFVKDSAVDKGHPNRSALSLPPGLRIGPSGIPQA 133                                                          
						TKGRNCYEYVDGKDKSWANWMRYVNCARDDEEQNLVAFQYHRQIFYRTCRVIRPGCELLV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						WYGDEYGQELGIKWGSKWKKE                                        	       1 MCQNFFIDSCAAHGPPTFVKDSAVDKGHPNRSALSLPPGLRIGPSGIPQA 50                                                           
						fourth amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 96 - 176 of PRD9_HUMAN, which   	     134 GLGVWNEASDLPLGLHFGPYEGRITEDEEAANNGYSWLI......TKGRN 177                                                          
						also corresponds to amino acids 173 - 253 of AF275816_P1, and	         ||||||||||||||||||||||||||||||||||||||:      |||||  
						a fifth amino acid sequence being at least 70%, optionally at	      51 GLGVWNEASDLPLGLHFGPYEGRITEDEEAANNGYSWLVRRACHFTKGRN 100                                                          
						least 80%, preferably at least 85%, more preferably at least 	                  .         .         .         .         .  
						90% and most preferably at least 95% homologous to a         	     178 CYEYVDGKDKSWANWMRYVNCARDDEEQNLVAFQYHRQIFYRTCRVIRPG 227                                                          
						polypeptide having the sequence LMAGRGRHHYYSFKRTGKKELS       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponding to amino acids 254 - 275 of AF275816_P1,       	     101 CYEYVDGKDKSWANWMRYVNCARDDEEQNLVAFQYHRQIFYRTCRVIRPG 150                                                          
						wherein said first amino acid sequence, second amino acid    	                  .         .                                
						sequence, third amino acid sequence, fourth amino acid       	     228 CELLVWYGDEYGQELGIKWGSKWKKE                         253                                                          
						sequence and fifth amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||                          
						a sequential order.2.An isolated polypeptide encoding for a  	     151 CELLVWYGDEYGQELGIKWGSKWKKE                         176                                                          
						head of AF275816_P1, comprising a polypeptide being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						FSNESSLKELSRTANLLNASGSEQAQKPVSPSGEASTSGQHSRLKLELRKKETERKMYSL 	                                                            
						RERKGHAYKEVSEPQDDDYLYCE                                      	                                                            
						at least about 95% homologous to the sequence of             	                                                            
						AF275816_P1.3.An isolated polypeptide encoding for an edge   	                                                            
						portion of AF275816_P1, comprising a polypeptide having a    	                                                            
						length "n", wherein n is at least about 10 amino acids in    	                                                            
						length, optionally at least about 20 amino acids in length,  	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise LIT having a structure as  	                                                            
						follows (numbering according to AF275816_P1): a sequence     	                                                            
						starting from any of amino acid numbers 171-x to 171; and    	                                                            
						ending at any of amino acid numbers 173 + ((n-2) - x), in    	                                                            
						which x varies from 0 to n-2.4.An isolated polypeptide       	                                                            
						encoding for a tail of AF275816_P1, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						LMAGRGRHHYYSFKRTGKKELS in AF275816_P1.                       	                                                            

17487	HMR136_AF275816_2_tr0_r1_1_gPRT		Comparison report between AF275816_P2 and PRD9_HUMANunique   	Sequence name: PRD9_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AF275816_P2, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 17487 x PRD9_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						MKSRTWWPSSTTGRSSIEPAESLGQAVNCWSGMGMNTARNWASSGAASGRKSSWQG     	                                                            
						corresponding to amino acids 1 - 56 of AF275816_P2, and a    	                     Quality: 5314.00                      Escore:       0                                               
						EEPKPEIHPCPSCCLAFSSQKFLSQHVERNHSSQNFPGPSARKLLQPENPCPGDQNQEQQ 	             Matching length:     519                Total length:     519                                               
						YPDPHSRNDKTKGQEIKERSKLLNKRTWQREISRAFSSPPKGQMGSCRVGKRIMEEESRT 	 Matching Percent Similarity:   99.61   Matching Percent Identity:   99.42                                               
						GQKVNPGNTGKLFVGVGISRIAKVKYGECGQGFSVKSDVITHQRTHTGEKLYVCRECGRG 	    Total Percent Similarity:   99.61      Total Percent Identity:   99.42                                               
						FSWKSHLLIHQRIHTGEKPYVCRECGRGFSWQSVLLTHQRTHTGEKPYVCRECGRGFSRQ 	                        Gaps:       0                        
						SVLLTHQRRHTGEKPYVCRECGRGFSRQSVLLTHQRRHTGEKPYVCRECGRGFSWQSVLL 	                                                            
						THQRTHTGEKPYVCRECGRGFSWQSVLLTHQRTHTGEKPYVCRECGRGFSNKSHLLRHQR 	Alignment:                                                   
						THTGEKPYVCRECGRGFRDKSHLLRHQRTHTGEKPYVCRECGRGFRDKSNLLSHQRTHTG 	                  .         .         .         .         .  
						EKPYVCRECGRGFSNKSHLLRHQRTHTGEKPYVCRECGRGFRNKSHLLRHQRTHTGEKPY 	      52 SSWQGEEPKPEIHPCPSCCLAFSSQKFLSQHVERNHSSQNFPGPSARKLL 101                                                          
						VCRECGRGFSDRSSLCYHQRTHTGEKPYVCREDE                           	         | |: |||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence being at least 90 % homologous to 	     171 SKWKKEEPKPEIHPCPSCCLAFSSQKFLSQHVERNHSSQNFPGPSARKLL 220                                                          
						corresponding to amino acids 176 - 689 of PRD9_HUMAN, which  	                  .         .         .         .         .  
						also corresponds to amino acids 57 - 570 of AF275816_P2,     	     102 QPENPCPGDQNQEQQYPDPHSRNDKTKGQEIKERSKLLNKRTWQREISRA 151                                                          
						wherein said first amino acid sequence and second amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     221 QPENPCPGDQNQEQQYPDPHSRNDKTKGQEIKERSKLLNKRTWQREISRA 270                                                          
						isolated polypeptide encoding for a head of AF275816_P2,     	                  .         .         .         .         .  
						comprising a polypeptide being at least 70%, optionally at   	     152 FSSPPKGQMGSCRVGKRIMEEESRTGQKVNPGNTGKLFVGVGISRIAKVK 201                                                          
						least about 80%, preferably at least about 85%, more         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 90% and most preferably at least   	     271 FSSPPKGQMGSCRVGKRIMEEESRTGQKVNPGNTGKLFVGVGISRIAKVK 320                                                          
						about 95% homologous to the sequence                         	                  .         .         .         .         .  
						MKSRTWWPSSTTGRSSIEPAESLGQAVNCWSGMGMNTARNWASSGAASGRKSSWQG of  	     202 YGECGQGFSVKSDVITHQRTHTGEKLYVCRECGRGFSWKSHLLIHQRIHT 251                                                          
						AF275816_P2.                                                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     321 YGECGQGFSVKSDVITHQRTHTGEKLYVCRECGRGFSWKSHLLIHQRIHT 370                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     252 GEKPYVCRECGRGFSWQSVLLTHQRTHTGEKPYVCRECGRGFSRQSVLLT 301                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     371 GEKPYVCRECGRGFSWQSVLLTHQRTHTGEKPYVCRECGRGFSRQSVLLT 420                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     302 HQRRHTGEKPYVCRECGRGFSRQSVLLTHQRRHTGEKPYVCRECGRGFSW 351                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     421 HQRRHTGEKPYVCRECGRGFSRQSVLLTHQRRHTGEKPYVCRECGRGFSW 470                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     352 QSVLLTHQRTHTGEKPYVCRECGRGFSWQSVLLTHQRTHTGEKPYVCREC 401                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     471 QSVLLTHQRTHTGEKPYVCRECGRGFSWQSVLLTHQRTHTGEKPYVCREC 520                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     402 GRGFSNKSHLLRHQRTHTGEKPYVCRECGRGFRDKSHLLRHQRTHTGEKP 451                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     521 GRGFSNKSHLLRHQRTHTGEKPYVCRECGRGFRDKSHLLRHQRTHTGEKP 570                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     452 YVCRECGRGFRDKSNLLSHQRTHTGEKPYVCRECGRGFSNKSHLLRHQRT 501                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     571 YVCRECGRGFRDKSNLLSHQRTHTGEKPYVCRECGRGFSNKSHLLRHQRT 620                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     502 HTGEKPYVCRECGRGFRNKSHLLRHQRTHTGEKPYVCRECGRGFSDRSSL 551                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     621 HTGEKPYVCRECGRGFRNKSHLLRHQRTHTGEKPYVCRECGRGFSDRSSL 670                                                          
						                                                            	                  .                                          
						                                                            	     552 CYHQRTHTGEKPYVCREDE                                570                                                          
						                                                            	         |||||||||||||||||||                                 
						                                                            	     671 CYHQRTHTGEKPYVCREDE                                689                                                          

18371	HMR136_AF285602_2_tr0_r1_1_gPRT		Comparison report between AF285602_P2 and RN17_HUMAN_V1short 	Sequence name: RN17_HUMAN_V1                                 
						unique head followed by partial WT sequence followed by a    	                                                            
						unique insertion with extra amino acids and a followed by a  	Sequence documentation:                                      
						unique tail.1.An isolated chimeric polypeptide encoding for  	                                                            
						AF285602_P2, comprising a first amino acid sequence being at 	Alignment of: 18371 x RN17_HUMAN_V1   ..                     
						least 70%, optionally at least 80%, preferably at least 85%, 	                                                            
						more preferably at least 90% and most preferably at least 95%	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence A            	                                                            
						corresponding to amino acids 1 - 1 of AF285602_P2, a second  	                     Quality: 6296.00                      Escore:       0                                               
						MAAEASKTGPSRSSYQRMGRKSQPWGAAEIQCTRCGRRVSRSSGHHCELQCGHAFCELCL 	             Matching length:     650                Total length:     680                                               
						LMTEECTTIICPDCEVATAVNTRQRYYPMAGYIKEDSIMEKLQPKTIKNCSQDFKKTADQ 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.85                                               
						LTTGLERSASTDKTLLNSSAVMLDTNTAEEIDEALNTAHHSFEQLSIAGKALEHMQKQTI 	    Total Percent Similarity:   95.59      Total Percent Identity:   95.44                                               
						EERERVIEVVEKQFDQLLAFFDSRKKNLCEEFARTTDDYLSNLIKAKSYIEEKKNNLNAA 	                        Gaps:       1                        
						MNIARALQLSPSLRTYCDLNQIIRTLQLTSDSELAQVSSPQLRNPPRLSVNCSEIICMFN 	                                                            
						NMGKIEFRDSTKCYPQENEIRQNVQKKYNNKKELSCYDTYPPLEKKKVDMSVLTSEAPPP 	Alignment:                                                   
						PLQPETNDVHLEAKNFQPQKDVATASPKTIAVLPQMGSSPDVIIEEIIEDNVE        	                  .         .         .         .         .  
						amino acid sequence being at least 90 % homologous to        	       2 MAAEASKTGPSRSSYQRMGRKSQPWGAAEIQCTRCGRRVSRSSGHHCELQ 51                                                           
						corresponding to amino acids 1 - 413 of RN17_HUMAN_V1, which 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						also corresponds to amino acids 2 - 414 of AF285602_P2, a    	       1 MAAEASKTGPSRSSYQRMGRKSQPWGAAEIQCTRCGRRVSRSSGHHCELQ 50                                                           
						third amino acid sequence being at least 70%, optionally at  	                  .         .         .         .         .  
						least 80%, preferably at least 85%, more preferably at least 	      52 CGHAFCELCLLMTEECTTIICPDCEVATAVNTRQRYYPMAGYIKEDSIME 101                                                          
						90% and most preferably at least 95% homologous to a         	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide having the sequence                              	      51 CGHAFCELCLLMTEECTTIICPDCEVATAVNTRQRYYPMAGYIKEDSIME 100                                                          
						TCGTDDLGETPRYPKKPLQKNSSVPFGSKAG corresponding to amino acids 	                  .         .         .         .         .  
						415 - 445 of AF285602_P2, a fourth amino acid sequence being 	     102 KLQPKTIKNCSQDFKKTADQLTTGLERSASTDKTLLNSSAVMLDTNTAEE 151                                                          
						SAELVFVSHVIDPCHFYIRKYSQIKDAKVLEKKVNEFCNRSSHLDPSDILELGARIFVSS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IKNGMWCRGTITELIPIEGRNTRKPCSPTRLFVHEVALIQIFMVDFGNSEVLIVTGVVDT 	     101 KLQPKTIKNCSQDFKKTADQLTTGLERSASTDKTLLNSSAVMLDTNTAEE 150                                                          
						HVRPEHSAKQHIALNDLCLVLRKSEPYTEGLLKDIQPLAQPCSLKDIVPQNSNEGWEEEA 	                  .         .         .         .         .  
						KVEFLKMVNNKAVSMKVFREEDGVLIVDLQKPPPNKISSDMPVSLRDALVFMELAK     	     152 IDEALNTAHHSFEQLSIAGKALEHMQKQTIEERERVIEVVEKQFDQLLAF 201                                                          
						at least 90 % homologous to corresponding to amino acids 415 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						- 650 of RN17_HUMAN_V1, which also corresponds to amino acids	     151 IDEALNTAHHSFEQLSIAGKALEHMQKQTIEERERVIEVVEKQFDQLLAF 200                                                          
						446 - 681 of AF285602_P2, and a fifth amino acid sequence    	                  .         .         .         .         .  
						being at least 70%, optionally at least 80%, preferably at   	     202 FDSRKKNLCEEFARTTDDYLSNLIKAKSYIEEKKNNLNAAMNIARALQLS 251                                                          
						least 85%, more preferably at least 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FKSQSLRSHFEKNTTLHYHPPILPKEMTDVSVTVCHINSPGDFYLQLIEGLDILFLLKTI 	     201 FDSRKKNLCEEFARTTDDYLSNLIKAKSYIEEKKNNLNAAMNIARALQLS 250                                                          
						EEFYKSEDGENLEILCPVQDQACVAKFEDGIWYRAKVIGLPGHQEVEVKYVDFGNTAKIT 	                  .         .         .         .         .  
						IKDVRKIKDEFLNAPEKAIKCKLAYIEPYKRTMQWSKEAKEKFEEKAQDKFMTCSVIKIL 	     252 PSLRTYCDLNQIIRTLQLTSDSELAQVSSPQLRNPPRLSVNCSEIICMFN 301                                                          
						EDNVLLVELFDSLGAPEMTTTSINDQLVKEGLASYEIGYILKDNSQKHIEVWDPSPEEII 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						SNEVHNLNPVSAKSLPNENFQSLYNKELPVHICNVISPEKIYVQWLLTENLLNSLEEKMI 	     251 PSLRTYCDLNQIIRTLQLTSDSELAQVSSPQLRNPPRLSVNCSEIICMFN 300                                                          
						AAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLYDVGVELVVNVDC 	                  .         .         .         .         .  
						LRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACDCLSLYLTGAVATIILQENNTTW 	     302 NMGKIEFRDSTKCYPQENEIRQNVQKKYNNKKELSCYDTYPPLEKKKVDM 351                                                          
						PLPVKIFCRDEKGERVDVSKYLIKKGLAL                                	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least 95% homologous to a polypeptide having the sequence 	     301 NMGKIEFRDSTKCYPQENEIRQNVQKKYNNKKELSCYDTYPPLEKKKVDM 350                                                          
						corresponding to amino acids 682 - 1130 of AF285602_P2,      	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	     352 SVLTSEAPPPPLQPETNDVHLEAKNFQPQKDVATASPKTIAVLPQMGSSP 401                                                          
						sequence, third amino acid sequence, fourth amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and fifth amino acid sequence are contiguous and in 	     351 SVLTSEAPPPPLQPETNDVHLEAKNFQPQKDVATASPKTIAVLPQMGSSP 400                                                          
						a sequential order.2.An isolated polypeptide encoding for an 	                  .         .         .         .         .  
						edge portion of AF285602_P2, comprising an amino acid        	     402 DVIIEEIIEDNVETCGTDDLGETPRYPKKPLQKNSSVPFGSKAGSAELVF 451                                                          
						sequence being at least 70%, optionally at least about 80%,  	         |||||||||||||:                              ||||||  
						preferably at least about 85%, more preferably at least about	     401 DVIIEEIIEDNVES..............................SAELVF 420                                                          
						90% and most preferably at least about 95% homologous to the 	                  .         .         .         .         .  
						sequence encoding for TCGTDDLGETPRYPKKPLQKNSSVPFGSKAG,       	     452 VSHVIDPCHFYIRKYSQIKDAKVLEKKVNEFCNRSSHLDPSDILELGARI 501                                                          
						corresponding to AF285602_P2.3.A bridge portion of           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AF285602_P2, comprising a polypeptide having a length "n",   	     421 VSHVIDPCHFYIRKYSQIKDAKVLEKKVNEFCNRSSHLDPSDILELGARI 470                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     502 FVSSIKNGMWCRGTITELIPIEGRNTRKPCSPTRLFVHEVALIQIFMVDF 551                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     471 FVSSIKNGMWCRGTITELIPIEGRNTRKPCSPTRLFVHEVALIQIFMVDF 520                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise ET, having a structure as  	     552 GNSEVLIVTGVVDTHVRPEHSAKQHIALNDLCLVLRKSEPYTEGLLKDIQ 601                                                          
						follows (numbering according to AF285602_P2): a sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 413-x to 413; and    	     521 GNSEVLIVTGVVDTHVRPEHSAKQHIALNDLCLVLRKSEPYTEGLLKDIQ 570                                                          
						ending at any of amino acid numbers 415 + ((n-2) - x), in    	                  .         .         .         .         .  
						which x varies from 0 to n-2.4.An isolated polypeptide       	     602 PLAQPCSLKDIVPQNSNEGWEEEAKVEFLKMVNNKAVSMKVFREEDGVLI 651                                                          
						encoding for a tail of AF285602_P2, comprising a polypeptide 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						being at least 70%, optionally at least about 80%, preferably	     571 PLAQPCSLKDIVPQNSNEGWEEEAKVEFLKMVNNKAVSMKVFREEDGVLI 620                                                          
						at least about 85%, more preferably at least about 90% and   	                  .         .         .                      
						FKSQSLRSHFEKNTTLHYHPPILPKEMTDVSVTVCHINSPGDFYLQLIEGLDILFLLKTI 	     652 VDLQKPPPNKISSDMPVSLRDALVFMELAK                     681                                                          
						EEFYKSEDGENLEILCPVQDQACVAKFEDGIWYRAKVIGLPGHQEVEVKYVDFGNTAKIT 	         ||||||||||||||||||||||||||||||                      
						IKDVRKIKDEFLNAPEKAIKCKLAYIEPYKRTMQWSKEAKEKFEEKAQDKFMTCSVIKIL 	     621 VDLQKPPPNKISSDMPVSLRDALVFMELAK                     650                                                          
						EDNVLLVELFDSLGAPEMTTTSINDQLVKEGLASYEIGYILKDNSQKHIEVWDPSPEEII 	                                                            
						SNEVHNLNPVSAKSLPNENFQSLYNKELPVHICNVISPEKIYVQWLLTENLLNSLEEKMI 	                                                            
						AAYENSKWEPVKWENDMHCAVKIQDKNQWRRGQIIRMVTDTLVEVLLYDVGVELVVNVDC 	                                                            
						LRKLEENLKTMGRLSLECSLVDIRPAGGSDKWTATACDCLSLYLTGAVATIILQENNTTW 	                                                            
						PLPVKIFCRDEKGERVDVSKYLIKKGLAL                                	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						in AF285602_P2.                                              	                                                            

20183	HMR136_AF330792_1_tr0_r1_1_gPRT		Comparison report between AF330792_P1 and Q8WXV5short unique 	Sequence name: Q8WXV5                                        
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AF330792_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 20183 x Q8WXV5   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence AA           	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 2 of AF330792_P1, a second  	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality:  375.00                      Escore:       0                                               
						MEPSGSLFPSLVVVGHVVTLAAVWHWRRGRRWAQDEQ corresponding to amino 	             Matching length:      37                Total length:      37                                               
						acids 1 - 37 of Q8WXV5, which also corresponds to amino acids	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						3 - 39 of AF330792_P1, and a third amino acid sequence being 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						at least 70%, optionally at least 80%, preferably at least   	                        Gaps:       0                        
						85%, more preferably at least 90% and most preferably at     	                                                            
						DERDRVQKKTFTKWVNKHLIKAQRHISDLYEDLRDGHNLISLLEVLSGDSLPREKGRMRF 	Alignment:                                                   
						HKLQNVQIALDYLRHRQVKLVNIRNDDIADGNPKLTLGLIWTIILHFQISDIQVSGQSED 	                  .         .         .                      
						MTAKEKLLLWSQRMVEGYQGLRCDNFTSSWRDGRLFNAIIHRHKPLLIDMNKVYRQTNLE 	       3 MEPSGSLFPSLVVVGHVVTLAAVWHWRRGRRWAQDEQ              39                                                           
						NLDQAFSVAERDLGVTRLLDPEDVDVPQPDEKSIITYVSSLYDAMPRVPDVQDGVRANEL 	         |||||||||||||||||||||||||||||||||||||               
						QLRWQEYRELVLLLLQWMRHHTAAFEERRFPSSFEEIE                       	       1 MEPSGSLFPSLVVVGHVVTLAAVWHWRRGRRWAQDEQ              37                                                           
						least 95% homologous to a polypeptide having the sequence    	                                                            
						corresponding to amino acids 40 - 317 of AF330792_P1, wherein	                                                            
						said first amino acid sequence, second amino acid sequence   	                                                            
						and third amino acid sequence are contiguous and in a        	                                                            
						sequential order.2.An isolated polypeptide encoding for a    	                                                            
						tail of AF330792_P1, comprising a polypeptide being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						DERDRVQKKTFTKWVNKHLIKAQRHISDLYEDLRDGHNLISLLEVLSGDSLPREKGRMRF 	                                                            
						HKLQNVQIALDYLRHRQVKLVNIRNDDIADGNPKLTLGLIWTIILHFQISDIQVSGQSED 	                                                            
						MTAKEKLLLWSQRMVEGYQGLRCDNFTSSWRDGRLFNAIIHRHKPLLIDMNKVYRQTNLE 	                                                            
						NLDQAFSVAERDLGVTRLLDPEDVDVPQPDEKSIITYVSSLYDAMPRVPDVQDGVRANEL 	                                                            
						QLRWQEYRELVLLLLQWMRHHTAAFEERRFPSSFEEIE                       	                                                            
						at least about 95% homologous to the sequence in AF330792_P1.	                                                            

21467	HMR136_AF358909_2_tr0_r1_1_gPRT		Comparison report between AF358909_P2 and CIWG_HUMANunique   	Sequence name: CIWG_HUMAN                                    
						head followed by partial WT sequence followed by a unique    	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AF358909_P2, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 21467 x CIWG_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence PGHS         	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 4 of AF358909_P2, a second  	                                                            
						MPSAGLCSCWGGRVLPLLLAYVCYLLLGATIFQLLERQAEAQSRDQFQLEKLRFLENYTC 	                     Quality: 2626.00                      Escore:       0                                               
						LDQWAMEQFVQVIMEAWVKGVNPKGNSTNPSNWDFGSSFFFAGTVVTTIGYGNLAPSTEA 	             Matching length:     268                Total length:     268                                               
						GQVFCVFYALLGIPLNVIFLNHLGTGLRAHLAAIERWEDRPRRSQVLQVLGLALFLTLGT 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						LVILIFPPMVFSHVEGWSFSEGFYFAFITLSTIGFGDYVVGTDPSKHYISVYRSLAAIWI 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						LLGLAWLALILPLGPLLLHRCCQLWLLS                                 	                        Gaps:       0                        
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 268 of CIWG_HUMAN, which    	Alignment:                                                   
						also corresponds to amino acids 5 - 272 of AF358909_P2, and a	                  .         .         .         .         .  
						third amino acid sequence being at least 70%, optionally at  	       5 MPSAGLCSCWGGRVLPLLLAYVCYLLLGATIFQLLERQAEAQSRDQFQLE 54                                                           
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	       1 MPSAGLCSCWGGRVLPLLLAYVCYLLLGATIFQLLERQAEAQSRDQFQLE 50                                                           
						polypeptide having the sequence RGLGVKDGAASDPSGLPRPQKIPISA   	                  .         .         .         .         .  
						corresponding to amino acids 273 - 298 of AF358909_P2,       	      55 KLRFLENYTCLDQWAMEQFVQVIMEAWVKGVNPKGNSTNPSNWDFGSSFF 104                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	      51 KLRFLENYTCLDQWAMEQFVQVIMEAWVKGVNPKGNSTNPSNWDFGSSFF 100                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						head of AF358909_P2, comprising a polypeptide being at least 	     105 FAGTVVTTIGYGNLAPSTEAGQVFCVFYALLGIPLNVIFLNHLGTGLRAH 154                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     101 FAGTVVTTIGYGNLAPSTEAGQVFCVFYALLGIPLNVIFLNHLGTGLRAH 150                                                          
						at least about 95% homologous to the sequence PGHS of        	                  .         .         .         .         .  
						AF358909_P2.3.An isolated polypeptide encoding for a tail of 	     155 LAAIERWEDRPRRSQVLQVLGLALFLTLGTLVILIFPPMVFSHVEGWSFS 204                                                          
						AF358909_P2, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     151 LAAIERWEDRPRRSQVLQVLGLALFLTLGTLVILIFPPMVFSHVEGWSFS 200                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						least about 95% homologous to the sequence                   	     205 EGFYFAFITLSTIGFGDYVVGTDPSKHYISVYRSLAAIWILLGLAWLALI 254                                                          
						RGLGVKDGAASDPSGLPRPQKIPISA in AF358909_P2.                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 EGFYFAFITLSTIGFGDYVVGTDPSKHYISVYRSLAAIWILLGLAWLALI 250                                                          
						                                                            	                  .                                          
						                                                            	     255 LPLGPLLLHRCCQLWLLS                                 272                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     251 LPLGPLLLHRCCQLWLLS                                 268                                                          

21545	HMR136_AF388366_2_tr0_r1_1_gPRT		Comparison report between AF388366_P2 and Q8N6A9partial WT   	Sequence name: Q8N6A9                                        
						sequence featuring skipped exon plus extra amino acids.1.An  	                                                            
						isolated chimeric polypeptide encoding for AF388366_P2,      	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MPSQQKKIIFCMAGVFSFACALGVVTALGTPLWIKATVLCKTGALLVNASGQELDKFMGE 	Alignment of: 21545 x Q8N6A9   ..                            
						MQYGLFHGEGVRQCGLGARPFRFS                                     	                                                            
						homologous to corresponding to amino acids 1 - 84 of Q8N6A9, 	Alignment segment 1/1:                                       
						which also corresponds to amino acids 1 - 84 of AF388366_P2, 	                                                            
						a second amino acid sequence bridging amino acid sequence    	                     Quality: 1581.00                      Escore:       0                                               
						comprising of C, and a third amino acid sequence being at    	             Matching length:     172                Total length:     232                                               
						SCGCLVMILFASEVKIHHLSEKIANYKEGTYVYKTQSEKYTTSFWVIFFCFFVHFLNGLL 	 Matching Percent Similarity:   99.42   Matching Percent Identity:   99.42                                               
						IRLAGFQFPFAKSKDAETTNVAADLMY                                  	    Total Percent Similarity:   73.71      Total Percent Identity:   73.71                                               
						least 90 % homologous to corresponding to amino acids 146 -  	                        Gaps:       1                        
						232 of Q8N6A9, which also corresponds to amino acids 86 - 172	                                                            
						of AF388366_P2, wherein said first amino acid sequence,      	Alignment:                                                   
						second amino acid sequence and third amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	       1 MPSQQKKIIFCMAGVFSFACALGVVTALGTPLWIKATVLCKTGALLVNAS 50                                                           
						polypeptide encoding for an edge portion of AF388366_P2,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						comprising a polypeptide having a length "n", wherein n is at	       1 MPSQQKKIIFCMAGVFSFACALGVVTALGTPLWIKATVLCKTGALLVNAS 50                                                           
						least about 10 amino acids in length, optionally at least    	                  .         .         .         .         .  
						about 20 amino acids in length, preferably at least about 30 	      51 GQELDKFMGEMQYGLFHGEGVRQCGLGARPFRFSC............... 85                                                           
						amino acids in length, more preferably at least about 40     	         ||||||||||||||||||||||||||||||||||                  
						amino acids in length and most preferably at least about 50  	      51 GQELDKFMGEMQYGLFHGEGVRQCGLGARPFRFSFFPDLLKAIPVSIHVN 100                                                          
						amino acids in length, wherein at least two amino acids      	                  .         .         .         .         .  
						comprise SCS having a structure as follows (numbering        	      86 .............................................SCGCL 90                                                           
						according to AF388366_P2): a sequence starting from any of   	                                                      |||||  
						amino acid numbers 84-x to 84; and ending at any of amino    	     101 VILFSAILIVLTMVGTAFFMYNAFGKPFETLHGPLGLYLLSFISGSCGCL 150                                                          
						acid numbers 86 + ((n-2) - x), in which x varies from 0 to   	                  .         .         .         .         .  
						n-2.                                                         	      91 VMILFASEVKIHHLSEKIANYKEGTYVYKTQSEKYTTSFWVIFFCFFVHF 140                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 VMILFASEVKIHHLSEKIANYKEGTYVYKTQSEKYTTSFWVIFFCFFVHF 200                                                          
						                                                            	                  .         .         .                      
						                                                            	     141 LNGLLIRLAGFQFPFAKSKDAETTNVAADLMY                   172                                                          
						                                                            	         ||||||||||||||||||||||||||||||||                    
						                                                            	     201 LNGLLIRLAGFQFPFAKSKDAETTNVAADLMY                   232                                                          

21798	HMR136_AF425642_1_tr0_r1_1_gPRT		Comparison report between AF425642_P1 and AS11_HUMANunique   	Sequence name: AS11_HUMAN                                    
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AF425642_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 21798 x AS11_HUMAN   ..                        
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence ERIRRSGPWKEISFGDYICHTFQG corresponding to	Alignment segment 1/1:                                       
						amino acids 1 - 24 of AF425642_P1, and a second amino acid   	                                                            
						DCWADRSPLHEAAAQGRLLALKTLIAQGVNVNLVTINRVSSLHEACLGGHVACAKALLEN 	                     Quality: 2556.00                      Escore:       0                                               
						GAHVNGVTVHGATPLFNACCSGSAACVNVLLEFGAKAQLEVHLASPIHEAVKRGHRECME 	             Matching length:     263                Total length:     263                                               
						ILLANNVNIDHEVPQLGTPLYVACTYQRVDCVKKLLELGASVDHGQWLDTPLHAAARQSN 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						VEVIHLLTDYGANLKRRNAQGKSALDLAAPKSSVEQALLLREGPPALSQLCRLCVRKCLG 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						RACHQAIHKLHLPEPLERFLLYQ                                      	                        Gaps:       0                        
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 61 - 323 of AS11_HUMAN, which also corresponds to	Alignment:                                                   
						amino acids 25 - 287 of AF425642_P1, wherein said first amino	                  .         .         .         .         .  
						acid sequence and second amino acid sequence are contiguous  	      25 DCWADRSPLHEAAAQGRLLALKTLIAQGVNVNLVTINRVSSLHEACLGGH 74                                                           
						and in a sequential order.2.An isolated polypeptide encoding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						for a head of AF425642_P1, comprising a polypeptide being at 	      61 DCWADRSPLHEAAAQGRLLALKTLIAQGVNVNLVTINRVSSLHEACLGGH 110                                                          
						least 70%, optionally at least about 80%, preferably at least	                  .         .         .         .         .  
						about 85%, more preferably at least about 90% and most       	      75 VACAKALLENGAHVNGVTVHGATPLFNACCSGSAACVNVLLEFGAKAQLE 124                                                          
						preferably at least about 95% homologous to the sequence     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						ERIRRSGPWKEISFGDYICHTFQG of AF425642_P1.                     	     111 VACAKALLENGAHVNGVTVHGATPLFNACCSGSAACVNVLLEFGAKAQLE 160                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     125 VHLASPIHEAVKRGHRECMEILLANNVNIDHEVPQLGTPLYVACTYQRVD 174                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     161 VHLASPIHEAVKRGHRECMEILLANNVNIDHEVPQLGTPLYVACTYQRVD 210                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     175 CVKKLLELGASVDHGQWLDTPLHAAARQSNVEVIHLLTDYGANLKRRNAQ 224                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     211 CVKKLLELGASVDHGQWLDTPLHAAARQSNVEVIHLLTDYGANLKRRNAQ 260                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     225 GKSALDLAAPKSSVEQALLLREGPPALSQLCRLCVRKCLGRACHQAIHKL 274                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     261 GKSALDLAAPKSSVEQALLLREGPPALSQLCRLCVRKCLGRACHQAIHKL 310                                                          
						                                                            	                  .                                          
						                                                            	     275 HLPEPLERFLLYQ                                      287                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     311 HLPEPLERFLLYQ                                      323                                                          

21800	HMR136_AF425642_2_tr0_r1_1_gPRT		Comparison report between AF425642_P2 and AS11_HUMANunique   	Sequence name: AS11_HUMAN                                    
						head followed by partial WT sequence featuring a skipped     	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AF425642_P2, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 21800 x AS11_HUMAN   ..                        
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						ERIRRSGPWKEISFGDYICHTFQG corresponding to amino acids 1 - 24 	                                                            
						of AF425642_P2, a second amino acid sequence being at least  	                     Quality: 2009.00                      Escore:       0                                               
						DCWADRSPLHEAAAQGRLLALKTLIAQGVNVNLVTINRVSSLHEACLGGHVACAKALLEN 	             Matching length:     218                Total length:     263                                               
						GAHVNGVTVHGATPLFNACCSGSAACVNVLLEFGAKAQLEVHLASPIHEAVKR        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						90 % homologous to corresponding to amino acids 61 - 173 of  	    Total Percent Similarity:   82.89      Total Percent Identity:   82.89                                               
						AS11_HUMAN, which also corresponds to amino acids 25 - 137 of	                        Gaps:       1                        
						AF425642_P2, and a third amino acid sequence being at least  	                                                            
						GASVDHGQWLDTPLHAAARQSNVEVIHLLTDYGANLKRRNAQGKSALDLAAPKSSVEQAL 	Alignment:                                                   
						LLREGPPALSQLCRLCVRKCLGRACHQAIHKLHLPEPLERFLLYQ                	                  .         .         .         .         .  
						90 % homologous to corresponding to amino acids 219 - 323 of 	      25 DCWADRSPLHEAAAQGRLLALKTLIAQGVNVNLVTINRVSSLHEACLGGH 74                                                           
						AS11_HUMAN, which also corresponds to amino acids 138 - 242  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						of AF425642_P2, wherein said first amino acid sequence,      	      61 DCWADRSPLHEAAAQGRLLALKTLIAQGVNVNLVTINRVSSLHEACLGGH 110                                                          
						second amino acid sequence and third amino acid sequence are 	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	      75 VACAKALLENGAHVNGVTVHGATPLFNACCSGSAACVNVLLEFGAKAQLE 124                                                          
						polypeptide encoding for a head of AF425642_P2, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	     111 VACAKALLENGAHVNGVTVHGATPLFNACCSGSAACVNVLLEFGAKAQLE 160                                                          
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	     125 VHLASPIHEAVKR..................................... 137                                                          
						to the sequence ERIRRSGPWKEISFGDYICHTFQG of AF425642_P2.3.An 	         |||||||||||||                                       
						isolated chimeric polypeptide encoding for an edge portion of	     161 VHLASPIHEAVKRGHRECMEILLANNVNIDHEVPQLGTPLYVACTYQRVD 210                                                          
						AF425642_P2, comprising a polypeptide having a length "n",   	                  .         .         .         .         .  
						wherein n is at least about 10 amino acids in length,        	     138 ........GASVDHGQWLDTPLHAAARQSNVEVIHLLTDYGANLKRRNAQ 179                                                          
						optionally at least about 20 amino acids in length,          	                 ||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 30 amino acids in length, more     	     211 CVKKLLELGASVDHGQWLDTPLHAAARQSNVEVIHLLTDYGANLKRRNAQ 260                                                          
						preferably at least about 40 amino acids in length and most  	                  .         .         .         .         .  
						preferably at least about 50 amino acids in length, wherein  	     180 GKSALDLAAPKSSVEQALLLREGPPALSQLCRLCVRKCLGRACHQAIHKL 229                                                          
						at least two amino acids comprise RG, having a structure as  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						follows: a sequence starting from any of amino acid numbers  	     261 GKSALDLAAPKSSVEQALLLREGPPALSQLCRLCVRKCLGRACHQAIHKL 310                                                          
						137-x to 138; and ending at any of amino acid numbers 138+   	                  .                                          
						((n-2) - x), in which x varies from 0 to n-2.                	     230 HLPEPLERFLLYQ                                      242                                                          
						                                                            	         |||||||||||||                                       
						                                                            	     311 HLPEPLERFLLYQ                                      323                                                          

22560	HMR136_AF497717_0_tr0_r1_1_gPRT		Comparison report between AF497717_P0 and Q8TD41unique head  	Sequence name: Q8TD41                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AF497717_P0, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 22560 x Q8TD41   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						DVHAVARPDPLVPCWREERGGT corresponding to amino acids 1 - 22 of	                                                            
						AF497717_P0, a second amino acid sequence being at least 90 %	                     Quality: 2274.00                      Escore:       0                                               
						MSHAVTIEEPQAQPQVSQTRYRERSRAGSHISSNRAYDFLYDPLFIVSSEKDHTQANIQA 	             Matching length:     228                Total length:     228                                               
						TLIRSRLRKVPRFKTMFSNLIHYPRYSLYWSKSDPVPPFISREWKGHKEKHREALRQLTT 	 Matching Percent Similarity:   99.56   Matching Percent Identity:   99.56                                               
						TDASFQMPKEVYEDPEVTGKNRYKYFERPFLPFFQQMPFNVVYAVSKAEPYTFPPTSTKH 	    Total Percent Similarity:   99.56      Total Percent Identity:   99.56                                               
						LSIPSKSTVGTQTDYRDADVQTDPYS                                   	                        Gaps:       0                        
						homologous to corresponding to amino acids 1 - 206 of Q8TD41,	                                                            
						which also corresponds to amino acids 23 - 228 of            	Alignment:                                                   
						AF497717_P0, a bridging amino acid A corresponding to amino  	                  .         .         .         .         .  
						acid 229 of AF497717_P0, a third amino acid sequence being at	      23 MSHAVTIEEPQAQPQVSQTRYRERSRAGSHISSNRAYDFLYDPLFIVSSE 72                                                           
						least 90 % homologous to EYVVCQDSIPELLTLATLTWG corresponding 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						to amino acids 208 - 228 of Q8TD41, which also corresponds to	       1 MSHAVTIEEPQAQPQVSQTRYRERSRAGSHISSNRAYDFLYDPLFIVSSE 50                                                           
						amino acids 230 - 250 of AF497717_P0, and a fourth amino acid	                  .         .         .         .         .  
						sequence being at least 70%, optionally at least 80%,        	      73 KDHTQANIQATLIRSRLRKVPRFKTMFSNLIHYPRYSLYWSKSDPVPPFI 122                                                          
						preferably at least 85%, more preferably at least 90% and    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least 95% homologous to a polypeptide     	      51 KDHTQANIQATLIRSRLRKVPRFKTMFSNLIHYPRYSLYWSKSDPVPPFI 100                                                          
						RGLPAGQAEVEMIERAREKRAWEASLPALSDTSQFEKRRKMMNEMERKEWAFREQEIEKL 	                  .         .         .         .         .  
						QEIRLEVLKELLRKREENQNEVNMKHLNARWSKLQEGKEAKMAKIQRTHVSTIRKLVGKR 	     123 SREWKGHKEKHREALRQLTTTDASFQMPKEVYEDPEVTGKNRYKYFERPF 172                                                          
						KNIEGKLERRNIIKDYSDYASQVYGPLSRLGCFPDNNSEDFVVKNYYLNTYEGLVELESC 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPDFVTQPQIRAPKPKVITTKAGFLKRAARLDYELAEVHKALLDKKNKVLEVKKPPRFLQ 	     101 SREWKGHKEKHREALRQLTTTDASFQMPKEVYEDPEVTGKNRYKYFERPF 150                                                          
						RNPIPQPRLPTPTLEMTSNEEEEMEMAVIYLQKLLRGRVVQNMMFEGKEKRLELIQELRT 	                  .         .         .         .         .  
						CHALQEDEKLVKKAEKQVTLALQRQRNLHEHKVSLVENHLAGLEGRALADMFDFLSKELV 	     173 LPFFQQMPFNVVYAVSKAEPYTFPPTSTKHLSIPSKSTVGTQTDYRDADV 222                                                          
						RLQEERRIHAFVMLAERQRRVREAEESGRRQVEKQRLREEDEIFKEVVKVHHSTISSYLE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DIILNTEANTAEEQARAEIEKMAEKINDIAYEMESRRTYLQSEEIVAELVYSFLIPEVQK 	     151 LPFFQQMPFNVVYAVSKAEPYTFPPTSTKHLSIPSKSTVGTQTDYRDADV 200                                                          
						YFVKEK                                                       	                  .         .                                
						having the sequence corresponding to amino acids 251 - 736 of	     223 QTDPYSAEYVVCQDSIPELLTLATLTWG                       250                                                          
						AF497717_P0, wherein said first amino acid sequence, second  	         |||||| |||||||||||||||||||||                        
						amino acid sequence, bridging amino acid, third amino acid   	     201 QTDPYSPEYVVCQDSIPELLTLATLTWG                       228                                                          
						sequence and fourth amino acid sequence are contiguous and in	                                                            
						a sequential order.2.An isolated polypeptide encoding for a  	                                                            
						head of AF497717_P0, comprising a polypeptide being at least 	                                                            
						70%, optionally at least about 80%, preferably at least about	                                                            
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						DVHAVARPDPLVPCWREERGGT of AF497717_P0.3.An isolated          	                                                            
						polypeptide encoding for a tail of AF497717_P0, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						RGLPAGQAEVEMIERAREKRAWEASLPALSDTSQFEKRRKMMNEMERKEWAFREQEIEKL 	                                                            
						QEIRLEVLKELLRKREENQNEVNMKHLNARWSKLQEGKEAKMAKIQRTHVSTIRKLVGKR 	                                                            
						KNIEGKLERRNIIKDYSDYASQVYGPLSRLGCFPDNNSEDFVVKNYYLNTYEGLVELESC 	                                                            
						LPDFVTQPQIRAPKPKVITTKAGFLKRAARLDYELAEVHKALLDKKNKVLEVKKPPRFLQ 	                                                            
						RNPIPQPRLPTPTLEMTSNEEEEMEMAVIYLQKLLRGRVVQNMMFEGKEKRLELIQELRT 	                                                            
						CHALQEDEKLVKKAEKQVTLALQRQRNLHEHKVSLVENHLAGLEGRALADMFDFLSKELV 	                                                            
						RLQEERRIHAFVMLAERQRRVREAEESGRRQVEKQRLREEDEIFKEVVKVHHSTISSYLE 	                                                            
						DIILNTEANTAEEQARAEIEKMAEKINDIAYEMESRRTYLQSEEIVAELVYSFLIPEVQK 	                                                            
						YFVKEK                                                       	                                                            
						to the sequence in AF497717_P0.                              	                                                            

22843	HMR136_AF513502_1_tr0_r1_1_gPRT		Comparison report between AF513502_P1 and AAP47163unique     	Sequence name: AAP47163                                      
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AF513502_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 22843 x AAP47163   ..                          
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						having the sequence                                          	Alignment segment 1/1:                                       
						EEEDEEEEDQEEEEEEEEEEEEEEEEEEEEEEEEEEKKVILYSPGTLSPDLMEFER     	                                                            
						corresponding to amino acids 1 - 56 of AF513502_P1, and a    	                     Quality: 1772.00                      Escore:       0                                               
						YLNFYKQTMDLLTGSGIITPQEAALPIVSAAISHLWQNLSEERKASLRQAWAQKHRGPAT 	             Matching length:     181                Total length:     181                                               
						LAEACREPACAEGSVKDSGVDSQGASCSLVSTPEEILFEDAFDVASFLDKSEVPSTSSSS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						SVLASCNPENPEEKFQLYMQIINFFKGLSCANTQVKQEASFPVDEEMIMLQCTETFDDED 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						L                                                            	                        Gaps:       0                        
						second amino acid sequence being at least 90 % homologous to 	                                                            
						corresponding to amino acids 150 - 330 of AAP47163, which    	Alignment:                                                   
						also corresponds to amino acids 57 - 237 of AF513502_P1,     	                  .         .         .         .         .  
						wherein said first amino acid sequence and second amino acid 	      57 YLNFYKQTMDLLTGSGIITPQEAALPIVSAAISHLWQNLSEERKASLRQA 106                                                          
						sequence are contiguous and in a sequential order.2.An       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						isolated polypeptide encoding for a head of AF513502_P1,     	     150 YLNFYKQTMDLLTGSGIITPQEAALPIVSAAISHLWQNLSEERKASLRQA 199                                                          
						comprising a polypeptide being at least 70%, optionally at   	                  .         .         .         .         .  
						least about 80%, preferably at least about 85%, more         	     107 WAQKHRGPATLAEACREPACAEGSVKDSGVDSQGASCSLVSTPEEILFED 156                                                          
						preferably at least about 90% and most preferably at least   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						about 95% homologous to the sequence                         	     200 WAQKHRGPATLAEACREPACAEGSVKDSGVDSQGASCSLVSTPEEILFED 249                                                          
						EEEDEEEEDQEEEEEEEEEEEEEEEEEEEEEEEEEEKKVILYSPGTLSPDLMEFER of  	                  .         .         .         .         .  
						AF513502_P1.                                                 	     157 AFDVASFLDKSEVPSTSSSSSVLASCNPENPEEKFQLYMQIINFFKGLSC 206                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     250 AFDVASFLDKSEVPSTSSSSSVLASCNPENPEEKFQLYMQIINFFKGLSC 299                                                          
						                                                            	                  .         .         .                      
						                                                            	     207 ANTQVKQEASFPVDEEMIMLQCTETFDDEDL                    237                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     300 ANTQVKQEASFPVDEEMIMLQCTETFDDEDL                    330                                                          

23343	HMR136_AF520800_7_tr0_r1_1_gPRT		Comparison report between AF520800_P7 and Q8IZS5partial WT   	Sequence name: Q8IZS5                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF520800_P7, comprising a first     	Sequence documentation:                                      
						MEREKFQQKALKQTKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLSACQTAEKKVI 	                                                            
						RHDMPDRTLAAHQQKFRLPASAEPKG                                   	Alignment of: 23343 x Q8IZS5   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 86 of Q8IZS5, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 86 of AF520800_P7, and a      	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality:  851.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:      86                Total length:      86                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence VTSVLIIFT corresponding to   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 87 - 95 of AF520800_P7, wherein said first amino 	                        Gaps:       0                        
						acid sequence and second amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	Alignment:                                                   
						for a tail of AF520800_P7, comprising a polypeptide being at 	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	       1 MEREKFQQKALKQTKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLS 50                                                           
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	       1 MEREKFQQKALKQTKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLS 50                                                           
						VTSVLIIFT in AF520800_P7.                                    	                  .         .         .                      
						                                                            	      51 ACQTAEKKVIRHDMPDRTLAAHQQKFRLPASAEPKG               86                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	      51 ACQTAEKKVIRHDMPDRTLAAHQQKFRLPASAEPKG               86                                                           

						Comparison report between AF520800_P7 and Q8IZS3unique head  	Sequence name: Q8IZS3                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AF520800_P7, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23343 x Q8IZS3   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MEREKFQQKALKQ	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 13 of AF520800_P7, a second 	                                                            
						TKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLSACQTAEKKVIRHDMPDRTLAAHQ 	                     Quality:  719.00                      Escore:       0                                               
						QKFRLPASAEPKG                                                	             Matching length:      73                Total length:      73                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 73 of Q8IZS3, which also    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 14 - 86 of AF520800_P7, and a     	                        Gaps:       0                        
						third amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence VTSVLIIFT corresponding to   	      14 TKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLSACQTAEKKVIRHD 63                                                           
						amino acids 87 - 95 of AF520800_P7, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence and third amino    	       1 TKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLSACQTAEKKVIRHD 50                                                           
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .                                
						isolated polypeptide encoding for a head of AF520800_P7,     	      64 MPDRTLAAHQQKFRLPASAEPKG                            86                                                           
						comprising a polypeptide being at least 70%, optionally at   	         |||||||||||||||||||||||                             
						least about 80%, preferably at least about 85%, more         	      51 MPDRTLAAHQQKFRLPASAEPKG                            73                                                           
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence MEREKFQQKALKQ of        	                                                            
						AF520800_P7.3.An isolated polypeptide encoding for a tail of 	                                                            
						AF520800_P7, comprising a polypeptide being at least 70%,    	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence VTSVLIIFT in      	                                                            
						AF520800_P7.                                                 	                                                            

						Comparison report between AF520800_P7 and Q8IZS2unique head  	Sequence name: Q8IZS2                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AF520800_P7, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23343 x Q8IZS2   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MEREKFQQKALKQTKQKK corresponding to amino acids 1 - 18 of    	                                                            
						AF520800_P7, a second amino acid sequence being at least 90 %	                     Quality:  669.00                      Escore:       0                                               
						SKSAEFLMVKEDREATEGTGNPAFNMSSPDLSACQTAEKKVIRHDMPDRTLAAHQQKFRL 	             Matching length:      68                Total length:      68                                               
						PASAEPKG                                                     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						homologous to corresponding to amino acids 1 - 68 of Q8IZS2, 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						which also corresponds to amino acids 19 - 86 of AF520800_P7,	                        Gaps:       0                        
						and a third amino acid sequence being at least 70%,          	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment:                                                   
						preferably at least 90% and most preferably at least 95%     	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence VTSVLIIFT    	      19 SKSAEFLMVKEDREATEGTGNPAFNMSSPDLSACQTAEKKVIRHDMPDRT 68                                                           
						corresponding to amino acids 87 - 95 of AF520800_P7, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence, second amino acid sequence   	       1 SKSAEFLMVKEDREATEGTGNPAFNMSSPDLSACQTAEKKVIRHDMPDRT 50                                                           
						and third amino acid sequence are contiguous and in a        	                  .                                          
						sequential order.2.An isolated polypeptide encoding for a    	      69 LAAHQQKFRLPASAEPKG                                 86                                                           
						head of AF520800_P7, comprising a polypeptide being at least 	         ||||||||||||||||||                                  
						70%, optionally at least about 80%, preferably at least about	      51 LAAHQQKFRLPASAEPKG                                 68                                                           
						85%, more preferably at least about 90% and most preferably  	                                                            
						at least about 95% homologous to the sequence                	                                                            
						MEREKFQQKALKQTKQKK of AF520800_P7.3.An isolated polypeptide  	                                                            
						encoding for a tail of AF520800_P7, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						VTSVLIIFT in AF520800_P7.                                    	                                                            

						Comparison report between AF520800_P7 and Q8IZS1unique head  	Sequence name: Q8IZS1                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AF520800_P7, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23343 x Q8IZS1   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence MEREKFQQKALKQ	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 13 of AF520800_P7, a second 	                                                            
						TKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLSACQTAEKKVIRHDMPDRTLAAHQ 	                     Quality:  719.00                      Escore:       0                                               
						QKFRLPASAEPKG                                                	             Matching length:      73                Total length:      73                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 73 of Q8IZS1, which also    	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 14 - 86 of AF520800_P7, and a     	                        Gaps:       0                        
						third amino acid sequence being at least 70%, optionally at  	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence VTSVLIIFT corresponding to   	      14 TKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLSACQTAEKKVIRHD 63                                                           
						amino acids 87 - 95 of AF520800_P7, wherein said first amino 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acid sequence, second amino acid sequence and third amino    	       1 TKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLSACQTAEKKVIRHD 50                                                           
						acid sequence are contiguous and in a sequential order.2.An  	                  .         .                                
						isolated polypeptide encoding for a head of AF520800_P7,     	      64 MPDRTLAAHQQKFRLPASAEPKG                            86                                                           
						comprising a polypeptide being at least 70%, optionally at   	         |||||||||||||||||||||||                             
						least about 80%, preferably at least about 85%, more         	      51 MPDRTLAAHQQKFRLPASAEPKG                            73                                                           
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence MEREKFQQKALKQ of        	                                                            
						AF520800_P7.3.An isolated polypeptide encoding for a tail of 	                                                            
						AF520800_P7, comprising a polypeptide being at least 70%,    	                                                            
						optionally at least about 80%, preferably at least about 85%,	                                                            
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence VTSVLIIFT in      	                                                            
						AF520800_P7.                                                 	                                                            

						Comparison report between AF520800_P7 and Q8IZS0partial WT   	Sequence name: Q8IZS0                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF520800_P7, comprising a first     	Sequence documentation:                                      
						MEREKFQQKALKQTKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLSACQTAEKKVI 	                                                            
						RHDMPDRTLAAHQQKFRLPASAEPKG                                   	Alignment of: 23343 x Q8IZS0   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 86 of Q8IZS0, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 86 of AF520800_P7, and a      	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality:  851.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:      86                Total length:      86                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence VTSVLIIFT corresponding to   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 87 - 95 of AF520800_P7, wherein said first amino 	                        Gaps:       0                        
						acid sequence and second amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	Alignment:                                                   
						for a tail of AF520800_P7, comprising a polypeptide being at 	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	       1 MEREKFQQKALKQTKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLS 50                                                           
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	       1 MEREKFQQKALKQTKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLS 50                                                           
						VTSVLIIFT in AF520800_P7.                                    	                  .         .         .                      
						                                                            	      51 ACQTAEKKVIRHDMPDRTLAAHQQKFRLPASAEPKG               86                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	      51 ACQTAEKKVIRHDMPDRTLAAHQQKFRLPASAEPKG               86                                                           

						Comparison report between AF520800_P7 and Q8IZR9partial WT   	Sequence name: Q8IZR9                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF520800_P7, comprising a first     	Sequence documentation:                                      
						MEREKFQQKALKQTKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLSACQTAEKKVI 	                                                            
						RHDMPDRTLAAHQQKFRLPASAEPKG                                   	Alignment of: 23343 x Q8IZR9   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 86 of Q8IZR9, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 86 of AF520800_P7, and a      	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality:  851.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:      86                Total length:      86                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence VTSVLIIFT corresponding to   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 87 - 95 of AF520800_P7, wherein said first amino 	                        Gaps:       0                        
						acid sequence and second amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	Alignment:                                                   
						for a tail of AF520800_P7, comprising a polypeptide being at 	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	       1 MEREKFQQKALKQTKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLS 50                                                           
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	       1 MEREKFQQKALKQTKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLS 50                                                           
						VTSVLIIFT in AF520800_P7.                                    	                  .         .         .                      
						                                                            	      51 ACQTAEKKVIRHDMPDRTLAAHQQKFRLPASAEPKG               86                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	      51 ACQTAEKKVIRHDMPDRTLAAHQQKFRLPASAEPKG               86                                                           

						Comparison report between AF520800_P7 and Q8IUL6partial WT   	Sequence name: Q8IUL6                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AF520800_P7, comprising a first     	Sequence documentation:                                      
						MEREKFQQKALKQTKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLSACQTAEKKVI 	                                                            
						RHDMPDRTLAAHQQKFRLPASAEPKG                                   	Alignment of: 23343 x Q8IUL6   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 69 - 154 of Q8IUL6, which also  	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 86 of AF520800_P7, and a      	                                                            
						second amino acid sequence being at least 70%, optionally at 	                     Quality:  851.00                      Escore:       0                                               
						least 80%, preferably at least 85%, more preferably at least 	             Matching length:      86                Total length:      86                                               
						90% and most preferably at least 95% homologous to a         	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						polypeptide having the sequence VTSVLIIFT corresponding to   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						amino acids 87 - 95 of AF520800_P7, wherein said first amino 	                        Gaps:       0                        
						acid sequence and second amino acid sequence are contiguous  	                                                            
						and in a sequential order.2.An isolated polypeptide encoding 	Alignment:                                                   
						for a tail of AF520800_P7, comprising a polypeptide being at 	                  .         .         .         .         .  
						least 70%, optionally at least about 80%, preferably at least	       1 MEREKFQQKALKQTKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLS 50                                                           
						about 85%, more preferably at least about 90% and most       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 95% homologous to the sequence     	      69 MEREKFQQKALKQTKQKKSKSAEFLMVKEDREATEGTGNPAFNMSSPDLS 118                                                          
						VTSVLIIFT in AF520800_P7.                                    	                  .         .         .                      
						                                                            	      51 ACQTAEKKVIRHDMPDRTLAAHQQKFRLPASAEPKG               86                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||                
						                                                            	     119 ACQTAEKKVIRHDMPDRTLAAHQQKFRLPASAEPKG               154                                                          

23708	HMR136_AI001156_4_tr0_r1_1_gPRT		Comparison report between AI001156_P4 and PS7L_HUMANpartial  	Sequence name: PS7L_HUMAN                                    
						WT sequence featuring skipped exon and a mismatch.1.An       	                                                            
						isolated chimeric polypeptide encoding for AI001156_P4,      	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 90 %   	                                                            
						MASRYDRAITVFSPDGHLFQVEYAQEAVKKGSTAVGIRGTNIVVLGVEKKSVAKLQDERT 	Alignment of: 23708 x PS7L_HUMAN   ..                        
						VRKICALDDHVCMAFA                                             	                                                            
						homologous to corresponding to amino acids 1 - 76 of         	Alignment segment 1/1:                                       
						PS7L_HUMAN, which also corresponds to amino acids 1 - 76 of  	                                                            
						AI001156_P4, a second amino acid sequence being at least 90 %	                     Quality: 1804.00                      Escore:       0                                               
						GLTADARVVINRARVECQSHKLTVEDPVTVEYITRFIATLKQKYTQSNGRRPFGISALIV 	             Matching length:     210                Total length:     256                                               
						GFDDDGISRLYQTDPSGTYHAWK                                      	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.52                                               
						homologous to corresponding to amino acids 83 - 165 of       	    Total Percent Similarity:   82.03      Total Percent Identity:   81.64                                               
						PS7L_HUMAN, which also corresponds to amino acids 77 - 159 of	                        Gaps:       2                        
						AI001156_P4, a third amino acid sequence being at least 90 % 	                                                            
						homologous to VVQSGG corresponding to amino acids 206 - 211  	Alignment:                                                   
						of PS7L_HUMAN, which also corresponds to amino acids 160 -   	                  .         .         .         .         .  
						165 of AI001156_P4, a bridging amino acid K corresponding to 	       1 MASRYDRAITVFSPDGHLFQVEYAQEAVKKGSTAVGIRGTNIVVLGVEKK 50                                                           
						amino acid 166 of AI001156_P4, and a fourth amino acid       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to                   	       1 MASRYDRAITVFSPDGHLFQVEYAQEAVKKGSTAVGIRGTNIVVLGVEKK 50                                                           
						NIELAIIRRNQPLKMFSAKEVELYVTEIEKEKEEAEKKKSKKSV corresponding to	                  .         .         .         .         .  
						amino acids 213 - 256 of PS7L_HUMAN, which also corresponds  	      51 SVAKLQDERTVRKICALDDHVCMAFA......GLTADARVVINRARVECQ 94                                                           
						to amino acids 167 - 210 of AI001156_P4, wherein said first  	         ||||||||||||||||||||||||||      ||||||||||||||||||  
						amino acid sequence, second amino acid sequence, third amino 	      51 SVAKLQDERTVRKICALDDHVCMAFAVLTIFIGLTADARVVINRARVECQ 100                                                          
						acid sequence, bridging amino acid and fourth amino acid     	                  .         .         .         .         .  
						sequence are contiguous and in a sequential order.2.An       	      95 SHKLTVEDPVTVEYITRFIATLKQKYTQSNGRRPFGISALIVGFDDDGIS 144                                                          
						isolated chimeric polypeptide encoding for an edge portion of	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AI001156_P4, comprising a polypeptide having a length "n",   	     101 SHKLTVEDPVTVEYITRFIATLKQKYTQSNGRRPFGISALIVGFDDDGIS 150                                                          
						wherein n is at least about 10 amino acids in length,        	                  .         .         .         .         .  
						optionally at least about 20 amino acids in length,          	     145 RLYQTDPSGTYHAWK................................... 159                                                          
						preferably at least about 30 amino acids in length, more     	         |||||||||||||||                                     
						preferably at least about 40 amino acids in length and most  	     151 RLYQTDPSGTYHAWKANAIGRSAKTVREFLEKNYTEDAIASDSEAIKLAI 200                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise AG, having a structure as  	     160 .....VVQSGGKNIELAIIRRNQPLKMFSAKEVELYVTEIEKEKEEAEKK 204                                                          
						follows: a sequence starting from any of amino acid numbers  	              ||||||:||||||||||||||||||||||||||||||||||||||  
						76-x to 77; and ending at any of amino acid numbers 77+      	     201 KALLEVVQSGGRNIELAIIRRNQPLKMFSAKEVELYVTEIEKEKEEAEKK 250                                                          
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	                                                             
						chimeric polypeptide encoding for an edge portion of         	     205 KSKKSV                                             210                                                          
						AI001156_P4, comprising a polypeptide having a length "n",   	         ||||||                                              
						wherein n is at least about 10 amino acids in length,        	     251 KSKKSV                                             256                                                          
						optionally at least about 20 amino acids in length,          	                                                            
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise KV, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						159-x to 160; and ending at any of amino acid numbers 160+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.                	                                                            

23808	HMR136_AI001791_1_tr0_r1_1_gPRT		Comparison report between AI001791_P1 and Q96LY9unique head  	Sequence name: Q96LY9                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AI001791_P1, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23808 x Q96LY9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						RMIQDTKQVPHTHEREINVMLYNKYFHQVLTICSESIIRVWELETGLQVYQILEPHGFNT 	Alignment segment 1/1:                                       
						EVTSAAVDESGFLFATGAYNGTVRIWDFGSGQEMKVLPEGKDWKEDEHCLRRLIFLKAQE 	                                                            
						KHQQLVLALERNGTIK                                             	                     Quality: 3722.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     377                Total length:     377                                               
						to amino acids 1 - 136 of AI001791_P1, a second amino acid   	 Matching Percent Similarity:   99.73   Matching Percent Identity:   99.73                                               
						MIQGKEDDIYLMVIWELPDVVPFLQDGKHAVHLRMSTRDRNMAIPFPDVELIVERNFSQP 	    Total Percent Similarity:   99.73      Total Percent Identity:   99.73                                               
						TDNPTMDLLRVNCIDLLQVEGYNLIAAGTLNGVIILWNFVTSTVKKVYRPEDCFTVNPDL 	                        Gaps:       0                        
						H                                                            	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment:                                                   
						amino acids 1 - 121 of Q96LY9, which also corresponds to     	                  .         .         .         .         .  
						amino acids 137 - 257 of AI001791_P1, a bridging amino acid P	     137 MIQGKEDDIYLMVIWELPDVVPFLQDGKHAVHLRMSTRDRNMAIPFPDVE 186                                                          
						corresponding to amino acid 258 of AI001791_P1, a third amino	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KHFKINDILFLFRTPECARRSSQDSICSSSQCESSKGPQSSKGSKQSIHDSEVKGEQTDV 	       1 MIQGKEDDIYLMVIWELPDVVPFLQDGKHAVHLRMSTRDRNMAIPFPDVE 50                                                           
						MVGKQQPMDKKHPGIANLPEAQPPILVTAHEDGHLRLWTLEGRLLKDMLPFTKHSAISLT 	                  .         .         .         .         .  
						SLYTDSCTRILLAGNVEGHVILCNISSFLDPPHDEKKFKQLLSWRAHSLEIIQVIYVEEK 	     187 LIVERNFSQPTDNPTMDLLRVNCIDLLQVEGYNLIAAGTLNGVIILWNFV 236                                                          
						QVVLTASIDGSVRLWHALNGHYCGYFGQRRLFELSQTRDFILPCDVTEYPIEIKEESKFT 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						EKQKYEYPLIFDREK                                              	      51 LIVERNFSQPTDNPTMDLLRVNCIDLLQVEGYNLIAAGTLNGVIILWNFV 100                                                          
						acid sequence being at least 90 % homologous to corresponding	                  .         .         .         .         .  
						to amino acids 123 - 377 of Q96LY9, which also corresponds to	     237 TSTVKKVYRPEDCFTVNPDLHPKHFKINDILFLFRTPECARRSSQDSICS 286                                                          
						amino acids 259 - 513 of AI001791_P1, and a fourth amino acid	         ||||||||||||||||||||| ||||||||||||||||||||||||||||  
						sequence being at least 70%, optionally at least 80%,        	     101 TSTVKKVYRPEDCFTVNPDLHSKHFKINDILFLFRTPECARRSSQDSICS 150                                                          
						preferably at least 85%, more preferably at least 90% and    	                  .         .         .         .         .  
						most preferably at least 95% homologous to a polypeptide     	     287 SSQCESSKGPQSSKGSKQSIHDSEVKGEQTDVMVGKQQPMDKKHPGIANL 336                                                          
						having the sequence FEDIPWKVS corresponding to amino acids   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						514 - 522 of AI001791_P1, wherein said first amino acid      	     151 SSQCESSKGPQSSKGSKQSIHDSEVKGEQTDVMVGKQQPMDKKHPGIANL 200                                                          
						sequence, second amino acid sequence, bridging amino acid,   	                  .         .         .         .         .  
						third amino acid sequence and fourth amino acid sequence are 	     337 PEAQPPILVTAHEDGHLRLWTLEGRLLKDMLPFTKHSAISLTSLYTDSCT 386                                                          
						contiguous and in a sequential order.2.An isolated           	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide encoding for a head of AI001791_P1, comprising a 	     201 PEAQPPILVTAHEDGHLRLWTLEGRLLKDMLPFTKHSAISLTSLYTDSCT 250                                                          
						polypeptide being at least 70%, optionally at least about    	                  .         .         .         .         .  
						80%, preferably at least about 85%, more preferably at least 	     387 RILLAGNVEGHVILCNISSFLDPPHDEKKFKQLLSWRAHSLEIIQVIYVE 436                                                          
						about 90% and most preferably at least about 95% homologous  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RMIQDTKQVPHTHEREINVMLYNKYFHQVLTICSESIIRVWELETGLQVYQILEPHGFNT 	     251 RILLAGNVEGHVILCNISSFLDPPHDEKKFKQLLSWRAHSLEIIQVIYVE 300                                                          
						EVTSAAVDESGFLFATGAYNGTVRIWDFGSGQEMKVLPEGKDWKEDEHCLRRLIFLKAQE 	                  .         .         .         .         .  
						KHQQLVLALERNGTIK                                             	     437 EKQVVLTASIDGSVRLWHALNGHYCGYFGQRRLFELSQTRDFILPCDVTE 486                                                          
						to the sequence of AI001791_P1.3.An isolated polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						encoding for a tail of AI001791_P1, comprising a polypeptide 	     301 EKQVVLTASIDGSVRLWHALNGHYCGYFGQRRLFELSQTRDFILPCDVTE 350                                                          
						being at least 70%, optionally at least about 80%, preferably	                  .         .                                
						at least about 85%, more preferably at least about 90% and   	     487 YPIEIKEESKFTEKQKYEYPLIFDREK                        513                                                          
						most preferably at least about 95% homologous to the sequence	         |||||||||||||||||||||||||||                         
						FEDIPWKVS in AI001791_P1.                                    	     351 YPIEIKEESKFTEKQKYEYPLIFDREK                        377                                                          

23810	HMR136_AI001791_2_tr0_r1_1_gPRT		Comparison report between AI001791_P2 and Q96LY9unique head  	Sequence name: Q96LY9                                        
						followed by partial WT sequence a mismatch and a followed by 	                                                            
						a unique tail.1.An isolated chimeric polypeptide encoding for	Sequence documentation:                                      
						AI001791_P2, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 23810 x Q96LY9   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						RMIQDTKQVPHTHEREINVMLYNKYFHQVLTICSESIIRVWELETGLQVYQILEPHGFNT 	Alignment segment 1/1:                                       
						EVTSAAVDESGFLFATGAYNGTVRIWDFGSGQEMKVLPEGKDWKEDEHCLRRLIFLKAQE 	                                                            
						KHQQLVLALERNGTIKMIQ                                          	                     Quality: 3103.00                      Escore:       0                                               
						homologous to a polypeptide having the sequence corresponding	             Matching length:     315                Total length:     315                                               
						to amino acids 1 - 139 of AI001791_P2, a second amino acid   	 Matching Percent Similarity:   99.68   Matching Percent Identity:   99.68                                               
						sequence being at least 90 % homologous to                   	    Total Percent Similarity:   99.68      Total Percent Identity:   99.68                                               
						NPTMDLLRVNCIDLLQVEGYNLIAAGTLNGVIILWNFVTSTVKKVYRPEDCFTVNPDLH  	                        Gaps:       0                        
						corresponding to amino acids 63 - 121 of Q96LY9, which also  	                                                            
						corresponds to amino acids 140 - 198 of AI001791_P2, a       	Alignment:                                                   
						bridging amino acid P corresponding to amino acid 199 of     	                  .         .         .         .         .  
						AI001791_P2, a third amino acid sequence being at least 90 % 	     140 NPTMDLLRVNCIDLLQVEGYNLIAAGTLNGVIILWNFVTSTVKKVYRPED 189                                                          
						KHFKINDILFLFRTPECARRSSQDSICSSSQCESSKGPQSSKGSKQSIHDSEVKGEQTDV 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MVGKQQPMDKKHPGIANLPEAQPPILVTAHEDGHLRLWTLEGRLLKDMLPFTKHSAISLT 	      63 NPTMDLLRVNCIDLLQVEGYNLIAAGTLNGVIILWNFVTSTVKKVYRPED 112                                                          
						SLYTDSCTRILLAGNVEGHVILCNISSFLDPPHDEKKFKQLLSWRAHSLEIIQVIYVEEK 	                  .         .         .         .         .  
						QVVLTASIDGSVRLWHALNGHYCGYFGQRRLFELSQTRDFILPCDVTEYPIEIKEESKFT 	     190 CFTVNPDLHPKHFKINDILFLFRTPECARRSSQDSICSSSQCESSKGPQS 239                                                          
						EKQKYEYPLIFDREK                                              	         ||||||||| ||||||||||||||||||||||||||||||||||||||||  
						homologous to corresponding to amino acids 123 - 377 of      	     113 CFTVNPDLHSKHFKINDILFLFRTPECARRSSQDSICSSSQCESSKGPQS 162                                                          
						Q96LY9, which also corresponds to amino acids 200 - 454 of   	                  .         .         .         .         .  
						AI001791_P2, and a fourth amino acid sequence being at least 	     240 SKGSKQSIHDSEVKGEQTDVMVGKQQPMDKKHPGIANLPEAQPPILVTAH 289                                                          
						70%, optionally at least 80%, preferably at least 85%, more  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least 90% and most preferably at least 95%     	     163 SKGSKQSIHDSEVKGEQTDVMVGKQQPMDKKHPGIANLPEAQPPILVTAH 212                                                          
						homologous to a polypeptide having the sequence FEDIPWKVS    	                  .         .         .         .         .  
						corresponding to amino acids 455 - 463 of AI001791_P2,       	     290 EDGHLRLWTLEGRLLKDMLPFTKHSAISLTSLYTDSCTRILLAGNVEGHV 339                                                          
						wherein said first amino acid sequence, second amino acid    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence, bridging amino acid, third amino acid sequence and 	     213 EDGHLRLWTLEGRLLKDMLPFTKHSAISLTSLYTDSCTRILLAGNVEGHV 262                                                          
						fourth amino acid sequence are contiguous and in a sequential	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     340 ILCNISSFLDPPHDEKKFKQLLSWRAHSLEIIQVIYVEEKQVVLTASIDG 389                                                          
						AI001791_P2, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     263 ILCNISSFLDPPHDEKKFKQLLSWRAHSLEIIQVIYVEEKQVVLTASIDG 312                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						RMIQDTKQVPHTHEREINVMLYNKYFHQVLTICSESIIRVWELETGLQVYQILEPHGFNT 	     390 SVRLWHALNGHYCGYFGQRRLFELSQTRDFILPCDVTEYPIEIKEESKFT 439                                                          
						EVTSAAVDESGFLFATGAYNGTVRIWDFGSGQEMKVLPEGKDWKEDEHCLRRLIFLKAQE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						KHQQLVLALERNGTIKMIQ                                          	     313 SVRLWHALNGHYCGYFGQRRLFELSQTRDFILPCDVTEYPIEIKEESKFT 362                                                          
						least about 95% homologous to the sequence of                	                  .                                          
						AI001791_P2.3.An isolated polypeptide encoding for a tail of 	     440 EKQKYEYPLIFDREK                                    454                                                          
						AI001791_P2, comprising a polypeptide being at least 70%,    	         |||||||||||||||                                     
						optionally at least about 80%, preferably at least about 85%,	     363 EKQKYEYPLIFDREK                                    377                                                          
						more preferably at least about 90% and most preferably at    	                                                            
						least about 95% homologous to the sequence FEDIPWKVS in      	                                                            
						AI001791_P2.                                                 	                                                            

24026	HMR136_AI002630_2_tr0_r1_1_gPRT		Comparison report between AI002630_P2 and Q8NB96partial WT   	Sequence name: Q8NB96                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for AI002630_P2, comprising a first     	Sequence documentation:                                      
						METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKIGHQAVLMDLI 	                                                            
						KKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPARHGEQMPSFYPAENLDNGLI 	Alignment of: 24026 x Q8NB96   ..                            
						DQRVLKQRRNVKQILARSKALQWTKSYVLPEFPYDVKCMLAEQKCPDHSMRIRIIEFLQA 	                                                            
						DMTKYLEGSLYPSTQQYNDVVNALLQAHPFLDEDGCGF                       	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 218 of Q8NB96, which also   	                     Quality: 2165.00                      Escore:       0                                               
						corresponds to amino acids 1 - 218 of AI002630_P2, and a     	             Matching length:     218                Total length:     218                                               
						second amino acid sequence being at least 70%, optionally at 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 80%, preferably at least 85%, more preferably at least 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	                        Gaps:       0                        
						polypeptide having the sequence AGV corresponding to amino   	                                                            
						acids 219 - 221 of AI002630_P2, wherein said first amino acid	Alignment:                                                   
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.                                          	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	                  .                                          
						                                                            	     201 VNALLQAHPFLDEDGCGF                                 218                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     201 VNALLQAHPFLDEDGCGF                                 218                                                          

						Comparison report between AI002630_P2 and Q8NAY1partial WT   	Sequence name: Q8NAY1                                        
						sequence followed by short unique tail.1.An isolated chimeric	                                                            
						polypeptide encoding for AI002630_P2, comprising a first     	Sequence documentation:                                      
						METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKIGHQAVLMDLI 	                                                            
						KKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPARHGEQMPSFYPAENLDNGLI 	Alignment of: 24026 x Q8NAY1   ..                            
						DQRVLKQRRNVKQILARSKALQWTKSYVLPEFPYDVKCMLAEQKCPDHSMRIRIIEFLQA 	                                                            
						DMTKYLEGSLYPSTQQYNDVVNALLQAHPFLDEDGCGF                       	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 218 of Q8NAY1, which also   	                     Quality: 2165.00                      Escore:       0                                               
						corresponds to amino acids 1 - 218 of AI002630_P2, and a     	             Matching length:     218                Total length:     218                                               
						second amino acid sequence being at least 70%, optionally at 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						least 80%, preferably at least 85%, more preferably at least 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						90% and most preferably at least 95% homologous to a         	                        Gaps:       0                        
						polypeptide having the sequence AGV corresponding to amino   	                                                            
						acids 219 - 221 of AI002630_P2, wherein said first amino acid	Alignment:                                                   
						sequence and second amino acid sequence are contiguous and in	                  .         .         .         .         .  
						a sequential order.                                          	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	                  .                                          
						                                                            	     201 VNALLQAHPFLDEDGCGF                                 218                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     201 VNALLQAHPFLDEDGCGF                                 218                                                          

						Comparison report between AI002630_P2 and Q8N6K7partial WT   	Sequence name: Q8N6K7                                        
						sequence followed by mismatch.1.An isolated chimeric         	                                                            
						polypeptide encoding for AI002630_P2, comprising a first     	Sequence documentation:                                      
						METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKIGHQAVLMDLI 	                                                            
						KKYKQNTQGLKSPENPKKAALVMQTEAARDYRD                            	Alignment of: 24026 x Q8N6K7   ..                            
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 93 of Q8N6K7, which also    	Alignment segment 1/1:                                       
						corresponds to amino acids 1 - 93 of AI002630_P2, a bridging 	                                                            
						amino acid E corresponding to amino acid 94 of AI002630_P2,  	                     Quality: 2180.00                      Escore:       0                                               
						and a second amino acid sequence being at least 90 %         	             Matching length:     221                Total length:     221                                               
						ESSSPARHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLPEFPY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.55                                               
						DVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDVVNALLQAHPFLDED 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.55                                               
						GCGFAGV                                                      	                        Gaps:       0                        
						homologous to corresponding to amino acids 95 - 221 of       	                                                            
						Q8N6K7, which also corresponds to amino acids 95 - 221 of    	Alignment:                                                   
						AI002630_P2, wherein said first amino acid sequence, bridging	                  .         .         .         .         .  
						amino acid and second amino acid sequence are contiguous and 	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						in a sequential order.                                       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						                                                            	                  .         .         .         .         .  
						                                                            	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||:||||||  
						                                                            	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDKESSSPA 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	                  .         .                                
						                                                            	     201 VNALLQAHPFLDEDGCGFAGV                              221                                                          
						                                                            	         |||||||||||||||||||||                               
						                                                            	     201 VNALLQAHPFLDEDGCGFAGV                              221                                                          

24024	HMR136_AI002630_6_tr0_r1_1_gPRT		Comparison report between AI002630_P6 and Q8NB96partial WT   	Sequence name: Q8NB96                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AI002630_P6, comprising a first     	Sequence documentation:                                      
						METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKIGHQAVLMDLI 	                                                            
						KKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPARHGEQMPSFYPAENLDNGLI 	Alignment of: 24024 x Q8NB96   ..                            
						DQRVLKQRRNVKQILARSKALQWTKSYVLPEFPYDVKCMLAEQKCPDHSMRIRIIEFLQA 	                                                            
						DMTKYLEGSLYPSTQQYNDVVNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDE 	Alignment segment 1/1:                                       
						QVIRNKCKFGHRRGQTRKSLADIRFDEIKLVQIKEEAVCFDSELDEHIKWFQQEYVKTEK 	                                                            
						DWREIDKRMSQTLEIRRKMIGSRTPLKDILKLFPFLKCPYQMFREFQLLTRTDIYKKTRH 	                     Quality: 3962.00                      Escore:       0                                               
						ILESYSENILTSFSVVDNPINIVLQEKMKHYTDEDMLK                       	             Matching length:     398                Total length:     398                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 398 of Q8NB96, which also   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 398 of AI002630_P6, and a     	                        Gaps:       0                        
						second amino acid sequence being at least 70%, optionally at 	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence CASVHTCVGS corresponding to  	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						amino acids 399 - 408 of AI002630_P6, wherein said first     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and second amino acid sequence are       	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of AI002630_P6, comprising a 	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence CASVHTCVGS in AI002630_P6.                   	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDEQVIRNKCKFG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDEQVIRNKCKFG 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 HRRGQTRKSLADIRFDEIKLVQIKEEAVCFDSELDEHIKWFQQEYVKTEK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 HRRGQTRKSLADIRFDEIKLVQIKEEAVCFDSELDEHIKWFQQEYVKTEK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 DWREIDKRMSQTLEIRRKMIGSRTPLKDILKLFPFLKCPYQMFREFQLLT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 DWREIDKRMSQTLEIRRKMIGSRTPLKDILKLFPFLKCPYQMFREFQLLT 350                                                          
						                                                            	                  .         .         .         .            
						                                                            	     351 RTDIYKKTRHILESYSENILTSFSVVDNPINIVLQEKMKHYTDEDMLK   398                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     351 RTDIYKKTRHILESYSENILTSFSVVDNPINIVLQEKMKHYTDEDMLK   398                                                          

						Comparison report between AI002630_P6 and Q8NAY1partial WT   	Sequence name: Q8NAY1                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AI002630_P6, comprising a first     	Sequence documentation:                                      
						METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKIGHQAVLMDLI 	                                                            
						KKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPARHGEQMPSFYPAENLDNGLI 	Alignment of: 24024 x Q8NAY1   ..                            
						DQRVLKQRRNVKQILARSKALQWTKSYVLPEFPYDVKCMLAEQKCPDHSMRIRIIEFLQA 	                                                            
						DMTKYLEGSLYPSTQQYNDVVNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDE 	Alignment segment 1/1:                                       
						QVIRNKCKFGHRRGQTRKSLADIRFDEIKLVQIKEEAVCFDSELDEHIKWFQQEYVKTEK 	                                                            
						DWREIDKRMSQTLEIRRKMIGSRTPLKDILKLFPFLKCPYQMFREFQLLTRTDIYKKTRH 	                     Quality: 3962.00                      Escore:       0                                               
						ILESYSENILTSFSVVDNPINIVLQEKMKHYTDEDMLK                       	             Matching length:     398                Total length:     398                                               
						amino acid sequence being at least 90 % homologous to        	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						corresponding to amino acids 1 - 398 of Q8NAY1, which also   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						corresponds to amino acids 1 - 398 of AI002630_P6, and a     	                        Gaps:       0                        
						second amino acid sequence being at least 70%, optionally at 	                                                            
						least 80%, preferably at least 85%, more preferably at least 	Alignment:                                                   
						90% and most preferably at least 95% homologous to a         	                  .         .         .         .         .  
						polypeptide having the sequence CASVHTCVGS corresponding to  	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						amino acids 399 - 408 of AI002630_P6, wherein said first     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence and second amino acid sequence are       	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						contiguous and in a sequential order.2.An isolated           	                  .         .         .         .         .  
						polypeptide encoding for a tail of AI002630_P6, comprising a 	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						polypeptide being at least 70%, optionally at least about    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						80%, preferably at least about 85%, more preferably at least 	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						about 90% and most preferably at least about 95% homologous  	                  .         .         .         .         .  
						to the sequence CASVHTCVGS in AI002630_P6.                   	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDEQVIRNKCKFG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDEQVIRNKCKFG 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     251 HRRGQTRKSLADIRFDEIKLVQIKEEAVCFDSELDEHIKWFQQEYVKTEK 300                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 HRRGQTRKSLADIRFDEIKLVQIKEEAVCFDSELDEHIKWFQQEYVKTEK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     301 DWREIDKRMSQTLEIRRKMIGSRTPLKDILKLFPFLKCPYQMFREFQLLT 350                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 DWREIDKRMSQTLEIRRKMIGSRTPLKDILKLFPFLKCPYQMFREFQLLT 350                                                          
						                                                            	                  .         .         .         .            
						                                                            	     351 RTDIYKKTRHILESYSENILTSFSVVDNPINIVLQEKMKHYTDEDMLK   398                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     351 RTDIYKKTRHILESYSENILTSFSVVDNPINIVLQEKMKHYTDEDMLK   398                                                          

						Comparison report between AI002630_P6 and Q8N6K7partial WT   	Sequence name: Q8N6K7                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AI002630_P6, comprising a first amino acid sequence being at 	                                                            
						METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKIGHQAVLMDLI 	Alignment of: 24024 x Q8N6K7   ..                            
						KKYKQNTQGLKSPENPKKAALVMQTEAARDYRD                            	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 93 	Alignment segment 1/1:                                       
						of Q8N6K7, which also corresponds to amino acids 1 - 93 of   	                                                            
						AI002630_P6, a bridging amino acid E corresponding to amino  	                     Quality: 2155.00                      Escore:       0                                               
						acid 94 of AI002630_P6, a second amino acid sequence being at	             Matching length:     218                Total length:     218                                               
						ESSSPARHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLPEFPY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.54                                               
						DVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDVVNALLQAHPFLDED 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.54                                               
						GCGF                                                         	                        Gaps:       0                        
						least 90 % homologous to corresponding to amino acids 95 -   	                                                            
						218 of Q8N6K7, which also corresponds to amino acids 95 - 218	Alignment:                                                   
						of AI002630_P6, and a third amino acid sequence being at     	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FLWKRALKDRFKYVRRPIEDDEQVIRNKCKFGHRRGQTRKSLADIRFDEIKLVQIKEEAV 	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						CFDSELDEHIKWFQQEYVKTEKDWREIDKRMSQTLEIRRKMIGSRTPLKDILKLFPFLKC 	                  .         .         .         .         .  
						PYQMFREFQLLTRTDIYKKTRHILESYSENILTSFSVVDNPINIVLQEKMKHYTDEDMLK 	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						CASVHTCVGS                                                   	         |||||||||||||||||||||||||||||||||||||||||||:||||||  
						homologous to a polypeptide having the sequence corresponding	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDKESSSPA 100                                                          
						to amino acids 219 - 408 of AI002630_P6, wherein said first  	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid, second amino acid  	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						tail of AI002630_P6, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FLWKRALKDRFKYVRRPIEDDEQVIRNKCKFGHRRGQTRKSLADIRFDEIKLVQIKEEAV 	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						CFDSELDEHIKWFQQEYVKTEKDWREIDKRMSQTLEIRRKMIGSRTPLKDILKLFPFLKC 	                  .                                          
						PYQMFREFQLLTRTDIYKKTRHILESYSENILTSFSVVDNPINIVLQEKMKHYTDEDMLK 	     201 VNALLQAHPFLDEDGCGF                                 218                                                          
						CASVHTCVGS                                                   	         ||||||||||||||||||                                  
						at least about 95% homologous to the sequence in AI002630_P6.	     201 VNALLQAHPFLDEDGCGF                                 218                                                          

24022	HMR136_AI002630_7_tr0_r1_1_gPRT		Comparison report between AI002630_P7 and Q8NB96partial WT   	Sequence name: Q8NB96                                        
						sequence featuring skipped exon.1.An isolated chimeric       	                                                            
						polypeptide encoding for AI002630_P7, comprising a first     	Sequence documentation:                                      
						METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKIGHQAVLMDLI 	                                                            
						KKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPARHGEQMPSFYPAENLDNGLI 	Alignment of: 24022 x Q8NB96   ..                            
						DQRVLKQR                                                     	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 128 of Q8NB96, which also   	                                                            
						corresponds to amino acids 1 - 128 of AI002630_P7, and a     	                     Quality: 4451.00                      Escore:       0                                               
						YPSTQQYNDVVNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDEQVIRNKCKFG 	             Matching length:     458                Total length:     520                                               
						HRRGQTRKSLADIRFDEIKLVQIKEEAVCFDSELDEHIKWFQQEYVKTEKDWREIDKRMS 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						QTLEIRRKMIGSRTPLKDILKLFPFLKCPYQMFREFQLLTRTDIYKKTRHILESYSENIL 	    Total Percent Similarity:   88.08      Total Percent Identity:   88.08                                               
						TSFSVVDNPINIVLQEKMKHYTDEDMLKYMKMTATCLLLPDVFGDDPSLFVIMNEQVQVS 	                        Gaps:       1                        
						TPVLEVKNPFNMEVCEFSLYLERERLTKVDDCVTALAALVAAFHVFRIECPRRLSQTFNF 	                                                            
						LETLIFDMHSPYFPSLKEKENEVGFQHPLT                               	Alignment:                                                   
						second amino acid sequence being at least 90 % homologous to 	                  .         .         .         .         .  
						corresponding to amino acids 191 - 520 of Q8NB96, which also 	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						corresponds to amino acids 129 - 458 of AI002630_P7, wherein 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						said first amino acid sequence and second amino acid sequence	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						are contiguous and in a sequential order.2.An isolated       	                  .         .         .         .         .  
						chimeric polypeptide encoding for an edge portion of         	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						AI002630_P7, comprising a polypeptide having a length "n",   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein n is at least about 10 amino acids in length,        	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						optionally at least about 20 amino acids in length,          	                  .         .         .         .         .  
						preferably at least about 30 amino acids in length, more     	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQR...................... 128                                                          
						preferably at least about 40 amino acids in length and most  	         ||||||||||||||||||||||||||||                        
						preferably at least about 50 amino acids in length, wherein  	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						at least two amino acids comprise RY, having a structure as  	                  .         .         .         .         .  
						follows: a sequence starting from any of amino acid numbers  	     129 ........................................YPSTQQYNDV 138                                                          
						128-x to 129; and ending at any of amino acid numbers 129+   	                                                 ||||||||||  
						((n-2) - x), in which x varies from 0 to n-2.                	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     139 VNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDEQVIRNKCKFG 188                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDEQVIRNKCKFG 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     189 HRRGQTRKSLADIRFDEIKLVQIKEEAVCFDSELDEHIKWFQQEYVKTEK 238                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 HRRGQTRKSLADIRFDEIKLVQIKEEAVCFDSELDEHIKWFQQEYVKTEK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     239 DWREIDKRMSQTLEIRRKMIGSRTPLKDILKLFPFLKCPYQMFREFQLLT 288                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 DWREIDKRMSQTLEIRRKMIGSRTPLKDILKLFPFLKCPYQMFREFQLLT 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     289 RTDIYKKTRHILESYSENILTSFSVVDNPINIVLQEKMKHYTDEDMLKYM 338                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RTDIYKKTRHILESYSENILTSFSVVDNPINIVLQEKMKHYTDEDMLKYM 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     339 KMTATCLLLPDVFGDDPSLFVIMNEQVQVSTPVLEVKNPFNMEVCEFSLY 388                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 KMTATCLLLPDVFGDDPSLFVIMNEQVQVSTPVLEVKNPFNMEVCEFSLY 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     389 LERERLTKVDDCVTALAALVAAFHVFRIECPRRLSQTFNFLETLIFDMHS 438                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 LERERLTKVDDCVTALAALVAAFHVFRIECPRRLSQTFNFLETLIFDMHS 500                                                          
						                                                            	                  .         .                                
						                                                            	     439 PYFPSLKEKENEVGFQHPLT                               458                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	     501 PYFPSLKEKENEVGFQHPLT                               520                                                          

						Comparison report between AI002630_P7 and Q8NAY1partial WT   	Sequence name: Q8NAY1                                        
						sequence featuring skipped exon and a mismatch.1.An isolated 	                                                            
						chimeric polypeptide encoding for AI002630_P7, comprising a  	Sequence documentation:                                      
						METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKIGHQAVLMDLI 	                                                            
						KKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPARHGEQMPSFYPAENLDNGLI 	Alignment of: 24022 x Q8NAY1   ..                            
						DQRVLKQR                                                     	                                                            
						first amino acid sequence being at least 90 % homologous to  	Alignment segment 1/1:                                       
						corresponding to amino acids 1 - 128 of Q8NAY1, which also   	                                                            
						corresponds to amino acids 1 - 128 of AI002630_P7, a second  	                     Quality: 4442.00                      Escore:       0                                               
						YPSTQQYNDVVNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDEQVIRNKCKFG 	             Matching length:     458                Total length:     520                                               
						HRRGQTRKSLADIRFDEIKLVQIKEEAVCFDSELDEHIKWFQQEYVKTEKDWREIDKRMS 	 Matching Percent Similarity:   99.78   Matching Percent Identity:   99.78                                               
						QTLEIRRKMIGSRTPLKDILKLFPFLKCPYQMFREFQLLTRTDIYKKTRHILESYSENIL 	    Total Percent Similarity:   87.88      Total Percent Identity:   87.88                                               
						TSFSVVDNPINIVLQEKMKHYTDEDMLKYMKMTATCLLLPDVFGDDPSLFVIMNEQVQVS 	                        Gaps:       1                        
						TPVLEVKNPFNMEVCEFSLYLERERLTKVDDCVTALAALVA                    	                                                            
						amino acid sequence being at least 90 % homologous to        	Alignment:                                                   
						corresponding to amino acids 191 - 471 of Q8NAY1, which also 	                  .         .         .         .         .  
						corresponds to amino acids 129 - 409 of AI002630_P7, a       	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						bridging amino acid A corresponding to amino acid 410 of     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AI002630_P7, and a third amino acid sequence being at least  	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						90 % homologous to                                           	                  .         .         .         .         .  
						FHVFRIECPRRLSQTFNFLETLIFDMHSPYFPSLKEKENEVGFQHPLT             	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						corresponding to amino acids 473 - 520 of Q8NAY1, which also 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						corresponds to amino acids 411 - 458 of AI002630_P7, wherein 	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						said first amino acid sequence, second amino acid sequence,  	                  .         .         .         .         .  
						bridging amino acid and third amino acid sequence are        	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQR...................... 128                                                          
						contiguous and in a sequential order.2.An isolated chimeric  	         ||||||||||||||||||||||||||||                        
						polypeptide encoding for an edge portion of AI002630_P7,     	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						comprising a polypeptide having a length "n", wherein n is at	                  .         .         .         .         .  
						least about 10 amino acids in length, optionally at least    	     129 ........................................YPSTQQYNDV 138                                                          
						about 20 amino acids in length, preferably at least about 30 	                                                 ||||||||||  
						amino acids in length, more preferably at least about 40     	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						amino acids in length and most preferably at least about 50  	                  .         .         .         .         .  
						amino acids in length, wherein at least two amino acids      	     139 VNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDEQVIRNKCKFG 188                                                          
						comprise RY, having a structure as follows: a sequence       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						starting from any of amino acid numbers 128-x to 129; and    	     201 VNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDEQVIRNKCKFG 250                                                          
						ending at any of amino acid numbers 129+ ((n-2) - x), in     	                  .         .         .         .         .  
						which x varies from 0 to n-2.                                	     189 HRRGQTRKSLADIRFDEIKLVQIKEEAVCFDSELDEHIKWFQQEYVKTEK 238                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 HRRGQTRKSLADIRFDEIKLVQIKEEAVCFDSELDEHIKWFQQEYVKTEK 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     239 DWREIDKRMSQTLEIRRKMIGSRTPLKDILKLFPFLKCPYQMFREFQLLT 288                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 DWREIDKRMSQTLEIRRKMIGSRTPLKDILKLFPFLKCPYQMFREFQLLT 350                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     289 RTDIYKKTRHILESYSENILTSFSVVDNPINIVLQEKMKHYTDEDMLKYM 338                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 RTDIYKKTRHILESYSENILTSFSVVDNPINIVLQEKMKHYTDEDMLKYM 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     339 KMTATCLLLPDVFGDDPSLFVIMNEQVQVSTPVLEVKNPFNMEVCEFSLY 388                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 KMTATCLLLPDVFGDDPSLFVIMNEQVQVSTPVLEVKNPFNMEVCEFSLY 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     389 LERERLTKVDDCVTALAALVAAFHVFRIECPRRLSQTFNFLETLIFDMHS 438                                                          
						                                                            	         ||||||||||||||||||||| ||||||||||||||||||||||||||||  
						                                                            	     451 LERERLTKVDDCVTALAALVAGFHVFRIECPRRLSQTFNFLETLIFDMHS 500                                                          
						                                                            	                  .         .                                
						                                                            	     439 PYFPSLKEKENEVGFQHPLT                               458                                                          
						                                                            	         ||||||||||||||||||||                                
						                                                            	     501 PYFPSLKEKENEVGFQHPLT                               520                                                          

						Comparison report between AI002630_P7 and Q8N6K7partial WT   	Sequence name: Q8N6K7                                        
						sequence followed by mismatch, featuring a skipped exon and a	                                                            
						followed by a unique tail.1.An isolated chimeric polypeptide 	Sequence documentation:                                      
						encoding for AI002630_P7, comprising a first amino acid      	                                                            
						METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKIGHQAVLMDLI 	Alignment of: 24022 x Q8N6K7   ..                            
						KKYKQNTQGLKSPENPKKAALVMQTEAARDYRD                            	                                                            
						sequence being at least 90 % homologous to corresponding to  	Alignment segment 1/1:                                       
						amino acids 1 - 93 of Q8N6K7, which also corresponds to amino	                                                            
						acids 1 - 93 of AI002630_P7, a bridging amino acid E         	                     Quality: 1435.00                      Escore:       0                                               
						corresponding to amino acid 94 of AI002630_P7, a second amino	             Matching length:     156                Total length:     218                                               
						acid sequence being at least 90 % homologous to              	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.36                                               
						ESSSPARHGEQMPSFYPAENLDNGLIDQRVLKQR corresponding to amino    	    Total Percent Similarity:   71.56      Total Percent Identity:   71.10                                               
						acids 95 - 128 of Q8N6K7, which also corresponds to amino    	                        Gaps:       1                        
						acids 95 - 128 of AI002630_P7, a third amino acid sequence   	                                                            
						being at least 90 % homologous to                            	Alignment:                                                   
						YPSTQQYNDVVNALLQAHPFLDEDGCGF corresponding to amino acids 191	                  .         .         .         .         .  
						- 218 of Q8N6K7, which also corresponds to amino acids 129 - 	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						156 of AI002630_P7, and a fourth amino acid sequence being at	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least 70%, optionally at least 80%, preferably at least 85%, 	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						more preferably at least 90% and most preferably at least 95%	                  .         .         .         .         .  
						FLWKRALKDRFKYVRRPIEDDEQVIRNKCKFGHRRGQTRKSLADIRFDEIKLVQIKEEAV 	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						CFDSELDEHIKWFQQEYVKTEKDWREIDKRMSQTLEIRRKMIGSRTPLKDILKLFPFLKC 	         |||||||||||||||||||||||||||||||||||||||||||:||||||  
						PYQMFREFQLLTRTDIYKKTRHILESYSENILTSFSVVDNPINIVLQEKMKHYTDEDMLK 	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDKESSSPA 100                                                          
						YMKMTATCLLLPDVFGDDPSLFVIMNEQVQVSTPVLEVKNPFNMEVCEFSLYLERERLTK 	                  .         .         .         .         .  
						VDDCVTALAALVAAFHVFRIECPRRLSQTFNFLETLIFDMHSPYFPSLKEKENEVGFQHP 	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQR...................... 128                                                          
						LT                                                           	         ||||||||||||||||||||||||||||                        
						homologous to a polypeptide having the sequence corresponding	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						to amino acids 157 - 458 of AI002630_P7, wherein said first  	                  .         .         .         .         .  
						amino acid sequence, bridging amino acid, second amino acid  	     129 ........................................YPSTQQYNDV 138                                                          
						sequence, third amino acid sequence and fourth amino acid    	                                                 ||||||||||  
						sequence are contiguous and in a sequential order.2.An       	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						isolated chimeric polypeptide encoding for an edge portion of	                  .                                          
						AI002630_P7, comprising a polypeptide having a length "n",   	     139 VNALLQAHPFLDEDGCGF                                 156                                                          
						wherein n is at least about 10 amino acids in length,        	         ||||||||||||||||||                                  
						optionally at least about 20 amino acids in length,          	     201 VNALLQAHPFLDEDGCGF                                 218                                                          
						preferably at least about 30 amino acids in length, more     	                                                            
						preferably at least about 40 amino acids in length and most  	                                                            
						preferably at least about 50 amino acids in length, wherein  	                                                            
						at least two amino acids comprise RY, having a structure as  	                                                            
						follows: a sequence starting from any of amino acid numbers  	                                                            
						128-x to 129; and ending at any of amino acid numbers 129+   	                                                            
						((n-2) - x), in which x varies from 0 to n-2.3.An isolated   	                                                            
						polypeptide encoding for a tail of AI002630_P7, comprising a 	                                                            
						polypeptide being at least 70%, optionally at least about    	                                                            
						80%, preferably at least about 85%, more preferably at least 	                                                            
						about 90% and most preferably at least about 95% homologous  	                                                            
						FLWKRALKDRFKYVRRPIEDDEQVIRNKCKFGHRRGQTRKSLADIRFDEIKLVQIKEEAV 	                                                            
						CFDSELDEHIKWFQQEYVKTEKDWREIDKRMSQTLEIRRKMIGSRTPLKDILKLFPFLKC 	                                                            
						PYQMFREFQLLTRTDIYKKTRHILESYSENILTSFSVVDNPINIVLQEKMKHYTDEDMLK 	                                                            
						YMKMTATCLLLPDVFGDDPSLFVIMNEQVQVSTPVLEVKNPFNMEVCEFSLYLERERLTK 	                                                            
						VDDCVTALAALVAAFHVFRIECPRRLSQTFNFLETLIFDMHSPYFPSLKEKENEVGFQHP 	                                                            
						LT                                                           	                                                            
						to the sequence in AI002630_P7.                              	                                                            

24028	HMR136_AI002630_9_tr0_r1_1_gPRT		Comparison report between AI002630_P9 and Q8NB96partial WT   	Sequence name: Q8NB96                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AI002630_P9, comprising a first     	Sequence documentation:                                      
						METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKIGHQAVLMDLI 	                                                            
						KKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPARHGEQMPSFYPAENLDNGLI 	Alignment of: 24028 x Q8NB96   ..                            
						DQRVLKQRRNVKQILARSKALQWTKSYVLPEFPYDVKCMLAEQKCPDHSMRIRIIEFLQA 	                                                            
						DMTKYLEGSLYPSTQQYNDVVNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDE 	Alignment segment 1/1:                                       
						QVIRNKCKFGHRRGQTRKSLADIRFDEIKLVQIK                           	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2719.00                      Escore:       0                                               
						corresponding to amino acids 1 - 274 of Q8NB96, which also   	             Matching length:     274                Total length:     274                                               
						corresponds to amino acids 1 - 274 of AI002630_P9, and a     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 80%, preferably at least 85%, more preferably at least 	                        Gaps:       0                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence VRLNS corresponding to amino 	Alignment:                                                   
						acids 275 - 279 of AI002630_P9, wherein said first amino acid	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of AI002630_P9, comprising a polypeptide being at least 	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						at least about 95% homologous to the sequence VRLNS in       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AI002630_P9.                                                 	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDEQVIRNKCKFG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDEQVIRNKCKFG 250                                                          
						                                                            	                  .         .                                
						                                                            	     251 HRRGQTRKSLADIRFDEIKLVQIK                           274                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     251 HRRGQTRKSLADIRFDEIKLVQIK                           274                                                          

						Comparison report between AI002630_P9 and Q8NAY1partial WT   	Sequence name: Q8NAY1                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AI002630_P9, comprising a first     	Sequence documentation:                                      
						METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKIGHQAVLMDLI 	                                                            
						KKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPARHGEQMPSFYPAENLDNGLI 	Alignment of: 24028 x Q8NAY1   ..                            
						DQRVLKQRRNVKQILARSKALQWTKSYVLPEFPYDVKCMLAEQKCPDHSMRIRIIEFLQA 	                                                            
						DMTKYLEGSLYPSTQQYNDVVNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDE 	Alignment segment 1/1:                                       
						QVIRNKCKFGHRRGQTRKSLADIRFDEIKLVQIK                           	                                                            
						amino acid sequence being at least 90 % homologous to        	                     Quality: 2719.00                      Escore:       0                                               
						corresponding to amino acids 1 - 274 of Q8NAY1, which also   	             Matching length:     274                Total length:     274                                               
						corresponds to amino acids 1 - 274 of AI002630_P9, and a     	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						second amino acid sequence being at least 70%, optionally at 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						least 80%, preferably at least 85%, more preferably at least 	                        Gaps:       0                        
						90% and most preferably at least 95% homologous to a         	                                                            
						polypeptide having the sequence VRLNS corresponding to amino 	Alignment:                                                   
						acids 275 - 279 of AI002630_P9, wherein said first amino acid	                  .         .         .         .         .  
						sequence and second amino acid sequence are contiguous and in	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						a sequential order.2.An isolated polypeptide encoding for a  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						tail of AI002630_P9, comprising a polypeptide being at least 	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						70%, optionally at least about 80%, preferably at least about	                  .         .         .         .         .  
						85%, more preferably at least about 90% and most preferably  	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						at least about 95% homologous to the sequence VRLNS in       	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						AI002630_P9.                                                 	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     201 VNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDEQVIRNKCKFG 250                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 VNALLQAHPFLDEDGCGFFLWKRALKDRFKYVRRPIEDDEQVIRNKCKFG 250                                                          
						                                                            	                  .         .                                
						                                                            	     251 HRRGQTRKSLADIRFDEIKLVQIK                           274                                                          
						                                                            	         ||||||||||||||||||||||||                            
						                                                            	     251 HRRGQTRKSLADIRFDEIKLVQIK                           274                                                          

						Comparison report between AI002630_P9 and Q8N6K7partial WT   	Sequence name: Q8N6K7                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AI002630_P9, comprising a first amino acid sequence being at 	                                                            
						METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKIGHQAVLMDLI 	Alignment of: 24028 x Q8N6K7   ..                            
						KKYKQNTQGLKSPENPKKAALVMQTEAARDYRD                            	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 93 	Alignment segment 1/1:                                       
						of Q8N6K7, which also corresponds to amino acids 1 - 93 of   	                                                            
						AI002630_P9, a bridging amino acid E corresponding to amino  	                     Quality: 2155.00                      Escore:       0                                               
						acid 94 of AI002630_P9, a second amino acid sequence being at	             Matching length:     218                Total length:     218                                               
						ESSSPARHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLPEFPY 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.54                                               
						DVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDVVNALLQAHPFLDED 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.54                                               
						GCGF                                                         	                        Gaps:       0                        
						least 90 % homologous to corresponding to amino acids 95 -   	                                                            
						218 of Q8N6K7, which also corresponds to amino acids 95 - 218	Alignment:                                                   
						of AI002630_P9, and a third amino acid sequence being at     	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FLWKRALKDRFKYVRRPIEDDEQVIRNKCKFGHRRGQTRKSLADIRFDEIKLVQIKVRLN 	       1 METWSVEQVCSWLVEKNLGELVHRFQEEEVSGAALLALNDRMVQQLVKKI 50                                                           
						S                                                            	                  .         .         .         .         .  
						homologous to a polypeptide having the sequence corresponding	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDEESSSPA 100                                                          
						to amino acids 219 - 279 of AI002630_P9, wherein said first  	         |||||||||||||||||||||||||||||||||||||||||||:||||||  
						amino acid sequence, bridging amino acid, second amino acid  	      51 GHQAVLMDLIKKYKQNTQGLKSPENPKKAALVMQTEAARDYRDKESSSPA 100                                                          
						sequence and third amino acid sequence are contiguous and in 	                  .         .         .         .         .  
						a sequential order.2.An isolated polypeptide encoding for a  	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						tail of AI002630_P9, comprising a polypeptide being at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						70%, optionally at least about 80%, preferably at least about	     101 RHGEQMPSFYPAENLDNGLIDQRVLKQRRNVKQILARSKALQWTKSYVLP 150                                                          
						85%, more preferably at least about 90% and most preferably  	                  .         .         .         .         .  
						FLWKRALKDRFKYVRRPIEDDEQVIRNKCKFGHRRGQTRKSLADIRFDEIKLVQIKVRLN 	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						S                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence in AI002630_P9.	     151 EFPYDVKCMLAEQKCPDHSMRIRIIEFLQADMTKYLEGSLYPSTQQYNDV 200                                                          
						                                                            	                  .                                          
						                                                            	     201 VNALLQAHPFLDEDGCGF                                 218                                                          
						                                                            	         ||||||||||||||||||                                  
						                                                            	     201 VNALLQAHPFLDEDGCGF                                 218                                                          

24141	HMR136_AI002801_1_tr0_r1_1_gPRT		Comparison report between AI002801_P1 and UT2_HUMANunique    	Sequence name: UT2_HUMAN                                     
						head followed by partial WT sequence1.An isolated chimeric   	                                                            
						polypeptide encoding for AI002801_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 70%, optionally at least  	                                                            
						80%, preferably at least 85%, more preferably at least 90%   	Alignment of: 24141 x UT2_HUMAN   ..                         
						and most preferably at least 95% homologous to a polypeptide 	                                                            
						DLAPVPGWSLFCGPESDRNTTPCPIALSVATPFETIYTGLWSYNCVLSCIAIGGMFYALT 	Alignment segment 1/1:                                       
						WQTHLLALICALFCAYMEAAISNIMSVVGVPPGTWAFCLATIIFLLLTTNNPAIFRLPLS 	                                                            
						KVTYPEANRIYYLTVKSGEEEKAPSGGGGEHPPTAGPKVEEGSEAVLSKHRSVFHIEWSS 	                     Quality: 3868.00                      Escore:       0                                               
						IRRRSKVFGKGEHQERQNKDPFPYRYRKPTVELLDLDT                       	             Matching length:     397                Total length:     397                                               
						having the sequence corresponding to amino acids 1 - 218 of  	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						AI002801_P1, and a second amino acid sequence being at least 	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						MEESSEIKVETNISKTSWIRSSMAASGKRVSKALSYITGEMKECGEGLKDKSPVFQFFDW 	                        Gaps:       0                        
						VLRGTSQVMFVNNPLSGILIILGLFIQNPWWAISGCLGTIMSTLTALILSQDKSAIAAGF 	                                                            
						HGYNGVLVGLLMAVFSDKGDYYWWLLLPVIIMSMSCPILSSALGTIFSKWDLPVFTLPFN 	Alignment:                                                   
						ITVTLYLAATGHYNLFFPTTLLQPASAMPNITWSEVQVPLLLRAIPVGIGQVYGCDNPWT 	                  .         .         .         .         .  
						GGIFLIALFISSPLICLHAAIGSTMGMLAALTIATPFDSIYFGLCGFNSTLACIAIGGMF 	     219 MEESSEIKVETNISKTSWIRSSMAASGKRVSKALSYITGEMKECGEGLKD 268                                                          
						YVITWQTHLLAIACALFAAYLGAALANMLSVFGLPPCTWPFCLSALTFLLLTTNNPAIYK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LPLSKVTYPEANRIYYLSQERNRRASIITKYQAYDVS                        	       1 MEESSEIKVETNISKTSWIRSSMAASGKRVSKALSYITGEMKECGEGLKD 50                                                           
						90 % homologous to corresponding to amino acids 1 - 397 of   	                  .         .         .         .         .  
						UT2_HUMAN, which also corresponds to amino acids 219 - 615 of	     269 KSPVFQFFDWVLRGTSQVMFVNNPLSGILIILGLFIQNPWWAISGCLGTI 318                                                          
						AI002801_P1, wherein said first amino acid sequence and      	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						second amino acid sequence are contiguous and in a sequential	      51 KSPVFQFFDWVLRGTSQVMFVNNPLSGILIILGLFIQNPWWAISGCLGTI 100                                                          
						order.2.An isolated polypeptide encoding for a head of       	                  .         .         .         .         .  
						AI002801_P1, comprising a polypeptide being at least 70%,    	     319 MSTLTALILSQDKSAIAAGFHGYNGVLVGLLMAVFSDKGDYYWWLLLPVI 368                                                          
						optionally at least about 80%, preferably at least about 85%,	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 90% and most preferably at    	     101 MSTLTALILSQDKSAIAAGFHGYNGVLVGLLMAVFSDKGDYYWWLLLPVI 150                                                          
						DLAPVPGWSLFCGPESDRNTTPCPIALSVATPFETIYTGLWSYNCVLSCIAIGGMFYALT 	                  .         .         .         .         .  
						WQTHLLALICALFCAYMEAAISNIMSVVGVPPGTWAFCLATIIFLLLTTNNPAIFRLPLS 	     369 IMSMSCPILSSALGTIFSKWDLPVFTLPFNITVTLYLAATGHYNLFFPTT 418                                                          
						KVTYPEANRIYYLTVKSGEEEKAPSGGGGEHPPTAGPKVEEGSEAVLSKHRSVFHIEWSS 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						IRRRSKVFGKGEHQERQNKDPFPYRYRKPTVELLDLDT                       	     151 IMSMSCPILSSALGTIFSKWDLPVFTLPFNITVTLYLAATGHYNLFFPTT 200                                                          
						least about 95% homologous to the sequence of AI002801_P1.   	                  .         .         .         .         .  
						                                                            	     419 LLQPASAMPNITWSEVQVPLLLRAIPVGIGQVYGCDNPWTGGIFLIALFI 468                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     201 LLQPASAMPNITWSEVQVPLLLRAIPVGIGQVYGCDNPWTGGIFLIALFI 250                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     469 SSPLICLHAAIGSTMGMLAALTIATPFDSIYFGLCGFNSTLACIAIGGMF 518                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     251 SSPLICLHAAIGSTMGMLAALTIATPFDSIYFGLCGFNSTLACIAIGGMF 300                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     519 YVITWQTHLLAIACALFAAYLGAALANMLSVFGLPPCTWPFCLSALTFLL 568                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     301 YVITWQTHLLAIACALFAAYLGAALANMLSVFGLPPCTWPFCLSALTFLL 350                                                          
						                                                            	                  .         .         .         .            
						                                                            	     569 LTTNNPAIYKLPLSKVTYPEANRIYYLSQERNRRASIITKYQAYDVS    615                                                          
						                                                            	         |||||||||||||||||||||||||||||||||||||||||||||||     
						                                                            	     351 LTTNNPAIYKLPLSKVTYPEANRIYYLSQERNRRASIITKYQAYDVS    397                                                          

24139	HMR136_AI002801_5_tr0_r1_1_gPRT		Comparison report between AI002801_P5 and Q8TEC4partial WT   	Sequence name: Q8TEC4                                        
						sequence followed by mismatch and a followed by a unique     	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AI002801_P5, comprising a first amino acid sequence being at 	                                                            
						MSDPHSSPLLPEPLSSRYKLYEAEFTSPSWPSTSPDTHPALPLLEMPEEKDLRSSNEDSH 	Alignment of: 24139 x Q8TEC4   ..                            
						IVKIEKLNERSKRKDDGVAHRDSAGQRCICLSKAVGYLTGDMKEYRIWLKDKHLALQFID 	                                                            
						WVLRGTAQVMF                                                  	Alignment segment 1/1:                                       
						least 90 % homologous to corresponding to amino acids 1 - 131	                                                            
						of Q8TEC4, which also corresponds to amino acids 1 - 131 of  	                     Quality: 2125.00                      Escore:       0                                               
						AI002801_P5, a bridging amino acid I corresponding to amino  	             Matching length:     216                Total length:     216                                               
						acid 132 of AI002801_P5, a second amino acid sequence being  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.54                                               
						NNPLSGLIIFIGLLIQNPWWTITGGLGTVVSTLTALALGQDRSAIASGLHGYNGMLVGLL 	    Total Percent Similarity:  100.00      Total Percent Identity:   99.54                                               
						MAVFSEKLDYYWWLLFPVTFTAMS                                     	                        Gaps:       0                        
						at least 90 % homologous to corresponding to amino acids 133 	                                                            
						- 216 of Q8TEC4, which also corresponds to amino acids 133 - 	Alignment:                                                   
						216 of AI002801_P5, and a third amino acid sequence being at 	                  .         .         .         .         .  
						least 70%, optionally at least 80%, preferably at least 85%, 	       1 MSDPHSSPLLPEPLSSRYKLYEAEFTSPSWPSTSPDTHPALPLLEMPEEK 50                                                           
						more preferably at least 90% and most preferably at least 95%	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						CPILSSALGTIFSKWDLPVFTLPFNITVTLYLAATGHYNLFFPTTLLQPASAMPNITWSE 	       1 MSDPHSSPLLPEPLSSRYKLYEAEFTSPSWPSTSPDTHPALPLLEMPEEK 50                                                           
						VQVPLLLRAIPVGIGQVYGCDNPWTGGIFLIALFISSPLICLHAAIGSTMGMLAALTIAT 	                  .         .         .         .         .  
						PFDSIYFGLCGFNSTLACIAIGGMFYVITWQTHLLAIACALFAAYLGAALANMLSVFGLP 	      51 DLRSSNEDSHIVKIEKLNERSKRKDDGVAHRDSAGQRCICLSKAVGYLTG 100                                                          
						PCTWPFCLSALTFLLLTTNNPAIYKLPLSKVTYPEANRIYYLSQERNRRASIITKYQAYD 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VS                                                           	      51 DLRSSNEDSHIVKIEKLNERSKRKDDGVAHRDSAGQRCICLSKAVGYLTG 100                                                          
						homologous to a polypeptide having the sequence corresponding	                  .         .         .         .         .  
						to amino acids 217 - 458 of AI002801_P5, wherein said first  	     101 DMKEYRIWLKDKHLALQFIDWVLRGTAQVMFINNPLSGLIIFIGLLIQNP 150                                                          
						amino acid sequence, bridging amino acid, second amino acid  	         |||||||||||||||||||||||||||||||:||||||||||||||||||  
						sequence and third amino acid sequence are contiguous and in 	     101 DMKEYRIWLKDKHLALQFIDWVLRGTAQVMFVNNPLSGLIIFIGLLIQNP 150                                                          
						a sequential order.2.An isolated polypeptide encoding for a  	                  .         .         .         .         .  
						tail of AI002801_P5, comprising a polypeptide being at least 	     151 WWTITGGLGTVVSTLTALALGQDRSAIASGLHGYNGMLVGLLMAVFSEKL 200                                                          
						70%, optionally at least about 80%, preferably at least about	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						85%, more preferably at least about 90% and most preferably  	     151 WWTITGGLGTVVSTLTALALGQDRSAIASGLHGYNGMLVGLLMAVFSEKL 200                                                          
						CPILSSALGTIFSKWDLPVFTLPFNITVTLYLAATGHYNLFFPTTLLQPASAMPNITWSE 	                  .                                          
						VQVPLLLRAIPVGIGQVYGCDNPWTGGIFLIALFISSPLICLHAAIGSTMGMLAALTIAT 	     201 DYYWWLLFPVTFTAMS                                   216                                                          
						PFDSIYFGLCGFNSTLACIAIGGMFYVITWQTHLLAIACALFAAYLGAALANMLSVFGLP 	         ||||||||||||||||                                    
						PCTWPFCLSALTFLLLTTNNPAIYKLPLSKVTYPEANRIYYLSQERNRRASIITKYQAYD 	     201 DYYWWLLFPVTFTAMS                                   216                                                          
						VS                                                           	                                                            
						at least about 95% homologous to the sequence in AI002801_P5.	                                                            

25391	HMR136_AI005002_0_tr0_r1_1_gPRT		Comparison report between AI005002_P0 and Q96LV6unique head  	Sequence name: Q96LV6                                        
						followed by partial WT sequence a mismatch, followed by a    	                                                            
						unique insertion and a followed by a unique tail.1.An        	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for AI005002_P0,      	                                                            
						comprising a first amino acid sequence being at least 70%,   	Alignment of: 25391 x Q96LV6   ..                            
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence              	                                                            
						MLVNHVCQSWGAEVVFEKK corresponding to amino acids 1 - 19 of   	                     Quality: 1383.00                      Escore:       0                                               
						AI005002_P0, a second amino acid sequence being at least 90 %	             Matching length:     161                Total length:     211                                               
						MLFIRMLRRAGQSPACGCWTPVLPVRFLGISPRQIPADANFHSASFSDTDHPRVLITGAL 	 Matching Percent Similarity:   96.89   Matching Percent Identity:   95.03                                               
						GQLGVGLANLLRKRFGKDSVILSD                                     	    Total Percent Similarity:   73.93      Total Percent Identity:   72.51                                               
						homologous to corresponding to amino acids 1 - 84 of Q96LV6, 	                        Gaps:       1                        
						which also corresponds to amino acids 20 - 103 of            	                                                            
						AI005002_P0, a bridging amino acid I corresponding to amino  	Alignment:                                                   
						acid 104 of AI005002_P0, a third amino acid sequence being at	                  .         .         .         .         .  
						least 90 % homologous to RKPPDHVFHS corresponding to amino   	      20 MLFIRMLRRAGQSPACGCWTPVLPVRFLGISPRQIPADANFHSASFSDTD 69                                                           
						acids 86 - 95 of Q96LV6, which also corresponds to amino     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 105 - 114 of AI005002_P0, a fourth amino acid sequence 	       1 MLFIRMLRRAGQSPACGCWTPVLPVRFLGISPRQIPADANFHSASFSDTD 50                                                           
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	      70 HPRVLITGALGQLGVGLANLLRKRFGKDSVILSDIRKPPDHVFHSGPFIY 119                                                          
						at least 95% homologous to a polypeptide having the sequence 	         |||||||||||||||||||||||||||||||||| ||||||||||       
						GPFIYSDILDYKNLREIVVNNRITWLFHYSALLSAFGEANVSLARAVNIT           	      51 HPRVLITGALGQLGVGLANLLRKRFGKDSVILSDRRKPPDHVFHS..... 95                                                           
						corresponding to amino acids 115 - 164 of AI005002_P0, a     	                  .         .         .         .         .  
						fifth amino acid sequence being at least 90 % homologous to  	     120 SDILDYKNLREIVVNNRITWLFHYSALLSAFGEANVSLARAVNITGLHNI 169                                                          
						GLHNILDVAAEHNLQLFVPSTIGAFGPTSPRNPTPDLCIQRPRTIYGVSKVHAELMGE   	                                                      |||||  
						corresponding to amino acids 96 - 153 of Q96LV6, which also  	      96 .............................................GLHNI 100                                                          
						corresponds to amino acids 165 - 222 of AI005002_P0, and a   	                  .         .         .         .         .  
						sixth amino acid sequence being at least 70%, optionally at  	     170 LDVAAEHNLQLFVPSTIGAFGPTSPRNPTPDLCIQRPRTIYGVSKVHAEL 219                                                          
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	     101 LDVAAEHNLQLFVPSTIGAFGPTSPRNPTPDLCIQRPRTIYGVSKVHAEL 150                                                          
						polypeptide having the sequence YYHYRYGLDF corresponding to  	                  .                                          
						amino acids 223 - 232 of AI005002_P0, wherein said first     	     220 MGEYYHYRYGL                                        230                                                          
						amino acid sequence, second amino acid sequence, bridging    	         |||  : |: :                                         
						amino acid, third amino acid sequence, fourth amino acid     	     151 MGETMQSRFSM                                        161                                                          
						sequence, fifth amino acid sequence and sixth amino acid     	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of AI005002_P0,     	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence MLVNHVCQSWGAEVVFEKK of  	                                                            
						AI005002_P0.3.An isolated polypeptide encoding for an edge   	                                                            
						portion of AI005002_P0, comprising an amino acid sequence    	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for                                                 	                                                            
						GPFIYSDILDYKNLREIVVNNRITWLFHYSALLSAFGEANVSLARAVNIT,          	                                                            
						corresponding to AI005002_P0.4.An isolated polypeptide       	                                                            
						encoding for a tail of AI005002_P0, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						YYHYRYGLDF in AI005002_P0.                                   	                                                            

						Comparison report between AI005002_P0 and Q96KT1partial WT   	Sequence name: Q96KT1                                        
						sequence followed by a unique tail.1.An isolated chimeric    	                                                            
						polypeptide encoding for AI005002_P0, comprising a first     	Sequence documentation:                                      
						MLVNHVCQSWGAEVVFEKKMLFIRMLRRAGQSPACGCWTPVLPVRFLGISPRQIPADANF 	                                                            
						HSASFSDTDHPRVLITGALGQLGVGLANLLRKRFGKDSVILSDIRKPPDHVFHSGPFIYS 	Alignment of: 25391 x Q96KT1   ..                            
						DILDYKNLREIVVNNRITWLFHYSALLSAFGEANVSLARAVNITGLHNILDVAAEHNLQL 	                                                            
						FVPSTIGAFGPTSPRNPTPDLCIQRPRTIYGVSKVHAELMGE                   	Alignment segment 1/1:                                       
						amino acid sequence being at least 90 % homologous to        	                                                            
						corresponding to amino acids 1 - 222 of Q96KT1, which also   	                     Quality: 2171.00                      Escore:       0                                               
						corresponds to amino acids 1 - 222 of AI005002_P0, and a     	             Matching length:     230                Total length:     230                                               
						second amino acid sequence being at least 70%, optionally at 	 Matching Percent Similarity:   98.26   Matching Percent Identity:   96.96                                               
						least 80%, preferably at least 85%, more preferably at least 	    Total Percent Similarity:   98.26      Total Percent Identity:   96.96                                               
						90% and most preferably at least 95% homologous to a         	                        Gaps:       0                        
						polypeptide having the sequence YYHYRYGLDF corresponding to  	                                                            
						amino acids 223 - 232 of AI005002_P0, wherein said first     	Alignment:                                                   
						amino acid sequence and second amino acid sequence are       	                  .         .         .         .         .  
						contiguous and in a sequential order.2.An isolated           	       1 MLVNHVCQSWGAEVVFEKKMLFIRMLRRAGQSPACGCWTPVLPVRFLGIS 50                                                           
						polypeptide encoding for a tail of AI005002_P0, comprising a 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						polypeptide being at least 70%, optionally at least about    	       1 MLVNHVCQSWGAEVVFEKKMLFIRMLRRAGQSPACGCWTPVLPVRFLGIS 50                                                           
						80%, preferably at least about 85%, more preferably at least 	                  .         .         .         .         .  
						about 90% and most preferably at least about 95% homologous  	      51 PRQIPADANFHSASFSDTDHPRVLITGALGQLGVGLANLLRKRFGKDSVI 100                                                          
						to the sequence YYHYRYGLDF in AI005002_P0.                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      51 PRQIPADANFHSASFSDTDHPRVLITGALGQLGVGLANLLRKRFGKDSVI 100                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 LSDIRKPPDHVFHSGPFIYSDILDYKNLREIVVNNRITWLFHYSALLSAF 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     101 LSDIRKPPDHVFHSGPFIYSDILDYKNLREIVVNNRITWLFHYSALLSAF 150                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     151 GEANVSLARAVNITGLHNILDVAAEHNLQLFVPSTIGAFGPTSPRNPTPD 200                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     151 GEANVSLARAVNITGLHNILDVAAEHNLQLFVPSTIGAFGPTSPRNPTPD 200                                                          
						                                                            	                  .         .         .                      
						                                                            	     201 LCIQRPRTIYGVSKVHAELMGEYYHYRYGL                     230                                                          
						                                                            	         ||||||||||||||||||||||  : |: :                      
						                                                            	     201 LCIQRPRTIYGVSKVHAELMGETMQSRFSM                     230                                                          

						Comparison report between AI005002_P0 and Q8IZJ6unique head  	Sequence name: Q8IZJ6                                        
						followed by partial WT sequence followed by a unique         	                                                            
						tail.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AI005002_P0, comprising a first amino acid sequence being at 	                                                            
						least 70%, optionally at least 80%, preferably at least 85%, 	Alignment of: 25391 x Q8IZJ6   ..                            
						more preferably at least 90% and most preferably at least 95%	                                                            
						homologous to a polypeptide having the sequence              	Alignment segment 1/1:                                       
						MLVNHVCQSWGAEVVFEKK corresponding to amino acids 1 - 19 of   	                                                            
						AI005002_P0, a second amino acid sequence being at least 90 %	                     Quality: 1976.00                      Escore:       0                                               
						MLFIRMLRRAGQSPACGCWTPVLPVRFLGISPRQIPADANFHSASFSDTDHPRVLITGAL 	             Matching length:     211                Total length:     211                                               
						GQLGVGLANLLRKRFGKDSVILSDIRKPPDHVFHSGPFIYSDILDYKNLREIVVNNRITW 	 Matching Percent Similarity:   98.10   Matching Percent Identity:   96.68                                               
						LFHYSALLSAFGEANVSLARAVNITGLHNILDVAAEHNLQLFVPSTIGAFGPTSPRNPTP 	    Total Percent Similarity:   98.10      Total Percent Identity:   96.68                                               
						DLCIQRPRTIYGVSKVHAELMGE                                      	                        Gaps:       0                        
						homologous to corresponding to amino acids 1 - 203 of Q8IZJ6,	                                                            
						which also corresponds to amino acids 20 - 222 of            	Alignment:                                                   
						AI005002_P0, and a third amino acid sequence being at least  	                  .         .         .         .         .  
						70%, optionally at least 80%, preferably at least 85%, more  	      20 MLFIRMLRRAGQSPACGCWTPVLPVRFLGISPRQIPADANFHSASFSDTD 69                                                           
						preferably at least 90% and most preferably at least 95%     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						homologous to a polypeptide having the sequence YYHYRYGLDF   	       1 MLFIRMLRRAGQSPACGCWTPVLPVRFLGISPRQIPADANFHSASFSDTD 50                                                           
						corresponding to amino acids 223 - 232 of AI005002_P0,       	                  .         .         .         .         .  
						wherein said first amino acid sequence, second amino acid    	      70 HPRVLITGALGQLGVGLANLLRKRFGKDSVILSDIRKPPDHVFHSGPFIY 119                                                          
						sequence and third amino acid sequence are contiguous and in 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						a sequential order.2.An isolated polypeptide encoding for a  	      51 HPRVLITGALGQLGVGLANLLRKRFGKDSVILSDIRKPPDHVFHSGPFIY 100                                                          
						head of AI005002_P0, comprising a polypeptide being at least 	                  .         .         .         .         .  
						70%, optionally at least about 80%, preferably at least about	     120 SDILDYKNLREIVVNNRITWLFHYSALLSAFGEANVSLARAVNITGLHNI 169                                                          
						85%, more preferably at least about 90% and most preferably  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 95% homologous to the sequence                	     101 SDILDYKNLREIVVNNRITWLFHYSALLSAFGEANVSLARAVNITGLHNI 150                                                          
						MLVNHVCQSWGAEVVFEKK of AI005002_P0.3.An isolated polypeptide 	                  .         .         .         .         .  
						encoding for a tail of AI005002_P0, comprising a polypeptide 	     170 LDVAAEHNLQLFVPSTIGAFGPTSPRNPTPDLCIQRPRTIYGVSKVHAEL 219                                                          
						being at least 70%, optionally at least about 80%, preferably	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						at least about 85%, more preferably at least about 90% and   	     151 LDVAAEHNLQLFVPSTIGAFGPTSPRNPTPDLCIQRPRTIYGVSKVHAEL 200                                                          
						most preferably at least about 95% homologous to the sequence	                  .                                          
						YYHYRYGLDF in AI005002_P0.                                   	     220 MGEYYHYRYGL                                        230                                                          
						                                                            	         |||  : |: :                                         
						                                                            	     201 MGETMQSRFSM                                        211                                                          

						Comparison report between AI005002_P0 and Q8IZJ5unique head  	Sequence name: Q8IZJ5                                        
						followed by partial WT sequence a mismatch, followed by a    	                                                            
						unique insertion and a followed by a unique tail.1.An        	Sequence documentation:                                      
						isolated chimeric polypeptide encoding for AI005002_P0,      	                                                            
						comprising a first amino acid sequence being at least 70%,   	Alignment of: 25391 x Q8IZJ5   ..                            
						optionally at least 80%, preferably at least 85%, more       	                                                            
						preferably at least 90% and most preferably at least 95%     	Alignment segment 1/1:                                       
						homologous to a polypeptide having the sequence              	                                                            
						MLVNHVCQSWGAEVVFEKK corresponding to amino acids 1 - 19 of   	                     Quality: 1382.00                      Escore:       0                                               
						AI005002_P0, a second amino acid sequence being at least 90 %	             Matching length:     153                Total length:     203                                               
						MLFIRMLRRAGQSPACGCWTPVLPVRFLGISPRQIPADANFHSASFSDTDHPRVLITGAL 	 Matching Percent Similarity:   99.35   Matching Percent Identity:   99.35                                               
						GQLGVGLANLLRKRFGKDSVILSD                                     	    Total Percent Similarity:   74.88      Total Percent Identity:   74.88                                               
						homologous to corresponding to amino acids 1 - 84 of Q8IZJ5, 	                        Gaps:       1                        
						which also corresponds to amino acids 20 - 103 of            	                                                            
						AI005002_P0, a bridging amino acid I corresponding to amino  	Alignment:                                                   
						acid 104 of AI005002_P0, a third amino acid sequence being at	                  .         .         .         .         .  
						least 90 % homologous to RKPPDHVFHS corresponding to amino   	      20 MLFIRMLRRAGQSPACGCWTPVLPVRFLGISPRQIPADANFHSASFSDTD 69                                                           
						acids 86 - 95 of Q8IZJ5, which also corresponds to amino     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids 105 - 114 of AI005002_P0, a fourth amino acid sequence 	       1 MLFIRMLRRAGQSPACGCWTPVLPVRFLGISPRQIPADANFHSASFSDTD 50                                                           
						being at least 70%, optionally at least 80%, preferably at   	                  .         .         .         .         .  
						least 85%, more preferably at least 90% and most preferably  	      70 HPRVLITGALGQLGVGLANLLRKRFGKDSVILSDIRKPPDHVFHSGPFIY 119                                                          
						at least 95% homologous to a polypeptide having the sequence 	         |||||||||||||||||||||||||||||||||| ||||||||||       
						GPFIYSDILDYKNLREIVVNNRITWLFHYSALLSAFGEANVSLARAVNIT           	      51 HPRVLITGALGQLGVGLANLLRKRFGKDSVILSDRRKPPDHVFHS..... 95                                                           
						corresponding to amino acids 115 - 164 of AI005002_P0, a     	                  .         .         .         .         .  
						fifth amino acid sequence being at least 90 % homologous to  	     120 SDILDYKNLREIVVNNRITWLFHYSALLSAFGEANVSLARAVNITGLHNI 169                                                          
						GLHNILDVAAEHNLQLFVPSTIGAFGPTSPRNPTPDLCIQRPRTIYGVSKVHAELMGE   	                                                      |||||  
						corresponding to amino acids 96 - 153 of Q8IZJ5, which also  	      96 .............................................GLHNI 100                                                          
						corresponds to amino acids 165 - 222 of AI005002_P0, and a   	                  .         .         .         .         .  
						sixth amino acid sequence being at least 70%, optionally at  	     170 LDVAAEHNLQLFVPSTIGAFGPTSPRNPTPDLCIQRPRTIYGVSKVHAEL 219                                                          
						least 80%, preferably at least 85%, more preferably at least 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						90% and most preferably at least 95% homologous to a         	     101 LDVAAEHNLQLFVPSTIGAFGPTSPRNPTPDLCIQRPRTIYGVSKVHAEL 150                                                          
						polypeptide having the sequence YYHYRYGLDF corresponding to  	                                                             
						amino acids 223 - 232 of AI005002_P0, wherein said first     	     220 MGE                                                222                                                          
						amino acid sequence, second amino acid sequence, bridging    	         |||                                                 
						amino acid, third amino acid sequence, fourth amino acid     	     151 MGE                                                153                                                          
						sequence, fifth amino acid sequence and sixth amino acid     	                                                            
						sequence are contiguous and in a sequential order.2.An       	                                                            
						isolated polypeptide encoding for a head of AI005002_P0,     	                                                            
						comprising a polypeptide being at least 70%, optionally at   	                                                            
						least about 80%, preferably at least about 85%, more         	                                                            
						preferably at least about 90% and most preferably at least   	                                                            
						about 95% homologous to the sequence MLVNHVCQSWGAEVVFEKK of  	                                                            
						AI005002_P0.3.An isolated polypeptide encoding for an edge   	                                                            
						portion of AI005002_P0, comprising an amino acid sequence    	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						encoding for                                                 	                                                            
						GPFIYSDILDYKNLREIVVNNRITWLFHYSALLSAFGEANVSLARAVNIT,          	                                                            
						corresponding to AI005002_P0.4.An isolated polypeptide       	                                                            
						encoding for a tail of AI005002_P0, comprising a polypeptide 	                                                            
						being at least 70%, optionally at least about 80%, preferably	                                                            
						at least about 85%, more preferably at least about 90% and   	                                                            
						most preferably at least about 95% homologous to the sequence	                                                            
						YYHYRYGLDF in AI005002_P0.                                   	                                                            

27556	HMR136_AI016313_5_tr0_r1_1_gPRT		Comparison report between AI016313_P5 and AAP33134partial WT 	Sequence name: AAP33134                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AI016313_P5, comprising a first amino acid      	                                                            
						MHRVEILPPANQEDKKMQPVTIASLQASVLPMVSMVGVQLSPPVTFQLRAGSGPVFLSGQ 	Alignment of: 27556 x AAP33134   ..                          
						ERYEASDLTWEEEEEEEGEEEEEEEEDDEDEDADISLEEQSPVKQVKRLVPQKQASVAKK 	                                                            
						KKLEKEEEEIRASVRDKSPVKKAKATARAKKPGFKK                         	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 59 - 214 of AAP33134, which also corresponds to  	                     Quality: 1512.00                      Escore:       0                                               
						amino acids 1 - 156 of AI016313_P5.                          	             Matching length:     156                Total length:     156                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MHRVEILPPANQEDKKMQPVTIASLQASVLPMVSMVGVQLSPPVTFQLRA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      59 MHRVEILPPANQEDKKMQPVTIASLQASVLPMVSMVGVQLSPPVTFQLRA 108                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 GSGPVFLSGQERYEASDLTWEEEEEEEGEEEEEEEEDDEDEDADISLEEQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     109 GSGPVFLSGQERYEASDLTWEEEEEEEGEEEEEEEEDDEDEDADISLEEQ 158                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SPVKQVKRLVPQKQASVAKKKKLEKEEEEIRASVRDKSPVKKAKATARAK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     159 SPVKQVKRLVPQKQASVAKKKKLEKEEEEIRASVRDKSPVKKAKATARAK 208                                                          
						                                                            	                                                             
						                                                            	     151 KPGFKK                                             156                                                          
						                                                            	         ||||||                                              
						                                                            	     209 KPGFKK                                             214                                                          

						Comparison report between AI016313_P5 and AAP33135partial WT 	Sequence name: AAP33135                                      
						sequence (truncation of last part or first part of sequence, 	                                                            
						no other amino acids)1.An isolated chimeric polypeptide      	Sequence documentation:                                      
						encoding for AI016313_P5, comprising a first amino acid      	                                                            
						MHRVEILPPANQEDKKMQPVTIASLQASVLPMVSMVGVQLSPPVTFQLRAGSGPVFLSGQ 	Alignment of: 27556 x AAP33135   ..                          
						ERYEASDLTWEEEEEEEGEEEEEEEEDDEDEDADISLEEQSPVKQVKRLVPQKQASVAKK 	                                                            
						KKLEKEEEEIRASVRDKSPVKKAKATARAKKPGFKK                         	Alignment segment 1/1:                                       
						sequence being at least 90 % homologous to corresponding to  	                                                            
						amino acids 59 - 214 of AAP33135, which also corresponds to  	                     Quality: 1512.00                      Escore:       0                                               
						amino acids 1 - 156 of AI016313_P5.                          	             Matching length:     156                Total length:     156                                               
						                                                            	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						                                                            	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						                                                            	                        Gaps:       0                        
						                                                            	                                                            
						                                                            	Alignment:                                                   
						                                                            	                  .         .         .         .         .  
						                                                            	       1 MHRVEILPPANQEDKKMQPVTIASLQASVLPMVSMVGVQLSPPVTFQLRA 50                                                           
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	      59 MHRVEILPPANQEDKKMQPVTIASLQASVLPMVSMVGVQLSPPVTFQLRA 108                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	      51 GSGPVFLSGQERYEASDLTWEEEEEEEGEEEEEEEEDDEDEDADISLEEQ 100                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     109 GSGPVFLSGQERYEASDLTWEEEEEEEGEEEEEEEEDDEDEDADISLEEQ 158                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     101 SPVKQVKRLVPQKQASVAKKKKLEKEEEEIRASVRDKSPVKKAKATARAK 150                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     159 SPVKQVKRLVPQKQASVAKKKKLEKEEEEIRASVRDKSPVKKAKATARAK 208                                                          
						                                                            	                                                             
						                                                            	     151 KPGFKK                                             156                                                          
						                                                            	         ||||||                                              
						                                                            	     209 KPGFKK                                             214                                                          

11027	HMR136_AI025081_3_tr0_r1_1_gPRT		Comparison report between AI025081_P3 and Q9NY45unique head  	Sequence name: Q9NY45                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for AI025081_P3,      	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 11027 x Q9NY45   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSS 	Alignment segment 1/1:                                       
						LAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKE 	                                                            
						LRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRV 	                     Quality: 4409.00                      Escore:       0                                               
						NLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSL 	             Matching length:     459                Total length:     490                                               
						FLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQ 	    Total Percent Similarity:   93.67      Total Percent Identity:   93.67                                               
						MYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKC 	                        Gaps:       1                        
						ERCSVLLLEDIESPVVKFTKSFEL                                     	                                                            
						homologous to a polypeptide having the sequence corresponding	Alignment:                                                   
						to amino acids 1 - 444 of AI025081_P3, a second amino acid   	                  .         .         .         .         .  
						MSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQI 	     445 MSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQD 494                                                          
						SGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFE                 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 MSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQD 50                                                           
						amino acids 1 - 104 of Q9NY45, which also corresponds to     	                  .         .         .         .         .  
						amino acids 445 - 548 of AI025081_P3, and a third amino acid 	     495 PRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQ 544                                                          
						VLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIV 	      51 PRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQ 100                                                          
						GCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSK 	                  .         .         .         .         .  
						EYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGA 	     545 RLFE...............................VLSYHATCSKAEVDK 563                                                          
						VTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMP 	         ||||                               |||||||||||||||  
						LYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSSPASVMVAKEDRN      	     101 RLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDK 150                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 136 - 490 of Q9NY45, which also corresponds to   	     564 FKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDY 613                                                          
						amino acids 549 - 903 of AI025081_P3, wherein said first     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acid sequence, second amino acid sequence and third    	     151 FKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDY 200                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     614 ETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEI 663                                                          
						AI025081_P3, comprising a polypeptide being at least 70%,    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     201 ETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEI 250                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSS 	     664 LAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMI 713                                                          
						LAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRV 	     251 LAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMI 300                                                          
						NLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSL 	                  .         .         .         .         .  
						FLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIP 	     714 LQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKG 763                                                          
						DAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						MYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKC 	     301 LQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKG 350                                                          
						ERCSVLLLEDIESPVVKFTKSFEL                                     	                  .         .         .         .         .  
						least about 95% homologous to the sequence of                	     764 EYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDR 813                                                          
						AI025081_P3.3.An isolated chimeric polypeptide encoding for  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						an edge portion of AI025081_P3, comprising a polypeptide     	     351 EYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDR 400                                                          
						having a length "n", wherein n is at least about 10 amino    	                  .         .         .         .         .  
						acids in length, optionally at least about 20 amino acids in 	     814 ERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPM 863                                                          
						length, preferably at least about 30 amino acids in length,  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						more preferably at least about 40 amino acids in length and  	     401 ERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPM 450                                                          
						most preferably at least about 50 amino acids in length,     	                  .         .         .         .            
						wherein at least two amino acids comprise EV, having a       	     864 LDSVATNRSKWEELHQKRLLASTASSSSPASVMVAKEDRN           903                                                          
						structure as follows: a sequence starting from any of amino  	         ||||||||||||||||||||||||||||||||||||||||            
						acid numbers 548-x to 549; and ending at any of amino acid   	     451 LDSVATNRSKWEELHQKRLLASTASSSSPASVMVAKEDRN           490                                                          
						numbers 549+ ((n-2) - x), in which x varies from 0 to n-2.   	                                                            

						Comparison report between AI025081_P3 and Q9GZY7unique head  	Sequence name: Q9GZY7                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for AI025081_P3,      	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 11027 x Q9GZY7   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSS 	Alignment segment 1/1:                                       
						LAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKE 	                                                            
						LRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRV 	                     Quality: 5764.00                      Escore:       0                                               
						NLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSL 	             Matching length:     600                Total length:     631                                               
						FLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.83                                               
						DAYQ                                                         	    Total Percent Similarity:   95.09      Total Percent Identity:   94.93                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       1                        
						to amino acids 1 - 304 of AI025081_P3, a second amino acid   	                                                            
						DRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLP 	Alignment:                                                   
						FCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCS 	                  .         .         .         .         .  
						VLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGL 	     304 QDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTE 353                                                          
						PVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQ 	         :|||||||||||||||||||||||||||||||||||||||||||||||||  
						RLFE                                                         	      54 KDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTE 103                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 55 - 298 of Q9GZY7, which also corresponds to    	     354 DDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDL 403                                                          
						amino acids 305 - 548 of AI025081_P3, and a third amino acid 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQK 	     104 DDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDL 153                                                          
						FKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIV 	                  .         .         .         .         .  
						GCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSK 	     404 EKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADA 453                                                          
						EYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMP 	     154 EKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADA 203                                                          
						LYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSSPASVMVAKEDRN      	                  .         .         .         .         .  
						sequence being at least 90 % homologous to corresponding to  	     454 ENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQ 503                                                          
						amino acids 330 - 684 of Q9GZY7, which also corresponds to   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						amino acids 549 - 903 of AI025081_P3, wherein said first     	     204 ENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQ 253                                                          
						amino acid sequence, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     504 ISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFE..... 548                                                          
						order.2.An isolated polypeptide encoding for a head of       	         |||||||||||||||||||||||||||||||||||||||||||||       
						AI025081_P3, comprising a polypeptide being at least 70%,    	     254 ISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIF 303                                                          
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .         .         .  
						more preferably at least about 90% and most preferably at    	     549 ..........................VLSYHATCSKAEVDKFKAANIPLV 572                                                          
						MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSS 	                                   ||||||||||||||||||||||||  
						LAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKE 	     304 CGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLV 353                                                          
						LRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRV 	                  .         .         .         .         .  
						NLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSL 	     573 SELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLT 622                                                          
						FLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						DAYQ                                                         	     354 SELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLT 403                                                          
						least about 95% homologous to the sequence of                	                  .         .         .         .         .  
						AI025081_P3.3.An isolated chimeric polypeptide encoding for  	     623 VRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLC 672                                                          
						an edge portion of AI025081_P3, comprising a polypeptide     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						having a length "n", wherein n is at least about 10 amino    	     404 VRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLC 453                                                          
						acids in length, optionally at least about 20 amino acids in 	                  .         .         .         .         .  
						length, preferably at least about 30 amino acids in length,  	     673 HDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIF 722                                                          
						more preferably at least about 40 amino acids in length and  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						most preferably at least about 50 amino acids in length,     	     454 HDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIF 503                                                          
						wherein at least two amino acids comprise EV, having a       	                  .         .         .         .         .  
						structure as follows: a sequence starting from any of amino  	     723 ANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNH 772                                                          
						acid numbers 548-x to 549; and ending at any of amino acid   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						numbers 549+ ((n-2) - x), in which x varies from 0 to n-2.   	     504 ANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNH 553                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     773 RDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTP 822                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     554 RDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTP 603                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     823 SAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRS 872                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     604 SAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRS 653                                                          
						                                                            	                  .         .         .                      
						                                                            	     873 KWEELHQKRLLASTASSSSPASVMVAKEDRN                    903                                                          
						                                                            	         |||||||||||||||||||||||||||||||                     
						                                                            	     654 KWEELHQKRLLASTASSSSPASVMVAKEDRN                    684                                                          

						Comparison report between AI025081_P3 and Q9HCR9partial WT   	Sequence name: Q9HCR9                                        
						sequence followed by mismatch and a featuring a skipped      	                                                            
						exon.1.An isolated chimeric polypeptide encoding for         	Sequence documentation:                                      
						AI025081_P3, comprising a first amino acid sequence being at 	                                                            
						MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSS 	Alignment of: 11027 x Q9HCR9   ..                            
						LAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKE 	                                                            
						LRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRV 	Alignment segment 1/1:                                       
						NLP                                                          	                                                            
						least 90 % homologous to corresponding to amino acids 1 - 183	                     Quality: 8717.00                      Escore:       0                                               
						of Q9HCR9, which also corresponds to amino acids 1 - 183 of  	             Matching length:     903                Total length:     934                                               
						AI025081_P3, a bridging amino acid R corresponding to amino  	 Matching Percent Similarity:  100.00   Matching Percent Identity:   99.89                                               
						acid 184 of AI025081_P3, a second amino acid sequence being  	    Total Percent Similarity:   96.68      Total Percent Identity:   96.57                                               
						YPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVE 	                        Gaps:       1                        
						GAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQ 	                                                            
						DRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLP 	Alignment:                                                   
						FCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCS 	                  .         .         .         .         .  
						VLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGL 	       1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALG 50                                                           
						PVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQ 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						RLFE                                                         	       1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALG 50                                                           
						at least 90 % homologous to corresponding to amino acids 185 	                  .         .         .         .         .  
						- 548 of Q9HCR9, which also corresponds to amino acids 185 - 	      51 PRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSP 100                                                          
						548 of AI025081_P3, and a third amino acid sequence being at 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQK 	      51 PRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSP 100                                                          
						FKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIV 	                  .         .         .         .         .  
						GCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSK 	     101 SWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLS 150                                                          
						EYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGA 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						VTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMP 	     101 SWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLS 150                                                          
						LYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSSPASVMVAKEDRN      	                  .         .         .         .         .  
						least 90 % homologous to corresponding to amino acids 580 -  	     151 SVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHN 200                                                          
						934 of Q9HCR9, which also corresponds to amino acids 549 -   	         |||||||||||||||||||||||||||||||||:||||||||||||||||  
						903 of AI025081_P3, wherein said first amino acid sequence,  	     151 SVRRRALLRKASSLPPTTAHILSALLESRVNLPQYPPTAIDYKCHLKKHN 200                                                          
						bridging amino acid, second amino acid sequence and third    	                  .         .         .         .         .  
						amino acid sequence are contiguous and in a sequential       	     201 ERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGK 250                                                          
						order.2.An isolated chimeric polypeptide encoding for an edge	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						portion of AI025081_P3, comprising a polypeptide having a    	     201 ERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGK 250                                                          
						length "n", wherein n is at least about 10 amino acids in    	                  .         .         .         .         .  
						length, optionally at least about 20 amino acids in length,  	     251 KTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIP 300                                                          
						preferably at least about 30 amino acids in length, more     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						preferably at least about 40 amino acids in length and most  	     251 KTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIP 300                                                          
						preferably at least about 50 amino acids in length, wherein  	                  .         .         .         .         .  
						at least two amino acids comprise EV, having a structure as  	     301 DAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAP 350                                                          
						follows: a sequence starting from any of amino acid numbers  	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						548-x to 549; and ending at any of amino acid numbers 549+   	     301 DAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAP 350                                                          
						((n-2) - x), in which x varies from 0 to n-2.                	                  .         .         .         .         .  
						                                                            	     351 FTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQ 400                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     351 FTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQ 400                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     401 TDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCS 450                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     401 TDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCS 450                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     451 ADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAE 500                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 ADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAE 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     501 ADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFE.. 548                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||    
						                                                            	     501 ADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAF 550                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     549 .............................VLSYHATCSKAEVDKFKAANI 569                                                          
						                                                            	                                      |||||||||||||||||||||  
						                                                            	     551 VIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANI 600                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     570 PLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRW 619                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     601 PLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRW 650                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     620 LLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVG 669                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     651 LLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVG 700                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     670 CLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGH 719                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     701 CLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGH 750                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     720 NIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNI 769                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     751 NIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNI 800                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     770 KNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELK 819                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     801 KNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELK 850                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     820 LTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVAT 869                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     851 LTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVAT 900                                                          
						                                                            	                  .         .         .                      
						                                                            	     870 NRSKWEELHQKRLLASTASSSSPASVMVAKEDRN                 903                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||                  
						                                                            	     901 NRSKWEELHQKRLLASTASSSSPASVMVAKEDRN                 934                                                          

						Comparison report between AI025081_P3 and Q9HB46unique head  	Sequence name: Q9HB46                                        
						followed by partial WT sequence featuring a skipped exon.1.An	                                                            
						isolated chimeric polypeptide encoding for AI025081_P3,      	Sequence documentation:                                      
						comprising a first amino acid sequence being at least 70%,   	                                                            
						optionally at least 80%, preferably at least 85%, more       	Alignment of: 11027 x Q9HB46   ..                            
						preferably at least 90% and most preferably at least 95%     	                                                            
						MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSS 	Alignment segment 1/1:                                       
						LAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKE 	                                                            
						LRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRV 	                     Quality: 5241.00                      Escore:       0                                               
						NLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSL 	             Matching length:     545                Total length:     576                                               
						FLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIP 	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						DAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKV   	    Total Percent Similarity:   94.62      Total Percent Identity:   94.62                                               
						homologous to a polypeptide having the sequence corresponding	                        Gaps:       1                        
						to amino acids 1 - 358 of AI025081_P3, a second amino acid   	                                                            
						MQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLL 	Alignment:                                                   
						KCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAEL 	                  .         .         .         .         .  
						VASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKP 	     359 MQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVK 408                                                          
						FDDADQRLFE                                                   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						sequence being at least 90 % homologous to corresponding to  	       1 MQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVK 50                                                           
						amino acids 1 - 190 of Q9HB46, which also corresponds to     	                  .         .         .         .         .  
						amino acids 359 - 548 of AI025081_P3, and a third amino acid 	     409 KIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFK 458                                                          
						VLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQK 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						FKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIV 	      51 KIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFK 100                                                          
						GCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSK 	                  .         .         .         .         .  
						EYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGA 	     459 ESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFH 508                                                          
						VTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMP 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSSPASVMVAKEDRN      	     101 ESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFH 150                                                          
						sequence being at least 90 % homologous to corresponding to  	                  .         .         .         .         .  
						amino acids 222 - 576 of Q9HB46, which also corresponds to   	     509 IRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFE.......... 548                                                          
						amino acids 549 - 903 of AI025081_P3, wherein said first     	         ||||||||||||||||||||||||||||||||||||||||            
						amino acid sequence, second amino acid sequence and third    	     151 IRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGI 200                                                          
						amino acid sequence are contiguous and in a sequential       	                  .         .         .         .         .  
						order.2.An isolated polypeptide encoding for a head of       	     549 .....................VLSYHATCSKAEVDKFKAANIPLVSELAI 577                                                          
						AI025081_P3, comprising a polypeptide being at least 70%,    	                              |||||||||||||||||||||||||||||  
						optionally at least about 80%, preferably at least about 85%,	     201 NNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAI 250                                                          
						more preferably at least about 90% and most preferably at    	                  .         .         .         .         .  
						MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSS 	     578 DDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNY 627                                                          
						LAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKE 	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						LRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRV 	     251 DDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNY 300                                                          
						NLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSL 	                  .         .         .         .         .  
						FLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIP 	     628 RMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDH 677                                                          
						DAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKV   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						least about 95% homologous to the sequence of                	     301 RMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDH 350                                                          
						AI025081_P3.3.An isolated chimeric polypeptide encoding for  	                  .         .         .         .         .  
						an edge portion of AI025081_P3, comprising a polypeptide     	     678 RGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSS 727                                                          
						having a length "n", wherein n is at least about 10 amino    	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						acids in length, optionally at least about 20 amino acids in 	     351 RGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSS 400                                                          
						length, preferably at least about 30 amino acids in length,  	                  .         .         .         .         .  
						more preferably at least about 40 amino acids in length and  	     728 KEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFR 777                                                          
						most preferably at least about 50 amino acids in length,     	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						wherein at least two amino acids comprise EV, having a       	     401 KEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFR 450                                                          
						structure as follows: a sequence starting from any of amino  	                  .         .         .         .         .  
						acid numbers 548-x to 549; and ending at any of amino acid   	     778 SMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFD 827                                                          
						numbers 549+ ((n-2) - x), in which x varies from 0 to n-2.   	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     451 SMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFD 500                                                          
						                                                            	                  .         .         .         .         .  
						                                                            	     828 RNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEEL 877                                                          
						                                                            	         ||||||||||||||||||||||||||||||||||||||||||||||||||  
						                                                            	     501 RNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEEL 550                                                          
						                                                            	                  .         .                                
						                                                            	     878 HQKRLLASTASSSSPASVMVAKEDRN                         903                                                          
						                                                            	         ||||||||||||||||||||||||||                          
						                                                            	     551 HQKRLLASTASSSSPASVMVAKEDRN                         576                                                          

19316	HMR136_AI084192_1_tr0_r1_1_gPRT		Comparison report between AI084192_P1 and SEF1_HUMANpartial  	Sequence name: SEF1_HUMAN                                    
						WT sequence followed by a unique tail.1.An isolated chimeric 	                                                            
						polypeptide encoding for AI084192_P1, comprising a first     	Sequence documentation:                                      
						amino acid sequence being at least 90 % homologous to        	                                                            
						MARGNQRELARQKNMKKTQEISKGKRKEDSLTASQRKQ corresponding to amino	Alignment of: 19316 x SEF1_HUMAN   ..                        
						acids 1 - 38 of SEF1_HUMAN, which also corresponds to amino  	                                                            
						acids 1 - 38 of AI084192_P1, and a second amino acid sequence	Alignment segment 1/1:                                       
						being at least 70%, optionally at least 80%, preferably at   	                                                            
						least 85%, more preferably at least 90% and most preferably  	                     Quality:  372.00                      Escore:       0                                               
						at least 95% homologous to a polypeptide having the sequence 	             Matching length:      38                Total length:      38                                               
						RDSEIMQEKQKAANEKKSMQTREK corresponding to amino acids 39 - 62	 Matching Percent Similarity:  100.00   Matching Percent Identity:  100.00                                               
						of AI084192_P1, wherein said first amino acid sequence and   	    Total Percent Similarity:  100.00      Total Percent Identity:  100.00                                               
						second amino acid sequence are contiguous and in a sequential	                        Gaps:       0                        
						order.2.An isolated polypeptide encoding for a tail of       	                                                            
						AI084192_P1, comprising a polypeptide being at least 70%,    	Alignment:                                                   
						optionally at least about 80%, preferably at least about 85%,	                  .         .         .                      
						more preferably at least about 90% and most preferably at    	       1 MARGNQRELARQKNMKKTQEISKGKRKEDSLTASQRKQ             38                                                           
						least about 95% homologous to the sequence                   	         ||||||||||||||||||||||||||||||||||||||              
						RDSEIMQEKQKAANEKKSMQTREK in AI084192_P1.                     	       1 MARGNQRELARQKNMKKTQEISKGKRKEDSLTASQRKQ             38                                                           

